23837	HMR136_M85518_3_tr0_r1_1_gPRT		Comparison report between M85518_P3 and GLSK_HUMANpartial WT 	Sequence name: GLSK_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85518_P3, comprising a first amino 	Sequence documentation:                                      
						MSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCL 	                                                            
						QSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSL 	Alignment of: 23837 x GLSK_HUMAN   ..                        
						IKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEG 	                                                            
						TDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCG 	Alignment segment 1/1:                                       
						MYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSL 	                                                            
						CNFHNYDNLRHFAKKLDPRREGGDQR                                   	                     Quality: 3240.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     326                Total length:     326                                               
						to amino acids 225 - 550 of GLSK_HUMAN, which also           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 326 of M85518_P3, and a second	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 70%, optionally at least  	                        Gaps:       0                        
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment:                                                   
						having the sequence                                          	                  .         .         .         .         .  
						HSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS             	       1 MSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHS 50                                                           
						corresponding to amino acids 327 - 374 of M85518_P3, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	     225 MSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHS 274                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85518_P3, comprising a   	      51 TGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLN 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     275 TGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLN 324                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     101 EDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFS 150                                                          
						HSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS in          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85518_P3.                                                   	     325 EDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFS 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 NATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTC 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 ESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAF 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 HVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSL 524                                                          
						                                                            	                  .         .                                
						                                                            	     301 CNFHNYDNLRHFAKKLDPRREGGDQR                         326                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     525 CNFHNYDNLRHFAKKLDPRREGGDQR                         550                                                          

23833	HMR136_M85518_7_tr0_r1_1_gPRT		Comparison report between M85518_P7 and GLSK_HUMANpartial WT 	Sequence name: GLSK_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85518_P7, comprising a first amino 	Sequence documentation:                                      
						MRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGG 	                                                            
						GWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGK 	Alignment of: 23833 x GLSK_HUMAN   ..                        
						ELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDM 	                                                            
						LRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQ 	Alignment segment 1/1:                                       
						SGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLG 	                                                            
						TEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIK                	                     Quality: 3361.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     345                Total length:     345                                               
						to amino acids 2 - 346 of GLSK_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 345 of M85518_P7, and a second amino acid 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence DWW corresponding to amino acids 346 -   	                  .         .         .         .         .  
						348 of M85518_P7, wherein said first amino acid sequence and 	       1 MRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAA 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	       2 MRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAA 51                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 ARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPA 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 APGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 APGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQ 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 EKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFK 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 KCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIP 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 QLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLG 301                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 TEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIK      345                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     302 TEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIK      346                                                          

24220	HMR136_M85527_14_tr0_r1_1_gPRT		Comparison report between M85527_P14 and MXI1_HUMANpartial   	Sequence name: MXI1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M85527_P14, comprising a first amino	                                                            
						MDSIGSTISSDRSDSEREEIEVDVESTEFSHGEVDNISTTSISDIDDHSSLPSIGSDEGY 	Alignment of: 24220 x MXI1_HUMAN   ..                        
						SSASVKLSFTS                                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 158 - 228 of MXI1_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 71 of M85527_P14.             	                     Quality:  668.00                      Escore:       0                                               
						                                                            	             Matching length:      71                Total length:      71                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDSIGSTISSDRSDSEREEIEVDVESTEFSHGEVDNISTTSISDIDDHSS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     158 MDSIGSTISSDRSDSEREEIEVDVESTEFSHGEVDNISTTSISDIDDHSS 207                                                          
						                                                            	                  .         .                                
						                                                            	      51 LPSIGSDEGYSSASVKLSFTS                              71                                                           
						                                                            	         |||||||||||||||||||||                               
						                                                            	     208 LPSIGSDEGYSSASVKLSFTS                              228                                                          

24463	HMR136_M85530_12_tr0_r1_1_gPRT		Comparison report between M85530_P12 and Q92551partial WT    	Sequence name: Q92551                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85530_P12, comprising a first amino	Sequence documentation:                                      
						MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKPLISREQRFYE 	                                                            
						SLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRR 	Alignment of: 24463 x Q92551   ..                            
						SLHRSGSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSSEKISH 	                                                            
						NPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEK 	Alignment segment 1/1:                                       
						AARQMRKCEQSTSATLGVRVCGMQV                                    	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2649.00                      Escore:       0                                               
						to amino acids 22 - 286 of Q92551, which also corresponds to 	             Matching length:     265                Total length:     265                                               
						amino acids 1 - 265 of M85530_P12, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence SYLCSEPRCCHLHDLGCAHTCL corresponding to  	Alignment:                                                   
						amino acids 266 - 287 of M85530_P12, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	       1 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a tail of M85530_P12, comprising a polypeptide being at  	      22 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 71                                                           
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      51 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 100                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SYLCSEPRCCHLHDLGCAHTCL in M85530_P12.                        	      72 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 121                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 271                                                          
						                                                            	                  .                                          
						                                                            	     251 STSATLGVRVCGMQV                                    265                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     272 STSATLGVRVCGMQV                                    286                                                          

24465	HMR136_M85530_3_tr0_r1_1_gPRT		Comparison report between M85530_P3 and Q92551partial WT     	Sequence name: Q92551                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85530_P3, comprising a first amino 	Sequence documentation:                                      
						MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKPLISREQRFYE 	                                                            
						SLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRR 	Alignment of: 24465 x Q92551   ..                            
						SLHRSGSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSSEKISH 	                                                            
						NPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEK 	Alignment segment 1/1:                                       
						AARQMRKCEQSTSATLGVRVCGMQV                                    	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2656.00                      Escore:       0                                               
						to amino acids 22 - 286 of Q92551, which also corresponds to 	             Matching length:     267                Total length:     267                                               
						amino acids 1 - 265 of M85530_P3, and a second amino acid    	 Matching Percent Similarity:   99.63   Matching Percent Identity:   99.63                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   99.63      Total Percent Identity:   99.63                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LQWENPG corresponding to amino acids 266 	Alignment:                                                   
						- 272 of M85530_P3, wherein said first amino acid sequence   	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	       1 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 50                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of M85530_P3, comprising a polypeptide being at least   	      22 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 71                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 100                                                          
						at least about 95% homologous to the sequence LQWENPG in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85530_P3.                                                   	      72 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 121                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 271                                                          
						                                                            	                  .                                          
						                                                            	     251 STSATLGVRVCGMQVLQ                                  267                                                          
						                                                            	         ||||||||||||||| |                                   
						                                                            	     272 STSATLGVRVCGMQVYQ                                  288                                                          

24467	HMR136_M85530_4_tr0_r1_1_gPRT		Comparison report between M85530_P4 and Q92551partial WT     	Sequence name: Q92551                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85530_P4, comprising a first amino acid        	                                                            
						MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKPLISREQRFYE 	Alignment of: 24467 x Q92551   ..                            
						SLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRR 	                                                            
						SLHRSGSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSSEKISH 	Alignment segment 1/1:                                       
						NPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEK 	                                                            
						AARQMRKCEQSTSATLGVRVCGMQVYQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNG 	                     Quality: 4389.00                      Escore:       0                                               
						LDLRRDLFEPILSKLRGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKH 	             Matching length:     441                Total length:     441                                               
						LDMVLPEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVHDGPDR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GYVFGLENLISIMEQMRDENQ                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 22 - 462 of Q92551, which also corresponds to    	                                                            
						amino acids 1 - 441 of M85530_P4.                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      22 MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP 71                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      72 LISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESE 121                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 TVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAK 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 SPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESK 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 DRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQ 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 STSATLGVRVCGMQVYQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 STSATLGVRVCGMQVYQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNG 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LDLRRDLFEPILSKLRGLKAVLERQASYRFYSSSLLVIYDGKECRAESCL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 LDLRRDLFEPILSKLRGLKAVLERQASYRFYSSSLLVIYDGKECRAESCL 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DRRSEMRLKHLDMVLPEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 DRRSEMRLKHLDMVLPEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDF 421                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 AHSTFKGFRDDPTVHDGPDRGYVFGLENLISIMEQMRDENQ          441                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     422 AHSTFKGFRDDPTVHDGPDRGYVFGLENLISIMEQMRDENQ          462                                                          

24461	HMR136_M85530_7_tr0_r1_1_gPRT		Comparison report between M85530_P7 and Q92551unique head    	Sequence name: Q92551                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85530_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 24461 x Q92551   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MCCILCPQCATGPQRNVCLSNHGSGAVWQECKSGWRPGSPPGALHPPS             	                                                            
						corresponding to amino acids 1 - 48 of M85530_P7, and a      	                     Quality: 3623.00                      Escore:       0                                               
						VVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEK 	             Matching length:     366                Total length:     366                                               
						ASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQSTSAT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LGVRVCGMQVYQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKL 	                        Gaps:       0                        
						RGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKHLDMVLPEVASSCGPS 	                                                            
						TSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVHDGPDRGYVFGLENLISIMEQ 	Alignment:                                                   
						MRDENQ                                                       	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      49 VVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRRSLHRS 98                                                           
						corresponding to amino acids 97 - 462 of Q92551, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 49 - 414 of M85530_P7, wherein    	      97 VVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRRSLHRS 146                                                          
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      99 GSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSS 148                                                          
						polypeptide encoding for a head of M85530_P7, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     147 GSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSS 196                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     149 EKISHNPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDL 198                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MCCILCPQCATGPQRNVCLSNHGSGAVWQECKSGWRPGSPPGALHPPS of          	     197 EKISHNPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDL 246                                                          
						M85530_P7.                                                   	                  .         .         .         .         .  
						                                                            	     199 KMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQVYQLDTGHYLC 248                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     247 KMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQVYQLDTGHYLC 296                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     249 RNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKLRGLKAVLERQ 298                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     297 RNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKLRGLKAVLERQ 346                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     299 ASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKHLDMVLPEVASSCGPS 348                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     347 ASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKHLDMVLPEVASSCGPS 396                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     349 TSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVHDGPDRGYVFG 398                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     397 TSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVHDGPDRGYVFG 446                                                          
						                                                            	                  .                                          
						                                                            	     399 LENLISIMEQMRDENQ                                   414                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     447 LENLISIMEQMRDENQ                                   462                                                          

24459	HMR136_M85530_8_tr0_r1_1_gPRT		Comparison report between M85530_P8 and Q92551partial WT     	Sequence name: Q92551                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85530_P8, comprising a first amino acid        	                                                            
						MLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDL 	Alignment of: 24459 x Q92551   ..                            
						KMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQVYQLDTGHYLCRNKYYGRGLS 	                                                            
						IEGFRNALYQYLHNGLDLRRDLFEPILSKLRGLKAVLERQASYRFYSSSLLVIYDGKECR 	Alignment segment 1/1:                                       
						AESCLDRRSEMRLKHLDMVLPEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDFAHSTF 	                                                            
						KGFRDDPTVHDGPDRGYVFGLENLISIMEQMRDENQ                         	                     Quality: 2741.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     276                Total length:     276                                               
						amino acids 187 - 462 of Q92551, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 276 of M85530_P8.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 MLDGNSGLSSEKISHNPWSLRCHKQQLSRMRSESKDRKLYKFLLLENVVH 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 HFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQV 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 YQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKL 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKHLDMVL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 RGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMRLKHLDMVL 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 PEVASSCGPSTSPSNTSPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVH 436                                                          
						                                                            	                  .         .                                
						                                                            	     251 DGPDRGYVFGLENLISIMEQMRDENQ                         276                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     437 DGPDRGYVFGLENLISIMEQMRDENQ                         462                                                          

24734	HMR136_M85534_3_tr0_r1_1_gPRT		Comparison report between M85534_P3 and Q96JE9partial WT     	Sequence name: Q96JE9                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85534_P3, comprising a first amino acid sequence being at   	                                                            
						MAWPCITRACCIARFWNQLDKADIAVPLVFTKYSEATEHPGAPPQPPPPQQQAQPALAPP 	Alignment of: 24734 x Q96JE9   ..                            
						SARAVAIETQPAQGELDAVARATGPAPGPTGEREPAAGPGRSGPGPGLGSGSTSGPADSV 	                                                            
						MRQDYRAWKVQRPEPSCRPRSEYQPSDAPFERETQYQKDFRAWPLPRRGDHPWIPKPVQI 	Alignment segment 1/1:                                       
						SAASQASAPILGAPKRRPQSQERWPVQAAAEAREQEAAPGGAGGLAAGKASGADERDTRR 	                                                            
						KAGPAW                                                       	                     Quality: 4341.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 15 -   	             Matching length:     439                Total length:     439                                               
						260 of Q96JE9, which also corresponds to amino acids 1 - 246 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						of M85534_P3, a bridging amino acid I corresponding to amino 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						acid 247 of M85534_P3, a second amino acid sequence being at 	                        Gaps:       0                        
						VRRAEGLGHEQTPLPAAQAQVQATGPEAGRGRAAADALNRQIREEVASAVSSSYRNEFRA 	                                                            
						WTDIKPVKPIKAKPQYKPPDDKMVHETSYSAQFKGEASKPTTADNKVIDRRRIRSLYSEP 	Alignment:                                                   
						FKEPPKVEKPSVQSSKPKKTSASHKPTRKAKDKQAVSGQAAKKKSAEGPSTTKPDDKEQS 	                  .         .         .         .         .  
						KEMNNKLAEAKE                                                 	       1 MAWPCITRACCIARFWNQLDKADIAVPLVFTKYSEATEHPGAPPQPPPPQ 50                                                           
						least 90 % homologous to corresponding to amino acids 262 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						453 of Q96JE9, which also corresponds to amino acids 248 -   	      15 MAWPCITRACCIARFWNQLDKADIAVPLVFTKYSEATEHPGAPPQPPPPQ 64                                                           
						439 of M85534_P3, and a third amino acid sequence being at   	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 QQAQPALAPPSARAVAIETQPAQGELDAVARATGPAPGPTGEREPAAGPG 100                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	      65 QQAQPALAPPSARAVAIETQPAQGELDAVARATGPAPGPTGEREPAAGPG 114                                                          
						LPLRYYWQAVRAKFWESEDGPGDALAKK corresponding to amino acids 440	                  .         .         .         .         .  
						- 467 of M85534_P3, wherein said first amino acid sequence,  	     101 RSGPGPGLGSGSTSGPADSVMRQDYRAWKVQRPEPSCRPRSEYQPSDAPF 150                                                          
						bridging amino acid, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     115 RSGPGPGLGSGSTSGPADSVMRQDYRAWKVQRPEPSCRPRSEYQPSDAPF 164                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						M85534_P3, comprising a polypeptide being at least 70%,      	     151 ERETQYQKDFRAWPLPRRGDHPWIPKPVQISAASQASAPILGAPKRRPQS 200                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     165 ERETQYQKDFRAWPLPRRGDHPWIPKPVQISAASQASAPILGAPKRRPQS 214                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						LPLRYYWQAVRAKFWESEDGPGDALAKK in M85534_P3.                   	     201 QERWPVQAAAEAREQEAAPGGAGGLAAGKASGADERDTRRKAGPAWIVRR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||:|||  
						                                                            	     215 QERWPVQAAAEAREQEAAPGGAGGLAAGKASGADERDTRRKAGPAWMVRR 264                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AEGLGHEQTPLPAAQAQVQATGPEAGRGRAAADALNRQIREEVASAVSSS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     265 AEGLGHEQTPLPAAQAQVQATGPEAGRGRAAADALNRQIREEVASAVSSS 314                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YRNEFRAWTDIKPVKPIKAKPQYKPPDDKMVHETSYSAQFKGEASKPTTA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     315 YRNEFRAWTDIKPVKPIKAKPQYKPPDDKMVHETSYSAQFKGEASKPTTA 364                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DNKVIDRRRIRSLYSEPFKEPPKVEKPSVQSSKPKKTSASHKPTRKAKDK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     365 DNKVIDRRRIRSLYSEPFKEPPKVEKPSVQSSKPKKTSASHKPTRKAKDK 414                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 QAVSGQAAKKKSAEGPSTTKPDDKEQSKEMNNKLAEAKE            439                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     415 QAVSGQAAKKKSAEGPSTTKPDDKEQSKEMNNKLAEAKE            453                                                          

25122	HMR136_M85541_1_tr0_r1_1_gPRT		Comparison report between M85541_P1 and Q96GN3unique head    	Sequence name: Q96GN3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85541_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 25122 x Q96GN3   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELSGENFEQTPLRRTFKSKVLARYPEN 	Alignment segment 1/1:                                       
						VEWNPFDQDAVGMLCMPKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSK 	                                                            
						QICSAMQTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDTLYVS 	                     Quality: 8600.00                      Escore:       0                                               
						KCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPLESYIYNVLYEVPLPPPGRSLKFSG 	             Matching length:     872                Total length:     872                                               
						VYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQLFTCALLEFQILLYSQHYQRLMTV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AETITALMFPFQWQHVYVPILPASLLHFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VDIDNHFIELPEDLPQFPNKLEFVQEVSEIL                              	                        Gaps:       0                        
						having the sequence corresponding to amino acids 1 - 391 of  	                                                            
						M85541_P1, and a second amino acid sequence being at least 90	Alignment:                                                   
						MAFGIPPEGNLHCSESASKLKRLRASELVSDKRNGNIAGSPLHSYELLKENETIARLQAL 	                  .         .         .         .         .  
						VKRTGVSLEKLEVREDPSSNKDLKVQCDEEELRIYQLNIQIREVFANRFTQMFADYEVFV 	     392 MAFGIPPEGNLHCSESASKLKRLRASELVSDKRNGNIAGSPLHSYELLKE 441                                                          
						IQPSQDKESWFTNREQMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DKDPVLRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTAIHPHL 	       1 MAFGIPPEGNLHCSESASKLKRLRASELVSDKRNGNIAGSPLHSYELLKE 50                                                           
						LDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKDRQKQHTEHLRLDNDQ 	                  .         .         .         .         .  
						REKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKFVEGLLKECRNKTKRMLVEKMGREAV 	     442 NETIARLQALVKRTGVSLEKLEVREDPSSNKDLKVQCDEEELRIYQLNIQ 491                                                          
						ELGHGEVNITGVEENTLIASLCDLLERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLSTSGILLDSERRKSDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKK 	      51 NETIARLQALVKRTGVSLEKLEVREDPSSNKDLKVQCDEEELRIYQLNIQ 100                                                          
						LLSRHLKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFTTILIP 	                  .         .         .         .         .  
						YHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTFECQNLGKLTTVQIGH 	     492 IREVFANRFTQMFADYEVFVIQPSQDKESWFTNREQMQNFDKASFLSDQP 541                                                          
						DNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGKGMDDGSLERILVGELLTSQPEVDER 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PCRTPPLQQSPSVIRRLVTISPNNKPKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTL 	     101 IREVFANRFTQMFADYEVFVIQPSQDKESWFTNREQMQNFDKASFLSDQP 150                                                          
						LLCGECGLVSALEQAFQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRA 	                  .         .         .         .         .  
						RNFCRFVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYEDVALIK 	     542 EPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPVLRVFDSRVDKIRLLN 591                                                          
						DHTLVNSLIRVLQTLQEFNITLETSLVKGIDI                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 872 of      	     151 EPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPVLRVFDSRVDKIRLLN 200                                                          
						Q96GN3, which also corresponds to amino acids 392 - 1263 of  	                  .         .         .         .         .  
						M85541_P1, wherein said first amino acid sequence and second 	     592 VRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTAIHPHLLDMKIGQGKY 641                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     201 VRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTAIHPHLLDMKIGQGKY 250                                                          
						M85541_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     642 EPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKDRQKQHTEHLRLDNDQ 691                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELSGENFEQTPLRRTFKSKVLARYPEN 	     251 EPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKDRQKQHTEHLRLDNDQ 300                                                          
						VEWNPFDQDAVGMLCMPKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSK 	                  .         .         .         .         .  
						QICSAMQTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDTLYVS 	     692 REKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKFVEGLLKECRNKTKRM 741                                                          
						KCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPLESYIYNVLYEVPLPPPGRSLKFSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQLFTCALLEFQILLYSQHYQRLMTV 	     301 REKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKFVEGLLKECRNKTKRM 350                                                          
						AETITALMFPFQWQHVYVPILPASLLHFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCF 	                  .         .         .         .         .  
						VDIDNHFIELPEDLPQFPNKLEFVQEVSEIL                              	     742 LVEKMGREAVELGHGEVNITGVEENTLIASLCDLLERIWSHGLQVKQGKS 791                                                          
						least about 95% homologous to the sequence of M85541_P1.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LVEKMGREAVELGHGEVNITGVEENTLIASLCDLLERIWSHGLQVKQGKS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     792 ALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRKSDASSLMPPLRISLI 841                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRKSDASSLMPPLRISLI 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     842 QDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRHLKQLLSDHELTKKLY 891                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRHLKQLLSDHELTKKLY 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     892 KRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFTTILIPYHILIVPSKK 941                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFTTILIPYHILIVPSKK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     942 LGGSMFTANPWICISGELGETQIMQIPRNVLEMTFECQNLGKLTTVQIGH 991                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LGGSMFTANPWICISGELGETQIMQIPRNVLEMTFECQNLGKLTTVQIGH 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     992 DNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGKGMDDGSLERILVGEL 1041                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGKGMDDGSLERILVGEL 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1042 LTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNKPKLNTGQIQESIGEA 1091                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNKPKLNTGQIQESIGEA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1092 VNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQAFQHGFKSPRLFKNVF 1141                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQAFQHGFKSPRLFKNVF 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1142 IWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCRFVTAINNTPRNIGKD 1191                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 IWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCRFVTAINNTPRNIGKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1192 GKFQMLVCLGARDHLLHHWIALLADCPITAHMYEDVALIKDHTLVNSLIR 1241                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 GKFQMLVCLGARDHLLHHWIALLADCPITAHMYEDVALIKDHTLVNSLIR 850                                                          
						                                                            	                  .         .                                
						                                                            	    1242 VLQTLQEFNITLETSLVKGIDI                             1263                                                         
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     851 VLQTLQEFNITLETSLVKGIDI                             872                                                          

						Comparison report between M85541_P1 and Q9UFV0partial WT     	Sequence name: Q9UFV0                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85541_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELS corresponding to amino  	Alignment of: 25122 x Q9UFV0   ..                            
						acids 5 - 40 of Q9UFV0, which also corresponds to amino acids	                                                            
						1 - 36 of M85541_P1, and a second amino acid sequence being  	Alignment segment 1/1:                                       
						GENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCMPKGLAFKTQADPREPQFHAF 	                                                            
						IITREDGSRTFGFALTFYEEVTSKQICSAMQTLYHMHNAEYDVLHAPPADDRDQSSMEDG 	                     Quality: 12394.00                      Escore:       0                                              
						EDTPVTKLQRFNSYDISRDTLYVSKCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPL 	             Matching length:    1263                Total length:    1287                                               
						ESYIYNVLYEVPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPILPASLLHFLDAPVPYL 	    Total Percent Similarity:   98.14      Total Percent Identity:   98.14                                               
						MGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQFPNKLEFVQEVSEILMAFGI 	                        Gaps:       1                        
						PPEGNLHCSESASKLKRLRASELVSDKRNGNIAGSPLHSYELLKENETIARLQALVKRTG 	                                                            
						VSLEKLEVREDPSSNKDLKVQCDEEELRIYQLNIQIREVFANRFTQMFADYEVFVIQPSQ 	Alignment:                                                   
						DKESWFTNREQMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPV 	                  .         .         .         .         .  
						LRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTAIHPHLLDMKI 	       1 MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELS.............. 36                                                           
						GQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKDRQKQHTEHLRLDNDQREKYI 	         ||||||||||||||||||||||||||||||||||||                
						QEARTMGSTIRQPKLSNLSPSVIAQTNWKFVEGLLKECRNKTKRMLVEKMGREAVELGHG 	       5 MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELSALCQYIQASKARDG 54                                                           
						EVNITGVEENTLIASLCDLLERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSGSLSTS 	                  .         .         .         .         .  
						GILLDSERRKSDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRH 	      37 ..........GENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCM 76                                                           
						LKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFTTILIPYHILI 	                   ||||||||||||||||||||||||||||||||||||||||  
						VPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTFECQNLGKLTTVQIGHDNSGL 	      55 ASPFISSTTEGENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCM 104                                                          
						YAKWLVEYVMVRNEITGHTYKFPCGRWLGKGMDDGSLERILVGELLTSQPEVDERPCRTP 	                  .         .         .         .         .  
						PLQQSPSVIRRLVTISPNNKPKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTLLLCGE 	      77 PKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSKQICSAM 126                                                          
						CGLVSALEQAFQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYEDVALIKDHTLV 	     105 PKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSKQICSAM 154                                                          
						NSLIRVLQTLQEFNITLETSLVKGIDI                                  	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 65 -	     127 QTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDT 176                                                          
						1291 of Q9UFV0, which also corresponds to amino acids 37 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1263 of M85541_P1, wherein said first amino acid sequence and	     155 QTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDT 204                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	     177 LYVSKCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPLESYIYNVLYE 226                                                          
						portion of M85541_P1, comprising a polypeptide having a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     205 LYVSKCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPLESYIYNVLYE 254                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     227 VPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQ 276                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     255 VPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQ 304                                                          
						at least two amino acids comprise SG, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     277 LFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPILPASLL 326                                                          
						36-x to 37; and ending at any of amino acid numbers 37+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     305 LFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPILPASLL 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 HFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQ 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 HFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQ 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 FPNKLEFVQEVSEILMAFGIPPEGNLHCSESASKLKRLRASELVSDKRNG 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 FPNKLEFVQEVSEILMAFGIPPEGNLHCSESASKLKRLRASELVSDKRNG 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 NIAGSPLHSYELLKENETIARLQALVKRTGVSLEKLEVREDPSSNKDLKV 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 NIAGSPLHSYELLKENETIARLQALVKRTGVSLEKLEVREDPSSNKDLKV 504                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 QCDEEELRIYQLNIQIREVFANRFTQMFADYEVFVIQPSQDKESWFTNRE 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     505 QCDEEELRIYQLNIQIREVFANRFTQMFADYEVFVIQPSQDKESWFTNRE 554                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 QMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPV 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     555 QMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPV 604                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 LRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTA 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     605 LRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTA 654                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     627 IHPHLLDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKD 676                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     655 IHPHLLDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKD 704                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     677 RQKQHTEHLRLDNDQREKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKF 726                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     705 RQKQHTEHLRLDNDQREKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKF 754                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     727 VEGLLKECRNKTKRMLVEKMGREAVELGHGEVNITGVEENTLIASLCDLL 776                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     755 VEGLLKECRNKTKRMLVEKMGREAVELGHGEVNITGVEENTLIASLCDLL 804                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     777 ERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRK 826                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     805 ERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRK 854                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     827 SDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRH 876                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     855 SDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRH 904                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     877 LKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFT 926                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     905 LKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFT 954                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     927 TILIPYHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTF 976                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     955 TILIPYHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTF 1004                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     977 ECQNLGKLTTVQIGHDNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGK 1026                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1005 ECQNLGKLTTVQIGHDNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGK 1054                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1027 GMDDGSLERILVGELLTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNK 1076                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1055 GMDDGSLERILVGELLTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNK 1104                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1077 PKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQA 1126                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1105 PKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQA 1154                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1127 FQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCR 1176                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1155 FQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCR 1204                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1177 FVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYED 1226                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1205 FVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYED 1254                                                         
						                                                            	                  .         .         .                      
						                                                            	    1227 VALIKDHTLVNSLIRVLQTLQEFNITLETSLVKGIDI              1263                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1255 VALIKDHTLVNSLIRVLQTLQEFNITLETSLVKGIDI              1291                                                         

						Comparison report between M85541_P1 and Q9UPR1partial WT     	Sequence name: Q9UPR1                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for M85541_P1, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELS corresponding to amino  	Alignment of: 25122 x Q9UPR1   ..                            
						acids 73 - 108 of Q9UPR1, which also corresponds to amino    	                                                            
						acids 1 - 36 of M85541_P1, a second amino acid sequence being	Alignment segment 1/1:                                       
						GENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCMPKGLAFKTQADPREPQFHAF 	                                                            
						IITREDGSRTFGFALTFYEEVTSKQICSAMQTLYHMHNAEYDVLHAPPADDRDQSSMEDG 	                     Quality: 12386.00                      Escore:       0                                              
						EDTPVTKLQRFNSYDISRDTLYVSKCICLITPMSFMKACRSVL                  	             Matching length:    1263                Total length:    1287                                               
						at least 90 % homologous to corresponding to amino acids 133 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.92                                               
						- 295 of Q9UPR1, which also corresponds to amino acids 37 -  	    Total Percent Similarity:   98.14      Total Percent Identity:   98.06                                               
						199 of M85541_P1, a bridging amino acid E corresponding to   	                        Gaps:       1                        
						amino acid 200 of M85541_P1, and a third amino acid sequence 	                                                            
						QLHQAVTSPQPPPLPLESYIYNVLYEVPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDF 	Alignment:                                                   
						PVKEVFELLGVENVFQLFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPI 	                  .         .         .         .         .  
						LPASLLHFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQFPNK 	       1 MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELS.............. 36                                                           
						LEFVQEVSEILMAFGIPPEGNLHCSESASKLKRLRASELVSDKRNGNIAGSPLHSYELLK 	         ||||||||||||||||||||||||||||||||||||                
						ENETIARLQALVKRTGVSLEKLEVREDPSSNKDLKVQCDEEELRIYQLNIQIREVFANRF 	      73 MSGGGGGGGSAPSRFADYFVICGLDTETGLEPDELSALCQYIQASKARDG 122                                                          
						TQMFADYEVFVIQPSQDKESWFTNREQMQNFDKASFLSDQPEPYLPFLSRFLETQMFASF 	                  .         .         .         .         .  
						IDNKIMCHDDDDKDPVLRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLA 	      37 ..........GENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCM 76                                                           
						KIDHTAIHPHLLDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKDRQKQ 	                   ||||||||||||||||||||||||||||||||||||||||  
						HTEHLRLDNDQREKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKFVEGLLKECRNKTKR 	     123 ASPFISSTTEGENFEQTPLRRTFKSKVLARYPENVEWNPFDQDAVGMLCM 172                                                          
						MLVEKMGREAVELGHGEVNITGVEENTLIASLCDLLERIWSHGLQVKQGKSALWSHLLHY 	                  .         .         .         .         .  
						QDNRQRKLTSGSLSTSGILLDSERRKSDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKA 	      77 PKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSKQICSAM 126                                                          
						RAWVRLSMEKKLLSRHLKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FTNVFTTILIPYHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTFECQN 	     173 PKGLAFKTQADPREPQFHAFIITREDGSRTFGFALTFYEEVTSKQICSAM 222                                                          
						LGKLTTVQIGHDNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGKGMDDGSLERILVGE 	                  .         .         .         .         .  
						LLTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNKPKLNTGQIQESIGEAVNGIVKHFH 	     127 QTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDT 176                                                          
						KPEKERGSLTLLLCGECGLVSALEQAFQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VVPEENWHTRARNFCRFVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPIT 	     223 QTLYHMHNAEYDVLHAPPADDRDQSSMEDGEDTPVTKLQRFNSYDISRDT 272                                                          
						AHMYEDVALIKDHTLVNSLIRVLQTLQEFNITLETSLVKGIDI                  	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     177 LYVSKCICLITPMSFMKACRSVLEQLHQAVTSPQPPPLPLESYIYNVLYE 226                                                          
						acids 297 - 1359 of Q9UPR1, which also corresponds to amino  	         |||||||||||||||||||||||:||||||||||||||||||||||||||  
						acids 201 - 1263 of M85541_P1, wherein said first amino acid 	     273 LYVSKCICLITPMSFMKACRSVLQQLHQAVTSPQPPPLPLESYIYNVLYE 322                                                          
						sequence, second amino acid sequence, bridging amino acid and	                  .         .         .         .         .  
						third amino acid sequence are contiguous and in a sequential 	     227 VPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQ 276                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of M85541_P1, comprising a polypeptide having a      	     323 VPLPPPGRSLKFSGVYGPIICQRPSTNELPLFDFPVKEVFELLGVENVFQ 372                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     277 LFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPILPASLL 326                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     373 LFTCALLEFQILLYSQHYQRLMTVAETITALMFPFQWQHVYVPILPASLL 422                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise SG, having a structure as  	     327 HFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQ 376                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						36-x to 37; and ending at any of amino acid numbers 37+      	     423 HFLDAPVPYLMGLHSNGLDDRSKLELPQEANLCFVDIDNHFIELPEDLPQ 472                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     377 FPNKLEFVQEVSEILMAFGIPPEGNLHCSESASKLKRLRASELVSDKRNG 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     473 FPNKLEFVQEVSEILMAFGIPPEGNLHCSESASKLKRLRASELVSDKRNG 522                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 NIAGSPLHSYELLKENETIARLQALVKRTGVSLEKLEVREDPSSNKDLKV 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     523 NIAGSPLHSYELLKENETIARLQALVKRTGVSLEKLEVREDPSSNKDLKV 572                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 QCDEEELRIYQLNIQIREVFANRFTQMFADYEVFVIQPSQDKESWFTNRE 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     573 QCDEEELRIYQLNIQIREVFANRFTQMFADYEVFVIQPSQDKESWFTNRE 622                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 QMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPV 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     623 QMQNFDKASFLSDQPEPYLPFLSRFLETQMFASFIDNKIMCHDDDDKDPV 672                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 LRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTA 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     673 LRVFDSRVDKIRLLNVRTPTLRTSMYQKCTTVDEAEKAIELRLAKIDHTA 722                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     627 IHPHLLDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKD 676                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     723 IHPHLLDMKIGQGKYEPGFFPKLQSDVLSTGPASNKWTKRNAPAQWRRKD 772                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     677 RQKQHTEHLRLDNDQREKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKF 726                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     773 RQKQHTEHLRLDNDQREKYIQEARTMGSTIRQPKLSNLSPSVIAQTNWKF 822                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     727 VEGLLKECRNKTKRMLVEKMGREAVELGHGEVNITGVEENTLIASLCDLL 776                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     823 VEGLLKECRNKTKRMLVEKMGREAVELGHGEVNITGVEENTLIASLCDLL 872                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     777 ERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRK 826                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     873 ERIWSHGLQVKQGKSALWSHLLHYQDNRQRKLTSGSLSTSGILLDSERRK 922                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     827 SDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRH 876                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     923 SDASSLMPPLRISLIQDMRHIQNIGEIKTDVGKARAWVRLSMEKKLLSRH 972                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     877 LKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFT 926                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     973 LKQLLSDHELTKKLYKRYAFLRCDDEKEQFLYHLLSFNAVDYFCFTNVFT 1022                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     927 TILIPYHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTF 976                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1023 TILIPYHILIVPSKKLGGSMFTANPWICISGELGETQIMQIPRNVLEMTF 1072                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     977 ECQNLGKLTTVQIGHDNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGK 1026                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1073 ECQNLGKLTTVQIGHDNSGLYAKWLVEYVMVRNEITGHTYKFPCGRWLGK 1122                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1027 GMDDGSLERILVGELLTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNK 1076                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1123 GMDDGSLERILVGELLTSQPEVDERPCRTPPLQQSPSVIRRLVTISPNNK 1172                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1077 PKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQA 1126                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1173 PKLNTGQIQESIGEAVNGIVKHFHKPEKERGSLTLLLCGECGLVSALEQA 1222                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1127 FQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCR 1176                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1223 FQHGFKSPRLFKNVFIWDFLEKAQTYYETLEKNEVVPEENWHTRARNFCR 1272                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1177 FVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYED 1226                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1273 FVTAINNTPRNIGKDGKFQMLVCLGARDHLLHHWIALLADCPITAHMYED 1322                                                         
						                                                            	                  .         .         .                      
						                                                            	    1227 VALIKDHTLVNSLIRVLQTLQEFNITLETSLVKGIDI              1263                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1323 VALIKDHTLVNSLIRVLQTLQEFNITLETSLVKGIDI              1359                                                         

25301	HMR136_M85542_1_tr0_r1_1_gPRT		Comparison report between M85542_P1 and GOG4_HUMANpartial WT 	Sequence name: GOG4_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85542_P1, comprising a first amino 	Sequence documentation:                                      
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	                                                            
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	Alignment of: 25301 x GOG4_HUMAN   ..                        
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                                                            
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	Alignment segment 1/1:                                       
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	                                                            
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRDAKNLIEQLEQ 	                     Quality: 21539.00                      Escore:       0                                              
						DKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEELREQKEKSERAAFEELEKAL 	             Matching length:    2221                Total length:    2221                                               
						STAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEEL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 	                        Gaps:       0                        
						HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKETLLKDK 	                                                            
						EIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQE 	Alignment:                                                   
						LEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVE 	                  .         .         .         .         .  
						NLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTK 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						QVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFKNQEKKMEKVK 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						QKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQANSAGISDAVSR 	                  .         .         .         .         .  
						LETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKEQEVAELKQKI 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						LLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRISHCQHRTTKV 	                  .         .         .         .         .  
						KEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMKADIESLVTEK 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						EALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEISSLSKQLTDLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSN 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						KFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 	                  .         .         .         .         .  
						EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKNYNQQKDIEHK 	     151 SSYRGKYSELVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQ 200                                                          
						ELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEHVNLSVKSKEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGTESHLSELNTK 	     151 SSYRGKYSELVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQ 200                                                          
						LQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISV 	                  .         .         .         .         .  
						LQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 	     201 QAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPMNVDVLKPLPQ 250                                                          
						LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQILEQKIKELD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKSHLVQPKLLSN 	     201 QAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPMNVDVLKPLPQ 250                                                          
						MEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKEYDQEREEKIK 	                  .         .         .         .         .  
						QEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQ 	     251 LEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 300                                                          
						LLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYATTVGTPYKGGN 	     251 LEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 300                                                          
						LYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQKILEREDARL 	                  .         .         .         .         .  
						M                                                            	     301 TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRD 350                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 2221 of GOG4_HUMAN, which also corresponds	     301 TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRD 350                                                          
						to amino acids 1 - 2221 of M85542_P1, and a second amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     351 AKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEE 400                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     351 AKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEE 400                                                          
						having the sequence SWLRSSS corresponding to amino acids 2222	                  .         .         .         .         .  
						- 2228 of M85542_P1, wherein said first amino acid sequence  	     401 LREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEE 450                                                          
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     401 LREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEE 450                                                          
						tail of M85542_P1, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     451 ERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKL 500                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence SWLRSSS in     	     451 ERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKL 500                                                          
						M85542_P1.                                                   	                  .         .         .         .         .  
						                                                            	     501 QTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEELELQKKAILTE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 QTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEELELQKKAILTE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKAR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKAR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRT 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 HKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKALKDQINQLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKALKDQINQLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVAEVEAQKK 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVAEVEAQKK 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFN 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFN 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 AKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKK 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 AKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKK 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LNQQAEELQEIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LNQQAEELQEIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 GVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLEVDLNKSLKEN 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 GVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLEVDLNKSLKEN 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 TFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 TFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLE 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLE 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 EKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSE 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 EKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSE 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 NINAVTLMKEELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLR 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 NINAVTLMKEELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLR 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 KQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSNKFSEWKKKAQ 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSNKFSEWKKKAQ 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 SRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 SRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAE 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAE 1600                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 LETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAA 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1601 LETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAA 1650                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 IKKQLLSQMEEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVES 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1651 IKKQLLSQMEEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVES 1700                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 SQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISVLQRNLTEKEK 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1701 SQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISVLQRNLTEKEK 1750                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 LLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1751 LLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 1800                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1801 LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 1850                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELL 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1851 ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELL 1900                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 EENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQ 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1901 EENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQ 1950                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1951 KDLRMLRKEHQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMRE 2000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1951 KDLRMLRKEHQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMRE 2000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2001 FNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQLLKKIAEKDD 2050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2001 FNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQLLKKIAEKDD 2050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2051 DLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 2100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2051 DLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 2100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2101 DNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 2150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2101 DNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 2150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2151 TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITT 2200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2151 TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITT 2200                                                         
						                                                            	                  .         .                                
						                                                            	    2201 VLKFPDDQTQKILEREDARLM                              2221                                                         
						                                                            	         |||||||||||||||||||||                               
						                                                            	    2201 VLKFPDDQTQKILEREDARLM                              2221                                                         

25305	HMR136_M85542_10_tr0_r1_1_gPRT		Comparison report between M85542_P10 and Q9H2G3unique head   	Sequence name: Q9H2G3                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85542_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25305 x Q9H2G3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	Alignment segment 1/1:                                       
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	                                                            
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                     Quality: 5954.00                      Escore:       0                                               
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	             Matching length:     623                Total length:     623                                               
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	 Matching Percent Similarity:   99.36   Matching Percent Identity:   98.88                                               
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	    Total Percent Similarity:   99.36      Total Percent Identity:   98.88                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 337 of M85542_P10, a second amino acid    	                                                            
						MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQ 	Alignment:                                                   
						GEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQ 	                  .         .         .         .         .  
						ELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEK 	     338 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 387                                                          
						SQSEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSLQENKNQSKDLAVHLEAEKNKHN                                    	       1 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 265 of Q9H2G3, which also corresponds to     	     388 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 437                                                          
						amino acids 338 - 602 of M85542_P10, a bridging amino acid K 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 603 of M85542_P10, a third amino 	      51 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 100                                                          
						EITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKETLLKDKEII 	                  .         .         .         .         .  
						FQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEA 	     438 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 487                                                          
						KMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVA 	     101 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 150                                                          
						EVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQEQTK 	                  .         .         .         .         .  
						QILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK              	     488 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 537                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 267 - 613 of Q9H2G3, which also corresponds to	     151 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 200                                                          
						amino acids 604 - 950 of M85542_P10, and a fourth amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     538 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 587                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     201 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 250                                                          
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                  .         .         .         .         .  
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	     588 KDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 637                                                          
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	         ||||||||||||||| ||||||||||||||||||||||||||||||||||  
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	     251 KDLAVHLEAEKNKHNMEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 300                                                          
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                  .         .         .         .         .  
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	     638 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 687                                                          
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	     301 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 350                                                          
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                  .         .         .         .         .  
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	     688 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 737                                                          
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	     351 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 400                                                          
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                  .         .         .         .         .  
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	     738 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 787                                                          
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	     401 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 450                                                          
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                  .         .         .         .         .  
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	     788 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 837                                                          
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	     451 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 500                                                          
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                  .         .         .         .         .  
						KILEREDARLMFTSPRSGIF                                         	     838 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 887                                                          
						having the sequence corresponding to amino acids 951 - 2230  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85542_P10, wherein said first amino acid sequence, second	     501 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 550                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     888 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 937                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M85542_P10, comprising a polypeptide being at least  	     551 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 600                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .                                
						85%, more preferably at least about 90% and most preferably  	     938 IHILNEEYETKFKNQEKKMEKVK                            960                                                          
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	         ||||||||||||| ::|| :| |                             
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	     601 IHILNEEYETKFKKKKKKKKKKK                            623                                                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                                                            
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	                                                            
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	                                                            
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85542_P10.3.An isolated polypeptide encoding for a tail of  	                                                            
						M85542_P10, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                                                            
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	                                                            
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	                                                            
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	                                                            
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                                                            
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	                                                            
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	                                                            
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	                                                            
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                                                            
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	                                                            
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	                                                            
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	                                                            
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                                                            
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	                                                            
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	                                                            
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	                                                            
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                                                            
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	                                                            
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	                                                            
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	                                                            
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                                                            
						KILEREDARLMFTSPRSGIF                                         	                                                            
						least about 95% homologous to the sequence in M85542_P10.    	                                                            

						Comparison report between M85542_P10 and AAH50444partial WT  	Sequence name: AAH50444                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85542_P10, comprising a first amino	Sequence documentation:                                      
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	                                                            
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	Alignment of: 25305 x AAH50444   ..                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSE                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 159 of AAH50444, which also corresponds to	                                                            
						amino acids 1 - 159 of M85542_P10, and a second amino acid   	                     Quality: 1534.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     159                Total length:     159                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                        Gaps:       0                        
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	Alignment:                                                   
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                  .         .         .         .         .  
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                  .         .         .         .         .  
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                  .         .         .         .         .  
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                             
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	     151 SSYRGKYSE                                          159                                                          
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	         |||||||||                                           
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	     151 SSYRGKYSE                                          159                                                          
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						having the sequence corresponding to amino acids 160 - 2230  	                                                            
						of M85542_P10, wherein said first amino acid sequence and    	                                                            
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						M85542_P10, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                                                            
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	                                                            
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                                                            
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	                                                            
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	                                                            
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	                                                            
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                                                            
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	                                                            
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	                                                            
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	                                                            
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                                                            
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	                                                            
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	                                                            
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	                                                            
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                            
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	                                                            
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	                                                            
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	                                                            
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						least about 95% homologous to the sequence in M85542_P10.    	                                                            

25307	HMR136_M85542_11_tr0_r1_1_gPRT		Comparison report between M85542_P11 and Q9H2G3unique head   	Sequence name: Q9H2G3                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85542_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25307 x Q9H2G3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	Alignment segment 1/1:                                       
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	                                                            
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                     Quality: 5954.00                      Escore:       0                                               
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	             Matching length:     623                Total length:     623                                               
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	 Matching Percent Similarity:   99.36   Matching Percent Identity:   98.88                                               
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	    Total Percent Similarity:   99.36      Total Percent Identity:   98.88                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 337 of M85542_P11, a second amino acid    	                                                            
						MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQ 	Alignment:                                                   
						GEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQ 	                  .         .         .         .         .  
						ELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEK 	     338 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 387                                                          
						SQSEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSLQENKNQSKDLAVHLEAEKNKHN                                    	       1 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 265 of Q9H2G3, which also corresponds to     	     388 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 437                                                          
						amino acids 338 - 602 of M85542_P11, a bridging amino acid K 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 603 of M85542_P11, a third amino 	      51 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 100                                                          
						EITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKETLLKDKEII 	                  .         .         .         .         .  
						FQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEA 	     438 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 487                                                          
						KMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVA 	     101 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 150                                                          
						EVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQEQTK 	                  .         .         .         .         .  
						QILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK              	     488 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 537                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 267 - 613 of Q9H2G3, which also corresponds to	     151 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 200                                                          
						amino acids 604 - 950 of M85542_P11, and a fourth amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     538 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 587                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     201 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 250                                                          
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                  .         .         .         .         .  
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	     588 KDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 637                                                          
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	         ||||||||||||||| ||||||||||||||||||||||||||||||||||  
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	     251 KDLAVHLEAEKNKHNMEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 300                                                          
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                  .         .         .         .         .  
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	     638 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 687                                                          
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	     301 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 350                                                          
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                  .         .         .         .         .  
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	     688 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 737                                                          
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	     351 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 400                                                          
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                  .         .         .         .         .  
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	     738 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 787                                                          
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	     401 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 450                                                          
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                  .         .         .         .         .  
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	     788 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 837                                                          
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	     451 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 500                                                          
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                  .         .         .         .         .  
						KILEREDARLMFTSPRSGIF                                         	     838 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 887                                                          
						having the sequence corresponding to amino acids 951 - 2230  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85542_P11, wherein said first amino acid sequence, second	     501 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 550                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     888 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 937                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M85542_P11, comprising a polypeptide being at least  	     551 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 600                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .                                
						85%, more preferably at least about 90% and most preferably  	     938 IHILNEEYETKFKNQEKKMEKVK                            960                                                          
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	         ||||||||||||| ::|| :| |                             
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	     601 IHILNEEYETKFKKKKKKKKKKK                            623                                                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                                                            
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	                                                            
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	                                                            
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85542_P11.3.An isolated polypeptide encoding for a tail of  	                                                            
						M85542_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                                                            
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	                                                            
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	                                                            
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	                                                            
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                                                            
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	                                                            
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	                                                            
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	                                                            
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                                                            
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	                                                            
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	                                                            
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	                                                            
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                                                            
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	                                                            
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	                                                            
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	                                                            
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                                                            
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	                                                            
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	                                                            
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	                                                            
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                                                            
						KILEREDARLMFTSPRSGIF                                         	                                                            
						least about 95% homologous to the sequence in M85542_P11.    	                                                            

						Comparison report between M85542_P11 and AAH50444partial WT  	Sequence name: AAH50444                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85542_P11, comprising a first amino	Sequence documentation:                                      
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	                                                            
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	Alignment of: 25307 x AAH50444   ..                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSE                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 159 of AAH50444, which also corresponds to	                                                            
						amino acids 1 - 159 of M85542_P11, and a second amino acid   	                     Quality: 1534.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     159                Total length:     159                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                        Gaps:       0                        
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	Alignment:                                                   
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                  .         .         .         .         .  
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                  .         .         .         .         .  
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                  .         .         .         .         .  
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                             
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	     151 SSYRGKYSE                                          159                                                          
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	         |||||||||                                           
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	     151 SSYRGKYSE                                          159                                                          
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						having the sequence corresponding to amino acids 160 - 2230  	                                                            
						of M85542_P11, wherein said first amino acid sequence and    	                                                            
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						M85542_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                                                            
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	                                                            
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                                                            
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	                                                            
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	                                                            
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	                                                            
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                                                            
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	                                                            
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	                                                            
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	                                                            
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                                                            
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	                                                            
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	                                                            
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	                                                            
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                            
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	                                                            
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	                                                            
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	                                                            
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						least about 95% homologous to the sequence in M85542_P11.    	                                                            

25309	HMR136_M85542_3_tr0_r1_1_gPRT		Comparison report between M85542_P3 and GOG4_HUMANpartial WT 	Sequence name: GOG4_HUMAN                                    
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85542_P3, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to                                     	Alignment of: 25309 x GOG4_HUMAN   ..                        
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRE       	                                                            
						corresponding to amino acids 1 - 54 of GOG4_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 54 of M85542_P3, a second     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality: 21439.00                      Escore:       0                                              
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:    2221                Total length:    2243                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence NASTHASKSPDSVNGSEPSIPQ corresponding to  	    Total Percent Similarity:   99.02      Total Percent Identity:   99.02                                               
						amino acids 55 - 76 of M85542_P3, a third amino acid sequence	                        Gaps:       1                        
						SGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASF 	                                                            
						DPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKL 	Alignment:                                                   
						QGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQR 	                  .         .         .         .         .  
						LRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENL 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						LKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRDAKNL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEELREQKEKSERAAFE 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						ELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSS 	                  .         .         .         .         .  
						EEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQES 	      51 PNRENASTHASKSPDSVNGSEPSIPQSGDTQSFAQKLQLRVPSVESLFRS 100                                                          
						LALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHL 	         ||||                      ||||||||||||||||||||||||  
						EAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKE 	      51 PNRE......................SGDTQSFAQKLQLRVPSVESLFRS 78                                                           
						TLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQT 	                  .         .         .         .         .  
						DKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKE 	     101 PIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDMDSEAEDLV 150                                                          
						HQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLED 	      79 PIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDMDSEAEDLV 128                                                          
						GNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFKNQEK 	                  .         .         .         .         .  
						KMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQANSAGI 	     151 GNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGIL 200                                                          
						SDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKEQEVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKA 	     129 GNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGIL 178                                                          
						HLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEK 	                  .         .         .         .         .  
						SNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRISHCQ 	     201 SQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQV 250                                                          
						HRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMKADIE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEISSLSK 	     179 SQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQV 228                                                          
						QLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQ 	                  .         .         .         .         .  
						VDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKR 	     251 SLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSV 300                                                          
						FDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKNYNQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEHVNLS 	     229 SLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSV 278                                                          
						VKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGTESHL 	                  .         .         .         .         .  
						SELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTY 	     301 KTLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQ 350                                                          
						EEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQILEQ 	     279 KTLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQ 328                                                          
						KIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKSHLVQ 	                  .         .         .         .         .  
						PKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKEYDQE 	     351 ELEKIKDLHMAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLE 400                                                          
						REEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAELLESH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQ 	     329 ELEKIKDLHMAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLE 378                                                          
						EENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYATTVGT 	                  .         .         .         .         .  
						PYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQKILE 	     401 MKEEEIAQLRSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEE 450                                                          
						REDARLM                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     379 MKEEEIAQLRSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEE 428                                                          
						acids 55 - 2221 of GOG4_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 77 - 2243 of M85542_P3, and a fourth amino acid  	     451 ARRKLKAEMDEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQI 500                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     429 ARRKLKAEMDEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQI 478                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence SWLRSSS corresponding to amino acids 2244	     501 AKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQE 550                                                          
						- 2250 of M85542_P3, wherein said first amino acid sequence, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     479 AKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQE 528                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     551 KEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEK 600                                                          
						of M85542_P3, comprising an amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     529 KEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEK 578                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     601 SLQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWT 650                                                          
						encoding for NASTHASKSPDSVNGSEPSIPQ, corresponding to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85542_P3.3.An isolated polypeptide encoding for a tail of   	     579 SLQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWT 628                                                          
						M85542_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     651 EKLQVLKQQYQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEK 700                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence SWLRSSS in        	     629 EKLQVLKQQYQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEK 678                                                          
						M85542_P3.                                                   	                  .         .         .         .         .  
						                                                            	     701 LDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     679 LDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQ 728                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 KNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAH 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     729 KNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAH 778                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 VENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     779 VENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKL 828                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEME 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     829 LDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEME 878                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 QKVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     879 QKVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILT 928                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 QKLSAKEDSIHILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     929 QKLSAKEDSIHILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQE 978                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 AKLKKELENTALELSQKEKQFNAKMLEMAQANSAGISDAVSRLETNQKEQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     979 AKLKKELENTALELSQKEKQFNAKMLEMAQANSAGISDAVSRLETNQKEQ 1028                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 IESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKEQEVAELKQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1029 IESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKEQEVAELKQ 1078                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 KILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQD 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1079 KILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQD 1128                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 ETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKL 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1129 ETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKL 1178                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 KTTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1179 KTTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALL 1228                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 EAKTNELINISSSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQL 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1229 EAKTNELINISSSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQL 1278                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 RQLTEEQNTLNISFQQATHQLEEKENQIKSMKADIESLVTEKEALQKEGG 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1279 RQLTEEQNTLNISFQQATHQLEEKENQIKSMKADIESLVTEKEALQKEGG 1328                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 NQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEISSLSKQLTD 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1329 NQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEISSLSKQLTD 1378                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 LNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEK 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1379 LNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEK 1428                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 ISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKD 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1429 ISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKD 1478                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 EQINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIM 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1479 EQINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIM 1528                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 ELEDHITQKTIEIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDN 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1529 ELEDHITQKTIEIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDN 1578                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 RVKEAEEKILTLENQVYSMKAELETKKKELEHVNLSVKSKEEELKALEDR 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1579 RVKEAEEKILTLENQVYSMKAELETKKKELEHVNLSVKSKEEELKALEDR 1628                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 LESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGTESHLSELN 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1629 LESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGTESHLSELN 1678                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 TKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQG 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1679 TKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQG 1728                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 CVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLI 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1729 CVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLI 1778                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 KLEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAK 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1779 KLEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAK 1828                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 QNLENVFDDVQKTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELT 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1829 QNLENVFDDVQKTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELT 1878                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 SKYEKLQALQQMDGRNKPTELLEENTEEKSKSHLVQPKLLSNMEAQHNDL 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1879 SKYEKLQALQQMDGRNKPTELLEENTEEKSKSHLVQPKLLSNMEAQHNDL 1928                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1951 EFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKEYDQEREEK 2000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1929 EFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKEYDQEREEK 1978                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2001 IKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEA 2050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1979 IKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEA 2028                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2051 ELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQ 2100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2029 ELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQ 2078                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2101 TQLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQE 2150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2079 TQLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQE 2128                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2151 FREQIHNLEDRLKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYL 2200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2129 FREQIHNLEDRLKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYL 2178                                                         
						                                                            	                  .         .         .         .            
						                                                            	    2201 RKVLFEYMMGRETKTMAKVITTVLKFPDDQTQKILEREDARLM        2243                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	    2179 RKVLFEYMMGRETKTMAKVITTVLKFPDDQTQKILEREDARLM        2221                                                         

25299	HMR136_M85542_7_tr0_r1_1_gPRT		Comparison report between M85542_P7 and GOG4_HUMANpartial WT 	Sequence name: GOG4_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85542_P7, comprising a first amino 	Sequence documentation:                                      
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	                                                            
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	Alignment of: 25299 x GOG4_HUMAN   ..                        
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                                                            
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	Alignment segment 1/1:                                       
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	                                                            
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRDAKNLIEQLEQ 	                     Quality: 21461.00                      Escore:       0                                              
						DKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEELREQKEKSERAAFEELEKAL 	             Matching length:    2223                Total length:    2230                                               
						STAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEEL 	    Total Percent Similarity:   99.69      Total Percent Identity:   99.69                                               
						ELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 	                        Gaps:       1                        
						HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKETLLKDK 	                                                            
						EIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQE 	Alignment:                                                   
						LEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVE 	                  .         .         .         .         .  
						NLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTK 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						QVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFKNQEKKMEKVK 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						QKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQANSAGISDAVSR 	                  .         .         .         .         .  
						LETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKEQEVAELKQKI 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						LLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRISHCQHRTTKV 	                  .         .         .         .         .  
						KEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMKADIESLVTEK 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						EALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEISSLSKQLTDLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSN 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						KFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 	                  .         .         .         .         .  
						EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKNYNQQKDIEHK 	     151 SSYRGKYSELVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQ 200                                                          
						ELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEHVNLSVKSKEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGTESHLSELNTK 	     151 SSYRGKYSELVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQ 200                                                          
						LQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISV 	                  .         .         .         .         .  
						LQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 	     201 QAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPMNVDVLKPLPQ 250                                                          
						LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQILEQKIKELD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKSHLVQPKLLSN 	     201 QAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPMNVDVLKPLPQ 250                                                          
						MEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKEYDQEREEKIK 	                  .         .         .         .         .  
						QEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQ 	     251 LEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 300                                                          
						LLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DN                                                           	     251 LEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 300                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 2102 of GOG4_HUMAN, which also corresponds	     301 TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRD 350                                                          
						to amino acids 1 - 2102 of M85542_P7, and a second amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYATTVGTPYKGGNLYHTDVSLF 	     301 TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMAEKTKLITQLRD 350                                                          
						GEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQKILEREDARLMFTSPRSGI 	                  .         .         .         .         .  
						F                                                            	     351 AKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEE 400                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 2110 - 2230 of GOG4_HUMAN, which also corresponds	     351 AKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGEE 400                                                          
						to amino acids 2103 - 2223 of M85542_P7, wherein said first  	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	     401 LREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEE 450                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85542_P7,       	     401 LREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEE 450                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     451 ERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKL 500                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     451 ERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKL 500                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     501 QTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEELELQKKAILTE 550                                                          
						comprise NT, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 2102-x to 2103; and  	     501 QTREREFQEQMKVALEKSQSEYLKISQEKEQQESLALEELELQKKAILTE 550                                                          
						ending at any of amino acid numbers 2103+ ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     551 SENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SENKLRDLQQEAETYRTRILELESSLEKSLQENKNQSKDLAVHLEAEKNK 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 HNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKAR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKAR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRT 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 HKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKALKDQINQLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKALKDQINQLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVAEVEAQKK 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVAEVEAQKK 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 QTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFN 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFN 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 AKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKK 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 AKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKK 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LNQQAEELQEIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LNQQAEELQEIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 GVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLEVDLNKSLKEN 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 GVKQDTTLNELQEQLKQKSAHVNSLAQDETKLKAHLEKLEVDLNKSLKEN 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 TFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 TFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKSSHEKSNKSLE 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 DKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLE 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLE 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 EKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSE 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 EKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSE 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 NINAVTLMKEELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLR 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 NINAVTLMKEELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLR 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 KQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSNKFSEWKKKAQ 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KQYDEEKCELLDQVQDLSFKVDTLSKEKISALEQVDDWSNKFSEWKKKAQ 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 SRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 SRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQQNKRFDCLKG 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 EMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAE 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAE 1600                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 LETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAA 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1601 LETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAA 1650                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 IKKQLLSQMEEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVES 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1651 IKKQLLSQMEEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVES 1700                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 SQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISVLQRNLTEKEK 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1701 SQSETLIVPRSAKNVAAYTEQEEADSQGCVQKTYEEKISVLQRNLTEKEK 1750                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 LLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1751 LLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHEDQSMIGHLQEE 1800                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1801 LEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 1850                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELL 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1851 ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELL 1900                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 EENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQ 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1901 EENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQ 1950                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1951 KDLRMLRKEHQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMRE 2000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1951 KDLRMLRKEHQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMRE 2000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2001 FNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQLLKKIAEKDD 2050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2001 FNTQLAQKEQELEMTIKETINKAQEVEAELLESHQEETNQLLKKIAEKDD 2050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2051 DLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 2100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2051 DLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQKLEQEENPGN 2100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2101 DN.......TQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 2143                                                         
						                                                            	         ||       |||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2101 DNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 2150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2144 TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITT 2193                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2151 TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITT 2200                                                         
						                                                            	                  .         .         .                      
						                                                            	    2194 VLKFPDDQTQKILEREDARLMFTSPRSGIF                     2223                                                         
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	    2201 VLKFPDDQTQKILEREDARLMFTSPRSGIF                     2230                                                         

25303	HMR136_M85542_9_tr0_r1_1_gPRT		Comparison report between M85542_P9 and Q9H2G3unique head    	Sequence name: Q9H2G3                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85542_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25303 x Q9H2G3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	Alignment segment 1/1:                                       
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	                                                            
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                     Quality: 5954.00                      Escore:       0                                               
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	             Matching length:     623                Total length:     623                                               
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	 Matching Percent Similarity:   99.36   Matching Percent Identity:   98.88                                               
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	    Total Percent Similarity:   99.36      Total Percent Identity:   98.88                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 337 of M85542_P9, a second amino acid     	                                                            
						MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQ 	Alignment:                                                   
						GEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQ 	                  .         .         .         .         .  
						ELSRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEK 	     338 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 387                                                          
						SQSEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSLQENKNQSKDLAVHLEAEKNKHN                                    	       1 MAEKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQL 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 265 of Q9H2G3, which also corresponds to     	     388 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 437                                                          
						amino acids 338 - 602 of M85542_P9, a bridging amino acid K  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 603 of M85542_P9, a third amino  	      51 RSRIKQMTTQGEELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEM 100                                                          
						EITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQTEMEKLREKCEQEKETLLKDKEII 	                  .         .         .         .         .  
						FQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEA 	     438 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 487                                                          
						KMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERILLTKQVA 	     101 DEQIKTIEKTSEEERISLQQELSRVKQEVVDVMKKSSEEQIAKLQKLHEK 150                                                          
						EVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQVYESKLEDGNKEQEQTK 	                  .         .         .         .         .  
						QILVEKENMILQMREGQKKEIEILTQKLSAKEDSIHILNEEYETKFK              	     488 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 537                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 267 - 613 of Q9H2G3, which also corresponds to	     151 ELARKEQELTKKLQTREREFQEQMKVALEKSQSEYLKISQEKEQQESLAL 200                                                          
						amino acids 604 - 950 of M85542_P9, and a fourth amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     538 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 587                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     201 EELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKSLQENKNQS 250                                                          
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                  .         .         .         .         .  
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	     588 KDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 637                                                          
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	         ||||||||||||||| ||||||||||||||||||||||||||||||||||  
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	     251 KDLAVHLEAEKNKHNMEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQ 300                                                          
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                  .         .         .         .         .  
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	     638 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 687                                                          
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	     301 YQTEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELE 350                                                          
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                  .         .         .         .         .  
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	     688 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 737                                                          
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	     351 SLSSELSEVLKARHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVD 400                                                          
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                  .         .         .         .         .  
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	     738 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 787                                                          
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	     401 SIIKEHEVSIQRTEKALKDQINQLELLLKERDKHLKEHQAHVENLEADIK 450                                                          
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                  .         .         .         .         .  
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	     788 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 837                                                          
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	     451 RSEGELQQASAKLDVFQSYQSATHEQTKAYEEQLAQLQQKLLDLETERIL 500                                                          
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                  .         .         .         .         .  
						KILEREDARLMFTSPRSGIF                                         	     838 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 887                                                          
						having the sequence corresponding to amino acids 951 - 2230  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85542_P9, wherein said first amino acid sequence, second 	     501 LTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQKVKSLTQV 550                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     888 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 937                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M85542_P9, comprising a polypeptide being at least   	     551 YESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDS 600                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .                                
						85%, more preferably at least about 90% and most preferably  	     938 IHILNEEYETKFKNQEKKMEKVK                            960                                                          
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	         ||||||||||||| ::|| :| |                             
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	     601 IHILNEEYETKFKKKKKKKKKKK                            623                                                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSELVTAYQMLQREKKKLQGILSQ 	                                                            
						SQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQYISVLQTQVSLLKQRLRNGPM 	                                                            
						NVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVKTLETLQQRVKRQENLLKRCKE 	                                                            
						TIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLH                        	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85542_P9.3.An isolated polypeptide encoding for a tail of   	                                                            
						M85542_P9, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						NQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQFNAKMLEMAQAN 	                                                            
						SAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQEIHEIQLQEKE 	                                                            
						QEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKSAHVNSLAQDET 	                                                            
						KLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLKTTDEEFQSLKS 	                                                            
						SHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINISSSKTNAILSRI 	                                                            
						SHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQLEEKENQIKSMK 	                                                            
						ADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMKEELKEKKVEIS 	                                                            
						SLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSFKVDTLSKEKIS 	                                                            
						ALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDEQINLLKEELDQ 	                                                            
						QNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTIEIESLNEVLKN 	                                                            
						YNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKAELETKKKELEH 	                                                            
						VNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQMEEKEEQYKKGT 	                                                            
						ESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYTEQEEADSQGCV 	                                                            
						QKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIKLEHAEAKQHED 	                                                            
						QSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQKTLQEKELTCQ 	                                                            
						ILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTELLEENTEEKSKS 	                                                            
						HLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKEHQQELEILKKE 	                                                            
						YDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKETINKAQEVEAEL 	                                                            
						LESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQTQLEELQKKYQQ 	                                                            
						KLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDRLKKYEKNVYAT 	                                                            
						TVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVITTVLKFPDDQTQ 	                                                            
						KILEREDARLMFTSPRSGIF                                         	                                                            
						least about 95% homologous to the sequence in M85542_P9.     	                                                            

						Comparison report between M85542_P9 and AAH50444partial WT   	Sequence name: AAH50444                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85542_P9, comprising a first amino 	Sequence documentation:                                      
						MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGTPNRESGDTQS 	                                                            
						FAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRESLNRLDLDSSTASFDPPSDM 	Alignment of: 25303 x AAH50444   ..                          
						DSEAEDLVGNSDSLNKEQLIQRLRRMERSLSSYRGKYSE                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 159 of AAH50444, which also corresponds to	                                                            
						amino acids 1 - 159 of M85542_P9, and a second amino acid    	                     Quality: 1534.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     159                Total length:     159                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                        Gaps:       0                        
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	Alignment:                                                   
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                  .         .         .         .         .  
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	       1 MFKKLKQKISEEQQQLQQALAPAQASSNSSTPTRMRSRTSSFTEQLDEGT 50                                                           
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                  .         .         .         .         .  
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	      51 PNRESGDTQSFAQKLQLRVPSVESLFRSPIKESLFRSSSKESLVRTSSRE 100                                                          
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                  .         .         .         .         .  
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	     101 SLNRLDLDSSTASFDPPSDMDSEAEDLVGNSDSLNKEQLIQRLRRMERSL 150                                                          
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                             
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	     151 SSYRGKYSE                                          159                                                          
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	         |||||||||                                           
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	     151 SSYRGKYSE                                          159                                                          
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						having the sequence corresponding to amino acids 160 - 2230  	                                                            
						of M85542_P9, wherein said first amino acid sequence and     	                                                            
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						M85542_P9, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						LVTAYQMLQREKKKLQGILSQSQDKSLRRIAELREELQMDQQAKKHLQEEFDASLEEKDQ 	                                                            
						YISVLQTQVSLLKQRLRNGPMNVDVLKPLPQLEPQAEVFTKEENPESDGEPVVEDGTSVK 	                                                            
						TLETLQQRVKRQENLLKRCKETIQSHKEQCTLLTSEKEALQEQLDERLQELEKIKDLHMA 	                                                            
						EKTKLITQLRDAKNLIEQLEQDKGMVIAETKRQMHETLEMKEEEIAQLRSRIKQMTTQGE 	                                                            
						ELREQKEKSERAAFEELEKALSTAQKTEEARRKLKAEMDEQIKTIEKTSEEERISLQQEL 	                                                            
						SRVKQEVVDVMKKSSEEQIAKLQKLHEKELARKEQELTKKLQTREREFQEQMKVALEKSQ 	                                                            
						SEYLKISQEKEQQESLALEELELQKKAILTESENKLRDLQQEAETYRTRILELESSLEKS 	                                                            
						LQENKNQSKDLAVHLEAEKNKHNKEITVMVEKHKTELESLKHQQDALWTEKLQVLKQQYQ 	                                                            
						TEMEKLREKCEQEKETLLKDKEIIFQAHIEEMNEKTLEKLDVKQTELESLSSELSEVLKA 	                                                            
						RHKLEEELSVLKDQTDKMKQELEAKMDEQKNHHQQQVDSIIKEHEVSIQRTEKALKDQIN 	                                                            
						QLELLLKERDKHLKEHQAHVENLEADIKRSEGELQQASAKLDVFQSYQSATHEQTKAYEE 	                                                            
						QLAQLQQKLLDLETERILLTKQVAEVEAQKKDVCTELDAHKIQVQDLMQQLEKQNSEMEQ 	                                                            
						KVKSLTQVYESKLEDGNKEQEQTKQILVEKENMILQMREGQKKEIEILTQKLSAKEDSIH 	                                                            
						ILNEEYETKFKNQEKKMEKVKQKAKEMQETLKKKLLDQEAKLKKELENTALELSQKEKQF 	                                                            
						NAKMLEMAQANSAGISDAVSRLETNQKEQIESLTEVHRRELNDVISIWEKKLNQQAEELQ 	                                                            
						EIHEIQLQEKEQEVAELKQKILLFGCEKEEMNKEITWLKEEGVKQDTTLNELQEQLKQKS 	                                                            
						AHVNSLAQDETKLKAHLEKLEVDLNKSLKENTFLQEQLVELKMLAEEDKRKVSELTSKLK 	                                                            
						TTDEEFQSLKSSHEKSNKSLEDKSLEFKKLSEELAIQLDICCKKTEALLEAKTNELINIS 	                                                            
						SSKTNAILSRISHCQHRTTKVKEALLIKTCTVSELEAQLRQLTEEQNTLNISFQQATHQL 	                                                            
						EEKENQIKSMKADIESLVTEKEALQKEGGNQQQAASEKESCITQLKKELSENINAVTLMK 	                                                            
						EELKEKKVEISSLSKQLTDLNVQLQNSISLSEKEAAISSLRKQYDEEKCELLDQVQDLSF 	                                                            
						KVDTLSKEKISALEQVDDWSNKFSEWKKKAQSRFTQHQNTVKELQIQLELKSKEAYEKDE 	                                                            
						QINLLKEELDQQNKRFDCLKGEMEDDKSKMEKKESNLETELKSQTARIMELEDHITQKTI 	                                                            
						EIESLNEVLKNYNQQKDIEHKELVQKLQHFQELGEEKDNRVKEAEEKILTLENQVYSMKA 	                                                            
						ELETKKKELEHVNLSVKSKEEELKALEDRLESESAAKLAELKRKAEQKIAAIKKQLLSQM 	                                                            
						EEKEEQYKKGTESHLSELNTKLQEREREVHILEEKLKSVESSQSETLIVPRSAKNVAAYT 	                                                            
						EQEEADSQGCVQKTYEEKISVLQRNLTEKEKLLQRVGQEKEETVSSHFEMRCQYQERLIK 	                                                            
						LEHAEAKQHEDQSMIGHLQEELEEKNKKYSLIVAQHVEKEGGKNNIQAKQNLENVFDDVQ 	                                                            
						KTLQEKELTCQILEQKIKELDSCLVRQKEVHRVEMEELTSKYEKLQALQQMDGRNKPTEL 	                                                            
						LEENTEEKSKSHLVQPKLLSNMEAQHNDLEFKLAGAEREKQKLGKEIVRLQKDLRMLRKE 	                                                            
						HQQELEILKKEYDQEREEKIKQEQEDLELKHNSTLKQLMREFNTQLAQKEQELEMTIKET 	                                                            
						INKAQEVEAELLESHQEETNQLLKKIAEKDDDLKRTAKRYEEILDAREEEMTAKVRDLQT 	                                                            
						QLEELQKKYQQKLEQEENPGNDNVTIMELQTQLAQKTTLISDSKLKEQEFREQIHNLEDR 	                                                            
						LKKYEKNVYATTVGTPYKGGNLYHTDVSLFGEPTEFEYLRKVLFEYMMGRETKTMAKVIT 	                                                            
						TVLKFPDDQTQKILEREDARLMFTSPRSGIF                              	                                                            
						least about 95% homologous to the sequence in M85542_P9.     	                                                            

2955	HMR136_M85543_12_tr0_r1_1_gPRT		Comparison report between M85543_P12 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P12, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2955 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P12, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P12, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P12, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P12, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESS 	                  .         .         .         .         .  
						EQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQ 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						EDT                                                          	         |||||||||||||||||||||||||||||||||||||               
						at least 95% homologous to a polypeptide having the sequence 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						corresponding to amino acids 317 - 979 of M85543_P12, wherein	                  .         .         .         .            
						said first amino acid sequence, second amino acid sequence,  	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						third amino acid sequence, fourth amino acid sequence and    	                     |||||||||||||||||||||||||||||:|         
						fifth amino acid sequence are contiguous and in a sequential 	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P12, comprising an amino acid sequence being at    	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P12.3.An isolated chimeric           	                                                            
						polypeptide encoding for an edge portion of M85543_P12,      	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESS 	                                                            
						EQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQ 	                                                            
						EDT                                                          	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P12.                                               	                                                            

						Comparison report between M85543_P12 and O94977unique head   	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P12,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2955 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 6744.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     710                Total length:     771                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   92.09      Total Percent Identity:   92.09                                               
						to amino acids 1 - 269 of M85543_P12, a second amino acid    	                        Gaps:       2                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P12, a third  	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						corresponding to amino acids 44 - 635 of O94977, which also  	                  .         .         .         .         .  
						corresponds to amino acids 288 - 879 of M85543_P12, and a    	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						EQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDT                     	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 672 - 771 of O94977, which also 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						corresponds to amino acids 880 - 979 of M85543_P12, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						polypeptide encoding for a head of M85543_P12, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                  .         .         .         .         .  
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of M85543_P12.3.An isolated chimeric         	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						polypeptide encoding for an edge portion of M85543_P12,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EE, having a structure as follows: a sequence       	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						starting from any of amino acid numbers 287-x to 288; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						which x varies from 0 to n-2.4.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85543_P12,      	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASG............... 879                                                          
						comprise GE, having a structure as follows: a sequence       	         |||||||||||||||||||||||||||||||||||                 
						starting from any of amino acid numbers 879-x to 880; and    	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						ending at any of amino acid numbers 880+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     880 .....................EQNSKLVDLKLKKLLEVQPQVANSPSSAA 908                                                          
						                                                            	                              |||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     909 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 958                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .                                
						                                                            	     959 FSQYIENRPEMKRQRSIQEDT                              979                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     751 FSQYIENRPEMKRQRSIQEDT                              771                                                          

2966	HMR136_M85543_13_tr0_r1_1_gPRT		Comparison report between M85543_P13 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P13, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2966 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P13, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P13, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P13, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P13, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                  .         .         .         .         .  
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	         |||||||||||||||||||||||||||||||||||||               
						VLNKKIKISQTWWCAPVVSATQEAEAGGLLD                              	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .            
						corresponding to amino acids 317 - 1067 of M85543_P13,       	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						wherein said first amino acid sequence, second amino acid    	                     |||||||||||||||||||||||||||||:|         
						sequence, third amino acid sequence, fourth amino acid       	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						sequence and fifth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for an 	                                                            
						edge portion of M85543_P13, comprising an amino acid sequence	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P13.3.An isolated chimeric           	                                                            
						polypeptide encoding for an edge portion of M85543_P13,      	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P13, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                                                            
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	                                                            
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	                                                            
						VLNKKIKISQTWWCAPVVSATQEAEAGGLLD                              	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P13.                                               	                                                            

						Comparison report between M85543_P13 and O94977unique head   	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for M85543_P13, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2966 x O94977   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	                                                            
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                     Quality: 7435.00                      Escore:       0                                               
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	             Matching length:     774                Total length:     799                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	 Matching Percent Similarity:   99.74   Matching Percent Identity:   99.74                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	    Total Percent Similarity:   96.62      Total Percent Identity:   96.62                                               
						having the sequence corresponding to amino acids 1 - 269 of  	                        Gaps:       1                        
						M85543_P13, a second amino acid sequence being at least 90 % 	                                                            
						homologous to FDDPDAAELNPFGDPDSE corresponding to amino acids	Alignment:                                                   
						1 - 18 of O94977, which also corresponds to amino acids 270 -	                  .         .         .         .         .  
						287 of M85543_P13, a third amino acid sequence being at least	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	         ||||||||||||||||||                         |||||||  
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	                  .         .         .         .         .  
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	                  .         .         .         .         .  
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEI 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						DTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKA 	                  .         .         .         .         .  
						VTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKR 	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						QRSIQEDTKKGNEEKAAITETQRKPSEDEVLNK                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 44 - 796 of  	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						O94977, which also corresponds to amino acids 288 - 1040 of  	                  .         .         .         .         .  
						M85543_P13, and a fourth amino acid sequence being at least  	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						KIKISQTWWCAPVVSATQEAEAGGLLD corresponding to amino acids 1041	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						- 1067 of M85543_P13, wherein said first amino acid sequence,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						M85543_P13, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						least about 95% homologous to the sequence of M85543_P13.3.An	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						M85543_P13, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						at least two amino acids comprise EE, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						287-x to 288; and ending at any of amino acid numbers 288+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						polypeptide encoding for a tail of M85543_P13, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 894                                                          
						to the sequence KIKISQTWWCAPVVSATQEAEAGGLLD in M85543_P13.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     895 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     945 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 994                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .            
						                                                            	     995 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKKIK  1043                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||  |   
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFK  799                                                          

2968	HMR136_M85543_14_tr0_r1_1_gPRT		Comparison report between M85543_P14 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P14, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2968 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P14, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P14, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P14, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P14, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                  .         .         .         .         .  
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDT                      	         |||||||||||||||||||||||||||||||||||||               
						at least 95% homologous to a polypeptide having the sequence 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						corresponding to amino acids 317 - 1015 of M85543_P14,       	                  .         .         .         .            
						wherein said first amino acid sequence, second amino acid    	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						sequence, third amino acid sequence, fourth amino acid       	                     |||||||||||||||||||||||||||||:|         
						sequence and fifth amino acid sequence are contiguous and in 	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	                                                            
						edge portion of M85543_P14, comprising an amino acid sequence	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P14.3.An isolated chimeric           	                                                            
						polypeptide encoding for an edge portion of M85543_P14,      	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P14, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                                                            
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	                                                            
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDT                      	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P14.                                               	                                                            

						Comparison report between M85543_P14 and O94977unique head   	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P14,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2968 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 7191.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     746                Total length:     771                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   96.76      Total Percent Identity:   96.76                                               
						to amino acids 1 - 269 of M85543_P14, a second amino acid    	                        Gaps:       1                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P14, and a    	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKA 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						VTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKR 	                  .         .         .         .         .  
						QRSIQEDT                                                     	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 44 - 771 of O94977, which also  	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						corresponds to amino acids 288 - 1015 of M85543_P14, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						head of M85543_P14, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                  .         .         .         .         .  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						at least about 95% homologous to the sequence of             	                  .         .         .         .         .  
						M85543_P14.3.An isolated chimeric polypeptide encoding for an	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						edge portion of M85543_P14, comprising a polypeptide having a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						at least two amino acids comprise EE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						287-x to 288; and ending at any of amino acid numbers 288+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 894                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     895 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     945 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 994                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .                                
						                                                            	     995 FSQYIENRPEMKRQRSIQEDT                              1015                                                         
						                                                            	         |||||||||||||||||||||                               
						                                                            	     751 FSQYIENRPEMKRQRSIQEDT                              771                                                          

2951	HMR136_M85543_15_tr0_r1_1_gPRT		Comparison report between M85543_P15 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P15, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2951 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P15, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P15, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P15, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P15, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDVRSIG                      	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						corresponding to amino acids 317 - 835 of M85543_P15, wherein	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						said first amino acid sequence, second amino acid sequence,  	         |||||||||||||||||||||||||||||||||||||               
						third amino acid sequence, fourth amino acid sequence and    	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                  .         .         .         .            
						order.2.An isolated polypeptide encoding for an edge portion 	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						of M85543_P15, comprising an amino acid sequence being at    	                     |||||||||||||||||||||||||||||:|         
						least 70%, optionally at least about 80%, preferably at least	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P15.3.An isolated chimeric           	                                                            
						polypeptide encoding for an edge portion of M85543_P15,      	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P15, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDVRSIG                      	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P15.                                               	                                                            

						Comparison report between M85543_P15 and O94977unique head   	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for M85543_P15, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2951 x O94977   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	                                                            
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                     Quality: 5405.00                      Escore:       0                                               
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	             Matching length:     561                Total length:     586                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	    Total Percent Similarity:   95.73      Total Percent Identity:   95.73                                               
						having the sequence corresponding to amino acids 1 - 269 of  	                        Gaps:       1                        
						M85543_P15, a second amino acid sequence being at least 90 % 	                                                            
						homologous to FDDPDAAELNPFGDPDSE corresponding to amino acids	Alignment:                                                   
						1 - 18 of O94977, which also corresponds to amino acids 270 -	                  .         .         .         .         .  
						287 of M85543_P15, a third amino acid sequence being at least	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	         ||||||||||||||||||                         |||||||  
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	                  .         .         .         .         .  
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	                  .         .         .         .         .  
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSD                                                          	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						90 % homologous to corresponding to amino acids 44 - 586 of  	                  .         .         .         .         .  
						O94977, which also corresponds to amino acids 288 - 830 of   	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						M85543_P15, and a fourth amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence VRSIG        	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						corresponding to amino acids 831 - 835 of M85543_P15, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						polypeptide encoding for a head of M85543_P15, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                  .         .         .         .         .  
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of M85543_P15.3.An isolated chimeric         	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						polypeptide encoding for an edge portion of M85543_P15,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise EE, having a structure as follows: a sequence       	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						starting from any of amino acid numbers 287-x to 288; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of M85543_P15, comprising a polypeptide  	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .                      
						at least about 85%, more preferably at least about 90% and   	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD               830                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||                
						VRSIG in M85543_P15.                                         	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD               586                                                          

2959	HMR136_M85543_16_tr0_r1_1_gPRT		Comparison report between M85543_P16 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P16, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2959 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P16, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P16, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P16, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P16, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDVRSIG    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						corresponding to amino acids 317 - 553 of M85543_P16, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						third amino acid sequence, fourth amino acid sequence and    	         |||||||||||                                   ||||  
						fifth amino acid sequence are contiguous and in a sequential 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	                  .         .         .         .         .  
						of M85543_P16, comprising an amino acid sequence being at    	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						least 70%, optionally at least about 80%, preferably at least	         |||||||||||||||||||||||||||||||||||||               
						about 85%, more preferably at least about 90% and most       	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						corresponding to M85543_P16.3.An isolated chimeric           	                     |||||||||||||||||||||||||||||:|         
						polypeptide encoding for an edge portion of M85543_P16,      	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P16, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDVRSIG    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P16.                                               	                                                            

						Comparison report between M85543_P16 and O94977unique head   	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for M85543_P16, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2959 x O94977   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	                                                            
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                     Quality: 2564.00                      Escore:       0                                               
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	             Matching length:     279                Total length:     586                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	    Total Percent Similarity:   47.61      Total Percent Identity:   47.61                                               
						having the sequence corresponding to amino acids 1 - 269 of  	                        Gaps:       2                        
						M85543_P16, a second amino acid sequence being at least 90 % 	                                                            
						homologous to FDDPDAAELNPFGDPDSE corresponding to amino acids	Alignment:                                                   
						1 - 18 of O94977, which also corresponds to amino acids 270 -	                  .         .         .         .         .  
						287 of M85543_P16, a third amino acid sequence being at least	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	         ||||||||||||||||||                         |||||||  
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	                  .         .         .         .         .  
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDM                            	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						90 % homologous to corresponding to amino acids 44 - 256 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						O94977, which also corresponds to amino acids 288 - 500 of   	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						M85543_P16, a fourth amino acid sequence being at least 90 % 	                  .         .         .         .         .  
						homologous to                                                	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						HRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 539 - 586 of O94977, which also 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						corresponds to amino acids 501 - 548 of M85543_P16, and a    	                  .         .         .         .         .  
						fifth amino acid sequence being at least 70%, optionally at  	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						polypeptide having the sequence VRSIG corresponding to amino 	                  .         .         .         .         .  
						acids 549 - 553 of M85543_P16, wherein said first amino acid 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, fourth amino acid sequence and fifth amino acid    	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M85543_P16,      	     495 LEPSDM............................................ 500                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||                                              
						least about 80%, preferably at least about 85%, more         	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     500 .................................................. 500                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     500 .................................................. 500                                                          
						about 95% homologous to the sequence of M85543_P16.3.An      	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						M85543_P16, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     500 .................................................. 500                                                          
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     500 .................................................. 500                                                          
						at least two amino acids comprise EE, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						287-x to 288; and ending at any of amino acid numbers 288+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     501 ......................................HRLLSRQEELKE 512                                                          
						chimeric polypeptide encoding for an edge portion of         	                                               ||||||||||||  
						M85543_P16, comprising a polypeptide having a length "n",    	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .                      
						optionally at least about 20 amino acids in length,          	     513 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD               548                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||                
						preferably at least about 40 amino acids in length and most  	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD               586                                                          
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise MH, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						500-x to 501; and ending at any of amino acid numbers 501+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                                                            
						polypeptide encoding for a tail of M85543_P16, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VRSIG in M85543_P16.                         	                                                            

2970	HMR136_M85543_17_tr0_r1_1_gPRT		Comparison report between M85543_P17 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P17, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2970 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P17, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P17, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P17, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P17, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKVGFYS                           	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						corresponding to amino acids 317 - 410 of M85543_P17, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						third amino acid sequence, fourth amino acid sequence and    	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	         |||||||||||                                   ||||  
						of M85543_P17, comprising an amino acid sequence being at    	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						preferably at least about 95% homologous to the sequence     	         |||||||||||||||||||||||||||||||||||||               
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						corresponding to M85543_P17.3.An isolated chimeric           	                  .         .         .         .            
						polypeptide encoding for an edge portion of M85543_P17,      	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						comprising a polypeptide having a length "n", wherein n is at	                     |||||||||||||||||||||||||||||:|         
						least about 10 amino acids in length, optionally at least    	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P17, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKVGFYS                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P17.                                               	                                                            

2949	HMR136_M85543_18_tr0_r1_1_gPRT		Comparison report between M85543_P18 and Q9NWI9partial WT    	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P18, comprising a first amino	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2949 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P18, a second amino acid       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P18, a third	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P18, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P18, and a fifth amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKKF                              	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						corresponding to amino acids 317 - 407 of M85543_P18, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						third amino acid sequence, fourth amino acid sequence and    	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	         |||||||||||                                   ||||  
						of M85543_P18, comprising an amino acid sequence being at    	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						preferably at least about 95% homologous to the sequence     	         |||||||||||||||||||||||||||||||||||||               
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						corresponding to M85543_P18.3.An isolated chimeric           	                  .         .         .         .            
						polypeptide encoding for an edge portion of M85543_P18,      	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						comprising a polypeptide having a length "n", wherein n is at	                     |||||||||||||||||||||||||||||:|         
						least about 10 amino acids in length, optionally at least    	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 287-x to 288; and    	                                                            
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of M85543_P18, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKKF                              	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85543_P18.                                               	                                                            

2972	HMR136_M85543_3_tr0_r1_1_gPRT		Comparison report between M85543_P3 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P3, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2972 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P3, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P3, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P3, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P3, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDSGTEDLRTERLQKTTERFRNPVVFSK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						DSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFK 	                  .         .         .         .         .  
						DTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNA 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						LIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNK 	         |||||||||||||||||||||||||||||||||||||               
						RDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMAKKEEKCVLQ                  	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						least 95% homologous to a polypeptide having the sequence    	                  .         .         .         .            
						corresponding to amino acids 317 - 1079 of M85543_P3, wherein	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						said first amino acid sequence, second amino acid sequence,  	                     |||||||||||||||||||||||||||||:|         
						third amino acid sequence, fourth amino acid sequence and    	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P3, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P3.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P3, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P3, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDSGTEDLRTERLQKTTERFRNPVVFSK 	                                                            
						DSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFK 	                                                            
						DTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNA 	                                                            
						LIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNK 	                                                            
						RDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMAKKEEKCVLQ                  	                                                            
						least about 95% homologous to the sequence in M85543_P3.     	                                                            

						Comparison report between M85543_P3 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P3,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2972 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 7729.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     810                Total length:     962                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   84.20      Total Percent Identity:   84.20                                               
						to amino acids 1 - 269 of M85543_P3, a second amino acid     	                        Gaps:       2                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P3, a third   	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						LSD                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						corresponding to amino acids 44 - 586 of O94977, which also  	                  .         .         .         .         .  
						corresponds to amino acids 288 - 830 of M85543_P3, and a     	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						SGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYL 	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAI 	                  .         .         .         .         .  
						EDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMA 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						KKEEKCVLQ                                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						corresponding to amino acids 714 - 962 of O94977, which also 	                  .         .         .         .         .  
						corresponds to amino acids 831 - 1079 of M85543_P3, wherein  	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M85543_P3, comprising a   	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						to the sequence of M85543_P3.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85543_P3,       	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						comprise EE, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 287-x to 288; and    	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated chimeric          	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSD.............. 830                                                          
						polypeptide encoding for an edge portion of M85543_P3,       	         ||||||||||||||||||||||||||||||||||||                
						comprising a polypeptide having a length "n", wherein n is at	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     830 .................................................. 830                                                          
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise DS, having a structure as follows: a sequence       	     830 .................................................. 830                                                          
						starting from any of amino acid numbers 830-x to 831; and    	                                                            
						ending at any of amino acid numbers 831+ ((n-2) - x), in     	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     831 .............SGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 867                                                          
						                                                            	                      |||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     868 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 917                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     918 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 967                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     968 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 1017                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1018 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 1067                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 950                                                          
						                                                            	                  .                                          
						                                                            	    1068 KMAKKEEKCVLQ                                       1079                                                         
						                                                            	         ||||||||||||                                        
						                                                            	     951 KMAKKEEKCVLQ                                       962                                                          

2957	HMR136_M85543_4_tr0_r1_1_gPRT		Comparison report between M85543_P4 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P4, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2957 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P4, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P4, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P4, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P4, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQQQDEERRRQLRERA 	         |||||||||||                                   ||||  
						RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDE 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						LTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLR 	                  .         .         .         .         .  
						TERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAA 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						ITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNT 	         |||||||||||||||||||||||||||||||||||||               
						EEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMAKKEEKCV 	                  .         .         .         .            
						LQ                                                           	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						least 95% homologous to a polypeptide having the sequence    	                     |||||||||||||||||||||||||||||:|         
						corresponding to amino acids 317 - 1158 of M85543_P4, wherein	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						said first amino acid sequence, second amino acid sequence,  	                                                            
						third amino acid sequence, fourth amino acid sequence and    	                                                            
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P4, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P4.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P4, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQQQDEERRRQLRERA 	                                                            
						RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDE 	                                                            
						LTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLR 	                                                            
						TERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAA 	                                                            
						ITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNT 	                                                            
						EEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 	                                                            
						AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMAKKEEKCV 	                                                            
						LQ                                                           	                                                            
						least about 95% homologous to the sequence in M85543_P4.     	                                                            

						Comparison report between M85543_P4 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P4,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2957 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 8480.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     889                Total length:     962                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   92.41      Total Percent Identity:   92.41                                               
						to amino acids 1 - 269 of M85543_P4, a second amino acid     	                        Gaps:       2                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P4, a third   	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQ                                              	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 44 - 538 of O94977, which also  	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						corresponds to amino acids 288 - 782 of M85543_P4, and a     	                  .         .         .         .         .  
						QQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTN 	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						EEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRS 	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						IQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALV 	                  .         .         .         .         .  
						EKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRE 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						LRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNKGKMAKKEEKCVLQ                                             	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 587 - 962 of O94977, which also 	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						corresponds to amino acids 783 - 1158 of M85543_P4, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						polypeptide encoding for a head of M85543_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                  .         .         .         .         .  
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of M85543_P4.3.An isolated chimeric          	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						polypeptide encoding for an edge portion of M85543_P4,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQ............ 782                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||              
						comprise EE, having a structure as follows: a sequence       	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						starting from any of amino acid numbers 287-x to 288; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	     783 ....................................QQDEERRRQLRERA 796                                                          
						which x varies from 0 to n-2.4.An isolated chimeric          	                                             ||||||||||||||  
						polypeptide encoding for an edge portion of M85543_P4,       	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     797 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 846                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     847 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 896                                                          
						comprise QQ, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 782-x to 783; and    	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						ending at any of amino acid numbers 783+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     897 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 946                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     947 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 996                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     997 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 1046                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1047 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 1096                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1097 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 1146                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 950                                                          
						                                                            	                  .                                          
						                                                            	    1147 KMAKKEEKCVLQ                                       1158                                                         
						                                                            	         ||||||||||||                                        
						                                                            	     951 KMAKKEEKCVLQ                                       962                                                          

2961	HMR136_M85543_5_tr0_r1_1_gPRT		Comparison report between M85543_P5 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P5, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2961 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P5, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P5, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P5, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P5, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESS 	                  .         .         .         .         .  
						EQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQ 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						EDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEK 	         |||||||||||||||||||||||||||||||||||||               
						RLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELR 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						AMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQN 	                  .         .         .         .            
						KGKMAKKEEKCVLQ                                               	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						least 95% homologous to a polypeptide having the sequence    	                     |||||||||||||||||||||||||||||:|         
						corresponding to amino acids 317 - 1170 of M85543_P5, wherein	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						said first amino acid sequence, second amino acid sequence,  	                                                            
						third amino acid sequence, fourth amino acid sequence and    	                                                            
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P5, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P5.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P5, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P5, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESS 	                                                            
						EQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQ 	                                                            
						EDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEK 	                                                            
						RLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELR 	                                                            
						AMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQN 	                                                            
						KGKMAKKEEKCVLQ                                               	                                                            
						least about 95% homologous to the sequence in M85543_P5.     	                                                            

						Comparison report between M85543_P5 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P5,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2961 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 8599.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     901                Total length:     962                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   93.66      Total Percent Identity:   93.66                                               
						to amino acids 1 - 269 of M85543_P5, a second amino acid     	                        Gaps:       2                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P5, a third   	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						corresponding to amino acids 44 - 635 of O94977, which also  	                  .         .         .         .         .  
						corresponds to amino acids 288 - 879 of M85543_P5, and a     	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						EQNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RNPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSED 	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						EVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWF 	                  .         .         .         .         .  
						MLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLD 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						ELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMAKKEEKCVLQ          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						corresponding to amino acids 672 - 962 of O94977, which also 	                  .         .         .         .         .  
						corresponds to amino acids 880 - 1170 of M85543_P5, wherein  	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M85543_P5, comprising a   	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						to the sequence of M85543_P5.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85543_P5,       	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						comprise EE, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 287-x to 288; and    	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated chimeric          	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						polypeptide encoding for an edge portion of M85543_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASG............... 879                                                          
						amino acids in length, more preferably at least about 40     	         |||||||||||||||||||||||||||||||||||                 
						amino acids in length and most preferably at least about 50  	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise GE, having a structure as follows: a sequence       	     880 .....................EQNSKLVDLKLKKLLEVQPQVANSPSSAA 908                                                          
						starting from any of amino acid numbers 879-x to 880; and    	                              |||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 880+ ((n-2) - x), in     	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     909 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 958                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     959 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 1008                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1009 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 1058                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1059 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 1108                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1109 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 1158                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 950                                                          
						                                                            	                  .                                          
						                                                            	    1159 KMAKKEEKCVLQ                                       1170                                                         
						                                                            	         ||||||||||||                                        
						                                                            	     951 KMAKKEEKCVLQ                                       962                                                          

2978	HMR136_M85543_6_tr0_r1_1_gPRT		Comparison report between M85543_P6 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P6, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2978 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P6, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P6, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P6, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P6, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						KASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQ 	                  .         .         .         .         .  
						VANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSF 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAA 	         |||||||||||                                   ||||  
						LENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLE 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						KEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQE 	                  .         .         .         .         .  
						KQAEEEDEHLERTLEQNKGKMAKKEEKCVLQ                              	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						least 95% homologous to a polypeptide having the sequence    	         |||||||||||||||||||||||||||||||||||||               
						corresponding to amino acids 317 - 947 of M85543_P6, wherein 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .            
						third amino acid sequence, fourth amino acid sequence and    	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                     |||||||||||||||||||||||||||||:|         
						order.2.An isolated polypeptide encoding for an edge portion 	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						of M85543_P6, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P6.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P6, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P6, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKH 	                                                            
						NTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERS 	                                                            
						KASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQ 	                                                            
						VANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSF 	                                                            
						SQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAA 	                                                            
						LENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLE 	                                                            
						KEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQE 	                                                            
						KQAEEEDEHLERTLEQNKGKMAKKEEKCVLQ                              	                                                            
						least about 95% homologous to the sequence in M85543_P6.     	                                                            

						Comparison report between M85543_P6 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P6,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2978 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 6429.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     678                Total length:     962                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   70.48      Total Percent Identity:   70.48                                               
						to amino acids 1 - 269 of M85543_P6, a second amino acid     	                        Gaps:       2                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P6, a third   	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDM                            	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						corresponding to amino acids 44 - 256 of O94977, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 288 - 500 of M85543_P6, and a     	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						TESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNT 	                  .         .         .         .         .  
						ATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASG 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						DENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYI 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						ENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENE 	                  .         .         .         .         .  
						QKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHD 	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						LERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEDEHLERTLEQNKGKMAKKEEKCVLQ                                  	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 516 - 962 of O94977, which also 	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						corresponds to amino acids 501 - 947 of M85543_P6, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     495 LEPSDM............................................ 500                                                          
						polypeptide encoding for a head of M85543_P6, comprising a   	         ||||||                                              
						polypeptide being at least 70%, optionally at least about    	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     500 .................................................. 500                                                          
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	                                                            
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                  .         .         .         .         .  
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	     500 .................................................. 500                                                          
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	                                                            
						to the sequence of M85543_P6.3.An isolated chimeric          	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						polypeptide encoding for an edge portion of M85543_P6,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     500 .................................................. 500                                                          
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     500 .................................................. 500                                                          
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise EE, having a structure as follows: a sequence       	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						starting from any of amino acid numbers 287-x to 288; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 288+ ((n-2) - x), in     	     501 ...............TESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 535                                                          
						which x varies from 0 to n-2.4.An isolated chimeric          	                        |||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85543_P6,       	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     536 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 585                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     586 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 635                                                          
						comprise MT, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 500-x to 501; and    	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						ending at any of amino acid numbers 501+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     636 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 685                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     686 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 735                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     736 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 785                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 835                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     836 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 885                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     886 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 935                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKG 950                                                          
						                                                            	                  .                                          
						                                                            	     936 KMAKKEEKCVLQ                                       947                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     951 KMAKKEEKCVLQ                                       962                                                          

2976	HMR136_M85543_7_tr0_r1_1_gPRT		Comparison report between M85543_P7 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P7, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2976 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P7, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P7, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P7, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P7, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                  .         .         .         .         .  
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	         |||||||||||||||||||||||||||||||||||||               
						VLNVY                                                        	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						least 95% homologous to a polypeptide having the sequence    	                  .         .         .         .            
						corresponding to amino acids 317 - 1041 of M85543_P7, wherein	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						said first amino acid sequence, second amino acid sequence,  	                     |||||||||||||||||||||||||||||:|         
						third amino acid sequence, fourth amino acid sequence and    	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P7, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P7.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P7, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P7, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                                                            
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	                                                            
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	                                                            
						VLNVY                                                        	                                                            
						least about 95% homologous to the sequence in M85543_P7.     	                                                            

						Comparison report between M85543_P7 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a short unique tail.1.An isolated chimeric     	Sequence documentation:                                      
						polypeptide encoding for M85543_P7, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 2976 x O94977   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	                                                            
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                     Quality: 7422.00                      Escore:       0                                               
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	             Matching length:     770                Total length:     795                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	    Total Percent Similarity:   96.86      Total Percent Identity:   96.86                                               
						having the sequence corresponding to amino acids 1 - 269 of  	                        Gaps:       1                        
						M85543_P7, a second amino acid sequence being at least 90 %  	                                                            
						homologous to FDDPDAAELNPFGDPDSE corresponding to amino acids	Alignment:                                                   
						1 - 18 of O94977, which also corresponds to amino acids 270 -	                  .         .         .         .         .  
						287 of M85543_P7, a third amino acid sequence being at least 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	         ||||||||||||||||||                         |||||||  
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	                  .         .         .         .         .  
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	                  .         .         .         .         .  
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEI 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						DTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKA 	                  .         .         .         .         .  
						VTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKR 	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						QRSIQEDTKKGNEEKAAITETQRKPSEDEVLN                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 44 - 795 of  	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						O94977, which also corresponds to amino acids 288 - 1039 of  	                  .         .         .         .         .  
						M85543_P7, and a fourth amino acid sequence being at least   	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						homologous to a polypeptide having the sequence VY           	                  .         .         .         .         .  
						corresponding to amino acids 1040 - 1041 of M85543_P7,       	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence and fourth amino acid    	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M85543_P7,       	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						about 95% homologous to the sequence of M85543_P7.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						M85543_P7, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						at least two amino acids comprise EE, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						287-x to 288; and ending at any of amino acid numbers 288+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 894                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     895 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     945 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 994                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .            
						                                                            	     995 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLN      1039                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLN      795                                                          

2974	HMR136_M85543_8_tr0_r1_1_gPRT		Comparison report between M85543_P8 and Q9NWI9partial WT     	Sequence name: Q9NWI9                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85543_P8, comprising a first amino 	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment of: 2974 x Q9NWI9   ..                             
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	Alignment segment 1/1:                                       
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKIT                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2602.00                      Escore:       0                                               
						to amino acids 1 - 211 of Q9NWI9, which also corresponds to  	             Matching length:     283                Total length:     343                                               
						amino acids 1 - 211 of M85543_P8, a second amino acid        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   82.51      Total Percent Identity:   82.22                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE      	Alignment:                                                   
						corresponding to amino acids 212 - 246 of M85543_P8, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						ELINKLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE corresponding to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 212 - 252 of Q9NWI9, which also corresponds to   	       1 MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRR 50                                                           
						amino acids 247 - 287 of M85543_P8, a fourth amino acid      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTK corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						278 - 306 of Q9NWI9, which also corresponds to amino acids   	      51 KSSKAHSWQPGIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTF 100                                                          
						288 - 316 of M85543_P8, and a fifth amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	     101 VIENESPSGRRKALATSSINMKQYASPMPTQTDVKLKFKPLSKKVVSAAL 150                                                          
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                  .         .         .         .         .  
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	     151 QFSLSCIFLREGKATDEDMQSLASLMSMKQADIGNLDDFEEDNEDDDENR 200                                                          
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                  .         .         .         .         .  
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	     201 VNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSEELIN 250                                                          
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	         |||||||||||                                   ||||  
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	     201 VNQEEKAAKIT...................................ELIN 215                                                          
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                  .         .         .         .         .  
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	     251 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSE............. 287                                                          
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	         |||||||||||||||||||||||||||||||||||||               
						VLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFM 	     216 KLNFLDEAEKDLATVNSNPFDDPDAAELNPFGDPDSEEPITETASPRKTE 265                                                          
						LVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDE 	                  .         .         .         .            
						LVALVNKRDALVRDLDAQEKQ                                        	     288 ............EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRK        318                                                          
						least 95% homologous to a polypeptide having the sequence    	                     |||||||||||||||||||||||||||||:|         
						corresponding to amino acids 317 - 1177 of M85543_P8, wherein	     266 DSFYNNSYNPFKEVQTPQYLNPFDEPEAFVTIKDSPPQSTKKK        308                                                          
						said first amino acid sequence, second amino acid sequence,  	                                                            
						third amino acid sequence, fourth amino acid sequence and    	                                                            
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for an edge portion 	                                                            
						of M85543_P8, comprising an amino acid sequence being at     	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EIVNQLNALSSLDEDQDDCIKQANMRSAKSASSSE,            	                                                            
						corresponding to M85543_P8.3.An isolated chimeric polypeptide	                                                            
						encoding for an edge portion of M85543_P8, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise EE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 287-x to 288; and ending at any of amino acid   	                                                            
						numbers 288+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85543_P8, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RKNIRPVDMSKYLYADSSKTEEEELDESNPFYEPKSTPPPNNLVNPVQELETERRVKRKA 	                                                            
						PAPPVLSPKTGVLNENTVSAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYR 	                                                            
						GVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLE 	                                                            
						PSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVGNYETDTNSSVDQ 	                                                            
						EKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDSGVGESESEHQTPDDHLSPSTAS 	                                                            
						PYCRRTKSDTEPQKSQQSSGRTSGSDDPGICSNTDSTQAQVLLGKKRLLKAETLELSDLY 	                                                            
						VSDKKKDMSPPFICEETDEQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPT 	                                                            
						SKLGYSYSRDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKERA 	                                                            
						RVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERARQLIAEARSGVK 	                                                            
						MSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIPEGFVVGGGDELTNLENDLDTPE 	                                                            
						QNSKLVDLKLKKLLEVQPQVANSPSSAAQKAVTESSEQDMKSGTEDLRTERLQKTTERFR 	                                                            
						NPVVFSKDSTVRKTQLQSFSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDE 	                                                            
						VLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFM 	                                                            
						LVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTEAQKRREQLLLDE 	                                                            
						LVALVNKRDALVRDLDAQEKQ                                        	                                                            
						least about 95% homologous to the sequence in M85543_P8.     	                                                            

						Comparison report between M85543_P8 and O94977unique head    	Sequence name: O94977                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85543_P8,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 2974 x O94977   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	Alignment segment 1/1:                                       
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	                                                            
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	                     Quality: 8758.00                      Escore:       0                                               
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	             Matching length:     908                Total length:     933                                               
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   97.32      Total Percent Identity:   97.32                                               
						to amino acids 1 - 269 of M85543_P8, a second amino acid     	                        Gaps:       1                        
						sequence being at least 90 % homologous to FDDPDAAELNPFGDPDSE	                                                            
						corresponding to amino acids 1 - 18 of O94977, which also    	Alignment:                                                   
						corresponds to amino acids 270 - 287 of M85543_P8, and a     	                  .         .         .         .         .  
						EVQTPQYLNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDESNPF 	     270 FDDPDAAELNPFGDPDSE.........................EVQTPQY 294                                                          
						YEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTVSAGKDLSTSPKPS 	         ||||||||||||||||||                         |||||||  
						PIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDY 	       1 FDDPDAAELNPFGDPDSEEPITETASPRKTEDSFYNNSYNPFKEVQTPQY 50                                                           
						KSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQEL 	                  .         .         .         .         .  
						NVVQIEENSSKSTYKVGNYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDD 	     295 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 344                                                          
						SVFVNDSGVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDPGIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETDEQKLQTLDIGSNL 	      51 LNPFDEPEAFVTIKDSPPQSTKRKNIRPVDMSKYLYADSSKTEEEELDES 100                                                          
						EKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYSRDLDLAKKKHASLRQTESDPDAD 	                  .         .         .         .         .  
						RTTLNHADHSSKIVQHRLLSRQEELKERARVLLEQARRDAALKAGNKHNTNTATPFCNRQ 	     345 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 394                                                          
						LSDQQDEERRRQLRERARQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DTNEEIPEGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAAQKA 	     101 NPFYEPKSTPPPNNLVNPVQELETERRVKRKAPAPPVLSPKTGVLNENTV 150                                                          
						VTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQSFSQYIENRPEMKR 	                  .         .         .         .         .  
						QRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKDTSQYVVGELAALENEQKQIDTRA 	     395 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 444                                                          
						ALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQ           	     151 SAGKDLSTSPKPSPIPSPVLGRKPNASQSLLVWCKEVTKNYRGVKITNFT 200                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 44 - 933 of O94977, which also  	     445 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 494                                                          
						corresponds to amino acids 288 - 1177 of M85543_P8, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	     201 TSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRL 250                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     495 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 544                                                          
						head of M85543_P8, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     251 LEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQELNVVQIEENSSKSTYKVG 300                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						MASVWKRLQRVGKHASKFQFVASYQELMVECTKKWQPDKLVVVWTRRSRRKSSKAHSWQP 	     545 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 594                                                          
						GIKNPYRGVVVWPVPENIEITVTLFKDPHAEEFEDKEWTFVIENESPSGRRKALATSSIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKQYASPMPTQTDVKLKFKPLSKKVVSAALQFSLSCIFLREGKATDEDMQSLASLMSMKQ 	     301 NYETDTNSSVDQEKFYAELSDLKREPELQQPISGAVDFLSQDDSVFVNDS 350                                                          
						ADIGNLDDFEEDNEDDDENRVNQEEKAAKITEIVNQLNALSSLDEDQDDCIKQANMRSAK 	                  .         .         .         .         .  
						SASSSEELINKLNFLDEAEKDLATVNSNP                                	     595 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 644                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85543_P8.3.An isolated chimeric polypeptide encoding for an 	     351 GVGESESEHQTPDDHLSPSTASPYCRRTKSDTEPQKSQQSSGRTSGSDDP 400                                                          
						edge portion of M85543_P8, comprising a polypeptide having a 	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     645 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 694                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     401 GICSNTDSTQAQVLLGKKRLLKAETLELSDLYVSDKKKDMSPPFICEETD 450                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     695 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 744                                                          
						at least two amino acids comprise EE, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     451 EQKLQTLDIGSNLEKEKLENSRSLECRSDPESPIKKTSLSPTSKLGYSYS 500                                                          
						287-x to 288; and ending at any of amino acid numbers 288+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     745 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 794                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RDLDLAKKKHASLRQTESDPDADRTTLNHADHSSKIVQHRLLSRQEELKE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     795 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RARVLLEQARRDAALKAGNKHNTNTATPFCNRQLSDQQDEERRRQLRERA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     845 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 894                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQLIAEARSGVKMSELPSYGEMAAEKLKERSKASGDENDNIEIDTNEEIP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     895 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EGFVVGGGDELTNLENDLDTPEQNSKLVDLKLKKLLEVQPQVANSPSSAA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     945 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 994                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QKAVTESSEQDMKSGTEDLRTERLQKTTERFRNPVVFSKDSTVRKTQLQS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     995 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 1044                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FSQYIENRPEMKRQRSIQEDTKKGNEEKAAITETQRKPSEDEVLNKGFKD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1045 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 1094                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEW 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1095 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 1144                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAIEDWQKTE 900                                                          
						                                                            	                  .         .         .                      
						                                                            	    1145 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQ                  1177                                                         
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     901 AQKRREQLLLDELVALVNKRDALVRDLDAQEKQ                  933                                                          

2953	HMR136_M85543_9_tr0_r1_1_gPRT		Comparison report between M85543_P9 and O94977partial WT     	Sequence name: O94977                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85543_P9, comprising a first amino acid        	                                                            
						MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAI 	Alignment of: 2953 x O94977   ..                             
						EDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMA 	                                                            
						KKEEKCVLQ                                                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 834 - 962 of O94977, which also corresponds to   	                     Quality: 1266.00                      Escore:       0                                               
						amino acids 1 - 129 of M85543_P9.                            	             Matching length:     129                Total length:     129                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     834 MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELL 883                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     884 NRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQ 933                                                          
						                                                            	                  .         .                                
						                                                            	     101 AEEEDEHLERTLEQNKGKMAKKEEKCVLQ                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     934 AEEEDEHLERTLEQNKGKMAKKEEKCVLQ                      962                                                          

						Comparison report between M85543_P9 and Q8NDI1partial WT     	Sequence name: Q8NDI1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85543_P9, comprising a first amino acid        	                                                            
						MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAI 	Alignment of: 2953 x Q8NDI1   ..                             
						EDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQAEEEDEHLERTLEQNKGKMA 	                                                            
						KKEEKCVLQ                                                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1103 - 1231 of Q8NDI1, which also corresponds to 	                     Quality: 1266.00                      Escore:       0                                               
						amino acids 1 - 129 of M85543_P9.                            	             Matching length:     129                Total length:     129                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1103 MDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELL 1152                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1153 NRELRAMLAIEDWQKTEAQKRREQLLLDELVALVNKRDALVRDLDAQEKQ 1202                                                         
						                                                            	                  .         .                                
						                                                            	     101 AEEEDEHLERTLEQNKGKMAKKEEKCVLQ                      129                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	    1203 AEEEDEHLERTLEQNKGKMAKKEEKCVLQ                      1231                                                         

25553	HMR136_M85547_9_tr0_r1_1_gPRT		Comparison report between M85547_P9 and Q14113partial WT     	Sequence name: Q14113                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85547_P9, comprising a first amino acid sequence being at   	                                                            
						MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKDHKEPRKGEEL 	Alignment of: 25553 x Q14113   ..                            
						EEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQRGRLNMQTGATEDDYYDGAW 	                                                            
						CAEDDARTQWIEVDTRRTTRFTGVITQGRDSSIHDDFVTTFFVGFSNDSQTWVMYTNGYE 	Alignment segment 1/1:                                       
						EMTFHGNVDKDTPVLSELPEPVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNE 	                                                            
						VVATDDLDFRHHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 	                     Quality: 7179.00                      Escore:       0                                               
						GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIHLVPSLNPDGY 	             Matching length:     729                Total length:     787                                               
						EVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAEERKWVPYRVPNNNLPIPERY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						LSPDATVSTEVRAIIAWMEKNPFVLGANLNGGERLVSYPYDMARTPTQEQLLAAAMAAAR 	    Total Percent Similarity:   92.63      Total Percent Identity:   92.50                                               
						GEDEDEVSEAQETPDHAIFRWLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNP 	                        Gaps:       1                        
						RTGTINDFSYLHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 	                                                            
						DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPSAKTCNVDYDI 	Alignment:                                                   
						GATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTPQQRRLQQRR            	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 314 -  	       1 MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKD 50                                                           
						1022 of Q14113, which also corresponds to amino acids 1 - 709	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85547_P9, a second amino acid sequence being at least 90 	     314 MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKD 363                                                          
						% homologous to SETETYTEVVTEFGTEVEP corresponding to amino   	                  .         .         .         .         .  
						acids 1081 - 1099 of Q14113, which also corresponds to amino 	      51 HKEPRKGEELEEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQ 100                                                          
						acids 710 - 728 of M85547_P9, and a third amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least 80%, preferably at   	     364 HKEPRKGEELEEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQ 413                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     101 RGRLNMQTGATEDDYYDGAWCAEDDARTQWIEVDTRRTTRFTGVITQGRD 150                                                          
						DLRPSWNPSLRKRRRRRKRRR corresponding to amino acids 729 - 749 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85547_P9, wherein said first amino acid sequence, second 	     414 RGRLNMQTGATEDDYYDGAWCAEDDARTQWIEVDTRRTTRFTGVITQGRD 463                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     151 SSIHDDFVTTFFVGFSNDSQTWVMYTNGYEEMTFHGNVDKDTPVLSELPE 200                                                          
						polypeptide encoding for an edge portion of M85547_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     464 SSIHDDFVTTFFVGFSNDSQTWVMYTNGYEEMTFHGNVDKDTPVLSELPE 513                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     201 PVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNEVVATDDLDFR 250                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     514 PVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNEVVATDDLDFR 563                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise RS, having a structure as follows: a sequence       	     251 HHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 300                                                          
						starting from any of amino acid numbers 709-x to 710; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 710+ ((n-2) - x), in     	     564 HHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 613                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of M85547_P9, comprising a polypeptide   	     301 GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIH 350                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     614 GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIH 663                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						DLRPSWNPSLRKRRRRRKRRR in M85547_P9.                          	     351 LVPSLNPDGYEVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     664 LVPSLNPDGYEVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAE 713                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ERKWVPYRVPNNNLPIPERYLSPDATVSTEVRAIIAWMEKNPFVLGANLN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     714 ERKWVPYRVPNNNLPIPERYLSPDATVSTEVRAIIAWMEKNPFVLGANLN 763                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GGERLVSYPYDMARTPTQEQLLAAAMAAARGEDEDEVSEAQETPDHAIFR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     764 GGERLVSYPYDMARTPTQEQLLAAAMAAARGEDEDEVSEAQETPDHAIFR 813                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 WLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNPRTGTINDFSY 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     814 WLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNPRTGTINDFSY 863                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     864 LHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 913                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     914 DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPS 963                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 AKTCNVDYDIGATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     964 AKTCNVDYDIGATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTP 1013                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 QQRRLQQRR......................................... 709                                                          
						                                                            	         |||||||||                                           
						                                                            	    1014 QQRRLQQRRLQHRLRLRAQMRLRRLNATTTLGPHTVPPTLPPAPATTLST 1063                                                         
						                                                            	                  .         .         .                      
						                                                            	     710 .................SETETYTEVVTEFGTEVEPD              729                                                          
						                                                            	                          |||||||||||||||||||:               
						                                                            	    1064 TIEPWGLIPPTTAGWEESETETYTEVVTEFGTEVEPE              1100                                                         

						Comparison report between M85547_P9 and Q8IUX7partial WT     	Sequence name: Q8IUX7                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85547_P9, comprising a first amino acid sequence being at   	                                                            
						MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKDHKEPRKGEEL 	Alignment of: 25553 x Q8IUX7   ..                            
						EEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQRGRLNMQTGATEDDYYDGAW 	                                                            
						CAEDDARTQWIEVDTRRTTRFTGVITQGRDSSIHDDFVTTFFVGFSNDSQTWVMYTNGYE 	Alignment segment 1/1:                                       
						EMTFHGNVDKDTPVLSELPEPVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNE 	                                                            
						VVATDDLDFRHHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 	                     Quality: 7179.00                      Escore:       0                                               
						GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIHLVPSLNPDGY 	             Matching length:     729                Total length:     787                                               
						EVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAEERKWVPYRVPNNNLPIPERY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						LSPDATVSTEVRAIIAWMEKNPFVLGANLNGGERLVSYPYDMARTPTQEQLLAAAMAAAR 	    Total Percent Similarity:   92.63      Total Percent Identity:   92.50                                               
						GEDEDEVSEAQETPDHAIFRWLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNP 	                        Gaps:       1                        
						RTGTINDFSYLHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 	                                                            
						DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPSAKTCNVDYDI 	Alignment:                                                   
						GATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTPQQRRLQQRR            	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 314 -  	       1 MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKD 50                                                           
						1022 of Q8IUX7, which also corresponds to amino acids 1 - 709	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85547_P9, a second amino acid sequence being at least 90 	     314 MDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKD 363                                                          
						% homologous to SETETYTEVVTEFGTEVEP corresponding to amino   	                  .         .         .         .         .  
						acids 1081 - 1099 of Q8IUX7, which also corresponds to amino 	      51 HKEPRKGEELEEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQ 100                                                          
						acids 710 - 728 of M85547_P9, and a third amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least 80%, preferably at   	     364 HKEPRKGEELEEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQ 413                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     101 RGRLNMQTGATEDDYYDGAWCAEDDARTQWIEVDTRRTTRFTGVITQGRD 150                                                          
						DLRPSWNPSLRKRRRRRKRRR corresponding to amino acids 729 - 749 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85547_P9, wherein said first amino acid sequence, second 	     414 RGRLNMQTGATEDDYYDGAWCAEDDARTQWIEVDTRRTTRFTGVITQGRD 463                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     151 SSIHDDFVTTFFVGFSNDSQTWVMYTNGYEEMTFHGNVDKDTPVLSELPE 200                                                          
						polypeptide encoding for an edge portion of M85547_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     464 SSIHDDFVTTFFVGFSNDSQTWVMYTNGYEEMTFHGNVDKDTPVLSELPE 513                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     201 PVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNEVVATDDLDFR 250                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     514 PVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNEVVATDDLDFR 563                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise RS, having a structure as follows: a sequence       	     251 HHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 300                                                          
						starting from any of amino acid numbers 709-x to 710; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 710+ ((n-2) - x), in     	     564 HHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHEL 613                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of M85547_P9, comprising a polypeptide   	     301 GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIH 350                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     614 GEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIH 663                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						DLRPSWNPSLRKRRRRRKRRR in M85547_P9.                          	     351 LVPSLNPDGYEVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     664 LVPSLNPDGYEVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAE 713                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ERKWVPYRVPNNNLPIPERYLSPDATVSTEVRAIIAWMEKNPFVLGANLN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     714 ERKWVPYRVPNNNLPIPERYLSPDATVSTEVRAIIAWMEKNPFVLGANLN 763                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GGERLVSYPYDMARTPTQEQLLAAAMAAARGEDEDEVSEAQETPDHAIFR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     764 GGERLVSYPYDMARTPTQEQLLAAAMAAARGEDEDEVSEAQETPDHAIFR 813                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 WLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNPRTGTINDFSY 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     814 WLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNPRTGTINDFSY 863                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     864 LHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVT 913                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     914 DEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPS 963                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 AKTCNVDYDIGATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     964 AKTCNVDYDIGATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTP 1013                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 QQRRLQQRR......................................... 709                                                          
						                                                            	         |||||||||                                           
						                                                            	    1014 QQRRLQQRRLQHRLRLRAQMRLRRLNATTTLGPHTVPPTLPPAPATTLST 1063                                                         
						                                                            	                  .         .         .                      
						                                                            	     710 .................SETETYTEVVTEFGTEVEPD              729                                                          
						                                                            	                          |||||||||||||||||||:               
						                                                            	    1064 TIEPWGLIPPTTAGWEESETETYTEVVTEFGTEVEPE              1100                                                         

3104	HMR136_M85559_3_tr0_r1_1_gPRT		Comparison report between M85559_P3 and PRDA_HUMANunique     	Sequence name: PRDA_HUMAN                                    
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids and a followed by a unique            	Sequence documentation:                                      
						insertion.1.An isolated chimeric polypeptide encoding for    	                                                            
						M85559_P3, comprising a first amino acid sequence being at   	Alignment of: 3104 x PRDA_HUMAN   ..                         
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MDSKDESSHVWPTSAEHEQNAAQVHFVPDTGTVAQIVYTDDQVRPPQQVVYTADGASYTS 	                                                            
						VDGPEHTLVYIHPVEAAQTLFTDPGQVAYVQQDATAQ                        	                     Quality: 10219.00                      Escore:       0                                              
						homologous to a polypeptide having the sequence corresponding	             Matching length:    1039                Total length:    1055                                               
						to amino acids 1 - 97 of M85559_P3, a second amino acid      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDTDLDDWEPDPP 	    Total Percent Similarity:   98.48      Total Percent Identity:   98.39                                               
						RPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRARASLPLVLYIDRFLGGVFSKR 	                        Gaps:       2                        
						RIPKRTQFGPVEGPLVRGSELKDCYIHLKVSLDKGDRKERDLHEDLWFELSDETLCNWMM 	                                                            
						FVRPAQNHLEQNLVAYQYGHHVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEER 	Alignment:                                                   
						KVLREQEKNWPCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 	                  .         .         .         .         .  
						GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPEQTTIPIPQLP 	      98 QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDT 147                                                          
						QETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRRAKRIR                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      20 QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDT 69                                                           
						amino acids 20 - 424 of PRDA_HUMAN, which also corresponds to	                  .         .         .         .         .  
						amino acids 98 - 502 of M85559_P3, a third amino acid        	     148 DLDDWEPDPPRPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRAR 197                                                          
						sequence bridging amino acid sequence comprising of R, a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGREGNCPLTCDLCNKGFISSTS 	      70 DLDDWEPDPPRPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRAR 119                                                          
						LESHMKLHSDQKTYSCIFCPESFDRLDLLKDHVAIHINDGYFTCPTCKKRFPDFIQVKKH 	                  .         .         .         .         .  
						VRSFHSEKIYQCTECDKAFCRPDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRM 	     198 ASLPLVLYIDRFLGGVFSKRRIPKRTQFGPVEGPLVRGSELKDCYIHLKV 247                                                          
						HNPEREAKKADRISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIRKLRPAGPGE 	     120 ASLPLVLYIDRFLGGVFSKRRIPKRTQFGPVEGPLVRGSELKDCYIHLKV 169                                                          
						PDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRKKHPEFAQLSNTIHTPLTTA 	                  .         .         .         .         .  
						VISATPAVLTTDSATGETVVTTDLLTQAMTELSQTLTTDYRTPQGDYQRIQYIPVSQSAS 	     248 SLDKGDRKERDLHEDLWFELSDETLCNWMMFVRPAQNHLEQNLVAYQYGH 297                                                          
						GLQQPQHIQLQVVQVASATSPHQSQQSTVDVGQLHDPQPYPQHAIQVQHI           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     170 SLDKGDRKERDLHEDLWFELSDETLCNWMMFVRPAQNHLEQNLVAYQYGH 219                                                          
						corresponding to amino acids 429 - 898 of PRDA_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 504 - 973 of M85559_P3, a    	     298 HVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEERKVLREQEKNW 347                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     220 HVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEERKVLREQEKNW 269                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence QVSEPTASAPSSA corresponding  	     348 PCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 397                                                          
						to amino acids 974 - 986 of M85559_P3, and a sixth amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QVSGQPLSPSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSFRG 	     270 PCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 319                                                          
						YSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSELEEKQTSALSGGV 	                  .         .         .         .         .  
						QVEPPAHSDSLDPQTNSQQQTTQYIITTTTNGNGSSEVHITKP                  	     398 GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPE 447                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 899 - 1061 of PRDA_HUMAN, which also corresponds 	     320 GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPE 369                                                          
						to amino acids 987 - 1149 of M85559_P3, wherein said first   	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     448 QTTIPIPQLPQETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRR 497                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and sixth amino acid sequence are contiguous and in 	     370 QTTIPIPQLPQETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRR 419                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of M85559_P3, comprising a polypeptide being at least   	     498 AKRIR...RNAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGRE 544                                                          
						70%, optionally at least about 80%, preferably at least about	         |||||   :|||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     420 AKRIRLELQNAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGRE 469                                                          
						MDSKDESSHVWPTSAEHEQNAAQVHFVPDTGTVAQIVYTDDQVRPPQQVVYTADGASYTS 	                  .         .         .         .         .  
						VDGPEHTLVYIHPVEAAQTLFTDPGQVAYVQQDATAQ                        	     545 GNCPLTCDLCNKGFISSTSLESHMKLHSDQKTYSCIFCPESFDRLDLLKD 594                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85559_P3.3.An isolated polypeptide encoding for an edge     	     470 GNCPLTCDLCNKGFISSTSLESHMKLHSDQKTYSCIFCPESFDRLDLLKD 519                                                          
						portion of M85559_P3, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     595 HVAIHINDGYFTCPTCKKRFPDFIQVKKHVRSFHSEKIYQCTECDKAFCR 644                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     520 HVAIHINDGYFTCPTCKKRFPDFIQVKKHVRSFHSEKIYQCTECDKAFCR 569                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     645 PDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRMHNPEREAKKAD 694                                                          
						at least two amino acids comprise RRN having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows (numbering according to M85559_P3): a sequence       	     570 PDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRMHNPEREAKKAD 619                                                          
						starting from any of amino acid numbers 502-x to 502; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 504 + ((n-2) - x), in    	     695 RISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMKI 744                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of M85559_P3, comprising an     	     620 RISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMKI 669                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						about 80%, preferably at least about 85%, more preferably at 	     745 EEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIR 794                                                          
						least about 90% and most preferably at least about 95%       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to the sequence encoding for QVSEPTASAPSSA,       	     670 EEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIR 719                                                          
						corresponding to M85559_P3.                                  	                  .         .         .         .         .  
						                                                            	     795 KLRPAGPGEPDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRK 844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     720 KLRPAGPGEPDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRK 769                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     845 KHPEFAQLSNTIHTPLTTAVISATPAVLTTDSATGETVVTTDLLTQAMTE 894                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     770 KHPEFAQLSNTIHTPLTTAVISATPAVLTTDSATGETVVTTDLLTQAMTE 819                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     895 LSQTLTTDYRTPQGDYQRIQYIPVSQSASGLQQPQHIQLQVVQVASATSP 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     820 LSQTLTTDYRTPQGDYQRIQYIPVSQSASGLQQPQHIQLQVVQVASATSP 869                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     945 HQSQQSTVDVGQLHDPQPYPQHAIQVQHIQVSEPTASAPSSAQVSGQPLS 994                                                          
						                                                            	         |||||||||||||||||||||||||||||             ||||||||  
						                                                            	     870 HQSQQSTVDVGQLHDPQPYPQHAIQVQHI.............QVSGQPLS 906                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     995 PSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSF 1044                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     907 PSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSF 956                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1045 RGYSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSEL 1094                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     957 RGYSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSEL 1006                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1095 EEKQTSALSGGVQVEPPAHSDSLDPQTNSQQQTTQYIITTTTNGNGSSEV 1144                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1007 EEKQTSALSGGVQVEPPAHSDSLDPQTNSQQQTTQYIITTTTNGNGSSEV 1056                                                         
						                                                            	                                                             
						                                                            	    1145 HITKP                                              1149                                                         
						                                                            	         |||||                                               
						                                                            	    1057 HITKP                                              1061                                                         

3106	HMR136_M85559_4_tr0_r1_1_gPRT		Comparison report between M85559_P4 and PRDA_HUMANunique     	Sequence name: PRDA_HUMAN                                    
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids, followed by a unique insertion and a 	Sequence documentation:                                      
						followed by a unique tail.1.An isolated chimeric polypeptide 	                                                            
						encoding for M85559_P4, comprising a first amino acid        	Alignment of: 3106 x PRDA_HUMAN   ..                         
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment segment 1/1:                                       
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MDSKDESSHVWPTSAEHEQNAAQVHFVPDTGTVAQIVYTDDQVRPPQQVVYTADGASYTS 	                     Quality: 10064.00                      Escore:       0                                              
						VDGPEHTLVYIHPVEAAQTLFTDPGQVAYVQQDATAQ                        	             Matching length:    1023                Total length:    1039                                               
						having the sequence corresponding to amino acids 1 - 97 of   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						M85559_P4, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   98.46      Total Percent Identity:   98.36                                               
						QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDTDLDDWEPDPP 	                        Gaps:       2                        
						RPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRARASLPLVLYIDRFLGGVFSKR 	                                                            
						RIPKRTQFGPVEGPLVRGSELKDCYIHLKVSLDKGDRKERDLHEDLWFELSDETLCNWMM 	Alignment:                                                   
						FVRPAQNHLEQNLVAYQYGHHVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEER 	                  .         .         .         .         .  
						KVLREQEKNWPCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 	      98 QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDT 147                                                          
						GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPEQTTIPIPQLP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRRAKRIR                	      20 QVLPSIESVDGSDPLATLQTPLGRLEAKEEEDEDEDEDTEEDEEEDGEDT 69                                                           
						homologous to corresponding to amino acids 20 - 424 of       	                  .         .         .         .         .  
						PRDA_HUMAN, which also corresponds to amino acids 98 - 502 of	     148 DLDDWEPDPPRPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRAR 197                                                          
						M85559_P4, a third amino acid sequence bridging amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence comprising of R, a fourth amino acid sequence being 	      70 DLDDWEPDPPRPFDPHDLWCEECNNAHASVCPKHGPLHPIPNRPVLTRAR 119                                                          
						NAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGREGNCPLTCDLCNKGFISSTS 	                  .         .         .         .         .  
						LESHMKLHSDQKTYSCIFCPESFDRLDLLKDHVAIHINDGYFTCPTCKKRFPDFIQVKKH 	     198 ASLPLVLYIDRFLGGVFSKRRIPKRTQFGPVEGPLVRGSELKDCYIHLKV 247                                                          
						VRSFHSEKIYQCTECDKAFCRPDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HNPEREAKKADRISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMK 	     120 ASLPLVLYIDRFLGGVFSKRRIPKRTQFGPVEGPLVRGSELKDCYIHLKV 169                                                          
						IEEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIRKLRPAGPGE 	                  .         .         .         .         .  
						PDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRKKHPEFAQLSNTIHTPLTTA 	     248 SLDKGDRKERDLHEDLWFELSDETLCNWMMFVRPAQNHLEQNLVAYQYGH 297                                                          
						VISATPAVLTTDSATGETVVTTDLLTQAMTELSQTLTTDYRTPQGDYQRIQYIPVSQSAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GLQQPQHIQLQVVQVASATSPHQSQQSTVDVGQLHDPQPYPQHAIQVQHI           	     170 SLDKGDRKERDLHEDLWFELSDETLCNWMMFVRPAQNHLEQNLVAYQYGH 219                                                          
						at least 90 % homologous to corresponding to amino acids 429 	                  .         .         .         .         .  
						- 898 of PRDA_HUMAN, which also corresponds to amino acids   	     298 HVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEERKVLREQEKNW 347                                                          
						504 - 973 of M85559_P4, a fifth amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     220 HVYYTTIKNVEPKQELKVWYAASYAEFVNQKIHDISEEERKVLREQEKNW 269                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence QVSEPTASAPSSA	     348 PCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 397                                                          
						corresponding to amino acids 974 - 986 of M85559_P4, a sixth 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QVSGQPLSPSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSFRG 	     270 PCYECNRRFISSEQLQQHLNSHDEKLDVFSRTRGRGRGRGKRRFGPGRRP 319                                                          
						YSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSELEEKQTSALSGGV 	                  .         .         .         .         .  
						QVEPPAHSDSLDPQTNSQQQTTQYIIT                                  	     398 GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPE 447                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 899 - 1045 of PRDA_HUMAN, which 	     320 GRPPKFIRLEITSENGEKSDDGTQDLLHFPTKEQFDEAEPATLNGLDQPE 369                                                          
						also corresponds to amino acids 987 - 1133 of M85559_P4, and 	                  .         .         .         .         .  
						a seventh amino acid sequence being at least 70%, optionally 	     448 QTTIPIPQLPQETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRR 497                                                          
						at least 80%, preferably at least 85%, more preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90% and most preferably at least 95% homologous to a   	     370 QTTIPIPQLPQETQSSLEHEPETHTLHLQPQHEESVVPTQSTLTADDMRR 419                                                          
						AGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTM 	                  .         .         .         .         .  
						TLGDIVFKRISKRI                                               	     498 AKRIR...RNAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGRE 544                                                          
						polypeptide having the sequence corresponding to amino acids 	         |||||   :|||||||||||||||||||||||||||||||||||||||||  
						1134 - 1207 of M85559_P4, wherein said first amino acid      	     420 AKRIRLELQNAALQHLFIRKSFRPFKCLQCGKAFREKDKLDQHLRFHGRE 469                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .         .         .  
						sequence, fourth amino acid sequence, fifth amino acid       	     545 GNCPLTCDLCNKGFISSTSLESHMKLHSDQKTYSCIFCPESFDRLDLLKD 594                                                          
						sequence, sixth amino acid sequence and seventh amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     470 GNCPLTCDLCNKGFISSTSLESHMKLHSDQKTYSCIFCPESFDRLDLLKD 519                                                          
						isolated polypeptide encoding for a head of M85559_P4,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     595 HVAIHINDGYFTCPTCKKRFPDFIQVKKHVRSFHSEKIYQCTECDKAFCR 644                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     520 HVAIHINDGYFTCPTCKKRFPDFIQVKKHVRSFHSEKIYQCTECDKAFCR 569                                                          
						MDSKDESSHVWPTSAEHEQNAAQVHFVPDTGTVAQIVYTDDQVRPPQQVVYTADGASYTS 	                  .         .         .         .         .  
						VDGPEHTLVYIHPVEAAQTLFTDPGQVAYVQQDATAQ                        	     645 PDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRMHNPEREAKKAD 694                                                          
						about 95% homologous to the sequence of M85559_P4.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     570 PDKLRLHMLRHSDRKDFLCSTCGKQFKRKDKLREHMQRMHNPEREAKKAD 619                                                          
						M85559_P4, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     695 RISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMKI 744                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     620 RISRSKTFKPRITSTDYDSFTFKCRLCMMGFRRRGMLVNHLSKRHPDMKI 669                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     745 EEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIR 794                                                          
						at least two amino acids comprise RRN having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows (numbering according to M85559_P4): a sequence       	     670 EEVPELTLPIIKPNRDYFCQYCDKVYKSASKRKAHILKNHPGAELPPSIR 719                                                          
						starting from any of amino acid numbers 502-x to 502; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 504 + ((n-2) - x), in    	     795 KLRPAGPGEPDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRK 844                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of M85559_P4, comprising an     	     720 KLRPAGPGEPDPMLSTHTQLTGTIATPPVCCPHCSKQYSSKTKMVQHIRK 769                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						about 80%, preferably at least about 85%, more preferably at 	     845 KHPEFAQLSNTIHTPLTTAVISATPAVLTTDSATGETVVTTDLLTQAMTE 894                                                          
						least about 90% and most preferably at least about 95%       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to the sequence encoding for QVSEPTASAPSSA,       	     770 KHPEFAQLSNTIHTPLTTAVISATPAVLTTDSATGETVVTTDLLTQAMTE 819                                                          
						corresponding to M85559_P4.5.An isolated polypeptide encoding	                  .         .         .         .         .  
						for a tail of M85559_P4, comprising a polypeptide being at   	     895 LSQTLTTDYRTPQGDYQRIQYIPVSQSASGLQQPQHIQLQVVQVASATSP 944                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     820 LSQTLTTDYRTPQGDYQRIQYIPVSQSASGLQQPQHIQLQVVQVASATSP 869                                                          
						AGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTM 	                  .         .         .         .         .  
						TLGDIVFKRISKRI                                               	     945 HQSQQSTVDVGQLHDPQPYPQHAIQVQHIQVSEPTASAPSSAQVSGQPLS 994                                                          
						preferably at least about 95% homologous to the sequence in  	         |||||||||||||||||||||||||||||             ||||||||  
						M85559_P4.                                                   	     870 HQSQQSTVDVGQLHDPQPYPQHAIQVQHI.............QVSGQPLS 906                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     995 PSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSF 1044                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     907 PSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQQQNSSVQHTYLPSAWNSF 956                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1045 RGYSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSEL 1094                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     957 RGYSSEIQMMTLPPGQFVITDSGVATPVTTGQVKAVTSGHYVLSESQSEL 1006                                                         
						                                                            	                  .         .         .                      
						                                                            	    1095 EEKQTSALSGGVQVEPPAHSDSLDPQTNSQQQTTQYIIT            1133                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	    1007 EEKQTSALSGGVQVEPPAHSDSLDPQTNSQQQTTQYIIT            1045                                                         

25908	HMR136_M85569_7_tr0_r1_1_gPRT		Comparison report between M85569_P7 and PSE3_HUMANpartial WT 	Sequence name: PSE3_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85569_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MASLLKVDQEVKL	                                                            
						corresponding to amino acids 1 - 13 of PSE3_HUMAN, which also	Alignment of: 25908 x PSE3_HUMAN   ..                        
						corresponds to amino acids 1 - 13 of M85569_P7, a second     	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment segment 1/1:                                       
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	                     Quality: 2355.00                      Escore:       0                                               
						having the sequence KMEKWILKKIKYLQSGGLSASYYSY corresponding  	             Matching length:     254                Total length:     279                                               
						to amino acids 14 - 38 of M85569_P7, and a third amino acid  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KVDSFRERITSEAEDLVANFFPKKLLELDSFLKEPILNIHDLTQIHSDMNLPVPDPILLT 	    Total Percent Similarity:   91.04      Total Percent Identity:   91.04                                               
						NSHDGLDGPTYKKRRLDECEEAFQGTKVFVMPNGMLKSNQQLVDIIEKVKPEIRLLIEKC 	                        Gaps:       1                        
						NTVKMWVQLLIPRIEDGNNFGVSIQEETVAELRTVESEAASYLDQISRYYITRAKLVSKI 	                                                            
						AKYPHVEDYRRTVTEIDEKEYISLRLIISELRNQYVTLHDMILKNIEKIKRPRSSNAETL 	Alignment:                                                   
						Y                                                            	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MASLLKVDQEVKLKMEKWILKKIKYLQSGGLSASYYSYKVDSFRERITSE 50                                                           
						amino acids 14 - 254 of PSE3_HUMAN, which also corresponds to	         |||||||||||||                         ||||||||||||  
						amino acids 39 - 279 of M85569_P7, wherein said first amino  	       1 MASLLKVDQEVKL.........................KVDSFRERITSE 25                                                           
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	      51 AEDLVANFFPKKLLELDSFLKEPILNIHDLTQIHSDMNLPVPDPILLTNS 100                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85569_P7, comprising an amino acid sequence being at least  	      26 AEDLVANFFPKKLLELDSFLKEPILNIHDLTQIHSDMNLPVPDPILLTNS 75                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 HDGLDGPTYKKRRLDECEEAFQGTKVFVMPNGMLKSNQQLVDIIEKVKPE 150                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KMEKWILKKIKYLQSGGLSASYYSY, corresponding to M85569_P7.       	      76 HDGLDGPTYKKRRLDECEEAFQGTKVFVMPNGMLKSNQQLVDIIEKVKPE 125                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IRLLIEKCNTVKMWVQLLIPRIEDGNNFGVSIQEETVAELRTVESEAASY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     126 IRLLIEKCNTVKMWVQLLIPRIEDGNNFGVSIQEETVAELRTVESEAASY 175                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LDQISRYYITRAKLVSKIAKYPHVEDYRRTVTEIDEKEYISLRLIISELR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     176 LDQISRYYITRAKLVSKIAKYPHVEDYRRTVTEIDEKEYISLRLIISELR 225                                                          
						                                                            	                  .         .                                
						                                                            	     251 NQYVTLHDMILKNIEKIKRPRSSNAETLY                      279                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     226 NQYVTLHDMILKNIEKIKRPRSSNAETLY                      254                                                          

26645	HMR136_M85593_1_tr0_r1_1_gPRT		Comparison report between M85593_P1 and CHD2_HUMANpartial WT 	Sequence name: CHD2_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85593_P1, comprising a first amino acid sequence being at   	                                                            
						MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHGSESNSSSESS 	Alignment of: 26645 x CHD2_HUMAN   ..                        
						ESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMWEEYPDVYGVRRSNRSRQEPS 	                                                            
						RFNIKEEASSGSESGSPKRRGQRQLKKQEKWKQEPSEDEQEQGTSAESEPEQKKVKARRP 	Alignment segment 1/1:                                       
						VPRRTVPKPRVKKQPKTQRGKRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFET 	                                                            
						DSDDLIEMTGEGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEK 	                     Quality: 17023.00                      Escore:       0                                              
						DEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQWLGKVSPEDV 	             Matching length:    1718                Total length:    1718                                               
						EYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPAHSRKPAPSNEPEYLCKWMGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.94                                               
						PYSECSWEDEALIGKKFQNCIDSFHSRNNSKTIPTRECKALKQRPRFVALKKQPAYLGGE 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.94                                               
						NLELRDYQLEGLNWLAHSWCKNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVV 	                        Gaps:       0                        
						PLSTLTSWQREFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILL 	                                                            
						KDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQNSLKELWSLL 	Alignment:                                                   
						HFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRRVKKDVEKSLPAKVEQILRVE 	                  .         .         .         .         .  
						MSALQKQYYKWILTRNYKALAKGTRGSTSGFLNIVMELKKCCNHCYLIKPPEENERENGQ 	       1 MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHG 50                                                           
						EILLSLIRSSGKLILLDKLLTRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKGEIRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQAR 	       1 MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHG 50                                                           
						AHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTILENNSGRSNS 	                  .         .         .         .         .  
						NPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILRLAETRENEVSTSATDELLSQ 	      51 SESNSSSESSESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMW 100                                                          
						FKVANFATMEDEEELEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIRSSTKKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTNDSDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFI 	      51 SESNSSSESSESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMW 100                                                          
						KAYKKFGLPLERLEC                                              	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 -    	     101 EEYPDVYGVRRSNRSRQEPSRFNIKEEASSGSESGSPKRRGQRQLKKQEK 150                                                          
						1155 of CHD2_HUMAN, which also corresponds to amino acids 1 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1155 of M85593_P1, a bridging amino acid I corresponding to  	     101 EEYPDVYGVRRSNRSRQEPSRFNIKEEASSGSESGSPKRRGQRQLKKQEK 150                                                          
						amino acid 1156 of M85593_P1, a second amino acid sequence   	                  .         .         .         .         .  
						ARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGKGPGKRRGPTIKISGVQ 	     151 WKQEPSEDEQEQGTSAESEPEQKKVKARRPVPRRTVPKPRVKKQPKTQRG 200                                                          
						VNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GYGNWELIKTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEE 	     151 WKQEPSEDEQEQGTSAESEPEQKKVKARRPVPRRTVPKPRVKKQPKTQRG 200                                                          
						AKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKE 	                  .         .         .         .         .  
						NKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAGSEPVPI 	     201 KRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDDLIEMTG 250                                                          
						GEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLEHTRNCLLKIGDRIAEC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGK 	     201 KRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDDLIEMTG 250                                                          
						KPFRPEASGSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNAD 	                  .         .         .         .         .  
						RGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSR 	     251 EGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEK 300                                                          
						KRPYDQYSSDRDHRGHRDYYDR                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     251 EGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEK 300                                                          
						acids 1157 - 1718 of CHD2_HUMAN, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1157 - 1718 of M85593_P1, and a third amino acid 	     301 DEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQ 350                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     301 DEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQ 350                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence SPLERSLEQKNNPDYNWNVRKT corresponding to  	     351 WLGKVSPEDVEYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPA 400                                                          
						amino acids 1719 - 1740 of M85593_P1, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	     351 WLGKVSPEDVEYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPA 400                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     401 HSRKPAPSNEPEYLCKWMGLPYSECSWEDEALIGKKFQNCIDSFHSRNNS 450                                                          
						tail of M85593_P1, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     401 HSRKPAPSNEPEYLCKWMGLPYSECSWEDEALIGKKFQNCIDSFHSRNNS 450                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     451 KTIPTRECKALKQRPRFVALKKQPAYLGGENLELRDYQLEGLNWLAHSWC 500                                                          
						SPLERSLEQKNNPDYNWNVRKT in M85593_P1.                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KTIPTRECKALKQRPRFVALKKQPAYLGGENLELRDYQLEGLNWLAHSWC 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 KNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLSTLTSWQR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLSTLTSWQR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 KDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQ 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 KDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQ 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 NSLKELWSLLHFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 NSLKELWSLLHFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VKKDVEKSLPAKVEQILRVEMSALQKQYYKWILTRNYKALAKGTRGSTSG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VKKDVEKSLPAKVEQILRVEMSALQKQYYKWILTRNYKALAKGTRGSTSG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 FLNIVMELKKCCNHCYLIKPPEENERENGQEILLSLIRSSGKLILLDKLL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FLNIVMELKKCCNHCYLIKPPEENERENGQEILLSLIRSSGKLILLDKLL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 TRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGEIRKQAL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGEIRKQAL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQAR 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQAR 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTI 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTI 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 LENNSGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILR 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 LENNSGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILR 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 LAETRENEVSTSATDELLSQFKVANFATMEDEEELEERPHKDWDEIIPEE 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 LAETRENEVSTSATDELLSQFKVANFATMEDEEELEERPHKDWDEIIPEE 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 QRKKVEEEERQKELEEIYMLPRIRSSTKKAQTNDSDSDTESKRQAQRSSA 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 QRKKVEEEERQKELEEIYMLPRIRSSTKKAQTNDSDSDTESKRQAQRSSA 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 SESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYKKFGLPL 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 SESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYKKFGLPL 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 ERLECIARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGK 1200                                                         
						                                                            	         |||||:||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 ERLECLARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGK 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 GPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTC 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 GPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTC 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 RVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELIKTDPELKLTDKILPVE 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 RVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELIKTDPELKLTDKILPVE 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 TDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEEAKLKKRKPRVKKEN 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 TDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEEAKLKKRKPRVKKEN 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 KVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKENKEN 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKENKEN 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 KEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAG 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAG 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 SEPVPIGEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLE 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 SEPVPIGEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLE 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 HTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHK 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 HTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHK 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 LYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEASGSSRDSLISQSHTSHN 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 LYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEASGSSRDSLISQSHTSHN 1600                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 LHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNADRGDWQRERKFNYGG 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1601 LHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNADRGDWQRERKFNYGG 1650                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 GNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSRKRPY 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1651 GNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSRKRPY 1700                                                         
						                                                            	                  .                                          
						                                                            	    1701 DQYSSDRDHRGHRDYYDR                                 1718                                                         
						                                                            	         ||||||||||||||||||                                  
						                                                            	    1701 DQYSSDRDHRGHRDYYDR                                 1718                                                         

26647	HMR136_M85593_15_tr0_r1_1_gPRT		Comparison report between M85593_P15 and CHD2_HUMANunique    	Sequence name: CHD2_HUMAN                                    
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for M85593_P15, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 26647 x CHD2_HUMAN   ..                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence RFQVCCSILSVADLPILQFSCGLFL corresponding  	                                                            
						to amino acids 1 - 25 of M85593_P15, a second amino acid     	                     Quality: 8771.00                      Escore:       0                                               
						QRLDGSIKGEIRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQND 	             Matching length:     885                Total length:     885                                               
						LQAQARAHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTILENN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						SGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILRLAETRENEVSTSAT 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						DELLSQFKVANFATMEDEEELEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIR 	                        Gaps:       0                        
						SSTKKAQTNDSDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDA 	                                                            
						EIRRFIKAYKKFGLPLERLEC                                        	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 835 - 1155 of CHD2_HUMAN, which also corresponds 	      26 QRLDGSIKGEIRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVI 75                                                           
						to amino acids 26 - 346 of M85593_P15, a bridging amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						I corresponding to amino acid 347 of M85593_P15, a third     	     835 QRLDGSIKGEIRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVI 884                                                          
						ARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGKGPGKRRGPTIKISGVQ 	                  .         .         .         .         .  
						VNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEH 	      76 FDSDWNPQNDLQAQARAHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMV 125                                                          
						GYGNWELIKTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKE 	     885 FDSDWNPQNDLQAQARAHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMV 934                                                          
						NKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAGSEPVPI 	                  .         .         .         .         .  
						GEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLEHTRNCLLKIGDRIAEC 	     126 LDHLVIQRMDTTGRTILENNSGRSNSNPFNKEELTAILKFGAEDLFKELE 175                                                          
						LKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KPFRPEASGSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNAD 	     935 LDHLVIQRMDTTGRTILENNSGRSNSNPFNKEELTAILKFGAEDLFKELE 984                                                          
						RGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSR 	                  .         .         .         .         .  
						KRPYDQYSSDRDHRGHRDYYDR                                       	     176 GEESEPQEMDIDEILRLAETRENEVSTSATDELLSQFKVANFATMEDEEE 225                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1157 - 1718 of CHD2_HUMAN, which	     985 GEESEPQEMDIDEILRLAETRENEVSTSATDELLSQFKVANFATMEDEEE 1034                                                         
						also corresponds to amino acids 348 - 909 of M85593_P15, and 	                  .         .         .         .         .  
						a fourth amino acid sequence being at least 70%, optionally  	     226 LEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIRSSTKKAQTND 275                                                          
						at least 80%, preferably at least 85%, more preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90% and most preferably at least 95% homologous to a   	    1035 LEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIRSSTKKAQTND 1084                                                         
						HHHDSKRRRSDEFRPQNYHQQDFRRMSDHRPAMGYHGQGPSDHYRSFHTDKLGEYKQPLP 	                  .         .         .         .         .  
						PLHPAVSDPRSPPSQKSPHDSKSPLDHRSPLERSLEQKNNPDYNWNVRKT           	     276 SDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDA 325                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						910 - 1019 of M85593_P15, wherein said first amino acid      	    1085 SDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDA 1134                                                         
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     326 EIRRFIKAYKKFGLPLERLECIARDAELVDKSVADLKRLGELIHNSCVSA 375                                                          
						contiguous and in a sequential order.2.An isolated           	         |||||||||||||||||||||:||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M85593_P15, comprising a  	    1135 EIRRFIKAYKKFGLPLERLECLARDAELVDKSVADLKRLGELIHNSCVSA 1184                                                         
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     376 MQEYEEQLKENASEGKGPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHK 425                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence RFQVCCSILSVADLPILQFSCGLFL of M85593_P15.3.An 	    1185 MQEYEEQLKENASEGKGPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHK 1234                                                         
						isolated polypeptide encoding for a tail of M85593_P15,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     426 SIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELI 475                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	    1235 SIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELI 1284                                                         
						HHHDSKRRRSDEFRPQNYHQQDFRRMSDHRPAMGYHGQGPSDHYRSFHTDKLGEYKQPLP 	                  .         .         .         .         .  
						PLHPAVSDPRSPPSQKSPHDSKSPLDHRSPLERSLEQKNNPDYNWNVRKT           	     476 KTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGG 525                                                          
						about 95% homologous to the sequence in M85593_P15.          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1285 KTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGG 1334                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     526 EEAKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLE 575                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1335 EEAKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLE 1384                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     576 KSPMKKKQKKKENKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKS 625                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1385 KSPMKKKQKKKENKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKS 1434                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     626 SSKSKRSQGPVHITAGSEPVPIGEDEDDDLDQETFSICKERMRPVKKALK 675                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1435 SSKSKRSQGPVHITAGSEPVPIGEDEDDDLDQETFSICKERMRPVKKALK 1484                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     676 QLDKPDKGLNVQEQLEHTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLW 725                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1485 QLDKPDKGLNVQEQLEHTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLW 1534                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     726 IFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEAS 775                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1535 IFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEAS 1584                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     776 GSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSN 825                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1585 GSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSN 1634                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     826 ADRGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAH 875                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1635 ADRGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAH 1684                                                         
						                                                            	                  .         .         .                      
						                                                            	     876 RSGSYRPNNMSRKRPYDQYSSDRDHRGHRDYYDRH                910                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||:                 
						                                                            	    1685 RSGSYRPNNMSRKRPYDQYSSDRDHRGHRDYYDRY                1719                                                         

26643	HMR136_M85593_8_tr0_r1_1_gPRT		Comparison report between M85593_P8 and CHD2_HUMANpartial WT 	Sequence name: CHD2_HUMAN                                    
						sequence featuring skipped exon, a mismatch and a followed by	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85593_P8, comprising a first amino acid sequence being at   	                                                            
						MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHGSESNSSSESS 	Alignment of: 26643 x CHD2_HUMAN   ..                        
						ESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMWEEYPDVYGVRRSNRSRQEPS 	                                                            
						RFNIKEEASSGSESGSPKRRGQRQLKKQ                                 	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 148	                                                            
						of CHD2_HUMAN, which also corresponds to amino acids 1 - 148 	                     Quality: 16558.00                      Escore:       0                                              
						of M85593_P8, a second amino acid sequence being at least 90 	             Matching length:    1683                Total length:    1719                                               
						TVPKPRVKKQPKTQRGKRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.88                                               
						LIEMTGEGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEKDEGE 	    Total Percent Similarity:   97.91      Total Percent Identity:   97.79                                               
						IQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQWLGKVSPEDVEYFN 	                        Gaps:       1                        
						CQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPAHSRKPAPSNEPEYLCKWMGLPYSE 	                                                            
						CSWEDEALIGKKFQNCIDSFHSRNNSKTIPTRECKALKQRPRFVALKKQPAYLGGENLEL 	Alignment:                                                   
						RDYQLEGLNWLAHSWCKNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLST 	                  .         .         .         .         .  
						LTSWQREFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILLKDKT 	       1 MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHG 50                                                           
						VLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQNSLKELWSLLHFIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRRVKKDVEKSLPAKVEQILRVEMSAL 	       1 MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHG 50                                                           
						QKQYYKWILTRNYKALAKGTRGSTSGFLNIVMELKKCCNHCYLIKPPEENERENGQEILL 	                  .         .         .         .         .  
						SLIRSSGKLILLDKLLTRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGE 	      51 SESNSSSESSESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMW 100                                                          
						IRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQARAHRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTILENNSGRSNSNPFN 	      51 SESNSSSESSESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMW 100                                                          
						KEELTAILKFGAEDLFKELEGEESEPQEMDIDEILRLAETRENEVSTSATDELLSQFKVA 	                  .         .         .         .         .  
						NFATMEDEEELEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIRSSTKKAQTND 	     101 EEYPDVYGVRRSNRSRQEPSRFNIKEEASSGSESGSPKRRGQRQLKKQ.. 148                                                          
						SDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						KFGLPLERLEC                                                  	     101 EEYPDVYGVRRSNRSRQEPSRFNIKEEASSGSESGSPKRRGQRQLKKQEK 150                                                          
						% homologous to corresponding to amino acids 185 - 1155 of   	                  .         .         .         .         .  
						CHD2_HUMAN, which also corresponds to amino acids 149 - 1119 	     149 ..................................TVPKPRVKKQPKTQRG 164                                                          
						of M85593_P8, a bridging amino acid I corresponding to amino 	                                           ||||||||||||||||  
						acid 1120 of M85593_P8, a third amino acid sequence being at 	     151 WKQEPSEDEQEQGTSAESEPEQKKVKARRPVPRRTVPKPRVKKQPKTQRG 200                                                          
						ARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGKGPGKRRGPTIKISGVQ 	                  .         .         .         .         .  
						VNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEH 	     165 KRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDDLIEMTG 214                                                          
						GYGNWELIKTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKE 	     201 KRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDDLIEMTG 250                                                          
						NKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAGSEPVPI 	                  .         .         .         .         .  
						GEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLEHTRNCLLKIGDRIAEC 	     215 EGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEK 264                                                          
						LKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KPFRPEASGSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNAD 	     251 EGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEK 300                                                          
						RGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSR 	                  .         .         .         .         .  
						KRPYDQYSSDRDHRGHRDYYDR                                       	     265 DEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQ 314                                                          
						least 90 % homologous to corresponding to amino acids 1157 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1718 of CHD2_HUMAN, which also corresponds to amino acids    	     301 DEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQ 350                                                          
						1121 - 1682 of M85593_P8, and a fourth amino acid sequence   	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     315 WLGKVSPEDVEYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPA 364                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HHHDSKRRRSDEFRPQNYHQQDFRRMSDHRPAMGYHGQGPSDHYRSFHTDKLGEYKQPLP 	     351 WLGKVSPEDVEYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPA 400                                                          
						PLHPAVSDPRSPPSQKSPHDSKSPLDHRSPLERSLEQKNNPDYNWNVRKT           	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     365 HSRKPAPSNEPEYLCKWMGLPYSECSWEDEALIGKKFQNCIDSFHSRNNS 414                                                          
						corresponding to amino acids 1683 - 1792 of M85593_P8,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     401 HSRKPAPSNEPEYLCKWMGLPYSECSWEDEALIGKKFQNCIDSFHSRNNS 450                                                          
						sequence, bridging amino acid, third amino acid sequence and 	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     415 KTIPTRECKALKQRPRFVALKKQPAYLGGENLELRDYQLEGLNWLAHSWC 464                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of M85593_P8, comprising a polypeptide having a      	     451 KTIPTRECKALKQRPRFVALKKQPAYLGGENLELRDYQLEGLNWLAHSWC 500                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     465 KNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLSTLTSWQR 514                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     501 KNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLSTLTSWQR 550                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise QT, having a structure as  	     515 EFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILL 564                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						148-x to 149; and ending at any of amino acid numbers 149+   	     551 EFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILL 600                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85593_P8, comprising a   	     565 KDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQ 614                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     601 KDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQ 650                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						HHHDSKRRRSDEFRPQNYHQQDFRRMSDHRPAMGYHGQGPSDHYRSFHTDKLGEYKQPLP 	     615 NSLKELWSLLHFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRR 664                                                          
						PLHPAVSDPRSPPSQKSPHDSKSPLDHRSPLERSLEQKNNPDYNWNVRKT           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in M85593_P8.                                	     651 NSLKELWSLLHFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     665 VKKDVEKSLPAKVEQILRVEMSALQKQYYKWILTRNYKALAKGTRGSTSG 714                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VKKDVEKSLPAKVEQILRVEMSALQKQYYKWILTRNYKALAKGTRGSTSG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     715 FLNIVMELKKCCNHCYLIKPPEENERENGQEILLSLIRSSGKLILLDKLL 764                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FLNIVMELKKCCNHCYLIKPPEENERENGQEILLSLIRSSGKLILLDKLL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     765 TRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGEIRKQAL 814                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGEIRKQAL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     815 DHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQAR 864                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQAR 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     865 AHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTI 914                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTI 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     915 LENNSGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILR 964                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 LENNSGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILR 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     965 LAETRENEVSTSATDELLSQFKVANFATMEDEEELEERPHKDWDEIIPEE 1014                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 LAETRENEVSTSATDELLSQFKVANFATMEDEEELEERPHKDWDEIIPEE 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1015 QRKKVEEEERQKELEEIYMLPRIRSSTKKAQTNDSDSDTESKRQAQRSSA 1064                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 QRKKVEEEERQKELEEIYMLPRIRSSTKKAQTNDSDSDTESKRQAQRSSA 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1065 SESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYKKFGLPL 1114                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 SESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYKKFGLPL 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1115 ERLECIARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGK 1164                                                         
						                                                            	         |||||:||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 ERLECLARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGK 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1165 GPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTC 1214                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 GPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTC 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1215 RVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELIKTDPELKLTDKILPVE 1264                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 RVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELIKTDPELKLTDKILPVE 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1265 TDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEEAKLKKRKPRVKKEN 1314                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 TDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEEAKLKKRKPRVKKEN 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1315 KVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKENKEN 1364                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKENKEN 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1365 KEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAG 1414                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAG 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1415 SEPVPIGEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLE 1464                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 SEPVPIGEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLE 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1465 HTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHK 1514                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 HTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHK 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1515 LYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEASGSSRDSLISQSHTSHN 1564                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 LYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEASGSSRDSLISQSHTSHN 1600                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1565 LHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNADRGDWQRERKFNYGG 1614                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1601 LHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNADRGDWQRERKFNYGG 1650                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1615 GNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSRKRPY 1664                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1651 GNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSRKRPY 1700                                                         
						                                                            	                  .                                          
						                                                            	    1665 DQYSSDRDHRGHRDYYDRH                                1683                                                         
						                                                            	         ||||||||||||||||||:                                 
						                                                            	    1701 DQYSSDRDHRGHRDYYDRY                                1719                                                         

26800	HMR136_M85608_17_tr0_r1_1_gPRT		Comparison report between M85608_P17 and Q8NDM4partial WT    	Sequence name: Q8NDM4                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P17, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26800 x Q8NDM4   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 264 - 631 of Q8NDM4, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P17.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 513                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     514 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 563                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 613                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     614 GAYLKDKMRKAVAEELAK                                 631                                                          

						Comparison report between M85608_P17 and Q9Y2F6unique head   	Sequence name: Q9Y2F6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85608_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26800 x Q9Y2F6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment segment 1/1:                                       
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQ                             	                                                            
						having the sequence corresponding to amino acids 1 - 92 of   	                     Quality: 2689.00                      Escore:       0                                               
						M85608_P17, and a second amino acid sequence being at least  	             Matching length:     277                Total length:     277                                               
						HVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLVWA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.64                                               
						LCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALLEYPEYSGPLLPA 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.64                                               
						SAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLEVATQYGWVLDAEVLLDSDGEFL 	                        Gaps:       0                        
						PVRDFVAPHLAQPTGSQSPPPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFL 	                                                            
						IVDVPFYEWLELKSEWQKGAYLKDKMRKAVAEELAK                         	Alignment:                                                   
						90 % homologous to corresponding to amino acids 246 - 521 of 	                  .         .         .         .         .  
						Q9Y2F6, which also corresponds to amino acids 93 - 368 of    	      92 QHVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGL 141                                                          
						M85608_P17, wherein said first amino acid sequence and second	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     245 KHVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGL 294                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85608_P17, comprising a polypeptide being at least 70%,     	     142 EPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKL 191                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     295 EPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKL 344                                                          
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	                  .         .         .         .         .  
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQ                             	     192 LHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLL 241                                                          
						least about 95% homologous to the sequence of M85608_P17.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 LHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLL 394                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     242 GSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSP 291                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     395 GSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSP 444                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     292 PPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEW 341                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 PPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEW 494                                                          
						                                                            	                  .         .                                
						                                                            	     342 LELKSEWQKGAYLKDKMRKAVAEELAK                        368                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     495 LELKSEWQKGAYLKDKMRKAVAEELAK                        521                                                          

						Comparison report between M85608_P17 and Q9BUC6partial WT    	Sequence name: Q9BUC6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P17, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26800 x Q9BUC6   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 89 - 456 of Q9BUC6, which also corresponds to    	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P17.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      89 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 138                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     139 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 188                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 438                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     439 GAYLKDKMRKAVAEELAK                                 456                                                          

						Comparison report between M85608_P17 and Q969Z0partial WT    	Sequence name: Q969Z0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P17, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26800 x Q969Z0   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 264 - 631 of Q969Z0, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P17.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 513                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     514 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 563                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 613                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     614 GAYLKDKMRKAVAEELAK                                 631                                                          

26802	HMR136_M85608_28_tr0_r1_1_gPRT		Comparison report between M85608_P28 and Q8NDM4partial WT    	Sequence name: Q8NDM4                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P28, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26802 x Q8NDM4   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 264 - 631 of Q8NDM4, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P28.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 513                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     514 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 563                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 613                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     614 GAYLKDKMRKAVAEELAK                                 631                                                          

						Comparison report between M85608_P28 and Q9Y2F6unique head   	Sequence name: Q9Y2F6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85608_P28, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26802 x Q9Y2F6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment segment 1/1:                                       
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQ                             	                                                            
						having the sequence corresponding to amino acids 1 - 92 of   	                     Quality: 2689.00                      Escore:       0                                               
						M85608_P28, and a second amino acid sequence being at least  	             Matching length:     277                Total length:     277                                               
						HVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLVWA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.64                                               
						LCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALLEYPEYSGPLLPA 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.64                                               
						SAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLEVATQYGWVLDAEVLLDSDGEFL 	                        Gaps:       0                        
						PVRDFVAPHLAQPTGSQSPPPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFL 	                                                            
						IVDVPFYEWLELKSEWQKGAYLKDKMRKAVAEELAK                         	Alignment:                                                   
						90 % homologous to corresponding to amino acids 246 - 521 of 	                  .         .         .         .         .  
						Q9Y2F6, which also corresponds to amino acids 93 - 368 of    	      92 QHVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGL 141                                                          
						M85608_P28, wherein said first amino acid sequence and second	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     245 KHVLNRAQDITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGL 294                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85608_P28, comprising a polypeptide being at least 70%,     	     142 EPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKL 191                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     295 EPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKL 344                                                          
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	                  .         .         .         .         .  
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQ                             	     192 LHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLL 241                                                          
						least about 95% homologous to the sequence of M85608_P28.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 LHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLL 394                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     242 GSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSP 291                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     395 GSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSP 444                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     292 PPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEW 341                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 PPGSKRLAFLRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEW 494                                                          
						                                                            	                  .         .                                
						                                                            	     342 LELKSEWQKGAYLKDKMRKAVAEELAK                        368                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     495 LELKSEWQKGAYLKDKMRKAVAEELAK                        521                                                          

						Comparison report between M85608_P28 and Q9BUC6partial WT    	Sequence name: Q9BUC6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P28, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26802 x Q9BUC6   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 89 - 456 of Q9BUC6, which also corresponds to    	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P28.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      89 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 138                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     139 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 188                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 438                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     439 GAYLKDKMRKAVAEELAK                                 456                                                          

						Comparison report between M85608_P28 and Q969Z0partial WT    	Sequence name: Q969Z0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85608_P28, comprising a first amino acid       	                                                            
						MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVSQRLATDLLSL 	Alignment of: 26802 x Q969Z0   ..                            
						MPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQDITLPHLCSVLLAFARLNFHP 	                                                            
						DQEDQFFSLVHEKLGSELPGLEPALQVDLVWALCVLQQAREAELQAVLHPEFHIQFLGGK 	Alignment segment 1/1:                                       
						SQKDQNTFQKLLHINATALLEYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGL 	                                                            
						LGSADKGSLEVATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 	                     Quality: 3567.00                      Escore:       0                                               
						LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQKGAYLKDKMRK 	             Matching length:     368                Total length:     368                                               
						AVAEELAK                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 264 - 631 of Q969Z0, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 368 of M85608_P28.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 MLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKLSFHQTQVS 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 QRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQHVLNRAQD 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 ITLPHLCSVLLAFARLNFHPDQEDQFFSLVHEKLGSELPGLEPALQVDLV 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 WALCVLQQAREAELQAVLHPEFHIQFLGGKSQKDQNTFQKLLHINATALL 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 EYPEYSGPLLPASAVAPGPSALDRKVTPLQKELQETLKGLLGSADKGSLE 513                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     514 VATQYGWVLDAEVLLDSDGEFLPVRDFVAPHLAQPTGSQSPPPGSKRLAF 563                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 LRWEFPNFNSRSKDLLGRFVLARRHIVAAGFLIVDVPFYEWLELKSEWQK 613                                                          
						                                                            	                  .                                          
						                                                            	     351 GAYLKDKMRKAVAEELAK                                 368                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     614 GAYLKDKMRKAVAEELAK                                 631                                                          

26798	HMR136_M85608_6_tr0_r1_1_gPRT		Comparison report between M85608_P6 and Q9Y2F6partial WT     	Sequence name: Q9Y2F6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85608_P6, comprising a first amino 	Sequence documentation:                                      
						MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHLPGSLMEPVEK 	                                                            
						ERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQAAMVLIRLSHLLSEKPEDKGL 	Alignment of: 26798 x Q9Y2F6   ..                            
						LIQDAHFHQLLCLLNSQIASVWHGTLSKLLGSLYALGIPKASKELQSVEQEVRWRMRKLK 	                                                            
						YKHLAFLAESCATLSQEQHSQELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMN 	Alignment segment 1/1:                                       
						RLEDK                                                        	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2382.00                      Escore:       0                                               
						to amino acids 1 - 245 of Q9Y2F6, which also corresponds to  	             Matching length:     245                Total length:     245                                               
						amino acids 1 - 245 of M85608_P6, and a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						CLELVEHFGPNELRKVLVMLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKL 	Alignment:                                                   
						SFHQTQVSQRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQRTSGFCASEL 	                  .         .         .         .         .  
						PSRPRGSVLQPGT                                                	       1 MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHL 50                                                           
						having the sequence corresponding to amino acids 246 - 378 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85608_P6, wherein said first amino acid sequence and second 	       1 MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHL 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 PGSLMEPVEKERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQA 100                                                          
						M85608_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 PGSLMEPVEKERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQA 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						CLELVEHFGPNELRKVLVMLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAYAYGKL 	     101 AMVLIRLSHLLSEKPEDKGLLIQDAHFHQLLCLLNSQIASVWHGTLSKLL 150                                                          
						SFHQTQVSQRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQRTSGFCASEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSRPRGSVLQPGT                                                	     101 AMVLIRLSHLLSEKPEDKGLLIQDAHFHQLLCLLNSQIASVWHGTLSKLL 150                                                          
						least about 95% homologous to the sequence in M85608_P6.     	                  .         .         .         .         .  
						                                                            	     151 GSLYALGIPKASKELQSVEQEVRWRMRKLKYKHLAFLAESCATLSQEQHS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GSLYALGIPKASKELQSVEQEVRWRMRKLKYKHLAFLAESCATLSQEQHS 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 QELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMNRLEDK      245                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     201 QELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMNRLEDK      245                                                          

						Comparison report between M85608_P6 and Q969Z0partial WT     	Sequence name: Q969Z0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85608_P6, comprising a first amino 	Sequence documentation:                                      
						MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHLPGSLMEPVEK 	                                                            
						ERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQAAMVLIRLSHLLSEKPEDKGL 	Alignment of: 26798 x Q969Z0   ..                            
						LIQDAHFHQLLCLLNSQIASVWHGTLSKLLGSLYALGIPKASKELQSVEQEVRWRMRKLK 	                                                            
						YKHLAFLAESCATLSQEQHSQELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMN 	Alignment segment 1/1:                                       
						RLEDKCLELVEHFGPNELRKVLVMLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAY 	                                                            
						AYGKLSFHQTQVSQRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLFEAFAQ      	                     Quality: 3438.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     355                Total length:     355                                               
						to amino acids 1 - 355 of Q969Z0, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 355 of M85608_P6, and a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence RTSGFCASELPSRPRGSVLQPGT corresponding to 	                  .         .         .         .         .  
						amino acids 356 - 378 of M85608_P6, wherein said first amino 	       1 MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHL 50                                                           
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	       1 MAAHLVKRCTCLLREAARQAPAMAPVGRLRLAWVAHKTLTSSATSPISHL 50                                                           
						for a tail of M85608_P6, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	      51 PGSLMEPVEKERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQA 100                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	      51 PGSLMEPVEKERASTPYIEKQVDHLIKKATRPEELLELLGGSHDLDSNQA 100                                                          
						RTSGFCASELPSRPRGSVLQPGT in M85608_P6.                        	                  .         .         .         .         .  
						                                                            	     101 AMVLIRLSHLLSEKPEDKGLLIQDAHFHQLLCLLNSQIASVWHGTLSKLL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AMVLIRLSHLLSEKPEDKGLLIQDAHFHQLLCLLNSQIASVWHGTLSKLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GSLYALGIPKASKELQSVEQEVRWRMRKLKYKHLAFLAESCATLSQEQHS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GSLYALGIPKASKELQSVEQEVRWRMRKLKYKHLAFLAESCATLSQEQHS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMNRLEDKCLELV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QELLAELLTHLERRWTEIEDSHTLVTVMMKVGHLSEPLMNRLEDKCLELV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EHFGPNELRKVLVMLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAY 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EHFGPNELRKVLVMLAAQSRRSVPLLRAISYHLVQKPFSLTKDVLLDVAY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AYGKLSFHQTQVSQRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AYGKLSFHQTQVSQRLATDLLSLMPSLTSGEVAHCAKSFALLKWLSLPLF 350                                                          
						                                                            	                                                             
						                                                            	     351 EAFAQ                                              355                                                          
						                                                            	         |||||                                               
						                                                            	     351 EAFAQ                                              355                                                          

26948	HMR136_M85611_4_tr0_r1_1_gPRT		Comparison report between M85611_P4 and BMS1_HUMANpartial WT 	Sequence name: BMS1_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85611_P4, comprising a first amino acid        	                                                            
						MLIDASFGFEMETFEFLNICQVHGFPKIMGVLTHLDSFKHNKQLKKTKKRLKHRFWTEVY 	Alignment of: 26948 x BMS1_HUMAN   ..                        
						PGAKLFYLSGMVHGEYQNQEIHNLGRFITVMKFRPLTWQTSHPYILADRMEDLTNPEDIR 	                                                            
						TNIKCDRKVSLYGYLRGAHLKNKSQIHMPGVGDFAVSDISFLPDPCALPEQQKKRCLNEK 	Alignment segment 1/1:                                       
						EKLVYAPLSGVGGVLYDKDAVYVDLGGSHVFQDEVGPTHELVQSLISTHSTIDAKMASSR 	                                                            
						VTLFSDSKPLGSEDIDNQGLMMPKEEKQMDLNTGRMRRKAIFGDEDESGDSDDEEDDEMS 	                     Quality: 11125.00                      Escore:       0                                              
						EDDGLENGSSDEEAEEEENAEMTDQYMAVKGIKRRKLELEEDSEMDLPAFADSDDDLERS 	             Matching length:    1131                Total length:    1131                                               
						SAEEGEAEEADESSEEEDCTAGEKGISGSKAAGEGSKAGLSPANCQSDRVNLEKSLLMKK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALPTFDSGHCTAEEVFASEDESEESSSLSAEEEDSENEEAIRKKLSKPSQVSSGQKLGP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QNFIDETSDIENLLKEEEDYKEENNDSKETSGALKWKEDLSRKAAEAFLRQQQAAPNLRK 	                        Gaps:       0                        
						LIYGTVTEDNEEEDDDTLEELGGLFRVNQPDRECKHKADSLDCSRFLVEAPHDWDLEEVM 	                                                            
						NSIRDCFVTGKWEDDKDAAKVLAEDEELYGDFEDLETGDVHKGKSGPNTQNEDIEKEVKE 	Alignment:                                                   
						EIDPDEEESAKKKHLDKKRKLKEMFDAEYDEGESTYFDDLKGEMQKQAQLNRAEFEDQDD 	                  .         .         .         .         .  
						EARVQYEGFRPGMYVRIEIENVPCEFVQNFDPHYPIILGGLGNSEGNVGYVQMRLKKHRW 	       1 MLIDASFGFEMETFEFLNICQVHGFPKIMGVLTHLDSFKHNKQLKKTKKR 50                                                           
						YKKILKSRDPIIFSVGWRRFQTIPLYYIEDHNGRQRLLKYTPQHMHCGAAFWGPITPQGT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GFLAIQSVSGIMPDFRIAATGVVLDLDKSIKIVKKLKLTGFPYKIFKNTSFIKGMFNSAL 	     152 MLIDASFGFEMETFEFLNICQVHGFPKIMGVLTHLDSFKHNKQLKKTKKR 201                                                          
						EVAKFEGAVIRTVSGIRGQIKKALRAPEGAFRASFEDKLLMSDIVFMRTWYPVSIPAFYN 	                  .         .         .         .         .  
						PVTSLLKPVGEKDTWSGMRTTGQLRLAHGVRLKANKDSLYKPILRQKKHFNSLHIPKALQ 	      51 LKHRFWTEVYPGAKLFYLSGMVHGEYQNQEIHNLGRFITVMKFRPLTWQT 100                                                          
						KALPFKNKPKTQAKAGKVPKDRRRPAVIREPHERKILALLDALSTVHSQKMKKAKEQRHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HNKEHFRAKQKEEEEKLKRQKDLRKKLFRIQGQKERRNQKSSLKGAEGQLQ          	     202 LKHRFWTEVYPGAKLFYLSGMVHGEYQNQEIHNLGRFITVMKFRPLTWQT 251                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 152 - 1282 of BMS1_HUMAN, which also corresponds 	     101 SHPYILADRMEDLTNPEDIRTNIKCDRKVSLYGYLRGAHLKNKSQIHMPG 150                                                          
						to amino acids 1 - 1131 of M85611_P4.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 SHPYILADRMEDLTNPEDIRTNIKCDRKVSLYGYLRGAHLKNKSQIHMPG 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VGDFAVSDISFLPDPCALPEQQKKRCLNEKEKLVYAPLSGVGGVLYDKDA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 VGDFAVSDISFLPDPCALPEQQKKRCLNEKEKLVYAPLSGVGGVLYDKDA 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VYVDLGGSHVFQDEVGPTHELVQSLISTHSTIDAKMASSRVTLFSDSKPL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 VYVDLGGSHVFQDEVGPTHELVQSLISTHSTIDAKMASSRVTLFSDSKPL 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GSEDIDNQGLMMPKEEKQMDLNTGRMRRKAIFGDEDESGDSDDEEDDEMS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 GSEDIDNQGLMMPKEEKQMDLNTGRMRRKAIFGDEDESGDSDDEEDDEMS 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDDGLENGSSDEEAEEEENAEMTDQYMAVKGIKRRKLELEEDSEMDLPAF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 EDDGLENGSSDEEAEEEENAEMTDQYMAVKGIKRRKLELEEDSEMDLPAF 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ADSDDDLERSSAEEGEAEEADESSEEEDCTAGEKGISGSKAAGEGSKAGL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 ADSDDDLERSSAEEGEAEEADESSEEEDCTAGEKGISGSKAAGEGSKAGL 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SPANCQSDRVNLEKSLLMKKAALPTFDSGHCTAEEVFASEDESEESSSLS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 SPANCQSDRVNLEKSLLMKKAALPTFDSGHCTAEEVFASEDESEESSSLS 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AEEEDSENEEAIRKKLSKPSQVSSGQKLGPQNFIDETSDIENLLKEEEDY 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 AEEEDSENEEAIRKKLSKPSQVSSGQKLGPQNFIDETSDIENLLKEEEDY 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 KEENNDSKETSGALKWKEDLSRKAAEAFLRQQQAAPNLRKLIYGTVTEDN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 KEENNDSKETSGALKWKEDLSRKAAEAFLRQQQAAPNLRKLIYGTVTEDN 701                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EEEDDDTLEELGGLFRVNQPDRECKHKADSLDCSRFLVEAPHDWDLEEVM 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     702 EEEDDDTLEELGGLFRVNQPDRECKHKADSLDCSRFLVEAPHDWDLEEVM 751                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 NSIRDCFVTGKWEDDKDAAKVLAEDEELYGDFEDLETGDVHKGKSGPNTQ 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     752 NSIRDCFVTGKWEDDKDAAKVLAEDEELYGDFEDLETGDVHKGKSGPNTQ 801                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 NEDIEKEVKEEIDPDEEESAKKKHLDKKRKLKEMFDAEYDEGESTYFDDL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     802 NEDIEKEVKEEIDPDEEESAKKKHLDKKRKLKEMFDAEYDEGESTYFDDL 851                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 KGEMQKQAQLNRAEFEDQDDEARVQYEGFRPGMYVRIEIENVPCEFVQNF 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     852 KGEMQKQAQLNRAEFEDQDDEARVQYEGFRPGMYVRIEIENVPCEFVQNF 901                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 DPHYPIILGGLGNSEGNVGYVQMRLKKHRWYKKILKSRDPIIFSVGWRRF 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     902 DPHYPIILGGLGNSEGNVGYVQMRLKKHRWYKKILKSRDPIIFSVGWRRF 951                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 QTIPLYYIEDHNGRQRLLKYTPQHMHCGAAFWGPITPQGTGFLAIQSVSG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     952 QTIPLYYIEDHNGRQRLLKYTPQHMHCGAAFWGPITPQGTGFLAIQSVSG 1001                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 IMPDFRIAATGVVLDLDKSIKIVKKLKLTGFPYKIFKNTSFIKGMFNSAL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1002 IMPDFRIAATGVVLDLDKSIKIVKKLKLTGFPYKIFKNTSFIKGMFNSAL 1051                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 EVAKFEGAVIRTVSGIRGQIKKALRAPEGAFRASFEDKLLMSDIVFMRTW 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1052 EVAKFEGAVIRTVSGIRGQIKKALRAPEGAFRASFEDKLLMSDIVFMRTW 1101                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 YPVSIPAFYNPVTSLLKPVGEKDTWSGMRTTGQLRLAHGVRLKANKDSLY 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1102 YPVSIPAFYNPVTSLLKPVGEKDTWSGMRTTGQLRLAHGVRLKANKDSLY 1151                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KPILRQKKHFNSLHIPKALQKALPFKNKPKTQAKAGKVPKDRRRPAVIRE 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1152 KPILRQKKHFNSLHIPKALQKALPFKNKPKTQAKAGKVPKDRRRPAVIRE 1201                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 PHERKILALLDALSTVHSQKMKKAKEQRHLHNKEHFRAKQKEEEEKLKRQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1202 PHERKILALLDALSTVHSQKMKKAKEQRHLHNKEHFRAKQKEEEEKLKRQ 1251                                                         
						                                                            	                  .         .         .                      
						                                                            	    1101 KDLRKKLFRIQGQKERRNQKSSLKGAEGQLQ                    1131                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1252 KDLRKKLFRIQGQKERRNQKSSLKGAEGQLQ                    1282                                                         

3485	HMR136_M85612_3_tr0_r1_1_gPRT		Comparison report between M85612_P3 and ST35_HUMANpartial WT 	Sequence name: ST35_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85612_P3, comprising a first amino 	Sequence documentation:                                      
						METGKDGARRGTQSPERKRRSPVPRAPSTKLRPAAAARAMDPVAAEAPGEAFLARRRPEG 	                                                            
						GGGSARPRYSLLAEIGRGSYGVVYEAVAGRSGARVAVKKIRCDAPENVELALAEFWALTS 	Alignment of: 3485 x ST35_HUMAN   ..                         
						LKRRHQNVVQFEECVLQRNGLAQRMSHGNKSSQLYLRLVETSLKG                	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 165 of ST35_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 165 of M85612_P3, and a second amino acid 	                     Quality: 1583.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     165                Total length:     165                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence RFLGTHSLTTSPPEDGRGYRWWPGRLAISRQLDPAM     	                        Gaps:       0                        
						corresponding to amino acids 166 - 201 of M85612_P3, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85612_P3, comprising a   	       1 METGKDGARRGTQSPERKRRSPVPRAPSTKLRPAAAARAMDPVAAEAPGE 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 METGKDGARRGTQSPERKRRSPVPRAPSTKLRPAAAARAMDPVAAEAPGE 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence RFLGTHSLTTSPPEDGRGYRWWPGRLAISRQLDPAM in      	      51 AFLARRRPEGGGGSARPRYSLLAEIGRGSYGVVYEAVAGRSGARVAVKKI 100                                                          
						M85612_P3.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AFLARRRPEGGGGSARPRYSLLAEIGRGSYGVVYEAVAGRSGARVAVKKI 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RCDAPENVELALAEFWALTSLKRRHQNVVQFEECVLQRNGLAQRMSHGNK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RCDAPENVELALAEFWALTSLKRRHQNVVQFEECVLQRNGLAQRMSHGNK 150                                                          
						                                                            	                  .                                          
						                                                            	     151 SSQLYLRLVETSLKG                                    165                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     151 SSQLYLRLVETSLKG                                    165                                                          

3488	HMR136_M85613_11_tr0_r1_1_gPRT		Comparison report between M85613_P11 and CN5A_HUMANunique    	Sequence name: CN5A_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for M85613_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 3488 x CN5A_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence ICSISRI corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of M85613_P11, and a second amino acid sequence being at   	                                                            
						VIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTL 	                     Quality: 4059.00                      Escore:       0                                               
						EVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLN 	             Matching length:     412                Total length:     412                                               
						LVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTAC 	                        Gaps:       0                        
						DLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDA 	                                                            
						ICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN         	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 464 -  	                  .         .         .         .         .  
						875 of CN5A_HUMAN, which also corresponds to amino acids 8 - 	       8 VIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVE 57                                                           
						419 of M85613_P11, wherein said first amino acid sequence and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     464 VIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVE 513                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85613_P11, comprising a polypeptide being at least 70%,     	      58 RAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSD 107                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     514 RAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSD 563                                                          
						least about 95% homologous to the sequence ICSISRI of        	                  .         .         .         .         .  
						M85613_P11.                                                  	     108 FELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYH 157                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 FELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYH 613                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 NWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNS 207                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     614 NWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNS 663                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     208 YIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTL 257                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     664 YIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTL 713                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     258 KIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTAC 307                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     714 KIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTAC 763                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     308 DLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKI 357                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     764 DLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKI 813                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     358 PSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKM 407                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     814 PSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKM 863                                                          
						                                                            	                  .                                          
						                                                            	     408 LINGESGQAKRN                                       419                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     864 LINGESGQAKRN                                       875                                                          

3490	HMR136_M85613_14_tr0_r1_1_gPRT		Comparison report between M85613_P14 and CN5A_HUMANpartial   	Sequence name: CN5A_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85613_P14, comprising a first amino	Sequence documentation:                                      
						MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAE 	                                                            
						RVHTIPVCKEGIRGHTESCSCPLQQSPRADNSVPGTPTRKISASEFDRPLRPIVVKDSEG 	Alignment of: 3490 x CN5A_HUMAN   ..                         
						TVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLI 	                                                            
						SADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPL 	Alignment segment 1/1:                                       
						NIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDE 	                                                            
						KDFAAYLAFCGIVLHNAQLYETSLLENKRNQV                             	                     Quality: 3292.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     334                Total length:     334                                               
						to amino acids 1 - 332 of CN5A_HUMAN, which also corresponds 	 Matching Percent Similarity:   99.70   Matching Percent Identity:   99.70                                               
						to amino acids 1 - 332 of M85613_P14, and a second amino acid	    Total Percent Similarity:   99.70      Total Percent Identity:   99.70                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence SLITKE corresponding to amino acids 333 -	                  .         .         .         .         .  
						338 of M85613_P14, wherein said first amino acid sequence and	       1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKAT 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKAT 50                                                           
						M85613_P14, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 REMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSVPGTPTRK 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence SLITKE in         	      51 REMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSVPGTPTRK 100                                                          
						M85613_P14.                                                  	                  .         .         .         .         .  
						                                                            	     101 ISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDE 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 KDFAAYLAFCGIVLHNAQLYETSLLENKRNQVSL                 334                                                          
						                                                            	         |||||||||||||||||||||||||||||||| |                  
						                                                            	     301 KDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLL                 334                                                          

3907	HMR136_M85632_10_tr0_r1_1_gPRT		Comparison report between M85632_P10 and Q9H4P4unique head   	Sequence name: Q9H4P4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85632_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 3907 x Q9H4P4   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLTKILSALFAVESWRSQYSLEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKH 	Alignment segment 1/1:                                       
						QLAEQKRDIQLLKAY                                              	                                                            
						having the sequence corresponding to amino acids 1 - 75 of   	                     Quality: 1393.00                      Escore:       0                                               
						M85632_P10, and a second amino acid sequence being at least  	             Matching length:     141                Total length:     141                                               
						MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVES 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GCPASIVNELIENAHERSWPQGLATLETRQMNRRYYENYVAKRIPGKQAVVVMACENQHM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GDDMVQEPGLVMIFAHGVEEI                                        	                        Gaps:       0                        
						90 % homologous to corresponding to amino acids 1 - 141 of   	                                                            
						Q9H4P4, which also corresponds to amino acids 76 - 216 of    	Alignment:                                                   
						M85632_P10, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      76 MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQ 125                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85632_P10, comprising a polypeptide being at least 70%,     	       1 MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQ 50                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     126 AVIKRSLVESGCPASIVNELIENAHERSWPQGLATLETRQMNRRYYENYV 175                                                          
						MLTKILSALFAVESWRSQYSLEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLAEQKRDIQLLKAY                                              	      51 AVIKRSLVESGCPASIVNELIENAHERSWPQGLATLETRQMNRRYYENYV 100                                                          
						least about 95% homologous to the sequence of M85632_P10.    	                  .         .         .         .            
						                                                            	     176 AKRIPGKQAVVVMACENQHMGDDMVQEPGLVMIFAHGVEEI          216                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     101 AKRIPGKQAVVVMACENQHMGDDMVQEPGLVMIFAHGVEEI          141                                                          

						Comparison report between M85632_P10 and O75598unique head   	Sequence name: O75598                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85632_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 3907 x O75598   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLTKILSALFAVESWRSQYS corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 20 of M85632_P10, and a second amino acid    	                                                            
						LEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQLLKAYMRAIR 	                     Quality: 1940.00                      Escore:       0                                               
						SVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVESGCPAS 	             Matching length:     196                Total length:     196                                               
						IVNELIENAHERSWPQGLATLETRQMNRRYYENYVAKRIPGKQAVVVMACENQHMGDDMV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QEPGLVMIFAHGVEEI                                             	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 122 - 317 of O75598, which also corresponds to   	                                                            
						amino acids 21 - 216 of M85632_P10, wherein said first amino 	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	      21 LEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQ 70                                                           
						for a head of M85632_P10, comprising a polypeptide being at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     122 LEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQ 171                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      71 LLKAYMRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTP 120                                                          
						MLTKILSALFAVESWRSQYS of M85632_P10.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 LLKAYMRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTP 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     121 DAVLQAVIKRSLVESGCPASIVNELIENAHERSWPQGLATLETRQMNRRY 170                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 DAVLQAVIKRSLVESGCPASIVNELIENAHERSWPQGLATLETRQMNRRY 271                                                          
						                                                            	                  .         .         .         .            
						                                                            	     171 YENYVAKRIPGKQAVVVMACENQHMGDDMVQEPGLVMIFAHGVEEI     216                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     272 YENYVAKRIPGKQAVVVMACENQHMGDDMVQEPGLVMIFAHGVEEI     317                                                          

3909	HMR136_M85632_11_tr0_r1_1_gPRT		Comparison report between M85632_P11 and Q9H4P4unique head   	Sequence name: Q9H4P4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85632_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 3909 x Q9H4P4   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MGYDVTRFQGDVDEDLICPICSGVLEEPVQAPHCEHAFCNACITQWFSQQQTCPVDRSVV 	Alignment segment 1/1:                                       
						TVAHLRPVPRIMRNMLSKLQIACDNAVFGCSAVVRLDNLMSHLSDCEHNPKRPVTCEQGC 	                                                            
						GLEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQLLKAY     	                     Quality:  739.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      76                Total length:      76                                               
						to amino acids 1 - 176 of M85632_P11, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVES 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GCPASIVNELIENAHE                                             	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 76 of Q9H4P4, which also corresponds to amino	Alignment:                                                   
						acids 177 - 252 of M85632_P11, and a third amino acid        	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     177 MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQ 226                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MRAIRSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQ 50                                                           
						having the sequence PHPWQAGCCRDGL corresponding to amino     	                  .         .                                
						acids 253 - 265 of M85632_P11, wherein said first amino acid 	     227 AVIKRSLVESGCPASIVNELIENAHE                         252                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||                          
						sequence are contiguous and in a sequential order.2.An       	      51 AVIKRSLVESGCPASIVNELIENAHE                         76                                                           
						isolated polypeptide encoding for a head of M85632_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MGYDVTRFQGDVDEDLICPICSGVLEEPVQAPHCEHAFCNACITQWFSQQQTCPVDRSVV 	                                                            
						TVAHLRPVPRIMRNMLSKLQIACDNAVFGCSAVVRLDNLMSHLSDCEHNPKRPVTCEQGC 	                                                            
						GLEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQLLKAY     	                                                            
						about 95% homologous to the sequence of M85632_P11.3.An      	                                                            
						isolated polypeptide encoding for a tail of M85632_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence PHPWQAGCCRDGL in        	                                                            
						M85632_P11.                                                  	                                                            

						Comparison report between M85632_P11 and O75598partial WT    	Sequence name: O75598                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85632_P11, comprising a first amino	Sequence documentation:                                      
						MGYDVTRFQGDVDEDLICPICSGVLEEPVQAPHCEHAFCNACITQWFSQQQTCPVDRSVV 	                                                            
						TVAHLRPVPRIMRNMLSKLQIACDNAVFGCSAVVRLDNLMSHLSDCEHNPKRPVTCEQGC 	Alignment of: 3909 x O75598   ..                             
						GLEMPKDELPNHNCIKHLRSVVQQQQTRIAELEKTSAEHKHQLAEQKRDIQLLKAYMRAI 	                                                            
						RSVNPNLQNLEETIEYNEILEWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVESGCPA 	Alignment segment 1/1:                                       
						SIVNELIENAHE                                                 	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2521.00                      Escore:       0                                               
						to amino acids 1 - 252 of O75598, which also corresponds to  	             Matching length:     252                Total length:     252                                               
						amino acids 1 - 252 of M85632_P11, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence PHPWQAGCCRDGL corresponding to amino     	Alignment:                                                   
						acids 253 - 265 of M85632_P11, wherein said first amino acid 	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MGYDVTRFQGDVDEDLICPICSGVLEEPVQAPHCEHAFCNACITQWFSQQ 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of M85632_P11, comprising a polypeptide being at least  	       1 MGYDVTRFQGDVDEDLICPICSGVLEEPVQAPHCEHAFCNACITQWFSQQ 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 QTCPVDRSVVTVAHLRPVPRIMRNMLSKLQIACDNAVFGCSAVVRLDNLM 100                                                          
						at least about 95% homologous to the sequence PHPWQAGCCRDGL  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in M85632_P11.                                               	      51 QTCPVDRSVVTVAHLRPVPRIMRNMLSKLQIACDNAVFGCSAVVRLDNLM 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SHLSDCEHNPKRPVTCEQGCGLEMPKDELPNHNCIKHLRSVVQQQQTRIA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SHLSDCEHNPKRPVTCEQGCGLEMPKDELPNHNCIKHLRSVVQQQQTRIA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ELEKTSAEHKHQLAEQKRDIQLLKAYMRAIRSVNPNLQNLEETIEYNEIL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ELEKTSAEHKHQLAEQKRDIQLLKAYMRAIRSVNPNLQNLEETIEYNEIL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVESGCPASIVNELIENA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EWVNSLQPARVTRWGGMISTPDAVLQAVIKRSLVESGCPASIVNELIENA 250                                                          
						                                                            	                                                             
						                                                            	     251 HE                                                 252                                                          
						                                                            	         ||                                                  
						                                                            	     251 HE                                                 252                                                          

4072	HMR136_M85634_1_tr0_r1_1_gPRT		Comparison report between M85634_P1 and O43432unique head    	Sequence name: O43432                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a featuring a skipped exon.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M85634_P1, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 4072 x O43432   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                                                            
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                     Quality: 15147.00                      Escore:       0                                              
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	             Matching length:    1566                Total length:    1596                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 163 of M85634_P1, a second amino acid sequence being at  	    Total Percent Similarity:   98.12      Total Percent Identity:   98.12                                               
						least 90 % homologous to MNSQPQTRSP corresponding to amino   	                        Gaps:       2                        
						acids 1 - 10 of O43432, which also corresponds to amino acids	                                                            
						164 - 173 of M85634_P1, a third amino acid sequence being at 	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     164 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 213                                                          
						homologous to a polypeptide having the sequence FAAGPRPPHHQ  	         ||||||||||           |||||||||||||||||||||||||||||  
						corresponding to amino acids 174 - 184 of M85634_P1, a fourth	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	                  .         .         .         .         .  
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	     214 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 263                                                          
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	                  .         .         .         .         .  
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	     264 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 313                                                          
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	                  .         .         .         .         .  
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	     314 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 363                                                          
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	                  .         .         .         .         .  
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	     364 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 413                                                          
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	                  .         .         .         .         .  
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	     414 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 463                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 11 - 1088 of O43432, which also 	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						corresponds to amino acids 185 - 1262 of M85634_P1, and a    	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     464 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 513                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     514 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 563                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						fifth amino acid sequence being at least 90 % homologous to  	     564 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 613                                                          
						corresponding to amino acids 1108 - 1585 of O43432, which    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 1263 - 1740 of M85634_P1,    	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence, third amino acid sequence, fourth amino acid       	     614 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 663                                                          
						sequence and fifth amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						head of M85634_P1, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     664 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 713                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	     714 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 763                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P1.3.An isolated polypeptide encoding for an edge     	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						portion of M85634_P1, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     764 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 813                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						encoding for FAAGPRPPHHQ, corresponding to M85634_P1.4.An    	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     814 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 863                                                          
						M85634_P1, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     864 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 913                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						at least two amino acids comprise TA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     914 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 963                                                          
						1262-x to 1263; and ending at any of amino acid numbers 1263+	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     964 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 1013                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1014 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 1063                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1114 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1163                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1164 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1213                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1214 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1262                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1263 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1294                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1295 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1345 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1394                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1395 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1444                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1445 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1494                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1495 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1544                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1545 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1594                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1439                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1595 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1644                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1440 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1489                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1645 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1694                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1490 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1539                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1695 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1740                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1540 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1585                                                         

						Comparison report between M85634_P1 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P1,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4072 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFAAGPRP 	                     Quality: 6511.00                      Escore:       0                                               
						PHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQY 	             Matching length:     680                Total length:     699                                               
						CIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPS 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						QVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQ 	                        Gaps:       1                        
						EGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSP 	                                                            
						REDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKL 	Alignment:                                                   
						SATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPP 	                  .         .         .         .         .  
						HTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILD 	    1061 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 1110                                                         
						SQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTF 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						PFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTL 	                  .         .         .         .         .  
						DPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHL 	    1111 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 1160                                                         
						KKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFE 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						KDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR                     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	    1161 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1210                                                         
						to amino acids 1 - 1060 of M85634_P1, a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	                  .         .         .         .         .  
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	    1211 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1260                                                         
						VPKAQLGSWGKGSSGGAKASET                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						amino acids 1 - 202 of Q15597, which also corresponds to     	                  .         .         .         .         .  
						amino acids 1061 - 1262 of M85634_P1, and a third amino acid 	    1261 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1291                                                         
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||                   |||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	    1292 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1341                                                         
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	    1342 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1391                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 222 - 699 of Q15597, which also corresponds to   	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						amino acids 1263 - 1740 of M85634_P1, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	    1392 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1441                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						M85634_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1442 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1491                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFAAGPRP 	    1492 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1541                                                         
						PHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIV 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						PTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPS 	                  .         .         .         .         .  
						QVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQ 	    1542 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1591                                                         
						EGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKL 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						SATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPP 	                  .         .         .         .         .  
						HTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILD 	    1592 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1641                                                         
						SQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTF 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						PFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTL 	                  .         .         .         .         .  
						DPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHL 	    1642 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1691                                                         
						KKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFE 	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						KDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR                     	                  .         .         .         .            
						least about 95% homologous to the sequence of M85634_P1.3.An 	    1692 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1740                                                         
						isolated chimeric polypeptide encoding for an edge portion of	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						M85634_P1, comprising a polypeptide having a length "n",     	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise TA, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1262-x to 1263; and ending at any of amino acid numbers 1263+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4082	HMR136_M85634_10_tr0_r1_1_gPRT		Comparison report between M85634_P10 and O43432unique head   	Sequence name: O43432                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P10,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4082 x O43432   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	                     Quality: 12452.00                      Escore:       0                                              
						homologous to a polypeptide having the sequence corresponding	             Matching length:    1286                Total length:    1585                                               
						to amino acids 1 - 163 of M85634_P10, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPV 	    Total Percent Similarity:   81.14      Total Percent Identity:   81.14                                               
						PQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQ 	                        Gaps:       2                        
						SAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTP 	                                                            
						PQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQ                       	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 218 of O43432, which also corresponds to     	     164 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 213                                                          
						amino acids 164 - 381 of M85634_P10, a third amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERDP 	       1 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 50                                                           
						SDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTDT 	                  .         .         .         .         .  
						EGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFT 	     214 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 263                                                          
						PAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEK 	      51 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 100                                                          
						AIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKK 	                  .         .         .         .         .  
						QKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIMHDCVVKLL 	     264 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 313                                                          
						KNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVID 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTV 	     101 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 150                                                          
						QGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     314 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 363                                                          
						amino acids 499 - 1088 of O43432, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 382 - 971 of M85634_P10, and a fourth amino acid 	     151 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 200                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	                  .         .         .         .         .  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     364 SAHLAASTPVTAASDQKQ................................ 381                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	         ||||||||||||||||||                                  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	     201 SAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 250                                                          
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	                  .         .         .         .         .  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     381 .................................................. 381                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                                                            
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	     251 SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 300                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1108 - 1585 of O43432, which also corresponds to 	     381 .................................................. 381                                                          
						amino acids 972 - 1449 of M85634_P10, wherein said first     	                                                            
						amino acid sequence, second amino acid sequence, third amino 	     301 CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLV 350                                                          
						acid sequence and fourth amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     381 .................................................. 381                                                          
						for a head of M85634_P10, comprising a polypeptide being at  	                                                            
						least 70%, optionally at least about 80%, preferably at least	     351 SSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLE 400                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     381 .................................................. 381                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	     401 CIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQR 450                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						M85634_P10.3.An isolated chimeric polypeptide encoding for an	     382 ................................................AQ 383                                                          
						edge portion of M85634_P10, comprising a polypeptide having a	                                                         ||  
						length "n", wherein n is at least about 10 amino acids in    	     451 VLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPAQ 500                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     384 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 433                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     501 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 550                                                          
						at least two amino acids comprise QA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     434 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 483                                                          
						381-x to 382; and ending at any of amino acid numbers 382+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     551 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 600                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85634_P10, comprising a polypeptide having a length "n",    	     484 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 533                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     601 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 650                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     534 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 583                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TA, having a structure as  	     651 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 700                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						971-x to 972; and ending at any of amino acid numbers 972+   	     584 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 633                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     634 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 683                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     684 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 733                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     734 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 783                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     784 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 833                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     834 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 883                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     884 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 933                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     934 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET............ 971                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1051 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSLNR 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     972 .......APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1014                                                         
						                                                            	                |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 FSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1015 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1064                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1065 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1114                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1115 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1164                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1165 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1214                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1215 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1264                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1265 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1314                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1315 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1364                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1365 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1414                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1550                                                         
						                                                            	                  .         .         .                      
						                                                            	    1415 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1449                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1551 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1585                                                         

						Comparison report between M85634_P10 and Q15597unique head   	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P10,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4082 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFFQRPQI 	                     Quality: 6511.00                      Escore:       0                                               
						QPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPP 	             Matching length:     680                Total length:     699                                               
						YVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYG 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						TVESAHLAASTPVTAASDQKQAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSI 	                        Gaps:       1                        
						DKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGST 	                                                            
						DSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKIN 	Alignment:                                                   
						QPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIIT 	                  .         .         .         .         .  
						VSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQV 	     770 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 819                                                          
						SGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR            	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 769 of M85634_P10, a second amino acid    	     820 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 869                                                          
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	                  .         .         .         .         .  
						VPKAQLGSWGKGSSGGAKASET                                       	     870 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 919                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 202 of Q15597, which also corresponds to     	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						amino acids 770 - 971 of M85634_P10, and a third amino acid  	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     920 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 969                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     970 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1000                                                         
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||                   |||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	    1001 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1050                                                         
						amino acids 222 - 699 of Q15597, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 972 - 1449 of M85634_P10, wherein said first     	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	    1051 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1100                                                         
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P10, comprising a polypeptide being at least 70%,     	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	    1101 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1150                                                         
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFFQRPQI 	                  .         .         .         .         .  
						QPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPP 	    1151 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1200                                                         
						YVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYG 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						TVESAHLAASTPVTAASDQKQAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSI 	                  .         .         .         .         .  
						DKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGST 	    1201 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1250                                                         
						DSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIIT 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						VSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQV 	                  .         .         .         .         .  
						SGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLL 	    1251 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1300                                                         
						LNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M85634_P10.3.An	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						M85634_P10, comprising a polypeptide having a length "n",    	    1301 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1350                                                         
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	    1351 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1400                                                         
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TA, having a structure as  	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .            
						971-x to 972; and ending at any of amino acid numbers 972+   	    1401 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1449                                                         
						((n-2) - x), in which x varies from 0 to n-2.                	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          

4058	HMR136_M85634_11_tr0_r1_1_gPRT		Comparison report between M85634_P11 and O43432unique head   	Sequence name: O43432                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion, featuring a skipped exon and a followed by a      	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						M85634_P11, comprising a first amino acid sequence being at  	Alignment of: 4058 x O43432   ..                             
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                                                            
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                     Quality: 11429.00                      Escore:       0                                              
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	             Matching length:    1182                Total length:    1212                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 163 of M85634_P11, a second amino acid    	    Total Percent Similarity:   97.52      Total Percent Identity:   97.52                                               
						sequence being at least 90 % homologous to MNSQPQTRSP        	                        Gaps:       2                        
						corresponding to amino acids 1 - 10 of O43432, which also    	                                                            
						corresponds to amino acids 164 - 173 of M85634_P11, a third  	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     164 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 213                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||           |||||||||||||||||||||||||||||  
						having the sequence FAAGPRPPHHQ corresponding to amino acids 	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						174 - 184 of M85634_P11, a fourth amino acid sequence being  	                  .         .         .         .         .  
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	     214 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 263                                                          
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	                  .         .         .         .         .  
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	     264 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 313                                                          
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	                  .         .         .         .         .  
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	     314 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 363                                                          
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	                  .         .         .         .         .  
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	     364 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 413                                                          
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	                  .         .         .         .         .  
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	     414 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 463                                                          
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 11 -	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						1088 of O43432, which also corresponds to amino acids 185 -  	                  .         .         .         .         .  
						1262 of M85634_P11, a fifth amino acid sequence being at     	     464 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 513                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRES                           	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						least 90 % homologous to corresponding to amino acids 1108 - 	                  .         .         .         .         .  
						1201 of O43432, which also corresponds to amino acids 1263 - 	     514 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 563                                                          
						1356 of M85634_P11, and a sixth amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						GSHAVCGRAECPGPTTCFCESGSGVHPGKEPDHQGSHGPITLSAGTVRKTQQTGLFQRFF 	     564 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 613                                                          
						RNFGIGR                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						to amino acids 1357 - 1423 of M85634_P11, wherein said first 	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     614 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 663                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and sixth amino acid sequence are contiguous and in 	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of M85634_P11, comprising a polypeptide being at least  	     664 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 713                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                  .         .         .         .         .  
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	     714 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 763                                                          
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of             	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						M85634_P11.3.An isolated polypeptide encoding for an edge    	                  .         .         .         .         .  
						portion of M85634_P11, comprising an amino acid sequence     	     764 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 813                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						encoding for FAAGPRPPHHQ, corresponding to M85634_P11.4.An   	     814 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 863                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P11, comprising a polypeptide having a length "n",    	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     864 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 913                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TA, having a structure as  	     914 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 963                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1262-x to 1263; and ending at any of amino acid numbers 1263+	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85634_P11, comprising a  	     964 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 1013                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						GSHAVCGRAECPGPTTCFCESGSGVHPGKEPDHQGSHGPITLSAGTVRKTQQTGLFQRFF 	    1014 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 1063                                                         
						RNFGIGR                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in M85634_P11.                               	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1114 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1163                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1164 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1213                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1214 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1262                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1263 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1294                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1295 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .                                          
						                                                            	    1345 STEAERNKTRES                                       1356                                                         
						                                                            	         ||||||||||||                                        
						                                                            	    1190 STEAERNKTRES                                       1201                                                         

4068	HMR136_M85634_12_tr0_r1_1_gPRT		Comparison report between M85634_P12 and O43432unique head   	Sequence name: O43432                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P12,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4068 x O43432   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence MPYKQCLPIFLFL	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of M85634_P12, a second  	                                                            
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	                     Quality: 9232.00                      Escore:       0                                               
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	             Matching length:     956                Total length:     975                                               
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	    Total Percent Similarity:   98.05      Total Percent Identity:   98.05                                               
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	                        Gaps:       1                        
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	                                                            
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	Alignment:                                                   
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      14 ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 63                                                           
						corresponding to amino acids 611 - 1088 of O43432, which also	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 14 - 491 of M85634_P12, and a     	     611 ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 660                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	                  .         .         .         .         .  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	      64 LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRR 113                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	     661 LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRR 710                                                          
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	                  .         .         .         .         .  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     114 EPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRS 163                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	     711 EPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRS 760                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 1108 - 1585 of O43432, which    	     164 ILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYA 213                                                          
						also corresponds to amino acids 492 - 969 of M85634_P12,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     761 ILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYA 810                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     214 NMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKKQK 263                                                          
						head of M85634_P12, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     811 NMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKKQK 860                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MPYKQCLPIFLFL  	     264 ELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 313                                                          
						of M85634_P12.3.An isolated chimeric polypeptide encoding for	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						an edge portion of M85634_P12, comprising a polypeptide      	     861 ELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 910                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     314 HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIV 363                                                          
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     911 HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIV 960                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise TA, having a       	     364 KERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEE 413                                                          
						structure as follows: a sequence starting from any of amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 491-x to 492; and ending at any of amino acid   	     961 KERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEE 1010                                                         
						numbers 492+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     414 QRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTI 463                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1011 QRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTI 1060                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     464 DEKIQLVPKAQLGSWGKGSSGGAKASET...................APS 494                                                          
						                                                            	         ||||||||||||||||||||||||||||                   |||  
						                                                            	    1061 DEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSLNRFSALQPPAPS 1110                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     495 GSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDL 544                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1111 GSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDL 1160                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     545 LDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMS 594                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1161 LDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMS 1210                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     595 AHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELNAQGLLHVFVR 644                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1211 AHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELNAQGLLHVFVR 1260                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     645 VGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFSETLELADDMA 694                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1261 VGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFSETLELADDMA 1310                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     695 IDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVGRAGVLLSEIL 744                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1311 IDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVGRAGVLLSEIL 1360                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     745 HLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIESDSP 794                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1361 HLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIESDSP 1410                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     795 CSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSP 844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1411 CSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSP 1460                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     845 TFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQA 894                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1461 TFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQA 1510                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     895 LYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWESSKDPAEQNG 944                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1511 LYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWESSKDPAEQNG 1560                                                         
						                                                            	                  .         .                                
						                                                            	     945 KGVALKSVTAFFTWLREAEEESEDN                          969                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	    1561 KGVALKSVTAFFTWLREAEEESEDN                          1585                                                         

						Comparison report between M85634_P12 and Q15597unique head   	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P12,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4068 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MPYKQCLPIFLFLESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKIN 	Alignment segment 1/1:                                       
						QPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIIT 	                                                            
						VSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQV 	                     Quality: 6511.00                      Escore:       0                                               
						SGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLL 	             Matching length:     680                Total length:     699                                               
						LNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						to amino acids 1 - 289 of M85634_P12, a second amino acid    	                        Gaps:       1                        
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	                                                            
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	Alignment:                                                   
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	                  .         .         .         .         .  
						VPKAQLGSWGKGSSGGAKASET                                       	     290 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 339                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 202 of Q15597, which also corresponds to     	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						amino acids 290 - 491 of M85634_P12, and a third amino acid  	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     340 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 389                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     390 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 439                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     440 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 489                                                          
						amino acids 222 - 699 of Q15597, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 492 - 969 of M85634_P12, wherein said first amino	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     490 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 520                                                          
						isolated polypeptide encoding for a head of M85634_P12,      	         ||                   |||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     521 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 570                                                          
						MPYKQCLPIFLFLESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIIT 	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						VSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQV 	                  .         .         .         .         .  
						SGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLL 	     571 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 620                                                          
						LNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of M85634_P12.3.An      	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						M85634_P12, comprising a polypeptide having a length "n",    	     621 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 670                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     671 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 720                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TA, having a structure as  	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						491-x to 492; and ending at any of amino acid numbers 492+   	     721 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 770                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     771 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 820                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     821 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 870                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     871 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 920                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	     921 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  969                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          

4060	HMR136_M85634_16_tr0_r1_1_gPRT		Comparison report between M85634_P16 and O43432unique head   	Sequence name: O43432                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion, featuring a skipped exon and a followed by a      	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						M85634_P16, comprising a first amino acid sequence being at  	Alignment of: 4060 x O43432   ..                             
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                                                            
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                     Quality: 11429.00                      Escore:       0                                              
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	             Matching length:    1182                Total length:    1212                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 163 of M85634_P16, a second amino acid    	    Total Percent Similarity:   97.52      Total Percent Identity:   97.52                                               
						sequence being at least 90 % homologous to MNSQPQTRSP        	                        Gaps:       2                        
						corresponding to amino acids 1 - 10 of O43432, which also    	                                                            
						corresponds to amino acids 164 - 173 of M85634_P16, a third  	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     164 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 213                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||           |||||||||||||||||||||||||||||  
						having the sequence FAAGPRPPHHQ corresponding to amino acids 	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						174 - 184 of M85634_P16, a fourth amino acid sequence being  	                  .         .         .         .         .  
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	     214 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 263                                                          
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	                  .         .         .         .         .  
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	     264 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 313                                                          
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	                  .         .         .         .         .  
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	     314 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 363                                                          
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	                  .         .         .         .         .  
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	     364 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 413                                                          
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	                  .         .         .         .         .  
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	     414 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 463                                                          
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 11 -	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						1088 of O43432, which also corresponds to amino acids 185 -  	                  .         .         .         .         .  
						1262 of M85634_P16, a fifth amino acid sequence being at     	     464 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 513                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRES                           	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						least 90 % homologous to corresponding to amino acids 1108 - 	                  .         .         .         .         .  
						1201 of O43432, which also corresponds to amino acids 1263 - 	     514 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 563                                                          
						1356 of M85634_P16, and a sixth amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						GSHAVCGRAECPGPTTCFCESGSGVHPGKEPDHQGSHGPITLSAGTVRKTQQTGLFQRFF 	     564 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 613                                                          
						RNFGIGR                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						to amino acids 1357 - 1423 of M85634_P16, wherein said first 	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     614 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 663                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and sixth amino acid sequence are contiguous and in 	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of M85634_P16, comprising a polypeptide being at least  	     664 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 713                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                  .         .         .         .         .  
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	     714 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 763                                                          
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of             	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						M85634_P16.3.An isolated polypeptide encoding for an edge    	                  .         .         .         .         .  
						portion of M85634_P16, comprising an amino acid sequence     	     764 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 813                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						encoding for FAAGPRPPHHQ, corresponding to M85634_P16.4.An   	     814 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 863                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P16, comprising a polypeptide having a length "n",    	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     864 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 913                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TA, having a structure as  	     914 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 963                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1262-x to 1263; and ending at any of amino acid numbers 1263+	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85634_P16, comprising a  	     964 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 1013                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						GSHAVCGRAECPGPTTCFCESGSGVHPGKEPDHQGSHGPITLSAGTVRKTQQTGLFQRFF 	    1014 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 1063                                                         
						RNFGIGR                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in M85634_P16.                               	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1114 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1163                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1164 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1213                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1214 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1262                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1263 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1294                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1295 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .                                          
						                                                            	    1345 STEAERNKTRES                                       1356                                                         
						                                                            	         ||||||||||||                                        
						                                                            	    1190 STEAERNKTRES                                       1201                                                         

4064	HMR136_M85634_2_tr0_r1_1_gPRT		Comparison report between M85634_P2 and O43432partial WT     	Sequence name: O43432                                        
						sequence followed by unique insertion and a featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						M85634_P2, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MNSQPQTRSP corresponding to amino   	Alignment of: 4064 x O43432   ..                             
						acids 1 - 10 of O43432, which also corresponds to amino acids	                                                            
						1 - 10 of M85634_P2, a second amino acid sequence being at   	Alignment segment 1/1:                                       
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	                     Quality: 15147.00                      Escore:       0                                              
						homologous to a polypeptide having the sequence FAAGPRPPHHQ  	             Matching length:    1566                Total length:    1596                                               
						corresponding to amino acids 11 - 21 of M85634_P2, a third   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	    Total Percent Similarity:   98.12      Total Percent Identity:   98.12                                               
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	                        Gaps:       2                        
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	                                                            
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	Alignment:                                                   
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	                  .         .         .         .         .  
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	       1 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 50                                                           
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	         ||||||||||           |||||||||||||||||||||||||||||  
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	                  .         .         .         .         .  
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	      51 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 100                                                          
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	                  .         .         .         .         .  
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	     101 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 150                                                          
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	                  .         .         .         .         .  
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	     151 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 200                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 11 - 1088 of O43432, which also 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						corresponds to amino acids 22 - 1099 of M85634_P2, and a     	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     201 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 250                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     251 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 300                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     301 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 350                                                          
						corresponding to amino acids 1108 - 1585 of O43432, which    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 1100 - 1577 of M85634_P2,    	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence, third amino acid sequence and fourth amino acid    	     351 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 400                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						M85634_P2, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     401 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 450                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						FAAGPRPPHHQ, corresponding to M85634_P2.3.An isolated        	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     451 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 500                                                          
						M85634_P2, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     501 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 550                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						at least two amino acids comprise TA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     551 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 600                                                          
						1099-x to 1100; and ending at any of amino acid numbers 1100+	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1099                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1100 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1131                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1132 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1181                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1182 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1231                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1232 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1281                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1282 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1331                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1332 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1381                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1382 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1431                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1439                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1432 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1481                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1440 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1489                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1482 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1531                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1490 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1539                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1532 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1577                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1540 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1585                                                         

						Comparison report between M85634_P2 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P2,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4064 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIM 	Alignment segment 1/1:                                       
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	                                                            
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	                     Quality: 6511.00                      Escore:       0                                               
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	             Matching length:     680                Total length:     699                                               
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	                        Gaps:       1                        
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	                                                            
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	Alignment:                                                   
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	                  .         .         .         .         .  
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	     898 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 947                                                          
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	                  .         .         .         .         .  
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	     948 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 997                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 897 of M85634_P2, a second amino acid     	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	                  .         .         .         .         .  
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	     998 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1047                                                         
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VPKAQLGSWGKGSSGGAKASET                                       	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 202 of Q15597, which also corresponds to     	    1048 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1097                                                         
						amino acids 898 - 1099 of M85634_P2, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	                  .         .         .         .         .  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	    1098 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1128                                                         
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	         ||                   |||||||||||||||||||||||||||||  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	                  .         .         .         .         .  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	    1129 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1178                                                         
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						amino acids 222 - 699 of Q15597, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1100 - 1577 of M85634_P2, wherein said first     	    1179 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1228                                                         
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85634_P2, comprising a polypeptide being at least 70%,      	    1229 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1278                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIM 	                  .         .         .         .         .  
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	    1279 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1328                                                         
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	                  .         .         .         .         .  
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	    1329 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1378                                                         
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	                  .         .         .         .         .  
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	    1379 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1428                                                         
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	                  .         .         .         .         .  
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	    1429 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1478                                                         
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M85634_P2.3.An 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						M85634_P2, comprising a polypeptide having a length "n",     	    1479 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1528                                                         
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .            
						preferably at least about 40 amino acids in length and most  	    1529 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1577                                                         
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						at least two amino acids comprise TA, having a structure as  	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1099-x to 1100; and ending at any of amino acid numbers 1100+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4078	HMR136_M85634_3_tr0_r1_1_gPRT		Comparison report between M85634_P3 and O43432partial WT     	Sequence name: O43432                                        
						sequence followed by unique insertion and a featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						M85634_P3, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MNSQPQTRSP corresponding to amino   	Alignment of: 4078 x O43432   ..                             
						acids 1 - 10 of O43432, which also corresponds to amino acids	                                                            
						1 - 10 of M85634_P3, a second amino acid sequence being at   	Alignment segment 1/1:                                       
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	                     Quality: 15147.00                      Escore:       0                                              
						homologous to a polypeptide having the sequence FAAGPRPPHHQ  	             Matching length:    1566                Total length:    1596                                               
						corresponding to amino acids 11 - 21 of M85634_P3, a third   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	    Total Percent Similarity:   98.12      Total Percent Identity:   98.12                                               
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	                        Gaps:       2                        
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	                                                            
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	Alignment:                                                   
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	                  .         .         .         .         .  
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	       1 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 50                                                           
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	         ||||||||||           |||||||||||||||||||||||||||||  
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	                  .         .         .         .         .  
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	      51 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 100                                                          
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	                  .         .         .         .         .  
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	     101 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 150                                                          
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	                  .         .         .         .         .  
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	     151 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 200                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 11 - 1088 of O43432, which also 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						corresponds to amino acids 22 - 1099 of M85634_P3, and a     	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     201 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 250                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     251 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 300                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     301 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 350                                                          
						corresponding to amino acids 1108 - 1585 of O43432, which    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 1100 - 1577 of M85634_P3,    	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence, third amino acid sequence and fourth amino acid    	     351 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 400                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						M85634_P3, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     401 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 450                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						FAAGPRPPHHQ, corresponding to M85634_P3.3.An isolated        	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     451 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 500                                                          
						M85634_P3, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     501 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 550                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						at least two amino acids comprise TA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     551 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 600                                                          
						1099-x to 1100; and ending at any of amino acid numbers 1100+	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1099                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1100 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1131                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1132 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1181                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1182 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1231                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1232 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1281                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1282 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1331                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1332 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1381                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1382 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1431                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1439                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1432 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1481                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1440 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1489                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1482 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1531                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1490 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1539                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1532 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1577                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1540 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1585                                                         

						Comparison report between M85634_P3 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P3,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4078 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIM 	Alignment segment 1/1:                                       
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	                                                            
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	                     Quality: 6511.00                      Escore:       0                                               
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	             Matching length:     680                Total length:     699                                               
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	                        Gaps:       1                        
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	                                                            
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	Alignment:                                                   
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	                  .         .         .         .         .  
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	     898 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 947                                                          
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	                  .         .         .         .         .  
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	     948 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 997                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 897 of M85634_P3, a second amino acid     	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	                  .         .         .         .         .  
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	     998 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1047                                                         
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VPKAQLGSWGKGSSGGAKASET                                       	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 202 of Q15597, which also corresponds to     	    1048 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1097                                                         
						amino acids 898 - 1099 of M85634_P3, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	                  .         .         .         .         .  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	    1098 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1128                                                         
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	         ||                   |||||||||||||||||||||||||||||  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	                  .         .         .         .         .  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	    1129 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1178                                                         
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						amino acids 222 - 699 of Q15597, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1100 - 1577 of M85634_P3, wherein said first     	    1179 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1228                                                         
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85634_P3, comprising a polypeptide being at least 70%,      	    1229 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1278                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIM 	                  .         .         .         .         .  
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	    1279 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1328                                                         
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	                  .         .         .         .         .  
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	    1329 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1378                                                         
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	                  .         .         .         .         .  
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	    1379 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1428                                                         
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	                  .         .         .         .         .  
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	    1429 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1478                                                         
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M85634_P3.3.An 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						M85634_P3, comprising a polypeptide having a length "n",     	    1479 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1528                                                         
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .            
						preferably at least about 40 amino acids in length and most  	    1529 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1577                                                         
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						at least two amino acids comprise TA, having a structure as  	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1099-x to 1100; and ending at any of amino acid numbers 1100+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4062	HMR136_M85634_4_tr0_r1_1_gPRT		Comparison report between M85634_P4 and O43432unique head    	Sequence name: O43432                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P4,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4062 x O43432   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MLKFLVWFLQWCVCVLVQPAKELLHCLKMQMRISKYTKCLQ corresponding to   	                                                            
						amino acids 1 - 41 of M85634_P4, a second amino acid sequence	                     Quality: 10314.00                      Escore:       0                                              
						AQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERDP 	             Matching length:    1068                Total length:    1087                                               
						SDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFT 	    Total Percent Similarity:   98.25      Total Percent Identity:   98.25                                               
						PAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQK 	                        Gaps:       1                        
						RDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEK 	                                                            
						AIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKK 	Alignment:                                                   
						QKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIMHDCVVKLL 	                  .         .         .         .         .  
						KNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVID 	      42 AQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKM 91                                                           
						LRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET           	     499 AQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKM 548                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 499 - 1088 of O43432, which also corresponds to amino  	      92 SQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTD 141                                                          
						acids 42 - 631 of M85634_P4, and a third amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     549 SQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTD 598                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	                  .         .         .         .         .  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     142 SSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPI 191                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     599 SSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPI 648                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	                  .         .         .         .         .  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     192 SDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLN 241                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     649 SDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLN 698                                                          
						acids 1108 - 1585 of O43432, which also corresponds to amino 	                  .         .         .         .         .  
						acids 632 - 1109 of M85634_P4, wherein said first amino acid 	     242 VGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPEN 291                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     699 VGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPEN 748                                                          
						isolated polypeptide encoding for a head of M85634_P4,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     292 IKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEK 341                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     749 IKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEK 798                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						MLKFLVWFLQWCVCVLVQPAKELLHCLKMQMRISKYTKCLQ of M85634_P4.3.An  	     342 AIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKD 391                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P4, comprising a polypeptide having a length "n",     	     799 AIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKD 848                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     392 KADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGE 441                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     849 KADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGE 898                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TA, having a structure as  	     442 LFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPR 491                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						631-x to 632; and ending at any of amino acid numbers 632+   	     899 LFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPR 948                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     492 MDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQ 541                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     949 MDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQ 998                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     542 IHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLD 591                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     999 IHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLD 1048                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     592 PSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET.......... 631                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	    1049 PSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSL 1098                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     632 .........APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARP 672                                                          
						                                                            	                  |||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1099 NRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARP 1148                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     673 NTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKT 722                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1149 NTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKT 1198                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     723 RESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEE 772                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1199 RESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEE 1248                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     773 LNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKG 822                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1249 LNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKG 1298                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     823 FSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLP 872                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1299 FSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLP 1348                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     873 VGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLL 922                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1349 VGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLL 1398                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     923 EQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWV 972                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1399 EQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWV 1448                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     973 EANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLK 1022                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1449 EANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLK 1498                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 YLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYK 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1499 YLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYK 1548                                                         
						                                                            	                  .         .         .                      
						                                                            	    1073 WESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN              1109                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1549 WESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN              1585                                                         

						Comparison report between M85634_P4 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P4,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4062 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MLKFLVWFLQWCVCVLVQPAKELLHCLKMQMRISKYTKCLQAQIAITVPKTWKKPKDRTR 	Alignment segment 1/1:                                       
						TTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPV 	                                                            
						RNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPA 	                     Quality: 6511.00                      Escore:       0                                               
						CIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLL 	             Matching length:     680                Total length:     699                                               
						NVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLV 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						TLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDE 	                        Gaps:       1                        
						LEEAKDKAR                                                    	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 429 of M85634_P4, a second amino acid     	                  .         .         .         .         .  
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	     430 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 479                                                          
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						VPKAQLGSWGKGSSGGAKASET                                       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     480 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 529                                                          
						amino acids 1 - 202 of Q15597, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 430 - 631 of M85634_P4, and a third amino acid   	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	                  .         .         .         .         .  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     530 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 579                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	                  .         .         .         .         .  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     580 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 629                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 222 - 699 of Q15597, which also corresponds to   	     630 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 660                                                          
						amino acids 632 - 1109 of M85634_P4, wherein said first amino	         ||                   |||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M85634_P4,       	     661 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 710                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MLKFLVWFLQWCVCVLVQPAKELLHCLKMQMRISKYTKCLQAQIAITVPKTWKKPKDRTR 	     711 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 760                                                          
						TTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPA 	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						CIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLL 	                  .         .         .         .         .  
						NVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRK 	     761 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 810                                                          
						VRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDE 	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						LEEAKDKAR                                                    	                  .         .         .         .         .  
						about 95% homologous to the sequence of M85634_P4.3.An       	     811 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 860                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P4, comprising a polypeptide having a length "n",     	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     861 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 910                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TA, having a structure as  	     911 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 960                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						631-x to 632; and ending at any of amino acid numbers 632+   	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     961 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1010                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1011 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1060                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	    1061 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1109                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          

4066	HMR136_M85634_5_tr0_r1_1_gPRT		Comparison report between M85634_P5 and O43432partial WT     	Sequence name: O43432                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85634_P5, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MNSQPQTRSP corresponding to amino   	Alignment of: 4066 x O43432   ..                             
						acids 1 - 10 of O43432, which also corresponds to amino acids	                                                            
						1 - 10 of M85634_P5, a second amino acid sequence being at   	Alignment segment 1/1:                                       
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	                     Quality: 4834.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence FAAGPRPPHHQ  	             Matching length:     500                Total length:     511                                               
						corresponding to amino acids 11 - 21 of M85634_P5, a third   	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.60                                               
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	    Total Percent Similarity:   97.65      Total Percent Identity:   97.46                                               
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	                        Gaps:       1                        
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	                                                            
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	Alignment:                                                   
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	                  .         .         .         .         .  
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	       1 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 50                                                           
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	         ||||||||||           |||||||||||||||||||||||||||||  
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						NSRRSPVP                                                     	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      51 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 100                                                          
						corresponding to amino acids 11 - 498 of O43432, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 22 - 509 of M85634_P5, and a      	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     101 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 150                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence GKPFCH corresponding to amino	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						acids 510 - 515 of M85634_P5, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, second amino acid sequence, third amino acid       	     151 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 200                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for an 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						edge portion of M85634_P5, comprising an amino acid sequence 	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     201 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 250                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						encoding for FAAGPRPPHHQ, corresponding to M85634_P5.3.An    	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of M85634_P5,       	     251 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 300                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence GKPFCH in M85634_P5.    	     301 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						                                                            	                  .                                          
						                                                            	     501 LNSRRSPVPGK                                        511                                                          
						                                                            	         ||||||||| :                                         
						                                                            	     490 LNSRRSPVPAQ                                        500                                                          

4076	HMR136_M85634_6_tr0_r1_1_gPRT		Comparison report between M85634_P6 and O43432partial WT     	Sequence name: O43432                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85634_P6, comprising a first amino 	Sequence documentation:                                      
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	                                                            
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	Alignment of: 4076 x O43432   ..                             
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	                                                            
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	Alignment segment 1/1:                                       
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	                                                            
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	                     Quality: 14745.00                      Escore:       0                                              
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	             Matching length:    1517                Total length:    1536                                               
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	    Total Percent Similarity:   98.76      Total Percent Identity:   98.76                                               
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	                        Gaps:       1                        
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	                                                            
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	Alignment:                                                   
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	                  .         .         .         .         .  
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 	       1 MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGP 50                                                           
						IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQE 	      50 MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGP 99                                                           
						EQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPK 	                  .         .         .         .         .  
						AQLGSWGKGSSGGAKASET                                          	      51 GPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQ 100                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 50 - 1088 of O43432, which also corresponds to	     100 GPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQ 149                                                          
						amino acids 1 - 1039 of M85634_P6, and a second amino acid   	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     101 GGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTV 150                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     150 GGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTV 199                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     151 ESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQ 200                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     200 ESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQ 249                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     201 TSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDD 250                                                          
						amino acids 1108 - 1585 of O43432, which also corresponds to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1040 - 1517 of M85634_P6, wherein said first     	     250 TSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDD 299                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     251 RCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 300                                                          
						polypeptide encoding for an edge portion of M85634_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     300 RCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 349                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     301 VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKL 350                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     350 VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKL 399                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise TA, having a structure as follows: a sequence       	     351 ECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQ 400                                                          
						starting from any of amino acid numbers 1039-x to 1040; and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 1040+ ((n-2) - x), in    	     400 ECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQ 449                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     401 RVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 RVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPA 499                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     500 QIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMS 549                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 QGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 QGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDS 599                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     600 SGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 649                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     650 DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNV 699                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 GSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENI 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     700 GSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENI 749                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 KTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKA 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     750 KTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKA 799                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 IDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDK 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     800 IDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDK 849                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGEL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     850 ADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGEL 899                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRM 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     900 FKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRM 949                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 DQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQI 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     950 DQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQI 999                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 HKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDP 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1000 HKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDP 1049                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 SKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET........... 1039                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	    1050 SKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSLN 1099                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1040 ........APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPN 1081                                                         
						                                                            	                 ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1100 RFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPN 1149                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1082 TFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTR 1131                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1150 TFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTR 1199                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1132 ESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEEL 1181                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1200 ESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEEL 1249                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1182 NAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGF 1231                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1250 NAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGF 1299                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1232 SETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPV 1281                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1300 SETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPV 1349                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1282 GRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLE 1331                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1350 GRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLE 1399                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1332 QKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVE 1381                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1400 QKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVE 1449                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1382 ANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKY 1431                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1450 ANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKY 1499                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1432 LDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKW 1481                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1500 LDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKW 1549                                                         
						                                                            	                  .         .         .                      
						                                                            	    1482 ESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN               1517                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	    1550 ESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN               1585                                                         

						Comparison report between M85634_P6 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P6,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4076 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	Alignment segment 1/1:                                       
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	                                                            
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	                     Quality: 6511.00                      Escore:       0                                               
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	             Matching length:     680                Total length:     699                                               
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	                        Gaps:       1                        
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	                                                            
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	Alignment:                                                   
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	                  .         .         .         .         .  
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	     838 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 887                                                          
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     888 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 937                                                          
						to amino acids 1 - 837 of M85634_P6, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	                  .         .         .         .         .  
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	     938 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 987                                                          
						VPKAQLGSWGKGSSGGAKASET                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						amino acids 1 - 202 of Q15597, which also corresponds to     	                  .         .         .         .         .  
						amino acids 838 - 1039 of M85634_P6, and a third amino acid  	     988 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1037                                                         
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	    1038 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1068                                                         
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||                   |||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	    1069 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1118                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 222 - 699 of Q15597, which also corresponds to   	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						amino acids 1040 - 1517 of M85634_P6, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	    1119 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1168                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						M85634_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1169 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1218                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYG 	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						TPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTP 	                  .         .         .         .         .  
						PIGRPTSTPTPPQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLK 	    1219 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1268                                                         
						SPSPVLRLVLSGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPL 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						VSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPS 	                  .         .         .         .         .  
						TVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEI 	    1269 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1318                                                         
						QNKIEVEADGQTEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAEEELSIDKVLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPIS 	                  .         .         .         .         .  
						DVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQR 	    1319 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1368                                                         
						REPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNQLMKQVSGLTVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGN 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						TVNFRKLLLNRCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85634_P6.3.An 	    1369 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1418                                                         
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P6, comprising a polypeptide having a length "n",     	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	    1419 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1468                                                         
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .            
						at least two amino acids comprise TA, having a structure as  	    1469 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1517                                                         
						follows: a sequence starting from any of amino acid numbers  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						1039-x to 1040; and ending at any of amino acid numbers 1040+	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4080	HMR136_M85634_7_tr0_r1_1_gPRT		Comparison report between M85634_P7 and O43432unique head    	Sequence name: O43432                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4080 x O43432   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	                     Quality: 15247.00                      Escore:       0                                              
						homologous to a polypeptide having the sequence corresponding	             Matching length:    1566                Total length:    1585                                               
						to amino acids 1 - 163 of M85634_P7, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPV 	    Total Percent Similarity:   98.80      Total Percent Identity:   98.80                                               
						PQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQ 	                        Gaps:       1                        
						SAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTP 	                                                            
						PQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLS 	Alignment:                                                   
						GEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 	                  .         .         .         .         .  
						CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEIN 	     164 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 213                                                          
						GVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQ 	       1 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 50                                                           
						TEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKV 	                  .         .         .         .         .  
						LESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 	     214 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 263                                                          
						GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSV 	      51 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 100                                                          
						KEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGL 	                  .         .         .         .         .  
						TVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNR 	     264 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 313                                                          
						CQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIV 	     101 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 150                                                          
						KERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTK 	                  .         .         .         .         .  
						EKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSS 	     314 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 363                                                          
						GGAKASET                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 200                                                          
						amino acids 1 - 1088 of O43432, which also corresponds to    	                  .         .         .         .         .  
						amino acids 164 - 1251 of M85634_P7, and a third amino acid  	     364 SAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 413                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     201 SAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 250                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	     414 SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 463                                                          
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     251 SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 300                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	     464 CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLV 513                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1108 - 1585 of O43432, which also corresponds to 	     301 CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLV 350                                                          
						amino acids 1252 - 1729 of M85634_P7, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     514 SSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLE 563                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     351 SSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLE 400                                                          
						M85634_P7, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     564 CIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQR 613                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     401 CIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQR 450                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	     614 VLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPAQ 663                                                          
						least about 95% homologous to the sequence of M85634_P7.3.An 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     451 VLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPAQ 500                                                          
						M85634_P7, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     664 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 713                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     501 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 550                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     714 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 763                                                          
						at least two amino acids comprise TA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     551 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 600                                                          
						1251-x to 1252; and ending at any of amino acid numbers 1252+	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     764 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 813                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     814 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 863                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     864 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 913                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     914 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 963                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     964 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 1013                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1014 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 1063                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1114 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 1163                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1164 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 1213                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1214 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET............ 1251                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1051 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSLNR 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1252 .......APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1294                                                         
						                                                            	                |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 FSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1295 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1345 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1394                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1395 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1444                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1445 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1494                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1495 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1544                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1545 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1594                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1595 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1644                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1645 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1694                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1550                                                         
						                                                            	                  .         .         .                      
						                                                            	    1695 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1729                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1551 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1585                                                         

						Comparison report between M85634_P7 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4080 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFFQRPQI 	                     Quality: 6511.00                      Escore:       0                                               
						QPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPP 	             Matching length:     680                Total length:     699                                               
						YVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYG 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						TVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQTSETTAIV 	                        Gaps:       1                        
						SIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDTIPIPSLT 	                                                            
						SCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVK 	Alignment:                                                   
						QEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAAT 	                  .         .         .         .         .  
						TVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPV 	    1050 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 1099                                                         
						PAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTD 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						TEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDF 	                  .         .         .         .         .  
						TPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQ 	    1100 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 1149                                                         
						KRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEK 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						KQKELEAASAPEERTRLHDELEEAKDKAR                                	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	    1150 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1199                                                         
						to amino acids 1 - 1049 of M85634_P7, a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	                  .         .         .         .         .  
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	    1200 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1249                                                         
						VPKAQLGSWGKGSSGGAKASET                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						amino acids 1 - 202 of Q15597, which also corresponds to     	                  .         .         .         .         .  
						amino acids 1050 - 1251 of M85634_P7, and a third amino acid 	    1250 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1280                                                         
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||                   |||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	    1281 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1330                                                         
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	    1331 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1380                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 222 - 699 of Q15597, which also corresponds to   	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						amino acids 1252 - 1729 of M85634_P7, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	    1381 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1430                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						M85634_P7, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1431 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1480                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFFQRPQI 	    1481 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1530                                                         
						QPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKR 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						EKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYG 	                  .         .         .         .         .  
						TVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQTSETTAIV 	    1531 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1580                                                         
						SIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDTIPIPSLT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVK 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						QEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAAT 	                  .         .         .         .         .  
						TVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPV 	    1581 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1630                                                         
						PAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQGFHPERD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKPESWKPTD 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						TEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDF 	                  .         .         .         .         .  
						TPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQ 	    1631 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1680                                                         
						KRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKADDDVFEK 	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						KQKELEAASAPEERTRLHDELEEAKDKAR                                	                  .         .         .         .            
						least about 95% homologous to the sequence of M85634_P7.3.An 	    1681 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1729                                                         
						isolated chimeric polypeptide encoding for an edge portion of	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						M85634_P7, comprising a polypeptide having a length "n",     	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise TA, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1251-x to 1252; and ending at any of amino acid numbers 1252+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4070	HMR136_M85634_8_tr0_r1_1_gPRT		Comparison report between M85634_P8 and O43432partial WT     	Sequence name: O43432                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85634_P8, comprising a first amino 	Sequence documentation:                                      
						MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPV 	                                                            
						PQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQ 	Alignment of: 4070 x O43432   ..                             
						SAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTP 	                                                            
						PQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLS 	Alignment segment 1/1:                                       
						GEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 	                                                            
						CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEIN 	                     Quality: 15247.00                      Escore:       0                                              
						GVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPT 	             Matching length:    1566                Total length:    1585                                               
						PPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKV 	    Total Percent Similarity:   98.80      Total Percent Identity:   98.80                                               
						LESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 	                        Gaps:       1                        
						GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 	                                                            
						LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSV 	Alignment:                                                   
						KEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGL 	                  .         .         .         .         .  
						TVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNR 	       1 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 50                                                           
						CQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIV 	       1 MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMM 50                                                           
						KERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTK 	                  .         .         .         .         .  
						EKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSS 	      51 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 100                                                          
						GGAKASET                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	      51 VNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPG 100                                                          
						to amino acids 1 - 1088 of O43432, which also corresponds to 	                  .         .         .         .         .  
						amino acids 1 - 1088 of M85634_P8, and a second amino acid   	     101 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 150                                                          
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     101 PGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREKKTIRIRDPNQG 150                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	     151 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 200                                                          
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     151 GKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPEHSPVVYGTVE 200                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	     201 SAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 250                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1108 - 1585 of O43432, which also corresponds to 	     201 SAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 250                                                          
						amino acids 1089 - 1566 of M85634_P8, wherein said first     	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	     251 SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 300                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85634_P8,       	     251 SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 300                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     301 CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLV 350                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     301 CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLV 350                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     351 SSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLE 400                                                          
						comprise TA, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 1088-x to 1089; and  	     351 SSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLE 400                                                          
						ending at any of amino acid numbers 1089+ ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     401 CIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 CIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTVSSPSAAITVQR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNLNSRRSPVPAQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 IAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISD 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKRDSQADDPENIK 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKGVIDLVFEKAI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELF 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 KLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMD 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 QYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIH 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPS 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET............ 1088                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1051 KFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETDALRSSASSLNR 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1089 .......APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1131                                                         
						                                                            	                |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 FSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1132 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1181                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 FMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERNSTEAERNKTRE 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1182 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1231                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 SAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDFKEAMQCVEELN 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1232 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1281                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 AQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEKLSKQDFFKGFS 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1282 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1331                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 ETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLLPVG 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1332 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1381                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 RAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQ 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1382 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1431                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 KLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1432 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1481                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 NLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVIKQRVPILLKYL 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1482 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1531                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 DSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEEVISEDAFYKWE 1550                                                         
						                                                            	                  .         .         .                      
						                                                            	    1532 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1566                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1551 SSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN                1585                                                         

						Comparison report between M85634_P8 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P8,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4070 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPV 	Alignment segment 1/1:                                       
						PQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQ 	                                                            
						SAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTP 	                     Quality: 6511.00                      Escore:       0                                               
						PQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLS 	             Matching length:     680                Total length:     699                                               
						GEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEIN 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						GVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPT 	                        Gaps:       1                        
						PPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQ 	                                                            
						TEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKV 	Alignment:                                                   
						LESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 	                  .         .         .         .         .  
						GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 	     887 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 936                                                          
						LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGL 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						TVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNR 	                  .         .         .         .         .  
						CQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR               	     937 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 986                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 886 of M85634_P8, a second amino acid     	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	                  .         .         .         .         .  
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	     987 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1036                                                         
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VPKAQLGSWGKGSSGGAKASET                                       	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 202 of Q15597, which also corresponds to     	    1037 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1086                                                         
						amino acids 887 - 1088 of M85634_P8, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	                  .         .         .         .         .  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	    1087 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1117                                                         
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	         ||                   |||||||||||||||||||||||||||||  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	                  .         .         .         .         .  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	    1118 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1167                                                         
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						amino acids 222 - 699 of Q15597, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1089 - 1566 of M85634_P8, wherein said first     	    1168 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1217                                                         
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85634_P8, comprising a polypeptide being at least 70%,      	    1218 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1267                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						MNSQPQTRSPFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPV 	                  .         .         .         .         .  
						PQGPQYCIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQ 	    1268 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1317                                                         
						SAPIIVPTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQQLPSQVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLS 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						GEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDR 	                  .         .         .         .         .  
						CELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEIN 	    1318 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1367                                                         
						GVSEKLSATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPASPPHTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQ 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						TEEILDSQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKV 	                  .         .         .         .         .  
						LESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSS 	    1368 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1417                                                         
						GDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPMRTLDPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSV 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						KEDVHLKKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGL 	                  .         .         .         .         .  
						TVDTEERLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNR 	    1418 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1467                                                         
						CQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M85634_P8.3.An 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						M85634_P8, comprising a polypeptide having a length "n",     	    1468 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1517                                                         
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .            
						preferably at least about 40 amino acids in length and most  	    1518 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1566                                                         
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						at least two amino acids comprise TA, having a structure as  	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1088-x to 1089; and ending at any of amino acid numbers 1089+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

4074	HMR136_M85634_9_tr0_r1_1_gPRT		Comparison report between M85634_P9 and O43432unique head    	Sequence name: O43432                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a featuring a skipped exon.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M85634_P9, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 4074 x O43432   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	                                                            
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                     Quality: 15147.00                      Escore:       0                                              
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	             Matching length:    1566                Total length:    1596                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 163 of M85634_P9, a second amino acid sequence being at  	    Total Percent Similarity:   98.12      Total Percent Identity:   98.12                                               
						least 90 % homologous to MNSQPQTRSP corresponding to amino   	                        Gaps:       2                        
						acids 1 - 10 of O43432, which also corresponds to amino acids	                                                            
						164 - 173 of M85634_P9, a third amino acid sequence being at 	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     164 MNSQPQTRSPFAAGPRPPHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPT 213                                                          
						homologous to a polypeptide having the sequence FAAGPRPPHHQ  	         ||||||||||           |||||||||||||||||||||||||||||  
						corresponding to amino acids 174 - 184 of M85634_P9, a fourth	       1 MNSQPQTRSP...........FFQRPQIQPPRATIPNSSPSIRPGAQTPT 39                                                           
						FFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQYCIPQ 	                  .         .         .         .         .  
						YRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQ 	     214 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 263                                                          
						QPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQEGQT 	      40 AVYQANQHIMMVNHLPMPYPVPQGPQYCIPQYRHSGPPYVGPPQQYPVQP 89                                                           
						SETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSPREDT 	                  .         .         .         .         .  
						IPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKLSATE 	     264 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 313                                                          
						SIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQNL 	      90 PGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIVPTQQQPPPAKREK 139                                                          
						NSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQDKMSQ 	                  .         .         .         .         .  
						GFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTFPFKP 	     314 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 363                                                          
						ESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTLDPRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAE 	     140 KTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPSQVP 189                                                          
						NAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLKG 	                  .         .         .         .         .  
						VIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFEKDKA 	     364 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 413                                                          
						DDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRSIGNIKFIGELFKLKMLTEAIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIR 	     190 EHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVL 239                                                          
						FMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRV 	                  .         .         .         .         .  
						DEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET   	     414 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 463                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 11 - 1088 of O43432, which also 	     240 SGEKKEQEGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSS 289                                                          
						corresponds to amino acids 185 - 1262 of M85634_P9, and a    	                  .         .         .         .         .  
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	     464 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 513                                                          
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	     290 QPIFTTAIDDRCELSSPREDTIPIPSLTSCTETSDPLPTNENDDDICKKP 339                                                          
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	                  .         .         .         .         .  
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	     514 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 563                                                          
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	     340 CSVAPNDIPLVSSTNLINEINGVSEKLSATESIVEIVKQEVLPLTLELEI 389                                                          
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	                  .         .         .         .         .  
						fifth amino acid sequence being at least 90 % homologous to  	     564 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 613                                                          
						corresponding to amino acids 1108 - 1585 of O43432, which    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 1263 - 1740 of M85634_P9,    	     390 LENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPPHTPVIVPAAATTV 439                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence, third amino acid sequence, fourth amino acid       	     614 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 663                                                          
						sequence and fifth amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     440 SSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILDSQN 489                                                          
						head of M85634_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     664 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 713                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     490 LNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDK 539                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQT                  	     714 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 763                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85634_P9.3.An isolated polypeptide encoding for an edge     	     540 VLESEQDKMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEG 589                                                          
						portion of M85634_P9, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     764 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 813                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     590 IDANSGSTDSSGDGVTFPFKPESWKPTDTEGKKQYDREFLLDFQFMPACI 639                                                          
						encoding for FAAGPRPPHHQ, corresponding to M85634_P9.4.An    	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     814 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 863                                                          
						M85634_P9, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     640 QKPEGLPPISDVVLDKINQPKLPMRTLDPRILPRGPDFTPAFADFGRQTP 689                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     864 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 913                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     690 GGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHLKKAENAWKPSQKR 739                                                          
						at least two amino acids comprise TA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     914 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 963                                                          
						1262-x to 1263; and ending at any of amino acid numbers 1263+	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     740 DSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEERLK 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     964 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 1013                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 GVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLN 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1014 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 1063                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 RCQKEFEKDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKARRRS 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 IGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKD 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1114 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 1163                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRA 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1164 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1213                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQ 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1214 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASET. 1262                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	    1040 GAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKASETD 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1263 ..................APSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1294                                                         
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	    1090 ALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREKNDK 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1295 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 PLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDVERN 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1345 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1394                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 STEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHINDF 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1395 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1444                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 KEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQSEK 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1445 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1494                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 LSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELT 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1495 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1544                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 IEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPE 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1545 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1594                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 GEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIEDKA 1439                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1595 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1644                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1440 NDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDTAVI 1489                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1645 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1694                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1490 KQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLYDEE 1539                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1695 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1740                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1540 VISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN     1585                                                         

						Comparison report between M85634_P9 and Q15597unique head    	Sequence name: Q15597                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85634_P9,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4074 x Q15597   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	Alignment segment 1/1:                                       
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                                                            
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFAAGPRP 	                     Quality: 6511.00                      Escore:       0                                               
						PHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQY 	             Matching length:     680                Total length:     699                                               
						CIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPS 	    Total Percent Similarity:   97.28      Total Percent Identity:   97.28                                               
						QVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQ 	                        Gaps:       1                        
						EGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSP 	                                                            
						REDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKL 	Alignment:                                                   
						SATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPP 	                  .         .         .         .         .  
						HTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILD 	    1061 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 1110                                                         
						SQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTF 	       1 RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTI 50                                                           
						PFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTL 	                  .         .         .         .         .  
						DPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHL 	    1111 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 1160                                                         
						KKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFE 	      51 GKDLDFEKAKPRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVS 100                                                          
						KDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR                     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	    1161 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 1210                                                         
						to amino acids 1 - 1060 of M85634_P9, a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRSIGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAK 	     101 RRADQGPKTIEQIHKEAKIEEQEEQRKVQQLMTKEKRRPGVQRVDEGGWN 150                                                          
						PRMDQYFNQMEKIVKERKTSSRIRFMLQDVIDLRLCNWVSRRADQGPKTIEQIHKEAKIE 	                  .         .         .         .         .  
						EQEEQRKVQQLMTKEKRRPGVQRVDEGGWNTVQGAKNSRVLDPSKFLKITKPTIDEKIQL 	    1211 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 1260                                                         
						VPKAQLGSWGKGSSGGAKASET                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 TVQGAKNSRVLDPSKFLKITKPTIDEKIQLVPKAQLGSWGKGSSGGAKAS 200                                                          
						amino acids 1 - 202 of Q15597, which also corresponds to     	                  .         .         .         .         .  
						amino acids 1061 - 1262 of M85634_P9, and a third amino acid 	    1261 ET...................APSGSTPSTPVEFDSRRTLTSRGSMGREK 1291                                                         
						APSGSTPSTPVEFDSRRTLTSRGSMGREKNDKPLPSATARPNTFMRGGSSKDLLDNQSQE 	         ||                   |||||||||||||||||||||||||||||  
						EQRREMLETVKQLTGGVDVERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSK 	     201 ETDALRSSASSLNRFSALQPPAPSGSTPSTPVEFDSRRTLTSRGSMGREK 250                                                          
						SIIDEFLHINDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQS 	                  .         .         .         .         .  
						EKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMRELTIEFSKPLL 	    1292 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 1341                                                         
						PVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDFLPEGEDVHNFLLEQKLDFIES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPCSSEALSKKELSAEELYKRLEKLIIEDKANDEQIFDWVEANLDEIQMSSPTFLRALM 	     251 NDKPLPSATARPNTFMRGGSSKDLLDNQSQEEQRREMLETVKQLTGGVDV 300                                                          
						TAVCKAAIIADSSTFRVDTAVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANL 	                  .         .         .         .         .  
						LRMFFDCLYDEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN   	    1342 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 1391                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 222 - 699 of Q15597, which also corresponds to   	     301 ERNSTEAERNKTRESAKPEISAMSAHDKAALSEEELERKSKSIIDEFLHI 350                                                          
						amino acids 1263 - 1740 of M85634_P9, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	    1392 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 1441                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     351 NDFKEAMQCVEELNAQGLLHVFVRVGVESTLERSQITRDHMGQLLYQLVQ 400                                                          
						M85634_P9, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1442 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 1491                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLPQKPALKSGTATAAGTGPGTGAAAAAAAAVPPPHPAAAAAAAAAAAAAAAAAVPPPH 	     401 SEKLSKQDFFKGFSETLELADDMAIDIPHIWLYLAELVTPMLKEGGISMR 450                                                          
						PNIRALQTQAPQQIPRGPVQQPLEDRIFTPAVSAVYSTVTQVARQPGTPTPSPYSAHEIN 	                  .         .         .         .         .  
						KGHPNLAATPPGHASSPGLSQTPYPSGQNAGPTTLVYPQTPQTMNSQPQTRSPFAAGPRP 	    1492 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 1541                                                         
						PHHQFFQRPQIQPPRATIPNSSPSIRPGAQTPTAVYQANQHIMMVNHLPMPYPVPQGPQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CIPQYRHSGPPYVGPPQQYPVQPPGPGPFYPGPGPGDFPNAYGTPFYPSQPVYQSAPIIV 	     451 ELTIEFSKPLLPVGRAGVLLSEILHLLCKQMSHKKVGALWREADLSWKDF 500                                                          
						PTQQQPPPAKREKKTIRIRDPNQGGKDITEEIMSGGGSRNPTPPIGRPTSTPTPPQQLPS 	                  .         .         .         .         .  
						QVPEHSPVVYGTVESAHLAASTPVTAASDQKQEEKPKPDPVLKSPSPVLRLVLSGEKKEQ 	    1542 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 1591                                                         
						EGQTSETTAIVSIAELPLPPSPTTVSSVARSTIAAPTSSALSSQPIFTTAIDDRCELSSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REDTIPIPSLTSCTETSDPLPTNENDDDICKKPCSVAPNDIPLVSSTNLINEINGVSEKL 	     501 LPEGEDVHNFLLEQKLDFIESDSPCSSEALSKKELSAEELYKRLEKLIIE 550                                                          
						SATESIVEIVKQEVLPLTLELEILENPPEEMKLECIPAPITPSTVPSFPPTPPTPPASPP 	                  .         .         .         .         .  
						HTPVIVPAAATTVSSPSAAITVQRVLEEDESIRTCLSEDAKEIQNKIEVEADGQTEEILD 	    1592 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 1641                                                         
						SQNLNSRRSPVPAQIAITVPKTWKKPKDRTRTTEEMLEAELELKAEEELSIDKVLESEQD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KMSQGFHPERDPSDLKKVKAVEENGEEAEPVRNGAESVSEGEGIDANSGSTDSSGDGVTF 	     551 DKANDEQIFDWVEANLDEIQMSSPTFLRALMTAVCKAAIIADSSTFRVDT 600                                                          
						PFKPESWKPTDTEGKKQYDREFLLDFQFMPACIQKPEGLPPISDVVLDKINQPKLPMRTL 	                  .         .         .         .         .  
						DPRILPRGPDFTPAFADFGRQTPGGRGVPLLNVGSRRSQPGQRREPRKIITVSVKEDVHL 	    1642 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 1691                                                         
						KKAENAWKPSQKRDSQADDPENIKTQELFRKVRSILNKLTPQMFNQLMKQVSGLTVDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLKGVIDLVFEKAIDEPSFSVAYANMCRCLVTLKVPMADKPGNTVNFRKLLLNRCQKEFE 	     601 AVIKQRVPILLKYLDSDTEKELQALYALQASIVKLDQPANLLRMFFDCLY 650                                                          
						KDKADDDVFEKKQKELEAASAPEERTRLHDELEEAKDKAR                     	                  .         .         .         .            
						least about 95% homologous to the sequence of M85634_P9.3.An 	    1692 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  1740                                                         
						isolated chimeric polypeptide encoding for an edge portion of	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						M85634_P9, comprising a polypeptide having a length "n",     	     651 DEEVISEDAFYKWESSKDPAEQNGKGVALKSVTAFFTWLREAEEESEDN  699                                                          
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise TA, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						1262-x to 1263; and ending at any of amino acid numbers 1263+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

28691	HMR136_M85646_10_tr0_r1_1_gPRT		Comparison report between M85646_P10 and Q8N0Z3partial WT    	Sequence name: Q8N0Z3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85646_P10, comprising a first amino	Sequence documentation:                                      
						MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLVRRHEIHKSKN 	                                                            
						RALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILSDQYQMQDVLEKSDHLIAAAK 	Alignment of: 28691 x Q8N0Z3   ..                            
						ELFPRRRTGFPNVTVAPDSSQGPIVVNQDPITQSIFNESVIEPQALNDVDGEEEGTVNSQ 	                                                            
						SGESENENELDNSLNSQSNTNTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTP 	Alignment segment 1/1:                                       
						SSALSSGEQRAALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 	                                                            
						PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYERWTGREVKGLQ 	                     Quality: 4170.00                      Escore:       0                                               
						SSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQLEQVLGDHRELIDALTAEILR 	             Matching length:     429                Total length:     429                                               
						LREENAATQ                                                    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 429 of Q8N0Z3, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 429 of M85646_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLV 50                                                           
						having the sequence Y corresponding to amino acids 430 - 430 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85646_P10, wherein said first amino acid sequence and    	       1 MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLV 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 RRHEIHKSKNRALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RRHEIHKSKNRALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILS 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DQYQMQDVLEKSDHLIAAAKELFPRRRTGFPNVTVAPDSSQGPIVVNQDP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DQYQMQDVLEKSDHLIAAAKELFPRRRTGFPNVTVAPDSSQGPIVVNQDP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ITQSIFNESVIEPQALNDVDGEEEGTVNSQSGESENENELDNSLNSQSNT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ITQSIFNESVIEPQALNDVDGEEEGTVNSQSGESENENELDNSLNSQSNT 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTPSSALSSGEQR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTPSSALSSGEQR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYER 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYER 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 WTGREVKGLQSSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 WTGREVKGLQSSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQL 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 EQVLGDHRELIDALTAEILRLREENAATQ                      429                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     401 EQVLGDHRELIDALTAEILRLREENAATQ                      429                                                          

28689	HMR136_M85646_9_tr0_r1_1_gPRT		Comparison report between M85646_P9 and Q8N0Z3partial WT     	Sequence name: Q8N0Z3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85646_P9, comprising a first amino 	Sequence documentation:                                      
						MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLVRRHEIHKSKN 	                                                            
						RALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILSDQYQMQDVLEKSDHLIAAAK 	Alignment of: 28689 x Q8N0Z3   ..                            
						ELFPRRRTGFPNVTVAPDSSQGPIVVNQDPITQSIFNESVIEPQALNDVDGEEEGTVNSQ 	                                                            
						SGESENENELDNSLNSQSNTNTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTP 	Alignment segment 1/1:                                       
						SSALSSGEQRAALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 	                                                            
						PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYERWTGREVKGLQ 	                     Quality: 4171.00                      Escore:       0                                               
						SSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQLEQVLGDHRELIDALTAEILR 	             Matching length:     430                Total length:     430                                               
						LREENAATQ                                                    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						to amino acids 1 - 429 of Q8N0Z3, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 429 of M85646_P9, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLV 50                                                           
						having the sequence SVQL corresponding to amino acids 430 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						433 of M85646_P9, wherein said first amino acid sequence and 	       1 MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLV 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 RRHEIHKSKNRALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILS 100                                                          
						M85646_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 RRHEIHKSKNRALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILS 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence SVQL in M85646_P9.	     101 DQYQMQDVLEKSDHLIAAAKELFPRRRTGFPNVTVAPDSSQGPIVVNQDP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DQYQMQDVLEKSDHLIAAAKELFPRRRTGFPNVTVAPDSSQGPIVVNQDP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ITQSIFNESVIEPQALNDVDGEEEGTVNSQSGESENENELDNSLNSQSNT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ITQSIFNESVIEPQALNDVDGEEEGTVNSQSGESENENELDNSLNSQSNT 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTPSSALSSGEQR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTPSSALSSGEQR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYER 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYER 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 WTGREVKGLQSSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 WTGREVKGLQSSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQL 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 EQVLGDHRELIDALTAEILRLREENAATQS                     430                                                          
						                                                            	         |||||||||||||||||||||||||||||:                      
						                                                            	     401 EQVLGDHRELIDALTAEILRLREENAATQA                     430                                                          

4293	HMR136_M85653_11_tr0_r1_1_gPRT		Comparison report between M85653_P11 and MK08_HUMANshort     	Sequence name: MK08_HUMAN                                    
						unique head followed by partial WT sequence followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85653_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4293 x MK08_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of M85653_P11, a second   	                                                            
						IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 	                     Quality: 1188.00                      Escore:       0                                               
						AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 	             Matching length:     121                Total length:     121                                               
						N                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 85 - 205 of MK08_HUMAN, which   	                        Gaps:       0                        
						also corresponds to amino acids 2 - 122 of M85653_P11, and a 	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       2 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 51                                                           
						polypeptide having the sequence GGRMGKGIFTRLQ corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 123 - 135 of M85653_P11, wherein said first   	      85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      52 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 101                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85653_P11, comprising a polypeptide being at least 70%,     	     135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .                                
						more preferably at least about 90% and most preferably at    	     102 YVVTRYYRAPEVILGMGYKEN                              122                                                          
						least about 95% homologous to the sequence GGRMGKGIFTRLQ in  	         |||||||||||||||||||||                               
						M85653_P11.                                                  	     185 YVVTRYYRAPEVILGMGYKEN                              205                                                          

4291	HMR136_M85653_17_tr0_r1_1_gPRT		Comparison report between M85653_P17 and MK08_HUMANpartial   	Sequence name: MK08_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85653_P17, comprising a first amino	Sequence documentation:                                      
						MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 	                                                            
						FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 	Alignment of: 4291 x MK08_HUMAN   ..                         
						MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 	                                                            
						MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 	Alignment segment 1/1:                                       
						LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 	                                                            
						MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE       	                     Quality: 3523.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     356                Total length:     356                                               
						to amino acids 1 - 354 of MK08_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.44                                               
						to amino acids 1 - 354 of M85653_P17, and a second amino acid	    Total Percent Similarity:  100.00      Total Percent Identity:   99.44                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence ILL corresponding to amino acids 355 -   	                  .         .         .         .         .  
						357 of M85653_P17, wherein said first amino acid sequence and	       1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER 50                                                           
						M85653_P17, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence ILL in M85653_P17.	      51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 MLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIE 350                                                          
						                                                            	                                                             
						                                                            	     351 EWKEIL                                             356                                                          
						                                                            	         ||||::                                              
						                                                            	     351 EWKELI                                             356                                                          

4289	HMR136_M85653_19_tr0_r1_1_gPRT		Comparison report between M85653_P19 and MK08_HUMANpartial   	Sequence name: MK08_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85653_P19, comprising a first amino	Sequence documentation:                                      
						MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 	                                                            
						FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 	Alignment of: 4289 x MK08_HUMAN   ..                         
						MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 	                                                            
						MMTPYVVTRYYRAPEVILGMGYKEN                                    	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 205 of MK08_HUMAN, which also corresponds 	                     Quality: 2011.00                      Escore:       0                                               
						to amino acids 1 - 205 of M85653_P19, and a second amino acid	             Matching length:     205                Total length:     205                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence GQHTHLFEIFF corresponding to amino acids 	                                                            
						206 - 216 of M85653_P19, wherein said first amino acid       	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER 50                                                           
						tail of M85653_P19, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence GQHTHLFEIFF in 	      51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100                                                          
						M85653_P19.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200                                                          
						                                                            	                                                             
						                                                            	     201 GYKEN                                              205                                                          
						                                                            	         |||||                                               
						                                                            	     201 GYKEN                                              205                                                          

4459	HMR136_M85660_19_tr0_r1_1_gPRT		Comparison report between M85660_P19 and M6B_HUMANpartial WT 	Sequence name: M6B_HUMAN                                     
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85660_P19, comprising a first amino acid sequence being at  	                                                            
						MKPAMETAAEENTEQSQERKGCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALA 	Alignment of: 4459 x M6B_HUMAN   ..                          
						GTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGFYTTSAVKELH 	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 120	Alignment segment 1/1:                                       
						of M6B_HUMAN, which also corresponds to amino acids 1 - 120  	                                                            
						of M85660_P19, a second amino acid sequence being at least 90	                     Quality: 1567.00                      Escore:       0                                               
						% homologous to                                              	             Matching length:     186                Total length:     258                                               
						GIIPWNAFPGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIAL corresponding	 Matching Percent Similarity:   96.24   Matching Percent Identity:   93.01                                               
						to amino acids 193 - 239 of M6B_HUMAN, which also corresponds	    Total Percent Similarity:   69.38      Total Percent Identity:   67.05                                               
						to amino acids 121 - 167 of M85660_P19, and a third amino    	                        Gaps:       1                        
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	       1 MKPAMETAAEENTEQSQERKGCFECCIKCLGGVPYASLVATILCFSGVAL 50                                                           
						IHFLMILSSNWAYLKDASKMQAYQDIKAKEEQELQDIQSRSKEQLNSYT            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 168 - 216 of M85660_P19, wherein	       1 MKPAMETAAEENTEQSQERKGCFECCIKCLGGVPYASLVATILCFSGVAL 50                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      51 FCGCGHVALAGTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFL 100                                                          
						sequential order.2.An isolated chimeric polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of M85660_P19, comprising a polypeptide  	      51 FCGCGHVALAGTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFL 100                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     101 YGIILLAEGFYTTSAVKELH.............................. 120                                                          
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||                                
						more preferably at least about 40 amino acids in length and  	     101 YGIILLAEGFYTTSAVKELHGEFKTTACGRCISGMFVFLTYVLGVAWLGV 150                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise HG, having a       	     121 ..........................................GIIPWNAF 128                                                          
						structure as follows: a sequence starting from any of amino  	                                                   ||||||||  
						acid numbers 120-x to 121; and ending at any of amino acid   	     151 FGFSAVPVFMFYNIWSTCEVIKSPQTNGTTGVEQICVDIRQYGIIPWNAF 200                                                          
						numbers 121+ ((n-2) - x), in which x varies from 0 to        	                  .         .         .         .         .  
						n-2.3.An isolated polypeptide encoding for a tail of         	     129 PGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIALIHFLMILSSNW 178                                                          
						M85660_P19, comprising a polypeptide being at least 70%,     	         |||||||||||||||||||||||||||||||||||||||: ::|  : |:  
						optionally at least about 80%, preferably at least about 85%,	     201 PGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIALLIYMMATTYNY 250                                                          
						more preferably at least about 90% and most preferably at    	                                                             
						least about 95% homologous to the sequence                   	     179 AYLKDASK                                           186                                                          
						IHFLMILSSNWAYLKDASKMQAYQDIKAKEEQELQDIQSRSKEQLNSYT in         	         | ||  |:                                            
						M85660_P19.                                                  	     251 AVLKFKSR                                           258                                                          

						Comparison report between M85660_P19 and AAH47295partial WT  	Sequence name: AAH47295                                      
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85660_P19, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to MKPAMETAAEENTEQSQERK corresponding  	Alignment of: 4459 x AAH47295   ..                           
						to amino acids 1 - 20 of AAH47295, which also corresponds to 	                                                            
						amino acids 1 - 20 of M85660_P19, a second amino acid        	Alignment segment 1/1:                                       
						GCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALAGTVAILEQHFSTNASDHALL 	                                                            
						SEVIQLMQYVIYGIASFFFLYGIILLAEGFYTTSAVKELH                     	                     Quality: 1467.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     186                Total length:     298                                               
						amino acids 61 - 160 of AAH47295, which also corresponds to  	 Matching Percent Similarity:   96.24   Matching Percent Identity:   93.01                                               
						amino acids 21 - 120 of M85660_P19, a third amino acid       	    Total Percent Similarity:   60.07      Total Percent Identity:   58.05                                               
						sequence being at least 90 % homologous to                   	                        Gaps:       2                        
						GIIPWNAFPGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIAL corresponding	                                                            
						to amino acids 233 - 279 of AAH47295, which also corresponds 	Alignment:                                                   
						to amino acids 121 - 167 of M85660_P19, and a fourth amino   	                  .         .         .         .         .  
						acid sequence being at least 70%, optionally at least 80%,   	       1 MKPAMETAAEENTEQSQERK.............................. 20                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||                                
						most preferably at least 95% homologous to a polypeptide     	       1 MKPAMETAAEENTEQSQERKVNSRAEMEIGRYHWMYPGSKNHQYHPVPTL 50                                                           
						having the sequence                                          	                  .         .         .         .         .  
						IHFLMILSSNWAYLKDASKMQAYQDIKAKEEQELQDIQSRSKEQLNSYT            	      21 ..........GCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALA 60                                                           
						corresponding to amino acids 168 - 216 of M85660_P19, wherein	                   ||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	      51 GDRASPLSSPGCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALA 100                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	      61 GTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGF 110                                                          
						polypeptide encoding for an edge portion of M85660_P19,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     101 GTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGF 150                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     111 YTTSAVKELH........................................ 120                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||                                          
						amino acids in length and most preferably at least about 50  	     151 YTTSAVKELHGEFKTTACGRCISGMFVFLTYVLGVAWLGVFGFSAVPVFM 200                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise KG, having a structure as follows: a sequence       	     121 ................................GIIPWNAFPGKICGSALE 138                                                          
						starting from any of amino acid numbers 20-x to 21; and      	                                         ||||||||||||||||||  
						ending at any of amino acid numbers 21+ ((n-2) - x), in which	     201 FYNIWSTCEVIKSPQTNGTTGVEQICVDIRQYGIIPWNAFPGKICGSALE 250                                                          
						x varies from 0 to n-2.3.An isolated chimeric polypeptide    	                  .         .         .         .            
						encoding for an edge portion of M85660_P19, comprising a     	     139 NICNTNEFYMSYHLFIVACAGAGATVIALIHFLMILSSNWAYLKDASK   186                                                          
						polypeptide having a length "n", wherein n is at least about 	         |||||||||||||||||||||||||||||: ::|  : |:| ||  |:    
						10 amino acids in length, optionally at least about 20 amino 	     251 NICNTNEFYMSYHLFIVACAGAGATVIALLIYMMATTYNYAVLKFKSR   298                                                          
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise HG, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 120-x to 121; and ending at any of amino acid   	                                                            
						numbers 121+ ((n-2) - x), in which x varies from 0 to        	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	                                                            
						M85660_P19, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						IHFLMILSSNWAYLKDASKMQAYQDIKAKEEQELQDIQSRSKEQLNSYT in         	                                                            
						M85660_P19.                                                  	                                                            

						Comparison report between M85660_P19 and Q8N956partial WT    	Sequence name: Q8N956                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85660_P19, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MKPAMETAAEENTEQSQERK corresponding to amino acids 1 - 20 of  	Alignment of: 4459 x Q8N956   ..                             
						Q8N956, which also corresponds to amino acids 1 - 20 of      	                                                            
						M85660_P19, a second amino acid sequence being at least 90 % 	Alignment segment 1/1:                                       
						GCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALAGTVAILEQHFSTNASDHALL 	                                                            
						SEVIQLMQYVIYGIASFFFLYGIILLAEGFYTTSAVKELH                     	                     Quality: 1914.00                      Escore:       0                                               
						homologous to corresponding to amino acids 61 - 160 of       	             Matching length:     216                Total length:     328                                               
						Q8N956, which also corresponds to amino acids 21 - 120 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M85660_P19, and a third amino acid sequence being at least 90	    Total Percent Similarity:   65.85      Total Percent Identity:   65.85                                               
						GIIPWNAFPGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIALIHFLMILSSNWAY 	                        Gaps:       2                        
						LKDASKMQAYQDIKAKEEQELQDIQSRSKEQLNSYT                         	                                                            
						% homologous to corresponding to amino acids 233 - 328 of    	Alignment:                                                   
						Q8N956, which also corresponds to amino acids 121 - 216 of   	                  .         .         .         .         .  
						M85660_P19, wherein said first amino acid sequence, second   	       1 MKPAMETAAEENTEQSQERK.............................. 20                                                           
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||                                
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MKPAMETAAEENTEQSQERKVNSRAEMEIGRYHWMYPGSKNHQYHPVPTL 50                                                           
						polypeptide encoding for an edge portion of M85660_P19,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	      21 ..........GCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALA 60                                                           
						least about 10 amino acids in length, optionally at least    	                   ||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	      51 GDRASPLSSPGCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALA 100                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	      61 GTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGF 110                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise KG, having a structure as follows: a sequence       	     101 GTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGF 150                                                          
						starting from any of amino acid numbers 20-x to 21; and      	                  .         .         .         .         .  
						ending at any of amino acid numbers 21+ ((n-2) - x), in which	     111 YTTSAVKELH........................................ 120                                                          
						x varies from 0 to n-2.3.An isolated chimeric polypeptide    	         ||||||||||                                          
						encoding for an edge portion of M85660_P19, comprising a     	     151 YTTSAVKELHGEFKTTACGRCISGMFVFLTYVLGVAWLGVFGFSAVPVFM 200                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     121 ................................GIIPWNAFPGKICGSALE 138                                                          
						acids in length, preferably at least about 30 amino acids in 	                                         ||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     201 FYNIWSTCEVIKSPQTNGTTGVEQICVDIRQYGIIPWNAFPGKICGSALE 250                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise HG, having 	     139 NICNTNEFYMSYHLFIVACAGAGATVIALIHFLMILSSNWAYLKDASKMQ 188                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 120-x to 121; and ending at any of amino acid   	     251 NICNTNEFYMSYHLFIVACAGAGATVIALIHFLMILSSNWAYLKDASKMQ 300                                                          
						numbers 121+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .                                
						                                                            	     189 AYQDIKAKEEQELQDIQSRSKEQLNSYT                       216                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     301 AYQDIKAKEEQELQDIQSRSKEQLNSYT                       328                                                          

4534	HMR136_M85671_1_tr0_r1_1_gPRT		Comparison report between M85671_P1 and Q9NVA8unique head    	Sequence name: Q9NVA8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M85671_P1, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 4534 x Q9NVA8   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	Alignment segment 1/1:                                       
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALFI                	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 3811.00                      Escore:       0                                               
						1 - 105 of M85671_P1, a second amino acid sequence being at  	             Matching length:     402                Total length:     402                                               
						ILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAASGSITMQNIGAMSSY 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.50                                               
						LFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLLVSLVVILPLSLFRNLGYLGYTSGLS 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.50                                               
						LLCMVFFLIVVICKKFQVPCPVEAALIINETINTTLTQPTALVPALS              	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 6 - 172	                                                            
						of Q9NVA8, which also corresponds to amino acids 106 - 272 of	Alignment:                                                   
						M85671_P1, a bridging amino acid H corresponding to amino    	                  .         .         .         .         .  
						acid 273 of M85671_P1, and a third amino acid sequence being 	     105 IILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAASGSI 154                                                          
						NVTENDSCRPHYFIFNSQTVYAVPILIFSFVCHPAVLPIYEELKDRSRRRMMNVSKISFF 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						AMFLMYLLAALFGYLTFYEHVESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFP 	       5 LILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAASGSI 54                                                           
						IRSSVTHLLCASKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLIFIL 	                  .         .         .         .         .  
						PSAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHNAPGGGH        	     155 TMQNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLLVSLV 204                                                          
						at least 90 % homologous to corresponding to amino acids 174 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 406 of Q9NVA8, which also corresponds to amino acids 274 - 	      55 TMQNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLLVSLV 104                                                          
						506 of M85671_P1, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence, bridging amino acid and third    	     205 VILPLSLFRNLGYLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAALIIN 254                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     105 VILPLSLFRNLGYLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAALIIN 154                                                          
						M85671_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     255 ETINTTLTQPTALVPALSHNVTENDSCRPHYFIFNSQTVYAVPILIFSFV 304                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||||||||| |||||||||||||||||||||||||||||||  
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	     155 ETINTTLTQPTALVPALSRNVTENDSCRPHYFIFNSQTVYAVPILIFSFV 204                                                          
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALFI                	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85671_P1.     	     305 CHPAVLPIYEELKDRSRRRMMNVSKISFFAMFLMYLLAALFGYLTFYEHV 354                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 CHPAVLPIYEELKDRSRRRMMNVSKISFFAMFLMYLLAALFGYLTFYEHV 254                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     355 ESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRSSVTHLLCA 404                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 ESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRSSVTHLLCA 304                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     405 SKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLIFILP 454                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 SKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLIFILP 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     455 SAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHNAPGG 504                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 SAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHNAPGG 404                                                          
						                                                            	                                                             
						                                                            	     505 GH                                                 506                                                          
						                                                            	         ||                                                  
						                                                            	     405 GH                                                 406                                                          

						Comparison report between M85671_P1 and Q96QD8partial WT     	Sequence name: Q96QD8                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for M85671_P1, comprising a first amino 	Sequence documentation:                                      
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	                                                            
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALFIILLTFVSIFSLYSVH 	Alignment of: 4534 x Q96QD8   ..                             
						LLLKTANEGGSLLYEQLGYKAFGLVGKLAASGSIT                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 155 of Q96QD8, which also corresponds to  	                                                            
						amino acids 1 - 155 of M85671_P1, a bridging amino acid M    	                     Quality: 4835.00                      Escore:       0                                               
						corresponding to amino acid 156 of M85671_P1, and a second   	             Matching length:     506                Total length:     506                                               
						QNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLLVSLVVILPLSLFRNLG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						YLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAALIINETINTTLTQPTALVPALSHNVT 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						ENDSCRPHYFIFNSQTVYAVPILIFSFVCHPAVLPIYEELKDRSRRRMMNVSKISFFAMF 	                        Gaps:       0                        
						LMYLLAALFGYLTFYEHVESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRS 	                                                            
						SVTHLLCASKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLIFILPSA 	Alignment:                                                   
						FYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHNAPGGGH           	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						corresponding to amino acids 157 - 506 of Q96QD8, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 157 - 506 of M85671_P1, wherein   	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IALFIILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IALFIILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SGSITMQNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLL 200                                                          
						                                                            	         |||||:||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SGSITVQNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VSLVVILPLSLFRNLGYLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VSLVVILPLSLFRNLGYLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LIINETINTTLTQPTALVPALSHNVTENDSCRPHYFIFNSQTVYAVPILI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LIINETINTTLTQPTALVPALSHNVTENDSCRPHYFIFNSQTVYAVPILI 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FSFVCHPAVLPIYEELKDRSRRRMMNVSKISFFAMFLMYLLAALFGYLTF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 FSFVCHPAVLPIYEELKDRSRRRMMNVSKISFFAMFLMYLLAALFGYLTF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YEHVESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRSSVTH 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YEHVESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRSSVTH 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LLCASKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLI 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LLCASKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLI 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FILPSAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 FILPSAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHN 500                                                          
						                                                            	                                                             
						                                                            	     501 APGGGH                                             506                                                          
						                                                            	         ||||||                                              
						                                                            	     501 APGGGH                                             506                                                          

4536	HMR136_M85671_17_tr0_r1_1_gPRT		Comparison report between M85671_P17 and Q96QD8partial WT    	Sequence name: Q96QD8                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P17, comprising a first amino	Sequence documentation:                                      
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	                                                            
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALF                 	Alignment of: 4536 x Q96QD8   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 104 of Q96QD8, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 104 of M85671_P17, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1017.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     105                Total length:     105                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.05                                               
						having the sequence M corresponding to amino acids 105 - 105 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.05                                               
						of M85671_P17, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	                                                             
						                                                            	     101 IALFM                                              105                                                          
						                                                            	         ||||:                                               
						                                                            	     101 IALFI                                              105                                                          

						Comparison report between M85671_P17 and BAA92620partial WT  	Sequence name: BAA92620                                      
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P17, comprising a first amino	Sequence documentation:                                      
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	                                                            
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALF                 	Alignment of: 4536 x BAA92620   ..                           
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 104 of BAA92620, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 104 of M85671_P17, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1017.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     105                Total length:     105                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.05                                               
						having the sequence M corresponding to amino acids 105 - 105 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.05                                               
						of M85671_P17, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	                                                             
						                                                            	     101 IALFM                                              105                                                          
						                                                            	         ||||:                                               
						                                                            	     101 IALFI                                              105                                                          

						Comparison report between M85671_P17 and Q9HAV3partial WT    	Sequence name: Q9HAV3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P17, comprising a first amino	Sequence documentation:                                      
						MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKK 	                                                            
						KYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALF                 	Alignment of: 4536 x Q9HAV3   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 104 of Q9HAV3, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 104 of M85671_P17, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1017.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     105                Total length:     105                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.05                                               
						having the sequence M corresponding to amino acids 105 - 105 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.05                                               
						of M85671_P17, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTG 100                                                          
						                                                            	                                                             
						                                                            	     101 IALFM                                              105                                                          
						                                                            	         ||||:                                               
						                                                            	     101 IALFI                                              105                                                          

4532	HMR136_M85671_18_tr0_r1_1_gPRT		Comparison report between M85671_P18 and Q96QD8partial WT    	Sequence name: Q96QD8                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P18, comprising a first amino	Sequence documentation:                                      
						MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKKKYETE 	                                                            
						F                                                            	Alignment of: 4532 x Q96QD8   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 6 - 66 of Q96QD8, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 61 of M85671_P18, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  609.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      61                Total length:      61                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence VS corresponding to amino acids 62 - 63  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of M85671_P18, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       6 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 55                                                           
						                                                            	                  .                                          
						                                                            	      51 NLGKKKYETEF                                        61                                                           
						                                                            	         |||||||||||                                         
						                                                            	      56 NLGKKKYETEF                                        66                                                           

						Comparison report between M85671_P18 and BAA92620partial WT  	Sequence name: BAA92620                                      
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P18, comprising a first amino	Sequence documentation:                                      
						MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKKKYETE 	                                                            
						F                                                            	Alignment of: 4532 x BAA92620   ..                           
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 6 - 66 of BAA92620, which also corresponds to 	Alignment segment 1/1:                                       
						amino acids 1 - 61 of M85671_P18, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  609.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      61                Total length:      61                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence VS corresponding to amino acids 62 - 63  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of M85671_P18, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       6 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 55                                                           
						                                                            	                  .                                          
						                                                            	      51 NLGKKKYETEF                                        61                                                           
						                                                            	         |||||||||||                                         
						                                                            	      56 NLGKKKYETEF                                        66                                                           

						Comparison report between M85671_P18 and Q9HAV3partial WT    	Sequence name: Q9HAV3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85671_P18, comprising a first amino	Sequence documentation:                                      
						MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKKKYETE 	                                                            
						F                                                            	Alignment of: 4532 x Q9HAV3   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 6 - 66 of Q9HAV3, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 61 of M85671_P18, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  609.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      61                Total length:      61                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence VS corresponding to amino acids 62 - 63  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of M85671_P18, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       6 MGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLES 55                                                           
						                                                            	                  .                                          
						                                                            	      51 NLGKKKYETEF                                        61                                                           
						                                                            	         |||||||||||                                         
						                                                            	      56 NLGKKKYETEF                                        66                                                           

4994	HMR136_M85695_12_tr0_r1_1_gPRT		Comparison report between M85695_P12 and Q9Y2I0unique head   	Sequence name: Q9Y2I0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85695_P12,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4994 x Q9Y2I0   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELK corresponding to amino acids 1 - 17 of     	                                                            
						M85695_P12, a second amino acid sequence being at least 90 % 	                     Quality: 4568.00                      Escore:       0                                               
						GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTGNSLSAFPSYT 	             Matching length:     470                Total length:     565                                               
						GAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYEQKLSVHTKSLQEECQQWTAS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPHLR                                                        	    Total Percent Similarity:   83.19      Total Percent Identity:   83.19                                               
						homologous to corresponding to amino acids 1 - 125 of Q9Y2I0,	                        Gaps:       1                        
						which also corresponds to amino acids 18 - 142 of M85695_P12,	                                                            
						and a third amino acid sequence being at least 90 %          	Alignment:                                                   
						EEGFHGKKSEAATEKQKLGYPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGF 	                  .         .         .         .         .  
						ASDDESNVAVTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDL 	      18 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 67                                                           
						LVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLSRNNLLPPIGT 	       1 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 50                                                           
						AEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLPDFFPRPNTTQSFLLDT 	                  .         .         .         .         .  
						QYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP                	      68 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 117                                                          
						homologous to corresponding to amino acids 221 - 565 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9Y2I0, which also corresponds to amino acids 143 - 487 of   	      51 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 100                                                          
						M85695_P12, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     118 QKLSVHTKSLQEECQQWTASFPHLR......................... 142                                                          
						contiguous and in a sequential order.2.An isolated           	         |||||||||||||||||||||||||                           
						polypeptide encoding for a head of M85695_P12, comprising a  	     101 QKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVSA 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     142 .................................................. 142                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MISRYTRKAVPQSLELK of M85695_P12.3.An isolated	     151 SYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSSSFCSMERDEED 200                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85695_P12, comprising a polypeptide having a length "n",    	     143 ....................EEGFHGKKSEAATEKQKLGYPPIAPFYCMK 172                                                          
						wherein n is at least about 10 amino acids in length,        	                             ||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 SIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLGYPPIAPFYCMK 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     173 EDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVAVTRPDSESSCV 222                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise RE, having a structure as  	     251 EDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVAVTRPDSESSCV 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						142-x to 143; and ending at any of amino acid numbers 143+   	     223 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 272                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     273 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 550                                                          
						                                                            	                  .                                          
						                                                            	     473 SQSGGRPVSRTRQGP                                    487                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     551 SQSGGRPVSRTRQGP                                    565                                                          

						Comparison report between M85695_P12 and Q96BN6unique head   	Sequence name: Q96BN6                                        
						followed by partial WT sequence featuring a skipped exon,    	                                                            
						followed by a unique insertion and a followed by a unique    	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						M85695_P12, comprising a first amino acid sequence being at  	Alignment of: 4994 x Q96BN6   ..                             
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	                                                            
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	                     Quality: 3044.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     327                Total length:     430                                               
						to amino acids 1 - 106 of M85695_P12, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.39                                               
						sequence being at least 90 % homologous to                   	    Total Percent Similarity:   76.05      Total Percent Identity:   75.58                                               
						MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLR corresponding to amino  	                        Gaps:       2                        
						acids 1 - 36 of Q96BN6, which also corresponds to amino acids	                                                            
						107 - 142 of M85695_P12, a third amino acid sequence being at	Alignment:                                                   
						EEGFHGKKSEAATEKQKLGYPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGF 	                  .         .         .         .         .  
						ASDDESNVAVTRPDSESSCVLSELHPLVLPRVPQSK                         	     107 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLR.............. 142                                                          
						least 90 % homologous to corresponding to amino acids 132 -  	         ||||||||||||||||||||||||||||||||||||                
						227 of Q96BN6, which also corresponds to amino acids 143 -   	       1 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYR 50                                                           
						238 of M85695_P12, a fourth amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     142 .................................................. 142                                                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence VLYITSNP     	      51 LYPRSPSAVSASYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSS 100                                                          
						corresponding to amino acids 239 - 246 of M85695_P12, a fifth	                  .         .         .         .         .  
						MSLCQASRHQPNVNDLLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRA 	     143 ...............................EEGFHGKKSEAATEKQKLG 161                                                          
						VEFSTSSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSP 	                                        |||||||||||||||||||  
						SPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLP 	     101 SFCSMERDEEDSIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLG 150                                                          
						DFFPRPNTTQSFL                                                	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     162 YPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVA 211                                                          
						corresponding to amino acids 228 - 420 of Q96BN6, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 247 - 439 of M85695_P12, and a    	     151 YPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVA 200                                                          
						sixth amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     212 VTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVND 261                                                          
						90% and most preferably at least 95% homologous to a         	         |||||||||||||||||||||||||||        |||||||||||||||  
						polypeptide having the sequence                              	     201 VTRPDSESSCVLSELHPLVLPRVPQSK........MSLCQASRHQPNVND 242                                                          
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP             	                  .         .         .         .         .  
						corresponding to amino acids 440 - 487 of M85695_P12, wherein	     262 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 311                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence, fourth amino acid sequence, fifth 	     243 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 292                                                          
						amino acid sequence and sixth amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     312 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 361                                                          
						polypeptide encoding for a head of M85695_P12, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     293 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 342                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     362 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 411                                                          
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	     343 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 392                                                          
						to the sequence of M85695_P12.3.An isolated chimeric         	                  .         .         .                      
						polypeptide encoding for an edge portion of M85695_P12,      	     412 DEPNYQQPQERLLLPDFFPRPNTTQSFLLD                     441                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||::                      
						least about 10 amino acids in length, optionally at least    	     393 DEPNYQQPQERLLLPDFFPRPNTTQSFLVE                     422                                                          
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise RE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 142-x to 143; and    	                                                            
						ending at any of amino acid numbers 143+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for an edge portion of M85695_P12, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for VLYITSNP,            	                                                            
						corresponding to M85695_P12.5.An isolated polypeptide        	                                                            
						encoding for a tail of M85695_P12, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP in          	                                                            
						M85695_P12.                                                  	                                                            

4992	HMR136_M85695_13_tr0_r1_1_gPRT		Comparison report between M85695_P13 and Q9Y2I0unique head   	Sequence name: Q9Y2I0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85695_P13,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4992 x Q9Y2I0   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELK corresponding to amino acids 1 - 17 of     	                                                            
						M85695_P13, a second amino acid sequence being at least 90 % 	                     Quality: 4432.00                      Escore:       0                                               
						GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTGNSLSAFPSYT 	             Matching length:     470                Total length:     565                                               
						GAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYEQKLSVHTKSLQEECQQWTAS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPHLRILGRQIITPSEGYRLYPRSPSAVSASYETTLSQERDST                  	    Total Percent Similarity:   83.19      Total Percent Identity:   83.19                                               
						homologous to corresponding to amino acids 1 - 163 of Q9Y2I0,	                        Gaps:       2                        
						which also corresponds to amino acids 18 - 180 of M85695_P13,	                                                            
						a third amino acid sequence being at least 90 % homologous to	Alignment:                                                   
						IEEGFHGKKSEAATEKQKLGYPPI corresponding to amino acids 220 -  	                  .         .         .         .         .  
						243 of Q9Y2I0, which also corresponds to amino acids 181 -   	      18 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 67                                                           
						204 of M85695_P13, and a fourth amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DDESNVAVTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLV 	       1 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 50                                                           
						HGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTRRR 	                  .         .         .         .         .  
						NPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLSRNNLLPPIGTAE 	      68 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 117                                                          
						VEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLPDFFPRPNTTQSFLLDTQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP                  	      51 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 100                                                          
						least 90 % homologous to corresponding to amino acids 283 -  	                  .         .         .         .         .  
						565 of Q9Y2I0, which also corresponds to amino acids 205 -   	     118 QKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVSA 167                                                          
						487 of M85695_P13, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     101 QKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVSA 150                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     168 SYETTLSQERDST..................................... 180                                                          
						M85695_P13, comprising a polypeptide being at least 70%,     	         |||||||||||||                                       
						optionally at least about 80%, preferably at least about 85%,	     151 SYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSSSFCSMERDEED 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MISRYTRKAVPQSLELK 	     181 ...................IEEGFHGKKSEAATEKQKLGYPPI....... 204                                                          
						of M85695_P13.3.An isolated chimeric polypeptide encoding for	                            ||||||||||||||||||||||||         
						an edge portion of M85695_P13, comprising a polypeptide      	     201 SIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLGYPPIAPFYCMK 250                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     205 ................................DDESNVAVTRPDSESSCV 222                                                          
						length, preferably at least about 30 amino acids in length,  	                                         ||||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     251 EDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVAVTRPDSESSCV 300                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise TI, having a       	     223 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 272                                                          
						structure as follows: a sequence starting from any of amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 180-x to 181; and ending at any of amino acid   	     301 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 350                                                          
						numbers 181+ ((n-2) - x), in which x varies from 0 to        	                  .         .         .         .         .  
						n-2.4.An isolated chimeric polypeptide encoding for an edge  	     273 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 322                                                          
						portion of M85695_P13, comprising a polypeptide having a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     351 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 400                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     323 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 372                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 450                                                          
						at least two amino acids comprise ID, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     373 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 422                                                          
						204-x to 205; and ending at any of amino acid numbers 205+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     451 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 550                                                          
						                                                            	                  .                                          
						                                                            	     473 SQSGGRPVSRTRQGP                                    487                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     551 SQSGGRPVSRTRQGP                                    565                                                          

						Comparison report between M85695_P13 and Q96BN6unique head   	Sequence name: Q96BN6                                        
						followed by partial WT sequence featuring a skipped exon,    	                                                            
						followed by a unique insertion and a followed by a unique    	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						M85695_P13, comprising a first amino acid sequence being at  	Alignment of: 4992 x Q96BN6   ..                             
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	                                                            
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	                     Quality: 2908.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     327                Total length:     430                                               
						to amino acids 1 - 106 of M85695_P13, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.39                                               
						MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVS 	    Total Percent Similarity:   76.05      Total Percent Identity:   75.58                                               
						ASYETTLSQERDST                                               	                        Gaps:       3                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 74 of Q96BN6, which also corresponds to amino	Alignment:                                                   
						acids 107 - 180 of M85695_P13, a third amino acid sequence   	                  .         .         .         .         .  
						being at least 90 % homologous to IEEGFHGKKSEAATEKQKLGYPPI   	     107 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYR 156                                                          
						corresponding to amino acids 131 - 154 of Q96BN6, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 181 - 204 of M85695_P13, a fourth 	       1 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYR 50                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						DDESNVAVTRPDSESSCVLSELHPLVLPRVPQSK corresponding to amino    	     157 LYPRSPSAVSASYETTLSQERDST.......................... 180                                                          
						acids 194 - 227 of Q96BN6, which also corresponds to amino   	         ||||||||||||||||||||||||                            
						acids 205 - 238 of M85695_P13, a fifth amino acid sequence   	      51 LYPRSPSAVSASYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSS 100                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     181 ..............................IEEGFHGKKSEAATEKQKLG 200                                                          
						at least 95% homologous to a polypeptide having the sequence 	                                       ||||||||||||||||||||  
						VLYITSNP corresponding to amino acids 239 - 246 of           	     101 SFCSMERDEEDSIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLG 150                                                          
						M85695_P13, a sixth amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						MSLCQASRHQPNVNDLLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRA 	     201 YPPI.......................................DDESNVA 211                                                          
						VEFSTSSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSP 	         ||||                                       |||||||  
						SPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLP 	     151 YPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVA 200                                                          
						DFFPRPNTTQSFL                                                	                  .         .         .         .         .  
						homologous to corresponding to amino acids 228 - 420 of      	     212 VTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVND 261                                                          
						Q96BN6, which also corresponds to amino acids 247 - 439 of   	         |||||||||||||||||||||||||||        |||||||||||||||  
						M85695_P13, and a seventh amino acid sequence being at least 	     201 VTRPDSESSCVLSELHPLVLPRVPQSK........MSLCQASRHQPNVND 242                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     262 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 311                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP             	     243 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 292                                                          
						corresponding to amino acids 440 - 487 of M85695_P13, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     312 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 361                                                          
						third amino acid sequence, fourth amino acid sequence, fifth 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, sixth amino acid sequence and seventh   	     293 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 342                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     362 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 411                                                          
						M85695_P13, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     343 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 392                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .                      
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	     412 DEPNYQQPQERLLLPDFFPRPNTTQSFLLD                     441                                                          
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	         ||||||||||||||||||||||||||||::                      
						least about 95% homologous to the sequence of M85695_P13.3.An	     393 DEPNYQQPQERLLLPDFFPRPNTTQSFLVE                     422                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						M85695_P13, comprising a polypeptide having a length "n",    	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise TI, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						180-x to 181; and ending at any of amino acid numbers 181+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						chimeric polypeptide encoding for an edge portion of         	                                                            
						M85695_P13, comprising a polypeptide having a length "n",    	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise ID, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						204-x to 205; and ending at any of amino acid numbers 205+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                                                            
						polypeptide encoding for an edge portion of M85695_P13,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						VLYITSNP, corresponding to M85695_P13.6.An isolated          	                                                            
						polypeptide encoding for a tail of M85695_P13, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence                                              	                                                            
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP in          	                                                            
						M85695_P13.                                                  	                                                            

4990	HMR136_M85695_9_tr0_r1_1_gPRT		Comparison report between M85695_P9 and Q9Y2I0unique head    	Sequence name: Q9Y2I0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85695_P9,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 4990 x Q9Y2I0   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELK corresponding to amino acids 1 - 17 of     	                                                            
						M85695_P9, a second amino acid sequence being at least 90 %  	                     Quality: 4939.00                      Escore:       0                                               
						GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTGNSLSAFPSYT 	             Matching length:     509                Total length:     565                                               
						GAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYEQKLSVHTKSLQEECQQWTAS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPHLRILGRQIITPSEGYRLYPRSPSAVSASYETTLSQERDST                  	    Total Percent Similarity:   90.09      Total Percent Identity:   90.09                                               
						homologous to corresponding to amino acids 1 - 163 of Q9Y2I0,	                        Gaps:       1                        
						which also corresponds to amino acids 18 - 180 of M85695_P9, 	                                                            
						and a third amino acid sequence being at least 90 %          	Alignment:                                                   
						IEEGFHGKKSEAATEKQKLGYPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEG 	                  .         .         .         .         .  
						FASDDESNVAVTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVND 	      18 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 67                                                           
						LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLSRNNLLPPIG 	       1 GITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESSFTSADTG 50                                                           
						TAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLPDFFPRPNTTQSFLLD 	                  .         .         .         .         .  
						TQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP               	      68 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 117                                                          
						homologous to corresponding to amino acids 220 - 565 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9Y2I0, which also corresponds to amino acids 181 - 526 of   	      51 NSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQTMFTAIDELLYE 100                                                          
						M85695_P9, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     118 QKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVSA 167                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M85695_P9, comprising a   	     101 QKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVSA 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     168 SYETTLSQERDST..................................... 180                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||                                       
						to the sequence MISRYTRKAVPQSLELK of M85695_P9.3.An isolated 	     151 SYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSSSFCSMERDEED 200                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85695_P9, comprising a polypeptide having a length "n",     	     181 ...................IEEGFHGKKSEAATEKQKLGYPPIAPFYCMK 211                                                          
						wherein n is at least about 10 amino acids in length,        	                            |||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     201 SIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLGYPPIAPFYCMK 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     212 EDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVAVTRPDSESSCV 261                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TI, having a structure as  	     251 EDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVAVTRPDSESSCV 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						180-x to 181; and ending at any of amino acid numbers 181+   	     262 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 311                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVNDLLVHGMPLQPR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     312 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFSTSSLSYTVQSTR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     362 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSPSPTPLS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQER 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LLLPDFFPRPNTTQSFLLDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTK 550                                                          
						                                                            	                  .                                          
						                                                            	     512 SQSGGRPVSRTRQGP                                    526                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     551 SQSGGRPVSRTRQGP                                    565                                                          

						Comparison report between M85695_P9 and Q96BN6unique head    	Sequence name: Q96BN6                                        
						followed by partial WT sequence featuring a skipped exon,    	                                                            
						followed by a unique insertion and a followed by a unique    	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						M85695_P9, comprising a first amino acid sequence being at   	Alignment of: 4990 x Q96BN6   ..                             
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	                                                            
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	                     Quality: 3415.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     366                Total length:     430                                               
						to amino acids 1 - 106 of M85695_P9, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.45                                               
						MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYRLYPRSPSAVS 	    Total Percent Similarity:   85.12      Total Percent Identity:   84.65                                               
						ASYETTLSQERDST                                               	                        Gaps:       2                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 74 of Q96BN6, which also corresponds to amino	Alignment:                                                   
						acids 107 - 180 of M85695_P9, a third amino acid sequence    	                  .         .         .         .         .  
						IEEGFHGKKSEAATEKQKLGYPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEG 	     107 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYR 156                                                          
						FASDDESNVAVTRPDSESSCVLSELHPLVLPRVPQSK                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 MFTAIDELLYEQKLSVHTKSLQEECQQWTASFPHLRILGRQIITPSEGYR 50                                                           
						acids 131 - 227 of Q96BN6, which also corresponds to amino   	                  .         .         .         .         .  
						acids 181 - 277 of M85695_P9, a fourth amino acid sequence   	     157 LYPRSPSAVSASYETTLSQERDST.......................... 180                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||                            
						least 85%, more preferably at least 90% and most preferably  	      51 LYPRSPSAVSASYETTLSQERDSTIFGIRGKKLHFSSSYAHKASSIAKSS 100                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						VLYITSNP corresponding to amino acids 278 - 285 of M85695_P9,	     181 ..............................IEEGFHGKKSEAATEKQKLG 200                                                          
						MSLCQASRHQPNVNDLLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRA 	                                       ||||||||||||||||||||  
						VEFSTSSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPDSLSSP 	     101 SFCSMERDEEDSIIVSEGIIEEYLAFDHIDIEEGFHGKKSEAATEKQKLG 150                                                          
						SPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVVDEPNYQQPQERLLLP 	                  .         .         .         .         .  
						DFFPRPNTTQSFL                                                	     201 YPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVA 250                                                          
						a fifth amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 228 - 420 of Q96BN6, which also 	     151 YPPIAPFYCMKEDVLAYVFDSVWCKVVSCMEQLTRSHWEGFASDDESNVA 200                                                          
						corresponds to amino acids 286 - 478 of M85695_P9, and a     	                  .         .         .         .         .  
						sixth amino acid sequence being at least 70%, optionally at  	     251 VTRPDSESSCVLSELHPLVLPRVPQSKVLYITSNPMSLCQASRHQPNVND 300                                                          
						least 80%, preferably at least 85%, more preferably at least 	         |||||||||||||||||||||||||||        |||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     201 VTRPDSESSCVLSELHPLVLPRVPQSK........MSLCQASRHQPNVND 242                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP             	     301 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 350                                                          
						corresponding to amino acids 479 - 526 of M85695_P9, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     243 LLVHGMPLQPRNLSLMDKLLDLDDKLLMRPGSSTILSTRNWPNRAVEFST 292                                                          
						third amino acid sequence, fourth amino acid sequence, fifth 	                  .         .         .         .         .  
						amino acid sequence and sixth amino acid sequence are        	     351 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 400                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M85695_P9, comprising a   	     293 SSLSYTVQSTRRRNPPPRTLHPISTSHSCAETPRSVEEILRGARVPVAPD 342                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     401 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 450                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MISRYTRKAVPQSLELKGITKHALNHHPPPEKLEEISPTSDSHEKDTSSQSKSDITRESS 	     343 SLSSPSPTPLSRNNLLPPIGTAEVEHVSTVGPQRQMKPHGDSSRAQSAVV 392                                                          
						FTSADTGNSLSAFPSYTGAGISTEGSSDFSWGYGELDQNATEKVQT               	                  .         .         .                      
						to the sequence of M85695_P9.3.An isolated chimeric          	     451 DEPNYQQPQERLLLPDFFPRPNTTQSFLLD                     480                                                          
						polypeptide encoding for an edge portion of M85695_P9,       	         ||||||||||||||||||||||||||||::                      
						comprising a polypeptide having a length "n", wherein n is at	     393 DEPNYQQPQERLLLPDFFPRPNTTQSFLVE                     422                                                          
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise TI, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 180-x to 181; and    	                                                            
						ending at any of amino acid numbers 181+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for an edge portion of M85695_P9, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for VLYITSNP,            	                                                            
						corresponding to M85695_P9.5.An isolated polypeptide encoding	                                                            
						for a tail of M85695_P9, comprising a polypeptide being at   	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						LDTQYRRSCAVEYPHQARPGRGSAGPQLHGSTKSQSGGRPVSRTRQGP in          	                                                            
						M85695_P9.                                                   	                                                            

5072	HMR136_M85697_2_tr0_r1_1_gPRT		Comparison report between M85697_P2 and Q8TB82unique head    	Sequence name: Q8TB82                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85697_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 5072 x Q8TB82   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						RNLLYIYPQSLNFANRQGSARNITVKVQFMYGEDPSNAMPVIFGKSSCSEFSKEAYTAVV 	Alignment segment 1/1:                                       
						YHNRSPDFHEEIKVKLPATLTDHHHLLFTFYHVSCQQKQNTPLETPVGYTWIPMLQNGRL 	                                                            
						KTGQFCLPVSLEKPPQAYSVLSPEVPLPGMKWVDNHKGVFNVEVVAVSSIHTQDPYLDKF 	                     Quality: 6141.00                      Escore:       0                                               
						FALVNALDEHLFPVRIGDMRIMENNLENELKSSISALNSSQLEPVVRFLHLLLDKLILLV 	             Matching length:     624                Total length:     624                                               
						IRPPVIAGQIVNLGQASFEAMASIINRLHKNLEGNHDQHGRNSLLASYIHYVFRLPNTYP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NSSSPGPGGLGGSVHYATMARSAVRPASLNLNRSRSLSNSNPDISGTPTSPDDEVRSIIG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SKGLDRSNSWVNTGGPKAAPWGSNPSPSAESTQLFHEELALQWVVCSGSVRESALQQAWF 	                        Gaps:       0                        
						FFELMVKSMVHHLYFNDKLEAPRKSRFPERFMDDIAALVSTIASDIVSRFQKDTEMVERL 	                                                            
						NTSLAFFLNDLLSVMDRGFVFSLIKSCYKQVSSKLYSLPNPSVLVSLRLDFLRIICSHEH 	Alignment:                                                   
						YVTLNLPCSLLTPPASPSPSVSSATSQSSGFSTNVQDQKIANMFELSVPFRQQHYLAGLV 	                  .         .         .         .         .  
						LTELAVILDPDAEGLFGLHKKVINMVHNLLSSHDSDPRYSDPQIKARVAMLYLPLIGIIM 	     916 MACNQSAVYLQHCFATQRALVSKFPELLFEEETEQCADLCLRLLRHCSSS 965                                                          
						ETVPQLYDFTETHNQRGRPICIATDDYESESGSMISQTVAMAIAGTSVPQLTRPGSFLLT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						STSGRQHTTFSAESSRSLLICLLWVLKNADETVLQKWFTDLSVLQLNRLLDLLYLCVSCF 	       1 MACNQSAVYLQHCFATQRALVSKFPELLFEEETEQCADLCLRLLRHCSSS 50                                                           
						EYKGKKVFERMNSLTFKKSKDMRAKLEEAILGSIGARQEMVRRSRGQLERSPSGSAFGSQ 	                  .         .         .         .         .  
						ENLRWRKDMTHWRQNTEKLDKSRAEIEHEALIDGNLATEANLIILDTLEIVVQTVSVTES 	     966 IGTIRSHASASLYLLMRQNFEIGNNFARVKMQVTMSLSSLVGTSQNFNEE 1015                                                         
						KESILGGVLKVLLHS                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 915 of  	      51 IGTIRSHASASLYLLMRQNFEIGNNFARVKMQVTMSLSSLVGTSQNFNEE 100                                                          
						M85697_P2, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						MACNQSAVYLQHCFATQRALVSKFPELLFEEETEQCADLCLRLLRHCSSSIGTIRSHASA 	    1016 FLRRSLKTILTYAEEDLELRETTFPDQVQDLVFNLHMILSDTVKMKEHQE 1065                                                         
						SLYLLMRQNFEIGNNFARVKMQVTMSLSSLVGTSQNFNEEFLRRSLKTILTYAEEDLELR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETTFPDQVQDLVFNLHMILSDTVKMKEHQEDPEMLIDLMYRIAKGYQTSPDLRLTWLQNM 	     101 FLRRSLKTILTYAEEDLELRETTFPDQVQDLVFNLHMILSDTVKMKEHQE 150                                                          
						AGKHSERSNHAEAAQCLVHSAALVAEYLSMLEDRKYLPVGCVTFQNISSNVLEESAVSDD 	                  .         .         .         .         .  
						VVSPDEEGICSGKYFTESGLVGLLEQAAASFSMAGMYEAVNEVYKVLIPIHEANRDAKKL 	    1066 DPEMLIDLMYRIAKGYQTSPDLRLTWLQNMAGKHSERSNHAEAAQCLVHS 1115                                                         
						STIHGKLQEAFSKIVHQDGKRMFGTYFRVGFYGTKFGDLDEQEFVYKEPAITKLAEISHR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LEGFYGERFGEDVVEVIKDSNPVDKCKLDPNKAYIQITYVEPYFDTYEMKDRITYFDKNY 	     151 DPEMLIDLMYRIAKGYQTSPDLRLTWLQNMAGKHSERSNHAEAAQCLVHS 200                                                          
						NLRRFMYCTPFTLDGRAHGELHEQFKRKTILTTSHAFPYIKTRVNVTHKEEIILTPIEVA 	                  .         .         .         .         .  
						IEDMQKKTQELAFATHQDPADPKMLQMVLQGSVGTTVNQGPLEVAQVFLSEIPSDPKLFR 	    1116 AALVAEYLSMLEDRKYLPVGCVTFQNISSNVLEESAVSDDVVSPDEEGIC 1165                                                         
						HHNKLRLCFKDFTKRCEDALRKNKSLIGPDQKEYQRELERNYHRLKEALQPLINRKIPQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YKAVLPVTCHRDSFSRMSLRKMDL                                     	     201 AALVAEYLSMLEDRKYLPVGCVTFQNISSNVLEESAVSDDVVSPDEEGIC 250                                                          
						% homologous to corresponding to amino acids 1 - 624 of      	                  .         .         .         .         .  
						Q8TB82, which also corresponds to amino acids 916 - 1539 of  	    1166 SGKYFTESGLVGLLEQAAASFSMAGMYEAVNEVYKVLIPIHEANRDAKKL 1215                                                         
						M85697_P2, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     251 SGKYFTESGLVGLLEQAAASFSMAGMYEAVNEVYKVLIPIHEANRDAKKL 300                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M85697_P2, comprising a polypeptide being at least 70%,      	    1216 STIHGKLQEAFSKIVHQDGKRMFGTYFRVGFYGTKFGDLDEQEFVYKEPA 1265                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     301 STIHGKLQEAFSKIVHQDGKRMFGTYFRVGFYGTKFGDLDEQEFVYKEPA 350                                                          
						RNLLYIYPQSLNFANRQGSARNITVKVQFMYGEDPSNAMPVIFGKSSCSEFSKEAYTAVV 	                  .         .         .         .         .  
						YHNRSPDFHEEIKVKLPATLTDHHHLLFTFYHVSCQQKQNTPLETPVGYTWIPMLQNGRL 	    1266 ITKLAEISHRLEGFYGERFGEDVVEVIKDSNPVDKCKLDPNKAYIQITYV 1315                                                         
						KTGQFCLPVSLEKPPQAYSVLSPEVPLPGMKWVDNHKGVFNVEVVAVSSIHTQDPYLDKF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FALVNALDEHLFPVRIGDMRIMENNLENELKSSISALNSSQLEPVVRFLHLLLDKLILLV 	     351 ITKLAEISHRLEGFYGERFGEDVVEVIKDSNPVDKCKLDPNKAYIQITYV 400                                                          
						IRPPVIAGQIVNLGQASFEAMASIINRLHKNLEGNHDQHGRNSLLASYIHYVFRLPNTYP 	                  .         .         .         .         .  
						NSSSPGPGGLGGSVHYATMARSAVRPASLNLNRSRSLSNSNPDISGTPTSPDDEVRSIIG 	    1316 EPYFDTYEMKDRITYFDKNYNLRRFMYCTPFTLDGRAHGELHEQFKRKTI 1365                                                         
						SKGLDRSNSWVNTGGPKAAPWGSNPSPSAESTQLFHEELALQWVVCSGSVRESALQQAWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFELMVKSMVHHLYFNDKLEAPRKSRFPERFMDDIAALVSTIASDIVSRFQKDTEMVERL 	     401 EPYFDTYEMKDRITYFDKNYNLRRFMYCTPFTLDGRAHGELHEQFKRKTI 450                                                          
						NTSLAFFLNDLLSVMDRGFVFSLIKSCYKQVSSKLYSLPNPSVLVSLRLDFLRIICSHEH 	                  .         .         .         .         .  
						YVTLNLPCSLLTPPASPSPSVSSATSQSSGFSTNVQDQKIANMFELSVPFRQQHYLAGLV 	    1366 LTTSHAFPYIKTRVNVTHKEEIILTPIEVAIEDMQKKTQELAFATHQDPA 1415                                                         
						LTELAVILDPDAEGLFGLHKKVINMVHNLLSSHDSDPRYSDPQIKARVAMLYLPLIGIIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETVPQLYDFTETHNQRGRPICIATDDYESESGSMISQTVAMAIAGTSVPQLTRPGSFLLT 	     451 LTTSHAFPYIKTRVNVTHKEEIILTPIEVAIEDMQKKTQELAFATHQDPA 500                                                          
						STSGRQHTTFSAESSRSLLICLLWVLKNADETVLQKWFTDLSVLQLNRLLDLLYLCVSCF 	                  .         .         .         .         .  
						EYKGKKVFERMNSLTFKKSKDMRAKLEEAILGSIGARQEMVRRSRGQLERSPSGSAFGSQ 	    1416 DPKMLQMVLQGSVGTTVNQGPLEVAQVFLSEIPSDPKLFRHHNKLRLCFK 1465                                                         
						ENLRWRKDMTHWRQNTEKLDKSRAEIEHEALIDGNLATEANLIILDTLEIVVQTVSVTES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KESILGGVLKVLLHS                                              	     501 DPKMLQMVLQGSVGTTVNQGPLEVAQVFLSEIPSDPKLFRHHNKLRLCFK 550                                                          
						least about 95% homologous to the sequence of M85697_P2.     	                  .         .         .         .         .  
						                                                            	    1466 DFTKRCEDALRKNKSLIGPDQKEYQRELERNYHRLKEALQPLINRKIPQL 1515                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DFTKRCEDALRKNKSLIGPDQKEYQRELERNYHRLKEALQPLINRKIPQL 600                                                          
						                                                            	                  .         .                                
						                                                            	    1516 YKAVLPVTCHRDSFSRMSLRKMDL                           1539                                                         
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     601 YKAVLPVTCHRDSFSRMSLRKMDL                           624                                                          

						Comparison report between M85697_P2 and Q96N67unique head    	Sequence name: Q96N67                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85697_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 5072 x Q96N67   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						RNLLYIYPQSLNFANRQGSARNITVKVQFMYGEDPSNAMPVIFGKSSCSEFSKEAYTAVV 	Alignment segment 1/1:                                       
						YHNRSPDFHEEIKVKLPATLTDHHHLLFTFYHVSCQQKQNTPLETPVGYTWIPMLQNGRL 	                                                            
						KTGQFCLPVSLEKPPQAYSVLSPEVPLPGMKWVDNHKGVFNVEVVAVSSIHTQDPYLDKF 	                     Quality: 7030.00                      Escore:       0                                               
						FALVNALDEHLFPVRIGDMRIMENNLENELKSSISALNSSQLEPVVRFLHLLLDKLILLV 	             Matching length:     724                Total length:     724                                               
						IRPPVIAGQIVNLGQASFEAMASIINRLHKNLEGNHDQHGRNSLLASYIHYVFRLPNTYP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NSSSPGPGGLGGSVHYATMARSAVRPASLNLNRSRSLSNSNPDISGTPTSPDDEVRSIIG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SKGLDRSNSWVNTGGPKAAPWGSNPSPSAESTQLFHEELALQWVVCSGSVRESALQQAWF 	                        Gaps:       0                        
						FFELMVKSMVHHLYFNDKLEAPRKSRFPERFMDDIAALVSTIASDIVSRFQKDTEMVERL 	                                                            
						NTSLAFFLNDLLSVMDRGFVFSLIKSCYKQVSSKLYSLPNPSVLVSLRLDFLRIICSHEH 	Alignment:                                                   
						YVTLNLPCSLLTPPASPSPSVSSATSQSSGFSTNVQDQKIAN                   	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     583 MFELSVPFRQQHYLAGLVLTELAVILDPDAEGLFGLHKKVINMVHNLLSS 632                                                          
						to amino acids 1 - 582 of M85697_P2, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MFELSVPFRQQHYLAGLVLTELAVILDPDAEGLFGLHKKVINMVHNLLSSHDSDPRYSDP 	       1 MFELSVPFRQQHYLAGLVLTELAVILDPDAEGLFGLHKKVINMVHNLLSS 50                                                           
						QIKARVAMLYLPLIGIIMETVPQLYDFTETHNQRGRPICIATDDYESESGSMISQTVAMA 	                  .         .         .         .         .  
						IAGTSVPQLTRPGSFLLTSTSGRQHTTFSAESSRSLLICLLWVLKNADETVLQKWFTDLS 	     633 HDSDPRYSDPQIKARVAMLYLPLIGIIMETVPQLYDFTETHNQRGRPICI 682                                                          
						VLQLNRLLDLLYLCVSCFEYKGKKVFERMNSLTFKKSKDMRAKLEEAILGSIGARQEMVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSRGQLERSPSGSAFGSQENLRWRKDMTHWRQNTEKLDKSRAEIEHEALIDGNLATEANL 	      51 HDSDPRYSDPQIKARVAMLYLPLIGIIMETVPQLYDFTETHNQRGRPICI 100                                                          
						IILDTLEIVVQTVSVTESKESILGGVLKVLLHSMACNQSAVYLQHCFATQRALVSKFPEL 	                  .         .         .         .         .  
						LFEEETEQCADLCLRLLRHCSSSIGTIRSHASASLYLLMRQNFEIGNNFARVKMQVTMSL 	     683 ATDDYESESGSMISQTVAMAIAGTSVPQLTRPGSFLLTSTSGRQHTTFSA 732                                                          
						SSLVGTSQNFNEEFLRRSLKTILTYAEEDLELRETTFPDQVQDLVFNLHMILSDTVKMKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQEDPEMLIDLMYRIAKGYQTSPDLRLTWLQNMAGKHSERSNHAEAAQCLVHSAALVAEY 	     101 ATDDYESESGSMISQTVAMAIAGTSVPQLTRPGSFLLTSTSGRQHTTFSA 150                                                          
						LSMLEDRKYLPVGCVTFQNISSNVLEESAVSDDVVSPDEEGICSGKYFTESGLVGLLEQA 	                  .         .         .         .         .  
						AASFSMAGMYEAVNEVYKVLIPIHEANRDAKKLSTIHGKLQEAFSKIVHQDGKRMFGTYF 	     733 ESSRSLLICLLWVLKNADETVLQKWFTDLSVLQLNRLLDLLYLCVSCFEY 782                                                          
						RVGFYGTKFGDLDEQEFVYKEPAITKLAEISHRLEGFYGERFGEDVVEVIKDSNPVDKCK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDPN                                                         	     151 ESSRSLLICLLWVLKNADETVLQKWFTDLSVLQLNRLLDLLYLCVSCFEY 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 724 of Q96N67, which also corresponds to     	     783 KGKKVFERMNSLTFKKSKDMRAKLEEAILGSIGARQEMVRRSRGQLERSP 832                                                          
						amino acids 583 - 1306 of M85697_P2, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     201 KGKKVFERMNSLTFKKSKDMRAKLEEAILGSIGARQEMVRRSRGQLERSP 250                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     833 SGSAFGSQENLRWRKDMTHWRQNTEKLDKSRAEIEHEALIDGNLATEANL 882                                                          
						KAYIQITYVEPYFDTYEMKDRITYFDKNYNLRRFMYCTPFTLDGRAHGELHEQFKRKTIL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTSHAFPYIKTRVNVTHKEEIILTPIEVAIEDMQKKTQELAFATHQDPADPKMLQMVLQG 	     251 SGSAFGSQENLRWRKDMTHWRQNTEKLDKSRAEIEHEALIDGNLATEANL 300                                                          
						SVGTTVNQGPLEVAQVFLSEIPSDPKLFRHHNKLRLCFKDFTKRCEDALRKNKSLIGPDQ 	                  .         .         .         .         .  
						KEYQRELERNYHRLKEALQPLINRKIPQLYKAVLPVTCHRDSFSRMSLRKMDL        	     883 IILDTLEIVVQTVSVTESKESILGGVLKVLLHSMACNQSAVYLQHCFATQ 932                                                          
						having the sequence corresponding to amino acids 1307 - 1539 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85697_P2, wherein said first amino acid sequence, second 	     301 IILDTLEIVVQTVSVTESKESILGGVLKVLLHSMACNQSAVYLQHCFATQ 350                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     933 RALVSKFPELLFEEETEQCADLCLRLLRHCSSSIGTIRSHASASLYLLMR 982                                                          
						polypeptide encoding for a head of M85697_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     351 RALVSKFPELLFEEETEQCADLCLRLLRHCSSSIGTIRSHASASLYLLMR 400                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     983 QNFEIGNNFARVKMQVTMSLSSLVGTSQNFNEEFLRRSLKTILTYAEEDL 1032                                                         
						RNLLYIYPQSLNFANRQGSARNITVKVQFMYGEDPSNAMPVIFGKSSCSEFSKEAYTAVV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YHNRSPDFHEEIKVKLPATLTDHHHLLFTFYHVSCQQKQNTPLETPVGYTWIPMLQNGRL 	     401 QNFEIGNNFARVKMQVTMSLSSLVGTSQNFNEEFLRRSLKTILTYAEEDL 450                                                          
						KTGQFCLPVSLEKPPQAYSVLSPEVPLPGMKWVDNHKGVFNVEVVAVSSIHTQDPYLDKF 	                  .         .         .         .         .  
						FALVNALDEHLFPVRIGDMRIMENNLENELKSSISALNSSQLEPVVRFLHLLLDKLILLV 	    1033 ELRETTFPDQVQDLVFNLHMILSDTVKMKEHQEDPEMLIDLMYRIAKGYQ 1082                                                         
						IRPPVIAGQIVNLGQASFEAMASIINRLHKNLEGNHDQHGRNSLLASYIHYVFRLPNTYP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSSSPGPGGLGGSVHYATMARSAVRPASLNLNRSRSLSNSNPDISGTPTSPDDEVRSIIG 	     451 ELRETTFPDQVQDLVFNLHMILSDTVKMKEHQEDPEMLIDLMYRIAKGYQ 500                                                          
						SKGLDRSNSWVNTGGPKAAPWGSNPSPSAESTQLFHEELALQWVVCSGSVRESALQQAWF 	                  .         .         .         .         .  
						FFELMVKSMVHHLYFNDKLEAPRKSRFPERFMDDIAALVSTIASDIVSRFQKDTEMVERL 	    1083 TSPDLRLTWLQNMAGKHSERSNHAEAAQCLVHSAALVAEYLSMLEDRKYL 1132                                                         
						NTSLAFFLNDLLSVMDRGFVFSLIKSCYKQVSSKLYSLPNPSVLVSLRLDFLRIICSHEH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YVTLNLPCSLLTPPASPSPSVSSATSQSSGFSTNVQDQKIAN                   	     501 TSPDLRLTWLQNMAGKHSERSNHAEAAQCLVHSAALVAEYLSMLEDRKYL 550                                                          
						to the sequence of M85697_P2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of M85697_P2, comprising a polypeptide   	    1133 PVGCVTFQNISSNVLEESAVSDDVVSPDEEGICSGKYFTESGLVGLLEQA 1182                                                         
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     551 PVGCVTFQNISSNVLEESAVSDDVVSPDEEGICSGKYFTESGLVGLLEQA 600                                                          
						KAYIQITYVEPYFDTYEMKDRITYFDKNYNLRRFMYCTPFTLDGRAHGELHEQFKRKTIL 	                  .         .         .         .         .  
						TTSHAFPYIKTRVNVTHKEEIILTPIEVAIEDMQKKTQELAFATHQDPADPKMLQMVLQG 	    1183 AASFSMAGMYEAVNEVYKVLIPIHEANRDAKKLSTIHGKLQEAFSKIVHQ 1232                                                         
						SVGTTVNQGPLEVAQVFLSEIPSDPKLFRHHNKLRLCFKDFTKRCEDALRKNKSLIGPDQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEYQRELERNYHRLKEALQPLINRKIPQLYKAVLPVTCHRDSFSRMSLRKMDL        	     601 AASFSMAGMYEAVNEVYKVLIPIHEANRDAKKLSTIHGKLQEAFSKIVHQ 650                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						in M85697_P2.                                                	    1233 DGKRMFGTYFRVGFYGTKFGDLDEQEFVYKEPAITKLAEISHRLEGFYGE 1282                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 DGKRMFGTYFRVGFYGTKFGDLDEQEFVYKEPAITKLAEISHRLEGFYGE 700                                                          
						                                                            	                  .         .                                
						                                                            	    1283 RFGEDVVEVIKDSNPVDKCKLDPN                           1306                                                         
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     701 RFGEDVVEVIKDSNPVDKCKLDPN                           724                                                          

9969	HMR136_M85703_4_tr0_r1_1_gPRT		Comparison report between M85703_P4 and Q9UPW8partial WT     	Sequence name: Q9UPW8                                        
						sequence featuring skipped exon, a mismatch and a followed by	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85703_P4, comprising a first amino acid sequence being at   	                                                            
						MRYGVESIYQAMTHFACLSSKYMCPGVPAVMSTLLANINAYYAHTTASTNVSASDRFAAS 	Alignment of: 9969 x Q9UPW8   ..                             
						NFGKERFVKLLDQLHNSLRIDLSMYRNNFPASSPERLQDLKSTVDLLTSITFFRMKVQEL 	                                                            
						QSPPRASQVVKDCVKACLNSTYEYIFNNCHELYSREYQTD                     	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 150 -  	                                                            
						309 of Q9UPW8, which also corresponds to amino acids 1 - 160 	                     Quality: 5122.00                      Escore:       0                                               
						of M85703_P4, a second amino acid sequence being at least 90 	             Matching length:     542                Total length:     549                                               
						PPEEQGPSIKNLDFWSKLITLIVSIIEEDKNSYTPCLNQFPQELNVGKISAEVMWNLFAQ 	 Matching Percent Similarity:   98.52   Matching Percent Identity:   97.79                                               
						DMKYAMEEHDKHRLCKSADYMNLHFKVKWLYNEYVTELP                      	    Total Percent Similarity:   97.27      Total Percent Identity:   96.54                                               
						% homologous to corresponding to amino acids 317 - 415 of    	                        Gaps:       1                        
						Q9UPW8, which also corresponds to amino acids 161 - 259 of   	                                                            
						M85703_P4, a bridging amino acid A corresponding to amino    	Alignment:                                                   
						acid 260 of M85703_P4, a third amino acid sequence being at  	                  .         .         .         .         .  
						FKDRVPEYPAWFEPFVIQWLDENEEVSRDFLHGALERDKKDGFQQTSEHALFSCSVVDVF 	       1 MRYGVESIYQAMTHFACLSSKYMCPGVPAVMSTLLANINAYYAHTTASTN 50                                                           
						SQLNQSFEIIKKLECPDPQIVGHYMRRFAKTISNVLLQYADIISKDFASYCSKEKEKVPC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILMNNTQQLRVQLEKMFEAMGGKELDAEASDILKELQVKLNNVLDELSRVFATSFQPHIE 	     150 MRYGVESIYQAMTHFACLSSKYMCPGVPAVMSTLLANINAYYAHTTASTN 199                                                          
						ECVKQMGDILSQVKGTGNVPASACSSVAQDADNVLQPIMDLLDSNLTLFAKICEKTVLKR 	                  .         .         .         .         .  
						VLKELWKLVMNTMEKTIVLPPLTDQT                                   	      51 VSASDRFAASNFGKERFVKLLDQLHNSLRIDLSMYRNNFPASSPERLQDL 100                                                          
						least 90 % homologous to corresponding to amino acids 417 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						682 of Q9UPW8, which also corresponds to amino acids 261 -   	     200 VSASDRFAASNFGKERFVKLLDQLHNSLRIDLSMYRNNFPASSPERLQDL 249                                                          
						526 of M85703_P4, and a fourth amino acid sequence being at  	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     101 KSTVDLLTSITFFRMKVQELQSPPRASQVVKDCVKACLNSTYEYIFNNCH 150                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRREPLEKTWQGIRKGQGEIAKPLRRNPDDLQCSQGAGSAVQTQGSHGTRRSQELDPKAV 	     250 KSTVDLLTSITFFRMKVQELQSPPRASQVVKDCVKACLNSTYEYIFNNCH 299                                                          
						RGC                                                          	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     151 ELYSREYQTD.......PPEEQGPSIKNLDFWSKLITLIVSIIEEDKNSY 193                                                          
						to amino acids 527 - 589 of M85703_P4, wherein said first    	         ||||||||||       |||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence, bridging    	     300 ELYSREYQTDPAKKGEVPPEEQGPSIKNLDFWSKLITLIVSIIEEDKNSY 349                                                          
						amino acid, third amino acid sequence and fourth amino acid  	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     194 TPCLNQFPQELNVGKISAEVMWNLFAQDMKYAMEEHDKHRLCKSADYMNL 243                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85703_P4, comprising a polypeptide having a length "n",     	     350 TPCLNQFPQELNVGKISAEVMWNLFAQDMKYAMEEHDKHRLCKSADYMNL 399                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     244 HFKVKWLYNEYVTELPAFKDRVPEYPAWFEPFVIQWLDENEEVSRDFLHG 293                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||:|||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     400 HFKVKWLYNEYVTELPSFKDRVPEYPAWFEPFVIQWLDENEEVSRDFLHG 449                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise DP, having a structure as  	     294 ALERDKKDGFQQTSEHALFSCSVVDVFSQLNQSFEIIKKLECPDPQIVGH 343                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						160-x to 161; and ending at any of amino acid numbers 161+   	     450 ALERDKKDGFQQTSEHALFSCSVVDVFSQLNQSFEIIKKLECPDPQIVGH 499                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85703_P4, comprising a   	     344 YMRRFAKTISNVLLQYADIISKDFASYCSKEKEKVPCILMNNTQQLRVQL 393                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     500 YMRRFAKTISNVLLQYADIISKDFASYCSKEKEKVPCILMNNTQQLRVQL 549                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						VRREPLEKTWQGIRKGQGEIAKPLRRNPDDLQCSQGAGSAVQTQGSHGTRRSQELDPKAV 	     394 EKMFEAMGGKELDAEASDILKELQVKLNNVLDELSRVFATSFQPHIEECV 443                                                          
						RGC                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence in M85703_P4.                                	     550 EKMFEAMGGKELDAEASDILKELQVKLNNVLDELSRVFATSFQPHIEECV 599                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 KQMGDILSQVKGTGNVPASACSSVAQDADNVLQPIMDLLDSNLTLFAKIC 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     600 KQMGDILSQVKGTGNVPASACSSVAQDADNVLQPIMDLLDSNLTLFAKIC 649                                                          
						                                                            	                  .         .         .         .            
						                                                            	     494 EKTVLKRVLKELWKLVMNTMEKTIVLPPLTDQTVRREPLEKTWQGIRKG  542                                                          
						                                                            	         |||||||||||||||||||||||||||||||||:    | |  :|: ||   
						                                                            	     650 EKTVLKRVLKELWKLVMNTMEKTIVLPPLTDQTMIGNLLRKHGKGLEKG  698                                                          

10182	HMR136_M85715_11_tr0_r1_1_gPRT		Comparison report between M85715_P11 and SH33_HUMANpartial   	Sequence name: SH33_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85715_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMER corresponding to amino	Alignment of: 10182 x SH33_HUMAN   ..                        
						acids 1 - 38 of SH33_HUMAN, which also corresponds to amino  	                                                            
						acids 1 - 38 of M85715_P11, and a second amino acid sequence 	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality:  366.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:      38                Total length:      38                                               
						VLTFPWTSPAVVVSMTLSQKTKEN corresponding to amino acids 39 - 62	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of M85715_P11, wherein said first amino acid sequence and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence are contiguous and in a sequential	                        Gaps:       0                        
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						M85715_P11, comprising a polypeptide being at least 70%,     	Alignment:                                                   
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	       1 MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMER             38                                                           
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||              
						VLTFPWTSPAVVVSMTLSQKTKEN in M85715_P11.                      	       1 MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMER             38                                                           

10184	HMR136_M85715_7_tr0_r1_1_gPRT		Comparison report between M85715_P7 and SH33_HUMANpartial WT 	Sequence name: SH33_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85715_P7, comprising a first amino 	Sequence documentation:                                      
						MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMERKIDVTNKVVAEILSKTTEYLQP 	                                                            
						NPAYRAKLGMLNTVSKIRGQVKTTGYPQTEGLLGDCMLKYGKELGEDSTFGNALIEVGES 	Alignment of: 10184 x SH33_HUMAN   ..                        
						MKLMAEVKDSLDINVKQTFIDPLQLLQDKDLKEIGHHLKKLEGRRLDYDYKKKRVGKIPD 	                                                            
						EEVRQAVEKFEESKELAERSMFNFLENDV                                	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 209 of SH33_HUMAN, which also corresponds 	                     Quality: 2015.00                      Escore:       0                                               
						to amino acids 1 - 209 of M85715_P7, and a second amino acid 	             Matching length:     209                Total length:     209                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence LTFPWTSPAVVVSMTLSQKTKEN corresponding to 	                                                            
						amino acids 210 - 232 of M85715_P7, wherein said first amino 	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	       1 MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMERKIDVTNKVVAEI 50                                                           
						for a tail of M85715_P7, comprising a polypeptide being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	       1 MSVAGLKKQFHKASQLFSEKISGAEGTKLDDEFLDMERKIDVTNKVVAEI 50                                                           
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      51 LSKTTEYLQPNPAYRAKLGMLNTVSKIRGQVKTTGYPQTEGLLGDCMLKY 100                                                          
						LTFPWTSPAVVVSMTLSQKTKEN in M85715_P7.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LSKTTEYLQPNPAYRAKLGMLNTVSKIRGQVKTTGYPQTEGLLGDCMLKY 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GKELGEDSTFGNALIEVGESMKLMAEVKDSLDINVKQTFIDPLQLLQDKD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GKELGEDSTFGNALIEVGESMKLMAEVKDSLDINVKQTFIDPLQLLQDKD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LKEIGHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LKEIGHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERS 200                                                          
						                                                            	                                                             
						                                                            	     201 MFNFLENDV                                          209                                                          
						                                                            	         |||||||||                                           
						                                                            	     201 MFNFLENDV                                          209                                                          

10186	HMR136_M85715_8_tr0_r1_1_gPRT		Comparison report between M85715_P8 and SH33_HUMANunique     	Sequence name: SH33_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85715_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10186 x SH33_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MLPIKLLQKFFQKPLNIFSQIQ corresponding to amino acids 1 - 22 of	                                                            
						M85715_P8, a second amino acid sequence being at least 90 %  	                     Quality: 1201.00                      Escore:       0                                               
						HHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMFNFLENDVEQVSQL 	             Matching length:     127                Total length:     127                                               
						AVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPRREYKPRPVKRSSSELNGVSTTSV 	 Matching Percent Similarity:   99.21   Matching Percent Identity:   98.43                                               
						VKTT                                                         	    Total Percent Similarity:   99.21      Total Percent Identity:   98.43                                               
						homologous to corresponding to amino acids 156 - 279 of      	                        Gaps:       0                        
						SH33_HUMAN, which also corresponds to amino acids 23 - 146 of	                                                            
						M85715_P8, and a third amino acid sequence being at least    	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	      20 QIQHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMF 69                                                           
						homologous to a polypeptide having the sequence AYSRLEPAD    	         :| |||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 147 - 155 of M85715_P8, wherein 	     153 EIGHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMF 202                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      70 NFLENDVEQVSQLAVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPR 119                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M85715_P8, comprising a polypeptide being at least   	     203 NFLENDVEQVSQLAVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPR 252                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .                                
						85%, more preferably at least about 90% and most preferably  	     120 REYKPRPVKRSSSELNGVSTTSVVKTT                        146                                                          
						at least about 95% homologous to the sequence                	         |||||||||||||||||||||||||||                         
						MLPIKLLQKFFQKPLNIFSQIQ of M85715_P8.3.An isolated polypeptide	     253 REYKPRPVKRSSSELNGVSTTSVVKTT                        279                                                          
						encoding for a tail of M85715_P8, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						AYSRLEPAD in M85715_P8.                                      	                                                            

						Comparison report between M85715_P8 and Q8IVP1unique head    	Sequence name: Q8IVP1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85715_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10186 x Q8IVP1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLPIKLLQKFFQKPLNIFSQIQ corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 22 of M85715_P8, and a second amino acid     	                                                            
						HHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMFNFLENDVEQVSQL 	                     Quality: 1288.00                      Escore:       0                                               
						AVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPRREYKPRPVKRSSSELNGVSTTSV 	             Matching length:     136                Total length:     136                                               
						VKTTAYSRLEPAD                                                	 Matching Percent Similarity:   99.26   Matching Percent Identity:   98.53                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:   99.26      Total Percent Identity:   98.53                                               
						amino acids 156 - 288 of Q8IVP1, which also corresponds to   	                        Gaps:       0                        
						amino acids 23 - 155 of M85715_P8, wherein said first amino  	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of M85715_P8, comprising a polypeptide being at   	      20 QIQHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMF 69                                                           
						least 70%, optionally at least about 80%, preferably at least	         :| |||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     153 EIGHHLKKLEGRRLDYDYKKKRVGKIPDEEVRQAVEKFEESKELAERSMF 202                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MLPIKLLQKFFQKPLNIFSQIQ of M85715_P8.                         	      70 NFLENDVEQVSQLAVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPR 119                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 NFLENDVEQVSQLAVFIEAALDYHRQSTEILQELQSKLQMRISAASSVPR 252                                                          
						                                                            	                  .         .         .                      
						                                                            	     120 REYKPRPVKRSSSELNGVSTTSVVKTTAYSRLEPAD               155                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     253 REYKPRPVKRSSSELNGVSTTSVVKTTAYSRLEPAD               288                                                          

10346	HMR136_M85718_8_tr0_r1_1_gPRT		Comparison report between M85718_P8 and TIC1_HUMANpartial WT 	Sequence name: TIC1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85718_P8, comprising a first amino 	Sequence documentation:                                      
						MPAIAVLAAAAAAWCFLQVESRHLDALAGGAGPNHGNFLDNDQWLSTVSQYDRDKYWNRF 	                                                            
						RDDDYFRNWNPNKPFDQALDPSKDPCLKVKCSPHKVCVTQDYQTALCVSRKHLLPRQKKG 	Alignment of: 10346 x TIC1_HUMAN   ..                        
						NVAQKHWVGPSNLVKCKPCPVAQSAMVCGSDGHSYTSKCKLEFHACSTGKSLATLCDGPC 	                                                            
						PCLPEPEPPKHKAERSACTDKELRNLASRLKDWFGALHEDANRVIKPTSSNTAQGRFDTS 	Alignment segment 1/1:                                       
						ILPICKDSLGWMFNKLDMNYDLLLDPSEINAIYLDKYEPCIKPLFNSCDSFKDGKLSNNE 	                                                            
						WCYCFQKPGGLPCQNEMNRIQKLSKGKSLLG                              	                     Quality: 3385.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     333                Total length:     333                                               
						to amino acids 1 - 331 of TIC1_HUMAN, which also corresponds 	 Matching Percent Similarity:   99.70   Matching Percent Identity:   99.40                                               
						to amino acids 1 - 331 of M85718_P8, and a second amino acid 	    Total Percent Similarity:   99.70      Total Percent Identity:   99.40                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence KYNFLPLI corresponding to amino acids 332	                  .         .         .         .         .  
						- 339 of M85718_P8, wherein said first amino acid sequence   	       1 MPAIAVLAAAAAAWCFLQVESRHLDALAGGAGPNHGNFLDNDQWLSTVSQ 50                                                           
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	       1 MPAIAVLAAAAAAWCFLQVESRHLDALAGGAGPNHGNFLDNDQWLSTVSQ 50                                                           
						tail of M85718_P8, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 YDRDKYWNRFRDDDYFRNWNPNKPFDQALDPSKDPCLKVKCSPHKVCVTQ 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence KYNFLPLI in    	      51 YDRDKYWNRFRDDDYFRNWNPNKPFDQALDPSKDPCLKVKCSPHKVCVTQ 100                                                          
						M85718_P8.                                                   	                  .         .         .         .         .  
						                                                            	     101 DYQTALCVSRKHLLPRQKKGNVAQKHWVGPSNLVKCKPCPVAQSAMVCGS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DYQTALCVSRKHLLPRQKKGNVAQKHWVGPSNLVKCKPCPVAQSAMVCGS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGHSYTSKCKLEFHACSTGKSLATLCDGPCPCLPEPEPPKHKAERSACTD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DGHSYTSKCKLEFHACSTGKSLATLCDGPCPCLPEPEPPKHKAERSACTD 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KELRNLASRLKDWFGALHEDANRVIKPTSSNTAQGRFDTSILPICKDSLG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KELRNLASRLKDWFGALHEDANRVIKPTSSNTAQGRFDTSILPICKDSLG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 WMFNKLDMNYDLLLDPSEINAIYLDKYEPCIKPLFNSCDSFKDGKLSNNE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WMFNKLDMNYDLLLDPSEINAIYLDKYEPCIKPLFNSCDSFKDGKLSNNE 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 WCYCFQKPGGLPCQNEMNRIQKLSKGKSLLGKY                  333                                                          
						                                                            	         ||||||||||||||||||||||||||||||| :                   
						                                                            	     301 WCYCFQKPGGLPCQNEMNRIQKLSKGKSLLGAF                  333                                                          

10874	HMR136_M85723_13_tr0_r1_1_gPRT		Comparison report between M85723_P13 and Q9BTA9partial WT    	Sequence name: Q9BTA9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85723_P13, comprising a first amino	Sequence documentation:                                      
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	                                                            
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	Alignment of: 10874 x Q9BTA9   ..                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	Alignment segment 1/1:                                       
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                     Quality: 5870.00                      Escore:       0                                               
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPI 	             Matching length:     597                Total length:     597                                               
						KPLISTPPVSSQPKVSTPVVKQGPVSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.66                                               
						PGPNHTSNSSNASNATVVPQNSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASR 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.66                                               
						LREEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLK      	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 595 of Q9BTA9, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 595 of M85723_P13, and a second amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						having the sequence NQNSFMV corresponding to amino acids 596 	                  .         .         .         .         .  
						- 602 of M85723_P13, wherein said first amino acid sequence  	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						tail of M85723_P13, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence NQNSFMV in     	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						M85723_P13.                                                  	                  .         .         .         .         .  
						                                                            	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDAS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDAS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     551 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKNQ    597                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||::     
						                                                            	     551 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKSE    597                                                          

						Comparison report between M85723_P13 and Q8TCK1partial WT    	Sequence name: Q8TCK1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85723_P13, comprising a first amino	Sequence documentation:                                      
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	                                                            
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	Alignment of: 10874 x Q8TCK1   ..                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	Alignment segment 1/1:                                       
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                     Quality: 3798.00                      Escore:       0                                               
						FLTAGPSAFNITSLISQAAQLSTQ                                     	             Matching length:     387                Total length:     387                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:   99.48   Matching Percent Identity:   99.48                                               
						to amino acids 1 - 384 of Q8TCK1, which also corresponds to  	    Total Percent Similarity:   99.48      Total Percent Identity:   99.48                                               
						amino acids 1 - 384 of M85723_P13, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						AQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGP 	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						VSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLR 	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						SLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSFMV                       	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 385 - 602 of	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						M85723_P13, wherein said first amino acid sequence and second	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						M85723_P13, comprising a polypeptide being at least 70%,     	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						AQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGP 	                  .         .         .         .         .  
						VSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSA 	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						RSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSFMV                       	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						least about 95% homologous to the sequence in M85723_P13.    	                  .         .         .         .         .  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQP              387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||  |               
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQDIP              387                                                          

						Comparison report between M85723_P13 and Q96DP3partial WT    	Sequence name: Q96DP3                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for M85723_P13, comprising a first amino	Sequence documentation:                                      
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	                                                            
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	Alignment of: 10874 x Q96DP3   ..                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	Alignment segment 1/1:                                       
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                     Quality: 5933.00                      Escore:       0                                               
						FLTAGPSAFNITSLISQAAQ                                         	             Matching length:     602                Total length:     602                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						to amino acids 1 - 380 of Q96DP3, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						amino acids 1 - 380 of M85723_P13, a bridging amino acid L   	                        Gaps:       0                        
						corresponding to amino acid 381 of M85723_P13, and a second  	                                                            
						STQAQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVK 	Alignment:                                                   
						QGPVSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQN 	                  .         .         .         .         .  
						SSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELK 	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						NLRSLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSFMV                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						corresponding to amino acids 382 - 602 of Q96DP3, which also 	                  .         .         .         .         .  
						corresponds to amino acids 382 - 602 of M85723_P13, wherein  	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDAS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||:|||||||||||||||||||  
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQFSTQAQPSNQSPMSLTSDAS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSF 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSF 600                                                          
						                                                            	                                                             
						                                                            	     601 MV                                                 602                                                          
						                                                            	         ||                                                  
						                                                            	     601 MV                                                 602                                                          

						Comparison report between M85723_P13 and Q9NZE0unique head   	Sequence name: Q9NZE0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85723_P13, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10874 x Q9NZE0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	Alignment segment 1/1:                                       
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	                                                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                     Quality:  639.00                      Escore:       0                                               
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	             Matching length:      66                Total length:      66                                               
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSP                             	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 392 of M85723_P13, a second amino acid    	Alignment:                                                   
						MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSATQQ 	                  .         .         .         .         .  
						PVTADK                                                       	     393 MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQ 442                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 66 of Q9NZE0, which also corresponds to amino	       1 MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQ 50                                                           
						acids 393 - 458 of M85723_P13, and a third amino acid        	                  .                                          
						sequence being at least 70%, optionally at least 80%,        	     443 GPVSQSATQQPVTADK                                   458                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||                                    
						most preferably at least 95% homologous to a polypeptide     	      51 GPVSQSATQQPVTADK                                   66                                                           
						QQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSARSTCSLTPALAAHF 	                                                            
						SENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLRE 	                                                            
						QRILFLRQQIKELEKLKNQNSFMV                                     	                                                            
						having the sequence corresponding to amino acids 459 - 602 of	                                                            
						M85723_P13, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M85723_P13, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	                                                            
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	                                                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	                                                            
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                                                            
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSP                             	                                                            
						to the sequence of M85723_P13.3.An isolated polypeptide      	                                                            
						encoding for a tail of M85723_P13, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						QQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSARSTCSLTPALAAHF 	                                                            
						SENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLRE 	                                                            
						QRILFLRQQIKELEKLKNQNSFMV                                     	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85723_P13.                                               	                                                            

						Comparison report between M85723_P13 and Q96JI3unique head   	Sequence name: Q96JI3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for M85723_P13, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 10874 x Q96JI3   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MRDAGDPSPPNKMLRRSDSPENK      	                                                            
						corresponding to amino acids 1 - 23 of M85723_P13, a second  	                     Quality: 3436.00                      Escore:       0                                               
						YSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHSALHSSNSHSSNPSNNPSKTSDAP 	             Matching length:     358                Total length:     361                                               
						YDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						REVMQATATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTPVQH 	    Total Percent Similarity:   99.17      Total Percent Identity:   99.17                                               
						PIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPTSSVPAQKTERKES 	                        Gaps:       1                        
						TSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPVSPVPQSPIPPLLQDPNLLRQLLP 	                                                            
						ALQATLQLNNSNVDISKINE                                         	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 320 of Q96JI3, which also   	      24 YSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHSALHSSNSHSSNPS 73                                                           
						corresponds to amino acids 24 - 343 of M85723_P13, a third   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	       1 YSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHSALHSSNSHSSNPS 50                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	      74 NNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLEREQ 123                                                          
						having the sequence VLT corresponding to amino acids 344 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						346 of M85723_P13, a fourth amino acid sequence being at     	      51 NNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLEREQ 100                                                          
						least 90 % homologous to                                     	                  .         .         .         .         .  
						AAVTQASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQ corresponding to amino	     124 RQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQ 173                                                          
						acids 321 - 358 of Q96JI3, which also corresponds to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 347 - 384 of M85723_P13, and a fifth amino acid        	     101 RQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQ 150                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     174 NILSQTSRHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPF 223                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGP 	     151 NILSQTSRHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPF 200                                                          
						VSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSA 	                  .         .         .         .         .  
						RSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLR 	     224 TLQSDHQPKKSFDANGASTLSKLPTPTSSVPAQKTERKESTSGDKPVSHS 273                                                          
						SLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSFMV                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 385 - 602 of	     201 TLQSDHQPKKSFDANGASTLSKLPTPTSSVPAQKTERKESTSGDKPVSHS 250                                                          
						M85723_P13, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, fourth amino 	     274 CTTPSTSSASGLNPTSAPPTSASAVPVSPVPQSPIPPLLQDPNLLRQLLP 323                                                          
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     251 CTTPSTSSASGLNPTSAPPTSASAVPVSPVPQSPIPPLLQDPNLLRQLLP 300                                                          
						for a head of M85723_P13, comprising a polypeptide being at  	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     324 ALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHKFLTAGPSAFNITS 373                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||   |||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     301 ALQATLQLNNSNVDISKINE...AAVTQASLQSIIHKFLTAGPSAFNITS 347                                                          
						MRDAGDPSPPNKMLRRSDSPENK of M85723_P13.3.An isolated          	                  .                                          
						polypeptide encoding for an edge portion of M85723_P13,      	     374 LISQAAQLSTQ                                        384                                                          
						comprising an amino acid sequence being at least 70%,        	         |||||||||||                                         
						optionally at least about 80%, preferably at least about 85%,	     348 LISQAAQLSTQ                                        358                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for VLT, 	                                                            
						corresponding to M85723_P13.4.An isolated polypeptide        	                                                            
						encoding for a tail of M85723_P13, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						AQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGP 	                                                            
						VSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSA 	                                                            
						RSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGTIHMSEICTELKNLR 	                                                            
						SLVRVCEIQATLREQRILFLRQQIKELEKLKNQNSFMV                       	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85723_P13.                                               	                                                            

						Comparison report between M85723_P13 and Q96FW6unique head   	Sequence name: Q96FW6                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M85723_P13, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 10874 x Q96FW6   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	Alignment segment 1/1:                                       
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	                                                            
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                     Quality: 2054.00                      Escore:       0                                               
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	             Matching length:     210                Total length:     210                                               
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSP                             	                        Gaps:       0                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 392 of M85723_P13, a second amino acid sequence being at 	Alignment:                                                   
						MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSATQQ 	                  .         .         .         .         .  
						PVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQNSSARSTCSLTP 	     393 MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQ 442                                                          
						ALAAHFSENLIKHVQGWPADHAE                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 143	       1 MSLTSDASSPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQ 50                                                           
						of Q96FW6, which also corresponds to amino acids 393 - 535 of	                  .         .         .         .         .  
						M85723_P13, a bridging amino acid K corresponding to amino   	     443 GPVSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNA 492                                                          
						acid 536 of M85723_P13, and a third amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASRLREEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKN 	      51 GPVSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNA 100                                                          
						QNSFMV                                                       	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 145 	     493 SNATVVPQNSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLR 542                                                          
						- 210 of Q96FW6, which also corresponds to amino acids 537 - 	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						602 of M85723_P13, wherein said first amino acid sequence,   	     101 SNATVVPQNSSARSTCSLTPALAAHFSENLIKHVQGWPADHAERQASRLR 150                                                          
						second amino acid sequence, bridging amino acid and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     543 EEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELE 592                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85723_P13, comprising a polypeptide being at least 70%,     	     151 EEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELE 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .                                          
						more preferably at least about 90% and most preferably at    	     593 KLKNQNSFMV                                         602                                                          
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	         ||||||||||                                          
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	     201 KLKNQNSFMV                                         210                                                          
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	                                                            
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                                                            
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSP                             	                                                            
						least about 95% homologous to the sequence of M85723_P13.    	                                                            

						Comparison report between M85723_P13 and AAH04258partial WT  	Sequence name: AAH04258                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85723_P13, comprising a first amino	Sequence documentation:                                      
						MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSYSPQENSHNHS 	                                                            
						ALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKKYYYNCRTEVSQWEKPKEWLE 	Alignment of: 10874 x AAH04258   ..                          
						REQRQKEANKMAVNSFPKDRDYRREVMQATATSGFASGMEDKHSSDASSLLPQNILSQTS 	                                                            
						RHNDRDYRLPRAETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGA 	Alignment segment 1/1:                                       
						STLSKLPTPTSSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 	                                                            
						SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVTQASLQSIIHK 	                     Quality: 5870.00                      Escore:       0                                               
						FLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDASSPRSYVSPRISTPQTNTVPI 	             Matching length:     597                Total length:     597                                               
						KPLISTPPVSSQPKVSTPVVKQGPVSQSATQQPVTADKQQGHEPVSPRSLQRSSSQRSPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.66                                               
						PGPNHTSNSSNASNATVVPQNSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASR 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.66                                               
						LREEAHNMGTIHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLK      	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 46 - 640 of AAH04258, which also corresponds  	Alignment:                                                   
						to amino acids 1 - 595 of M85723_P13, and a second amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      46 MRDAGDPSPPNKMLRRSDSPENKYSDSTGHSKAKNVHTHRVRERDGGTSY 95                                                           
						having the sequence NQNSFMV corresponding to amino acids 596 	                  .         .         .         .         .  
						- 602 of M85723_P13, wherein said first amino acid sequence  	      51 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 100                                                          
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      96 SPQENSHNHSALHSSNSHSSNPSNNPSKTSDAPYDSADDWSEHISSSGKK 145                                                          
						tail of M85723_P13, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     101 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 150                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence NQNSFMV in     	     146 YYYNCRTEVSQWEKPKEWLEREQRQKEANKMAVNSFPKDRDYRREVMQAT 195                                                          
						M85723_P13.                                                  	                  .         .         .         .         .  
						                                                            	     151 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     196 ATSGFASGMEDKHSSDASSLLPQNILSQTSRHNDRDYRLPRAETHSSSTP 245                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 VQHPIKPVVHPTATPSTVPSSPFTLQSDHQPKKSFDANGASTLSKLPTPT 295                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     296 SSVPAQKTERKESTSGDKPVSHSCTTPSTSSASGLNPTSAPPTSASAVPV 345                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     346 SPVPQSPIPPLLQDPNLLRQLLPALQATLQLNNSNVDISKINEVLTAAVT 395                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDAS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     396 QASLQSIIHKFLTAGPSAFNITSLISQAAQLSTQAQPSNQSPMSLTSDAS 445                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     446 SPRSYVSPRISTPQTNTVPIKPLISTPPVSSQPKVSTPVVKQGPVSQSAT 495                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     496 QQPVTADKQQGHEPVSPRSLQRSSSQRSPSPGPNHTSNSSNASNATVVPQ 545                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     546 NSSARSTCSLTPALAAHFSENLIKHVQGWPADHAEKQASRLREEAHNMGT 595                                                          
						                                                            	                  .         .         .         .            
						                                                            	     551 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKNQ    597                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||::     
						                                                            	     596 IHMSEICTELKNLRSLVRVCEIQATLREQRILFLRQQIKELEKLKSE    642                                                          

11342	HMR136_M85743_18_tr0_r1_1_gPRT		Comparison report between M85743_P18 and HIFA_HUMANpartial   	Sequence name: HIFA_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85743_P18, comprising a first amino	Sequence documentation:                                      
						MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNVSSHLDKASVM 	                                                            
						RLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFVMVLTDDGDMIYISDNVNKYM 	Alignment of: 11342 x HIFA_HUMAN   ..                        
						GLTQ                                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 124 of HIFA_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 124 of M85743_P18, and a second amino acid	                     Quality: 1204.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     128                Total length:     128                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:   98.44   Matching Percent Identity:   97.66                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   98.44      Total Percent Identity:   97.66                                               
						having the sequence VKCTHIKSSSICFYDFMI corresponding to amino	                        Gaps:       0                        
						acids 125 - 142 of M85743_P18, wherein said first amino acid 	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of M85743_P18, comprising a polypeptide being at least  	       1 MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV 50                                                           
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						VKCTHIKSSSICFYDFMI in M85743_P18.                            	      51 SSHLDKASVMRLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 SSHLDKASVMRLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFV 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 MVLTDDGDMIYISDNVNKYMGLTQVKCT                       128                                                          
						                                                            	         |||||||||||||||||||||||| : |                        
						                                                            	     101 MVLTDDGDMIYISDNVNKYMGLTQFELT                       128                                                          

6034	HMR136_M85760_7_tr0_r1_1_gPRT		Comparison report between M85760_P7 and ABD3_HUMANpartial WT 	Sequence name: ABD3_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85760_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNE            	Alignment of: 6034 x ABD3_HUMAN   ..                         
						corresponding to amino acids 1 - 49 of ABD3_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 49 of M85760_P7, and a second 	Alignment segment 1/1:                                       
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                     Quality:  471.00                      Escore:       0                                               
						and most preferably at least 95% homologous to a polypeptide 	             Matching length:      49                Total length:      49                                               
						having the sequence VKV corresponding to amino acids 50 - 52 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of M85760_P7, wherein said first amino acid sequence and     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence are contiguous and in a sequential	                        Gaps:       0                        
						order.                                                       	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .            
						                                                            	       1 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNE  49                                                           
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	       1 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNE  49                                                           

6112	HMR136_M85761_18_tr0_r1_1_gPRT		Comparison report between M85761_P18 and UTX_HUMANpartial WT 	Sequence name: UTX_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85761_P18, comprising a first amino	Sequence documentation:                                      
						MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFV 	                                                            
						RFHEDGARTKALLGK                                              	Alignment of: 6112 x UTX_HUMAN   ..                          
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 75 of UTX_HUMAN, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 75 of M85761_P18, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  698.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      75                Total length:      75                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence                                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VRQLRVGARTPSPWPAPRSPRAPRPGLCSLWPRTMVEGLPETISCLCSPPTPGYPACSL  	                        Gaps:       0                        
						corresponding to amino acids 76 - 134 of M85761_P18, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85761_P18, comprising a  	       1 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALG 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALG 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .                                
						to the sequence                                              	      51 GLDSRLFGFVRFHEDGARTKALLGK                          75                                                           
						VRQLRVGARTPSPWPAPRSPRAPRPGLCSLWPRTMVEGLPETISCLCSPPTPGYPACSL  	         |||||||||||||||||||||||||                           
						in M85761_P18.                                               	      51 GLDSRLFGFVRFHEDGARTKALLGK                          75                                                           

6118	HMR136_M85761_9_tr0_r1_1_gPRT		Comparison report between M85761_P9 and CAD89904unique head  	Sequence name: CAD89904                                      
						followed by partial WT sequence featuring a skipped exon, a  	                                                            
						mismatch and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M85761_P9, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6118 x CAD89904   ..                           
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFV 	                                                            
						RFHEDGARTKALLGKAVRCYESLILKAEGKVESDFFCQLGHFNLLLEDYPKALSAYQRYY 	                     Quality: 9043.00                      Escore:       0                                               
						SLQSDYWKNAAFLYGLGLVYFHYNAFQWAIKAFQEVLYVDPSFCRAKEIHLRLGLMFKVN 	             Matching length:     917                Total length:     969                                               
						TDYESSLKHFQLALVDCNPCTLSNAEIQFHIAHLYETQRKYHSAKEAYEQLLQTENLSAQ 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.89                                               
						VKATVLQQLGWMHHTVDLLGDKATKESYAIQYLQKSLEADPNSGQSWYFLGRCYSSIGKV 	    Total Percent Similarity:   94.53      Total Percent Identity:   94.53                                               
						QDAFISYRQSIDKSEASADTWCSIGVLYQQQNQPMDALQAYICAVQLDHGHAAAWMDLGT 	                        Gaps:       1                        
						LYESCNQPQDAIKCYLNATRSKSCSNTSALAARIKYLQAQLCNLPQGSLQNKTKLLPS   	                                                            
						polypeptide having the sequence corresponding to amino acids 	Alignment:                                                   
						1 - 418 of M85761_P9, a second amino acid sequence being at  	                  .         .         .         .         .  
						least 90 % homologous to IEEAWSLPIPAELTSRQGAMNTAQQ           	     419 IEEAWSLPIPAELTSRQGAMNTAQQ......................... 443                                                          
						corresponding to amino acids 1 - 25 of CAD89904, which also  	         |||||||||||||||||||||||||                           
						corresponds to amino acids 419 - 443 of M85761_P9, a third   	       1 IEEAWSLPIPAELTSRQGAMNTAQQACKPHHPNTEPVLGLSQTPISQQSL 50                                                           
						NTSDNWSGGHAVSHPPVQQQAHSWCLTPQKLQHLEQLRANRNNLNPAQKLMLEQLESQFV 	                  .         .         .         .         .  
						LMQQHQMRPTGVAQVRSTGIPNGPTADSSLPTNSVSGQQPQLALTRVPSVSQPGVRPACP 	     444 ...........................NTSDNWSGGHAVSHPPVQQQAHS 466                                                          
						GQPLANGPFSAGHVPCSTSRTLGSTDTILIGNNHITGSGSNGNVPYLQRNALTLPHNRTN 	                                    |||||||||||||||||||||||  
						LTSSAEEPWKNQLSNSTQGLHKGQSSHSAGPNGERPLSSTGPSQHLQAAGSGIQNQNGHP 	      51 PLHMIPSSQVDDLSSPAKRKRTSSPTKNTSDNWSGGHAVSHPPVQQQAHS 100                                                          
						TLPSNSVTQGAALNHLSSHTATSGGQQGITLTKESKPSGNIL                   	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     467 WCLTPQKLQHLEQLRANRNNLNPAQKLMLEQLESQFVLMQQHQMRPTGVA 516                                                          
						corresponding to amino acids 78 - 359 of CAD89904, which also	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 444 - 725 of M85761_P9, a bridging	     101 WCLTPQKLQHLEQLRANRNNLNPAQKLMLEQLESQFVLMQQHQMRPTGVA 150                                                          
						amino acid T corresponding to amino acid 726 of M85761_P9, a 	                  .         .         .         .         .  
						VPETSRHTGETPNSTASVEGLPNHVHQMTADAVCSPSHGDSKSPGLLSSDNPQLSALLMG 	     517 QVRSTGIPNGPTADSSLPTNSVSGQQPQLALTRVPSVSQPGVRPACPGQP 566                                                          
						KANNNVGTGTCDKVNNIHPAVHTKTDNSVASSPSSAISTATPSPKSTEQTTTNSVTSLNS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PHSGLHTINGEGMEESQSPMKTDLLLVNHKPSPQIIPSMSVSIYPSSAEVLKACRNLGKN 	     151 QVRSTGIPNGPTADSSLPTNSVSGQQPQLALTRVPSVSQPGVRPACPGQP 200                                                          
						GLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNP 	                  .         .         .         .         .  
						VTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESN 	     567 LANGPFSAGHVPCSTSRTLGSTDTILIGNNHITGSGSNGNVPYLQRNALT 616                                                          
						RSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGH 	     201 LANGPFSAGHVPCSTSRTLGSTDTILIGNNHITGSGSNGNVPYLQRNALT 250                                                          
						QENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVP 	                  .         .         .         .         .  
						VYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKS 	     617 LPHNRTNLTSSAEEPWKNQLSNSTQGLHKGQSSHSAGPNGERPLSSTGPS 666                                                          
						IVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAHYCSICE                                                    	     251 LPHNRTNLTSSAEEPWKNQLSNSTQGLHKGQSSHSAGPNGERPLSSTGPS 300                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 361 - 969 of CAD89904, which    	     667 QHLQAAGSGIQNQNGHPTLPSNSVTQGAALNHLSSHTATSGGQQGITLTK 716                                                          
						also corresponds to amino acids 727 - 1335 of M85761_P9, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a fifth amino acid sequence being at least 70%, optionally at	     301 QHLQAAGSGIQNQNGHPTLPSNSVTQGAALNHLSSHTATSGGQQGITLTK 350                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     717 ESKPSGNILTVPETSRHTGETPNSTASVEGLPNHVHQMTADAVCSPSHGD 766                                                          
						polypeptide having the sequence APPLPSASS corresponding to   	         ||||||||| ||||||||||||||||||||||||||||||||||||||||  
						amino acids 1336 - 1344 of M85761_P9, wherein said first     	     351 ESKPSGNILKVPETSRHTGETPNSTASVEGLPNHVHQMTADAVCSPSHGD 400                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence, bridging amino acid, fourth amino acid        	     767 SKSPGLLSSDNPQLSALLMGKANNNVGTGTCDKVNNIHPAVHTKTDNSVA 816                                                          
						sequence and fifth amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     401 SKSPGLLSSDNPQLSALLMGKANNNVGTGTCDKVNNIHPAVHTKTDNSVA 450                                                          
						head of M85761_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     817 SSPSSAISTATPSPKSTEQTTTNSVTSLNSPHSGLHTINGEGMEESQSPM 866                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKSCGVSLATAAAAAAAFGDEEKKMAAGKASGESEEASPSLTAEEREALGGLDSRLFGFV 	     451 SSPSSAISTATPSPKSTEQTTTNSVTSLNSPHSGLHTINGEGMEESQSPM 500                                                          
						RFHEDGARTKALLGKAVRCYESLILKAEGKVESDFFCQLGHFNLLLEDYPKALSAYQRYY 	                  .         .         .         .         .  
						SLQSDYWKNAAFLYGLGLVYFHYNAFQWAIKAFQEVLYVDPSFCRAKEIHLRLGLMFKVN 	     867 KTDLLLVNHKPSPQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLD 916                                                          
						TDYESSLKHFQLALVDCNPCTLSNAEIQFHIAHLYETQRKYHSAKEAYEQLLQTENLSAQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VKATVLQQLGWMHHTVDLLGDKATKESYAIQYLQKSLEADPNSGQSWYFLGRCYSSIGKV 	     501 KTDLLLVNHKPSPQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLD 550                                                          
						QDAFISYRQSIDKSEASADTWCSIGVLYQQQNQPMDALQAYICAVQLDHGHAAAWMDLGT 	                  .         .         .         .         .  
						LYESCNQPQDAIKCYLNATRSKSCSNTSALAARIKYLQAQLCNLPQGSLQNKTKLLPS   	     917 KCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNP 966                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85761_P9.3.An isolated chimeric polypeptide encoding for an 	     551 KCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNP 600                                                          
						edge portion of M85761_P9, comprising a polypeptide having a 	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     967 VTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTG 1016                                                         
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     601 VTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTG 650                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	    1017 TKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSEST 1066                                                         
						at least two amino acids comprise QN, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     651 TKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSEST 700                                                          
						443-x to 444; and ending at any of amino acid numbers 444+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	    1067 SSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAG 1116                                                         
						polypeptide encoding for a tail of M85761_P9, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     701 SSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAG 750                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	    1117 NLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEW 1166                                                         
						to the sequence APPLPSASS in M85761_P9.                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 NLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEW 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1167 FVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGD 1216                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 FVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGD 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1217 LVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKS 1266                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKS 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1267 IVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKE 1316                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 IVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKE 950                                                          
						                                                            	                  .                                          
						                                                            	    1317 IIWHGRTKEEPAHYCSICE                                1335                                                         
						                                                            	         |||||||||||||||||||                                 
						                                                            	     951 IIWHGRTKEEPAHYCSICE                                969                                                          

12596	HMR136_M85762_10_tr0_r1_1_gPRT		Comparison report between M85762_P10 and ELV4_HUMANpartial   	Sequence name: ELV4_HUMAN                                    
						WT sequence followed by mismatch.1.An isolated chimeric      	                                                            
						polypeptide encoding for M85762_P10, comprising a first amino	Sequence documentation:                                      
						MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 	                                                            
						EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMAYGVKRLMSG 	Alignment of: 12596 x ELV4_HUMAN   ..                        
						PVPPSAC                                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 143 - 269 of ELV4_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 127 of M85762_P10, a bridging 	                     Quality: 2325.00                      Escore:       0                                               
						amino acid P corresponding to amino acid 128 of M85762_P10,  	             Matching length:     238                Total length:     238                                               
						and a second amino acid sequence being at least 90 %         	 Matching Percent Similarity:   99.58   Matching Percent Identity:   99.58                                               
						PRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIR 	    Total Percent Similarity:   99.58      Total Percent Identity:   99.58                                               
						DFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS           	                        Gaps:       0                        
						homologous to corresponding to amino acids 271 - 380 of      	                                                            
						ELV4_HUMAN, which also corresponds to amino acids 129 - 238  	Alignment:                                                   
						of M85762_P10, wherein said first amino acid sequence,       	                  .         .         .         .         .  
						bridging amino acid and second amino acid sequence are       	       1 MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKG 50                                                           
						contiguous and in a sequential order.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     143 MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKG 192                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 LNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQ 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RFRLDNLLNMAYGVKRLMSGPVPPSACPPRFSPITIDGMTSLVGMNIPGH 150                                                          
						                                                            	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						                                                            	     243 RFRLDNLLNMAYGVKRLMSGPVPPSACSPRFSPITIDGMTSLVGMNIPGH 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 TGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGF 342                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 VTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS             238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     343 VTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS             380                                                          

12600	HMR136_M85762_5_tr0_r1_1_gPRT		Comparison report between M85762_P5 and ELV4_HUMANunique     	Sequence name: ELV4_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for M85762_P5, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 12600 x ELV4_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MFEISRTLNAALLNNE             	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 16 of M85762_P5, a second   	                                                            
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	                     Quality: 3675.00                      Escore:       0                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	             Matching length:     377                Total length:     377                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						FRLDNLLNMAYGVKRLMSGPVPPSAC                                   	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 4 - 269 of ELV4_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 17 - 282 of M85762_P5, a     	                  .         .         .         .         .  
						bridging amino acid P corresponding to amino acid 283 of     	      17 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 66                                                           
						M85762_P5, and a third amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIR 	       4 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 53                                                           
						DFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS           	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 271 - 380 of    	      67 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 116                                                          
						ELV4_HUMAN, which also corresponds to amino acids 284 - 393  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85762_P5, wherein said first amino acid sequence, second 	      54 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 103                                                          
						amino acid sequence, bridging amino acid and third amino acid	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     117 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 166                                                          
						isolated polypeptide encoding for a head of M85762_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     104 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 153                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     167 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 216                                                          
						about 95% homologous to the sequence MFEISRTLNAALLNNE of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P5.                                                   	     154 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 203                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     217 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 253                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     267 YGVKRLMSGPVPPSACPPRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 316                                                          
						                                                            	         |||||||||||||||| |||||||||||||||||||||||||||||||||  
						                                                            	     254 YGVKRLMSGPVPPSACSPRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     317 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 353                                                          
						                                                            	                  .         .                                
						                                                            	     367 AIASLNGYRLGDRVLQVSFKTNKAHKS                        393                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     354 AIASLNGYRLGDRVLQVSFKTNKAHKS                        380                                                          

						Comparison report between M85762_P5 and Q96J74unique head    	Sequence name: Q96J74                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85762_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12600 x Q96J74   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MFEISRTLNAALLNNE corresponding to amino acids 1 - 16 of      	                                                            
						M85762_P5, a second amino acid sequence being at least 90 %  	                     Quality: 3443.00                      Escore:       0                                               
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	             Matching length:     363                Total length:     377                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	    Total Percent Similarity:   96.29      Total Percent Identity:   96.29                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	                        Gaps:       1                        
						FRLDNLLNMAYGVK                                               	                                                            
						homologous to corresponding to amino acids 21 - 274 of       	Alignment:                                                   
						Q96J74, which also corresponds to amino acids 17 - 270 of    	                  .         .         .         .         .  
						M85762_P5, a third amino acid sequence being at least 70%,   	      17 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 66                                                           
						optionally at least 80%, preferably at least 85%, more       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      21 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 70                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						RLMSGPVPPSACPP corresponding to amino acids 271 - 284 of     	      67 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 116                                                          
						M85762_P5, and a fourth amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRD 	      71 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 120                                                          
						FNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS            	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 275 - 383 of    	     117 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 166                                                          
						Q96J74, which also corresponds to amino acids 285 - 393 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P5, wherein said first amino acid sequence, second    	     121 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 170                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     167 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 216                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P5, comprising a polypeptide being at least 70%,      	     171 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 220                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     217 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 266                                                          
						least about 95% homologous to the sequence MFEISRTLNAALLNNE  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85762_P5.3.An isolated polypeptide encoding for an edge  	     221 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 270                                                          
						portion of M85762_P5, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     267 YGVKRLMSGPVPPSACPPRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 316                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||              ||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     271 YGVK..............RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 306                                                          
						encoding for RLMSGPVPPSACPP, corresponding to M85762_P5.     	                  .         .         .         .         .  
						                                                            	     317 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 356                                                          
						                                                            	                  .         .                                
						                                                            	     367 AIASLNGYRLGDRVLQVSFKTNKAHKS                        393                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     357 AIASLNGYRLGDRVLQVSFKTNKAHKS                        383                                                          

						Comparison report between M85762_P5 and Q96J75unique head    	Sequence name: Q96J75                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85762_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12600 x Q96J75   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MFEISRTLNAALLNNE corresponding to amino acids 1 - 16 of      	                                                            
						M85762_P5, a second amino acid sequence being at least 90 %  	                     Quality: 3445.00                      Escore:       0                                               
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	             Matching length:     364                Total length:     378                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.73                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	    Total Percent Similarity:   96.30      Total Percent Identity:   96.03                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	                        Gaps:       1                        
						FRLDNLLNMAYGVK                                               	                                                            
						homologous to corresponding to amino acids 4 - 257 of Q96J75,	Alignment:                                                   
						which also corresponds to amino acids 17 - 270 of M85762_P5, 	                  .         .         .         .         .  
						a third amino acid sequence being at least 70%, optionally at	      16 EIISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNY 65                                                           
						least 80%, preferably at least 85%, more preferably at least 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       3 QIISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNY 52                                                           
						polypeptide having the sequence RLMSGPVPPSACPP corresponding 	                  .         .         .         .         .  
						to amino acids 271 - 284 of M85762_P5, and a fourth amino    	      66 LPQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEK 115                                                          
						RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS            	      53 LPQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEK 102                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 258 - 366 of Q96J75, which also corresponds to	     116 AINTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLF 165                                                          
						amino acids 285 - 393 of M85762_P5, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, third amino acid  	     103 AINTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLF 152                                                          
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     166 SQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 215                                                          
						head of M85762_P5, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     153 SQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 202                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     216 EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNM 265                                                          
						MFEISRTLNAALLNNE of M85762_P5.3.An isolated polypeptide      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of M85762_P5, comprising an     	     203 EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNM 252                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						about 80%, preferably at least about 85%, more preferably at 	     266 AYGVKRLMSGPVPPSACPPRFSPITIDGMTSLVGMNIPGHTGTGWCIFVY 315                                                          
						least about 90% and most preferably at least about 95%       	         |||||              |||||||||||||||||||||||||||||||  
						homologous to the sequence encoding for RLMSGPVPPSACPP,      	     253 AYGVK..............RFSPITIDGMTSLVGMNIPGHTGTGWCIFVY 288                                                          
						corresponding to M85762_P5.                                  	                  .         .         .         .         .  
						                                                            	     316 NLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAA 365                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 NLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAA 338                                                          
						                                                            	                  .         .                                
						                                                            	     366 MAIASLNGYRLGDRVLQVSFKTNKAHKS                       393                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     339 MAIASLNGYRLGDRVLQVSFKTNKAHKS                       366                                                          

12594	HMR136_M85762_8_tr0_r1_1_gPRT		Comparison report between M85762_P8 and ELV4_HUMANunique     	Sequence name: ELV4_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85762_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12594 x ELV4_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MFEISRTLNAALLNNE corresponding to amino acids 1 - 16 of      	                                                            
						M85762_P8, a second amino acid sequence being at least 90 %  	                     Quality: 3318.00                      Escore:       0                                               
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	             Matching length:     350                Total length:     377                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	    Total Percent Similarity:   92.84      Total Percent Identity:   92.84                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	                        Gaps:       1                        
						F                                                            	                                                            
						homologous to corresponding to amino acids 4 - 244 of        	Alignment:                                                   
						ELV4_HUMAN, which also corresponds to amino acids 17 - 257 of	                  .         .         .         .         .  
						M85762_P8, and a third amino acid sequence being at least 90 	      17 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 66                                                           
						RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS            	       4 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 53                                                           
						% homologous to corresponding to amino acids 272 - 380 of    	                  .         .         .         .         .  
						ELV4_HUMAN, which also corresponds to amino acids 258 - 366  	      67 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 116                                                          
						of M85762_P8, wherein said first amino acid sequence, second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      54 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 103                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M85762_P8, comprising a   	     117 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 166                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     104 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 153                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MFEISRTLNAALLNNE of M85762_P8.3.An isolated  	     167 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 216                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P8, comprising a polypeptide having a length "n",     	     154 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 203                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     217 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRF......... 257                                                          
						preferably at least about 30 amino acids in length, more     	         |||||||||||||||||||||||||||||||||||||||||           
						preferably at least about 40 amino acids in length and most  	     204 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 253                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise FR, having a structure as  	     258 ..................RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 289                                                          
						follows: a sequence starting from any of amino acid numbers  	                           ||||||||||||||||||||||||||||||||  
						257-x to 258; and ending at any of amino acid numbers 258+   	     254 YGVKRLMSGPVPPSACSPRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYN 303                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     290 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 339                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 LSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAM 353                                                          
						                                                            	                  .         .                                
						                                                            	     340 AIASLNGYRLGDRVLQVSFKTNKAHKS                        366                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     354 AIASLNGYRLGDRVLQVSFKTNKAHKS                        380                                                          

						Comparison report between M85762_P8 and Q96J74unique head    	Sequence name: Q96J74                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85762_P8,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12594 x Q96J74   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MFEISRTLNAALLNNE corresponding to amino acids 1 - 16 of      	                                                            
						M85762_P8, a second amino acid sequence being at least 90 %  	                     Quality: 3318.00                      Escore:       0                                               
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	             Matching length:     350                Total length:     363                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	    Total Percent Similarity:   96.42      Total Percent Identity:   96.42                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	                        Gaps:       1                        
						F                                                            	                                                            
						homologous to corresponding to amino acids 21 - 261 of       	Alignment:                                                   
						Q96J74, which also corresponds to amino acids 17 - 257 of    	                  .         .         .         .         .  
						M85762_P8, and a third amino acid sequence being at least 90 	      17 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 66                                                           
						RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS            	      21 IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYL 70                                                           
						% homologous to corresponding to amino acids 275 - 383 of    	                  .         .         .         .         .  
						Q96J74, which also corresponds to amino acids 258 - 366 of   	      67 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 116                                                          
						M85762_P8, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      71 PQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKA 120                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M85762_P8, comprising a   	     117 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 166                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     121 INTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLFS 170                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MFEISRTLNAALLNNE of M85762_P8.3.An isolated  	     167 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 216                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P8, comprising a polypeptide having a length "n",     	     171 QYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATE 220                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     217 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRF......... 257                                                          
						preferably at least about 30 amino acids in length, more     	         |||||||||||||||||||||||||||||||||||||||||           
						preferably at least about 40 amino acids in length and most  	     221 PITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMA 270                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise FR, having a structure as  	     258 ....RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLF 303                                                          
						follows: a sequence starting from any of amino acid numbers  	             ||||||||||||||||||||||||||||||||||||||||||||||  
						257-x to 258; and ending at any of amino acid numbers 258+   	     271 YGVKRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLF 320                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     304 GPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRV 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 GPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRV 370                                                          
						                                                            	                  .                                          
						                                                            	     354 LQVSFKTNKAHKS                                      366                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     371 LQVSFKTNKAHKS                                      383                                                          

						Comparison report between M85762_P8 and Q96J75unique head    	Sequence name: Q96J75                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85762_P8,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12594 x Q96J75   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MFEISRTLNAALLNNE corresponding to amino acids 1 - 16 of      	                                                            
						M85762_P8, a second amino acid sequence being at least 90 %  	                     Quality: 3320.00                      Escore:       0                                               
						IISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNYLPQNMTQEEFR 	             Matching length:     351                Total length:     364                                               
						SLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEKAINTLNGLRLQTKTIKVSYAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.72                                               
						PSSASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKR 	    Total Percent Similarity:   96.43      Total Percent Identity:   96.15                                               
						IEAEEAIKGLNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQR 	                        Gaps:       1                        
						F                                                            	                                                            
						homologous to corresponding to amino acids 4 - 244 of Q96J75,	Alignment:                                                   
						which also corresponds to amino acids 17 - 257 of M85762_P8, 	                  .         .         .         .         .  
						and a third amino acid sequence being at least 90 %          	      16 EIISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNY 65                                                           
						RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRD 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS            	       3 QIISTMEPQVSNGPTSNTSNGPSSNNRNCPSPMQTGATTDDSKTNLIVNY 52                                                           
						homologous to corresponding to amino acids 258 - 366 of      	                  .         .         .         .         .  
						Q96J75, which also corresponds to amino acids 258 - 366 of   	      66 LPQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEK 115                                                          
						M85762_P8, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      53 LPQNMTQEEFRSLFGSIGEIESCKLVRDKITGQSLGYGFVNYIDPKDAEK 102                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M85762_P8, comprising a   	     116 AINTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLF 165                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     103 AINTLNGLRLQTKTIKVSYARPSSASIRDANLYVSGLPKTMTQKELEQLF 152                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MFEISRTLNAALLNNE of M85762_P8.3.An isolated  	     166 SQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 215                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85762_P8, comprising a polypeptide having a length "n",     	     153 SQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 202                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     216 EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRF........ 257                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||          
						preferably at least about 40 amino acids in length and most  	     203 EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNM 252                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise FR, having a structure as  	     258 .....RFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQL 302                                                          
						follows: a sequence starting from any of amino acid numbers  	              |||||||||||||||||||||||||||||||||||||||||||||  
						257-x to 258; and ending at any of amino acid numbers 258+   	     253 AYGVKRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQL 302                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     303 FGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDR 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 FGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDR 352                                                          
						                                                            	                  .                                          
						                                                            	     353 VLQVSFKTNKAHKS                                     366                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     353 VLQVSFKTNKAHKS                                     366                                                          

12598	HMR136_M85762_9_tr0_r1_1_gPRT		Comparison report between M85762_P9 and ELV4_HUMANpartial WT 	Sequence name: ELV4_HUMAN                                    
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for M85762_P9, comprising a first amino 	Sequence documentation:                                      
						MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGAT 	                                                            
						EPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQRFRLDNLLNMAYGVKRLMSG 	Alignment of: 12598 x ELV4_HUMAN   ..                        
						PVPPSAC                                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 143 - 269 of ELV4_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 127 of M85762_P9, a bridging  	                     Quality: 2325.00                      Escore:       0                                               
						amino acid P corresponding to amino acid 128 of M85762_P9,   	             Matching length:     238                Total length:     238                                               
						and a second amino acid sequence being at least 90 %         	 Matching Percent Similarity:   99.58   Matching Percent Identity:   99.58                                               
						PRFSPITIDGMTSLVGMNIPGHTGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIR 	    Total Percent Similarity:   99.58      Total Percent Identity:   99.58                                               
						DFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS           	                        Gaps:       0                        
						homologous to corresponding to amino acids 271 - 380 of      	                                                            
						ELV4_HUMAN, which also corresponds to amino acids 129 - 238  	Alignment:                                                   
						of M85762_P9, wherein said first amino acid sequence,        	                  .         .         .         .         .  
						bridging amino acid and second amino acid sequence are       	       1 MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKG 50                                                           
						contiguous and in a sequential order.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     143 MTQKELEQLFSQYGRIITSRILVDQVTGVSRGVGFIRFDKRIEAEEAIKG 192                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 LNGQKPSGATEPITVKFANNPSQKSSQALLSQLYQSPNRRYPGPLHHQAQ 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RFRLDNLLNMAYGVKRLMSGPVPPSACPPRFSPITIDGMTSLVGMNIPGH 150                                                          
						                                                            	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						                                                            	     243 RFRLDNLLNMAYGVKRLMSGPVPPSACSPRFSPITIDGMTSLVGMNIPGH 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 TGTGWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGF 342                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 VTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS             238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     343 VTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS             380                                                          

12931	HMR136_M85774_17_tr0_r1_1_gPRT		Comparison report between M85774_P17 and O60643unique head   	Sequence name: O60643                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85774_P17, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12931 x O60643   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	Alignment segment 1/1:                                       
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKI                            	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2089.00                      Escore:       0                                               
						to amino acids 1 - 93 of M85774_P17, a second amino acid     	             Matching length:     216                Total length:     216                                               
						IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPVYCG 	 Matching Percent Similarity:   99.54   Matching Percent Identity:   99.54                                               
						LIPPSLQGV                                                    	    Total Percent Similarity:   99.54      Total Percent Identity:   99.54                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 69 of O60643, which also corresponds to amino	                                                            
						acids 94 - 162 of M85774_P17, a bridging amino acid R        	Alignment:                                                   
						corresponding to amino acid 163 of M85774_P17, a third amino 	                  .         .         .         .         .  
						YVDGGISDNLPLYELKNTITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLS 	      94 IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANV 143                                                          
						KALFPPEPLVLREMCKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEDYSQLPGEDHILEHLPARLNEALL                                   	       1 IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANV 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 71 - 216 of O60643, which also corresponds to 	     144 CSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDI 193                                                          
						amino acids 164 - 309 of M85774_P17, and a fourth amino acid 	         ||||||||||||||||||| ||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 CSGFIPVYCGLIPPSLQGVGYVDGGISDNLPLYELKNTITVSPFSGESDI 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     194 CPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYR 243                                                          
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	     101 CPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYR 150                                                          
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	                  .         .         .         .         .  
						PSAR                                                         	     244 DGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGE 293                                                          
						having the sequence corresponding to amino acids 310 - 493 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P17, wherein said first amino acid sequence, second   	     151 DGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGE 200                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .                                          
						sequence and fourth amino acid sequence are contiguous and in	     294 DHILEHLPARLNEALL                                   309                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||                                    
						head of M85774_P17, comprising a polypeptide being at least  	     201 DHILEHLPARLNEALL                                   216                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKI                            	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85774_P17.3.An isolated polypeptide encoding for a tail of  	                                                            
						M85774_P17, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	                                                            
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	                                                            
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	                                                            
						PSAR                                                         	                                                            
						least about 95% homologous to the sequence in M85774_P17.    	                                                            

						Comparison report between M85774_P17 and Q9NQ61partial WT    	Sequence name: Q9NQ61                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P17, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12931 x Q9NQ61   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 31 - 339 of Q9NQ61, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P17, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	                  .         .         .         .         .  
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSAR                                                         	      31 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 80                                                           
						having the sequence corresponding to amino acids 310 - 493 of	                  .         .         .         .         .  
						M85774_P17, wherein said first amino acid sequence and second	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	      81 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 130                                                          
						M85774_P17, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	     131 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 180                                                          
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	                  .         .         .         .         .  
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						PSAR                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in M85774_P17.    	     181 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 230                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     231 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 280                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     281 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 330                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     331 PARLNEALL                                          339                                                          

						Comparison report between M85774_P17 and Q96AD5partial WT    	Sequence name: Q96AD5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P17, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12931 x Q96AD5   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 1 - 309 of Q96AD5, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P17, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	                  .         .         .         .         .  
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSAR                                                         	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						having the sequence corresponding to amino acids 310 - 493 of	                  .         .         .         .         .  
						M85774_P17, wherein said first amino acid sequence and second	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						M85774_P17, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	                  .         .         .         .         .  
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						PSAR                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in M85774_P17.    	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     301 PARLNEALL                                          309                                                          

						Comparison report between M85774_P17 and Q9NQ62partial WT    	Sequence name: Q9NQ62                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P17, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12931 x Q9NQ62   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 25 - 333 of Q9NQ62, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P17, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	                  .         .         .         .         .  
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSAR                                                         	      25 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 74                                                           
						having the sequence corresponding to amino acids 310 - 493 of	                  .         .         .         .         .  
						M85774_P17, wherein said first amino acid sequence and second	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	      75 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 124                                                          
						M85774_P17, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQRELEQQLHAQAAEHL 	     125 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 174                                                          
						EAQAQNSQLWRAHEALRTQLEGAQEQIRRLESEARGRQEQTQRDVVAVSRNMQKEKVSLL 	                  .         .         .         .         .  
						RQLELLRELNTRLRDDRDACEARRAGSSCRKALTTARLPGPTCCCCCCWARPPRRGSGHL 	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						PSAR                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in M85774_P17.    	     175 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 324                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     325 PARLNEALL                                          333                                                          

12929	HMR136_M85774_18_tr0_r1_1_gPRT		Comparison report between M85774_P18 and O60643unique head   	Sequence name: O60643                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85774_P18, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12929 x O60643   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	Alignment segment 1/1:                                       
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKI                            	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2089.00                      Escore:       0                                               
						to amino acids 1 - 93 of M85774_P18, a second amino acid     	             Matching length:     216                Total length:     216                                               
						IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPVYCG 	 Matching Percent Similarity:   99.54   Matching Percent Identity:   99.54                                               
						LIPPSLQGV                                                    	    Total Percent Similarity:   99.54      Total Percent Identity:   99.54                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 69 of O60643, which also corresponds to amino	                                                            
						acids 94 - 162 of M85774_P18, a bridging amino acid R        	Alignment:                                                   
						corresponding to amino acid 163 of M85774_P18, a third amino 	                  .         .         .         .         .  
						YVDGGISDNLPLYELKNTITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLS 	      94 IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANV 143                                                          
						KALFPPEPLVLREMCKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEDYSQLPGEDHILEHLPARLNEALL                                   	       1 IRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANV 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 71 - 216 of O60643, which also corresponds to 	     144 CSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDI 193                                                          
						amino acids 164 - 309 of M85774_P18, and a fourth amino acid 	         ||||||||||||||||||| ||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 CSGFIPVYCGLIPPSLQGVGYVDGGISDNLPLYELKNTITVSPFSGESDI 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     194 CPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYR 243                                                          
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG      	     101 CPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYR 150                                                          
						corresponding to amino acids 310 - 364 of M85774_P18, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     244 DGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGE 293                                                          
						bridging amino acid, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     151 DGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGE 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .                                          
						M85774_P18, comprising a polypeptide being at least 70%,     	     294 DHILEHLPARLNEALL                                   309                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||                                    
						more preferably at least about 90% and most preferably at    	     201 DHILEHLPARLNEALL                                   216                                                          
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKI                            	                                                            
						least about 95% homologous to the sequence of M85774_P18.3.An	                                                            
						isolated polypeptide encoding for a tail of M85774_P18,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG in   	                                                            
						M85774_P18.                                                  	                                                            

						Comparison report between M85774_P18 and Q9NQ61partial WT    	Sequence name: Q9NQ61                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P18, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12929 x Q9NQ61   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 31 - 339 of Q9NQ61, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P18, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence                                          	                  .         .         .         .         .  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG      	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						corresponding to amino acids 310 - 364 of M85774_P18, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	      31 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 80                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85774_P18, comprising a  	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      81 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 130                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P18.                                                  	     131 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 180                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     181 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 230                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     231 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 280                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     281 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 330                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     331 PARLNEALL                                          339                                                          

						Comparison report between M85774_P18 and Q96AD5partial WT    	Sequence name: Q96AD5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P18, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12929 x Q96AD5   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 1 - 309 of Q96AD5, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P18, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence                                          	                  .         .         .         .         .  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG      	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						corresponding to amino acids 310 - 364 of M85774_P18, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85774_P18, comprising a  	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P18.                                                  	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     301 PARLNEALL                                          309                                                          

						Comparison report between M85774_P18 and Q9NQ62partial WT    	Sequence name: Q9NQ62                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85774_P18, comprising a first amino	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12929 x Q9NQ62   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 	                                                            
						PARLNEALL                                                    	                     Quality: 3001.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     309                Total length:     309                                               
						to amino acids 25 - 333 of Q9NQ62, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 309 of M85774_P18, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence                                          	                  .         .         .         .         .  
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG      	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						corresponding to amino acids 310 - 364 of M85774_P18, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	      25 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 74                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85774_P18, comprising a  	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      75 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 124                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						HGRAAGGGSVVLRASQNFARGERRSRLELELQIREQDLERAGLRQREGAEYTAAG in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P18.                                                  	     125 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 174                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     175 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 324                                                          
						                                                            	                                                             
						                                                            	     301 PARLNEALL                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     325 PARLNEALL                                          333                                                          

12927	HMR136_M85774_7_tr0_r1_1_gPRT		Comparison report between M85774_P7 and Q9NQ61partial WT     	Sequence name: Q9NQ61                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for M85774_P7, comprising a    	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12927 x Q9NQ61   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRN                                                 	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 4284.00                      Escore:       0                                               
						corresponding to amino acids 31 - 282 of Q9NQ61, which also  	             Matching length:     450                Total length:     504                                               
						corresponds to amino acids 1 - 252 of M85774_P7, a second    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWM 	    Total Percent Similarity:   89.29      Total Percent Identity:   89.09                                               
						KEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRR                          	                        Gaps:       1                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 337 - 431 of Q9NQ61, which also 	Alignment:                                                   
						corresponds to amino acids 253 - 347 of M85774_P7, a bridging	                  .         .         .         .         .  
						amino acid V corresponding to amino acid 348 of M85774_P7,   	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						and a third amino acid sequence being at least 90 %          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMR 	      31 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 80                                                           
						APADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIGALGL                   	                  .         .         .         .         .  
						homologous to corresponding to amino acids 433 - 534 of      	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						Q9NQ61, which also corresponds to amino acids 349 - 450 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P7, wherein said first amino acid sequence, second    	      81 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 130                                                          
						amino acid sequence, bridging amino acid and third amino acid	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P7, comprising a polypeptide having a length "n",     	     131 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 180                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     181 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 230                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise NA, having a structure as  	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						252-x to 253; and ending at any of amino acid numbers 253+   	     231 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 280                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     251 RN................................................ 252                                                          
						                                                            	         ||                                                  
						                                                            	     281 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 330                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 ......ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 296                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     331 PARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 430                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 RVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 396                                                          
						                                                            	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 RLQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 NVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIG 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 NVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIG 530                                                          
						                                                            	                                                             
						                                                            	     447 ALGL                                               450                                                          
						                                                            	         ||||                                                
						                                                            	     531 ALGL                                               534                                                          

						Comparison report between M85774_P7 and Q96AD5partial WT     	Sequence name: Q96AD5                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for M85774_P7, comprising a    	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12927 x Q96AD5   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRN                                                 	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 4273.00                      Escore:       0                                               
						corresponding to amino acids 1 - 252 of Q96AD5, which also   	             Matching length:     450                Total length:     504                                               
						corresponds to amino acids 1 - 252 of M85774_P7, a second    	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWM 	    Total Percent Similarity:   89.09      Total Percent Identity:   89.09                                               
						KEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNN 	                        Gaps:       1                        
						LSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQ       	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 307 - 480 of Q96AD5, which also 	                  .         .         .         .         .  
						corresponds to amino acids 253 - 426 of M85774_P7, a bridging	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						amino acid P corresponding to amino acid 427 of M85774_P7,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and a third amino acid sequence being at least 90 %          	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						homologous to AGPAPLLSTPAPEARPVIGALGL corresponding to amino 	                  .         .         .         .         .  
						acids 482 - 504 of Q96AD5, which also corresponds to amino   	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						acids 428 - 450 of M85774_P7, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						portion of M85774_P7, comprising a polypeptide having a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						at least two amino acids comprise NA, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						252-x to 253; and ending at any of amino acid numbers 253+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RN................................................ 252                                                          
						                                                            	         ||                                                  
						                                                            	     251 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 ......ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 296                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 RVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 396                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 NVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIG 446                                                          
						                                                            	         |||||||||||||||||||||||||||||| |||||||||||||||||||  
						                                                            	     451 NVAFPPEALRMRAPADPAPAPADPASPQHQLAGPAPLLSTPAPEARPVIG 500                                                          
						                                                            	                                                             
						                                                            	     447 ALGL                                               450                                                          
						                                                            	         ||||                                                
						                                                            	     501 ALGL                                               504                                                          

						Comparison report between M85774_P7 and Q96ET6unique head    	Sequence name: Q96ET6                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85774_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12927 x Q96ET6   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	Alignment segment 1/1:                                       
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	                                                            
						VSDGENVIISHFNSKDE                                            	                     Quality: 2980.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     313                Total length:     367                                               
						to amino acids 1 - 137 of M85774_P7, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQD 	    Total Percent Similarity:   85.29      Total Percent Identity:   85.29                                               
						SSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQRN      	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 115 of Q96ET6, which also corresponds to     	Alignment:                                                   
						amino acids 138 - 252 of M85774_P7, and a third amino acid   	                  .         .         .         .         .  
						ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWM 	     138 LIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPF 187                                                          
						KEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAP 	       1 LIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPF 50                                                           
						LLSTPAPEARPVIGALGL                                           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     188 SGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREM 237                                                          
						amino acids 170 - 367 of Q96ET6, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 253 - 450 of M85774_P7, wherein said first amino 	      51 SGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREM 100                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     238 CKQGYRDGLRFLQRN................................... 252                                                          
						isolated polypeptide encoding for a head of M85774_P7,       	         |||||||||||||||                                     
						comprising a polypeptide being at least 70%, optionally at   	     101 CKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDY 150                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     253 ...................ALLEACVEPTDLLTTLSNMLPVRLATAMMVP 283                                                          
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                            |||||||||||||||||||||||||||||||  
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	     151 SQLPGEDHILEHLPARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVP 200                                                          
						VSDGENVIISHFNSKDE                                            	                  .         .         .         .         .  
						about 95% homologous to the sequence of M85774_P7.3.An       	     284 YTLPLESALSFTIRLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGR 333                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P7, comprising a polypeptide having a length "n",     	     201 YTLPLESALSFTIRLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGR 250                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     334 HLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWE 383                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 HLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWE 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise NA, having a structure as  	     384 ECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPL 433                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						252-x to 253; and ending at any of amino acid numbers 253+   	     301 ECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPL 350                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .                                          
						                                                            	     434 LSTPAPEARPVIGALGL                                  450                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     351 LSTPAPEARPVIGALGL                                  367                                                          

						Comparison report between M85774_P7 and Q9NQ62partial WT     	Sequence name: Q9NQ62                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for M85774_P7, comprising a    	Sequence documentation:                                      
						MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGV 	                                                            
						CLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTR 	Alignment of: 12927 x Q9NQ62   ..                            
						VSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 	                                                            
						TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 	Alignment segment 1/1:                                       
						GYRDGLRFLQRN                                                 	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 4284.00                      Escore:       0                                               
						corresponding to amino acids 25 - 276 of Q9NQ62, which also  	             Matching length:     450                Total length:     504                                               
						corresponds to amino acids 1 - 252 of M85774_P7, a second    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWM 	    Total Percent Similarity:   89.29      Total Percent Identity:   89.09                                               
						KEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRR                          	                        Gaps:       1                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 331 - 425 of Q9NQ62, which also 	Alignment:                                                   
						corresponds to amino acids 253 - 347 of M85774_P7, a bridging	                  .         .         .         .         .  
						amino acid V corresponding to amino acid 348 of M85774_P7,   	       1 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 50                                                           
						and a third amino acid sequence being at least 90 %          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMR 	      25 MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGA 74                                                           
						APADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIGALGL                   	                  .         .         .         .         .  
						homologous to corresponding to amino acids 427 - 528 of      	      51 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 100                                                          
						Q9NQ62, which also corresponds to amino acids 349 - 450 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P7, wherein said first amino acid sequence, second    	      75 LTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLK 124                                                          
						amino acid sequence, bridging amino acid and third amino acid	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     101 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 150                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85774_P7, comprising a polypeptide having a length "n",     	     125 VLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPV 174                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     151 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 200                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     175 YCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSST 224                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise NA, having a structure as  	     201 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 250                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						252-x to 253; and ending at any of amino acid numbers 253+   	     225 NIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQ 274                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     251 RN................................................ 252                                                          
						                                                            	         ||                                                  
						                                                            	     275 RNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHL 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 ......ALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 296                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 PARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTI 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 RLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELR 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 RVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 396                                                          
						                                                            	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 RLQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCT 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 NVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIG 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 NVAFPPEALRMRAPADPAPAPADPASPQHQPAGPAPLLSTPAPEARPVIG 524                                                          
						                                                            	                                                             
						                                                            	     447 ALGL                                               450                                                          
						                                                            	         ||||                                                
						                                                            	     525 ALGL                                               528                                                          

13063	HMR136_M85780_10_tr0_r1_1_gPRT		Comparison report between M85780_P10 and Q8N5U3partial WT    	Sequence name: Q8N5U3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85780_P10, comprising a first amino	Sequence documentation:                                      
						MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQMLPDKTIASL 	                                                            
						VKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEG 	Alignment of: 13063 x Q8N5U3   ..                            
						NTEQPVQTSKIGLGRREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTILR 	                                                            
						QLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPE                       	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 122 - 339 of Q8N5U3, which also corresponds to	                     Quality: 2197.00                      Escore:       0                                               
						amino acids 1 - 218 of M85780_P10, and a second amino acid   	             Matching length:     219                Total length:     219                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.54                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:   99.54                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						AQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARF 	                                                            
						IQPRPTLNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH       	Alignment:                                                   
						having the sequence corresponding to amino acids 219 - 332 of	                  .         .         .         .         .  
						M85780_P10, wherein said first amino acid sequence and second	       1 MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQ 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     122 MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQ 171                                                          
						M85780_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 MLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEET 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARF 	     172 MLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEET 221                                                          
						IQPRPTLNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH       	                  .         .         .         .         .  
						least about 95% homologous to the sequence in M85780_P10.    	     101 HPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 HPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRS 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDMELISLKRQVQNAKQVN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 KCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDMELISLKRQVQNAKQVN 321                                                          
						                                                            	                  .                                          
						                                                            	     201 SALKQKMEGGIEEFKPPEA                                219                                                          
						                                                            	         ||||||||||||||||||:                                 
						                                                            	     322 SALKQKMEGGIEEFKPPES                                340                                                          

						Comparison report between M85780_P10 and Q9P2K3partial WT    	Sequence name: Q9P2K3                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85780_P10, comprising a first amino	Sequence documentation:                                      
						MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQMLPDKTIASL 	                                                            
						VKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEG 	Alignment of: 13063 x Q9P2K3   ..                            
						NTEQPVQTSKIGLGRREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTILR 	                                                            
						QLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPP                        	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 89 - 305 of Q9P2K3, which also corresponds to 	                     Quality: 3241.00                      Escore:       0                                               
						amino acids 1 - 217 of M85780_P10, and a second amino acid   	             Matching length:     332                Total length:     432                                               
						EAQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FIQPRPTLNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH      	    Total Percent Similarity:   76.85      Total Percent Identity:   76.85                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 406 - 520 of Q9P2K3, which also corresponds to   	                                                            
						amino acids 218 - 332 of M85780_P10, wherein said first amino	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	       1 MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQ 50                                                           
						encoding for an edge portion of M85780_P10, comprising a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	      89 MLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQ 138                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	      51 MLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEET 100                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     139 MLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEET 188                                                          
						length, wherein at least two amino acids comprise PE, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     101 HPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRS 150                                                          
						acid numbers 217-x to 218; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 218+ ((n-2) - x), in which x varies from 0 to n-2.   	     189 HPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRS 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDMELISLKRQVQNAKQVN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 KCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDMELISLKRQVQNAKQVN 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SALKQKMEGGIEEFKPP................................. 217                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     289 SALKQKMEGGIEEFKPPESNQKINARWTTEEQLLAVQGVRKYGKDFQAIA 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     217 .................................................. 217                                                          
						                                                            	                                                            
						                                                            	     339 DVIGNKTVGQVKNFFVNYRRRFNLEEVLQEWEAEQGTQASNGDASTLGEE 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     218 .................EAQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQ 250                                                          
						                                                            	                          |||||||||||||||||||||||||||||||||  
						                                                            	     389 TKSASNVPSGKSTDEEEEAQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQ 438                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPTLNQPPPPLIRPANSMP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     439 PPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPTLNQPPPPLIRPANSMP 488                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 PRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH                   332                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     489 PRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH                   520                                                          

13065	HMR136_M85780_22_tr0_r1_1_gPRT		Comparison report between M85780_P22 and Q8N5U3partial WT    	Sequence name: Q8N5U3                                        
						sequence with short unique insertion and a followed by a     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85780_P22, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 13065 x Q8N5U3   ..                            
						MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCSSDDEH      	                                                            
						corresponding to amino acids 1 - 55 of Q8N5U3, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 55 of M85780_P22, a second    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality:  630.00                      Escore:       0                                               
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:      74                Total length:      75                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence G corresponding to amino acids 56 - 56 of	    Total Percent Similarity:   98.67      Total Percent Identity:   98.67                                               
						M85780_P22, a third amino acid sequence being at least 90 %  	                        Gaps:       1                        
						homologous to DVGMRVGAEYQARIPEFDP corresponding to amino     	                                                            
						acids 56 - 74 of Q8N5U3, which also corresponds to amino     	Alignment:                                                   
						acids 57 - 75 of M85780_P22, and a fourth amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						ALGS corresponding to amino acids 76 - 79 of M85780_P22,     	                  .         .                                
						wherein said first amino acid sequence, second amino acid    	      51 SDDEHGDVGMRVGAEYQARIPEFDP                          75                                                           
						sequence, third amino acid sequence and fourth amino acid    	         ||||| |||||||||||||||||||                           
						sequence are contiguous and in a sequential order.2.An       	      51 SDDEH.DVGMRVGAEYQARIPEFDP                          74                                                           
						isolated polypeptide encoding for an edge portion of         	                                                            
						M85780_P22, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for G,	                                                            
						corresponding to M85780_P22.3.An isolated polypeptide        	                                                            
						encoding for a tail of M85780_P22, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						ALGS in M85780_P22.                                          	                                                            

13067	HMR136_M85780_23_tr0_r1_1_gPRT		Comparison report between M85780_P23 and Q8N5U3partial WT    	Sequence name: Q8N5U3                                        
						sequence with short unique insertion and a followed by a     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85780_P23, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 13067 x Q8N5U3   ..                            
						MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCSSDDEH      	                                                            
						corresponding to amino acids 1 - 55 of Q8N5U3, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 55 of M85780_P23, a second    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality:  630.00                      Escore:       0                                               
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:      74                Total length:      75                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence G corresponding to amino acids 56 - 56 of	    Total Percent Similarity:   98.67      Total Percent Identity:   98.67                                               
						M85780_P23, a third amino acid sequence being at least 90 %  	                        Gaps:       1                        
						homologous to DVGMRVGAEYQARIPEFDP corresponding to amino     	                                                            
						acids 56 - 74 of Q8N5U3, which also corresponds to amino     	Alignment:                                                   
						acids 57 - 75 of M85780_P23, and a fourth amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						ALGS corresponding to amino acids 76 - 79 of M85780_P23,     	                  .         .                                
						wherein said first amino acid sequence, second amino acid    	      51 SDDEHGDVGMRVGAEYQARIPEFDP                          75                                                           
						sequence, third amino acid sequence and fourth amino acid    	         ||||| |||||||||||||||||||                           
						sequence are contiguous and in a sequential order.2.An       	      51 SDDEH.DVGMRVGAEYQARIPEFDP                          74                                                           
						isolated polypeptide encoding for an edge portion of         	                                                            
						M85780_P23, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for G,	                                                            
						corresponding to M85780_P23.3.An isolated polypeptide        	                                                            
						encoding for a tail of M85780_P23, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						ALGS in M85780_P23.                                          	                                                            

13069	HMR136_M85780_9_tr0_r1_1_gPRT		Comparison report between M85780_P9 and Q8N5U3partial WT     	Sequence name: Q8N5U3                                        
						sequence with short unique insertion, a mismatch and a       	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for M85780_P9, comprising a first amino acid        	                                                            
						sequence being at least 90 % homologous to                   	Alignment of: 13069 x Q8N5U3   ..                            
						MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCSSDDEH      	                                                            
						corresponding to amino acids 1 - 55 of Q8N5U3, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 55 of M85780_P9, a second     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality: 3480.00                      Escore:       0                                               
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:     359                Total length:     360                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.72                                               
						having the sequence G corresponding to amino acids 56 - 56 of	    Total Percent Similarity:   99.72      Total Percent Identity:   99.44                                               
						M85780_P9, a third amino acid sequence being at least 90 %   	                        Gaps:       1                        
						homologous to DVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDA   	                                                            
						corresponding to amino acids 56 - 99 of Q8N5U3, which also   	Alignment:                                                   
						corresponds to amino acids 57 - 100 of M85780_P9, a bridging 	                  .         .         .         .         .  
						amino acid K corresponding to amino acid 101 of M85780_P9, a 	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						LDEYIAIAKEKHGYNVEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FHGKSFHRIQQMLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEE 	       1 MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCS 50                                                           
						THPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRSKCRPPKGMY 	                  .         .         .         .         .  
						LTQEDVVAVSCSPNAANTILRQLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPES 	      51 SDDEHGDVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDA 100                                                          
						NQKINARWTTEEQLLAVQG                                          	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	      51 SDDEH.DVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDA 99                                                           
						corresponding to amino acids 101 - 359 of Q8N5U3, which also 	                  .         .         .         .         .  
						corresponds to amino acids 102 - 360 of M85780_P9, and a     	     101 KLDEYIAIAKEKHGYNVEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTV 150                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     100 RLDEYIAIAKEKHGYNVEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTV 149                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						VRKYGKDFQAIADVIGNKTVGQVKNFFVNYRRRFNLEEAQTPQAPRTLGPSPPAPSSTPT 	     151 EDKVLFEQAFSFHGKSFHRIQQMLPDKTIASLVKYYYSWKKTRSRTSLMD 200                                                          
						PTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPTLNQPPPPLIRPANSMP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH                             	     150 EDKVLFEQAFSFHGKSFHRIQQMLPDKTIASLVKYYYSWKKTRSRTSLMD 199                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						361 - 512 of M85780_P9, wherein said first amino acid        	     201 RQARKLANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEGNTEQPVQT 250                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid, fourth amino acid sequence and	     200 RQARKLANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEGNTEQPVQT 249                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     251 SKIGLGRREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTI 300                                                          
						of M85780_P9, comprising an amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     250 SKIGLGRREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTI 299                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     301 LRQLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPESNQKINARWT 350                                                          
						encoding for G, corresponding to M85780_P9.3.An isolated     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of M85780_P9, comprising a   	     300 LRQLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPESNQKINARWT 349                                                          
						polypeptide being at least 70%, optionally at least about    	                  .                                          
						80%, preferably at least about 85%, more preferably at least 	     351 TEEQLLAVQG                                         360                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||                                          
						VRKYGKDFQAIADVIGNKTVGQVKNFFVNYRRRFNLEEAQTPQAPRTLGPSPPAPSSTPT 	     350 TEEQLLAVQG                                         359                                                          
						PTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPTLNQPPPPLIRPANSMP 	                                                            
						PRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH                             	                                                            
						to the sequence in M85780_P9.                                	                                                            

						Comparison report between M85780_P9 and Q9P2K3unique head    	Sequence name: Q9P2K3                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85780_P9,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 13069 x Q9P2K3   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCSSDDEHG     	                                                            
						corresponding to amino acids 1 - 56 of M85780_P9, a second   	                     Quality: 4460.00                      Escore:       0                                               
						DVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDAKLDEYIAIAKEKHGYN 	             Matching length:     456                Total length:     498                                               
						VEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLFEQAFSFHGKSFHRIQQMLPD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KTIASLVKYYYSWKKTRSRTSLMDRQARKLANRHNQGDSDDDVEETHPMDGNDSDYDPKK 	    Total Percent Similarity:   91.57      Total Percent Identity:   91.57                                               
						EAKKEGNTEQPVQTSKIGLGRREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNA 	                        Gaps:       1                        
						ANTILRQLDMELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPESNQKINARWTTEEQLL 	                                                            
						AVQGVRKYGKDFQAIADVIGNKTVGQVKNFFVNYRRRFNL                     	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 23 - 362 of Q9P2K3, which also  	      57 DVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDAKLDEYI 106                                                          
						corresponds to amino acids 57 - 396 of M85780_P9, and a third	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEAQTPQAPRTLGPSPPAPSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQA 	      23 DVGMRVGAEYQARIPEFDPGATKYTDKDNGGMLVWSPYHSIPDAKLDEYI 72                                                           
						RFIQPRPTLNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH     	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     107 AIAKEKHGYNVEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLF 156                                                          
						corresponding to amino acids 405 - 520 of Q9P2K3, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 397 - 512 of M85780_P9, wherein   	      73 AIAKEKHGYNVEQALGMLFWHKHNIEKSLADLPNFTPFPDEWTVEDKVLF 122                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     157 EQAFSFHGKSFHRIQQMLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKL 206                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M85780_P9, comprising a polypeptide being at least   	     123 EQAFSFHGKSFHRIQQMLPDKTIASLVKYYYSWKKTRSRTSLMDRQARKL 172                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     207 ANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLG 256                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPGMMEKGPELLGKNRSANGSAKSPAGGGGSGASSTNGGLHYSEPESGCSSDDEHG of  	     173 ANRHNQGDSDDDVEETHPMDGNDSDYDPKKEAKKEGNTEQPVQTSKIGLG 222                                                          
						M85780_P9.3.An isolated chimeric polypeptide encoding for an 	                  .         .         .         .         .  
						edge portion of M85780_P9, comprising a polypeptide having a 	     257 RREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDM 306                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     223 RREYQSLQHRHHSQRSKCRPPKGMYLTQEDVVAVSCSPNAANTILRQLDM 272                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     307 ELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPESNQKINARWTTEEQLL 356                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise LE, having a structure as  	     273 ELISLKRQVQNAKQVNSALKQKMEGGIEEFKPPESNQKINARWTTEEQLL 322                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						396-x to 397; and ending at any of amino acid numbers 397+   	     357 AVQGVRKYGKDFQAIADVIGNKTVGQVKNFFVNYRRRFNL.......... 396                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     323 AVQGVRKYGKDFQAIADVIGNKTVGQVKNFFVNYRRRFNLEEVLQEWEAE 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 ................................EEAQTPQAPRTLGPSPPA 414                                                          
						                                                            	                                         ||||||||||||||||||  
						                                                            	     373 QGTQASNGDASTLGEETKSASNVPSGKSTDEEEEAQTPQAPRTLGPSPPA 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     415 PSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPT 464                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 PSSTPTPTAPIATLNQPPPLLRPTLPAAPALHRQPPPLQQQARFIQPRPT 472                                                          
						                                                            	                  .         .         .         .            
						                                                            	     465 LNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH   512                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     473 LNQPPPPLIRPANSMPPRLNPRPVLSTVGGQQPPSLIGIQTDSQSSLH   520                                                          

13188	HMR136_M85784_7_tr0_r1_1_gPRT		Comparison report between M85784_P7 and Y173_HUMANpartial WT 	Sequence name: Y173_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85784_P7, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MASAGTQHYSIGLRQKNSFKQSGPSGTVPATPP   	Alignment of: 13188 x Y173_HUMAN   ..                        
						corresponding to amino acids 1 - 33 of Y173_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 33 of M85784_P7, a bridging   	Alignment segment 1/1:                                       
						amino acid E corresponding to amino acid 34 of M85784_P7, a  	                                                            
						KPSEGRVWPQAHQQVKPIWKLEKKQVETLSAGLGPGLLGVPPQPAYFFCPSTLCSSGTTA 	                     Quality: 7177.00                      Escore:       0                                               
						VIAGHSSSCYLHSLPDLFNSTLLYRRSSYRQKPYQQLESFCLRSSPSEKSPFSLPQKSLP 	             Matching length:     722                Total length:     722                                               
						VSLTANKATSSMVFSMAQPMASSSTEPYLCLAAAGENPSGKSLASAISGKIPSPLSSSYK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						PMLNNNSFMWPNSTPVPLLQTTQGLKPVSPPKIQPVSWHHSGGTGDCAPQPVDHKVPKSI 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						GTVPADASAHIALSTASSHDTSTTSVASSWYNRNNLAMRAEPLSCALDDSSDSQDPTKEI 	                        Gaps:       0                        
						RFTEAVRKLTARGFEKMPRQGCQLEQSSFLNPSFQWNVLNRSRRWKPPAVNQQFPQEDAG 	                                                            
						SVRRVLPGASDTLGLDNTVFCTKRISIHLLASHASGLNHNPACESVIDSSAFGEGKAPGP 	Alignment:                                                   
						PFPQTLGIANVATRLSSIQLGQSEKERPEEARELDSSDRDISSATDLQPDQAETEDTEEE 	                  .         .         .         .         .  
						LVDGLEDCCSRDENEEEEGDSECSSLSAVSPSESVAMISRSCMEILTKPLSNHEKVVRPA 	       1 MASAGTQHYSIGLRQKNSFKQSGPSGTVPATPPEKPSEGRVWPQAHQQVK 50                                                           
						LIYSLFPNVPPTIYFGTRDERVEKLPWEQRKLLRWKMSTVTPNIVKQTIGRSHFKISKRN 	         |||||||||||||||||||||||||||||||||:||||||||||||||||  
						DDWLGCWGHHMKSPSFRSIREHQKLNHFPGSFQIGRKDRLWRNLSRMQSRFGKKEFSFFP 	       1 MASAGTQHYSIGLRQKNSFKQSGPSGTVPATPPQKPSEGRVWPQAHQQVK 50                                                           
						QSFILPQDAKLLRKAWESSSRQKWIVKP                                 	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      51 PIWKLEKKQVETLSAGLGPGLLGVPPQPAYFFCPSTLCSSGTTAVIAGHS 100                                                          
						corresponding to amino acids 35 - 722 of Y173_HUMAN, which   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 35 - 722 of M85784_P7, and a 	      51 PIWKLEKKQVETLSAGLGPGLLGVPPQPAYFFCPSTLCSSGTTAVIAGHS 100                                                          
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     101 SSCYLHSLPDLFNSTLLYRRSSYRQKPYQQLESFCLRSSPSEKSPFSLPQ 150                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence VFAFHEEPWQ corresponding to  	     101 SSCYLHSLPDLFNSTLLYRRSSYRQKPYQQLESFCLRSSPSEKSPFSLPQ 150                                                          
						amino acids 723 - 732 of M85784_P7, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, bridging amino acid, second amino acid        	     151 KSLPVSLTANKATSSMVFSMAQPMASSSTEPYLCLAAAGENPSGKSLASA 200                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     151 KSLPVSLTANKATSSMVFSMAQPMASSSTEPYLCLAAAGENPSGKSLASA 200                                                          
						tail of M85784_P7, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     201 ISGKIPSPLSSSYKPMLNNNSFMWPNSTPVPLLQTTQGLKPVSPPKIQPV 250                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence VFAFHEEPWQ in  	     201 ISGKIPSPLSSSYKPMLNNNSFMWPNSTPVPLLQTTQGLKPVSPPKIQPV 250                                                          
						M85784_P7.                                                   	                  .         .         .         .         .  
						                                                            	     251 SWHHSGGTGDCAPQPVDHKVPKSIGTVPADASAHIALSTASSHDTSTTSV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SWHHSGGTGDCAPQPVDHKVPKSIGTVPADASAHIALSTASSHDTSTTSV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ASSWYNRNNLAMRAEPLSCALDDSSDSQDPTKEIRFTEAVRKLTARGFEK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ASSWYNRNNLAMRAEPLSCALDDSSDSQDPTKEIRFTEAVRKLTARGFEK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 MPRQGCQLEQSSFLNPSFQWNVLNRSRRWKPPAVNQQFPQEDAGSVRRVL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 MPRQGCQLEQSSFLNPSFQWNVLNRSRRWKPPAVNQQFPQEDAGSVRRVL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PGASDTLGLDNTVFCTKRISIHLLASHASGLNHNPACESVIDSSAFGEGK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PGASDTLGLDNTVFCTKRISIHLLASHASGLNHNPACESVIDSSAFGEGK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 APGPPFPQTLGIANVATRLSSIQLGQSEKERPEEARELDSSDRDISSATD 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 APGPPFPQTLGIANVATRLSSIQLGQSEKERPEEARELDSSDRDISSATD 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LQPDQAETEDTEEELVDGLEDCCSRDENEEEEGDSECSSLSAVSPSESVA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LQPDQAETEDTEEELVDGLEDCCSRDENEEEEGDSECSSLSAVSPSESVA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 MISRSCMEILTKPLSNHEKVVRPALIYSLFPNVPPTIYFGTRDERVEKLP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 MISRSCMEILTKPLSNHEKVVRPALIYSLFPNVPPTIYFGTRDERVEKLP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 WEQRKLLRWKMSTVTPNIVKQTIGRSHFKISKRNDDWLGCWGHHMKSPSF 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 WEQRKLLRWKMSTVTPNIVKQTIGRSHFKISKRNDDWLGCWGHHMKSPSF 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RSIREHQKLNHFPGSFQIGRKDRLWRNLSRMQSRFGKKEFSFFPQSFILP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 RSIREHQKLNHFPGSFQIGRKDRLWRNLSRMQSRFGKKEFSFFPQSFILP 700                                                          
						                                                            	                  .         .                                
						                                                            	     701 QDAKLLRKAWESSSRQKWIVKP                             722                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     701 QDAKLLRKAWESSSRQKWIVKP                             722                                                          

13508	HMR136_M85789_11_tr0_r1_1_gPRT		Comparison report between M85789_P11 and MKI1_HUMANpartial   	Sequence name: MKI1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85789_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MADDLKRFLYKKLPSVEGLHAIVVSDRDGVPVIK corresponding to amino    	Alignment of: 13508 x MKI1_HUMAN   ..                        
						acids 1 - 34 of MKI1_HUMAN, which also corresponds to amino  	                                                            
						acids 1 - 34 of M85789_P11, and a second amino acid sequence 	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality:  322.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:      34                Total length:      34                                               
						GKTEHLNANVFFAFD corresponding to amino acids 35 - 49 of      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M85789_P11, wherein said first amino acid sequence and second	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence are contiguous and in a sequential       	                        Gaps:       0                        
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						M85789_P11, comprising a polypeptide being at least 70%,     	Alignment:                                                   
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	       1 MADDLKRFLYKKLPSVEGLHAIVVSDRDGVPVIK                 34                                                           
						least about 95% homologous to the sequence GKTEHLNANVFFAFD in	         ||||||||||||||||||||||||||||||||||                  
						M85789_P11.                                                  	       1 MADDLKRFLYKKLPSVEGLHAIVVSDRDGVPVIK                 34                                                           

14032	HMR136_M85796_10_tr0_r1_1_gPRT		Comparison report between M85796_P10 and YA02_HUMANshort     	Sequence name: YA02_HUMAN                                    
						unique head followed by partial WT sequence1.An isolated     	                                                            
						chimeric polypeptide encoding for M85796_P10, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 14032 x YA02_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence M corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 1 of M85796_P10, and a second amino acid sequence  	                                                            
						ADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQPLPTSNYSTS 	                     Quality: 5414.00                      Escore:       0                                               
						SHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYRPLSHPVAYSPQRGQQLPQPS 	             Matching length:     542                Total length:     542                                               
						QQPGLQPMMPNQQQAAYQGMIGVQQPQNQGLLSSQRSSMGGQMQGLVVQYTPLPSYQVPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GSDSQNVVQPPFQQPMLVPVSQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQPPGS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EQYQMPQSPSPCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYS 	                        Gaps:       0                        
						MDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTGLSPLPVLTQF 	                                                            
						PRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVHQGQSGLKHGNRGKRQALKSA 	Alignment:                                                   
						STDLGTADVVLGRVLEVTDLPEGITRTEADKLFTQLAMSGAKIQWLKDAQGLPGGGGGDN 	                  .         .         .         .         .  
						SGTAENGRHSDLAALYTIVAVFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRILERAS 	       2 ADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQ 51                                                           
						SQ                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     299 ADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQ 348                                                          
						acids 299 - 840 of YA02_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 2 - 543 of M85796_P10, wherein said first amino  	      52 PLPTSNYSTSSHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYR 101                                                          
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.                                   	     349 PLPTSNYSTSSHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYR 398                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     102 PLSHPVAYSPQRGQQLPQPSQQPGLQPMMPNQQQAAYQGMIGVQQPQNQG 151                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     399 PLSHPVAYSPQRGQQLPQPSQQPGLQPMMPNQQQAAYQGMIGVQQPQNQG 448                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     152 LLSSQRSSMGGQMQGLVVQYTPLPSYQVPVGSDSQNVVQPPFQQPMLVPV 201                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     449 LLSSQRSSMGGQMQGLVVQYTPLPSYQVPVGSDSQNVVQPPFQQPMLVPV 498                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     202 SQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQPPGSEQYQMPQSPS 251                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     499 SQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQPPGSEQYQMPQSPS 548                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     252 PCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYS 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     549 PCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYS 598                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     302 MDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTG 351                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     599 MDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTG 648                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     352 LSPLPVLTQFPRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVH 401                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     649 LSPLPVLTQFPRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVH 698                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     402 QGQSGLKHGNRGKRQALKSASTDLGTADVVLGRVLEVTDLPEGITRTEAD 451                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     699 QGQSGLKHGNRGKRQALKSASTDLGTADVVLGRVLEVTDLPEGITRTEAD 748                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     452 KLFTQLAMSGAKIQWLKDAQGLPGGGGGDNSGTAENGRHSDLAALYTIVA 501                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     749 KLFTQLAMSGAKIQWLKDAQGLPGGGGGDNSGTAENGRHSDLAALYTIVA 798                                                          
						                                                            	                  .         .         .         .            
						                                                            	     502 VFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRILERASSQ         543                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     799 VFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRILERASSQ         840                                                          

14038	HMR136_M85796_6_tr0_r1_1_gPRT		Comparison report between M85796_P6 and YA02_HUMANunique     	Sequence name: YA02_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a featuring a skipped exon.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M85796_P6, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 14038 x YA02_HUMAN   ..                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MSNSNTTQETLEIMKESEKKLVEESVNKNKFISKTPSKEEIEKECEDTSLRQETQRRTSN 	                                                            
						HGHARKRAKSNSKLKLVRSLAVCEESSTPFADGPLETQDIIQLHISCPSDKEEEKSTKDV 	                     Quality: 7882.00                      Escore:       0                                               
						SEKEDKDKNKEKIPRK                                             	             Matching length:     822                Total length:     906                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 136 of M85796_P6, a second amino acid sequence being at  	    Total Percent Similarity:   90.73      Total Percent Identity:   90.73                                               
						MLSRDSSQEYTDSTGIDLHEFLVNTLKKNPRDRMMLLKLEQEILEFINDNNNQFKKFPQM 	                        Gaps:       3                        
						TSYHRMLLHRVAAYFGMDHNVDQTGKAVIINKTSNTRIPEQRFSEHIKDEKNTEFQQRFI 	                                                            
						LKRDDASMDRDDNQ                                               	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 1 - 134	                  .         .         .         .         .  
						of YA02_HUMAN, which also corresponds to amino acids 137 -   	     137 MLSRDSSQEYTDSTGIDLHEFLVNTLKKNPRDRMMLLKLEQEILEFINDN 186                                                          
						270 of M85796_P6, a third amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MLSRDSSQEYTDSTGIDLHEFLVNTLKKNPRDRMMLLKLEQEILEFINDN 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     187 NNQFKKFPQMTSYHRMLLHRVAAYFGMDHNVDQTGKAVIINKTSNTRIPE 236                                                          
						IRVPLQDGRRSKSIEEREEEYQRVRERIFARE corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						271 - 302 of M85796_P6, a fourth amino acid sequence being at	      51 NNQFKKFPQMTSYHRMLLHRVAAYFGMDHNVDQTGKAVIINKTSNTRIPE 100                                                          
						least 90 % homologous to TGQNGYLNDI corresponding to amino   	                  .         .         .         .         .  
						acids 135 - 144 of YA02_HUMAN, which also corresponds to     	     237 QRFSEHIKDEKNTEFQQRFILKRDDASMDRDDNQIRVPLQDGRRSKSIEE 286                                                          
						amino acids 303 - 312 of M85796_P6, a fifth amino acid       	         ||||||||||||||||||||||||||||||||||                  
						RGNREGLSRTSSSRQSSTDSELKSLEPRPWSSTDSDGSVRSMRPPVTKASSFSGISILTR 	     101 QRFSEHIKDEKNTEFQQRFILKRDDASMDRDDNQ................ 134                                                          
						GDSIGSSKGGSAGRISRPGMALGAPEVCNQVTSSQSVRGLLPCTAQQQQQQQQQQLPALP 	                  .         .         .         .         .  
						PTPQQQPPLNNHMISQ                                             	     287 REEEYQRVRERIFARETGQNGYLNDI..................RGNREG 318                                                          
						sequence being at least 90 % homologous to corresponding to  	                         ||||||||||                  ||||||  
						amino acids 163 - 298 of YA02_HUMAN, which also corresponds  	     135 ................TGQNGYLNDIRLSKEAFSSSSHKRRQIFRGNREG 168                                                          
						to amino acids 313 - 448 of M85796_P6, a sixth amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     319 LSRTSSSRQSSTDSELKSLEPRPWSSTDSDGSVRSMRPPVTKASSFSGIS 368                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     169 LSRTSSSRQSSTDSELKSLEPRPWSSTDSDGSVRSMRPPVTKASSFSGIS 218                                                          
						having the sequence PVPALQPSPQPVQFSPSSCPQVLLPVSPPQQYNM       	                  .         .         .         .         .  
						corresponding to amino acids 449 - 482 of M85796_P6, and a   	     369 ILTRGDSIGSSKGGSAGRISRPGMALGAPEVCNQVTSSQSVRGLLPCTAQ 418                                                          
						ADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQPLPTSNYSTS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYRPLSHPVAYSPQRGQQLPQPS 	     219 ILTRGDSIGSSKGGSAGRISRPGMALGAPEVCNQVTSSQSVRGLLPCTAQ 268                                                          
						QQPGLQPMMPNQQQAAYQGMIGVQQPQNQGLLSSQRSSMGGQMQGLVVQYTPLPSYQVPV 	                  .         .         .         .         .  
						GSDSQNVVQPPFQQPMLVPVSQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQPPGS 	     419 QQQQQQQQQLPALPPTPQQQPPLNNHMISQPVPALQPSPQPVQFSPSSCP 468                                                          
						EQYQMPQSPSPCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYS 	         ||||||||||||||||||||||||||||||                      
						MDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTGLSPLPVLTQF 	     269 QQQQQQQQQLPALPPTPQQQPPLNNHMISQ.................... 298                                                          
						PRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVHQGQSGLKHGNRGKRQALKSA 	                  .         .         .         .         .  
						STDLGTADVVLGRVLEVTDLPEGITRTEADKLFTQLAMSGAKIQWLKDAQGLPGGGGGDN 	     469 QVLLPVSPPQQYNMADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQ 518                                                          
						SGTAENGRHSDLAALYTIVAVFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRILERAS 	                       ||||||||||||||||||||||||||||||||||||  
						SQ                                                           	     299 ..............ADDLSNPFGQMSLSRQGSTEAADPSAALFQTPLISQ 334                                                          
						seventh amino acid sequence being at least 90 % homologous to	                  .         .         .         .         .  
						corresponding to amino acids 299 - 840 of YA02_HUMAN, which  	     519 HPQQTSFIMASTGQPLPTSNYSTSSHAPPTQQVLPPQGYMQPPQQIQVSY 568                                                          
						also corresponds to amino acids 483 - 1024 of M85796_P6,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     335 HPQQTSFIMASTGQPLPTSNYSTSSHAPPTQQVLPPQGYMQPPQQIQVSY 384                                                          
						sequence, third amino acid sequence, fourth amino acid       	                  .         .         .         .         .  
						sequence, fifth amino acid sequence, sixth amino acid        	     569 YPPGQYPNSNQQYRPLSHPVAYSPQRGQQLPQPSQQPGLQPMMPNQQQAA 618                                                          
						sequence and seventh amino acid sequence are contiguous and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in a sequential order.2.An isolated polypeptide encoding for 	     385 YPPGQYPNSNQQYRPLSHPVAYSPQRGQQLPQPSQQPGLQPMMPNQQQAA 434                                                          
						a head of M85796_P6, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     619 YQGMIGVQQPQNQGLLSSQRSSMGGQMQGLVVQYTPLPSYQVPVGSDSQN 668                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSNSNTTQETLEIMKESEKKLVEESVNKNKFISKTPSKEEIEKECEDTSLRQETQRRTSN 	     435 YQGMIGVQQPQNQGLLSSQRSSMGGQMQGLVVQYTPLPSYQVPVGSDSQN 484                                                          
						HGHARKRAKSNSKLKLVRSLAVCEESSTPFADGPLETQDIIQLHISCPSDKEEEKSTKDV 	                  .         .         .         .         .  
						SEKEDKDKNKEKIPRK                                             	     669 VVQPPFQQPMLVPVSQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQ 718                                                          
						at least about 95% homologous to the sequence of             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85796_P6.3.An isolated polypeptide encoding for an edge     	     485 VVQPPFQQPMLVPVSQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQ 534                                                          
						portion of M85796_P6, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     719 PPGSEQYQMPQSPSPCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQ 768                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     535 PPGSEQYQMPQSPSPCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQ 584                                                          
						encoding for IRVPLQDGRRSKSIEEREEEYQRVRERIFARE, corresponding 	                  .         .         .         .         .  
						to M85796_P6.4.An isolated chimeric polypeptide encoding for 	     769 NPSMVQWSHCKYYSMDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSP 818                                                          
						an edge portion of M85796_P6, comprising a polypeptide having	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a length "n", wherein n is at least about 10 amino acids in  	     585 NPSMVQWSHCKYYSMDQRGQKPGDLYSPDSSPQANTQMSSSPVTSPTQSP 634                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     819 APSPVTSLSSVCTGLSPLPVLTQFPRPGGPAQGDGRYSLLGQPLQYNLSI 868                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     635 APSPVTSLSSVCTGLSPLPVLTQFPRPGGPAQGDGRYSLLGQPLQYNLSI 684                                                          
						at least two amino acids comprise IR, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     869 CPPLLHGQSTYTVHQGQSGLKHGNRGKRQALKSASTDLGTADVVLGRVLE 918                                                          
						312-x to 313; and ending at any of amino acid numbers 313+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	     685 CPPLLHGQSTYTVHQGQSGLKHGNRGKRQALKSASTDLGTADVVLGRVLE 734                                                          
						polypeptide encoding for an edge portion of M85796_P6,       	                  .         .         .         .         .  
						comprising an amino acid sequence being at least 70%,        	     919 VTDLPEGITRTEADKLFTQLAMSGAKIQWLKDAQGLPGGGGGDNSGTAEN 968                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     735 VTDLPEGITRTEADKLFTQLAMSGAKIQWLKDAQGLPGGGGGDNSGTAEN 784                                                          
						least about 95% homologous to the sequence encoding for      	                  .         .         .         .         .  
						PVPALQPSPQPVQFSPSSCPQVLLPVSPPQQYNM, corresponding to         	     969 GRHSDLAALYTIVAVFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRIL 1018                                                         
						M85796_P6.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     785 GRHSDLAALYTIVAVFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRIL 834                                                          
						                                                            	                                                             
						                                                            	    1019 ERASSQ                                             1024                                                         
						                                                            	         ||||||                                              
						                                                            	     835 ERASSQ                                             840                                                          

14036	HMR136_M85796_9_tr0_r1_1_gPRT		Comparison report between M85796_P9 and YA02_HUMANpartial WT 	Sequence name: YA02_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85796_P9, comprising a first amino acid        	                                                            
						MSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQPLPTSNYSTSSHAPPTQQVL 	Alignment of: 14036 x YA02_HUMAN   ..                        
						PPQGYMQPPQQIQVSYYPPGQYPNSNQQYRPLSHPVAYSPQRGQQLPQPSQQPGLQPMMP 	                                                            
						NQQQAAYQGMIGVQQPQNQGLLSSQRSSMGGQMQGLVVQYTPLPSYQVPVGSDSQNVVQP 	Alignment segment 1/1:                                       
						PFQQPMLVPVSQSVQGGLPAAGVPVYYSMIPPAQQNGTSPSVGFLQPPGSEQYQMPQSPS 	                                                            
						PCSPPQMPQQYSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYSMDQRGQKPGD 	                     Quality: 5315.00                      Escore:       0                                               
						LYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTGLSPLPVLTQFPRPGGPAQGD 	             Matching length:     532                Total length:     532                                               
						GRYSLLGQPLQYNLSICPPLLHGQSTYTVHQGQSGLKHGNRGKRQALKSASTDLGTADVV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LGRVLEVTDLPEGITRTEADKLFTQLAMSGAKIQWLKDAQGLPGGGGGDNSGTAENGRHS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DLAALYTIVAVFPSPLAAQNASLRLNNSVSRFKLRMAKKNYDLRILERASSQ         	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 309 - 840 of YA02_HUMAN, which also corresponds  	Alignment:                                                   
						to amino acids 1 - 532 of M85796_P9.                         	                  .         .         .         .         .  
						                                                            	       1 MSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQPLPTSNYSTS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     309 MSLSRQGSTEAADPSAALFQTPLISQHPQQTSFIMASTGQPLPTSNYSTS 358                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYRPLSHPVAYSP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 SHAPPTQQVLPPQGYMQPPQQIQVSYYPPGQYPNSNQQYRPLSHPVAYSP 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QRGQQLPQPSQQPGLQPMMPNQQQAAYQGMIGVQQPQNQGLLSSQRSSMG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 QRGQQLPQPSQQPGLQPMMPNQQQAAYQGMIGVQQPQNQGLLSSQRSSMG 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GQMQGLVVQYTPLPSYQVPVGSDSQNVVQPPFQQPMLVPVSQSVQGGLPA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 GQMQGLVVQYTPLPSYQVPVGSDSQNVVQPPFQQPMLVPVSQSVQGGLPA 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AGVPVYYSMIPPAQQNGTSPSVGFLQPPGSEQYQMPQSPSPCSPPQMPQQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 AGVPVYYSMIPPAQQNGTSPSVGFLQPPGSEQYQMPQSPSPCSPPQMPQQ 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYSMDQRGQKPGD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 YSGVSPSGPGVVVMQLNVPNGPQPPQNPSMVQWSHCKYYSMDQRGQKPGD 608                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTGLSPLPVLTQF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     609 LYSPDSSPQANTQMSSSPVTSPTQSPAPSPVTSLSSVCTGLSPLPVLTQF 658                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVHQGQSGLKHGN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     659 PRPGGPAQGDGRYSLLGQPLQYNLSICPPLLHGQSTYTVHQGQSGLKHGN 708                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RGKRQALKSASTDLGTADVVLGRVLEVTDLPEGITRTEADKLFTQLAMSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     709 RGKRQALKSASTDLGTADVVLGRVLEVTDLPEGITRTEADKLFTQLAMSG 758                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AKIQWLKDAQGLPGGGGGDNSGTAENGRHSDLAALYTIVAVFPSPLAAQN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     759 AKIQWLKDAQGLPGGGGGDNSGTAENGRHSDLAALYTIVAVFPSPLAAQN 808                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 ASLRLNNSVSRFKLRMAKKNYDLRILERASSQ                   532                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     809 ASLRLNNSVSRFKLRMAKKNYDLRILERASSQ                   840                                                          

6588	HMR136_M85807_2_tr0_r1_1_gPRT		Comparison report between M85807_P2 and CAD89897partial WT   	Sequence name: CAD89897                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85807_P2, comprising a first amino acid        	                                                            
						MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNAVVLIDDSVPT 	Alignment of: 6588 x CAD89897   ..                           
						TKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAALDFILVTSFPNKELTDESLTL 	                                                            
						LEADILNTVLLQQLK                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 195 - 329 of CAD89897, which also corresponds to 	                     Quality: 1283.00                      Escore:       0                                               
						amino acids 1 - 135 of M85807_P2.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     195 MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNA 244                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VVLIDDSVPTTKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAAL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 VVLIDDSVPTTKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAAL 294                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 DFILVTSFPNKELTDESLTLLEADILNTVLLQQLK                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     295 DFILVTSFPNKELTDESLTLLEADILNTVLLQQLK                329                                                          

						Comparison report between M85807_P2 and CAD89972partial WT   	Sequence name: CAD89972                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85807_P2, comprising a first amino acid        	                                                            
						MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNAVVLIDDSVPT 	Alignment of: 6588 x CAD89972   ..                           
						TKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAALDFILVTSFPNKELTDESLTL 	                                                            
						LEADILNTVLLQQLK                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 195 - 329 of CAD89972, which also corresponds to 	                     Quality: 1283.00                      Escore:       0                                               
						amino acids 1 - 135 of M85807_P2.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     195 MEDHQDQEYIKPRLRFKAFSGEGQKLGSLTPEIVSTPSSPEEEDKSILNA 244                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VVLIDDSVPTTKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAAL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 VVLIDDSVPTTKIQIRLADGSRLIQRFNSTHRILDVRNFIVQSRPEFAAL 294                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 DFILVTSFPNKELTDESLTLLEADILNTVLLQQLK                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     295 DFILVTSFPNKELTDESLTLLEADILNTVLLQQLK                329                                                          

14371	HMR136_M85810_9_tr0_r1_1_gPRT		Comparison report between M85810_P9 and AAH42899partial WT   	Sequence name: AAH42899                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85810_P9, comprising a first amino 	Sequence documentation:                                      
						MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLCRVSSDNGQRL 	                                                            
						LDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSIKIKPNGMPNGYRKEMIKIPM 	Alignment of: 14371 x AAH42899   ..                          
						PELERSQYPMEWGKTFLAFLYALSCFVLTTVMISVVHERVPPKEVQPPLPDTFFDHFNRV 	                                                            
						QWAFSICEINGMILVGLWLIQWLLLKYK                                 	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 208 of AAH42899, which also corresponds to	                     Quality: 2115.00                      Escore:       0                                               
						amino acids 1 - 208 of M85810_P9, and a second amino acid    	             Matching length:     208                Total length:     208                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence IGLSSH corresponding to amino acids 209 -	                                                            
						214 of M85810_P9, wherein said first amino acid sequence and 	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLC 50                                                           
						M85810_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLC 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence IGLSSH in         	      51 RVSSDNGQRLLDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSI 100                                                          
						M85810_P9.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RVSSDNGQRLLDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSI 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KIKPNGMPNGYRKEMIKIPMPELERSQYPMEWGKTFLAFLYALSCFVLTT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KIKPNGMPNGYRKEMIKIPMPELERSQYPMEWGKTFLAFLYALSCFVLTT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VMISVVHERVPPKEVQPPLPDTFFDHFNRVQWAFSICEINGMILVGLWLI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VMISVVHERVPPKEVQPPLPDTFFDHFNRVQWAFSICEINGMILVGLWLI 200                                                          
						                                                            	                                                             
						                                                            	     201 QWLLLKYK                                           208                                                          
						                                                            	         ||||||||                                            
						                                                            	     201 QWLLLKYK                                           208                                                          

						Comparison report between M85810_P9 and AAP37279partial WT   	Sequence name: AAP37279                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85810_P9, comprising a first amino 	Sequence documentation:                                      
						MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLCRVSSDNGQRL 	                                                            
						LDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSIKIKPNGMPNGYRKEMIKIPM 	Alignment of: 14371 x AAP37279   ..                          
						PELERSQYPMEWGKTFLAFLYALSCFVLTTVMISVVHERVPPKEVQPPLPDTFFDHFNRV 	                                                            
						QWAFSICEINGMILVGLWLIQWLLLKYK                                 	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 208 of AAP37279, which also corresponds to	                     Quality: 2115.00                      Escore:       0                                               
						amino acids 1 - 208 of M85810_P9, and a second amino acid    	             Matching length:     208                Total length:     208                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence IGLSSH corresponding to amino acids 209 -	                                                            
						214 of M85810_P9, wherein said first amino acid sequence and 	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLC 50                                                           
						M85810_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MKEVVYWSPKKVADWLLENAMPEYCEPLEHFTGQDLINLTQEDFKKPPLC 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence IGLSSH in         	      51 RVSSDNGQRLLDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSI 100                                                          
						M85810_P9.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RVSSDNGQRLLDMIETLKMEHHLEAHKNGHANGHLNIGVDIPTPDGSFSI 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KIKPNGMPNGYRKEMIKIPMPELERSQYPMEWGKTFLAFLYALSCFVLTT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KIKPNGMPNGYRKEMIKIPMPELERSQYPMEWGKTFLAFLYALSCFVLTT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VMISVVHERVPPKEVQPPLPDTFFDHFNRVQWAFSICEINGMILVGLWLI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VMISVVHERVPPKEVQPPLPDTFFDHFNRVQWAFSICEINGMILVGLWLI 200                                                          
						                                                            	                                                             
						                                                            	     201 QWLLLKYK                                           208                                                          
						                                                            	         ||||||||                                            
						                                                            	     201 QWLLLKYK                                           208                                                          

6729	HMR136_M85811_10_tr0_r1_1_gPRT		Comparison report between M85811_P10 and PDK1_HUMANpartial   	Sequence name: PDK1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M85811_P10, comprising a first amino	                                                            
						MAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGKGKGSPSHRKH 	Alignment of: 6729 x PDK1_HUMAN   ..                         
						IGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEELNAKSPGQPIQVVYVPSHLYH 	                                                            
						MVFELFKNAMRATMEHHANRGVYPPIQVHVTLGNEDLTVKMSDRGGGVPLRKIDRLFNYM 	Alignment segment 1/1:                                       
						YSTAPRPRVETSRAVPLAGFGYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTD 	                                                            
						SIERLPVYNKAAWKHYNTNHEADDWCVPSREPKDMTTFRSA                    	                     Quality: 2789.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     281                Total length:     281                                               
						to amino acids 156 - 436 of PDK1_HUMAN, which also           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 281 of M85811_P10.            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 MAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGK 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEEL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 GKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEEL 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 NAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHV 305                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     306 TLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGF 355                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     356 GYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNK 405                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 AAWKHYNTNHEADDWCVPSREPKDMTTFRSA                    281                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     406 AAWKHYNTNHEADDWCVPSREPKDMTTFRSA                    436                                                          

6940	HMR136_M85815_25_tr0_r1_1_gPRT		Comparison report between M85815_P25 and                     	Sequence name: BPEA_HUMAN_V4                                 
						BPEA_HUMAN_V4partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for M85815_P25, comprising a   	                                                            
						MTDISHGYEDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPT 	Alignment of: 6940 x BPEA_HUMAN_V4   ..                      
						DTEAVKTQVEQNKSFEAELKQNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKW 	                                                            
						QELNQLTIDRQQKLEESSNNLTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQ 	Alignment segment 1/1:                                       
						QVQILLQEFATRKPQYEQLTAAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSD 	                                                            
						RCDWIDQAIVKSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEI 	                     Quality: 30194.00                      Escore:       0                                              
						QQEKKQIKVAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACA 	             Matching length:    3097                Total length:    3097                                               
						SSHQFQQMSRDFQAWLDTKKEEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IAEGENLLLKTQGSEKAALQLQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVET 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LWPWIDKCQNNLEEIKFCLDPAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCE 	                        Gaps:       0                        
						IDKEVVTDENKSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLD 	                                                            
						IHDSLGSQAYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVE 	Alignment:                                                   
						TIAQEHSTLSQQVDEKCSFLETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAET 	                  .         .         .         .         .  
						LQKQKETIKAFLKKLEALMASNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLL 	       1 MTDISHGYEDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTA 50                                                           
						DRAQAREEQVEGTIKRLEEFYSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FQKEEIEPLQGKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQ 	    2075 MTDISHGYEDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTA 2124                                                         
						LQEALLHCGRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRK 	                  .         .         .         .         .  
						STVEVIKREGEKIATTAEPADKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQF 	      51 TKWQQTPAPTDTEAVKTQVEQNKSFEAELKQNVNKVQELKDKLTELLEEN 100                                                          
						HETLEPLNEWLTTIEKRLVNCEPIGTQASKLEEQIAQHKALEDDIINHNKHLHQAVSIGQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLKVLSSREDKDMVQSKLDFSQVWYIEIQEKSHSRSELLQQALCNAKIFGEDEVELMNWL 	    2125 TKWQQTPAPTDTEAVKTQVEQNKSFEAELKQNVNKVQELKDKLTELLEEN 2174                                                         
						NEVHDKLSKLSVQDYSTEGLWKQQSELRVLQEDILLRKQNVDQALLNGLELLKQTTGDEV 	                  .         .         .         .         .  
						LIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYE 	     101 PDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNNLTQFQTVEAQ 150                                                          
						TQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERYRLVSDTITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSA 	    2175 PDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNNLTQFQTVEAQ 2224                                                         
						QLQVQKTFTMEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINS 	                  .         .         .         .         .  
						ERYLQLERAQSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLREL 	     151 LKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 200                                                          
						IAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						STQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLK 	    2225 LKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 2274                                                         
						QRGEEMIARSGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCD 	                  .         .         .         .         .  
						HMSLIVTIKDTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELI 	     201 AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIV 250                                                          
						AACGEPDKPIVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHT 	    2275 AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIV 2324                                                         
						VQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPV 	                  .         .         .         .         .  
						GGDPKAIEIELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQR 	     251 KSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEI 300                                                          
						WQNVLEKTEQRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NVHMEVCAAFEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNER 	    2325 KSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEI 2374                                                         
						KTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVN 	                  .         .         .         .         .  
						SHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRA 	     301 QQEKKQIKVAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAEN 350                                                          
						KQFHEAWSKLMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQAL 	    2375 QQEKKQIKVAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAEN 2424                                                         
						IDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSR 	                  .         .         .         .         .  
						DDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLR 	     351 HVQHLQSACASSHQFQQMSRDFQAWLDTKKEEQNKSHPISAKLDVLESLI 400                                                          
						FHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWIT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IIRARFEEVLAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEI 	    2425 HVQHLQSACASSHQFQQMSRDFQAWLDTKKEEQNKSHPISAKLDVLESLI 2474                                                         
						EEVKALIAEHQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPA 	                  .         .         .         .         .  
						SSLYPSGSQTQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDI 	     401 KDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQLQLNTIKTNW 450                                                          
						WRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDNKYR 	    2475 KDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQLQLNTIKTNW 2524                                                         
						FFLGNQFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRAKGRTNMELREKFIL 	                  .         .         .         .         .  
						ADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQVPATTTPKILHPLTRN 	     451 DTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 500                                                          
						YGKPWLTNSKMSTPCKAAECSDFPVPSAEGTPIQGSKLRLPGYLSGKGFHSGEDSGLITT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAARVRTQFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQT 	    2525 DTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 2574                                                         
						HRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR                        	                  .         .         .         .         .  
						first amino acid sequence being at least 90 % homologous to  	     501 PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDEN 550                                                          
						corresponding to amino acids 2075 - 5171 of BPEA_HUMAN_V4,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 1 - 3097 of M85815_P25.	    2575 PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDEN 2624                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2625 KSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLD 2674                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 IHDSLGSQAYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSK 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2675 IHDSLGSQAYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSK 2724                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 GTSDVLLQVETIAQEHSTLSQQVDEKCSFLETKLQGIGHFQNTIREMFSQ 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2725 GTSDVLLQVETIAQEHSTLSQQVDEKCSFLETKLQGIGHFQNTIREMFSQ 2774                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 FAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMASNDNANKTCK 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2775 FAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMASNDNANKTCK 2824                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 MMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2825 MMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 2874                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2875 YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQ 2924                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 GKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQ 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2925 GKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQ 2974                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 LQEALLHCGRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQK 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2975 LQEALLHCGRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQK 3024                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 LLQRLLDDRKSTVEVIKREGEKIATTAEPADKVKILKQLSLLDSRWEALL 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3025 LLQRLLDDRKSTVEVIKREGEKIATTAEPADKVKILKQLSLLDSRWEALL 3074                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 NKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVNCEPIGTQASK 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3075 NKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVNCEPIGTQASK 3124                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEEQIAQHKALEDDIINHNKHLHQAVSIGQSLKVLSSREDKDMVQSKLDF 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3125 LEEQIAQHKALEDDIINHNKHLHQAVSIGQSLKVLSSREDKDMVQSKLDF 3174                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 SQVWYIEIQEKSHSRSELLQQALCNAKIFGEDEVELMNWLNEVHDKLSKL 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3175 SQVWYIEIQEKSHSRSELLQQALCNAKIFGEDEVELMNWLNEVHDKLSKL 3224                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 SVQDYSTEGLWKQQSELRVLQEDILLRKQNVDQALLNGLELLKQTTGDEV 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3225 SVQDYSTEGLWKQQSELRVLQEDILLRKQNVDQALLNGLELLKQTTGDEV 3274                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 LIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLD 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3275 LIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLD 3324                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 KVEVELLSYETQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSAL 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3325 KVEVELLSYETQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSAL 3374                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 LELVPWRAREGLEKMVAEDNERYRLVSDTITQKVEEIDAAILRSQQFDQA 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3375 LELVPWRAREGLEKMVAEDNERYRLVSDTITQKVEEIDAAILRSQQFDQA 3424                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 ADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFTMEILRHKDIID 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3425 ADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFTMEILRHKDIID 3474                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 DLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERAQ 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3475 DLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERAQ 3524                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 SLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLREL 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3525 SLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLREL 3574                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 IAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKR 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3575 IAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKR 3624                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 AVALDEAISQSTQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQIS 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3625 AVALDEAISQSTQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQIS 3674                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 ENKNVSVDMEKLQPLYETLKQRGEEMIARSGGTDKDISAKAVQDKLDQMV 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3675 ENKNVSVDMEKLQPLYETLKQRGEEMIARSGGTDKDISAKAVQDKLDQMV 3724                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 FIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIKDTQDFIRDLED 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3725 FIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIKDTQDFIRDLED 3774                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 PGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKPI 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3775 PGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKPI 3824                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 VKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIA 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3825 VKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIA 3874                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 GGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLK 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3875 GGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLK 3924                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 KVTEESDKHTVQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHAL 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3925 KVTEESDKHTVQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHAL 3974                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 DELLAWLTHTEGLLSEQKPVGGDPKAIEIELAKHHVLQNDVLAHQSTVEA 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    3975 DELLAWLTHTEGLLSEQKPVGGDPKAIEIELAKHHVLQNDVLAHQSTVEA 4024                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1951 VNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTEQRKQQLDGALR 2000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4025 VNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTEQRKQQLDGALR 4074                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2001 QAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAAF 2050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4075 QAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAAF 4124                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2051 EAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNER 2100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4125 EAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNER 4174                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2101 KTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQID 2150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4175 KTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQID 4224                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2151 EHKVFANEVNSHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWE 2200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4225 EHKVFANEVNSHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWE 4274                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2201 KVVQRLVERGRSLDDARKRAKQFHEAWSKLMEWLEESEKSLDSELEIAND 2250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4275 KVVQRLVERGRSLDDARKRAKQFHEAWSKLMEWLEESEKSLDSELEIAND 4324                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2251 PDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKTSLADDNLKLDD 2300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4325 PDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKTSLADDNLKLDD 4374                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2301 MLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEPQ 2350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4375 MLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEPQ 4424                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2351 LAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSR 2400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4425 LAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSR 4474                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2401 DDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLE 2450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4475 DDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLE 4524                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2451 WLAEAEQTLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMG 2500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4525 WLAEAEQTLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMG 4574                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2501 DTVLAICHPDSITTIKHWITIIRARFEEVLAWAKQHQQRLASALAGLIAK 2550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4575 DTVLAICHPDSITTIKHWITIIRARFEEVLAWAKQHQQRLASALAGLIAK 4624                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2551 QELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAEHQTFMEEMTRK 2600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4625 QELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAEHQTFMEEMTRK 4674                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2601 QPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQT 2650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4675 QPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQT 4724                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2651 QIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDI 2700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4725 QIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDI 4774                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2701 WRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRL 2750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4775 WRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRL 4824                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2751 EMSAVADIFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQV 2800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4825 EMSAVADIFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQV 4874                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2801 AKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGG 2850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4875 AKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGG 4924                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2851 WMALDEFLVKNDPCRAKGRTNMELREKFILADGASQGMAAFRPRGRRSRP 2900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4925 WMALDEFLVKNDPCRAKGRTNMELREKFILADGASQGMAAFRPRGRRSRP 4974                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2901 SSRGASPNRSTSVSSQAAQAASPQVPATTTPKILHPLTRNYGKPWLTNSK 2950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    4975 SSRGASPNRSTSVSSQAAQAASPQVPATTTPKILHPLTRNYGKPWLTNSK 5024                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2951 MSTPCKAAECSDFPVPSAEGTPIQGSKLRLPGYLSGKGFHSGEDSGLITT 3000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    5025 MSTPCKAAECSDFPVPSAEGTPIQGSKLRLPGYLSGKGFHSGEDSGLITT 5074                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    3001 AAARVRTQFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSV 3050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    5075 AAARVRTQFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSV 5124                                                         
						                                                            	                  .         .         .         .            
						                                                            	    3051 CSDVETVPQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR    3097                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	    5125 CSDVETVPQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR    5171                                                         

6942	HMR136_M85815_3_tr0_r1_1_gPRT		Comparison report between M85815_P3 and Q9BSP9unique head    	Sequence name: Q9BSP9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85815_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6942 x Q9BSP9   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	Alignment segment 1/1:                                       
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	                     Quality: 2313.00                      Escore:       0                                               
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	             Matching length:     260                Total length:     290                                               
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	    Total Percent Similarity:   89.66      Total Percent Identity:   89.66                                               
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                        Gaps:       2                        
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	                                                            
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	Alignment:                                                   
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	                  .         .         .         .         .  
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	    5126 EVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVM 5175                                                         
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	         ||||||||||||||||||||||||||      ||||||||||||||||||  
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	       2 EVTRQVAKCKCAKRFQVEQIGDNKYR......FGDSQQLRLVRILRSTVM 45                                                           
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	                  .         .         .         .         .  
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	    5176 VRVGGGWMALDEFLVKNDPCRVHHHGSKMLRSESNSSITTTQPTIAKGRT 5225                                                         
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	         |||||||||||||||||||||                        |||||  
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	      46 VRVGGGWMALDEFLVKNDPCR........................AKGRT 71                                                           
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	                  .         .         .         .         .  
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	    5226 NMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQA 5275                                                         
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	      72 NMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQA 121                                                          
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	                  .         .         .         .         .  
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	    5276 ASPQVPATTTPKGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRT 5325                                                         
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	     122 ASPQVPATTTPKGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRT 171                                                          
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	                  .         .         .         .         .  
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	    5326 QFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETV 5375                                                         
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	     172 QFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETV 221                                                          
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	                  .         .         .         .            
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	    5376 PQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR           5415                                                         
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	         ||||||||||||||||||||||||||||||||||||||||            
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	     222 PQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR           261                                                          
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						LMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKT 	                                                            
						SLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEP 	                                                            
						QLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQ 	                                                            
						MQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDE 	                                                            
						DALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEV 	                                                            
						LAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAE 	                                                            
						HQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQ 	                                                            
						TQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWM 	                                                            
						NHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDY 	                                                            
						YEFVAALHPNKDAYKPITDADKIED                                    	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 5125 of M85815_P3, a second amino acid    	                                                            
						sequence being at least 90 % homologous to                   	                                                            
						EVTRQVAKCKCAKRFQVEQIGDNKYR corresponding to amino acids 2 -  	                                                            
						27 of Q9BSP9, which also corresponds to amino acids 5126 -   	                                                            
						5151 of M85815_P3, a third amino acid sequence being at least	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	                                                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence FFLGNQ       	                                                            
						corresponding to amino acids 5152 - 5157 of M85815_P3, a     	                                                            
						fourth amino acid sequence being at least 90 % homologous to 	                                                            
						FGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCR corresponding to     	                                                            
						amino acids 28 - 66 of Q9BSP9, which also corresponds to     	                                                            
						amino acids 5158 - 5196 of M85815_P3, a fifth amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VHHHGSKMLRSESNSSITTTQPTI corresponding to	                                                            
						amino acids 5197 - 5220 of M85815_P3, and a sixth amino acid 	                                                            
						AKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQV 	                                                            
						PATTTPKGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFADSKKTPSRPGSR 	                                                            
						AGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTPRAGSRPSTAKPSKIPTP 	                                                            
						QRKSPASKLDKSSKR                                              	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 67 - 261 of Q9BSP9, which also corresponds to    	                                                            
						amino acids 5221 - 5415 of M85815_P3, wherein said first     	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, fourth amino acid sequence, fifth amino acid  	                                                            
						sequence and sixth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of M85815_P3, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	                                                            
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	                                                            
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	                                                            
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	                                                            
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	                                                            
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                                                            
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	                                                            
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	                                                            
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	                                                            
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	                                                            
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	                                                            
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	                                                            
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	                                                            
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	                                                            
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	                                                            
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	                                                            
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	                                                            
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	                                                            
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	                                                            
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	                                                            
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	                                                            
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	                                                            
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	                                                            
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	                                                            
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	                                                            
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	                                                            
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	                                                            
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	                                                            
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	                                                            
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	                                                            
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	                                                            
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	                                                            
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						LMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKT 	                                                            
						SLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEP 	                                                            
						QLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQ 	                                                            
						MQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDE 	                                                            
						DALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEV 	                                                            
						LAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAE 	                                                            
						HQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQ 	                                                            
						TQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWM 	                                                            
						NHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDY 	                                                            
						YEFVAALHPNKDAYKPITDADKIED                                    	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85815_P3.3.An isolated polypeptide encoding for an edge     	                                                            
						portion of M85815_P3, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for FFLGNQ, corresponding to M85815_P3.4.An isolated	                                                            
						polypeptide encoding for an edge portion of M85815_P3,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						VHHHGSKMLRSESNSSITTTQPTI, corresponding to M85815_P3.        	                                                            

						Comparison report between M85815_P3 and Q9UN10unique head    	Sequence name: Q9UN10                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85815_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6942 x Q9UN10   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	Alignment segment 1/1:                                       
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQ   	                     Quality:  501.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      51                Total length:      51                                               
						to amino acids 1 - 178 of M85815_P3, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.04                                               
						sequence being at least 90 % homologous to                   	    Total Percent Similarity:  100.00      Total Percent Identity:   98.04                                               
						ISDIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNA           	                        Gaps:       0                        
						corresponding to amino acids 32 - 81 of Q9UN10, which also   	                                                            
						corresponds to amino acids 179 - 228 of M85815_P3, and a     	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     178 QISDIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFN 227                                                          
						90% and most preferably at least 95% homologous to a         	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						IIHKYRPDLIDMNTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVS 	      31 EISDIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFN 80                                                           
						SLYDAFPKVPEGGEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKA 	                                                             
						LYNQYLQFKETEIPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIA 	     228 A                                                  228                                                          
						MLEREKALRPEVERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEA 	         |                                                   
						EIAGYILECENLLRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGR 	      81 A                                                  81                                                           
						ILTTEQTKLMISGITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLT 	                                                            
						PSVTPAYTPGFPSGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFV 	                                                            
						QDLLNWVDEMQVQLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAP 	                                                            
						LKLTYAEKLHRLESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWS 	                                                            
						ERNTNIARKKDYHAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWS 	                                                            
						WILQLCQCVEQHIKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQ 	                                                            
						ESMEEKEELLQYKSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKD 	                                                            
						DECVLANNSHRAKWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHE 	                                                            
						SHINMKSVVSWHYLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQV 	                                                            
						FSGSDITQLEKEVNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIR 	                                                            
						QIRTPLERDDLHESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRS 	                                                            
						ELNVVLQNMNQVYSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNI 	                                                            
						ENLISTLKQWRSEVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLV 	                                                            
						ERWQNVHVQIDNRLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLA 	                                                            
						TQLNQQKMLVSEIEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRR 	                                                            
						MQSSADLIIQEFMDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKE 	                                                            
						LQKWVSNISKTLKDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTD 	                                                            
						EERNELEKQVKTLQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICD 	                                                            
						LLTQTENRLIGHQEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKEN 	                                                            
						GEKLSQEDKALIEQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEE 	                                                            
						SKTKIENLLDWLSNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETD 	                                                            
						VDGQVGTTQENLNQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQ 	                                                            
						KNMKELKVHYETALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGAD 	                                                            
						DINGLMTKLKRQKSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREV 	                                                            
						QRKLDHATDRFRSLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEP 	                                                            
						IAVDPKNLQRQLEETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDI 	                                                            
						VGRYEDLSKSVNERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQ 	                                                            
						DIISKNIMLEQDIAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKH 	                                                            
						KETLAKMEELKTKVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFL 	                                                            
						EHKKHLEVLHSLLKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQL 	                                                            
						DAFQVLVKSLKSWIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNS 	                                                            
						GISLCNLISAVTTPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGY 	                                                            
						EDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQ 	                                                            
						VEQNKSFEAELKQNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTI 	                                                            
						DRQQKLEESSNNLTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQE 	                                                            
						FATRKPQYEQLTAAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQA 	                                                            
						IVKSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIK 	                                                            
						VAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQM 	                                                            
						SRDFQAWLDTKKEEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLL 	                                                            
						LKTQGSEKAALQLQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKC 	                                                            
						QNNLEEIKFCLDPAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTD 	                                                            
						ENKSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQ 	                                                            
						AYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHST 	                                                            
						LSQQVDEKCSFLETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETI 	                                                            
						KAFLKKLEALMASNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREE 	                                                            
						QVEGTIKRLEEFYSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEP 	                                                            
						LQGKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHC 	                                                            
						GRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKR 	                                                            
						EGEKIATTAEPADKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLN 	                                                            
						EWLTTIEKRLVNCEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTG 	                                                            
						DEVLIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELL 	                                                            
						SYETQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVA 	                                                            
						EDNERYRLVSDTITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQ 	                                                            
						TSAQLQVQKTFTMEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQ 	                                                            
						INSERYLQLERAQSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQL 	                                                            
						RELIAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEA 	                                                            
						ISQSTQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYE 	                                                            
						TLKQRGEEMIARSGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKF 	                                                            
						WCDHMSLIVTIKDTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGS 	                                                            
						ELIAACGEPDKPIVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWV 	                                                            
						DIAGGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESD 	                                                            
						KHTVQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQ 	                                                            
						KPVGGDPKAIEIELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVL 	                                                            
						NQRWQNVLEKTEQRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAK 	                                                            
						EQLNVHMEVCAAFEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKL 	                                                            
						NERKTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFAN 	                                                            
						EVNSHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDAR 	                                                            
						KRAKQFHEAWSKLMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDT 	                                                            
						TNRTGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDAL 	                                                            
						QALIDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIE 	                                                            
						GSRDDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQ 	                                                            
						TLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKH 	                                                            
						WITIIRARFEEVLAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIP 	                                                            
						QEIEEVKALIAEHQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKR 	                                                            
						FPASSLYPSGSQTQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFD 	                                                            
						FDIWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVAD 	                                                            
						IFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDN 	                                                            
						KYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRVHHHGSKMLRSE 	                                                            
						SNSSITTTQPTIAKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSV 	                                                            
						SSQAAQAASPQVPATTTPKGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFA 	                                                            
						DSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTPRAGSR 	                                                            
						PSTAKPSKIPTPQRKSPASKLDKSSKR                                  	                                                            
						polypeptide having the sequence corresponding to amino acids 	                                                            
						229 - 5415 of M85815_P3, wherein said first amino acid       	                                                            
						sequence, second amino acid sequence and third amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of M85815_P3,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	                                                            
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQ   	                                                            
						about 95% homologous to the sequence of M85815_P3.3.An       	                                                            
						isolated polypeptide encoding for a tail of M85815_P3,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IIHKYRPDLIDMNTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVS 	                                                            
						SLYDAFPKVPEGGEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKA 	                                                            
						LYNQYLQFKETEIPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIA 	                                                            
						MLEREKALRPEVERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEA 	                                                            
						EIAGYILECENLLRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGR 	                                                            
						ILTTEQTKLMISGITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLT 	                                                            
						PSVTPAYTPGFPSGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFV 	                                                            
						QDLLNWVDEMQVQLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAP 	                                                            
						LKLTYAEKLHRLESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWS 	                                                            
						ERNTNIARKKDYHAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWS 	                                                            
						WILQLCQCVEQHIKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQ 	                                                            
						ESMEEKEELLQYKSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKD 	                                                            
						DECVLANNSHRAKWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHE 	                                                            
						SHINMKSVVSWHYLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQV 	                                                            
						FSGSDITQLEKEVNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIR 	                                                            
						QIRTPLERDDLHESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRS 	                                                            
						ELNVVLQNMNQVYSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNI 	                                                            
						ENLISTLKQWRSEVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLV 	                                                            
						ERWQNVHVQIDNRLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLA 	                                                            
						TQLNQQKMLVSEIEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRR 	                                                            
						MQSSADLIIQEFMDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKE 	                                                            
						LQKWVSNISKTLKDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTD 	                                                            
						EERNELEKQVKTLQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICD 	                                                            
						LLTQTENRLIGHQEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKEN 	                                                            
						GEKLSQEDKALIEQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEE 	                                                            
						SKTKIENLLDWLSNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETD 	                                                            
						VDGQVGTTQENLNQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQ 	                                                            
						KNMKELKVHYETALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGAD 	                                                            
						DINGLMTKLKRQKSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREV 	                                                            
						QRKLDHATDRFRSLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEP 	                                                            
						IAVDPKNLQRQLEETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDI 	                                                            
						VGRYEDLSKSVNERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQ 	                                                            
						DIISKNIMLEQDIAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKH 	                                                            
						KETLAKMEELKTKVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFL 	                                                            
						EHKKHLEVLHSLLKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQL 	                                                            
						DAFQVLVKSLKSWIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNS 	                                                            
						GISLCNLISAVTTPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGY 	                                                            
						EDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQ 	                                                            
						VEQNKSFEAELKQNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTI 	                                                            
						DRQQKLEESSNNLTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQE 	                                                            
						FATRKPQYEQLTAAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQA 	                                                            
						IVKSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIK 	                                                            
						VAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQM 	                                                            
						SRDFQAWLDTKKEEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLL 	                                                            
						LKTQGSEKAALQLQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKC 	                                                            
						QNNLEEIKFCLDPAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTD 	                                                            
						ENKSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQ 	                                                            
						AYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHST 	                                                            
						LSQQVDEKCSFLETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETI 	                                                            
						KAFLKKLEALMASNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREE 	                                                            
						QVEGTIKRLEEFYSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEP 	                                                            
						LQGKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHC 	                                                            
						GRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKR 	                                                            
						EGEKIATTAEPADKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLN 	                                                            
						EWLTTIEKRLVNCEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTG 	                                                            
						DEVLIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELL 	                                                            
						SYETQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVA 	                                                            
						EDNERYRLVSDTITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQ 	                                                            
						TSAQLQVQKTFTMEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQ 	                                                            
						INSERYLQLERAQSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQL 	                                                            
						RELIAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEA 	                                                            
						ISQSTQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYE 	                                                            
						TLKQRGEEMIARSGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKF 	                                                            
						WCDHMSLIVTIKDTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGS 	                                                            
						ELIAACGEPDKPIVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWV 	                                                            
						DIAGGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESD 	                                                            
						KHTVQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQ 	                                                            
						KPVGGDPKAIEIELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVL 	                                                            
						NQRWQNVLEKTEQRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAK 	                                                            
						EQLNVHMEVCAAFEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKL 	                                                            
						NERKTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFAN 	                                                            
						EVNSHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDAR 	                                                            
						KRAKQFHEAWSKLMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDT 	                                                            
						TNRTGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDAL 	                                                            
						QALIDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIE 	                                                            
						GSRDDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQ 	                                                            
						TLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKH 	                                                            
						WITIIRARFEEVLAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIP 	                                                            
						QEIEEVKALIAEHQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKR 	                                                            
						FPASSLYPSGSQTQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFD 	                                                            
						FDIWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVAD 	                                                            
						IFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDN 	                                                            
						KYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRVHHHGSKMLRSE 	                                                            
						SNSSITTTQPTIAKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSV 	                                                            
						SSQAAQAASPQVPATTTPKGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFA 	                                                            
						DSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTPRAGSR 	                                                            
						PSTAKPSKIPTPQRKSPASKLDKSSKR                                  	                                                            
						about 95% homologous to the sequence in M85815_P3.           	                                                            

						Comparison report between M85815_P3 and AAH51772unique head  	Sequence name: AAH51772                                      
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a featuring a skipped exon.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M85815_P3, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6942 x AAH51772   ..                           
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	                                                            
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                     Quality: 1931.00                      Escore:       0                                               
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	             Matching length:     221                Total length:     282                                               
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	    Total Percent Similarity:   78.37      Total Percent Identity:   78.37                                               
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	                        Gaps:       2                        
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                                                            
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	Alignment:                                                   
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	                  .         .         .         .         .  
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	    5171 RSTVMVRVGGGWMALDEFLVKNDPCRVHHHGSKMLRSESNSSITTTQPTI 5220                                                         
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	         ||||||||||||||||||||||||||                          
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	       1 RSTVMVRVGGGWMALDEFLVKNDPCR........................ 26                                                           
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	                  .         .         .         .         .  
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	    5221 AKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSS 5270                                                         
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	      27 AKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSS 76                                                           
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	                  .         .         .         .         .  
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	    5271 QAAQAASPQVPATTTPK................................. 5287                                                         
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	         |||||||||||||||||                                   
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	      77 QAAQAASPQVPATTTPKILHPLTRNYGKPWLTNSKMSTPCKAAECSDFPV 126                                                          
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	                  .         .         .         .         .  
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	    5288 ....GTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFADSKKT 5333                                                         
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	             ||||||||||||||||||||||||||||||||||||||||||||||  
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	     127 PSAEGTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFADSKKT 176                                                          
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	                  .         .         .         .         .  
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	    5334 PSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTP 5383                                                         
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	     177 PSRPGSRAGSKAGSRASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTP 226                                                          
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	                  .         .         .                      
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	    5384 RAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR                   5415                                                         
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	         ||||||||||||||||||||||||||||||||                    
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	     227 RAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR                   258                                                          
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	                                                            
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						LMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKT 	                                                            
						SLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEP 	                                                            
						QLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQ 	                                                            
						MQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDE 	                                                            
						DALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEV 	                                                            
						LAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAE 	                                                            
						HQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQ 	                                                            
						TQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWM 	                                                            
						NHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDY 	                                                            
						YEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGD 	                                                            
						SQQLRLVRIL                                                   	                                                            
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 5170 of M85815_P3, a second amino acid sequence being at 	                                                            
						least 90 % homologous to RSTVMVRVGGGWMALDEFLVKNDPCR          	                                                            
						corresponding to amino acids 1 - 26 of AAH51772, which also  	                                                            
						corresponds to amino acids 5171 - 5196 of M85815_P3, a third 	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence VHHHGSKMLRSESNSSITTTQPTI corresponding to	                                                            
						amino acids 5197 - 5220 of M85815_P3, a fourth amino acid    	                                                            
						AKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQV 	                                                            
						PATTTPK                                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 27 - 93 of AAH51772, which also corresponds to   	                                                            
						amino acids 5221 - 5287 of M85815_P3, and a fifth amino acid 	                                                            
						GTPIQGSKLRLPGYLSGKGFHSGEDSGLITTAAARVRTQFADSKKTPSRPGSRAGSKAGS 	                                                            
						RASSRRGSDASDFDISEIQSVCSDVETVPQTHRPTPRAGSRPSTAKPSKIPTPQRKSPAS 	                                                            
						KLDKSSKR                                                     	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 131 - 258 of AAH51772, which also corresponds to 	                                                            
						amino acids 5288 - 5415 of M85815_P3, wherein said first     	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, fourth amino acid sequence and fifth amino    	                                                            
						acid sequence are contiguous and in a sequential order.2.An  	                                                            
						isolated polypeptide encoding for a head of M85815_P3,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	                                                            
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	                                                            
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	                                                            
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	                                                            
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	                                                            
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                                                            
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	                                                            
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	                                                            
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	                                                            
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	                                                            
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	                                                            
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	                                                            
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	                                                            
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	                                                            
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	                                                            
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	                                                            
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	                                                            
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	                                                            
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	                                                            
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	                                                            
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	                                                            
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	                                                            
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	                                                            
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	                                                            
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	                                                            
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	                                                            
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	                                                            
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	                                                            
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	                                                            
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	                                                            
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	                                                            
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	                                                            
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						LMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKT 	                                                            
						SLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEP 	                                                            
						QLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQ 	                                                            
						MQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDE 	                                                            
						DALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEV 	                                                            
						LAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAE 	                                                            
						HQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQ 	                                                            
						TQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWM 	                                                            
						NHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDY 	                                                            
						YEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGD 	                                                            
						SQQLRLVRIL                                                   	                                                            
						about 95% homologous to the sequence of M85815_P3.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						M85815_P3, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VHHHGSKMLRSESNSSITTTQPTI, corresponding to M85815_P3.4.An    	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						M85815_P3, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KG, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						5287-x to 5288; and ending at any of amino acid numbers 5288+	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between M85815_P3 and Q9H722unique head    	Sequence name: Q9H722                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85815_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6942 x Q9H722   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	Alignment segment 1/1:                                       
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	                     Quality: 1390.00                      Escore:       0                                               
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	             Matching length:     142                Total length:     142                                               
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                        Gaps:       0                        
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	                                                            
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	Alignment:                                                   
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	                  .         .         .         .         .  
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	    4562 MEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNR 4611                                                         
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	       1 MEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNR 50                                                           
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	                  .         .         .         .         .  
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	    4612 TGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFS 4661                                                         
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	      51 TGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFS 100                                                          
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	                  .         .         .         .            
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	    4662 GQFTDALQALIDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHK         4703                                                         
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	         ||||||||||||||||||||||||||||||||||||||||||          
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	     101 GQFTDALQALIDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHK         142                                                          
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	                                                            
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	                                                            
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	                                                            
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	                                                            
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	                                                            
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	                                                            
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	                                                            
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	                                                            
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	                                                            
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	                                                            
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	                                                            
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	                                                            
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						L                                                            	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 4561 of M85815_P3, a second amino acid    	                                                            
						MEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKTS 	                                                            
						LADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEPQ 	                                                            
						LAEDQPVHGDIDLVMNLIDNHK                                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 142 of Q9H722, which also corresponds to     	                                                            
						amino acids 4562 - 4703 of M85815_P3, and a third amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						AFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQMQELSTRWETVCALSISKQTRLE 	                                                            
						AALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAE 	                                                            
						LNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEVLAWAKQHQQRLASALAGLIAKQE 	                                                            
						LLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAEHQTFMEEMTRKQPDVDKVTKTYK 	                                                            
						RRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQTQIETKNPRVNLLVSKWQQVWLL 	                                                            
						ALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKIT 	                                                            
						RQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKI 	                                                            
						EDEVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGGWM 	                                                            
						ALDEFLVKNDPCRVHHHGSKMLRSESNSSITTTQPTIAKGRTNMELREKFILADGASQGM 	                                                            
						AAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQVPATTTPKGTPIQGSKLRLPGYLS 	                                                            
						GKGFHSGEDSGLITTAAARVRTQFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDIS 	                                                            
						EIQSVCSDVETVPQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR         	                                                            
						having the sequence corresponding to amino acids 4704 - 5415 	                                                            
						of M85815_P3, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M85815_P3, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MSSGNASYRCSMSSSADFSDEDDFSQKSGSASPAPGDTLPWNLPKHERSKRKIQGGSVLD 	                                                            
						PAERAVLRIADERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDT 	                                                            
						LPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQIS 	                                                            
						DIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDM 	                                                            
						NTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEG 	                                                            
						GEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETE 	                                                            
						IPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEV 	                                                            
						ERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENL 	                                                            
						LRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMIS 	                                                            
						GITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFP 	                                                            
						SGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQV 	                                                            
						QLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRL 	                                                            
						ESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDY 	                                                            
						HAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQH 	                                                            
						IKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQY 	                                                            
						KSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRA 	                                                            
						KWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWH 	                                                            
						YLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKE 	                                                            
						VNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLH 	                                                            
						ESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQV 	                                                            
						YSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRS 	                                                            
						EVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDN 	                                                            
						RLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSE 	                                                            
						IEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEF 	                                                            
						MDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTL 	                                                            
						KDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKT 	                                                            
						LQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGH 	                                                            
						QEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALI 	                                                            
						EQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWL 	                                                            
						SNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENL 	                                                            
						NQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYET 	                                                            
						ALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQ 	                                                            
						KSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFR 	                                                            
						SLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQL 	                                                            
						EETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVN 	                                                            
						ERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQD 	                                                            
						IAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKT 	                                                            
						KVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSL 	                                                            
						LKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKS 	                                                            
						WIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVT 	                                                            
						TPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIA 	                                                            
						ELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELK 	                                                            
						QNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNN 	                                                            
						LTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLT 	                                                            
						AAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLR 	                                                            
						SLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSAL 	                                                            
						VKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKK 	                                                            
						EEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQ 	                                                            
						LQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLD 	                                                            
						PAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMV 	                                                            
						TEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQT 	                                                            
						QQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFL 	                                                            
						ETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMA 	                                                            
						SNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEF 	                                                            
						YSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLG 	                                                            
						QGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLS 	                                                            
						WMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPA 	                                                            
						DKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVN 	                                                            
						CEPIGTQASKLEEQIAQHKVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEA 	                                                            
						IKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEA 	                                                            
						SQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDT 	                                                            
						ITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFT 	                                                            
						MEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERA 	                                                            
						QSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHID 	                                                            
						KMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKID 	                                                            
						QILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIAR 	                                                            
						SGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIK 	                                                            
						DTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKP 	                                                            
						IVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSP 	                                                            
						IGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELK 	                                                            
						LIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEI 	                                                            
						ELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTE 	                                                            
						QRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAA 	                                                            
						FEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALN 	                                                            
						LAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIEL 	                                                            
						DKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSK 	                                                            
						L                                                            	                                                            
						to the sequence of M85815_P3.3.An isolated polypeptide       	                                                            
						encoding for a tail of M85815_P3, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						AFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQMQELSTRWETVCALSISKQTRLE 	                                                            
						AALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAE 	                                                            
						LNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEVLAWAKQHQQRLASALAGLIAKQE 	                                                            
						LLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAEHQTFMEEMTRKQPDVDKVTKTYK 	                                                            
						RRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQTQIETKNPRVNLLVSKWQQVWLL 	                                                            
						ALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKIT 	                                                            
						RQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKI 	                                                            
						EDEVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGGWM 	                                                            
						ALDEFLVKNDPCRVHHHGSKMLRSESNSSITTTQPTIAKGRTNMELREKFILADGASQGM 	                                                            
						AAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQVPATTTPKGTPIQGSKLRLPGYLS 	                                                            
						GKGFHSGEDSGLITTAAARVRTQFADSKKTPSRPGSRAGSKAGSRASSRRGSDASDFDIS 	                                                            
						EIQSVCSDVETVPQTHRPTPRAGSRPSTAKPSKIPTPQRKSPASKLDKSSKR         	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M85815_P3.                                                	                                                            

15088	HMR136_M85830_1_tr0_r1_1_gPRT		Comparison report between M85830_P1 and Q9BWS3unique head    	Sequence name: Q9BWS3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85830_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15088 x Q9BWS3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MARAAPLLAALTALLAAAAAGGDAPPGKI corresponding to amino acids 1 	                                                            
						- 29 of M85830_P1, a second amino acid sequence being at     	                     Quality:  667.00                      Escore:       0                                               
						AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYESGAASFHSLSL 	             Matching length:      70                Total length:      70                                               
						HMQDFVKLLG                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 13 - 82	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of Q9BWS3, which also corresponds to amino acids 30 - 99 of  	                        Gaps:       0                        
						M85830_P1, and a third amino acid sequence being at least    	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      30 AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYES 79                                                           
						EWSVLGLQCPAPWGW corresponding to amino acids 100 - 114 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85830_P1, wherein said first amino acid sequence, second    	      13 AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYES 62                                                           
						amino acid sequence and third amino acid sequence are        	                  .         .                                
						contiguous and in a sequential order.2.An isolated           	      80 GAASFHSLSLHMQDFVKLLG                               99                                                           
						polypeptide encoding for a head of M85830_P1, comprising a   	         ||||||||||||||||||||                                
						polypeptide being at least 70%, optionally at least about    	      63 GAASFHSLSLHMQDFVKLLG                               82                                                           
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MARAAPLLAALTALLAAAAAGGDAPPGKI of             	                                                            
						M85830_P1.3.An isolated polypeptide encoding for a tail of   	                                                            
						M85830_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence EWSVLGLQCPAPWGW in	                                                            
						M85830_P1.                                                   	                                                            

						Comparison report between M85830_P1 and Q8NBM8partial WT     	Sequence name: Q8NBM8                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85830_P1, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MARA corresponding to amino acids 1 	Alignment of: 15088 x Q8NBM8   ..                            
						- 4 of Q8NBM8, which also corresponds to amino acids 1 - 4 of	                                                            
						M85830_P1, a bridging amino acid A corresponding to amino    	Alignment segment 1/1:                                       
						acid 5 of M85830_P1, a second amino acid sequence being at   	                                                            
						PLLAALTALLAAAAAGGDAPPGKIAVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGG 	                     Quality:  915.00                      Escore:       0                                               
						RLATISVNKQHYESGAASFHSLSLHMQDFVKLLG                           	             Matching length:      99                Total length:      99                                               
						least 90 % homologous to corresponding to amino acids 6 - 99 	 Matching Percent Similarity:   98.99   Matching Percent Identity:   98.99                                               
						of Q8NBM8, which also corresponds to amino acids 6 - 99 of   	    Total Percent Similarity:   98.99      Total Percent Identity:   98.99                                               
						M85830_P1, and a third amino acid sequence being at least    	                        Gaps:       0                        
						70%, optionally at least 80%, preferably at least 85%, more  	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment:                                                   
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						EWSVLGLQCPAPWGW corresponding to amino acids 100 - 114 of    	       1 MARAAPLLAALTALLAAAAAGGDAPPGKIAVVGAGIGGSAVAHFLQQHFG 50                                                           
						M85830_P1, wherein said first amino acid sequence, bridging  	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						amino acid, second amino acid sequence and third amino acid  	       1 MARAPPLLAALTALLAAAAAGGDAPPGKIAVVGAGIGGSAVAHFLQQHFG 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .            
						isolated polypeptide encoding for a tail of M85830_P1,       	      51 PRVQIDVYEKGTVGGRLATISVNKQHYESGAASFHSLSLHMQDFVKLLG  99                                                           
						comprising a polypeptide being at least 70%, optionally at   	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						least about 80%, preferably at least about 85%, more         	      51 PRVQIDVYEKGTVGGRLATISVNKQHYESGAASFHSLSLHMQDFVKLLG  99                                                           
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence EWSVLGLQCPAPWGW in      	                                                            
						M85830_P1.                                                   	                                                            

						Comparison report between M85830_P1 and Q8NCY5unique head    	Sequence name: Q8NCY5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85830_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15088 x Q8NCY5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MARAAPLLAALTALLAAAAAGGDAPPGKI corresponding to amino acids 1 	                                                            
						- 29 of M85830_P1, a second amino acid sequence being at     	                     Quality:  667.00                      Escore:       0                                               
						AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYESGAASFHSLSL 	             Matching length:      70                Total length:      70                                               
						HMQDFVKLLG                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 1 - 70 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						of Q8NCY5, which also corresponds to amino acids 30 - 99 of  	                        Gaps:       0                        
						M85830_P1, and a third amino acid sequence being at least    	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      30 AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYES 79                                                           
						EWSVLGLQCPAPWGW corresponding to amino acids 100 - 114 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85830_P1, wherein said first amino acid sequence, second    	       1 AVVGAGIGGSAVAHFLQQHFGPRVQIDVYEKGTVGGRLATISVNKQHYES 50                                                           
						amino acid sequence and third amino acid sequence are        	                  .         .                                
						contiguous and in a sequential order.2.An isolated           	      80 GAASFHSLSLHMQDFVKLLG                               99                                                           
						polypeptide encoding for a head of M85830_P1, comprising a   	         ||||||||||||||||||||                                
						polypeptide being at least 70%, optionally at least about    	      51 GAASFHSLSLHMQDFVKLLG                               70                                                           
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MARAAPLLAALTALLAAAAAGGDAPPGKI of             	                                                            
						M85830_P1.3.An isolated polypeptide encoding for a tail of   	                                                            
						M85830_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence EWSVLGLQCPAPWGW in	                                                            
						M85830_P1.                                                   	                                                            

15085	HMR136_M85830_4_tr0_r1_1_gPRT		Comparison report between M85830_P4 and Q9BWS3partial WT     	Sequence name: Q9BWS3                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85830_P4, comprising a first amino 	Sequence documentation:                                      
						MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGISFLRLQMWVEE 	                                                            
						VMEKFM                                                       	Alignment of: 15085 x Q9BWS3   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 74 - 139 of Q9BWS3, which also corresponds to 	Alignment segment 1/1:                                       
						amino acids 1 - 66 of M85830_P4, a second amino acid sequence	                                                            
						being at least 70%, optionally at least 80%, preferably at   	                     Quality: 3313.00                      Escore:       0                                               
						least 85%, more preferably at least 90% and most preferably  	             Matching length:     345                Total length:     404                                               
						at least 95% homologous to a polypeptide having the sequence 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVSAVLRA  	    Total Percent Similarity:   85.40      Total Percent Identity:   85.40                                               
						corresponding to amino acids 67 - 125 of M85830_P4, and a    	                        Gaps:       1                        
						SYGQSAAMPAFAGAMSLAGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTE 	                                                            
						GKALYQVAYENEVGNSSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVS 	Alignment:                                                   
						LVHGYLNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQEAAVWR 	                  .         .         .         .         .  
						VQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALHDQLFYLNALEWAASS 	       1 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 50                                                           
						VEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKVKTEL                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	      74 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 123                                                          
						corresponding to amino acids 140 - 418 of Q9BWS3, which also 	                  .         .         .         .         .  
						corresponds to amino acids 126 - 404 of M85830_P4, wherein   	      51 FLRLQMWVEEVMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHS 100                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||                                    
						and third amino acid sequence are contiguous and in a        	     124 FLRLQMWVEEVMEKFM.................................. 139                                                          
						sequential order.2.An isolated polypeptide encoding for an   	                  .         .         .         .         .  
						edge portion of M85830_P4, comprising an amino acid sequence 	     101 VAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSLAGAQGSLW 150                                                          
						being at least 70%, optionally at least about 80%, preferably	                                  |||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     140 .........................SYGQSAAMPAFAGAMSLAGAQGSLW 164                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						encoding for RIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVSAVLRA,                                                	     151 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 200                                                          
						corresponding to M85830_P4.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     165 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 214                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     215 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 264                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     265 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 314                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     315 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 364                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     365 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 414                                                          
						                                                            	                                                             
						                                                            	     401 KTEL                                               404                                                          
						                                                            	         ||||                                                
						                                                            	     415 KTEL                                               418                                                          

						Comparison report between M85830_P4 and Q8NBM8partial WT     	Sequence name: Q8NBM8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85830_P4, comprising a first amino acid        	                                                            
						MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGISFLRLQMWVEE 	Alignment of: 15085 x Q8NBM8   ..                            
						VMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVS 	                                                            
						AVLRASYGQSAAMPAFAGAMSLAGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSVT 	Alignment segment 1/1:                                       
						LHSTEGKALYQVAYENEVGNSSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQ 	                                                            
						PTVVSLVHGYLNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 	                     Quality: 3972.00                      Escore:       0                                               
						AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALHDQLFYLNALE 	             Matching length:     404                Total length:     404                                               
						WAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKVKTEL                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 91 - 494 of Q8NBM8, which also corresponds to    	                        Gaps:       0                        
						amino acids 1 - 404 of M85830_P4.                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      91 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 140                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FLRLQMWVEEVMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     141 FLRLQMWVEEVMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHS 190                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSLAGAQGSLW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     191 VAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSLAGAQGSLW 240                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     241 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 290                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     291 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 340                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     341 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 390                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     391 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 440                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     441 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 490                                                          
						                                                            	                                                             
						                                                            	     401 KTEL                                               404                                                          
						                                                            	         ||||                                                
						                                                            	     491 KTEL                                               494                                                          

						Comparison report between M85830_P4 and Q9BTE8unique head    	Sequence name: Q9BTE8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M85830_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15085 x Q9BTE8   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGISFLRLQMWVEE 	Alignment segment 1/1:                                       
						VMEKFMRIYKYQAHGYAFSGVE                                       	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 3134.00                      Escore:       0                                               
						1 - 82 of M85830_P4, a second amino acid sequence being at   	             Matching length:     325                Total length:     325                                               
						ELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSL 	 Matching Percent Similarity:   99.38   Matching Percent Identity:   99.08                                               
						AGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGNSS 	    Total Percent Similarity:   99.38      Total Percent Identity:   99.08                                               
						DFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGYLNSSYFGFPDPK 	                        Gaps:       0                        
						LFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQ                        	                                                            
						least 90 % homologous to corresponding to amino acids 4 - 220	Alignment:                                                   
						of Q9BTE8, which also corresponds to amino acids 83 - 299 of 	                  .         .         .         .         .  
						M85830_P4, a bridging amino acid E corresponding to amino    	      80 GVEELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVSAVLRASYGQ 129                                                          
						acid 300 of M85830_P4, and a third amino acid sequence being 	         |  |||||||||||||||||||||||||||||||||||||||||||||||  
						AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALHDQLFYLNALE 	       1 GTRELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVSAVLRASYGQ 50                                                           
						WAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKVKTEL                 	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 222 	     130 SAAMPAFAGAMSLAGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSV 179                                                          
						- 325 of Q9BTE8, which also corresponds to amino acids 301 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						404 of M85830_P4, wherein said first amino acid sequence,    	      51 SAAMPAFAGAMSLAGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSV 100                                                          
						second amino acid sequence, bridging amino acid and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     180 TLHSTEGKALYQVAYENEVGNSSDFYDIVVIATPLHLDNSSSNLTFAGFH 229                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85830_P4, comprising a polypeptide being at least 70%,      	     101 TLHSTEGKALYQVAYENEVGNSSDFYDIVVIATPLHLDNSSSNLTFAGFH 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     230 PPIDDVQGSFQPTVVSLVHGYLNSSYFGFPDPKLFPFANILTTDFPSFFC 279                                                          
						MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGISFLRLQMWVEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VMEKFMRIYKYQAHGYAFSGVE                                       	     151 PPIDDVQGSFQPTVVSLVHGYLNSSYFGFPDPKLFPFANILTTDFPSFFC 200                                                          
						least about 95% homologous to the sequence of M85830_P4.     	                  .         .         .         .         .  
						                                                            	     280 TLDNICPVNISASFRRKQPQEAAVWRVQSPKPLFRTQLKTLFRSYYSVQT 329                                                          
						                                                            	         ||||||||||||||||||||:|||||||||||||||||||||||||||||  
						                                                            	     201 TLDNICPVNISASFRRKQPQDAAVWRVQSPKPLFRTQLKTLFRSYYSVQT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     330 AEWQAHPLYGSRPTLPRFALHDQLFYLNALEWAASSVEVMAVAAKNVALL 379                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AEWQAHPLYGSRPTLPRFALHDQLFYLNALEWAASSVEVMAVAAKNVALL 300                                                          
						                                                            	                  .         .                                
						                                                            	     380 AYNRWYQDLDKIDQKDLMHKVKTEL                          404                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     301 AYNRWYQDLDKIDQKDLMHKVKTEL                          325                                                          

						Comparison report between M85830_P4 and Q8NCY5partial WT     	Sequence name: Q8NCY5                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for M85830_P4, comprising a first amino 	Sequence documentation:                                      
						MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGISFLRLQMWVEE 	                                                            
						VMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHSVAESLLQVGVTQRFIDDVVS 	Alignment of: 15085 x Q8NCY5   ..                            
						AVLRASYGQSAAMPAFAGAMSLAGAQGSLWSVEGGNKLVCSGLLKLTKANVIHATVTSVT 	                                                            
						LHSTEGKALYQVAYENEVGNSSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQ 	Alignment segment 1/1:                                       
						PTVVSLVHGYLNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQ  	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 3964.00                      Escore:       0                                               
						to amino acids 62 - 360 of Q8NCY5, which also corresponds to 	             Matching length:     404                Total length:     404                                               
						amino acids 1 - 299 of M85830_P4, a bridging amino acid E    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.75                                               
						corresponding to amino acid 300 of M85830_P4, and a second   	    Total Percent Similarity:  100.00      Total Percent Identity:   99.75                                               
						AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALHDQLFYLNALE 	                        Gaps:       0                        
						WAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKVKTEL                 	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 362 - 465 of Q8NCY5, which also 	                  .         .         .         .         .  
						corresponds to amino acids 301 - 404 of M85830_P4, wherein   	       1 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 50                                                           
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      62 MQDFVKLLGLRHRREVVGRSAIFGGEHFMLEETDWYLLNLFRLWWHYGIS 111                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	      51 FLRLQMWVEEVMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     112 FLRLQMWVEEVMEKFMRIYKYQAHGYAFSGVEELLYSLGESTFVNMTQHS 161                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSLAGAQGSLW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     162 VAESLLQVGVTQRFIDDVVSAVLRASYGQSAAMPAFAGAMSLAGAQGSLW 211                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     212 SVEGGNKLVCSGLLKLTKANVIHATVTSVTLHSTEGKALYQVAYENEVGN 261                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     262 SSDFYDIVVIATPLHLDNSSSNLTFAGFHPPIDDVQGSFQPTVVSLVHGY 311                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQE 300                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     312 LNSSYFGFPDPKLFPFANILTTDFPSFFCTLDNICPVNISASFRRKQPQD 361                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     362 AAVWRVQSPKPLFRTQLKTLFRSYYSVQTAEWQAHPLYGSRPTLPRFALH 411                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     412 DQLFYLNALEWAASSVEVMAVAAKNVALLAYNRWYQDLDKIDQKDLMHKV 461                                                          
						                                                            	                                                             
						                                                            	     401 KTEL                                               404                                                          
						                                                            	         ||||                                                
						                                                            	     462 KTEL                                               465                                                          

15556	HMR136_M85837_3_tr0_r1_1_gPRT		Comparison report between M85837_P3 and BIEA_HUMANshort      	Sequence name: BIEA_HUMAN                                    
						unique head followed by partial WT sequence featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						M85837_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15556 x BIEA_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MNT          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of M85837_P3, a second    	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2379.00                      Escore:       0                                               
						EPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVS corresponding to   	             Matching length:     256                Total length:     296                                               
						amino acids 4 - 44 of BIEA_HUMAN, which also corresponds to  	 Matching Percent Similarity:   99.61   Matching Percent Identity:   99.61                                               
						amino acids 4 - 44 of M85837_P3, and a third amino acid      	    Total Percent Similarity:   86.15      Total Percent Identity:   86.15                                               
						RQFLNAGKHVLVEYPMTLSLAAAQELWELAEQKGKVLHEEHVELLMEEFAFLKKEVVGKD 	                        Gaps:       1                        
						LLKGSLLFTAGPLEEERFGFPAFSGISRLTWLVSLFGELSLVSATLEERKEDQYMKMTVC 	                                                            
						LETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLENVPNVGVNKNIFLKDQNIFVQKLLG 	Alignment:                                                   
						QFSEKELAAEKKRILHCLGLAEEIQKYCCSRK                             	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MNTEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVS...... 44                                                           
						amino acids 85 - 296 of BIEA_HUMAN, which also corresponds to	         || |||||||||||||||||||||||||||||||||||||||||        
						amino acids 45 - 256 of M85837_P3, wherein said first amino  	       1 MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGS 50                                                           
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	      45 ..................................RQFLNAGKHVLVEYPM 60                                                           
						isolated chimeric polypeptide encoding for an edge portion of	                                           ||||||||||||||||  
						M85837_P3, comprising a polypeptide having a length "n",     	      51 IDGVQQISLEDALSSQEVEVAYICSESSSHEDYIRQFLNAGKHVLVEYPM 100                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	      61 TLSLAAAQELWELAEQKGKVLHEEHVELLMEEFAFLKKEVVGKDLLKGSL 110                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     101 TLSLAAAQELWELAEQKGKVLHEEHVELLMEEFAFLKKEVVGKDLLKGSL 150                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise SR, having a structure as  	     111 LFTAGPLEEERFGFPAFSGISRLTWLVSLFGELSLVSATLEERKEDQYMK 160                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						44-x to 45; and ending at any of amino acid numbers 45+      	     151 LFTAGPLEEERFGFPAFSGISRLTWLVSLFGELSLVSATLEERKEDQYMK 200                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     161 MTVCLETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLENVPNVGVNKNI 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 MTVCLETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLENVPNVGVNKNI 250                                                          
						                                                            	                  .         .         .         .            
						                                                            	     211 FLKDQNIFVQKLLGQFSEKELAAEKKRILHCLGLAEEIQKYCCSRK     256                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     251 FLKDQNIFVQKLLGQFSEKELAAEKKRILHCLGLAEEIQKYCCSRK     296                                                          

7411	HMR136_M85850_15_tr0_r1_1_gPRT		Comparison report between M85850_P15 and C3G_HUMAN_V1unique  	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85850_P15, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7411 x C3G_HUMAN_V1   ..                       
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P15, a second amino acid sequence being at least 90 % 	                     Quality: 10448.00                      Escore:       0                                              
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:    1074                Total length:    1127                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   95.30      Total Percent Identity:   95.30                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      21 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 70                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 4 - 618 of        	      71 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 120                                                          
						C3G_HUMAN_V1, which also corresponds to amino acids 21 - 635 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85850_P15, a third amino acid sequence being at least    	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     121 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 170                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						corresponding to amino acids 636 - 688 of M85850_P15, and a  	                  .         .         .         .         .  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     171 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 220                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	                  .         .         .         .         .  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     221 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 270                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     271 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 320                                                          
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 689 - 1147 of          	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						M85850_P15, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     321 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 370                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						M85850_P15, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     371 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 420                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						MSGGLGLRRSPEMSGKIEKA of M85850_P15.3.An isolated polypeptide 	                  .         .         .         .         .  
						encoding for an edge portion of M85850_P15, comprising an    	     421 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 470                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 80%, preferably at least about 85%, more preferably at 	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						least about 90% and most preferably at least about 95%       	                  .         .         .         .         .  
						homologous to the sequence encoding for                      	     471 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 520                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to M85850_P15.                                 	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     521 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 570                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     571 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 620                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     621 ELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLS 670                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     604 ELAPPPALPPKQRQL................................... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     671 VSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 720                                                          
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	     619 ..................EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     721 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 770                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     771 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 820                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     821 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 870                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     871 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 920                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     921 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 970                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     971 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 1020                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1021 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1070                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1071 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1120                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1050                                                         
						                                                            	                  .         .                                
						                                                            	    1121 EEALWELSLKIKPRNITRRKTDREEKT                        1147                                                         
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1051 EEALWELSLKIKPRNITRRKTDREEKT                        1077                                                         

						Comparison report between M85850_P15 and Q8IV73unique head   	Sequence name: Q8IV73                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85850_P15, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7411 x Q8IV73   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P15, a second amino acid sequence being at least 90 % 	                     Quality: 10456.00                      Escore:       0                                              
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:    1076                Total length:    1129                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:   99.91   Matching Percent Identity:   99.91                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   95.22      Total Percent Identity:   95.22                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      19 KADSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 68                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	      20 KQDSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 69                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 22 - 636 of       	      69 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 118                                                          
						Q8IV73, which also corresponds to amino acids 21 - 635 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85850_P15, a third amino acid sequence being at least 70%,  	      70 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 119                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     119 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 168                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	     120 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 169                                                          
						corresponding to amino acids 636 - 688 of M85850_P15, and a  	                  .         .         .         .         .  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     169 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 218                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     170 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 219                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	                  .         .         .         .         .  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     219 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 268                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     220 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 269                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     269 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 318                                                          
						corresponding to amino acids 637 - 1095 of Q8IV73, which also	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 689 - 1147 of M85850_P15, wherein 	     270 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 319                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     319 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 368                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M85850_P15, comprising a  	     320 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 369                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     369 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 418                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MSGGLGLRRSPEMSGKIEKA of M85850_P15.3.An      	     370 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 419                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85850_P15, comprising an amino acid sequence being at least 	     419 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 468                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     420 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 469                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	     469 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 518                                                          
						corresponding to M85850_P15.                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 618                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 619                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     619 VQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQG 668                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     620 VQELAPPPALPPKQRQL................................. 636                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     669 LSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSER 718                                                          
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	     637 ....................EPPAGKDGHPRDPSAVSGVPGKDSRDGSER 666                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     719 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 768                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     667 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 716                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     769 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 818                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     717 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 766                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     819 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 868                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     767 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 816                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     869 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 918                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     817 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 866                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     919 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 968                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     867 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 916                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     969 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 1018                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     917 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 966                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1019 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1068                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     967 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1016                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1069 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1118                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1017 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1066                                                         
						                                                            	                  .         .                                
						                                                            	    1119 LAEEALWELSLKIKPRNITRRKTDREEKT                      1147                                                         
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	    1067 LAEEALWELSLKIKPRNITRRKTDREEKT                      1095                                                         

7409	HMR136_M85850_2_tr0_r1_1_gPRT		Comparison report between M85850_P2 and C3G_HUMAN_V1unique   	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85850_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7409 x C3G_HUMAN_V1   ..                       
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P2, a second amino acid sequence being at least 90 %  	                     Quality: 10448.00                      Escore:       0                                              
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:    1074                Total length:    1127                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   95.30      Total Percent Identity:   95.30                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      21 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 70                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 4 - 618 of        	      71 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 120                                                          
						C3G_HUMAN_V1, which also corresponds to amino acids 21 - 635 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85850_P2, a third amino acid sequence being at least 70%,	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     121 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 170                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						corresponding to amino acids 636 - 688 of M85850_P2, and a   	                  .         .         .         .         .  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     171 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 220                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	                  .         .         .         .         .  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     221 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 270                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     271 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 320                                                          
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 689 - 1147 of          	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						M85850_P2, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     321 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 370                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						M85850_P2, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     371 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 420                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						MSGGLGLRRSPEMSGKIEKA of M85850_P2.3.An isolated polypeptide  	                  .         .         .         .         .  
						encoding for an edge portion of M85850_P2, comprising an     	     421 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 470                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 80%, preferably at least about 85%, more preferably at 	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						least about 90% and most preferably at least about 95%       	                  .         .         .         .         .  
						homologous to the sequence encoding for                      	     471 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 520                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to M85850_P2.                                  	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     521 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 570                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     571 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 620                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     621 ELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLS 670                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     604 ELAPPPALPPKQRQL................................... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     671 VSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 720                                                          
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	     619 ..................EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     721 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 770                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     771 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 820                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     821 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 870                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     871 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 920                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     921 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 970                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     971 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 1020                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1021 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1070                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1071 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1120                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1050                                                         
						                                                            	                  .         .                                
						                                                            	    1121 EEALWELSLKIKPRNITRRKTDREEKT                        1147                                                         
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1051 EEALWELSLKIKPRNITRRKTDREEKT                        1077                                                         

						Comparison report between M85850_P2 and Q8IV73unique head    	Sequence name: Q8IV73                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85850_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7409 x Q8IV73   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P2, a second amino acid sequence being at least 90 %  	                     Quality: 10456.00                      Escore:       0                                              
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:    1076                Total length:    1129                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:   99.91   Matching Percent Identity:   99.91                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   95.22      Total Percent Identity:   95.22                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      19 KADSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 68                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	      20 KQDSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 69                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 22 - 636 of       	      69 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 118                                                          
						Q8IV73, which also corresponds to amino acids 21 - 635 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85850_P2, a third amino acid sequence being at least 70%,   	      70 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 119                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     119 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 168                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	     120 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 169                                                          
						corresponding to amino acids 636 - 688 of M85850_P2, and a   	                  .         .         .         .         .  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     169 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 218                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     170 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 219                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	                  .         .         .         .         .  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     219 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 268                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     220 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 269                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	     269 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 318                                                          
						corresponding to amino acids 637 - 1095 of Q8IV73, which also	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 689 - 1147 of M85850_P2, wherein  	     270 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 319                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     319 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 368                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M85850_P2, comprising a   	     320 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 369                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     369 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 418                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MSGGLGLRRSPEMSGKIEKA of M85850_P2.3.An       	     370 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 419                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85850_P2, comprising an amino acid sequence being at least  	     419 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 468                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     420 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 469                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	     469 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 518                                                          
						corresponding to M85850_P2.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 618                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 619                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     619 VQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQG 668                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     620 VQELAPPPALPPKQRQL................................. 636                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     669 LSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSER 718                                                          
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	     637 ....................EPPAGKDGHPRDPSAVSGVPGKDSRDGSER 666                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     719 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 768                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     667 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 716                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     769 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 818                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     717 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 766                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     819 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 868                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     767 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 816                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     869 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 918                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     817 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 866                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     919 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 968                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     867 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 916                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     969 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 1018                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     917 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 966                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1019 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1068                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     967 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1016                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1069 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1118                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1017 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1066                                                         
						                                                            	                  .         .                                
						                                                            	    1119 LAEEALWELSLKIKPRNITRRKTDREEKT                      1147                                                         
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	    1067 LAEEALWELSLKIKPRNITRRKTDREEKT                      1095                                                         

7399	HMR136_M85850_21_tr0_r1_1_gPRT		Comparison report between M85850_P21 and C3G_HUMAN_V1unique  	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85850_P21, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7399 x C3G_HUMAN_V1   ..                       
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P21, a second amino acid sequence being at least 90 % 	                     Quality: 6067.00                      Escore:       0                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:     616                Total length:     616                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       0                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      21 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 70                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 4 - 618 of        	      71 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 120                                                          
						C3G_HUMAN_V1, which also corresponds to amino acids 21 - 635 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M85850_P21, and a third amino acid sequence being at least	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     121 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 170                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSYKSVFRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YSQDFVPHHQASVPPFLPPTSSSSPHFPPAHQSQSSDLAVPTMAGPPPSTVDGPLSASQE 	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						SSFHGNTVCLPSETSFTDS                                          	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     171 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 220                                                          
						to amino acids 636 - 774 of M85850_P21, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     221 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 270                                                          
						M85850_P21, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     271 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 320                                                          
						MSGGLGLRRSPEMSGKIEKA of M85850_P21.3.An isolated polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of M85850_P21, comprising a polypeptide  	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     321 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 370                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSYKSVFRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YSQDFVPHHQASVPPFLPPTSSSSPHFPPAHQSQSSDLAVPTMAGPPPSTVDGPLSASQE 	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						SSFHGNTVCLPSETSFTDS                                          	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     371 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 420                                                          
						in M85850_P21.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     421 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 470                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     471 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 520                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     521 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 570                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     571 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 620                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						                                                            	                  .                                          
						                                                            	     621 ELAPPPALPPKQRQLQ                                   636                                                          
						                                                            	         |||||||||||||||:                                    
						                                                            	     604 ELAPPPALPPKQRQLE                                   619                                                          

						Comparison report between M85850_P21 and Q8IV73unique head   	Sequence name: Q8IV73                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85850_P21, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7399 x Q8IV73   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSGGLGLRRSPEMSGKIEKA corresponding to amino acids 1 - 20 of  	                                                            
						M85850_P21, a second amino acid sequence being at least 90 % 	                     Quality: 6075.00                      Escore:       0                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:     618                Total length:     618                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.68                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.68                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       0                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      19 KADSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 68                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	      20 KQDSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 69                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						homologous to corresponding to amino acids 22 - 636 of       	      69 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 118                                                          
						Q8IV73, which also corresponds to amino acids 21 - 635 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85850_P21, and a third amino acid sequence being at least   	      70 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 119                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     119 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 168                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSYKSVFRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YSQDFVPHHQASVPPFLPPTSSSSPHFPPAHQSQSSDLAVPTMAGPPPSTVDGPLSASQE 	     120 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 169                                                          
						SSFHGNTVCLPSETSFTDS                                          	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     169 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 218                                                          
						to amino acids 636 - 774 of M85850_P21, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     170 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 219                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     219 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 268                                                          
						M85850_P21, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     220 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 269                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     269 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 318                                                          
						MSGGLGLRRSPEMSGKIEKA of M85850_P21.3.An isolated polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of M85850_P21, comprising a polypeptide  	     270 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 319                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     319 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 368                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSYKSVFRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YSQDFVPHHQASVPPFLPPTSSSSPHFPPAHQSQSSDLAVPTMAGPPPSTVDGPLSASQE 	     320 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 369                                                          
						SSFHGNTVCLPSETSFTDS                                          	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     369 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 418                                                          
						in M85850_P21.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     419 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 468                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     469 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 518                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 618                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 619                                                          
						                                                            	                  .                                          
						                                                            	     619 VQELAPPPALPPKQRQLQ                                 636                                                          
						                                                            	         |||||||||||||||||:                                  
						                                                            	     620 VQELAPPPALPPKQRQLE                                 637                                                          

7405	HMR136_M85850_22_tr0_r1_1_gPRT		Comparison report between M85850_P22 and C3G_HUMAN_V1unique  	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for M85850_P22, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 7405 x C3G_HUMAN_V1   ..                       
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MSGGLGLRRSPEMSGKIEKA         	                                                            
						corresponding to amino acids 1 - 20 of M85850_P22, a second  	                     Quality: 6615.00                      Escore:       0                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:     682                Total length:     735                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   92.79      Total Percent Identity:   92.79                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      21 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 70                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      71 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 120                                                          
						corresponding to amino acids 4 - 618 of C3G_HUMAN_V1, which  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 21 - 635 of M85850_P22, a    	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     121 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 170                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	                  .         .         .         .         .  
						corresponding to amino acids 636 - 688 of M85850_P22, a      	     171 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 220                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLTLKQE                                                      	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 619 - 685 of C3G_HUMAN_V1, which	     221 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 270                                                          
						also corresponds to amino acids 689 - 755 of M85850_P22, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a fifth amino acid sequence being at least 70%, optionally at	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     271 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 320                                                          
						VRTSRAGALQPGPTEESRWGREECDLVISRTTLGGLETKSFNAPGEPLGCGLWRGRLQGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CAVSF                                                        	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						756 - 820 of M85850_P22, wherein said first amino acid       	     321 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 370                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, fourth amino acid sequence and fifth amino acid    	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M85850_P22,      	     371 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 420                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MSGGLGLRRSPEMSGKIEKA of 	     421 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 470                                                          
						M85850_P22.3.An isolated polypeptide encoding for an edge    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of M85850_P22, comprising an amino acid sequence     	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     471 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 520                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for                                                 	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	                  .         .         .         .         .  
						corresponding to M85850_P22.4.An isolated polypeptide        	     521 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 570                                                          
						encoding for a tail of M85850_P22, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						VRTSRAGALQPGPTEESRWGREECDLVISRTTLGGLETKSFNAPGEPLGCGLWRGRLQGK 	     571 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 620                                                          
						CAVSF                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						in M85850_P22.                                               	                  .         .         .         .         .  
						                                                            	     621 ELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLS 670                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     604 ELAPPPALPPKQRQL................................... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     671 VSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 720                                                          
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	     619 ..................EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 650                                                          
						                                                            	                  .         .         .                      
						                                                            	     721 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQE                755                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     651 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQE                685                                                          

						Comparison report between M85850_P22 and Q8IV73unique head   	Sequence name: Q8IV73                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for M85850_P22, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 7405 x Q8IV73   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MSGGLGLRRSPEMSGKIEKA         	                                                            
						corresponding to amino acids 1 - 20 of M85850_P22, a second  	                     Quality: 6623.00                      Escore:       0                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEATDRFLPEGYPL 	             Matching length:     684                Total length:     737                                               
						PLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEM 	 Matching Percent Similarity:   99.85   Matching Percent Identity:   99.85                                               
						LPGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKE 	    Total Percent Similarity:   92.67      Total Percent Identity:   92.67                                               
						MVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEI 	                        Gaps:       1                        
						LNKTTGMSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 	                                                            
						APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQ 	Alignment:                                                   
						LSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGS 	                  .         .         .         .         .  
						PFLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPS 	      19 KADSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 68                                                           
						QYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPL 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						PEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 	      20 KQDSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 69                                                           
						ELAPPPALPPKQRQL                                              	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      69 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 118                                                          
						corresponding to amino acids 22 - 636 of Q8IV73, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 21 - 635 of M85850_P22, a third   	      70 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 119                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     119 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 168                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence                                          	     120 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 169                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	                  .         .         .         .         .  
						corresponding to amino acids 636 - 688 of M85850_P22, a      	     169 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 218                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLTLKQE                                                      	     170 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 219                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 637 - 703 of Q8IV73, which also 	     219 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 268                                                          
						corresponds to amino acids 689 - 755 of M85850_P22, and a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     220 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 269                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     269 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 318                                                          
						VRTSRAGALQPGPTEESRWGREECDLVISRTTLGGLETKSFNAPGEPLGCGLWRGRLQGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CAVSF                                                        	     270 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 319                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						756 - 820 of M85850_P22, wherein said first amino acid       	     319 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 368                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, fourth amino acid sequence and fifth amino acid    	     320 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 369                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M85850_P22,      	     369 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 418                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     370 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 419                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MSGGLGLRRSPEMSGKIEKA of 	     419 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 468                                                          
						M85850_P22.3.An isolated polypeptide encoding for an edge    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of M85850_P22, comprising an amino acid sequence     	     420 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 469                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     469 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 518                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for                                                 	     470 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 519                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	                  .         .         .         .         .  
						corresponding to M85850_P22.4.An isolated polypeptide        	     519 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 568                                                          
						encoding for a tail of M85850_P22, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     520 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 569                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						VRTSRAGALQPGPTEESRWGREECDLVISRTTLGGLETKSFNAPGEPLGCGLWRGRLQGK 	     569 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 618                                                          
						CAVSF                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     570 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 619                                                          
						in M85850_P22.                                               	                  .         .         .         .         .  
						                                                            	     619 VQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQG 668                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     620 VQELAPPPALPPKQRQL................................. 636                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     669 LSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSER 718                                                          
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	     637 ....................EPPAGKDGHPRDPSAVSGVPGKDSRDGSER 666                                                          
						                                                            	                  .         .         .                      
						                                                            	     719 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQE              755                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     667 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQE              703                                                          

7403	HMR136_M85850_3_tr0_r1_1_gPRT		Comparison report between M85850_P3 and C3G_HUMAN_V1unique   	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence featuring a skipped exon	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85850_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 7403 x C3G_HUMAN_V1   ..                       
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MSGGLGLRRSPEMSGKIEKA corresponding to    	                                                            
						amino acids 1 - 20 of M85850_P3, a second amino acid sequence	                     Quality: 9979.00                      Escore:       0                                               
						being at least 90 % homologous to                            	             Matching length:    1036                Total length:    1127                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN corresponding 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 4 - 49 of C3G_HUMAN_V1, which also corresponds	    Total Percent Similarity:   91.93      Total Percent Identity:   91.93                                               
						to amino acids 21 - 66 of M85850_P3, a third amino acid      	                        Gaps:       2                        
						KNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQH 	                                                            
						SSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTI 	Alignment:                                                   
						EKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAP 	                  .         .         .         .         .  
						PKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDFDVD 	      21 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN.... 66                                                           
						CYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYD 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						PDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPG 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						QQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVPYAPF 	                  .         .         .         .         .  
						AAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPS 	      67 ..................................KNLSWLEEKEKEVVSA 82                                                           
						MFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQL          	                                           ||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						amino acids 88 - 618 of C3G_HUMAN_V1, which also corresponds 	                  .         .         .         .         .  
						to amino acids 67 - 597 of M85850_P3, a fourth amino acid    	      83 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 132                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	     133 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 182                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 598 - 650 of M85850_P3, and a   	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	                  .         .         .         .         .  
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	     183 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 232                                                          
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	                  .         .         .         .         .  
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	     233 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 282                                                          
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						fifth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	     283 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 332                                                          
						which also corresponds to amino acids 651 - 1109 of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85850_P3, wherein said first amino acid sequence, second    	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence and fifth amino acid sequence are contiguous   	     333 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 382                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of M85850_P3, comprising a polypeptide being at   	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     383 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 432                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSGGLGLRRSPEMSGKIEKA of M85850_P3.3.An isolated chimeric     	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						polypeptide encoding for an edge portion of M85850_P3,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     433 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 482                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     483 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 532                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise NK, having a structure as follows: a sequence       	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						starting from any of amino acid numbers 66-x to 67; and      	                  .         .         .         .         .  
						ending at any of amino acid numbers 67+ ((n-2) - x), in which	     533 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 582                                                          
						x varies from 0 to n-2.4.An isolated polypeptide encoding for	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						an edge portion of M85850_P3, comprising an amino acid       	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .         .         .         .         .  
						preferably at least about 85%, more preferably at least about	     583 ELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLS 632                                                          
						90% and most preferably at least about 95% homologous to the 	         |||||||||||||||                                     
						sequence encoding for                                        	     604 ELAPPPALPPKQRQL................................... 618                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	                  .         .         .         .         .  
						corresponding to M85850_P3.                                  	     633 VSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 682                                                          
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	     619 ..................EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     683 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 732                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     733 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 782                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     783 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 832                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     833 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 882                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     883 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 932                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     933 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 982                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     983 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1032                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1033 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1082                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1050                                                         
						                                                            	                  .         .                                
						                                                            	    1083 EEALWELSLKIKPRNITRRKTDREEKT                        1109                                                         
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1051 EEALWELSLKIKPRNITRRKTDREEKT                        1077                                                         

						Comparison report between M85850_P3 and Q8IV73unique head    	Sequence name: Q8IV73                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique insertion.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for M85850_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 7403 x Q8IV73   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MSGGLGLRRSPEMSGKIEKA corresponding to    	                                                            
						amino acids 1 - 20 of M85850_P3, a second amino acid sequence	                     Quality: 9987.00                      Escore:       0                                               
						being at least 90 % homologous to                            	             Matching length:    1038                Total length:    1129                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN corresponding 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						to amino acids 22 - 67 of Q8IV73, which also corresponds to  	    Total Percent Similarity:   91.85      Total Percent Identity:   91.85                                               
						amino acids 21 - 66 of M85850_P3, a third amino acid sequence	                        Gaps:       2                        
						KNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQH 	                                                            
						SSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTI 	Alignment:                                                   
						EKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAP 	                  .         .         .         .         .  
						PKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDFDVD 	      19 KADSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN.. 66                                                           
						CYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYD 	         | ||||||||||||||||||||||||||||||||||||||||||||||    
						PDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPG 	      20 KQDSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKE 69                                                           
						QQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVPYAPF 	                  .         .         .         .         .  
						AAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPS 	      67 ....................................KNLSWLEEKEKEVV 80                                                           
						MFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQL          	                                             ||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	      70 ATDRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVV 119                                                          
						acids 106 - 636 of Q8IV73, which also corresponds to amino   	                  .         .         .         .         .  
						acids 67 - 597 of M85850_P3, a fourth amino acid sequence    	      81 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 130                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     120 SALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSAL 169                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	     131 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 180                                                          
						corresponding to amino acids 598 - 650 of M85850_P3, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     170 SSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKE 219                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	                  .         .         .         .         .  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     181 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 230                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     220 LVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMS 269                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	                  .         .         .         .         .  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     231 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 280                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 90 % homologous to  	     270 QSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVA 319                                                          
						corresponding to amino acids 637 - 1095 of Q8IV73, which also	                  .         .         .         .         .  
						corresponds to amino acids 651 - 1109 of M85850_P3, wherein  	     281 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 330                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence, fourth amino acid sequence and    	     320 VVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPC 369                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     331 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 380                                                          
						M85850_P3, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     370 SSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNAD 419                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     381 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 430                                                          
						MSGGLGLRRSPEMSGKIEKA of M85850_P3.3.An isolated chimeric     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85850_P3,       	     420 QIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTD 469                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     431 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 480                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     470 TPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPS 519                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     481 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 530                                                          
						comprise NK, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 66-x to 67; and      	     520 VPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHM 569                                                          
						ending at any of amino acid numbers 67+ ((n-2) - x), in which	                  .         .         .         .         .  
						x varies from 0 to n-2.4.An isolated polypeptide encoding for	     531 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 580                                                          
						an edge portion of M85850_P3, comprising an amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	     570 LAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDS 619                                                          
						preferably at least about 85%, more preferably at least about	                  .         .         .         .         .  
						90% and most preferably at least about 95% homologous to the 	     581 VQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQG 630                                                          
						sequence encoding for                                        	         |||||||||||||||||                                   
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	     620 VQELAPPPALPPKQRQL................................. 636                                                          
						corresponding to M85850_P3.                                  	                  .         .         .         .         .  
						                                                            	     631 LSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSER 680                                                          
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	     637 ....................EPPAGKDGHPRDPSAVSGVPGKDSRDGSER 666                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     681 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 730                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     667 APKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGD 716                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     731 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 780                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     717 ILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFAD 766                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     781 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 830                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     767 TFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 816                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     831 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 880                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     817 RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQL 866                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     881 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 930                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     867 TLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIM 916                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     931 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 980                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     917 LQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQK 966                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     981 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1030                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     967 QTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLG 1016                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1031 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1080                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1017 NPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDH 1066                                                         
						                                                            	                  .         .                                
						                                                            	    1081 LAEEALWELSLKIKPRNITRRKTDREEKT                      1109                                                         
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	    1067 LAEEALWELSLKIKPRNITRRKTDREEKT                      1095                                                         

7397	HMR136_M85850_4_tr0_r1_1_gPRT		Comparison report between M85850_P4 and C3G_HUMAN_V1partial  	Sequence name: C3G_HUMAN_V1                                  
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for M85850_P4, comprising a    	Sequence documentation:                                      
						MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEMLPGSASKVLEA 	                                                            
						ILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKA 	Alignment of: 7397 x C3G_HUMAN_V1   ..                       
						VLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQST 	                                                            
						ELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSS 	Alignment segment 1/1:                                       
						LPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 	                                                            
						SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPL 	                     Quality: 9744.00                      Escore:       0                                               
						GGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQ 	             Matching length:    1003                Total length:    1056                                               
						STAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLAY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPK 	    Total Percent Similarity:   94.98      Total Percent Identity:   94.98                                               
						QRQL                                                         	                        Gaps:       1                        
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 75 - 618 of C3G_HUMAN_V1, which 	Alignment:                                                   
						also corresponds to amino acids 1 - 544 of M85850_P4, a      	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEML 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      75 MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEML 124                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	      51 PGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVML 100                                                          
						corresponding to amino acids 545 - 597 of M85850_P4, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     125 PGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVML 174                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	                  .         .         .         .         .  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     101 EGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSP 150                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     175 EGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSP 224                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	                  .         .         .         .         .  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     151 ASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAPPKPPLPG 200                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	     225 ASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAPPKPPLPG 274                                                          
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	                  .         .         .         .         .  
						which also corresponds to amino acids 598 - 1056 of          	     201 IRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDF 250                                                          
						M85850_P4, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     275 IRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDF 324                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of M85850_P4,       	     251 DVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 300                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     325 DVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 374                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     301 SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSP 350                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to M85850_P4.                                  	     375 SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSP 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGC 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 FLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGC 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RVSYERHPSQYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEF 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 RVSYERHPSQYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEF 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 VGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQ 574                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQLQASCAA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     575 NEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQL...... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSEPP 600                                                          
						                                                            	                                                        |||  
						                                                            	     619 ...............................................EPP 621                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     622 AGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLI 671                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DHNEIMSRLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     672 DHNEIMSRLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLT 721                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 TYRTFISPEELIKKLQYRYEKFSPFADTFKKRVSKNTFFVLVRVVDELCL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     722 TYRTFISPEELIKKLQYRYEKFSPFADTFKKRVSKNTFFVLVRVVDELCL 771                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VELTEEILKLLMELVFRLVCNGELSLARVLRKNILDKVDQKKLLRCATSS 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     772 VELTEEILKLLMELVFRLVCNGELSLARVLRKNILDKVDQKKLLRCATSS 821                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 QPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYKIEIPEVLLWAKEQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     822 QPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYKIEIPEVLLWAKEQ 871                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 NEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMKHLR 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     872 NEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMKHLR 921                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 KLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYR 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     922 KLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYR 971                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 AALSEVEPPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDS 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     972 AALSEVEPPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDS 1021                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 MRCFQQAHYDMRRNDDIINFFNDFSDHLAEEALWELSLKIKPRNITRRKT 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1022 MRCFQQAHYDMRRNDDIINFFNDFSDHLAEEALWELSLKIKPRNITRRKT 1071                                                         
						                                                            	                                                             
						                                                            	    1051 DREEKT                                             1056                                                         
						                                                            	         ||||||                                              
						                                                            	    1072 DREEKT                                             1077                                                         

7401	HMR136_M85850_5_tr0_r1_1_gPRT		Comparison report between M85850_P5 and C3G_HUMAN_V1partial  	Sequence name: C3G_HUMAN_V1                                  
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for M85850_P5, comprising a    	Sequence documentation:                                      
						MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEMLPGSASKVLEA 	                                                            
						ILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKA 	Alignment of: 7401 x C3G_HUMAN_V1   ..                       
						VLDGVKELVRLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQST 	                                                            
						ELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSS 	Alignment segment 1/1:                                       
						LPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 	                                                            
						SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPL 	                     Quality: 9744.00                      Escore:       0                                               
						GGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQ 	             Matching length:    1003                Total length:    1056                                               
						STAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLAY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPK 	    Total Percent Similarity:   94.98      Total Percent Identity:   94.98                                               
						QRQL                                                         	                        Gaps:       1                        
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 75 - 618 of C3G_HUMAN_V1, which 	Alignment:                                                   
						also corresponds to amino acids 1 - 544 of M85850_P5, a      	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEML 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      75 MSTSAVASRSQRQKNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEML 124                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	      51 PGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVML 100                                                          
						corresponding to amino acids 545 - 597 of M85850_P5, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	     125 PGSASKVLEAILPLVQNDPRIQHSSALSSCYSRVYQSLANLIRWSDQVML 174                                                          
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	                  .         .         .         .         .  
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	     101 EGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSP 150                                                          
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	     175 EGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTIEKQGRPSPTSPVKPSSP 224                                                          
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	                  .         .         .         .         .  
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	     151 ASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAPPKPPLPG 200                                                          
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	     225 ASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAPPKPPLPG 274                                                          
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	                  .         .         .         .         .  
						which also corresponds to amino acids 598 - 1056 of          	     201 IRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDF 250                                                          
						M85850_P5, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     275 IRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDF 324                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of M85850_P5,       	     251 DVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 300                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     325 DVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQC 374                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     301 SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSP 350                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to M85850_P5.                                  	     375 SRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSP 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGC 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 FLGPPFQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGC 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RVSYERHPSQYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEF 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 RVSYERHPSQYDNISGEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEF 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 VGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPSMFYQTPQ 574                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQLQASCAA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     575 NEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQL...... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPSEPP 600                                                          
						                                                            	                                                        |||  
						                                                            	     619 ...............................................EPP 621                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     622 AGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLI 671                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DHNEIMSRLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     672 DHNEIMSRLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLT 721                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 TYRTFISPEELIKKLQYRYEKFSPFADTFKKRVSKNTFFVLVRVVDELCL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     722 TYRTFISPEELIKKLQYRYEKFSPFADTFKKRVSKNTFFVLVRVVDELCL 771                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VELTEEILKLLMELVFRLVCNGELSLARVLRKNILDKVDQKKLLRCATSS 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     772 VELTEEILKLLMELVFRLVCNGELSLARVLRKNILDKVDQKKLLRCATSS 821                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 QPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYKIEIPEVLLWAKEQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     822 QPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYKIEIPEVLLWAKEQ 871                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 NEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMKHLR 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     872 NEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMKHLR 921                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 KLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYR 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     922 KLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYR 971                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 AALSEVEPPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDS 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     972 AALSEVEPPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDS 1021                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 MRCFQQAHYDMRRNDDIINFFNDFSDHLAEEALWELSLKIKPRNITRRKT 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1022 MRCFQQAHYDMRRNDDIINFFNDFSDHLAEEALWELSLKIKPRNITRRKT 1071                                                         
						                                                            	                                                             
						                                                            	    1051 DREEKT                                             1056                                                         
						                                                            	         ||||||                                              
						                                                            	    1072 DREEKT                                             1077                                                         

7415	HMR136_M85850_6_tr0_r1_1_gPRT		Comparison report between M85850_P6 and C3G_HUMAN_V1unique   	Sequence name: C3G_HUMAN_V1                                  
						head followed by partial WT sequence featuring a skipped exon	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for M85850_P6, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 7415 x C3G_HUMAN_V1   ..                       
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MPISFLGFRPSLTTLEQNKRTGGVVP corresponding 	                                                            
						to amino acids 1 - 26 of M85850_P6, a second amino acid      	                     Quality: 9979.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:    1036                Total length:    1127                                               
						DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN corresponding 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 4 - 49 of C3G_HUMAN_V1, which also corresponds	    Total Percent Similarity:   91.93      Total Percent Identity:   91.93                                               
						to amino acids 27 - 72 of M85850_P6, a third amino acid      	                        Gaps:       2                        
						KNLSWLEEKEKEVVSALRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQH 	                                                            
						SSALSSCYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELVRLTI 	Alignment:                                                   
						EKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQSTELLPDATDEEVAP 	                  .         .         .         .         .  
						PKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRATSGSSLPVGINRQDFDVD 	      27 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVN.... 72                                                           
						CYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYD 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						PDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPG 	       4 DSQRSHLSSFTMKLMDKFHSPKIKRTPSKKGKPAEVSVKIPEKPVNKEAT 53                                                           
						QQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVPYAPF 	                  .         .         .         .         .  
						AAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLAYMQLLEDYSEPQPS 	      73 ..................................KNLSWLEEKEKEVVSA 88                                                           
						MFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPPALPPKQRQL          	                                           ||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      54 DRFLPEGYPLPLDLEQQAVEFMSTSAVASRSQRQKNLSWLEEKEKEVVSA 103                                                          
						amino acids 88 - 618 of C3G_HUMAN_V1, which also corresponds 	                  .         .         .         .         .  
						to amino acids 73 - 603 of M85850_P6, a fourth amino acid    	      89 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 138                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     104 LRYFKTIVDKMAIDKKVLEMLPGSASKVLEAILPLVQNDPRIQHSSALSS 153                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	     139 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 188                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 604 - 656 of M85850_P6, and a   	     154 CYSRVYQSLANLIRWSDQVMLEGVNSEDKEMVTTVKGVIKAVLDGVKELV 203                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	                  .         .         .         .         .  
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	     189 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 238                                                          
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	     204 RLTIEKQGRPSPTSPVKPSSPASKPDGPAELPLTDREVEILNKTTGMSQS 253                                                          
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	                  .         .         .         .         .  
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	     239 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 288                                                          
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	     254 TELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVV 303                                                          
						fifth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	     289 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 338                                                          
						which also corresponds to amino acids 657 - 1115 of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85850_P6, wherein said first amino acid sequence, second    	     304 APMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSS 353                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence and fifth amino acid sequence are contiguous   	     339 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 388                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of M85850_P6, comprising a polypeptide being at   	     354 IGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQI 403                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     389 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 438                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPISFLGFRPSLTTLEQNKRTGGVVP of M85850_P6.3.An isolated        	     404 PQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQTDTP 453                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85850_P6, comprising a polypeptide having a length "n",     	     439 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 488                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     454 PALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPIPSVP 503                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     489 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 538                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise NK, having a structure as  	     504 YAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNKHMLA 553                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						72-x to 73; and ending at any of amino acid numbers 73+      	     539 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 588                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M85850_P6,       	     554 YMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQ 603                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     589 ELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLS 638                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||||||                                     
						least about 95% homologous to the sequence encoding for      	     604 ELAPPPALPPKQRQL................................... 618                                                          
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	                  .         .         .         .         .  
						corresponding to M85850_P6.                                  	     639 VSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 688                                                          
						                                                            	                           ||||||||||||||||||||||||||||||||  
						                                                            	     619 ..................EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     689 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGSGDIL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 788                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPFADTF 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     789 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 838                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 KKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLARV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     839 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 888                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     889 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 938                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQ 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     939 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 988                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 EKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEWQKQT 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     989 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1038                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVHLGNP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1039 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1088                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 DYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFSDHLA 1050                                                         
						                                                            	                  .         .                                
						                                                            	    1089 EEALWELSLKIKPRNITRRKTDREEKT                        1115                                                         
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1051 EEALWELSLKIKPRNITRRKTDREEKT                        1077                                                         

7407	HMR136_M85850_8_tr0_r1_1_gPRT		Comparison report between M85850_P8 and C3G_HUMAN_V1partial  	Sequence name: C3G_HUMAN_V1                                  
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for M85850_P8, comprising a    	Sequence documentation:                                      
						MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRA 	                                                            
						TSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDR 	Alignment of: 7407 x C3G_HUMAN_V1   ..                       
						DSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPP 	                                                            
						FQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNIS 	Alignment segment 1/1:                                       
						GEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 	                                                            
						HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPP 	                     Quality: 8069.00                      Escore:       0                                               
						ALPPKQRQL                                                    	             Matching length:     828                Total length:     881                                               
						first amino acid sequence being at least 90 % homologous to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 250 - 618 of C3G_HUMAN_V1, which	    Total Percent Similarity:   93.98      Total Percent Identity:   93.98                                               
						also corresponds to amino acids 1 - 369 of M85850_P8, a      	                        Gaps:       1                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	       1 MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTR 50                                                           
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 370 - 422 of M85850_P8, and a   	     250 MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTR 299                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	                  .         .         .         .         .  
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	      51 VAVVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLS 100                                                          
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	     300 VAVVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLS 349                                                          
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	                  .         .         .         .         .  
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	     101 PCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSN 150                                                          
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	     350 PCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSN 399                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	     151 ADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQ 200                                                          
						which also corresponds to amino acids 423 - 881 of M85850_P8,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     400 ADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQ 449                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	     201 TDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPI 250                                                          
						edge portion of M85850_P8, comprising an amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     450 TDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPI 499                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     251 PSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 300                                                          
						encoding for                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	     500 PSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 549                                                          
						corresponding to M85850_P8.                                  	                  .         .         .         .         .  
						                                                            	     301 HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGV 599                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DSVQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAA 400                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     600 DSVQELAPPPALPPKQRQL............................... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 QGLSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGS 450                                                          
						                                                            	                               ||||||||||||||||||||||||||||  
						                                                            	     619 ......................EPPAGKDGHPRDPSAVSGVPGKDSRDGS 646                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ERAPKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     647 ERAPKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGS 696                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPF 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     697 GDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPF 746                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     747 ADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELS 796                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LARVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     797 LARVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAE 846                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QLTLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSI 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     847 QLTLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSI 896                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 IMLQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEW 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     897 IMLQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEW 946                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 QKQTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVH 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     947 QKQTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVH 996                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 LGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     997 LGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFS 1046                                                         
						                                                            	                  .         .         .                      
						                                                            	     851 DHLAEEALWELSLKIKPRNITRRKTDREEKT                    881                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1047 DHLAEEALWELSLKIKPRNITRRKTDREEKT                    1077                                                         

7413	HMR136_M85850_9_tr0_r1_1_gPRT		Comparison report between M85850_P9 and C3G_HUMAN_V1partial  	Sequence name: C3G_HUMAN_V1                                  
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for M85850_P9, comprising a    	Sequence documentation:                                      
						MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTRVAVVAPMSRA 	                                                            
						TSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLSPCSSIGKLSKSDEQLSSLDR 	Alignment of: 7413 x C3G_HUMAN_V1   ..                       
						DSGQCSRNTSCETLDHYDPDYEFLQQDLSNADQIPQQTAWNLSPLPESLGESGSPFLGPP 	                                                            
						FQLPLGGHPQPDGPLAPGQQTDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNIS 	Alignment segment 1/1:                                       
						GEDLQSTAPIPSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 	                                                            
						HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGVDSVQELAPPP 	                     Quality: 8069.00                      Escore:       0                                               
						ALPPKQRQL                                                    	             Matching length:     828                Total length:     881                                               
						first amino acid sequence being at least 90 % homologous to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 250 - 618 of C3G_HUMAN_V1, which	    Total Percent Similarity:   93.98      Total Percent Identity:   93.98                                               
						also corresponds to amino acids 1 - 369 of M85850_P9, a      	                        Gaps:       1                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	       1 MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTR 50                                                           
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 370 - 422 of M85850_P9, and a   	     250 MSQSTELLPDATDEEVAPPKPPLPGIRVVDNSPPPALPPKKRQSAPSPTR 299                                                          
						EPPAGKDGHPRDPSAVSGVPGKDSRDGSERAPKSPDALESAQSEEEVDELSLIDHNEIMS 	                  .         .         .         .         .  
						RLTLKQEGDDGPDVRGGSGDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQY 	      51 VAVVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLS 100                                                          
						RYEKFSPFADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELSLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAEQLTLLDAELFYK 	     300 VAVVAPMSRATSGSSLPVGINRQDFDVDCYAQRRLSGGSHSYGGESPRLS 349                                                          
						IEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSIIMLQEKAQDRERLLLKFIKIMK 	                  .         .         .         .         .  
						HLRKLNNFNSYLAILSALDSAPIRRLEWQKQTSEGLAEYCTLIDSSSSFRAYRAALSEVE 	     101 PCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSN 150                                                          
						PPCIPYLGLILQDLTFVHLGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						INFFNDFSDHLAEEALWELSLKIKPRNITRRKTDREEKT                      	     350 PCSSIGKLSKSDEQLSSLDRDSGQCSRNTSCETLDHYDPDYEFLQQDLSN 399                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 619 - 1077 of C3G_HUMAN_V1,     	     151 ADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQ 200                                                          
						which also corresponds to amino acids 423 - 881 of M85850_P9,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     400 ADQIPQQTAWNLSPLPESLGESGSPFLGPPFQLPLGGHPQPDGPLAPGQQ 449                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	     201 TDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPI 250                                                          
						edge portion of M85850_P9, comprising an amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     450 TDTPPALPEKKRRSAASQTADGSGCRVSYERHPSQYDNISGEDLQSTAPI 499                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     251 PSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 300                                                          
						encoding for                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QASCAASSFSSVSHCVQQTKVAFTPEDGSAAQGLSVSVSNSFLSRHGSLPVPS,       	     500 PSVPYAPFAAILPFQHGGSSAPVEFVGDFTAPESTGDPEKPPPLPEKKNK 549                                                          
						corresponding to M85850_P9.                                  	                  .         .         .         .         .  
						                                                            	     301 HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 HMLAYMQLLEDYSEPQPSMFYQTPQNEHIYQQKNKLLMEVYGFSDSFSGV 599                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DSVQELAPPPALPPKQRQLQASCAASSFSSVSHCVQQTKVAFTPEDGSAA 400                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     600 DSVQELAPPPALPPKQRQL............................... 618                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 QGLSVSVSNSFLSRHGSLPVPSEPPAGKDGHPRDPSAVSGVPGKDSRDGS 450                                                          
						                                                            	                               ||||||||||||||||||||||||||||  
						                                                            	     619 ......................EPPAGKDGHPRDPSAVSGVPGKDSRDGS 646                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ERAPKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     647 ERAPKSPDALESAQSEEEVDELSLIDHNEIMSRLTLKQEGDDGPDVRGGS 696                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPF 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     697 GDILLVHATETDRKDLVLYCEAFLTTYRTFISPEELIKKLQYRYEKFSPF 746                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     747 ADTFKKRVSKNTFFVLVRVVDELCLVELTEEILKLLMELVFRLVCNGELS 796                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LARVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     797 LARVLRKNILDKVDQKKLLRCATSSQPLAARGVAARPGTLHDFHSHEIAE 846                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QLTLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSI 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     847 QLTLLDAELFYKIEIPEVLLWAKEQNEEKSPNLTQFTEHFNNMSYWVRSI 896                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 IMLQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEW 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     897 IMLQEKAQDRERLLLKFIKIMKHLRKLNNFNSYLAILSALDSAPIRRLEW 946                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 QKQTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVH 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     947 QKQTSEGLAEYCTLIDSSSSFRAYRAALSEVEPPCIPYLGLILQDLTFVH 996                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 LGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     997 LGNPDYIDGKVNFSKRWQQFNILDSMRCFQQAHYDMRRNDDIINFFNDFS 1046                                                         
						                                                            	                  .         .         .                      
						                                                            	     851 DHLAEEALWELSLKIKPRNITRRKTDREEKT                    881                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1047 DHLAEEALWELSLKIKPRNITRRKTDREEKT                    1077                                                         

16471	HMR136_M85859_20_tr0_r1_1_gPRT		Comparison report between M85859_P20 and Q8N4J2partial WT    	Sequence name: Q8N4J2                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85859_P20, comprising a first amino acid sequence being at  	                                                            
						MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIREEEHEEKNSG 	Alignment of: 16471 x Q8N4J2   ..                            
						NSESSSSKPNQKKL                                               	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 74 	Alignment segment 1/1:                                       
						of Q8N4J2, which also corresponds to amino acids 1 - 74 of   	                                                            
						M85859_P20, a bridging amino acid I corresponding to amino   	                     Quality: 2238.00                      Escore:       0                                               
						acid 75 of M85859_P20, a second amino acid sequence being at 	             Matching length:     231                Total length:     231                                               
						VLSDSEVIQLSDGSEVITLSDEDSIYRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.57                                               
						DIEKPKSEERSGVIREVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.57                                               
						GCENSVTEGEDGINWSISDKDIEAQIANNRTPGRWT                         	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 76 -   	                                                            
						231 of Q8N4J2, which also corresponds to amino acids 76 - 231	Alignment:                                                   
						of M85859_P20, and a third amino acid sequence being at least	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QRYYSANKNIICRNCDKRGHLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKM 	       1 MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						LDHSCLFRHSWDKQCDRCHMLGHYTDACTEIWRQYHLTVSRNTFFIFPKT           	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	      51 EEEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						to amino acids 232 - 341 of M85859_P20, wherein said first   	         ||||||||||||||||||||||||:|||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	      51 EEEHEEKNSGNSESSSSKPNQKKLVVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						tail of M85859_P20, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						QRYYSANKNIICRNCDKRGHLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKM 	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						LDHSCLFRHSWDKQCDRCHMLGHYTDACTEIWRQYHLTVSRNTFFIFPKT           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in M85859_P20. 	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 VTEGEDGINWSISDKDIEAQIANNRTPGRWT                    231                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     201 VTEGEDGINWSISDKDIEAQIANNRTPGRWT                    231                                                          

						Comparison report between M85859_P20 and Q9H648short unique  	Sequence name: Q9H648                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85859_P20, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16471 x Q9H648   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MMF          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of M85859_P20, a second   	                                                            
						GGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIREEEHEEKNSGNSE 	                     Quality: 3283.00                      Escore:       0                                               
						SSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIYRCKGKNVRVQAQENAHGLSSSL 	             Matching length:     329                Total length:     329                                               
						QSNELVDKKCKSDIEKPKSEERSGVIREVMIIEVSSSEEEESTISEGDNVESWMLLGCEV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.70                                               
						DDKDDDILLNLVGCENSVTEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIIC 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.70                                               
						RNCDKRGHLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHSWD 	                        Gaps:       0                        
						KQCDRCHMLGHYTDACTEIWRQYHLT                                   	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 4 - 329 of Q9H648, which also   	                  .         .         .         .         .  
						corresponds to amino acids 4 - 329 of M85859_P20, and a third	       1 MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						amino acid sequence being at least 70%, optionally at least  	         ||:|||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MMLGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence VSRNTFFIFPKT corresponding to amino acids	      51 EEEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						330 - 341 of M85859_P20, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	      51 EEEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of M85859_P20,      	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence VSRNTFFIFPKT in         	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						M85859_P20.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VTEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRH 300                                                          
						                                                            	                  .         .                                
						                                                            	     301 SWDKQCDRCHMLGHYTDACTEIWRQYHLT                      329                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     301 SWDKQCDRCHMLGHYTDACTEIWRQYHLT                      329                                                          

						Comparison report between M85859_P20 and Q8TBK8partial WT    	Sequence name: Q8TBK8                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85859_P20, comprising a first amino acid sequence being at  	                                                            
						MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIREEEHEEKNSG 	Alignment of: 16471 x Q8TBK8   ..                            
						NSES                                                         	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 64 	Alignment segment 1/1:                                       
						of Q8TBK8, which also corresponds to amino acids 1 - 64 of   	                                                            
						M85859_P20, a bridging amino acid S corresponding to amino   	                     Quality: 1962.00                      Escore:       0                                               
						acid 65 of M85859_P20, a second amino acid sequence being at 	             Matching length:     206                Total length:     206                                               
						SSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIYRCKGKNVRVQAQENAHGLSSSLQS 	 Matching Percent Similarity:   99.51   Matching Percent Identity:   98.54                                               
						NELVDKKCKSDIEKPKSEERSGVIREVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDD 	    Total Percent Similarity:   99.51      Total Percent Identity:   98.54                                               
						KDDDILLNLVGCENSVTEG                                          	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 66 -   	                                                            
						204 of Q8TBK8, which also corresponds to amino acids 66 - 204	Alignment:                                                   
						of M85859_P20, and a third amino acid sequence being at least	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRGHLSKNCPLPRKVRR 	       1 MMFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIR 50                                                           
						CFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHSWDKQCDRCHMLGHYTDACTEIWR 	                  .         .         .         .         .  
						QYHLTVSRNTFFIFPKT                                            	      51 EEEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						homologous to a polypeptide having the sequence corresponding	         |||||||||||||| |||||||||||||||||||||||||||||||||||  
						to amino acids 205 - 341 of M85859_P20, wherein said first   	      51 EEEHEEKNSGNSESPSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSI 100                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of M85859_P20, comprising a polypeptide being at least  	     101 YRCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIR 150                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						EDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRGHLSKNCPLPRKVRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHSWDKQCDRCHMLGHYTDACTEIWR 	     151 EVMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENS 200                                                          
						QYHLTVSRNTFFIFPKT                                            	                                                             
						at least about 95% homologous to the sequence in M85859_P20. 	     201 VTEGED                                             206                                                          
						                                                            	         ||||::                                              
						                                                            	     201 VTEGQE                                             206                                                          

						Comparison report between M85859_P20 and Q8N3Z6short unique  	Sequence name: Q8N3Z6                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85859_P20, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16471 x Q8N3Z6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of M85859_P20, a second   	                                                            
						MFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIREEEHEEKNSGN 	                     Quality: 3282.00                      Escore:       0                                               
						SESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIYRCKGKNVRVQAQENAHGLSS 	             Matching length:     328                Total length:     328                                               
						SLQSNELVDKKCKSDIEKPKSEERSGVIREVMIIEVSSSEEEESTISEGDNVESWMLLGC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EVDDKDDDILLNLVGCENSVTEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ICRNCDKRGHLSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHS 	                        Gaps:       0                        
						WDKQCDRCHMLGHYTDACTEIWRQYHLT                                 	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 1 - 328 of Q8N3Z6, which also   	                  .         .         .         .         .  
						corresponds to amino acids 2 - 329 of M85859_P20, and a third	       2 MFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIRE 51                                                           
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MFGGYETIEAYEDDLYRDESSSELSVDSEVEFQLYSQIHYAQDLDDVIRE 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence VSRNTFFIFPKT corresponding to amino acids	      52 EEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIY 101                                                          
						330 - 341 of M85859_P20, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	      51 EEHEEKNSGNSESSSSKPNQKKLIVLSDSEVIQLSDGSEVITLSDEDSIY 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of M85859_P20,      	     102 RCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIRE 151                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 RCKGKNVRVQAQENAHGLSSSLQSNELVDKKCKSDIEKPKSEERSGVIRE 150                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence VSRNTFFIFPKT in         	     152 VMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENSV 201                                                          
						M85859_P20.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VMIIEVSSSEEEESTISEGDNVESWMLLGCEVDDKDDDILLNLVGCENSV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     202 TEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRGH 251                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TEGEDGINWSISDKDIEAQIANNRTPGRWTQRYYSANKNIICRNCDKRGH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     252 LSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHS 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LSKNCPLPRKVRRCFLCSRRGHLLYSCPAPLCEYCPVPKMLDHSCLFRHS 300                                                          
						                                                            	                  .         .                                
						                                                            	     302 WDKQCDRCHMLGHYTDACTEIWRQYHLT                       329                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     301 WDKQCDRCHMLGHYTDACTEIWRQYHLT                       328                                                          

812	HMR136_M85871_11_tr0_r1_1_gPRT		Comparison report between M85871_P11 and ARI1_HUMANpartial   	Sequence name: ARI1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85871_P11, comprising a first amino	Sequence documentation:                                      
						MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEPGLGVGGERDG 	                                                            
						LLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYRYEVLTAEQILQHMVECIREV 	Alignment of: 812 x ARI1_HUMAN   ..                          
						NEVIQNPATITRILLSHFNWDKEKLMERYFDGNLEKLFAECHVINPSKKSRTRQMNTRSS 	                                                            
						AQDMPCQICYLNYPNSYFTGLECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILV 	Alignment segment 1/1:                                       
						DDNTVMRLITDSKVKLKYQHLITNSFVECNRLLKWCPAPDCHHVVKVQYPDAKPVRCKCG 	                                                            
						RQFCFNCGENWHDPVKCKWLKKWIKKCDDDSETSNWIAANTKECPKCHVTIEKDGGCNHM 	                     Quality: 3956.00                      Escore:       0                                               
						VCRNQNCKAEFCWVCLGPWEPHGSA                                    	             Matching length:     385                Total length:     385                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 385 of ARI1_HUMAN, which also corresponds 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 385 of M85871_P11, and a second amino acid	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence CDLGQPCRGTCSTVIAI corresponding to amino 	       1 MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEP 50                                                           
						acids 386 - 402 of M85871_P11, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	       1 MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEP 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of M85871_P11, comprising a polypeptide being at least  	      51 GLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYR 100                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      51 GLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYR 100                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						CDLGQPCRGTCSTVIAI in M85871_P11.                             	     101 YEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 YEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVMRLIT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVMRLIT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DSKVKLKYQHLITNSFVECNRLLKWCPAPDCHHVVKVQYPDAKPVRCKCG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DSKVKLKYQHLITNSFVECNRLLKWCPAPDCHHVVKVQYPDAKPVRCKCG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RQFCFNCGENWHDPVKCKWLKKWIKKCDDDSETSNWIAANTKECPKCHVT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RQFCFNCGENWHDPVKCKWLKKWIKKCDDDSETSNWIAANTKECPKCHVT 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 IEKDGGCNHMVCRNQNCKAEFCWVCLGPWEPHGSA                385                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     351 IEKDGGCNHMVCRNQNCKAEFCWVCLGPWEPHGSA                385                                                          

810	HMR136_M85871_12_tr0_r1_1_gPRT		Comparison report between M85871_P12 and ARI1_HUMANpartial   	Sequence name: ARI1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M85871_P12, comprising a first amino	                                                            
						MVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDDAKAARDAQERSRAALQRYLFYCN 	Alignment of: 810 x ARI1_HUMAN   ..                          
						RYMNHMQSLRFEHKLYAQVKQKMEEMQQHNMSWIEVQFLKKAVDVLCQCRATLMYTYVFA 	                                                            
						FYLKKNNQSIIFENNQADLENATEVLSGYLERDISQDSLQDIKQKVQDKYRYCESRRRVL 	Alignment segment 1/1:                                       
						LQHVHEGYEKDLWEYIED                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2042.00                      Escore:       0                                               
						to amino acids 360 - 557 of ARI1_HUMAN, which also           	             Matching length:     198                Total length:     198                                               
						corresponds to amino acids 1 - 198 of M85871_P12.            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDDAKAARDAQERSRA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     360 MVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDDAKAARDAQERSRA 409                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ALQRYLFYCNRYMNHMQSLRFEHKLYAQVKQKMEEMQQHNMSWIEVQFLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 ALQRYLFYCNRYMNHMQSLRFEHKLYAQVKQKMEEMQQHNMSWIEVQFLK 459                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KAVDVLCQCRATLMYTYVFAFYLKKNNQSIIFENNQADLENATEVLSGYL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     460 KAVDVLCQCRATLMYTYVFAFYLKKNNQSIIFENNQADLENATEVLSGYL 509                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 ERDISQDSLQDIKQKVQDKYRYCESRRRVLLQHVHEGYEKDLWEYIED   198                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     510 ERDISQDSLQDIKQKVQDKYRYCESRRRVLLQHVHEGYEKDLWEYIED   557                                                          

808	HMR136_M85871_16_tr0_r1_1_gPRT		Comparison report between M85871_P16 and ARI1_HUMANpartial   	Sequence name: ARI1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M85871_P16, comprising a first amino	                                                            
						MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEPGLGVGGERDG 	Alignment of: 808 x ARI1_HUMAN   ..                          
						LLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYRYEVLTAEQILQHMVECIREV 	                                                            
						NEVIQNPATITRILLSHFNWDKEKLMERYFDGNLEKLFAECHVINPSKKSRTRQMNTRSS 	Alignment segment 1/1:                                       
						AQDMPCQICYLNYPNSYFTGLECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILV 	                                                            
						DDNTVM                                                       	                     Quality: 2465.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     246                Total length:     246                                               
						to amino acids 1 - 246 of ARI1_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 246 of M85871_P16.                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEP 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYR 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 YEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTG 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 LECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVM     246                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     201 LECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVM     246                                                          

20339	HMR136_M85878_3_tr0_r1_1_gPRT		Comparison report between M85878_P3 and TLN2_HUMANpartial WT 	Sequence name: TLN2_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85878_P3, comprising a first amino 	Sequence documentation:                                      
						MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVMRVDEKTKEVL 	                                                            
						QEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQISQLIAGYIDIILKKKQSKDR 	Alignment of: 20339 x TLN2_HUMAN   ..                        
						FGLEGDEESTMLEESVSPKKSTILQQQFNRTGKAEHGSVALPAVMRSGSSGPETFNVGSM 	                                                            
						PSPQQQVMVGQMHRGHMPPLTSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMAS 	Alignment segment 1/1:                                       
						RVWVQNKVDESKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 	                                                            
						KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVLTAAGSIGQAS 	                     Quality: 21170.00                      Escore:       0                                              
						GDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKNVAQVAEDTVLQNRVIAAATQ 	             Matching length:    2251                Total length:    2266                                               
						CALSTSQLVACAKVVSPTISSPVCQEQLIEAGKLVDRSVENCVRACQAATTDSELLKQVS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AAASVVSQALHDLLQHVRQFASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARV 	    Total Percent Similarity:   99.34      Total Percent Identity:   99.34                                               
						LAQATSDLVNAMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 	                        Gaps:       1                        
						RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNAAVSNKNPAAQ 	                                                            
						QQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIISSQNFLQPGSKMVSSAKAAVP 	Alignment:                                                   
						TVSDQAAAMQLSQCAKNLATSLAELRTASQKAHEACGPMEIDSALNTVQTLKNELQDAKM 	                  .         .         .         .         .  
						AAVESQLKPLPGETLEKCAQDLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALK 	       1 MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVM 50                                                           
						TLAQAARGVAASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQSELNQAAADL 	     292 MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVM 341                                                          
						NQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMAGQAQTKEDQIQVIGNLKNIS 	                  .         .         .         .         .  
						MASSKLLLAAKSLSVDPGAPNAKNLLAAAARAVTESINQLITLCTQQAPGQKECDNALRE 	      51 RVDEKTKEVLQEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQI 100                                                          
						LETVKGMLDNPNEPVSDLSYFDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKALCGLTEAAAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 	     342 RVDEKTKEVLQEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQI 391                                                          
						QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANLVKTIKALDGD 	                  .         .         .         .         .  
						FSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQISSEGSQAQEPILVSAKTMLES 	     101 SQLIAGYIDIILKKKQSKDRFGLEGDEESTMLEESVSPKKSTILQQQFNR 150                                                          
						SSYLIRTARSLAINPKDPPTWSVLAGHSHTVSDSIKSLITSIRDKAPGQRECDYSIDGIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCIRDIEQASLAAVSQSLATRDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGH 	     392 SQLIAGYIDIILKKKQSKDRFGLEGDEESTMLEESVSPKKSTILQQQFNR 441                                                          
						KVTQLASYFEPLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 	                  .         .         .         .         .  
						HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDEGTPPEPKGTF 	     151 TGKAEHGSVALPAVMRSGSSGPETFNVGSMPSPQQQVMVGQMHRGHMPPL 200                                                          
						VDYQTTVVKYSKAIAVTAQEMMTKSVTNPEELGGLASQMTSDYGHLAFQGQMAAATAEPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EIGFQIRTRVQDLGHGCIFLVQKAGALQVCPTDSYTKRELIECARAVTEKVSLVLSALQA 	     442 TGKAEHGSVALPAVMRSGSSGPETFNVGSMPSPQQQVMVGQMHRGHMPPL 491                                                          
						GNKGTQACITAATAVSGIIADLDTTIMFATAGTLNAENSETFADHRENILKTAKALVEDT 	                  .         .         .         .         .  
						KLLVSGAASTPDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVLINAIKDVAKA 	     201 TSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMASRVWVQNKVDE 250                                                          
						LSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEATRGTRALEATI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAVAAGNSCRQEDVIATANLSRK 	     492 TSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMASRVWVQNKVDE 541                                                          
						AVSDMLTACKQASFHPDVSDEVRTRALRFGTECTLGYLDLLEHVLVILQKPTPEFKQQLA 	                  .         .         .         .         .  
						AFSKRVAGAVTELIQAAEAMKGTEWVDPEDPTVIAETELLGAAASIEAAAKKLEQLKPRA 	     251 SKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 300                                                          
						KPKQADETLDFEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIPANAADDGQWS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLVACKVKADQDS 	     542 SKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 591                                                          
						EAMRRLQ                                                      	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     301 KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVL 350                                                          
						to amino acids 292 - 2458 of TLN2_HUMAN, which also          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 1 - 2167 of M85878_P3, a second   	     592 KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVL 641                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     351 TAAGSIGQASGDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKN 400                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VMVTDAGGKILLLER corresponding to amino   	     642 TAAGSIGQASGDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKN 691                                                          
						acids 2168 - 2182 of M85878_P3, and a third amino acid       	                  .         .         .         .         .  
						AAGNAVKRASDNLVRAAQKAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEA 	     401 VAQVAEDTVLQNRVIAAATQCALSTSQLVACAKVVSPTISSPVCQEQLIE 450                                                          
						RKKLAQIRQQQYKFLPTELREDEG                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     692 VAQVAEDTVLQNRVIAAATQCALSTSQLVACAKVVSPTISSPVCQEQLIE 741                                                          
						amino acids 2459 - 2542 of TLN2_HUMAN, which also corresponds	                  .         .         .         .         .  
						to amino acids 2183 - 2266 of M85878_P3, wherein said first  	     451 AGKLVDRSVENCVRACQAATTDSELLKQVSAAASVVSQALHDLLQHVRQF 500                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     742 AGKLVDRSVENCVRACQAATTDSELLKQVSAAASVVSQALHDLLQHVRQF 791                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	                  .         .         .         .         .  
						of M85878_P3, comprising an amino acid sequence being at     	     501 ASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARVLAQATSDLVN 550                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     792 ASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARVLAQATSDLVN 841                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for VMVTDAGGKILLLER, corresponding to M85878_P3.    	     551 AMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     842 AMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 891                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     892 RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNA 941                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 AVSNKNPAAQQQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIIS 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     942 AVSNKNPAAQQQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIIS 991                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SQNFLQPGSKMVSSAKAAVPTVSDQAAAMQLSQCAKNLATSLAELRTASQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     992 SQNFLQPGSKMVSSAKAAVPTVSDQAAAMQLSQCAKNLATSLAELRTASQ 1041                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 KAHEACGPMEIDSALNTVQTLKNELQDAKMAAVESQLKPLPGETLEKCAQ 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1042 KAHEACGPMEIDSALNTVQTLKNELQDAKMAAVESQLKPLPGETLEKCAQ 1091                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALKTLAQAARGVA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1092 DLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALKTLAQAARGVA 1141                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 ASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1142 ASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 1191                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQ 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1192 KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQ 1241                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 SELNQAAADLNQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1242 SELNQAAADLNQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMA 1291                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 GQAQTKEDQIQVIGNLKNISMASSKLLLAAKSLSVDPGAPNAKNLLAAAA 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1292 GQAQTKEDQIQVIGNLKNISMASSKLLLAAKSLSVDPGAPNAKNLLAAAA 1341                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 RAVTESINQLITLCTQQAPGQKECDNALRELETVKGMLDNPNEPVSDLSY 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1342 RAVTESINQLITLCTQQAPGQKECDNALRELETVKGMLDNPNEPVSDLSY 1391                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 FDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIASKALCGLTEA 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1392 FDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIASKALCGLTEA 1441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 AAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1442 AAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 1491                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1492 QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANL 1541                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VKTIKALDGDFSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQIS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1542 VKTIKALDGDFSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQIS 1591                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 SEGSQAQEPILVSAKTMLESSSYLIRTARSLAINPKDPPTWSVLAGHSHT 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1592 SEGSQAQEPILVSAKTMLESSSYLIRTARSLAINPKDPPTWSVLAGHSHT 1641                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 VSDSIKSLITSIRDKAPGQRECDYSIDGINRCIRDIEQASLAAVSQSLAT 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1642 VSDSIKSLITSIRDKAPGQRECDYSIDGINRCIRDIEQASLAAVSQSLAT 1691                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 RDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGHKVTQLASYFE 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1692 RDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGHKVTQLASYFE 1741                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 PLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1742 PLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 1791                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDE 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1792 HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDE 1841                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 GTPPEPKGTFVDYQTTVVKYSKAIAVTAQEMMTKSVTNPEELGGLASQMT 1600                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1842 GTPPEPKGTFVDYQTTVVKYSKAIAVTAQEMMTKSVTNPEELGGLASQMT 1891                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1601 SDYGHLAFQGQMAAATAEPEEIGFQIRTRVQDLGHGCIFLVQKAGALQVC 1650                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1892 SDYGHLAFQGQMAAATAEPEEIGFQIRTRVQDLGHGCIFLVQKAGALQVC 1941                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1651 PTDSYTKRELIECARAVTEKVSLVLSALQAGNKGTQACITAATAVSGIIA 1700                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1942 PTDSYTKRELIECARAVTEKVSLVLSALQAGNKGTQACITAATAVSGIIA 1991                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1701 DLDTTIMFATAGTLNAENSETFADHRENILKTAKALVEDTKLLVSGAAST 1750                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1992 DLDTTIMFATAGTLNAENSETFADHRENILKTAKALVEDTKLLVSGAAST 2041                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1751 PDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVLINAIKDVAKA 1800                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2042 PDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVLINAIKDVAKA 2091                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1801 LSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEAT 1850                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2092 LSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEAT 2141                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1851 RGTRALEATIECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAV 1900                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2142 RGTRALEATIECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAV 2191                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1901 AAGNSCRQEDVIATANLSRKAVSDMLTACKQASFHPDVSDEVRTRALRFG 1950                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2192 AAGNSCRQEDVIATANLSRKAVSDMLTACKQASFHPDVSDEVRTRALRFG 2241                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1951 TECTLGYLDLLEHVLVILQKPTPEFKQQLAAFSKRVAGAVTELIQAAEAM 2000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2242 TECTLGYLDLLEHVLVILQKPTPEFKQQLAAFSKRVAGAVTELIQAAEAM 2291                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2001 KGTEWVDPEDPTVIAETELLGAAASIEAAAKKLEQLKPRAKPKQADETLD 2050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2292 KGTEWVDPEDPTVIAETELLGAAASIEAAAKKLEQLKPRAKPKQADETLD 2341                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2051 FEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIPANAADDGQWS 2100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2342 FEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIPANAADDGQWS 2391                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2101 QGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLV 2150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2392 QGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLV 2441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2151 ACKVKADQDSEAMRRLQVMVTDAGGKILLLERAAGNAVKRASDNLVRAAQ 2200                                                         
						                                                            	         |||||||||||||||||               ||||||||||||||||||  
						                                                            	    2442 ACKVKADQDSEAMRRLQ...............AAGNAVKRASDNLVRAAQ 2476                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2201 KAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEARKKLAQIR 2250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2477 KAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEARKKLAQIR 2526                                                         
						                                                            	                  .                                          
						                                                            	    2251 QQQYKFLPTELREDEG                                   2266                                                         
						                                                            	         ||||||||||||||||                                    
						                                                            	    2527 QQQYKFLPTELREDEG                                   2542                                                         

20337	HMR136_M85878_4_tr0_r1_1_gPRT		Comparison report between M85878_P4 and TLN2_HUMANpartial WT 	Sequence name: TLN2_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						M85878_P4, comprising a first amino acid sequence being at   	                                                            
						MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVMRVDEKTKEVL 	Alignment of: 20337 x TLN2_HUMAN   ..                        
						QEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQISQLIAGYIDIILKKKQSKDR 	                                                            
						FGLEGDEESTMLEESVSPKKSTILQQQFNRTGKAEHGSVALPAVMRSGSSGPETFNVGSM 	Alignment segment 1/1:                                       
						PSPQQQVMVGQMHRGHMPPLTSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMAS 	                                                            
						RVWVQNKVDESKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 	                     Quality: 20207.00                      Escore:       0                                              
						KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVLTAAGSIGQAS 	             Matching length:    2162                Total length:    2266                                               
						GDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKNVAQVAEDTVLQNRVIAAATQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CALSTSQLVACAKVVSPTISSPVCQEQLIEAGKLVDRSVENCVRACQAATTDSELLKQVS 	    Total Percent Similarity:   95.41      Total Percent Identity:   95.41                                               
						AAASVVSQALHDLLQHVRQFASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARV 	                        Gaps:       2                        
						LAQATSDLVNAMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 	                                                            
						RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNAAVSNKNPAAQ 	Alignment:                                                   
						QQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIISSQNFLQPGSKMVSSAKAAVP 	                  .         .         .         .         .  
						TVSDQAAAMQLSQCAKNLATSLAELRTASQKAHEACGPMEIDSALNTVQTLKNELQDAKM 	       1 MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVM 50                                                           
						AAVESQLKPLPGETLEKCAQDLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLAQAARGVAASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 	     292 MSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVM 341                                                          
						KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQSELNQAAADL 	                  .         .         .         .         .  
						NQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMAGQAQTKEDQIQVIGNLKNIS 	      51 RVDEKTKEVLQEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQI 100                                                          
						MASSKLLLAAKSLSVDPGAPNAKNLLAAAARAVTESINQLITLCTQQAPGQKECDNALRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LETVKGMLDNPNEPVSDLSYFDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIA 	     342 RVDEKTKEVLQEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQI 391                                                          
						SKALCGLTEAAAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 	                  .         .         .         .         .  
						QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANLVKTIKALDGD 	     101 SQLIAGYIDIILKKKQSKDRFGLEGDEESTMLEESVSPKKSTILQQQFNR 150                                                          
						FSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQISSEGSQAQEPILVSAKTMLES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSYLIRTARSLAINPKDPPTWSVLAGHSHTVSDSIKSLITSIRDKAPGQRECDYSIDGIN 	     392 SQLIAGYIDIILKKKQSKDRFGLEGDEESTMLEESVSPKKSTILQQQFNR 441                                                          
						RCIRDIEQASLAAVSQSLATRDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGH 	                  .         .         .         .         .  
						KVTQLASYFEPLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 	     151 TGKAEHGSVALPAVMRSGSSGPETFNVGSMPSPQQQVMVGQMHRGHMPPL 200                                                          
						HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDEGTPPEPKGTF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDYQTTVVKYSKAIAVTAQEM                                        	     442 TGKAEHGSVALPAVMRSGSSGPETFNVGSMPSPQQQVMVGQMHRGHMPPL 491                                                          
						least 90 % homologous to corresponding to amino acids 292 -  	                  .         .         .         .         .  
						1872 of TLN2_HUMAN, which also corresponds to amino acids 1 -	     201 TSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMASRVWVQNKVDE 250                                                          
						1581 of M85878_P4, a second amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSLVLSALQAGNKGTQACITAATAVSGIIADLDTTIMFATAGTLNAENSETFADHRENIL 	     492 TSAQQALMGTINTSMHAVQQAQDDLSELDSLPPLGQDMASRVWVQNKVDE 541                                                          
						KTAKALVEDTKLLVSGAASTPDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVL 	                  .         .         .         .         .  
						INAIKDVAKALSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEAT 	     251 SKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 300                                                          
						RGTRALEATIECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAVAAGNSCRQED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VIATANLSRKAVSDMLTACKQASFHPDVSDEVRTRALRFGTECTLGYLDLLEHVLVILQK 	     542 SKHEIHSQVDAITAGTASVVNLTAGDPADTDYTAVGCAITTISSNLTEMS 591                                                          
						PTPEFKQQLAAFSKRVAGAVTELIQAAEAMKGTEWVDPEDPTVIAETELLGAAASIEAAA 	                  .         .         .         .         .  
						KKLEQLKPRAKPKQADETLDFEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIP 	     301 KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVL 350                                                          
						ANAADDGQWSQGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ACKVKADQDSEAMRRLQ                                            	     592 KGVKLLAALMDDEVGSGEDLLRAARTLAGAVSDLLKAVQPTSGEPRQTVL 641                                                          
						least 90 % homologous to corresponding to amino acids 1962 - 	                  .         .         .         .         .  
						2458 of TLN2_HUMAN, which also corresponds to amino acids    	     351 TAAGSIGQASGDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKN 400                                                          
						1582 - 2078 of M85878_P4, a third amino acid sequence being  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least 80%, preferably at least   	     642 TAAGSIGQASGDLLRQIGENETDERFQDVLMSLAKAVANAAAMLVLKAKN 691                                                          
						85%, more preferably at least 90% and most preferably at     	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	     401 VAQVAEDTVLQNRVIAAATQCALSTSQLVACAKVVSPTISSPVCQEQLIE 450                                                          
						VMVTDAGGKILLLER corresponding to amino acids 2079 - 2093 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85878_P4, and a fourth amino acid sequence being at least 90	     692 VAQVAEDTVLQNRVIAAATQCALSTSQLVACAKVVSPTISSPVCQEQLIE 741                                                          
						AAGNAVKRASDNLVRAAQKAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEA 	                  .         .         .         .         .  
						RKKLAQIRQQQYKFLPTELREDEG                                     	     451 AGKLVDRSVENCVRACQAATTDSELLKQVSAAASVVSQALHDLLQHVRQF 500                                                          
						% homologous to corresponding to amino acids 2459 - 2542 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLN2_HUMAN, which also corresponds to amino acids 2094 - 2177	     742 AGKLVDRSVENCVRACQAATTDSELLKQVSAAASVVSQALHDLLQHVRQF 791                                                          
						of M85878_P4, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     501 ASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARVLAQATSDLVN 550                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated chimeric polypeptide encoding for an edge	     792 ASRGEPIGRYDQATDTIMCVTESIFSSMGDAGEMVRQARVLAQATSDLVN 841                                                          
						portion of M85878_P4, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     551 AMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 600                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     842 AMRSDAEAEIDMENSKKLLAAAKLLADSTARMVEAAKGAAANPENEDQQQ 891                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     601 RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNA 650                                                          
						at least two amino acids comprise MV, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     892 RLREAAEGLRVATNAAAQNAIKKKIVNRLEVAAKQAAAAATQTIAASQNA 941                                                          
						1581-x to 1582; and ending at any of amino acid numbers 1582+	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     651 AVSNKNPAAQQQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIIS 700                                                          
						polypeptide encoding for an edge portion of M85878_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     942 AVSNKNPAAQQQLVQSCKAVADHIPQLVQGVRGSQAQAEDLSAQLALIIS 991                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     701 SQNFLQPGSKMVSSAKAAVPTVSDQAAAMQLSQCAKNLATSLAELRTASQ 750                                                          
						least about 95% homologous to the sequence encoding for      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VMVTDAGGKILLLER, corresponding to M85878_P4.                 	     992 SQNFLQPGSKMVSSAKAAVPTVSDQAAAMQLSQCAKNLATSLAELRTASQ 1041                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 KAHEACGPMEIDSALNTVQTLKNELQDAKMAAVESQLKPLPGETLEKCAQ 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1042 KAHEACGPMEIDSALNTVQTLKNELQDAKMAAVESQLKPLPGETLEKCAQ 1091                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALKTLAQAARGVA 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1092 DLGSTSKAVGSSMAQLLTCAAQGNEHYTGVAARETAQALKTLAQAARGVA 1141                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 ASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1142 ASTTDPAAAHAMLDSARDVMEGSAMLIQEAKQALIAPGDAERQQRLAQVA 1191                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQ 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1192 KAVSHSLNNCVNCLPGQKDVDVALKSIGESSKKLLVDSLPPSTKPFQEAQ 1241                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 SELNQAAADLNQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1242 SELNQAAADLNQSAGEVVHATRGQSGELAAASGKFSDDFDEFLDAGIEMA 1291                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 GQAQTKEDQIQVIGNLKNISMASSKLLLAAKSLSVDPGAPNAKNLLAAAA 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1292 GQAQTKEDQIQVIGNLKNISMASSKLLLAAKSLSVDPGAPNAKNLLAAAA 1341                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 RAVTESINQLITLCTQQAPGQKECDNALRELETVKGMLDNPNEPVSDLSY 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1342 RAVTESINQLITLCTQQAPGQKECDNALRELETVKGMLDNPNEPVSDLSY 1391                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 FDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIASKALCGLTEA 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1392 FDCIESVMENSKVLGESMAGISQNAKTGDLPAFGECVGIASKALCGLTEA 1441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 AAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1442 AAQAAYLVGISDPNSQAGHQGLVDPIQFARANQAIQMACQNLVDPGSSPS 1491                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1492 QVLSAATIVAKHTSALCNACRIASSKTANPVAKRHFVQSAKEVANSTANL 1541                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 VKTIKALDGDFSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQIS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1542 VKTIKALDGDFSEDNRNKCRIATAPLIEAVENLTAFASNPEFVSIPAQIS 1591                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 SEGSQAQEPILVSAKTMLESSSYLIRTARSLAINPKDPPTWSVLAGHSHT 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1592 SEGSQAQEPILVSAKTMLESSSYLIRTARSLAINPKDPPTWSVLAGHSHT 1641                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1351 VSDSIKSLITSIRDKAPGQRECDYSIDGINRCIRDIEQASLAAVSQSLAT 1400                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1642 VSDSIKSLITSIRDKAPGQRECDYSIDGINRCIRDIEQASLAAVSQSLAT 1691                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1401 RDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGHKVTQLASYFE 1450                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1692 RDDISVEALQEQLTSVVQEIGHLIDPIATAARGEAAQLGHKVTQLASYFE 1741                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1451 PLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 1500                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1742 PLILAAVGVASKILDHQQQMTVLDQTKTLAESALQMLYAAKEGGGNPKAQ 1791                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1501 HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDE 1550                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1792 HTHDAITEAAQLMKEAVDDIMVTLNEAASEVGLVGGMVDAIAEAMSKLDE 1841                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1551 GTPPEPKGTFVDYQTTVVKYSKAIAVTAQEM................... 1581                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1842 GTPPEPKGTFVDYQTTVVKYSKAIAVTAQEMMTKSVTNPEELGGLASQMT 1891                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1581 .................................................. 1581                                                         
						                                                            	                                                            
						                                                            	    1892 SDYGHLAFQGQMAAATAEPEEIGFQIRTRVQDLGHGCIFLVQKAGALQVC 1941                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1582 ....................VSLVLSALQAGNKGTQACITAATAVSGIIA 1611                                                         
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	    1942 PTDSYTKRELIECARAVTEKVSLVLSALQAGNKGTQACITAATAVSGIIA 1991                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1612 DLDTTIMFATAGTLNAENSETFADHRENILKTAKALVEDTKLLVSGAAST 1661                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1992 DLDTTIMFATAGTLNAENSETFADHRENILKTAKALVEDTKLLVSGAAST 2041                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1662 PDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVLINAIKDVAKA 1711                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2042 PDKLAQAAQSSAATITQLAEVVKLGAASLGSDDPETQVVLINAIKDVAKA 2091                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1712 LSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEAT 1761                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2092 LSDLISATKGAASKPVDDPSMYQLKGAAKVMVTNVTSLLKTVKAVEDEAT 2141                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1762 RGTRALEATIECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAV 1811                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2142 RGTRALEATIECIKQELTVFQSKDVPEKTSSPEESIRMTKGITMATAKAV 2191                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1812 AAGNSCRQEDVIATANLSRKAVSDMLTACKQASFHPDVSDEVRTRALRFG 1861                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2192 AAGNSCRQEDVIATANLSRKAVSDMLTACKQASFHPDVSDEVRTRALRFG 2241                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1862 TECTLGYLDLLEHVLVILQKPTPEFKQQLAAFSKRVAGAVTELIQAAEAM 1911                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2242 TECTLGYLDLLEHVLVILQKPTPEFKQQLAAFSKRVAGAVTELIQAAEAM 2291                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1912 KGTEWVDPEDPTVIAETELLGAAASIEAAAKKLEQLKPRAKPKQADETLD 1961                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2292 KGTEWVDPEDPTVIAETELLGAAASIEAAAKKLEQLKPRAKPKQADETLD 2341                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1962 FEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIPANAADDGQWS 2011                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2342 FEEQILEAAKSIAAATSALVKSASAAQRELVAQGKVGSIPANAADDGQWS 2391                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2012 QGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLV 2061                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2392 QGLISAARMVAAATSSLCEAANASVQGHASEEKLISSAKQVAASTAQLLV 2441                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2062 ACKVKADQDSEAMRRLQVMVTDAGGKILLLERAAGNAVKRASDNLVRAAQ 2111                                                         
						                                                            	         |||||||||||||||||               ||||||||||||||||||  
						                                                            	    2442 ACKVKADQDSEAMRRLQ...............AAGNAVKRASDNLVRAAQ 2476                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    2112 KAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEARKKLAQIR 2161                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    2477 KAAFGKADDDDVVVKTKFVGGIAQIIAAQEEMLKKERELEEARKKLAQIR 2526                                                         
						                                                            	                  .                                          
						                                                            	    2162 QQQYKFLPTELREDEG                                   2177                                                         
						                                                            	         ||||||||||||||||                                    
						                                                            	    2527 QQQYKFLPTELREDEG                                   2542                                                         

7794	HMR136_M85905_2_tr0_r1_1_gPRT		Comparison report between M85905_P2 and NFIB_HUMAN_V1partial 	Sequence name: NFIB_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85905_P2, comprising a first amino 	Sequence documentation:                                      
						MYSPICLTQDEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDEL 	                                                            
						LSEKPEIKQKWASRLLAKLRKDIRQEYREDFVLTVTGKKHPCCVLSNPDQKGKIRRIDCL 	Alignment of: 7794 x NFIB_HUMAN_V1   ..                      
						RQADKVWRLDLVMVILFKGIPLESTDGERLMKSPHCTNPALCVQPHHITVSVKELDLFLA 	                                                            
						YYVQEQDSGQSGSPSHNDPAKNPPGYLEDSFVKSGVFNVSELVRVSRTPITQGTGVNFPI 	Alignment segment 1/1:                                       
						GEIPSQPYYHDMNSGVNLQRSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSR 	                                                            
						TWHERDQDMSSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVAHSVISTRTPP 	                     Quality: 4170.00                      Escore:       0                                               
						PPSPLPFPTQAILPPAPSSYFSHPTIRYPPHLNPQDTLKNYVPSYDPSSPQTSQ       	             Matching length:     414                Total length:     414                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 2 - 415 of NFIB_HUMAN_V1, which also          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 414 of M85905_P2, and a second	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITTSTEAYTASGTSQANRYV 	       1 MYSPICLTQDEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSK 50                                                           
						GLSPRDPSFLHQQQSWYLG                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 415 - 493 of	       2 MYSPICLTQDEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSK 51                                                           
						M85905_P2, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      51 DEERAVKDELLSEKPEIKQKWASRLLAKLRKDIRQEYREDFVLTVTGKKH 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85905_P2, comprising a polypeptide being at least 70%,      	      52 DEERAVKDELLSEKPEIKQKWASRLLAKLRKDIRQEYREDFVLTVTGKKH 101                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 PCCVLSNPDQKGKIRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERL 150                                                          
						PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITTSTEAYTASGTSQANRYV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GLSPRDPSFLHQQQSWYLG                                          	     102 PCCVLSNPDQKGKIRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERL 151                                                          
						least about 95% homologous to the sequence in M85905_P2.     	                  .         .         .         .         .  
						                                                            	     151 MKSPHCTNPALCVQPHHITVSVKELDLFLAYYVQEQDSGQSGSPSHNDPA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 MKSPHCTNPALCVQPHHITVSVKELDLFLAYYVQEQDSGQSGSPSHNDPA 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KNPPGYLEDSFVKSGVFNVSELVRVSRTPITQGTGVNFPIGEIPSQPYYH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 KNPPGYLEDSFVKSGVFNVSELVRVSRTPITQGTGVNFPIGEIPSQPYYH 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DMNSGVNLQRSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 DMNSGVNLQRSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSR 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TWHERDQDMSSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 TWHERDQDMSSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVA 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HSVISTRTPPPPSPLPFPTQAILPPAPSSYFSHPTIRYPPHLNPQDTLKN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 HSVISTRTPPPPSPLPFPTQAILPPAPSSYFSHPTIRYPPHLNPQDTLKN 401                                                          
						                                                            	                  .                                          
						                                                            	     401 YVPSYDPSSPQTSQ                                     414                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     402 YVPSYDPSSPQTSQ                                     415                                                          

7796	HMR136_M85905_9_tr0_r1_1_gPRT		Comparison report between M85905_P9 and NFIB_HUMAN_V1unique  	Sequence name: NFIB_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for M85905_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7796 x NFIB_HUMAN_V1   ..                      
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MCRCEMLD corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of M85905_P9, and a second amino acid sequence being at    	                                                            
						DEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDELLSEKPEIKQ 	                     Quality: 4130.00                      Escore:       0                                               
						KWASRLLAKLRKDIRQEYREDFVLTVTGKKHPCCVLSNPDQKGKIRRIDCLRQADKVWRL 	             Matching length:     410                Total length:     410                                               
						DLVMVILFKGIPLESTDGERLMKSPHCTNPALCVQPHHITVSVKELDLFLAYYVQEQDSG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QSGSPSHNDPAKNPPGYLEDSFVKSGVFNVSELVRVSRTPITQGTGVNFPIGEIPSQPYY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HDMNSGVNLQRSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSRTWHERDQDM 	                        Gaps:       0                        
						SSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVAHSVISTRTPPPPSPLPFPT 	                                                            
						QAILPPAPSSYFSHPTIRYPPHLNPQDTLKNYVPSYDPSSPQTSQSWYLG           	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 11 -   	                  .         .         .         .         .  
						420 of NFIB_HUMAN_V1, which also corresponds to amino acids 9	       9 DEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDE 58                                                           
						- 418 of M85905_P9, wherein said first amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and second amino acid sequence are contiguous and in a       	      11 DEFHPFIEALLPHVRAIAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDE 60                                                           
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						head of M85905_P9, comprising a polypeptide being at least   	      59 LLSEKPEIKQKWASRLLAKLRKDIRQEYREDFVLTVTGKKHPCCVLSNPD 108                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      61 LLSEKPEIKQKWASRLLAKLRKDIRQEYREDFVLTVTGKKHPCCVLSNPD 110                                                          
						at least about 95% homologous to the sequence MCRCEMLD of    	                  .         .         .         .         .  
						M85905_P9.                                                   	     109 QKGKIRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERLMKSPHCTNP 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     111 QKGKIRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERLMKSPHCTNP 160                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 ALCVQPHHITVSVKELDLFLAYYVQEQDSGQSGSPSHNDPAKNPPGYLED 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     161 ALCVQPHHITVSVKELDLFLAYYVQEQDSGQSGSPSHNDPAKNPPGYLED 210                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 SFVKSGVFNVSELVRVSRTPITQGTGVNFPIGEIPSQPYYHDMNSGVNLQ 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     211 SFVKSGVFNVSELVRVSRTPITQGTGVNFPIGEIPSQPYYHDMNSGVNLQ 260                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 RSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSRTWHERDQDM 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     261 RSLSSPPSSKRPKTISIDENMEPSPTGDFYPSPSSPAAGSRTWHERDQDM 310                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 SSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVAHSVISTRTP 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     311 SSPTTMKKPEKPLFSSASPQDSSPRLSTFPQHHHPGIPGVAHSVISTRTP 360                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 PPPSPLPFPTQAILPPAPSSYFSHPTIRYPPHLNPQDTLKNYVPSYDPSS 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     361 PPPSPLPFPTQAILPPAPSSYFSHPTIRYPPHLNPQDTLKNYVPSYDPSS 410                                                          
						                                                            	                  .                                          
						                                                            	     409 PQTSQSWYLG                                         418                                                          
						                                                            	         ||||||||||                                          
						                                                            	     411 PQTSQSWYLG                                         420                                                          

10702	HMR136_M85909_15_tr0_r1_1_gPRT		Comparison report between M85909_P15 and NCO6_HUMANpartial   	Sequence name: NCO6_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85909_P15, comprising a first amino	Sequence documentation:                                      
						MVLDDLPNLEDIYTSLCSSTMEDSEMDFDSGLEDDDTKSDSILEDSTIFVAFKGNIDDKD 	                                                            
						FKWKLDAILKNVPNLLHMESSKLKVQKVEPWNSVRVTFNIPREAAERLRILAQSNNQQLR 	Alignment of: 10702 x NCO6_HUMAN   ..                        
						DLGILSVQIEGEGAINLALAQNRSQDVRMNGPMGAGNSVRMEAGFPMASGPGIIRMNNPA 	                                                            
						TVMIPPGGNVSSSMMAPGPNPELQPRTPRPASQSDAMDPLLSGLHIQQQSHPSGSLAPPH 	Alignment segment 1/1:                                       
						HPMQPVSVNRQMNPANFPQLQQQQQQQQQQQQQQQQQQQQQQQQQLQARPPQQHQQQQPQ 	                                                            
						GIRPQFTAPTQVPVPPGWNQLPSGALQPPPAQGSLGTMTANQGWKKAPLPGPMQQQLQAR 	                     Quality: 5173.00                      Escore:       0                                               
						PSLATVQTPSHPPPPYPFGSQQASQAHTNFPQMSNPGQFTAPQMKSLQGGPSRVPTPLQQ 	             Matching length:     510                Total length:     510                                               
						PHLTNKSPASSPSSFQQGSPASSPTVNQTQQQMGPRPPQNNPLPQGFQQPVSSPGRNPMV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QQGNVPPNFMVMQQQPPNQGPQSLHPGLGG                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 510 of NCO6_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 510 of M85909_P15, and a second amino acid	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MVLDDLPNLEDIYTSLCSSTMEDSEMDFDSGLEDDDTKSDSILEDSTIFV 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence EEHCSYLCW corresponding to amino acids   	       1 MVLDDLPNLEDIYTSLCSSTMEDSEMDFDSGLEDDDTKSDSILEDSTIFV 50                                                           
						511 - 519 of M85909_P15, wherein said first amino acid       	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	      51 AFKGNIDDKDFKWKLDAILKNVPNLLHMESSKLKVQKVEPWNSVRVTFNI 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of M85909_P15, comprising a polypeptide being at least  	      51 AFKGNIDDKDFKWKLDAILKNVPNLLHMESSKLKVQKVEPWNSVRVTFNI 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 PREAAERLRILAQSNNQQLRDLGILSVQIEGEGAINLALAQNRSQDVRMN 150                                                          
						at least about 95% homologous to the sequence EEHCSYLCW in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85909_P15.                                                  	     101 PREAAERLRILAQSNNQQLRDLGILSVQIEGEGAINLALAQNRSQDVRMN 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GPMGAGNSVRMEAGFPMASGPGIIRMNNPATVMIPPGGNVSSSMMAPGPN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GPMGAGNSVRMEAGFPMASGPGIIRMNNPATVMIPPGGNVSSSMMAPGPN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PELQPRTPRPASQSDAMDPLLSGLHIQQQSHPSGSLAPPHHPMQPVSVNR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PELQPRTPRPASQSDAMDPLLSGLHIQQQSHPSGSLAPPHHPMQPVSVNR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QMNPANFPQLQQQQQQQQQQQQQQQQQQQQQQQQQLQARPPQQHQQQQPQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QMNPANFPQLQQQQQQQQQQQQQQQQQQQQQQQQQLQARPPQQHQQQQPQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GIRPQFTAPTQVPVPPGWNQLPSGALQPPPAQGSLGTMTANQGWKKAPLP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GIRPQFTAPTQVPVPPGWNQLPSGALQPPPAQGSLGTMTANQGWKKAPLP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 GPMQQQLQARPSLATVQTPSHPPPPYPFGSQQASQAHTNFPQMSNPGQFT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GPMQQQLQARPSLATVQTPSHPPPPYPFGSQQASQAHTNFPQMSNPGQFT 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 APQMKSLQGGPSRVPTPLQQPHLTNKSPASSPSSFQQGSPASSPTVNQTQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 APQMKSLQGGPSRVPTPLQQPHLTNKSPASSPSSFQQGSPASSPTVNQTQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 QQMGPRPPQNNPLPQGFQQPVSSPGRNPMVQQGNVPPNFMVMQQQPPNQG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QQMGPRPPQNNPLPQGFQQPVSSPGRNPMVQQGNVPPNFMVMQQQPPNQG 500                                                          
						                                                            	                  .                                          
						                                                            	     501 PQSLHPGLGG                                         510                                                          
						                                                            	         ||||||||||                                          
						                                                            	     501 PQSLHPGLGG                                         510                                                          

15317	HMR136_M85921_10_tr0_r1_1_gPRT		Comparison report between M85921_P10 and Q99974partial WT    	Sequence name: Q99974                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85921_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARWY          	Alignment of: 15317 x Q99974   ..                            
						corresponding to amino acids 1 - 51 of Q99974, which also    	                                                            
						corresponds to amino acids 1 - 51 of M85921_P10, and a second	Alignment segment 1/1:                                       
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                     Quality:  519.00                      Escore:       0                                               
						and most preferably at least 95% homologous to a polypeptide 	             Matching length:      51                Total length:      51                                               
						having the sequence VSV corresponding to amino acids 52 - 54 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of M85921_P10, wherein said first amino acid sequence and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence are contiguous and in a sequential	                        Gaps:       0                        
						order.                                                       	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARW 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARW 50                                                           
						                                                            	                                                             
						                                                            	      51 Y                                                  51                                                           
						                                                            	         |                                                   
						                                                            	      51 Y                                                  51                                                           

						Comparison report between M85921_P10 and BAA24862partial WT  	Sequence name: BAA24862                                      
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M85921_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARWY          	Alignment of: 15317 x BAA24862   ..                          
						corresponding to amino acids 26 - 76 of BAA24862, which also 	                                                            
						corresponds to amino acids 1 - 51 of M85921_P10, and a second	Alignment segment 1/1:                                       
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                     Quality:  519.00                      Escore:       0                                               
						and most preferably at least 95% homologous to a polypeptide 	             Matching length:      51                Total length:      51                                               
						having the sequence VSV corresponding to amino acids 52 - 54 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of M85921_P10, wherein said first amino acid sequence and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence are contiguous and in a sequential	                        Gaps:       0                        
						order.                                                       	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARW 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      26 MPRIMIKGGVWRNTEDEILKAAVMKYGKNQWSRIASLLHRKSAKQCKARW 75                                                           
						                                                            	                                                             
						                                                            	      51 Y                                                  51                                                           
						                                                            	         |                                                   
						                                                            	      76 Y                                                  76                                                           

338	HMR136_M85931_1_tr0_r1_1_gPRT		Comparison report between M85931_P1 and Q9UK51unique head    	Sequence name: Q9UK51                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85931_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 338 x Q9UK51   ..                              
						more preferably at least 90% and most preferably at least 95%	                                                            
						AINGLRRGRQNAVTATRPKASKMSYTLDSLGNPSAYRRVTETRSSFSRVSGSPSSGFRSQ 	Alignment segment 1/1:                                       
						SWSRGSPSTVSSSYKRSMLAPRLAYSSAMLSSAESSLDFSQSSSLLNGGSGPGGDYKLSR 	                                                            
						SNEKEQLQGLNDRFAGYIEKVHYLEQQNKEIEAEIQALRQKQASHAQLGDAYDQEIRELR 	                     Quality: 1597.00                      Escore:       0                                               
						ATLEMVNHEKAQVQLDSDHLEEDIHRLKERFEEEARLRDDTEAAIRALRKDIEEASLVKV 	             Matching length:     169                Total length:     169                                               
						ELDKKVQSLQDEVAFLRSNHEEEVADLLAQIQASHITVERKDYLKTDISTALKEIRSQLE 	 Matching Percent Similarity:   99.41   Matching Percent Identity:   99.41                                               
						SHSDQNMHQAEEWFKCRYAKLTEAAEQNKEAIRSAKEEIAEYRRQLQSKSIELESVRGTK 	    Total Percent Similarity:   99.41      Total Percent Identity:   99.41                                               
						ESLERQLSDIEERHNHDLSSYQDTIQQLENELRGTKWEMARHLREYQDLLNVKMALDIEI 	                        Gaps:       0                        
						AAYRKLLEGEETRFSTFAGSITGPLYTHRPPITISSKIQKP                    	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 461 of M85931_P1, a second amino acid     	                  .         .         .         .         .  
						KVEAPKLKVQHKFVEEIIEETKVEDEKSEMEEALTAITEELAVSMKEEKKEAAEEKEEEP 	     460 KPKVEAPKLKVQHKFVEEIIEETKVEDEKSEMEEALTAITEELAVSMKEE 509                                                          
						EAEEEEVAAKKSPVKATAPEVKEEEGEKEEEEGQEEEEEEDEGAKSDQAEEGGSEKEGSS 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						EKEEGEQEEGETEAEAEGEEAEAKEEKKVEEKSEEVATKEELVADAK              	       1 KTKVEAPKLKVQHKFVEEIIEETKVEDEKSEMEEALTAITEELAVSMKEE 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 3 - 169 of Q9UK51, which also corresponds to     	     510 KKEAAEEKEEEPEAEEEEVAAKKSPVKATAPEVKEEEGEKEEEEGQEEEE 559                                                          
						amino acids 462 - 628 of M85931_P1, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 KKEAAEEKEEEPEAEEEEVAAKKSPVKATAPEVKEEEGEKEEEEGQEEEE 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     560 EEDEGAKSDQAEEGGSEKEGSSEKEEGEQEEGETEAEAEGEEAEAKEEKK 609                                                          
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKPNLLCQNHQWKRQSQKQKWGKVNRKRKKKRKSRKLPRKRR corresponding to  	     101 EEDEGAKSDQAEEGGSEKEGSSEKEEGEQEEGETEAEAEGEEAEAKEEKK 150                                                          
						amino acids 629 - 670 of M85931_P1, wherein said first amino 	                  .                                          
						acid sequence, second amino acid sequence and third amino    	     610 VEEKSEEVATKEELVADAK                                628                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         |||||||||||||||||||                                 
						isolated polypeptide encoding for a head of M85931_P1,       	     151 VEEKSEEVATKEELVADAK                                169                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						AINGLRRGRQNAVTATRPKASKMSYTLDSLGNPSAYRRVTETRSSFSRVSGSPSSGFRSQ 	                                                            
						SWSRGSPSTVSSSYKRSMLAPRLAYSSAMLSSAESSLDFSQSSSLLNGGSGPGGDYKLSR 	                                                            
						SNEKEQLQGLNDRFAGYIEKVHYLEQQNKEIEAEIQALRQKQASHAQLGDAYDQEIRELR 	                                                            
						ATLEMVNHEKAQVQLDSDHLEEDIHRLKERFEEEARLRDDTEAAIRALRKDIEEASLVKV 	                                                            
						ELDKKVQSLQDEVAFLRSNHEEEVADLLAQIQASHITVERKDYLKTDISTALKEIRSQLE 	                                                            
						SHSDQNMHQAEEWFKCRYAKLTEAAEQNKEAIRSAKEEIAEYRRQLQSKSIELESVRGTK 	                                                            
						ESLERQLSDIEERHNHDLSSYQDTIQQLENELRGTKWEMARHLREYQDLLNVKMALDIEI 	                                                            
						AAYRKLLEGEETRFSTFAGSITGPLYTHRPPITISSKIQKP                    	                                                            
						about 95% homologous to the sequence of M85931_P1.3.An       	                                                            
						isolated polypeptide encoding for a tail of M85931_P1,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						RKPNLLCQNHQWKRQSQKQKWGKVNRKRKKKRKSRKLPRKRR in M85931_P1.     	                                                            

17648	HMR136_M85939_21_tr0_r1_1_gPRT		Comparison report between M85939_P21 and LCFF_HUMANpartial   	Sequence name: LCFF_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for M85939_P21, comprising a first amino	Sequence documentation:                                      
						MQTQEILRILRLPELGDLGQFFRSLSATTLVSMGALAAILAYWFTHRPKALQPPCNLLMQ 	                                                            
						SEEVEDSGGARRSVIGSGPQLLTHYYDDARTMYQVFRRGLSISGNGPCLGFRKPKQPYQW 	Alignment of: 17648 x LCFF_HUMAN   ..                        
						LSYQEVADRAEFLGSGLLQHNCKACTDQFIGVFAQNRPEWIIVELACYTYSMVVVPLYDT 	                                                            
						LGPGAIRYIINTADISTVIVDKPQKAVLLLEHVERKETPGLKLIILMDPFEEALKERGQK 	Alignment segment 1/1:                                       
						CGVVIKSMQAVEDCGQENHQAPVPPQPDDLSIVCFTSGTTGNPKGAMLTHGNVVADFSGF 	                                                            
						LKVTESQWAPTCADVHISYLPLAHMFERMVQ                              	                     Quality: 3260.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     331                Total length:     331                                               
						to amino acids 1 - 331 of LCFF_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 331 of M85939_P21, and a second amino acid	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence VRPWHQGGTLCA corresponding to amino acids	                  .         .         .         .         .  
						332 - 343 of M85939_P21, wherein said first amino acid       	       1 MQTQEILRILRLPELGDLGQFFRSLSATTLVSMGALAAILAYWFTHRPKA 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MQTQEILRILRLPELGDLGQFFRSLSATTLVSMGALAAILAYWFTHRPKA 50                                                           
						tail of M85939_P21, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 LQPPCNLLMQSEEVEDSGGARRSVIGSGPQLLTHYYDDARTMYQVFRRGL 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence VRPWHQGGTLCA in	      51 LQPPCNLLMQSEEVEDSGGARRSVIGSGPQLLTHYYDDARTMYQVFRRGL 100                                                          
						M85939_P21.                                                  	                  .         .         .         .         .  
						                                                            	     101 SISGNGPCLGFRKPKQPYQWLSYQEVADRAEFLGSGLLQHNCKACTDQFI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SISGNGPCLGFRKPKQPYQWLSYQEVADRAEFLGSGLLQHNCKACTDQFI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GVFAQNRPEWIIVELACYTYSMVVVPLYDTLGPGAIRYIINTADISTVIV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GVFAQNRPEWIIVELACYTYSMVVVPLYDTLGPGAIRYIINTADISTVIV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DKPQKAVLLLEHVERKETPGLKLIILMDPFEEALKERGQKCGVVIKSMQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DKPQKAVLLLEHVERKETPGLKLIILMDPFEEALKERGQKCGVVIKSMQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VEDCGQENHQAPVPPQPDDLSIVCFTSGTTGNPKGAMLTHGNVVADFSGF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VEDCGQENHQAPVPPQPDDLSIVCFTSGTTGNPKGAMLTHGNVVADFSGF 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 LKVTESQWAPTCADVHISYLPLAHMFERMVQ                    331                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     301 LKVTESQWAPTCADVHISYLPLAHMFERMVQ                    331                                                          

17827	HMR136_M85947_4_tr0_r1_1_gPRT		Comparison report between M85947_P4 and VP39_HUMANpartial WT 	Sequence name: VP39_HUMAN                                    
						sequence featuring skipped exon plus extra amino acids and a 	                                                            
						featuring a skipped exon.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for M85947_P4, comprising a first amino acid        	                                                            
						sequence being at least 90 % homologous to                   	Alignment of: 17827 x VP39_HUMAN   ..                        
						MHDAFEPVPILEKLPLQIDCLAAWEEWLLVGTKQGHLLLYRIRKDV corresponding 	                                                            
						to amino acids 1 - 46 of VP39_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 46 of M85947_P4, a second amino acid      	                                                            
						sequence bridging amino acid sequence comprising of G, a     	                     Quality: 8071.00                      Escore:       0                                               
						CNRFEVTLEKSNKNFSKKIQQIHVVSQFKILVSLLENNIYVHDLLTFQQITTVSKAKGAS 	             Matching length:     842                Total length:     886                                               
						LFTCD                                                        	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.88                                               
						third amino acid sequence being at least 90 % homologous to  	    Total Percent Similarity:   94.92      Total Percent Identity:   94.92                                               
						corresponding to amino acids 59 - 123 of VP39_HUMAN, which   	                        Gaps:       2                        
						also corresponds to amino acids 48 - 112 of M85947_P4, and a 	                                                            
						LQGDFSVPDVPKSMAWCENSICVGFKRDYYLIRVDGKGSIKELFPTGKQLEPLVAPLADG 	Alignment:                                                   
						KVAVGQDDLTVVLNEEGICTQKCALNWTDIPVAMEHQPPYIIAVLPRYVEIRTFEPRLLV 	                  .         .         .         .         .  
						QSIELQRPRFITSGGSNIIYVASNHFVWRLIPVPMATQIQQLLQDKQFELALQLAEMKDD 	       1 MHDAFEPVPILEKLPLQIDCLAAWEEWLLVGTKQGHLLLYRIRKDV.... 46                                                           
						SDSEKQQQIHHIKNLYAFNLFCQKRFDESMQVFAKLGTDPTHVMGLYPDLLPTDYRKQLQ 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						YPNPLPVLSGAELEKAHLALIDYLTQKRSQLVKKLNDSDHQSSTSPLMEGTPTIKSKKKL 	       1 MHDAFEPVPILEKLPLQIDCLAAWEEWLLVGTKQGHLLLYRIRKDVVPAD 50                                                           
						LQIIDTTLLKCYLHTNVALVAPLLRLENNHCHIEESEHVLKKAHKYSELIILYEKKGLHE 	                  .         .         .         .         .  
						KALQVLVDQSKKANSPLKGHERTVQYLQHLGTENLHLIFSYSVWVLRDFPEDGLKIFTED 	      47 .......GCNRFEVTLEKSNKNFSKKIQQIHVVSQFKILVSLLENNIYVH 89                                                           
						LPEVESLPRDRVLGFLIENFKGLAIPYLEHIIHVWEETGSRFHNCLIQLYCEKVQGLMKE 	                 ||||||||||||||||||||||||||||||||||||||||||  
						YLLSFPAGKTPVPAGEEEGELGEYRQKLLMFLEISSYYDPGRLICDFPFDGLLEERALLL 	      51 VASPESGSCNRFEVTLEKSNKNFSKKIQQIHVVSQFKILVSLLENNIYVH 100                                                          
						GRMGKHEQALFIYVHILKDTRMAEEYCHKHYDRNKDGNKDVYLSLLRMYLSPPSIHCLGP 	                  .         .         .         .         .  
						IKLELLEPKANLQAALQVLELHHSKLDTTKALNLLPANTQINDIRIFLEKVLEENAQKKR 	      90 DLLTFQQITTVSKAKGASLFTCD........................... 112                                                          
						FNQVLKNLLHAEFLRVQEERILHQQVKCIITEEKVCMVCKKKIGNSAFARYPNGVVVHYF 	         |||||||||||||||||||||||                             
						CSKEVNPADT                                                   	     101 DLLTFQQITTVSKAKGASLFTCDLQHTETGEEVLQMCVAVKKKLQLYFWK 150                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 157 - 886 of VP39_HUMAN, which  	     113 ......LQGDFSVPDVPKSMAWCENSICVGFKRDYYLIRVDGKGSIKELF 156                                                          
						also corresponds to amino acids 113 - 842 of M85947_P4,      	               ||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     151 DREFHELQGDFSVPDVPKSMAWCENSICVGFKRDYYLIRVDGKGSIKELF 200                                                          
						sequence, third amino acid sequence and fourth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     157 PTGKQLEPLVAPLADGKVAVGQDDLTVVLNEEGICTQKCALNWTDIPVAM 206                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85947_P4, comprising a polypeptide having a length "n",     	     201 PTGKQLEPLVAPLADGKVAVGQDDLTVVLNEEGICTQKCALNWTDIPVAM 250                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     207 EHQPPYIIAVLPRYVEIRTFEPRLLVQSIELQRPRFITSGGSNIIYVASN 256                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 EHQPPYIIAVLPRYVEIRTFEPRLLVQSIELQRPRFITSGGSNIIYVASN 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise VGC having a structure as  	     257 HFVWRLIPVPMATQIQQLLQDKQFELALQLAEMKDDSDSEKQQQIHHIKN 306                                                          
						follows (numbering according to M85947_P4): a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 46-x to 46; and      	     301 HFVWRLIPVPMATQIQQLLQDKQFELALQLAEMKDDSDSEKQQQIHHIKN 350                                                          
						ending at any of amino acid numbers 48 + ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.3.An isolated chimeric          	     307 LYAFNLFCQKRFDESMQVFAKLGTDPTHVMGLYPDLLPTDYRKQLQYPNP 356                                                          
						polypeptide encoding for an edge portion of M85947_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     351 LYAFNLFCQKRFDESMQVFAKLGTDPTHVMGLYPDLLPTDYRKQLQYPNP 400                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     357 LPVLSGAELEKAHLALIDYLTQKRSQLVKKLNDSDHQSSTSPLMEGTPTI 406                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     401 LPVLSGAELEKAHLALIDYLTQKRSQLVKKLNDSDHQSSTSPLMEGTPTI 450                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise DL, having a structure as follows: a sequence       	     407 KSKKKLLQIIDTTLLKCYLHTNVALVAPLLRLENNHCHIEESEHVLKKAH 456                                                          
						starting from any of amino acid numbers 112-x to 113; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 113+ ((n-2) - x), in     	     451 KSKKKLLQIIDTTLLKCYLHTNVALVAPLLRLENNHCHIEESEHVLKKAH 500                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     457 KYSELIILYEKKGLHEKALQVLVDQSKKANSPLKGHERTVQYLQHLGTEN 506                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KYSELIILYEKKGLHEKALQVLVDQSKKANSPLKGHERTVQYLQHLGTEN 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     507 LHLIFSYSVWVLRDFPEDGLKIFTEDLPEVESLPRDRVLGFLIENFKGLA 556                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LHLIFSYSVWVLRDFPEDGLKIFTEDLPEVESLPRDRVLGFLIENFKGLA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     557 IPYLEHIIHVWEETGSRFHNCLIQLYCEKVQGLMKEYLLSFPAGKTPVPA 606                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 IPYLEHIIHVWEETGSRFHNCLIQLYCEKVQGLMKEYLLSFPAGKTPVPA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     607 GEEEGELGEYRQKLLMFLEISSYYDPGRLICDFPFDGLLEERALLLGRMG 656                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GEEEGELGEYRQKLLMFLEISSYYDPGRLICDFPFDGLLEERALLLGRMG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     657 KHEQALFIYVHILKDTRMAEEYCHKHYDRNKDGNKDVYLSLLRMYLSPPS 706                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 KHEQALFIYVHILKDTRMAEEYCHKHYDRNKDGNKDVYLSLLRMYLSPPS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     707 IHCLGPIKLELLEPKANLQAALQVLELHHSKLDTTKALNLLPANTQINDI 756                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 IHCLGPIKLELLEPKANLQAALQVLELHHSKLDTTKALNLLPANTQINDI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     757 RIFLEKVLEENAQKKRFNQVLKNLLHAEFLRVQEERILHQQVKCIITEEK 806                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 RIFLEKVLEENAQKKRFNQVLKNLLHAEFLRVQEERILHQQVKCIITEEK 850                                                          
						                                                            	                  .         .         .                      
						                                                            	     807 VCMVCKKKIGNSAFARYPNGVVVHYFCSKEVNPADT               842                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     851 VCMVCKKKIGNSAFARYPNGVVVHYFCSKEVNPADT               886                                                          

18124	HMR136_M85954_6_tr0_r1_1_gPRT		Comparison report between M85954_P6 and MK14_HUMANpartial WT 	Sequence name: MK14_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85954_P6, comprising a first amino acid        	                                                            
						MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 	Alignment of: 18124 x MK14_HUMAN   ..                        
						QSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES                         	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 265 - 360 of MK14_HUMAN, which also corresponds  	                                                            
						to amino acids 1 - 96 of M85954_P6.                          	                     Quality:  948.00                      Escore:       0                                               
						                                                            	             Matching length:      96                Total length:      96                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     265 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314                                                          
						                                                            	                  .         .         .         .            
						                                                            	      51 DDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES     96                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     315 DDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES     360                                                          

18122	HMR136_M85954_9_tr0_r1_1_gPRT		Comparison report between M85954_P9 and MK14_HUMANpartial WT 	Sequence name: MK14_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85954_P9, comprising a first amino 	Sequence documentation:                                      
						MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 	                                                            
						SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 	Alignment of: 18122 x MK14_HUMAN   ..                        
						KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 	                                                            
						GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 	Alignment segment 1/1:                                       
						TPGAELLKKISSES                                               	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2492.00                      Escore:       0                                               
						to amino acids 1 - 254 of MK14_HUMAN, which also corresponds 	             Matching length:     254                Total length:     254                                               
						to amino acids 1 - 254 of M85954_P9, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DAKP corresponding to amino acids 255 -  	Alignment:                                                   
						258 of M85954_P9, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 50                                                           
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85954_P9, comprising a polypeptide being at least 70%,      	       1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 50                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	      51 AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100                                                          
						least about 95% homologous to the sequence DAKP in M85954_P9.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250                                                          
						                                                            	                                                             
						                                                            	     251 SSES                                               254                                                          
						                                                            	         ||||                                                
						                                                            	     251 SSES                                               254                                                          

18246	HMR136_M85957_10_tr0_r1_1_gPRT		Comparison report between M85957_P10 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85957_P10, comprising a first amino acid       	                                                            
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	Alignment of: 18246 x Q9H8M7   ..                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment segment 1/1:                                       
						RCLQTKWPYIELLWTTDRSPSLN                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2010.00                      Escore:       0                                               
						amino acids 243 - 445 of Q9H8M7, which also corresponds to   	             Matching length:     203                Total length:     203                                               
						amino acids 1 - 203 of M85957_P10.                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 442                                                          
						                                                            	                                                             
						                                                            	     201 SLN                                                203                                                          
						                                                            	         |||                                                 
						                                                            	     443 SLN                                                445                                                          

18248	HMR136_M85957_11_tr0_r1_1_gPRT		Comparison report between M85957_P11 and Q9H3I4unique head   	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18248 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQEEEQKELLCHTLCDILESACCDHSGSYCL 	Alignment segment 1/1:                                       
						VSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDA 	                                                            
						VLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTG 	                     Quality: 2010.00                      Escore:       0                                               
						HAVSNVWDGDRECSG                                              	             Matching length:     203                Total length:     203                                               
						having the sequence corresponding to amino acids 1 - 195 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M85957_P11, and a second amino acid sequence being at least  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                        Gaps:       0                        
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment:                                                   
						RCLQTKWPYIELLWTTDRSPSLN                                      	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 203 of   	     196 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 245                                                          
						Q9H3I4, which also corresponds to amino acids 196 - 398 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85957_P11, wherein said first amino acid sequence and second	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     246 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 295                                                          
						M85957_P11, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQEEEQKELLCHTLCDILESACCDHSGSYCL 	     296 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 345                                                          
						VSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTG 	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						HAVSNVWDGDRECSG                                              	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85957_P11.    	     346 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 395                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	                                                             
						                                                            	     396 SLN                                                398                                                          
						                                                            	         |||                                                 
						                                                            	     201 SLN                                                203                                                          

						Comparison report between M85957_P11 and Q8WUF1partial WT    	Sequence name: Q8WUF1                                        
						sequence featuring skipped exon, a mismatch and a followed by	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85957_P11, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to MSELTKELMELVWGTKSSPGLSDTIFCRWTQ     	Alignment of: 18248 x Q8WUF1   ..                            
						corresponding to amino acids 1 - 31 of Q8WUF1, which also    	                                                            
						corresponds to amino acids 1 - 31 of M85957_P11, a second    	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						EEEQKELLCHTLCDILE corresponding to amino acids 79 - 95 of    	                     Quality:  786.00                      Escore:       0                                               
						Q8WUF1, which also corresponds to amino acids 32 - 48 of     	             Matching length:      89                Total length:     136                                               
						M85957_P11, a bridging amino acid S corresponding to amino   	 Matching Percent Similarity:   98.88   Matching Percent Identity:   98.88                                               
						acid 49 of M85957_P11, a third amino acid sequence being at  	    Total Percent Similarity:   64.71      Total Percent Identity:   64.71                                               
						least 90 % homologous to                                     	                        Gaps:       1                        
						ACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS corresponding to    	                                                            
						amino acids 97 - 136 of Q8WUF1, which also corresponds to    	Alignment:                                                   
						amino acids 50 - 89 of M85957_P11, and a fourth amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQ................... 31                                                           
						preferably at least 85%, more preferably at least 90% and    	         |||||||||||||||||||||||||||||||                     
						most preferably at least 95% homologous to a polypeptide     	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                  .         .         .         .         .  
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	      32 ............................EEEQKELLCHTLCDILESACCD 53                                                           
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                     ||||||||||||||||| ||||  
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILEGACCD 100                                                          
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	                  .         .         .                      
						TTDRSPSLN                                                    	      54 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               89                                                           
						having the sequence corresponding to amino acids 90 - 398 of 	         ||||||||||||||||||||||||||||||||||||                
						M85957_P11, wherein said first amino acid sequence, second   	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               136                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                                                            
						sequence and fourth amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated chimeric polypeptide        	                                                            
						encoding for an edge portion of M85957_P11, comprising a     	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise QE, having 	                                                            
						a structure as follows: a sequence starting from any of amino	                                                            
						acid numbers 31-x to 32; and ending at any of amino acid     	                                                            
						numbers 32+ ((n-2) - x), in which x varies from 0 to n-2.3.An	                                                            
						isolated polypeptide encoding for a tail of M85957_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                                                            
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                                                            
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	                                                            
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	                                                            
						TTDRSPSLN                                                    	                                                            
						about 95% homologous to the sequence in M85957_P11.          	                                                            

						Comparison report between M85957_P11 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQ corresponding to amino acids 	Alignment of: 18248 x Q9H8M7   ..                            
						1 - 31 of Q9H8M7, which also corresponds to amino acids 1 -  	                                                            
						31 of M85957_P11, and a second amino acid sequence being at  	Alignment segment 1/1:                                       
						EEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSA 	                                                            
						LAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIK 	                     Quality: 3830.00                      Escore:       0                                               
						NEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLT 	             Matching length:     398                Total length:     445                                               
						LMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPE 	    Total Percent Similarity:   89.44      Total Percent Identity:   89.44                                               
						SFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTT 	                        Gaps:       1                        
						DRSPSLN                                                      	                                                            
						least 90 % homologous to corresponding to amino acids 79 -   	Alignment:                                                   
						445 of Q9H8M7, which also corresponds to amino acids 32 - 398	                  .         .         .         .         .  
						of M85957_P11, wherein said first amino acid sequence and    	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQ................... 31                                                           
						second amino acid sequence are contiguous and in a sequential	         |||||||||||||||||||||||||||||||                     
						order.2.An isolated chimeric polypeptide encoding for an edge	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						portion of M85957_P11, comprising a polypeptide having a     	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	      32 ............................EEEQKELLCHTLCDILESACCD 53                                                           
						length, optionally at least about 20 amino acids in length,  	                                     ||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      54 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 103                                                          
						at least two amino acids comprise QE, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						31-x to 32; and ending at any of amino acid numbers 32+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     104 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 153                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     154 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 203                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     204 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 253                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     254 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 303                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     304 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     354 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      398                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      445                                                          

18260	HMR136_M85957_14_tr0_r1_1_gPRT		Comparison report between M85957_P14 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85957_P14, comprising a first amino acid       	                                                            
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	Alignment of: 18260 x Q9H8M7   ..                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment segment 1/1:                                       
						RCLQTKWPYIELLWTTDRSPSLN                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2010.00                      Escore:       0                                               
						amino acids 243 - 445 of Q9H8M7, which also corresponds to   	             Matching length:     203                Total length:     203                                               
						amino acids 1 - 203 of M85957_P14.                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 442                                                          
						                                                            	                                                             
						                                                            	     201 SLN                                                203                                                          
						                                                            	         |||                                                 
						                                                            	     443 SLN                                                445                                                          

18244	HMR136_M85957_15_tr0_r1_1_gPRT		Comparison report between M85957_P15 and Q9H3I4unique head   	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P15, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18244 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment segment 1/1:                                       
						LLKKLLFSSEKSSWRDCSE                                          	                                                            
						having the sequence corresponding to amino acids 1 - 79 of   	                     Quality: 1988.00                      Escore:       0                                               
						M85957_P15, and a second amino acid sequence being at least  	             Matching length:     201                Total length:     201                                               
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	                        Gaps:       0                        
						LQTKWPYIELLWTTDRSPSLN                                        	                                                            
						90 % homologous to corresponding to amino acids 3 - 203 of   	Alignment:                                                   
						Q9H3I4, which also corresponds to amino acids 80 - 280 of    	                  .         .         .         .         .  
						M85957_P15, wherein said first amino acid sequence and second	      80 LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAK 129                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       3 LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAK 52                                                           
						M85957_P15, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     130 DMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYI 179                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	      53 DMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYI 102                                                          
						LLKKLLFSSEKSSWRDCSE                                          	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85957_P15.    	     180 NLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYN 229                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 NLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYN 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     230 EKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSL 279                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 EKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSL 202                                                          
						                                                            	                                                             
						                                                            	     280 N                                                  280                                                          
						                                                            	         |                                                   
						                                                            	     203 N                                                  203                                                          

						Comparison report between M85957_P15 and Q8WUF1partial WT    	Sequence name: Q8WUF1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85957_P15, comprising a first amino	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDCSE                                          	Alignment of: 18244 x Q8WUF1   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 79 of Q8WUF1, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 79 of M85957_P15, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  782.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      79                Total length:      79                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	                        Gaps:       0                        
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	                                                            
						LQTKWPYIELLWTTDRSPSLN                                        	Alignment:                                                   
						having the sequence corresponding to amino acids 80 - 280 of 	                  .         .         .         .         .  
						M85957_P15, wherein said first amino acid sequence and second	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						M85957_P15, comprising a polypeptide being at least 70%,     	                  .         .                                
						optionally at least about 80%, preferably at least about 85%,	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSE                      79                                                           
						more preferably at least about 90% and most preferably at    	         |||||||||||||||||||||||||||||                       
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSE                      79                                                           
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	                                                            
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	                                                            
						LQTKWPYIELLWTTDRSPSLN                                        	                                                            
						least about 95% homologous to the sequence in M85957_P15.    	                                                            

						Comparison report between M85957_P15 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P15, comprising a first amino	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDCSE                                          	Alignment of: 18244 x Q9H8M7   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 79 of Q9H8M7, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 79 of M85957_P15, and a second amino acid    	                                                            
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	                     Quality: 2670.00                      Escore:       0                                               
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	             Matching length:     280                Total length:     445                                               
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQTKWPYIELLWTTDRSPSLN                                        	    Total Percent Similarity:   62.92      Total Percent Identity:   62.92                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 245 - 445 of Q9H8M7, which also corresponds to   	                                                            
						amino acids 80 - 280 of M85957_P15, wherein said first amino 	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						encoding for an edge portion of M85957_P15, comprising a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSE..................... 79                                                           
						length, more preferably at least about 40 amino acids in     	         |||||||||||||||||||||||||||||                       
						length and most preferably at least about 50 amino acids in  	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						length, wherein at least two amino acids comprise EL, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	      79 .................................................. 79                                                           
						acid numbers 79-x to 80; and ending at any of amino acid     	                                                            
						numbers 80+ ((n-2) - x), in which x varies from 0 to n-2.    	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      79 .................................................. 79                                                           
						                                                            	                                                            
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      80 ............................................LLGIHE 85                                                           
						                                                            	                                                     ||||||  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      86 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 135                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     136 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 185                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     186 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 235                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     236 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      280                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      445                                                          

18258	HMR136_M85957_16_tr0_r1_1_gPRT		Comparison report between M85957_P16 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85957_P16, comprising a first amino acid       	                                                            
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	Alignment of: 18258 x Q9H8M7   ..                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment segment 1/1:                                       
						RCLQTKWPYIELLWTTDRSPSLN                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2010.00                      Escore:       0                                               
						amino acids 243 - 445 of Q9H8M7, which also corresponds to   	             Matching length:     203                Total length:     203                                               
						amino acids 1 - 203 of M85957_P16.                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 442                                                          
						                                                            	                                                             
						                                                            	     201 SLN                                                203                                                          
						                                                            	         |||                                                 
						                                                            	     443 SLN                                                445                                                          

18254	HMR136_M85957_17_tr0_r1_1_gPRT		Comparison report between M85957_P17 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85957_P17, comprising a first amino acid       	                                                            
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	Alignment of: 18254 x Q9H8M7   ..                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment segment 1/1:                                       
						RCLQTKWPYIELLWTTDRSPSLN                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2010.00                      Escore:       0                                               
						amino acids 243 - 445 of Q9H8M7, which also corresponds to   	             Matching length:     203                Total length:     203                                               
						amino acids 1 - 203 of M85957_P17.                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 442                                                          
						                                                            	                                                             
						                                                            	     201 SLN                                                203                                                          
						                                                            	         |||                                                 
						                                                            	     443 SLN                                                445                                                          

18270	HMR136_M85957_18_tr0_r1_1_gPRT		Comparison report between M85957_P18 and Q9H3I4unique head   	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P18, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18270 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MSELTKELMELVWGTKSSPGLSDTIFCRWTQE         	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 32 of M85957_P18, and a     	                                                            
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	                     Quality: 1988.00                      Escore:       0                                               
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	             Matching length:     201                Total length:     201                                               
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQTKWPYIELLWTTDRSPSLN                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 3 - 203 of Q9H3I4, which also   	                                                            
						corresponds to amino acids 33 - 233 of M85957_P18, wherein   	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      33 LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAK 82                                                           
						polypeptide encoding for a head of M85957_P18, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       3 LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAK 52                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      83 DMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYI 132                                                          
						to the sequence MSELTKELMELVWGTKSSPGLSDTIFCRWTQE of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85957_P18.                                                  	      53 DMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYI 102                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     133 NLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYN 182                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 NLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYN 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     183 EKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSL 232                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 EKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSL 202                                                          
						                                                            	                                                             
						                                                            	     233 N                                                  233                                                          
						                                                            	         |                                                   
						                                                            	     203 N                                                  203                                                          

						Comparison report between M85957_P18 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon plus extra amino acids.1.An  	                                                            
						isolated chimeric polypeptide encoding for M85957_P18,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						homologous to MSELTKELMELVWGTKSSPGLSDTIFCRWTQ corresponding  	Alignment of: 18270 x Q9H8M7   ..                            
						to amino acids 1 - 31 of Q9H8M7, which also corresponds to   	                                                            
						amino acids 1 - 31 of M85957_P18, a second amino acid        	Alignment segment 1/1:                                       
						sequence bridging amino acid sequence comprising of E, and a 	                                                            
						LLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAP 	                     Quality: 2202.00                      Escore:       0                                               
						SEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPF 	             Matching length:     233                Total length:     445                                               
						LQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.57                                               
						LQTKWPYIELLWTTDRSPSLN                                        	    Total Percent Similarity:   52.36      Total Percent Identity:   52.13                                               
						third amino acid sequence being at least 90 % homologous to  	                        Gaps:       1                        
						corresponding to amino acids 245 - 445 of Q9H8M7, which also 	                                                            
						corresponds to amino acids 33 - 233 of M85957_P18, wherein   	Alignment:                                                   
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQ................... 31                                                           
						sequential order.2.An isolated polypeptide encoding for an   	         |||||||||||||||||||||||||||||||                     
						edge portion of M85957_P18, comprising a polypeptide having a	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      31 .................................................. 31                                                           
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise QEL having a structure as  	      31 .................................................. 31                                                           
						follows (numbering according to M85957_P18): a sequence      	                                                            
						starting from any of amino acid numbers 31-x to 31; and      	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						ending at any of amino acid numbers 33 + ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	      31 .................................................. 31                                                           
						                                                            	                                                            
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      32 ...........................................ELLGIHE 38                                                           
						                                                            	                                                    :||||||  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      39 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 88                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      89 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 138                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     139 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     189 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      233                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      445                                                          

18250	HMR136_M85957_20_tr0_r1_1_gPRT		Comparison report between M85957_P20 and Q9H3I4unique head   	Sequence name: Q9H3I4                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85957_P20,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 18250 x Q9H3I4   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment segment 1/1:                                       
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	                                                            
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                     Quality: 1666.00                      Escore:       0                                               
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	             Matching length:     179                Total length:     203                                               
						SG                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   88.18      Total Percent Identity:   88.18                                               
						to amino acids 1 - 242 of M85957_P20, a second amino acid    	                        Gaps:       1                        
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                                                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	Alignment:                                                   
						PFLQEFFPDQ                                                   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						amino acids 1 - 130 of Q9H3I4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 243 - 372 of M85957_P20, and a third amino acid  	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						corresponding to amino acids 155 - 203 of Q9H3I4, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 373 - 421 of M85957_P20, wherein  	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQ.................... 372                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||                      
						head of M85957_P20, comprising a polypeptide being at least  	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     373 ....VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 418                                                          
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	             ||||||||||||||||||||||||||||||||||||||||||||||  
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                                                             
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	     419 SLN                                                421                                                          
						SG                                                           	         |||                                                 
						at least about 95% homologous to the sequence of             	     201 SLN                                                203                                                          
						M85957_P20.3.An isolated chimeric polypeptide encoding for an	                                                            
						edge portion of M85957_P20, comprising a polypeptide having a	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise QV, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						372-x to 373; and ending at any of amino acid numbers 373+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between M85957_P20 and Q8WUF1partial WT    	Sequence name: Q8WUF1                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85957_P20, comprising a first amino acid sequence being at  	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment of: 18250 x Q8WUF1   ..                            
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILE                          	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 95 	Alignment segment 1/1:                                       
						of Q8WUF1, which also corresponds to amino acids 1 - 95 of   	                                                            
						M85957_P20, a bridging amino acid S corresponding to amino   	                     Quality: 1344.00                      Escore:       0                                               
						acid 96 of M85957_P20, a second amino acid sequence being at 	             Matching length:     136                Total length:     136                                               
						least 90 % homologous to                                     	 Matching Percent Similarity:   99.26   Matching Percent Identity:   99.26                                               
						ACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS corresponding to    	    Total Percent Similarity:   99.26      Total Percent Identity:   99.26                                               
						amino acids 97 - 136 of Q8WUF1, which also corresponds to    	                        Gaps:       0                        
						amino acids 97 - 136 of M85957_P20, and a third amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                  .         .         .         .         .  
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQVMYV 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN                	         ||||||||||||||||||||||||||||||||||||||||||||| ||||  
						having the sequence corresponding to amino acids 137 - 421 of	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILEGACCD 100                                                          
						M85957_P20, wherein said first amino acid sequence, bridging 	                  .         .         .                      
						amino acid, second amino acid sequence and third amino acid  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               136                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||                
						isolated polypeptide encoding for a tail of M85957_P20,      	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               136                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                                                            
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                                                            
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQVMYV 	                                                            
						EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN                	                                                            
						about 95% homologous to the sequence in M85957_P20.          	                                                            

						Comparison report between M85957_P20 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P20, comprising a first amino	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	Alignment of: 18250 x Q9H8M7   ..                            
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                                                            
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	Alignment segment 1/1:                                       
						SGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 	                                                            
						PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIIL 	                     Quality: 4044.00                      Escore:       0                                               
						LGPFLQEFFPDQ                                                 	             Matching length:     421                Total length:     445                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 372 of Q9H8M7, which also corresponds to  	    Total Percent Similarity:   94.61      Total Percent Identity:   94.61                                               
						amino acids 1 - 372 of M85957_P20, and a second amino acid   	                        Gaps:       1                        
						sequence being at least 90 % homologous to                   	                                                            
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	Alignment:                                                   
						corresponding to amino acids 397 - 445 of Q9H8M7, which also 	                  .         .         .         .         .  
						corresponds to amino acids 373 - 421 of M85957_P20, wherein  	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85957_P20, comprising a polypeptide having a length "n",    	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QV, having a structure as  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						372-x to 373; and ending at any of amino acid numbers 373+   	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQ........................VMYV 376                                                          
						                                                            	         ||||||||||||||||||||||                        ||||  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     377 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      421                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      445                                                          

18252	HMR136_M85957_22_tr0_r1_1_gPRT		Comparison report between M85957_P22 and Q9H3I4partial WT    	Sequence name: Q9H3I4                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P22, comprising a first amino	Sequence documentation:                                      
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                                                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	Alignment of: 18252 x Q9H3I4   ..                            
						PFLQEFFPDQ                                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 130 of Q9H3I4, which also corresponds to  	                                                            
						amino acids 1 - 130 of M85957_P22, and a second amino acid   	                     Quality: 1666.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:     179                Total length:     203                                               
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 155 - 203 of Q9H3I4, which also 	    Total Percent Similarity:   88.18      Total Percent Identity:   88.18                                               
						corresponds to amino acids 131 - 179 of M85957_P22, wherein  	                        Gaps:       1                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85957_P22, comprising a polypeptide having a length "n",    	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QV, having a structure as  	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						130-x to 131; and ending at any of amino acid numbers 131+   	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQ.................... 130                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||                      
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     131 ....VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 176                                                          
						                                                            	             ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	                                                             
						                                                            	     177 SLN                                                179                                                          
						                                                            	         |||                                                 
						                                                            	     201 SLN                                                203                                                          

						Comparison report between M85957_P22 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P22, comprising a first amino	Sequence documentation:                                      
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                                                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	Alignment of: 18252 x Q9H8M7   ..                            
						PFLQEFFPDQ                                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 243 - 372 of Q9H8M7, which also corresponds to	                                                            
						amino acids 1 - 130 of M85957_P22, and a second amino acid   	                     Quality: 1666.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:     179                Total length:     203                                               
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 397 - 445 of Q9H8M7, which also 	    Total Percent Similarity:   88.18      Total Percent Identity:   88.18                                               
						corresponds to amino acids 131 - 179 of M85957_P22, wherein  	                        Gaps:       1                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						M85957_P22, comprising a polypeptide having a length "n",    	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QV, having a structure as  	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						130-x to 131; and ending at any of amino acid numbers 131+   	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQ.................... 130                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||                      
						                                                            	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     131 ....VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 176                                                          
						                                                            	             ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 442                                                          
						                                                            	                                                             
						                                                            	     177 SLN                                                179                                                          
						                                                            	         |||                                                 
						                                                            	     443 SLN                                                445                                                          

18268	HMR136_M85957_26_tr0_r1_1_gPRT		Comparison report between M85957_P26 and Q9H3I4unique head   	Sequence name: Q9H3I4                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M85957_P26,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 18268 x Q9H3I4   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	Alignment segment 1/1:                                       
						WDGDRECSG                                                    	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1666.00                      Escore:       0                                               
						to amino acids 1 - 69 of M85957_P26, a second amino acid     	             Matching length:     179                Total length:     203                                               
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	    Total Percent Similarity:   88.18      Total Percent Identity:   88.18                                               
						PFLQEFFPDQ                                                   	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 130 of Q9H3I4, which also corresponds to     	Alignment:                                                   
						amino acids 70 - 199 of M85957_P26, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	      70 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 119                                                          
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 155 - 203 of Q9H3I4, which also 	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						corresponds to amino acids 200 - 248 of M85957_P26, wherein  	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     120 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 169                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						head of M85957_P26, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     170 YINLMKNKLDPEGLGIILLGPFLQEFFPDQ.................... 199                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||                      
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						WDGDRECSG                                                    	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     200 ....VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 245                                                          
						M85957_P26.3.An isolated chimeric polypeptide encoding for an	             ||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of M85957_P26, comprising a polypeptide having a	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						length "n", wherein n is at least about 10 amino acids in    	                                                             
						length, optionally at least about 20 amino acids in length,  	     246 SLN                                                248                                                          
						preferably at least about 30 amino acids in length, more     	         |||                                                 
						preferably at least about 40 amino acids in length and most  	     201 SLN                                                203                                                          
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise QV, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						199-x to 200; and ending at any of amino acid numbers 200+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between M85957_P26 and Q9H8M7partial WT    	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85957_P26, comprising a first amino	Sequence documentation:                                      
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	                                                            
						WDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFA 	Alignment of: 18268 x Q9H8M7   ..                            
						KDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDP 	                                                            
						EGLGIILLGPFLQEFFPDQ                                          	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 174 - 372 of Q9H8M7, which also corresponds to	                     Quality: 2338.00                      Escore:       0                                               
						amino acids 1 - 199 of M85957_P26, and a second amino acid   	             Matching length:     248                Total length:     272                                               
						sequence being at least 90 % homologous to                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN            	    Total Percent Similarity:   91.18      Total Percent Identity:   91.18                                               
						corresponding to amino acids 397 - 445 of Q9H8M7, which also 	                        Gaps:       1                        
						corresponds to amino acids 200 - 248 of M85957_P26, wherein  	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	       1 MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINL 50                                                           
						M85957_P26, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     174 MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINL 223                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 LLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLK 100                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     224 LLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLK 273                                                          
						at least two amino acids comprise QV, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     101 SPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFI 150                                                          
						199-x to 200; and ending at any of amino acid numbers 200+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     274 SPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFI 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQ. 199                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     324 PDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQG 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     200 .......................VMYVEGTAVVMGFEDPMLQTDDTPIKR 226                                                          
						                                                            	                                |||||||||||||||||||||||||||  
						                                                            	     374 SSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKR 423                                                          
						                                                            	                  .         .                                
						                                                            	     227 CLQTKWPYIELLWTTDRSPSLN                             248                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     424 CLQTKWPYIELLWTTDRSPSLN                             445                                                          

18266	HMR136_M85957_6_tr0_r1_1_gPRT		Comparison report between M85957_P6 and Q9H3I4unique head    	Sequence name: Q9H3I4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85957_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18266 x Q9H3I4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment segment 1/1:                                       
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	                                                            
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                     Quality: 1514.00                      Escore:       0                                               
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	             Matching length:     154                Total length:     154                                               
						SG                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 242 of M85957_P6, a second amino acid     	                        Gaps:       0                        
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                                                            
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	Alignment:                                                   
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEK                           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     243 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 292                                                          
						amino acids 1 - 154 of Q9H3I4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 243 - 396 of M85957_P6, and a third amino acid   	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     293 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 342                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence MRHLRRGDQVTHPGSHSKSLAEQGLELSS            	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						corresponding to amino acids 397 - 425 of M85957_P6, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     343 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 392                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						head of M85957_P6, comprising a polypeptide being at least   	                                                             
						70%, optionally at least about 80%, preferably at least about	     393 YNEK                                               396                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||                                                
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	     151 YNEK                                               154                                                          
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	                                                            
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                                                            
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	                                                            
						SG                                                           	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						M85957_P6.3.An isolated polypeptide encoding for a tail of   	                                                            
						M85957_P6, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						MRHLRRGDQVTHPGSHSKSLAEQGLELSS in M85957_P6.                  	                                                            

						Comparison report between M85957_P6 and Q8WUF1partial WT     	Sequence name: Q8WUF1                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85957_P6, comprising a first amino acid sequence being at   	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment of: 18266 x Q8WUF1   ..                            
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILE                          	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 95 	Alignment segment 1/1:                                       
						of Q8WUF1, which also corresponds to amino acids 1 - 95 of   	                                                            
						M85957_P6, a bridging amino acid S corresponding to amino    	                     Quality: 1344.00                      Escore:       0                                               
						acid 96 of M85957_P6, a second amino acid sequence being at  	             Matching length:     136                Total length:     136                                               
						least 90 % homologous to                                     	 Matching Percent Similarity:   99.26   Matching Percent Identity:   99.26                                               
						ACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS corresponding to    	    Total Percent Similarity:   99.26      Total Percent Identity:   99.26                                               
						amino acids 97 - 136 of Q8WUF1, which also corresponds to    	                        Gaps:       0                        
						amino acids 97 - 136 of M85957_P6, and a third amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                  .         .         .         .         .  
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						PESFTVYHYNGLKQSNYNEKMRHLRRGDQVTHPGSHSKSLAEQGLELSS            	         ||||||||||||||||||||||||||||||||||||||||||||| ||||  
						having the sequence corresponding to amino acids 137 - 425 of	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILEGACCD 100                                                          
						M85957_P6, wherein said first amino acid sequence, bridging  	                  .         .         .                      
						amino acid, second amino acid sequence and third amino acid  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               136                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||                
						isolated polypeptide encoding for a tail of M85957_P6,       	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS               136                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                                                            
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                                                            
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	                                                            
						PESFTVYHYNGLKQSNYNEKMRHLRRGDQVTHPGSHSKSLAEQGLELSS            	                                                            
						about 95% homologous to the sequence in M85957_P6.           	                                                            

						Comparison report between M85957_P6 and Q9H8M7partial WT     	Sequence name: Q9H8M7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85957_P6, comprising a first amino 	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETA 	Alignment of: 18266 x Q9H8M7   ..                            
						SISGSPAESSCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFG 	                                                            
						VLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDREC 	Alignment segment 1/1:                                       
						SGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 	                                                            
						PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIIL 	                     Quality: 3892.00                      Escore:       0                                               
						LGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEK                         	             Matching length:     396                Total length:     396                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 396 of Q9H8M7, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 396 of M85957_P6, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence MRHLRRGDQVTHPGSHSKSLAEQGLELSS            	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						corresponding to amino acids 397 - 425 of M85957_P6, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M85957_P6, comprising a   	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MRHLRRGDQVTHPGSHSKSLAEQGLELSS in M85957_P6.  	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEK     396                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEK     396                                                          

18262	HMR136_M85957_7_tr0_r1_1_gPRT		Comparison report between M85957_P7 and Q9H3I4unique head    	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18262 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	Alignment segment 1/1:                                       
						LLKKLLFSSEKSSWRDCSAALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNK 	                                                            
						FGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDR 	                     Quality: 2010.00                      Escore:       0                                               
						ECSG                                                         	             Matching length:     203                Total length:     203                                               
						having the sequence corresponding to amino acids 1 - 184 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M85957_P7, and a second amino acid sequence being at least 90	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                        Gaps:       0                        
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment:                                                   
						RCLQTKWPYIELLWTTDRSPSLN                                      	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 203 of      	     185 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 234                                                          
						Q9H3I4, which also corresponds to amino acids 185 - 387 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85957_P7, wherein said first amino acid sequence and second 	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     235 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 284                                                          
						M85957_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	     285 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 334                                                          
						LLKKLLFSSEKSSWRDCSAALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDR 	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						ECSG                                                         	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85957_P7.     	     335 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 384                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	                                                             
						                                                            	     385 SLN                                                387                                                          
						                                                            	         |||                                                 
						                                                            	     201 SLN                                                203                                                          

						Comparison report between M85957_P7 and Q8WUF1partial WT     	Sequence name: Q8WUF1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M85957_P7, comprising a first amino 	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDCS                                           	Alignment of: 18262 x Q8WUF1   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 78 of Q8WUF1, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 78 of M85957_P7, and a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  772.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      78                Total length:      78                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                        Gaps:       0                        
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	Alignment:                                                   
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	                  .         .         .         .         .  
						TTDRSPSLN                                                    	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						having the sequence corresponding to amino acids 79 - 387 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85957_P7, wherein said first amino acid sequence and second 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .                                
						order.2.An isolated polypeptide encoding for a tail of       	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCS                       78                                                           
						M85957_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||                        
						optionally at least about 80%, preferably at least about 85%,	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCS                       78                                                           
						more preferably at least about 90% and most preferably at    	                                                            
						AALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                                                            
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                                                            
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	                                                            
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	                                                            
						TTDRSPSLN                                                    	                                                            
						least about 95% homologous to the sequence in M85957_P7.     	                                                            

						Comparison report between M85957_P7 and Q9H8M7partial WT     	Sequence name: Q9H8M7                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for M85957_P7, comprising a    	Sequence documentation:                                      
						MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGPCAVIAPVQAF 	                                                            
						LLKKLLFSSEKSSWRDC                                            	Alignment of: 18262 x Q9H8M7   ..                            
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 77 of Q9H8M7, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 77 of M85957_P7, a second     	                                                            
						amino acid sequence being at least 90 % homologous to S      	                     Quality: 3697.00                      Escore:       0                                               
						corresponding to amino acids 136 - 136 of Q9H8M7, which also 	             Matching length:     387                Total length:     445                                               
						corresponds to amino acids 78 - 78 of M85957_P7, a bridging  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.74                                               
						amino acid A corresponding to amino acid 79 of M85957_P7, and	    Total Percent Similarity:   86.97      Total Percent Identity:   86.74                                               
						ALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENI 	                        Gaps:       1                        
						KNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFL 	                                                            
						TLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDP 	Alignment:                                                   
						EDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGP 	                  .         .         .         .         .  
						ESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWT 	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						TDRSPSLN                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 90 % homologous to	       1 MSELTKELMELVWGTKSSPGLSDTIFCRWTQGFVFSESEGSALEQFEGGP 50                                                           
						corresponding to amino acids 138 - 445 of Q9H8M7, which also 	                  .         .         .         .         .  
						corresponds to amino acids 80 - 387 of M85957_P7, wherein    	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDC....................... 77                                                           
						said first amino acid sequence, second amino acid sequence,  	         |||||||||||||||||||||||||||                         
						bridging amino acid and third amino acid sequence are        	      51 CAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLCDILESACCD 100                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of M85957_P7,       	      78 ...................................SAALAVEELGFERFH 92                                                           
						comprising a polypeptide having a length "n", wherein n is at	                                            |:|||||||||||||  
						least about 10 amino acids in length, optionally at least    	     101 HSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFH 150                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	      93 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 142                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     151 ALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNE 200                                                          
						comprise CS, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 77-x to 78; and      	     143 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 192                                                          
						ending at any of amino acid numbers 78+ ((n-2) - x), in which	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						x varies from 0 to n-2.                                      	     201 IEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     193 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 242                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     243 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 292                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     293 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYV 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     343 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      387                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 EGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN      445                                                          

18256	HMR136_M85957_8_tr0_r1_1_gPRT		Comparison report between M85957_P8 and Q9H3I4unique head    	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18256 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	Alignment segment 1/1:                                       
						WDGDRECSG                                                    	                                                            
						having the sequence corresponding to amino acids 1 - 69 of   	                     Quality: 2010.00                      Escore:       0                                               
						M85957_P8, and a second amino acid sequence being at least 90	             Matching length:     203                Total length:     203                                               
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	                        Gaps:       0                        
						RCLQTKWPYIELLWTTDRSPSLN                                      	                                                            
						% homologous to corresponding to amino acids 1 - 203 of      	Alignment:                                                   
						Q9H3I4, which also corresponds to amino acids 70 - 272 of    	                  .         .         .         .         .  
						M85957_P8, wherein said first amino acid sequence and second 	      70 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 119                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						M85957_P8, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     120 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 169                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						WDGDRECSG                                                    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85957_P8.     	     170 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 219                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     220 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 269                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	                                                             
						                                                            	     270 SLN                                                272                                                          
						                                                            	         |||                                                 
						                                                            	     201 SLN                                                203                                                          

						Comparison report between M85957_P8 and Q9H8M7partial WT     	Sequence name: Q9H8M7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M85957_P8, comprising a first amino acid        	                                                            
						MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNV 	Alignment of: 18256 x Q9H8M7   ..                            
						WDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFA 	                                                            
						KDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDP 	Alignment segment 1/1:                                       
						EGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPM 	                                                            
						LQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN                             	                     Quality: 2682.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     272                Total length:     272                                               
						amino acids 174 - 445 of Q9H8M7, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 272 of M85957_P8.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     174 MWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINL 223                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 LLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLK 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 SPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFI 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 PDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQG 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     374 SSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKR 423                                                          
						                                                            	                  .         .                                
						                                                            	     251 CLQTKWPYIELLWTTDRSPSLN                             272                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     424 CLQTKWPYIELLWTTDRSPSLN                             445                                                          

18264	HMR136_M85957_9_tr0_r1_1_gPRT		Comparison report between M85957_P9 and Q9H3I4unique head    	Sequence name: Q9H3I4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18264 x Q9H3I4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKDSFSCYLNYIFNLSYLLSFLGFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSS 	Alignment segment 1/1:                                       
						EKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAES 	                                                            
						SCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVL 	                     Quality: 2010.00                      Escore:       0                                               
						LTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSG        	             Matching length:     203                Total length:     203                                               
						having the sequence corresponding to amino acids 1 - 233 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M85957_P9, and a second amino acid sequence being at least 90	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPE 	                        Gaps:       0                        
						APSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLG 	                                                            
						PFLQEFFPDQGSSGPESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIK 	Alignment:                                                   
						RCLQTKWPYIELLWTTDRSPSLN                                      	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 203 of      	     234 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 283                                                          
						Q9H3I4, which also corresponds to amino acids 234 - 436 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85957_P9, wherein said first amino acid sequence and second 	       1 MKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFF 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     284 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 333                                                          
						M85957_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 AKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDVMKALDLVSDPE 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MKDSFSCYLNYIFNLSYLLSFLGFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSS 	     334 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 383                                                          
						EKSSWRDCSEEEQKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SCQVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVL 	     101 YINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQSN 150                                                          
						LTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSG        	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M85957_P9.     	     384 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 433                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSP 200                                                          
						                                                            	                                                             
						                                                            	     434 SLN                                                436                                                          
						                                                            	         |||                                                 
						                                                            	     201 SLN                                                203                                                          

						Comparison report between M85957_P9 and Q8WUF1unique head    	Sequence name: Q8WUF1                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M85957_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18264 x Q8WUF1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MKDSFSCYLNYIFNLSYLLSFL corresponding to amino acids 1 - 22 of	                                                            
						M85957_P9, a second amino acid sequence being at least 90 %  	                     Quality: 1030.00                      Escore:       0                                               
						GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLC 	             Matching length:     105                Total length:     105                                               
						DILE                                                         	 Matching Percent Similarity:   99.05   Matching Percent Identity:   99.05                                               
						homologous to corresponding to amino acids 32 - 95 of Q8WUF1,	    Total Percent Similarity:   99.05      Total Percent Identity:   99.05                                               
						which also corresponds to amino acids 23 - 86 of M85957_P9, a	                        Gaps:       0                        
						bridging amino acid S corresponding to amino acid 87 of      	                                                            
						M85957_P9, a third amino acid sequence being at least 90 %   	Alignment:                                                   
						homologous to ACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHS       	                  .         .         .         .         .  
						corresponding to amino acids 97 - 136 of Q8WUF1, which also  	      23 GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEE 72                                                           
						corresponds to amino acids 88 - 127 of M85957_P9, and a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 70%, optionally at 	      32 GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEE 81                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      73 QKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAESSC 122                                                          
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	         |||||||||||||| |||||||||||||||||||||||||||||||||||  
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	      82 QKELLCHTLCDILEGACCDHSGSYCLVSWLRGKTTEETASISGSPAESSC 131                                                          
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                             
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	     123 QVEHS                                              127                                                          
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	         |||||                                               
						TTDRSPSLN                                                    	     132 QVEHS                                              136                                                          
						polypeptide having the sequence corresponding to amino acids 	                                                            
						128 - 436 of M85957_P9, wherein said first amino acid        	                                                            
						sequence, second amino acid sequence, bridging amino acid,   	                                                            
						third amino acid sequence and fourth amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M85957_P9, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MKDSFSCYLNYIFNLSYLLSFL of M85957_P9.3.An     	                                                            
						isolated polypeptide encoding for a tail of M85957_P9,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						SALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIEN 	                                                            
						IKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGF 	                                                            
						LTLMEALRYCKVGSYLKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYD 	                                                            
						PEDNGFIPDSLLEDVMKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSG 	                                                            
						PESFTVYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLW 	                                                            
						TTDRSPSLN                                                    	                                                            
						about 95% homologous to the sequence in M85957_P9.           	                                                            

						Comparison report between M85957_P9 and Q9H8M7unique head    	Sequence name: Q9H8M7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85957_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 18264 x Q9H8M7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MKDSFSCYLNYIFNLSYLLSFL corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 22 of M85957_P9, and a second amino acid     	                                                            
						GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEEQKELLCHTLC 	                     Quality: 4074.00                      Escore:       0                                               
						DILESACCDHSGSYCLVSWLRGKTTEETASISGSPAESSCQVEHSSALAVEELGFERFHA 	             Matching length:     414                Total length:     414                                               
						LIQKRSFRSLPELKDAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIKNEIEDASEPLIDP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VYGHGSQSLINLLLTGHAVSNVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKSPKFPIWIVGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDV 	                        Gaps:       0                        
						MKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFTVYHYNGLKQS 	                                                            
						NYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPYIELLWTTDRSPSLN       	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 32 - 445 of Q9H8M7, which also corresponds to    	      23 GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEE 72                                                           
						amino acids 23 - 436 of M85957_P9, wherein said first amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	      32 GFVFSESEGSALEQFEGGPCAVIAPVQAFLLKKLLFSSEKSSWRDCSEEE 81                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of M85957_P9, comprising a polypeptide being at   	      73 QKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAESSC 122                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      82 QKELLCHTLCDILESACCDHSGSYCLVSWLRGKTTEETASISGSPAESSC 131                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MKDSFSCYLNYIFNLSYLLSFL of M85957_P9.                         	     123 QVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGV 172                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     132 QVEHSSALAVEELGFERFHALIQKRSFRSLPELKDAVLDQYSMWGNKFGV 181                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     173 LLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVS 222                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     182 LLFLYSVLLTKGIENIKNEIEDASEPLIDPVYGHGSQSLINLLLTGHAVS 231                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     223 NVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWI 272                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     232 NVWDGDRECSGMKLLGIHEQAAVGFLTLMEALRYCKVGSYLKSPKFPIWI 281                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     273 VGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDV 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     282 VGSETHLTVFFAKDMALVAPEAPSEQARRVFQTYDPEDNGFIPDSLLEDV 331                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 MKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFT 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     332 MKALDLVSDPEYINLMKNKLDPEGLGIILLGPFLQEFFPDQGSSGPESFT 381                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 VYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPY 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     382 VYHYNGLKQSNYNEKVMYVEGTAVVMGFEDPMLQTDDTPIKRCLQTKWPY 431                                                          
						                                                            	                  .                                          
						                                                            	     423 IELLWTTDRSPSLN                                     436                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     432 IELLWTTDRSPSLN                                     445                                                          

701	HMR136_M85962_9_tr0_r1_1_gPRT		Comparison report between M85962_P9 and MPK2_HUMANpartial WT 	Sequence name: MPK2_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85962_P9, comprising a first amino 	Sequence documentation:                                      
						MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQ 	                                                            
						KAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARK                    	Alignment of: 701 x MPK2_HUMAN   ..                          
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 101 of MPK2_HUMAN, which also corresponds 	Alignment segment 1/1:                                       
						to amino acids 1 - 101 of M85962_P9, and a second amino acid 	                                                            
						VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAP 	                     Quality: 3070.00                      Escore:       0                                               
						ERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 	             Matching length:     325                Total length:     400                                               
						RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV                 	    Total Percent Similarity:   81.25      Total Percent Identity:   81.25                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 177 - 400 of MPK2_HUMAN, which also corresponds  	                                                            
						to amino acids 102 - 325 of M85962_P9, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQ 50                                                           
						polypeptide encoding for an edge portion of M85962_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQ 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 KKRLEAFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMAR 100                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	      51 KKRLEAFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMAR 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise KV, having a structure as follows: a sequence       	     101 K................................................. 101                                                          
						starting from any of amino acid numbers 101-x to 102; and    	         |                                                   
						ending at any of amino acid numbers 102+ ((n-2) - x), in     	     101 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 150                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     102 ..........................VLRGLAYLREKHQIMHRDVKPSNI 125                                                          
						                                                            	                                   ||||||||||||||||||||||||  
						                                                            	     151 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     126 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDI 175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     176 WSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 225                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     226 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 275                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     276 IKNPAERADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV 325                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IKNPAERADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV 400                                                          

944	HMR136_M85983_9_tr0_r1_1_gPRT		Comparison report between M85983_P9 and O75141unique head    	Sequence name: O75141                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85983_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 944 x O75141   ..                              
						more preferably at least 90% and most preferably at least 95%	                                                            
						ENIQKLGNYTLKLQVVLNESNADTYAGRPLPSKAIKFSVKEGKPEKFSFGLLDLPFRVGV 	Alignment segment 1/1:                                       
						PFNIPLEFQDEFGHTSQLVTDIQPVLEASGLSLHYEEITKGPNCVIRGVTAKGPVNSCQG 	                                                            
						KNYNLKVTLPGLKEDSQILKIRLLPGHPRRLKVKPDSEILVIENGTAFPFQVEVLDESDN 	                     Quality: 6528.00                      Escore:       0                                               
						ITAQPKLIVHCKFSGAPNLPVYVVDCSSSGTSILTGSAIQVQNIKKDQTLKARIEIPSCK 	             Matching length:     668                Total length:     668                                               
						DVAPVEKTIKLLPSSHVARLQIFSVEGQKAIQIKHQDEVNWIAGDIMHNLIFQMYDEGER 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EINITSALAEKIKVNWTPEINKEHLLQGLLPDVQVPTSVKDMRYCQVSFQDDHVSLESAF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TVRPLPDEPKHLKCEMKG                                           	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 378 of M85983_P9, a second amino acid     	Alignment:                                                   
						GKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGVGLDSSNLKTTFQENTQSI 	                  .         .         .         .         .  
						SVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKLLLIDWPELKESIPVINGRDL 	     379 GKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGVGLDSSNLK 428                                                          
						QNPIIVQLCDQWDNPAPVQHVKISLTKASNLKLMPSNQQHKTDEKGRANLGVFSVFAPRG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHTLQVKAIYNKSIIEGPIIKLMILPDPEKPVRLNVKYDKDASFLAGGLFTDFMISVISE 	       1 GKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGVGLDSSNLK 50                                                           
						DDSIIKNINPARISMKMWKLSTSGNRPPANAETFSCNKIKDNDKEDGCFYFRDKVIPNKV 	                  .         .         .         .         .  
						GTYCIQFGFMMDKTNILNSEQVIVEVLPNQPVKLVPKIKPPTPAVSNVRSVASRTLVRDL 	     429 TTFQENTQSISVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKL 478                                                          
						HLSITDDYDNHTGIDLVGTIIATIKGSNEEDTDTPLFIGKVRTLEFPFVNGSAEIMSLVL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AESSPGRDSTEYFIVFEPRLPLLSRTLEPYILPFMFYNDVKKQQQMAALTKEKDQLSQSI 	      51 TTFQENTQSISVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKL 100                                                          
						VMYKSLFEASQQLLNEMKCQVEEARLKEAQLRNELKIHNIDIPTTQQVPHIEALLKRKLS 	                  .         .         .         .         .  
						EQEELKKKPRRSCTLPNYTKGSGDVLGKIAHLAQIEDDRAAMVISWHLASDMDCVVTLTT 	     479 LLIDWPELKESIPVINGRDLQNPIIVQLCDQWDNPAPVQHVKISLTKASN 528                                                          
						DAARRIYDETQGRQQVLPLDSIYKKTLPDWKRSLPHFRNGKLYFKPIGDPVFARDLLTFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DNVEHCET                                                     	     101 LLIDWPELKESIPVINGRDLQNPIIVQLCDQWDNPAPVQHVKISLTKASN 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 668 of O75141, which also corresponds to     	     529 LKLMPSNQQHKTDEKGRANLGVFSVFAPRGEHTLQVKAIYNKSIIEGPII 578                                                          
						amino acids 379 - 1046 of M85983_P9, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 LKLMPSNQQHKTDEKGRANLGVFSVFAPRGEHTLQVKAIYNKSIIEGPII 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     579 KLMILPDPEKPVRLNVKYDKDASFLAGGLFTDFMISVISEDDSIIKNINP 628                                                          
						having the sequence GKRHYGDFTFVQMLNL corresponding to amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 1047 - 1062 of M85983_P9, wherein said first amino acid	     201 KLMILPDPEKPVRLNVKYDKDASFLAGGLFTDFMISVISEDDSIIKNINP 250                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     629 ARISMKMWKLSTSGNRPPANAETFSCNKIKDNDKEDGCFYFRDKVIPNKV 678                                                          
						isolated polypeptide encoding for a head of M85983_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     251 ARISMKMWKLSTSGNRPPANAETFSCNKIKDNDKEDGCFYFRDKVIPNKV 300                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     679 GTYCIQFGFMMDKTNILNSEQVIVEVLPNQPVKLVPKIKPPTPAVSNVRS 728                                                          
						ENIQKLGNYTLKLQVVLNESNADTYAGRPLPSKAIKFSVKEGKPEKFSFGLLDLPFRVGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PFNIPLEFQDEFGHTSQLVTDIQPVLEASGLSLHYEEITKGPNCVIRGVTAKGPVNSCQG 	     301 GTYCIQFGFMMDKTNILNSEQVIVEVLPNQPVKLVPKIKPPTPAVSNVRS 350                                                          
						KNYNLKVTLPGLKEDSQILKIRLLPGHPRRLKVKPDSEILVIENGTAFPFQVEVLDESDN 	                  .         .         .         .         .  
						ITAQPKLIVHCKFSGAPNLPVYVVDCSSSGTSILTGSAIQVQNIKKDQTLKARIEIPSCK 	     729 VASRTLVRDLHLSITDDYDNHTGIDLVGTIIATIKGSNEEDTDTPLFIGK 778                                                          
						DVAPVEKTIKLLPSSHVARLQIFSVEGQKAIQIKHQDEVNWIAGDIMHNLIFQMYDEGER 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EINITSALAEKIKVNWTPEINKEHLLQGLLPDVQVPTSVKDMRYCQVSFQDDHVSLESAF 	     351 VASRTLVRDLHLSITDDYDNHTGIDLVGTIIATIKGSNEEDTDTPLFIGK 400                                                          
						TVRPLPDEPKHLKCEMKG                                           	                  .         .         .         .         .  
						about 95% homologous to the sequence of M85983_P9.3.An       	     779 VRTLEFPFVNGSAEIMSLVLAESSPGRDSTEYFIVFEPRLPLLSRTLEPY 828                                                          
						isolated polypeptide encoding for a tail of M85983_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     401 VRTLEFPFVNGSAEIMSLVLAESSPGRDSTEYFIVFEPRLPLLSRTLEPY 450                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     829 ILPFMFYNDVKKQQQMAALTKEKDQLSQSIVMYKSLFEASQQLLNEMKCQ 878                                                          
						about 95% homologous to the sequence GKRHYGDFTFVQMLNL in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M85983_P9.                                                   	     451 ILPFMFYNDVKKQQQMAALTKEKDQLSQSIVMYKSLFEASQQLLNEMKCQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     879 VEEARLKEAQLRNELKIHNIDIPTTQQVPHIEALLKRKLSEQEELKKKPR 928                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VEEARLKEAQLRNELKIHNIDIPTTQQVPHIEALLKRKLSEQEELKKKPR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     929 RSCTLPNYTKGSGDVLGKIAHLAQIEDDRAAMVISWHLASDMDCVVTLTT 978                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RSCTLPNYTKGSGDVLGKIAHLAQIEDDRAAMVISWHLASDMDCVVTLTT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     979 DAARRIYDETQGRQQVLPLDSIYKKTLPDWKRSLPHFRNGKLYFKPIGDP 1028                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DAARRIYDETQGRQQVLPLDSIYKKTLPDWKRSLPHFRNGKLYFKPIGDP 650                                                          
						                                                            	                  .                                          
						                                                            	    1029 VFARDLLTFPDNVEHCET                                 1046                                                         
						                                                            	         ||||||||||||||||||                                  
						                                                            	     651 VFARDLLTFPDNVEHCET                                 668                                                          

						Comparison report between M85983_P9 and Q9UG39unique head    	Sequence name: Q9UG39                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M85983_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 944 x Q9UG39   ..                              
						more preferably at least 90% and most preferably at least 95%	                                                            
						ENIQKLGNYTLKLQVVLNESNADTYAGRPLPSKAIKFSVKEGKPEKFSFGLLDLPFRVGV 	Alignment segment 1/1:                                       
						PFNIPLEFQDEFGHTSQLVTDIQPVLEASGLSLHYEEITKGPNCVIRGVTAKGPVNSCQG 	                                                            
						KNYNLKVTLPGLKEDSQILKIRLLPGHPRRLKVKPDSEILVIENGTAFPFQVEVLDESDN 	                     Quality: 5361.00                      Escore:       0                                               
						ITAQPKLIVHCKFSGAPNLPVYVVDCSSSGTSILTGSAIQVQNIKKDQTLKARIEIPSCK 	             Matching length:     548                Total length:     548                                               
						DVAPVEKTIKLLPSSHVARLQIFSVEGQKAIQIKHQDEVNWIAGDIMHNLIFQMYDEGER 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						EINITSALAEKIKVNWTPEINKEHLLQGLLPDVQVPTSVKDMRYCQVSFQDDHVSLESAF 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						TVRPLPDEPKHLKCEMKGGKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGV 	                        Gaps:       0                        
						GLDSSNLKTTFQENTQSISVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKLLL 	                                                            
						IDWPELKESIPVINGRDLQ                                          	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 499 of M85983_P9, a second amino acid     	     499 QNPIIVQLCDQWDNPAPVQHVKISLTKASNLKLMPSNQQHKTDEKGRANL 548                                                          
						NPIIVQLCDQWDNPAPVQHVKISLTKASNLKLMPSNQQHKTDEKGRANLGVFSVFAPRGE 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						HTLQVKAIYNKSIIEGPIIKLMILPDPEKPVRLNVKYDKDASFLAGGLFTDFMISVISED 	       1 ENPIIVQLCDQWDNPAPVQHVKISLTKASNLKLMPSNQQHKTDEKGRANL 50                                                           
						DSIIKNINPARISMKMWKLSTSGNRPPANAETFSCNKIKDNDKEDGCFYFRDKVIPNKVG 	                  .         .         .         .         .  
						TYCIQFGFMMDKTNILNSEQVIVEVLPNQPVKLVPKIKPPTPAVSNVRSVASRTLVRDLH 	     549 GVFSVFAPRGEHTLQVKAIYNKSIIEGPIIKLMILPDPEKPVRLNVKYDK 598                                                          
						LSITDDYDNHTGIDLVGTIIATIKGSNEEDTDTPLFIGKVRTLEFPFVNGSAEIMSLVLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESSPGRDSTEYFIVFEPRLPLLSRTLEPYILPFMFYNDVKKQQQMAALTKEKDQLSQSIV 	      51 GVFSVFAPRGEHTLQVKAIYNKSIIEGPIIKLMILPDPEKPVRLNVKYDK 100                                                          
						MYKSLFEASQQLLNEMKCQVEEARLKEAQLRNELKIHNIDIPTTQQVPHIEALLKRKLSE 	                  .         .         .         .         .  
						QEELKKKPRRSCTLPNYTKGSGDVLGKIAHLAQIEDDRAAMVISWHLASDMDCVVTLTTD 	     599 DASFLAGGLFTDFMISVISEDDSIIKNINPARISMKMWKLSTSGNRPPAN 648                                                          
						AARRIYDETQGRQQVLPLDSIYKKTLPDWKRSLPHFRNGKLYFKPIGDPVFARDLLTFPD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NVEHCET                                                      	     101 DASFLAGGLFTDFMISVISEDDSIIKNINPARISMKMWKLSTSGNRPPAN 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 2 - 548 of Q9UG39, which also corresponds to     	     649 AETFSCNKIKDNDKEDGCFYFRDKVIPNKVGTYCIQFGFMMDKTNILNSE 698                                                          
						amino acids 500 - 1046 of M85983_P9, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 AETFSCNKIKDNDKEDGCFYFRDKVIPNKVGTYCIQFGFMMDKTNILNSE 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     699 QVIVEVLPNQPVKLVPKIKPPTPAVSNVRSVASRTLVRDLHLSITDDYDN 748                                                          
						having the sequence GKRHYGDFTFVQMLNL corresponding to amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 1047 - 1062 of M85983_P9, wherein said first amino acid	     201 QVIVEVLPNQPVKLVPKIKPPTPAVSNVRSVASRTLVRDLHLSITDDYDN 250                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     749 HTGIDLVGTIIATIKGSNEEDTDTPLFIGKVRTLEFPFVNGSAEIMSLVL 798                                                          
						isolated polypeptide encoding for a head of M85983_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     251 HTGIDLVGTIIATIKGSNEEDTDTPLFIGKVRTLEFPFVNGSAEIMSLVL 300                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     799 AESSPGRDSTEYFIVFEPRLPLLSRTLEPYILPFMFYNDVKKQQQMAALT 848                                                          
						ENIQKLGNYTLKLQVVLNESNADTYAGRPLPSKAIKFSVKEGKPEKFSFGLLDLPFRVGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PFNIPLEFQDEFGHTSQLVTDIQPVLEASGLSLHYEEITKGPNCVIRGVTAKGPVNSCQG 	     301 AESSPGRDSTEYFIVFEPRLPLLSRTLEPYILPFMFYNDVKKQQQMAALT 350                                                          
						KNYNLKVTLPGLKEDSQILKIRLLPGHPRRLKVKPDSEILVIENGTAFPFQVEVLDESDN 	                  .         .         .         .         .  
						ITAQPKLIVHCKFSGAPNLPVYVVDCSSSGTSILTGSAIQVQNIKKDQTLKARIEIPSCK 	     849 KEKDQLSQSIVMYKSLFEASQQLLNEMKCQVEEARLKEAQLRNELKIHNI 898                                                          
						DVAPVEKTIKLLPSSHVARLQIFSVEGQKAIQIKHQDEVNWIAGDIMHNLIFQMYDEGER 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EINITSALAEKIKVNWTPEINKEHLLQGLLPDVQVPTSVKDMRYCQVSFQDDHVSLESAF 	     351 KEKDQLSQSIVMYKSLFEASQQLLNEMKCQVEEARLKEAQLRNELKIHNI 400                                                          
						TVRPLPDEPKHLKCEMKGGKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGV 	                  .         .         .         .         .  
						GLDSSNLKTTFQENTQSISVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKLLL 	     899 DIPTTQQVPHIEALLKRKLSEQEELKKKPRRSCTLPNYTKGSGDVLGKIA 948                                                          
						IDWPELKESIPVINGRDLQ                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of M85983_P9.3.An       	     401 DIPTTQQVPHIEALLKRKLSEQEELKKKPRRSCTLPNYTKGSGDVLGKIA 450                                                          
						isolated polypeptide encoding for a tail of M85983_P9,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     949 HLAQIEDDRAAMVISWHLASDMDCVVTLTTDAARRIYDETQGRQQVLPLD 998                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     451 HLAQIEDDRAAMVISWHLASDMDCVVTLTTDAARRIYDETQGRQQVLPLD 500                                                          
						about 95% homologous to the sequence GKRHYGDFTFVQMLNL in     	                  .         .         .         .            
						M85983_P9.                                                   	     999 SIYKKTLPDWKRSLPHFRNGKLYFKPIGDPVFARDLLTFPDNVEHCET   1046                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     501 SIYKKTLPDWKRSLPHFRNGKLYFKPIGDPVFARDLLTFPDNVEHCET   548                                                          

19455	HMR136_M85985_14_tr0_r1_1_gPRT		Comparison report between M85985_P14 and THA4_HUMANshort     	Sequence name: THA4_HUMAN                                    
						unique head followed by partial WT sequence followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M85985_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19455 x THA4_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of M85985_P14, a second   	                                                            
						EPPKMNPVVEPLSWMLGTWLSDPPGAGTYPTLQPFQYLEEVHISHVGQPMLNFSFNSFHP 	                     Quality:  931.00                      Escore:       0                                               
						DTRKPMHRECGFIRLKPDTNKVAFVSAQNT                               	             Matching length:      96                Total length:      96                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:   96.88   Matching Percent Identity:   95.83                                               
						corresponding to amino acids 414 - 503 of THA4_HUMAN, which  	    Total Percent Similarity:   96.88      Total Percent Identity:   95.83                                               
						also corresponds to amino acids 2 - 91 of M85985_P14, and a  	                        Gaps:       0                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence DHPEVQAEF corresponding to   	       2 EPPKMNPVVEPLSWMLGTWLSDPPGAGTYPTLQPFQYLEEVHISHVGQPM 51                                                           
						amino acids 92 - 100 of M85985_P14, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	     414 EPPKMNPVVEPLSWMLGTWLSDPPGAGTYPTLQPFQYLEEVHISHVGQPM 463                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .            
						isolated polypeptide encoding for a tail of M85985_P14,      	      52 LNFSFNSFHPDTRKPMHRECGFIRLKPDTNKVAFVSAQNTDHPEVQ     97                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||   ||:      
						least about 80%, preferably at least about 85%, more         	     464 LNFSFNSFHPDTRKPMHRECGFIRLKPDTNKVAFVSAQNTGVVEVE     509                                                          
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence DHPEVQAEF in M85985_P14.	                                                            

19938	HMR136_M85991_2_tr0_r1_1_gPRT		Comparison report between M85991_P2 and Q9GZZ1partial WT     	Sequence name: Q9GZZ1                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M85991_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKL             	Alignment of: 19938 x Q9GZZ1   ..                            
						corresponding to amino acids 1 - 48 of Q9GZZ1, which also    	                                                            
						corresponds to amino acids 1 - 48 of M85991_P2, and a second 	Alignment segment 1/1:                                       
						GTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAH 	                                                            
						VLQKNLKVPSGQNADVQKTDN                                        	                     Quality: 1164.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     129                Total length:     169                                               
						corresponding to amino acids 89 - 169 of Q9GZZ1, which also  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 49 - 129 of M85991_P2, wherein    	    Total Percent Similarity:   76.33      Total Percent Identity:   76.33                                               
						said first amino acid sequence and second amino acid sequence	                        Gaps:       1                        
						are contiguous and in a sequential order.2.An isolated       	                                                            
						chimeric polypeptide encoding for an edge portion of         	Alignment:                                                   
						M85991_P2, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	       1 MKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKL.. 48                                                           
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						preferably at least about 30 amino acids in length, more     	       1 MKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAY 50                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      49 ......................................GTKMLNHVLNIC 60                                                           
						at least two amino acids comprise LG, having a structure as  	                                               ||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	      51 FNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNIC 100                                                          
						48-x to 49; and ending at any of amino acid numbers 49+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      61 EKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVL 110                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVL 150                                                          
						                                                            	                  .                                          
						                                                            	     111 QKNLKVPSGQNADVQKTDN                                129                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     151 QKNLKVPSGQNADVQKTDN                                169                                                          

19936	HMR136_M85991_3_tr0_r1_1_gPRT		Comparison report between M85991_P3 and Q9GZZ1unique head    	Sequence name: Q9GZZ1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M85991_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19936 x Q9GZZ1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MKG corresponding to amino acids 1 - 3 of	Alignment segment 1/1:                                       
						M85991_P3, and a second amino acid sequence being at least 90	                                                            
						% homologous to                                              	                     Quality:  571.00                      Escore:       0                                               
						HVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN   	             Matching length:      58                Total length:      58                                               
						corresponding to amino acids 112 - 169 of Q9GZZ1, which also 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 4 - 61 of M85991_P3, wherein said 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						first amino acid sequence and second amino acid sequence are 	                        Gaps:       0                        
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M85991_P3, comprising a   	Alignment:                                                   
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	       4 HVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQN 53                                                           
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MKG of M85991_P3.                            	     112 HVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQN 161                                                          
						                                                            	                                                             
						                                                            	      54 ADVQKTDN                                           61                                                           
						                                                            	         ||||||||                                            
						                                                            	     162 ADVQKTDN                                           169                                                          

20877	HMR136_M86010_2_tr0_r1_1_gPRT		Comparison report between M86010_P2 and Q96E51partial WT     	Sequence name: Q96E51                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86010_P2, comprising a first amino 	Sequence documentation:                                      
						MDVLASYSIFQELQLVHDTGYFSALPSLEETWQQTCLELERYLQTEPRRISETFGEDLDC 	                                                            
						FLHASPPPCIEESFRRLDPLLLPVEAAICEKSSAVDILLSRDKLLSETCLSLQPASSSLD 	Alignment of: 20877 x Q96E51   ..                            
						SYTAVNQAQLNAVTSLTPPSSPELSRHLVKTSQTLSAVDGTVTLKLVAKKAALSSVKV   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 178 of Q96E51, which also corresponds to  	                                                            
						amino acids 1 - 178 of M86010_P2, and a second amino acid    	                     Quality: 1704.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     178                Total length:     178                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GGVATAAAAVTAAGAVKSGQSDSDQGGLGAEACPENKKRVHRCQFNGCRKVYTKSSHLKA 	                        Gaps:       0                        
						HQRTHTGEKPYKCSWEGCEWRFARSDELTRHYRKHTGAKPFKCNHCDRCFSRSDHLALHM 	                                                            
						KRHI                                                         	Alignment:                                                   
						having the sequence corresponding to amino acids 179 - 302 of	                  .         .         .         .         .  
						M86010_P2, wherein said first amino acid sequence and second 	       1 MDVLASYSIFQELQLVHDTGYFSALPSLEETWQQTCLELERYLQTEPRRI 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDVLASYSIFQELQLVHDTGYFSALPSLEETWQQTCLELERYLQTEPRRI 50                                                           
						M86010_P2, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 SETFGEDLDCFLHASPPPCIEESFRRLDPLLLPVEAAICEKSSAVDILLS 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGVATAAAAVTAAGAVKSGQSDSDQGGLGAEACPENKKRVHRCQFNGCRKVYTKSSHLKA 	      51 SETFGEDLDCFLHASPPPCIEESFRRLDPLLLPVEAAICEKSSAVDILLS 100                                                          
						HQRTHTGEKPYKCSWEGCEWRFARSDELTRHYRKHTGAKPFKCNHCDRCFSRSDHLALHM 	                  .         .         .         .         .  
						KRHI                                                         	     101 RDKLLSETCLSLQPASSSLDSYTAVNQAQLNAVTSLTPPSSPELSRHLVK 150                                                          
						least about 95% homologous to the sequence in M86010_P2.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RDKLLSETCLSLQPASSSLDSYTAVNQAQLNAVTSLTPPSSPELSRHLVK 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 TSQTLSAVDGTVTLKLVAKKAALSSVKV                       178                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     151 TSQTLSAVDGTVTLKLVAKKAALSSVKV                       178                                                          

21729	HMR136_M86030_4_tr0_r1_1_gPRT		Comparison report between M86030_P4 and DCX_HUMANpartial WT  	Sequence name: DCX_HUMAN                                     
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						M86030_P4, comprising a first amino acid sequence being at   	                                                            
						MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEKKAKKVRFYRN 	Alignment of: 21729 x DCX_HUMAN   ..                         
						GDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQGVRYIYTIDGSRKIGSMDELE 	                                                            
						EGESYVCSSDNFFKKVEYTKNVNPNWSVNVKTSANMKAPQSLASSNSAQARENKDFVRPK 	Alignment segment 1/1:                                       
						LVTIIRSGVKPRKAVRVLLNKKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLH 	                                                            
						DFFGDDDVFIACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 	                     Quality: 3251.00                      Escore:       0                                               
						MRRSKSPADS                                                   	             Matching length:     346                Total length:     351                                               
						least 90 % homologous to corresponding to amino acids 43 -   	 Matching Percent Similarity:   99.42   Matching Percent Identity:   99.42                                               
						352 of DCX_HUMAN, which also corresponds to amino acids 1 -  	    Total Percent Similarity:   98.01      Total Percent Identity:   98.01                                               
						310 of M86030_P4, a second amino acid sequence being at least	                        Gaps:       1                        
						70%, optionally at least 80%, preferably at least 85%, more  	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment:                                                   
						homologous to a polypeptide having the sequence GNDQD        	                  .         .         .         .         .  
						corresponding to amino acids 311 - 315 of M86030_P4, a third 	       1 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANGTSSSQLSTPKSKQSPISTPTSPGSLRKHK corresponding to amino acids	      43 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 92                                                           
						353 - 384 of DCX_HUMAN, which also corresponds to amino acids	                  .         .         .         .         .  
						316 - 347 of M86030_P4, and a fourth amino acid sequence     	      51 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 100                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	      93 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 142                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						VLCLLYLTKPLCTQFPEWLGEGFLFHSNSTAH corresponding to amino acids	     101 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 150                                                          
						348 - 379 of M86030_P4, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     143 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 192                                                          
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	     151 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 200                                                          
						edge portion of M86030_P4, comprising an amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     193 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 242                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     201 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 250                                                          
						encoding for GNDQD, corresponding to M86030_P4.3.An isolated 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of M86030_P4, comprising a   	     243 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 292                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     251 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 300                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VLCLLYLTKPLCTQFPEWLGEGFLFHSNSTAH in          	     293 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 342                                                          
						M86030_P4.                                                   	                  .         .         .         .         .  
						                                                            	     301 MRRSKSPADSGNDQDANGTSSSQLSTPKSKQSPISTPTSPGSLRKHKVLC 350                                                          
						                                                            	         ||||||||||     |||||||||||||||||||||||||||||||| |   
						                                                            	     343 MRRSKSPADS.....ANGTSSSQLSTPKSKQSPISTPTSPGSLRKHKDLY 387                                                          
						                                                            	                                                             
						                                                            	     351 L                                                  351                                                          
						                                                            	         |                                                   
						                                                            	     388 L                                                  388                                                          

21733	HMR136_M86030_5_tr0_r1_1_gPRT		Comparison report between M86030_P5 and DCX_HUMANpartial WT  	Sequence name: DCX_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86030_P5, comprising a first amino 	Sequence documentation:                                      
						MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEKKAKKVRFYRN 	                                                            
						GDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQGVRYIYTIDGSRKIGSMDELE 	Alignment of: 21733 x DCX_HUMAN   ..                         
						EGESYVCSSDNFFKKVEYTKNVNPNWSVNVKTSANMKAPQSLASSNSAQARENKDFVRPK 	                                                            
						LVTIIRSGVKPRKAVRVLLNKKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLH 	Alignment segment 1/1:                                       
						DFFGDDDVFIACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 	                                                            
						MRRSKSPADS                                                   	                     Quality: 3048.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     312                Total length:     312                                               
						to amino acids 43 - 352 of DCX_HUMAN, which also corresponds 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						to amino acids 1 - 310 of M86030_P5, and a second amino acid 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence GNDQDGECSFPNCAR corresponding to amino   	                  .         .         .         .         .  
						acids 311 - 325 of M86030_P5, wherein said first amino acid  	       1 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      43 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 92                                                           
						tail of M86030_P5, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence GNDQDGECSFPNCAR	      93 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 142                                                          
						in M86030_P5.                                                	                  .         .         .         .         .  
						                                                            	     101 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     143 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 192                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 342                                                          
						                                                            	                  .                                          
						                                                            	     301 MRRSKSPADSGN                                       312                                                          
						                                                            	         |||||||||| |                                        
						                                                            	     343 MRRSKSPADSAN                                       354                                                          

21731	HMR136_M86030_6_tr0_r1_1_gPRT		Comparison report between M86030_P6 and DCX_HUMANpartial WT  	Sequence name: DCX_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86030_P6, comprising a first amino 	Sequence documentation:                                      
						MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEKKAKKVRFYRN 	                                                            
						GDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQGVRYIYTIDGSRKIGSMDELE 	Alignment of: 21731 x DCX_HUMAN   ..                         
						EGESYVCSSDNFFKKVEYTKNVNPNWSVNVKTSANMKAPQSLASSNSAQARENKDFVRPK 	                                                            
						LVTIIRSGVKPRKAVRVLLNKKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLH 	Alignment segment 1/1:                                       
						DFFGDDDVFIACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 	                                                            
						MRRSKSPADS                                                   	                     Quality: 3048.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     312                Total length:     312                                               
						to amino acids 43 - 352 of DCX_HUMAN, which also corresponds 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						to amino acids 1 - 310 of M86030_P6, and a second amino acid 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence GNDQDGECSFPNCAR corresponding to amino   	                  .         .         .         .         .  
						acids 311 - 325 of M86030_P6, wherein said first amino acid  	       1 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      43 MELDFGHFDERDKTSRNMRGSRMNGLPSPTHSAHCSFYRTRTLQALSNEK 92                                                           
						tail of M86030_P6, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence GNDQDGECSFPNCAR	      93 KAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQG 142                                                          
						in M86030_P6.                                                	                  .         .         .         .         .  
						                                                            	     101 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     143 VRYIYTIDGSRKIGSMDELEEGESYVCSSDNFFKKVEYTKNVNPNWSVNV 192                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 KTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLN 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 KKTAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFI 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 ACGPEKFRYAQDDFSLDENECRVMKGNPSATAGPKASPTPQKTSAKSPGP 342                                                          
						                                                            	                  .                                          
						                                                            	     301 MRRSKSPADSGN                                       312                                                          
						                                                            	         |||||||||| |                                        
						                                                            	     343 MRRSKSPADSAN                                       354                                                          

21852	HMR136_M86038_4_tr0_r1_1_gPRT		Comparison report between M86038_P4 and Q9NYC6unique head    	Sequence name: Q9NYC6                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique insertion with extra amino acids.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for M86038_P4, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 21852 x Q9NYC6   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ corresponding to amino    	                     Quality: 1152.00                      Escore:       0                                               
						acids 1 - 34 of M86038_P4, a second amino acid sequence being	             Matching length:     125                Total length:     145                                               
						at least 90 % homologous to                                  	 Matching Percent Similarity:   98.40   Matching Percent Identity:   97.60                                               
						MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDC corresponding to amino 	    Total Percent Similarity:   84.83      Total Percent Identity:   84.14                                               
						acids 1 - 37 of Q9NYC6, which also corresponds to amino acids	                        Gaps:       1                        
						35 - 71 of M86038_P4, a bridging amino acid L corresponding  	                                                            
						to amino acid 72 of M86038_P4, a third amino acid sequence   	Alignment:                                                   
						being at least 90 % homologous to KCACCDCR corresponding to  	                  .         .         .         .         .  
						amino acids 39 - 46 of Q9NYC6, which also corresponds to     	      35 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 84                                                           
						amino acids 73 - 80 of M86038_P4, a fourth amino acid        	         ||||||||||||||||||||||||||||||||||||| ||||||||      
						sequence being at least 70%, optionally at least 80%,        	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCPKCACCDCR.... 46                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      85 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 134                                                          
						having the sequence LGEVGSTLYTKANLILCRRDYL corresponding to  	                         : ||||||||||||||||||||||||||||||||  
						amino acids 81 - 102 of M86038_P4, and a fifth amino acid    	      47 ................WERLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 80                                                           
						RLFGVTGNCAACSKLIPAFEMVMRAKDNVYHLDCFACQLCNQRFCVGDKFFLKNNMILCQ 	                  .         .         .         .            
						TDYEEGLMKEGYAPQVR                                            	     135 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      179                                                          
						sequence being at least 90 % homologous to corresponding to  	         |||||||||||||||||||||||||||||||||||||||||||||       
						amino acids 49 - 125 of Q9NYC6, which also corresponds to    	      81 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      125                                                          
						amino acids 103 - 179 of M86038_P4, wherein said first amino 	                                                            
						acid sequence, second amino acid sequence, bridging amino    	                                                            
						acid, third amino acid sequence, fourth amino acid sequence  	                                                            
						and fifth amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of M86038_P4, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ of M86038_P4.3.An isolated	                                                            
						polypeptide encoding for an edge portion of M86038_P4,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						LGEVGSTLYTKANLILCRRDYL, corresponding to M86038_P4.4.A bridge	                                                            
						portion of M86038_P4, comprising a polypeptide having a      	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise R, having a structure as   	                                                            
						follows (numbering according to M86038_P4): a sequence       	                                                            
						starting from any of amino acid numbers 46-x to 46; and      	                                                            
						ending at any of amino acid numbers 81 + ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between M86038_P4 and Q8TAP4unique head    	Sequence name: Q8TAP4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86038_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 21852 x Q8TAP4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 34 of M86038_P4, and a      	                                                            
						MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEVGSTLYTKANL 	                     Quality: 1480.00                      Escore:       0                                               
						ILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHLDCFACQLCNQRFCVGDKFFL 	             Matching length:     145                Total length:     145                                               
						KNNMILCQTDYEEGLMKEGYAPQVR                                    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 145 of Q8TAP4, which also   	                        Gaps:       0                        
						corresponds to amino acids 35 - 179 of M86038_P4, wherein    	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of M86038_P4, comprising a   	      35 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 84                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ of        	      85 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 134                                                          
						M86038_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 100                                                          
						                                                            	                  .         .         .         .            
						                                                            	     135 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      179                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     101 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      145                                                          

						Comparison report between M86038_P4 and Q8N974unique head    	Sequence name: Q8N974                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M86038_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 21852 x Q8N974   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment segment 1/1:                                       
						STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ corresponding to amino    	                                                            
						acids 1 - 34 of M86038_P4, a second amino acid sequence being	                     Quality: 1465.00                      Escore:       0                                               
						at least 90 % homologous to MLSVQPDTKPKGCAGCNRKIKDRYLLKA     	             Matching length:     145                Total length:     145                                               
						corresponding to amino acids 1 - 28 of Q8N974, which also    	 Matching Percent Similarity:   99.31   Matching Percent Identity:   99.31                                               
						corresponds to amino acids 35 - 62 of M86038_P4, a bridging  	    Total Percent Similarity:   99.31      Total Percent Identity:   99.31                                               
						amino acid L corresponding to amino acid 63 of M86038_P4, and	                        Gaps:       0                        
						DKYWHEDCLKCACCDCRLGEVGSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEM 	                                                            
						VMRAKDNVYHLDCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR     	Alignment:                                                   
						a third amino acid sequence being at least 90 % homologous to	                  .         .         .         .         .  
						corresponding to amino acids 30 - 145 of Q8N974, which also  	      35 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 84                                                           
						corresponds to amino acids 64 - 179 of M86038_P4, wherein    	         |||||||||||||||||||||||||||| |||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKAPDKYWHEDCLKCACCDCRLGEV 50                                                           
						bridging amino acid and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      85 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 134                                                          
						polypeptide encoding for a head of M86038_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	      51 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 100                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .            
						about 90% and most preferably at least about 95% homologous  	     135 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      179                                                          
						to the sequence STSTFGFGAQCEAAATQTRLSQLMQKKEKSFGIQ of        	         |||||||||||||||||||||||||||||||||||||||||||||       
						M86038_P4.                                                   	     101 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      145                                                          

21854	HMR136_M86038_5_tr0_r1_1_gPRT		Comparison report between M86038_P5 and Q9NYC6partial WT     	Sequence name: Q9NYC6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion with extra amino acids.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for M86038_P5, comprising a first amino 	                                                            
						acid sequence being at least 90 % homologous to              	Alignment of: 21854 x Q9NYC6   ..                            
						MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDC corresponding to amino 	                                                            
						acids 1 - 37 of Q9NYC6, which also corresponds to amino acids	Alignment segment 1/1:                                       
						1 - 37 of M86038_P5, a bridging amino acid L corresponding to	                                                            
						amino acid 38 of M86038_P5, a second amino acid sequence     	                     Quality: 1152.00                      Escore:       0                                               
						being at least 90 % homologous to KCACCDCR corresponding to  	             Matching length:     125                Total length:     145                                               
						amino acids 39 - 46 of Q9NYC6, which also corresponds to     	 Matching Percent Similarity:   98.40   Matching Percent Identity:   97.60                                               
						amino acids 39 - 46 of M86038_P5, a third amino acid sequence	    Total Percent Similarity:   84.83      Total Percent Identity:   84.14                                               
						being at least 70%, optionally at least 80%, preferably at   	                        Gaps:       1                        
						least 85%, more preferably at least 90% and most preferably  	                                                            
						at least 95% homologous to a polypeptide having the sequence 	Alignment:                                                   
						LGEVGSTLYTKANLILCRRDYL corresponding to amino acids 47 - 68  	                  .         .         .         .         .  
						of M86038_P5, and a fourth amino acid sequence being at least	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 50                                                           
						RLFGVTGNCAACSKLIPAFEMVMRAKDNVYHLDCFACQLCNQRFCVGDKFFLKNNMILCQ 	         ||||||||||||||||||||||||||||||||||||| ||||||||      
						TDYEEGLMKEGYAPQVR                                            	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCPKCACCDCR.... 46                                                           
						90 % homologous to corresponding to amino acids 49 - 125 of  	                  .         .         .         .         .  
						Q9NYC6, which also corresponds to amino acids 69 - 145 of    	      51 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 100                                                          
						M86038_P5, wherein said first amino acid sequence, bridging  	                         : ||||||||||||||||||||||||||||||||  
						amino acid, second amino acid sequence, third amino acid     	      47 ................WERLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 80                                                           
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .         .            
						a sequential order.2.An isolated polypeptide encoding for an 	     101 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      145                                                          
						edge portion of M86038_P5, comprising an amino acid sequence 	         |||||||||||||||||||||||||||||||||||||||||||||       
						being at least 70%, optionally at least about 80%, preferably	      81 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      125                                                          
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for LGEVGSTLYTKANLILCRRDYL, corresponding to        	                                                            
						M86038_P5.3.A bridge portion of M86038_P5, comprising a      	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise R, having a	                                                            
						structure as follows (numbering according to M86038_P5): a   	                                                            
						sequence starting from any of amino acid numbers 46-x to 46; 	                                                            
						and ending at any of amino acid numbers 47 + ((n-2) - x), in 	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between M86038_P5 and Q8N974partial WT     	Sequence name: Q8N974                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for M86038_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MLSVQPDTKPKGCAGCNRKIKDRYLLKA corresponding to amino acids 1 -	Alignment of: 21854 x Q8N974   ..                            
						28 of Q8N974, which also corresponds to amino acids 1 - 28 of	                                                            
						M86038_P5, a bridging amino acid L corresponding to amino    	Alignment segment 1/1:                                       
						acid 29 of M86038_P5, and a second amino acid sequence being 	                                                            
						DKYWHEDCLKCACCDCRLGEVGSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEM 	                     Quality: 1465.00                      Escore:       0                                               
						VMRAKDNVYHLDCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR     	             Matching length:     145                Total length:     145                                               
						at least 90 % homologous to corresponding to amino acids 30 -	 Matching Percent Similarity:   99.31   Matching Percent Identity:   99.31                                               
						145 of Q8N974, which also corresponds to amino acids 30 - 145	    Total Percent Similarity:   99.31      Total Percent Identity:   99.31                                               
						of M86038_P5, wherein said first amino acid sequence,        	                        Gaps:       0                        
						bridging amino acid and second amino acid sequence are       	                                                            
						contiguous and in a sequential order.                        	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKALDKYWHEDCLKCACCDCRLGEV 50                                                           
						                                                            	         |||||||||||||||||||||||||||| |||||||||||||||||||||  
						                                                            	       1 MLSVQPDTKPKGCAGCNRKIKDRYLLKAPDKYWHEDCLKCACCDCRLGEV 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GSTLYTKANLILCRRDYLRLFGVTGNCAACSKLIPAFEMVMRAKDNVYHL 100                                                          
						                                                            	                  .         .         .         .            
						                                                            	     101 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      145                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     101 DCFACQLCNQRFCVGDKFFLKNNMILCQTDYEEGLMKEGYAPQVR      145                                                          

22090	HMR136_M86044_12_tr0_r1_1_gPRT		Comparison report between M86044_P12 and CNO7_HUMANunique    	Sequence name: CNO7_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for M86044_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22090 x CNO7_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MFECCLSLSSAR corresponding to amino acids	Alignment segment 1/1:                                       
						1 - 12 of M86044_P12, and a second amino acid sequence being 	                                                            
						EDMYAQDSIELLTTSGIQFKKHEEEGIETQYFAELLMTSGVVLCEGVKWLSFHSGYDFGY 	                     Quality: 1782.00                      Escore:       0                                               
						LIKILTNSNLPEEELDFFEILRLFFPVIYDVKYLMKSCKNLKGGLQEVAEQLELERIGPQ 	             Matching length:     181                Total length:     181                                               
						HQAGSDSLLTGMAFFKMREMFFEDHIDDAKYCGHLYGLGSGSSYVQNGTGNAYEEEANKQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						S                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 90 % homologous to corresponding to amino acids 105 	                        Gaps:       0                        
						- 285 of CNO7_HUMAN, which also corresponds to amino acids 13	                                                            
						- 193 of M86044_P12, wherein said first amino acid sequence  	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      13 EDMYAQDSIELLTTSGIQFKKHEEEGIETQYFAELLMTSGVVLCEGVKWL 62                                                           
						head of M86044_P12, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     105 EDMYAQDSIELLTTSGIQFKKHEEEGIETQYFAELLMTSGVVLCEGVKWL 154                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MFECCLSLSSAR of	      63 SFHSGYDFGYLIKILTNSNLPEEELDFFEILRLFFPVIYDVKYLMKSCKN 112                                                          
						M86044_P12.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     155 SFHSGYDFGYLIKILTNSNLPEEELDFFEILRLFFPVIYDVKYLMKSCKN 204                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     113 LKGGLQEVAEQLELERIGPQHQAGSDSLLTGMAFFKMREMFFEDHIDDAK 162                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 LKGGLQEVAEQLELERIGPQHQAGSDSLLTGMAFFKMREMFFEDHIDDAK 254                                                          
						                                                            	                  .         .         .                      
						                                                            	     163 YCGHLYGLGSGSSYVQNGTGNAYEEEANKQS                    193                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     255 YCGHLYGLGSGSSYVQNGTGNAYEEEANKQS                    285                                                          

22241	HMR136_M86046_15_tr0_r1_1_gPRT		Comparison report between M86046_P15 and PSF1_HUMANpartial   	Sequence name: PSF1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M86046_P15, comprising a first amino	                                                            
						MIVDPLRSGFPRALIDPSSGLPNRLPPGAVPPGARFDPFGPIGTSPPGPNPDHLPPPGYD 	Alignment of: 22241 x PSF1_HUMAN   ..                        
						DMYL                                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 208 - 271 of PSF1_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 64 of M86046_P15.             	                     Quality:  649.00                      Escore:       0                                               
						                                                            	             Matching length:      64                Total length:      64                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MIVDPLRSGFPRALIDPSSGLPNRLPPGAVPPGARFDPFGPIGTSPPGPN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     208 MIVDPLRSGFPRALIDPSSGLPNRLPPGAVPPGARFDPFGPIGTSPPGPN 257                                                          
						                                                            	                  .                                          
						                                                            	      51 PDHLPPPGYDDMYL                                     64                                                           
						                                                            	         ||||||||||||||                                      
						                                                            	     258 PDHLPPPGYDDMYL                                     271                                                          

22617	HMR136_M86052_10_tr0_r1_1_gPRT		Comparison report between M86052_P10 and Q96HM0partial WT    	Sequence name: Q96HM0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86052_P10, comprising a first amino	Sequence documentation:                                      
						MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPG 	                                                            
						SITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR                	Alignment of: 22617 x Q96HM0   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 105 of Q96HM0, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 105 of M86052_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1050.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     105                Total length:     105                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSK 	                        Gaps:       0                        
						KLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQ 	                                                            
						AKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKA 	Alignment:                                                   
						STNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 	                  .         .         .         .         .  
						YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPS 	       1 MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKP 50                                                           
						KQLEYLARIQGFQV                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 106 - 479 of	       1 MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKP 50                                                           
						M86052_P10, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      51 PKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRG 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86052_P10, comprising a polypeptide being at least 70%,     	      51 PKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRG 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                                                             
						more preferably at least about 90% and most preferably at    	     101 MYNQR                                              105                                                          
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKD 	         |||||                                               
						MDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSK 	     101 MYNQR                                              105                                                          
						KLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQ 	                                                            
						AKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKA 	                                                            
						STNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 	                                                            
						YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPS 	                                                            
						KQLEYLARIQGFQV                                               	                                                            
						least about 95% homologous to the sequence in M86052_P10.    	                                                            

						Comparison report between M86052_P10 and Q9NUL3unique head   	Sequence name: Q9NUL3                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22617 x Q9NUL3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MLQINQ       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 6 of M86052_P10, a second   	                                                            
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	                     Quality: 4646.00                      Escore:       0                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFF 	             Matching length:     473                Total length:     473                                               
						GEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						RNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						PVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRR 	                        Gaps:       0                        
						EFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPK 	                                                            
						PGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTS 	Alignment:                                                   
						NSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQ         	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						corresponding to amino acids 39 - 510 of Q9NUL3, which also  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 7 - 478 of M86052_P10, and a third	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence V corresponding to amino acids 479 - 479 	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						of M86052_P10, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     106 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 155                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M86052_P10, comprising a  	     138 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 187                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     156 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 205                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MLQINQ of M86052_P10.                        	     188 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 237                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     238 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 287                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     288 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 337                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     338 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 387                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     388 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 437                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     438 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 487                                                          
						                                                            	                  .         .                                
						                                                            	     456 TPPCSPVQPSKQLEYLARIQGFQ                            478                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     488 TPPCSPVQPSKQLEYLARIQGFQ                            510                                                          

						Comparison report between M86052_P10 and Q96HM1partial WT    	Sequence name: Q96HM1                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M86052_P10, comprising a first amino	Sequence documentation:                                      
						MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPG 	                                                            
						SITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTV 	Alignment of: 22617 x Q96HM1   ..                            
						GNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLV 	                                                            
						FEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQEL 	Alignment segment 1/1:                                       
						KKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSER 	                                                            
						GMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENK 	                     Quality: 4705.00                      Escore:       0                                               
						GWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFF 	             Matching length:     478                Total length:     478                                               
						SISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQ   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 478 of Q96HM1, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 478 of M86052_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKP 50                                                           
						having the sequence V corresponding to amino acids 479 - 479 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M86052_P10, wherein said first amino acid sequence and    	       1 MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKP 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 PKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRG 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSER 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSER 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVIS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVIS 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGL 450                                                          
						                                                            	                  .         .                                
						                                                            	     451 KGSSPTPPCSPVQPSKQLEYLARIQGFQ                       478                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     451 KGSSPTPPCSPVQPSKQLEYLARIQGFQ                       478                                                          

						Comparison report between M86052_P10 and Q9NVI5unique head   	Sequence name: Q9NVI5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86052_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22617 x Q9NVI5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPG 	Alignment segment 1/1:                                       
						SITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTV 	                                                            
						GNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLV 	                     Quality: 2017.00                      Escore:       0                                               
						FEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQEL 	             Matching length:     206                Total length:     206                                               
						KKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQG                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 273 of  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						M86052_P10, and a second amino acid sequence being at least  	                        Gaps:       0                        
						MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNA 	                                                            
						AEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEA 	Alignment:                                                   
						SRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGS 	                  .         .         .         .         .  
						SPTPPCSPVQPSKQLEYLARIQGFQV                                   	     274 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 323                                                          
						90 % homologous to corresponding to amino acids 1 - 206 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9NVI5, which also corresponds to amino acids 274 - 479 of   	       1 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 50                                                           
						M86052_P10, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     324 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 373                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86052_P10, comprising a polypeptide being at least 70%,     	      51 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     374 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 423                                                          
						MLQINQMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTV 	     101 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 150                                                          
						GNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLV 	                  .         .         .         .         .  
						FEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQEL 	     424 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 473                                                          
						KKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQG                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M86052_P10.    	     151 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 200                                                          
						                                                            	                                                             
						                                                            	     474 IQGFQV                                             479                                                          
						                                                            	         ||||||                                              
						                                                            	     201 IQGFQV                                             206                                                          

22611	HMR136_M86052_14_tr0_r1_1_gPRT		Comparison report between M86052_P14 and Q9UGG6partial WT    	Sequence name: Q9UGG6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M86052_P14, comprising a first amino acid       	                                                            
						MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTR 	Alignment of: 22611 x Q9UGG6   ..                            
						QAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVS 	                                                            
						FEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKP 	Alignment segment 1/1:                                       
						KLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQV 	                                                            
						KVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 	                     Quality: 4012.00                      Escore:       0                                               
						TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATI 	             Matching length:     407                Total length:     407                                               
						ARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQV              	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 73 - 479 of Q9UGG6, which also corresponds to    	                        Gaps:       0                        
						amino acids 1 - 407 of M86052_P14.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      73 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 122                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     123 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 172                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 472                                                          
						                                                            	                                                             
						                                                            	     401 RIQGFQV                                            407                                                          
						                                                            	         |||||||                                             
						                                                            	     473 RIQGFQV                                            479                                                          

						Comparison report between M86052_P14 and Q9NUL3partial WT    	Sequence name: Q9NUL3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M86052_P14, comprising a first amino	Sequence documentation:                                      
						MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTR 	                                                            
						QAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVS 	Alignment of: 22611 x Q9NUL3   ..                            
						FEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKP 	                                                            
						KLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQV 	Alignment segment 1/1:                                       
						KVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 	                                                            
						TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATI 	                     Quality: 4004.00                      Escore:       0                                               
						ARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQ               	             Matching length:     406                Total length:     406                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 105 - 510 of Q9NUL3, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 406 of M86052_P14, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence V corresponding to amino acids 407 - 407 	       1 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 50                                                           
						of M86052_P14, wherein said first amino acid sequence and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     105 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 154                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	      51 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     155 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 204                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 254                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 304                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 504                                                          
						                                                            	                                                             
						                                                            	     401 RIQGFQ                                             406                                                          
						                                                            	         ||||||                                              
						                                                            	     505 RIQGFQ                                             510                                                          

						Comparison report between M86052_P14 and Q96HM1partial WT    	Sequence name: Q96HM1                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M86052_P14, comprising a first amino	Sequence documentation:                                      
						MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTR 	                                                            
						QAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVS 	Alignment of: 22611 x Q96HM1   ..                            
						FEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKP 	                                                            
						KLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQV 	Alignment segment 1/1:                                       
						KVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 	                                                            
						TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATI 	                     Quality: 4004.00                      Escore:       0                                               
						ARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQ               	             Matching length:     406                Total length:     406                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 73 - 478 of Q96HM1, which also corresponds to 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 406 of M86052_P14, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence V corresponding to amino acids 407 - 407 	       1 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 50                                                           
						of M86052_P14, wherein said first amino acid sequence and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      73 MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGN 122                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	      51 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     123 NEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDA 172                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 NKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEG 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 NSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQ 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 GMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGT 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 GPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEP 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 TNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSI 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 SPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLA 472                                                          
						                                                            	                                                             
						                                                            	     401 RIQGFQ                                             406                                                          
						                                                            	         ||||||                                              
						                                                            	     473 RIQGFQ                                             478                                                          

						Comparison report between M86052_P14 and Q9NVI5unique head   	Sequence name: Q9NVI5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86052_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22611 x Q9NVI5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTR 	Alignment segment 1/1:                                       
						QAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVS 	                                                            
						FEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKP 	                     Quality: 2017.00                      Escore:       0                                               
						KLFFKKRPKTIVKAGPEYGQG                                        	             Matching length:     206                Total length:     206                                               
						having the sequence corresponding to amino acids 1 - 201 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						M86052_P14, and a second amino acid sequence being at least  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNA 	                        Gaps:       0                        
						AEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEA 	                                                            
						SRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGS 	Alignment:                                                   
						SPTPPCSPVQPSKQLEYLARIQGFQV                                   	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 206 of   	     202 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 251                                                          
						Q9NVI5, which also corresponds to amino acids 202 - 407 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86052_P14, wherein said first amino acid sequence and second	       1 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     252 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 301                                                          
						M86052_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTR 	     302 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 351                                                          
						QAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKP 	     101 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 150                                                          
						KLFFKKRPKTIVKAGPEYGQG                                        	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M86052_P14.    	     352 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 401                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 200                                                          
						                                                            	                                                             
						                                                            	     402 IQGFQV                                             407                                                          
						                                                            	         ||||||                                              
						                                                            	     201 IQGFQV                                             206                                                          

22613	HMR136_M86052_27_tr0_r1_1_gPRT		Comparison report between M86052_P27 and Q9UGG6unique head   	Sequence name: Q9UGG6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P27, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22613 x Q9UGG6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK corresponding to amino	                                                            
						acids 1 - 38 of M86052_P27, a second amino acid sequence     	                     Quality: 1525.00                      Escore:       0                                               
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	             Matching length:     153                Total length:     153                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.35                                               
						GEGKTRQAARHNAAMKALQALQNEPIPERSPQ                             	    Total Percent Similarity:  100.00      Total Percent Identity:   99.35                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       0                        
						acids 7 - 158 of Q9UGG6, which also corresponds to amino     	                                                            
						acids 39 - 190 of M86052_P27, and a third amino acid sequence	Alignment:                                                   
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						at least 95% homologous to a polypeptide having the sequence 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						VWCCCM corresponding to amino acids 191 - 196 of M86052_P27, 	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M86052_P27, comprising a polypeptide being at least  	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     138 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 187                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of M86052_P27.3.An    	     106 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 155                                                          
						isolated polypeptide encoding for a tail of M86052_P27,      	                                                             
						comprising a polypeptide being at least 70%, optionally at   	     188 SPQ                                                190                                                          
						least about 80%, preferably at least about 85%, more         	         |||                                                 
						preferably at least about 90% and most preferably at least   	     156 SPQ                                                158                                                          
						about 95% homologous to the sequence VWCCCM in M86052_P27.   	                                                            

						Comparison report between M86052_P27 and Q96HM0unique head   	Sequence name: Q96HM0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P27, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22613 x Q96HM0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK corresponding to amino	                                                            
						acids 1 - 38 of M86052_P27, a second amino acid sequence     	                     Quality:  991.00                      Escore:       0                                               
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	             Matching length:     100                Total length:     100                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.00                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.00                                               
						acids 7 - 105 of Q96HM0, which also corresponds to amino     	                        Gaps:       0                        
						acids 39 - 137 of M86052_P27, and a third amino acid sequence	                                                            
						being at least 70%, optionally at least 80%, preferably at   	Alignment:                                                   
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQVWCCCM  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 138 - 196 of M86052_P27, wherein	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M86052_P27, comprising a polypeptide being at least  	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of M86052_P27.3.An    	                                                            
						isolated polypeptide encoding for a tail of M86052_P27,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQVWCCCM  	                                                            
						in M86052_P27.                                               	                                                            

						Comparison report between M86052_P27 and Q9NUL3partial WT    	Sequence name: Q9NUL3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86052_P27, comprising a first amino	Sequence documentation:                                      
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQTWESEGSSIKK 	                                                            
						AQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKP 	Alignment of: 22613 x Q9NUL3   ..                            
						FPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQ 	                                                            
						NEPIPERSPQ                                                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 190 of Q9NUL3, which also corresponds to  	                     Quality: 1906.00                      Escore:       0                                               
						amino acids 1 - 190 of M86052_P27, and a second amino acid   	             Matching length:     190                Total length:     190                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence VWCCCM corresponding to amino acids 191 -	                                                            
						196 of M86052_P27, wherein said first amino acid sequence and	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQT 50                                                           
						M86052_P27, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQT 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence VWCCCM in         	      51 WESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVEL 100                                                          
						M86052_P27.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 WESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVEL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQL 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 TVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQ           190                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     151 TVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQ           190                                                          

						Comparison report between M86052_P27 and Q96HM1unique head   	Sequence name: Q96HM1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P27, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22613 x Q96HM1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK corresponding to amino	                                                            
						acids 1 - 38 of M86052_P27, a second amino acid sequence     	                     Quality: 1525.00                      Escore:       0                                               
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	             Matching length:     153                Total length:     153                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.35                                               
						GEGKTRQAARHNAAMKALQALQNEPIPERSPQ                             	    Total Percent Similarity:  100.00      Total Percent Identity:   99.35                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       0                        
						acids 7 - 158 of Q96HM1, which also corresponds to amino     	                                                            
						acids 39 - 190 of M86052_P27, and a third amino acid sequence	Alignment:                                                   
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						at least 95% homologous to a polypeptide having the sequence 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						VWCCCM corresponding to amino acids 191 - 196 of M86052_P27, 	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M86052_P27, comprising a polypeptide being at least  	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     138 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 187                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of M86052_P27.3.An    	     106 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 155                                                          
						isolated polypeptide encoding for a tail of M86052_P27,      	                                                             
						comprising a polypeptide being at least 70%, optionally at   	     188 SPQ                                                190                                                          
						least about 80%, preferably at least about 85%, more         	         |||                                                 
						preferably at least about 90% and most preferably at least   	     156 SPQ                                                158                                                          
						about 95% homologous to the sequence VWCCCM in M86052_P27.   	                                                            

22615	HMR136_M86052_6_tr0_r1_1_gPRT		Comparison report between M86052_P6 and Q9UGG6unique head    	Sequence name: Q9UGG6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86052_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22615 x Q9UGG6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK   	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 38 of M86052_P6, and a      	                                                            
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	                     Quality: 4654.00                      Escore:       0                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFF 	             Matching length:     474                Total length:     474                                               
						GEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						RNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						PVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRR 	                        Gaps:       0                        
						EFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPK 	                                                            
						PGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTS 	Alignment:                                                   
						NSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQV        	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						corresponding to amino acids 7 - 479 of Q9UGG6, which also   	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 39 - 511 of M86052_P6, wherein    	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						polypeptide encoding for a head of M86052_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     138 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 187                                                          
						to the sequence MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86052_P6.                                                   	     106 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 155                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 305                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     306 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 355                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     356 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 405                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     406 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 455                                                          
						                                                            	                  .         .                                
						                                                            	     488 TPPCSPVQPSKQLEYLARIQGFQV                           511                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     456 TPPCSPVQPSKQLEYLARIQGFQV                           479                                                          

						Comparison report between M86052_P6 and Q96HM0unique head    	Sequence name: Q96HM0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22615 x Q96HM0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK corresponding to amino	                                                            
						acids 1 - 38 of M86052_P6, a second amino acid sequence being	                     Quality:  991.00                      Escore:       0                                               
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	             Matching length:     100                Total length:     100                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.00                                               
						at least 90 % homologous to corresponding to amino acids 7 - 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.00                                               
						105 of Q96HM0, which also corresponds to amino acids 39 - 137	                        Gaps:       0                        
						of M86052_P6, and a third amino acid sequence being at least 	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKD 	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						MDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSK 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						KLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQ 	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						AKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKA 	                  .         .         .         .         .  
						STNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KQLEYLARIQGFQV                                               	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 138 - 511 of M86052_P6, wherein said first    	                                                            
						amino acid sequence, second amino acid sequence and third    	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						M86052_P6, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of M86052_P6.3.An     	                                                            
						isolated polypeptide encoding for a tail of M86052_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKD 	                                                            
						MDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSK 	                                                            
						KLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQ 	                                                            
						AKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKA 	                                                            
						STNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 	                                                            
						YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPS 	                                                            
						KQLEYLARIQGFQV                                               	                                                            
						about 95% homologous to the sequence in M86052_P6.           	                                                            

						Comparison report between M86052_P6 and Q9NUL3partial WT     	Sequence name: Q9NUL3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for M86052_P6, comprising a first amino 	Sequence documentation:                                      
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQTWESEGSSIKK 	                                                            
						AQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKP 	Alignment of: 22615 x Q9NUL3   ..                            
						FPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQ 	                                                            
						NEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFV 	Alignment segment 1/1:                                       
						TRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGP 	                                                            
						EYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKI 	                     Quality: 5027.00                      Escore:       0                                               
						AKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVY 	             Matching length:     510                Total length:     510                                               
						QEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GLKGSSPTPPCSPVQPSKQLEYLARIQGFQ                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 510 of Q9NUL3, which also corresponds to  	                                                            
						amino acids 1 - 510 of M86052_P6, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQT 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence V corresponding to amino acids 511 - 511 	       1 MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQT 50                                                           
						of M86052_P6, wherein said first amino acid sequence and     	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 WESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVEL 100                                                          
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 WESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVEL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDD 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFVTRVSVGEFSA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 FPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 FPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 FFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQL 500                                                          
						                                                            	                  .                                          
						                                                            	     501 EYLARIQGFQ                                         510                                                          
						                                                            	         ||||||||||                                          
						                                                            	     501 EYLARIQGFQ                                         510                                                          

						Comparison report between M86052_P6 and Q96HM1unique head    	Sequence name: Q96HM1                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86052_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22615 x Q96HM1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK corresponding to amino	                                                            
						acids 1 - 38 of M86052_P6, a second amino acid sequence being	                     Quality: 4646.00                      Escore:       0                                               
						MFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTV 	             Matching length:     473                Total length:     473                                               
						ELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						GEGKTRQAARHNAAMKALQALQNEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						RNMPVSFEVIKESGPPHMKSFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPL 	                        Gaps:       0                        
						PVVEKPKLFFKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRRR 	                                                            
						EFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPK 	Alignment:                                                   
						PGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSISPTS 	                  .         .         .         .         .  
						NSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLARIQGFQ         	      38 KMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 87                                                           
						at least 90 % homologous to corresponding to amino acids 7 - 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						478 of Q96HM1, which also corresponds to amino acids 39 - 510	       6 QMFSVQLSLGEQTWESEGSSIKKAQQAVANKALTESTLPKPVQKPPKSNV 55                                                           
						of M86052_P6, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      88 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 137                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence V            	      56 NNNPGSITPTVELNGLAMKRGEPAIYRPLDPKPFPNYRANYNFRGMYNQR 105                                                          
						corresponding to amino acids 511 - 511 of M86052_P6, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     138 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 187                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     106 YHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQNEPIPER 155                                                          
						head of M86052_P6, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     188 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 237                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     156 SPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMK 205                                                          
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSK of M86052_P6.         	                  .         .         .         .         .  
						                                                            	     238 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 SFVTRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLF 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 FKKRPKTIVKAGPEYGQGMNPISRLAQIQQAKKEKEPDYVLLSERGMPRR 305                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     306 REFVMQVKVGNEVATGTGPNKKIAKKNAAEAMLLQLGYKASTNLQDQLEK 355                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     356 TGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEASRHKVISGTTLG 405                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     406 YLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGSSP 455                                                          
						                                                            	                  .         .                                
						                                                            	     488 TPPCSPVQPSKQLEYLARIQGFQ                            510                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     456 TPPCSPVQPSKQLEYLARIQGFQ                            478                                                          

						Comparison report between M86052_P6 and Q9NVI5unique head    	Sequence name: Q9NVI5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86052_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22615 x Q9NVI5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQTWESEGSSIKK 	Alignment segment 1/1:                                       
						AQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKP 	                                                            
						FPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQ 	                     Quality: 2017.00                      Escore:       0                                               
						NEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFV 	             Matching length:     206                Total length:     206                                               
						TRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EYGQG                                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 305 of  	                        Gaps:       0                        
						M86052_P6, and a second amino acid sequence being at least 90	                                                            
						MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTGPNKKIAKKNA 	Alignment:                                                   
						AEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPTNNTPKGILHLSPDVYQEMEA 	                  .         .         .         .         .  
						SRHKVISGTTLGYLSPKDMNQPSSSFFSISPTSNSSATIARELLMNGTSSTAEAIGLKGS 	     306 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 355                                                          
						SPTPPCSPVQPSKQLEYLARIQGFQV                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 206 of      	       1 MNPISRLAQIQQAKKEKEPDYVLLSERGMPRRREFVMQVKVGNEVATGTG 50                                                           
						Q9NVI5, which also corresponds to amino acids 306 - 511 of   	                  .         .         .         .         .  
						M86052_P6, wherein said first amino acid sequence and second 	     356 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 405                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 PNKKIAKKNAAEAMLLQLGYKASTNLQDQLEKTGENKGWSGPKPGFPEPT 100                                                          
						M86052_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     406 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 455                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MANPKEKTAMCLVNELARFNRVQPQYKLLNERGPAHSKMFSVQLSLGEQTWESEGSSIKK 	     101 NNTPKGILHLSPDVYQEMEASRHKVISGTTLGYLSPKDMNQPSSSFFSIS 150                                                          
						AQQAVANKALTESTLPKPVQKPPKSNVNNNPGSITPTVELNGLAMKRGEPAIYRPLDPKP 	                  .         .         .         .         .  
						FPNYRANYNFRGMYNQRYHCPVPKIFYVQLTVGNNEFFGEGKTRQAARHNAAMKALQALQ 	     456 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 505                                                          
						NEPIPERSPQNGESGKDMDDDKDANKSEISLVFEIALKRNMPVSFEVIKESGPPHMKSFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TRVSVGEFSAEGEGNSKKLSKKRAATTVLQELKKLPPLPVVEKPKLFFKKRPKTIVKAGP 	     151 PTSNSSATIARELLMNGTSSTAEAIGLKGSSPTPPCSPVQPSKQLEYLAR 200                                                          
						EYGQG                                                        	                                                             
						least about 95% homologous to the sequence of M86052_P6.     	     506 IQGFQV                                             511                                                          
						                                                            	         ||||||                                              
						                                                            	     201 IQGFQV                                             206                                                          

22762	HMR136_M86053_3_tr0_r1_1_gPRT		Comparison report between M86053_P3 and Q9NWC2unique head    	Sequence name: Q9NWC2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22762 x Q9NWC2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	Alignment segment 1/1:                                       
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	                                                            
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	                     Quality: 1257.00                      Escore:       0                                               
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	             Matching length:     130                Total length:     130                                               
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSS                        	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 397 of M86053_P3, a second amino acid     	Alignment:                                                   
						MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDEL 	                  .         .         .         .         .  
						TCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESE 	     398 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 447                                                          
						VISQNETCSP                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 50                                                           
						amino acids 1 - 130 of Q9NWC2, which also corresponds to     	                  .         .         .         .         .  
						amino acids 398 - 527 of M86053_P3, and a third amino acid   	     448 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 497                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .                      
						EVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAE 	     498 EAFLVLSDEEDISGEKDESEVISQNETCSP                     527                                                          
						FQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLT 	         ||||||||||||||||||||||||||||||                      
						ELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 	     101 EAFLVLSDEEDISGEKDESEVISQNETCSP                     130                                                          
						SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTAT 	                                                            
						VVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQ 	                                                            
						SPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHS 	                                                            
						IVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTI 	                                                            
						DASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 	                                                            
						RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANH 	                                                            
						QVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQL 	                                                            
						TVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIVLS 	                                                            
						WSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYY 	                                                            
						FAVRAKDIYGRFGPFCDPQSTDVISSTQSS                               	                                                            
						having the sequence corresponding to amino acids 528 - 1277  	                                                            
						of M86053_P3, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M86053_P3, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	                                                            
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	                                                            
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	                                                            
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	                                                            
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	                                                            
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	                                                            
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSS                        	                                                            
						to the sequence of M86053_P3.3.An isolated polypeptide       	                                                            
						encoding for a tail of M86053_P3, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						EVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAE 	                                                            
						FQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLT 	                                                            
						ELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 	                                                            
						SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTAT 	                                                            
						VVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQ 	                                                            
						SPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHS 	                                                            
						IVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTI 	                                                            
						DASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 	                                                            
						RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANH 	                                                            
						QVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQL 	                                                            
						TVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIVLS 	                                                            
						WSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYY 	                                                            
						FAVRAKDIYGRFGPFCDPQSTDVISSTQSS                               	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M86053_P3.                                                	                                                            

						Comparison report between M86053_P3 and Q9Y4X8unique head    	Sequence name: Q9Y4X8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22762 x Q9Y4X8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	Alignment segment 1/1:                                       
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	                                                            
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	                     Quality: 4997.00                      Escore:       0                                               
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	             Matching length:     514                Total length:     514                                               
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINE 	                        Gaps:       0                        
						NVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKME 	                                                            
						SSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEE 	Alignment:                                                   
						EEQVIHEDDER                                                  	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     552 PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQK 601                                                          
						to amino acids 1 - 551 of M86053_P3, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLE 	       1 PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQK 50                                                           
						EKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRH 	                  .         .         .         .         .  
						EHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTN 	     602 LQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQA 651                                                          
						LVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 	      51 LQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQA 100                                                          
						NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNR 	                  .         .         .         .         .  
						GPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSS 	     652 KIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 701                                                          
						GVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPA                           	     101 KIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 514 of Q9Y4X8, which also corresponds to     	     702 VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTS 751                                                          
						amino acids 552 - 1065 of M86053_P3, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTS 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     752 GSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQ 801                                                          
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIV 	     201 GSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQ 250                                                          
						LSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSK 	                  .         .         .         .         .  
						YYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                             	     802 PQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 851                                                          
						having the sequence corresponding to amino acids 1066 - 1277 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M86053_P3, wherein said first amino acid sequence, second 	     251 PQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 300                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     852 NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGP 901                                                          
						polypeptide encoding for a head of M86053_P3, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     301 NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGP 350                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     902 SGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASV 951                                                          
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	     351 SGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASV 400                                                          
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	                  .         .         .         .         .  
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	     952 SKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 1001                                                         
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	     401 SKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 450                                                          
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINE 	                  .         .         .         .         .  
						NVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKME 	    1002 SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPV 1051                                                         
						SSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEQVIHEDDER                                                  	     451 SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPV 500                                                          
						to the sequence of M86053_P3.3.An isolated polypeptide       	                  .                                          
						encoding for a tail of M86053_P3, comprising a polypeptide   	    1052 TQVTTRLPVPRAPA                                     1065                                                         
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||                                      
						at least about 85%, more preferably at least about 90% and   	     501 TQVTTRLPVPRAPA                                     514                                                          
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGP 	                                                            
						QLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIV 	                                                            
						LSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSK 	                                                            
						YYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                             	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M86053_P3.                                                	                                                            

						Comparison report between M86053_P3 and Q9NVJ9unique head    	Sequence name: Q9NVJ9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M86053_P3, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 22762 x Q9NVJ9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	Alignment segment 1/1:                                       
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	                                                            
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	                     Quality: 6924.00                      Escore:       0                                               
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	             Matching length:     709                Total length:     709                                               
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	    Total Percent Similarity:   99.86      Total Percent Identity:   99.86                                               
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINE 	                        Gaps:       0                        
						NVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKME 	                                                            
						SSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEE 	Alignment:                                                   
						EEQVIHEDDERPSEKNEFSRRKRSKSED                                 	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     569 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 618                                                          
						1 - 568 of M86053_P3, a second amino acid sequence being at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAE 	       1 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 50                                                           
						LKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDV 	                  .         .         .         .         .  
						NSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTP 	     619 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 668                                                          
						VTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 	      51 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 100                                                          
						SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSA 	                  .         .         .         .         .  
						AEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQD 	     669 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 718                                                          
						PKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQ 	     101 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 150                                                          
						TTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 	                  .         .         .         .         .  
						QKPHLKLARVQSQNGIVLSW                                         	     719 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 768                                                          
						least 90 % homologous to corresponding to amino acids 1 - 620	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9NVJ9, which also corresponds to amino acids 569 - 1188  	     151 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 200                                                          
						of M86053_P3, a bridging amino acid S corresponding to amino 	                  .         .         .         .         .  
						acid 1189 of M86053_P3, and a third amino acid sequence being	     769 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 818                                                          
						VLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRAKDIYGRFGPFCDPQSTDVISSTQSS                                 	     201 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 250                                                          
						at least 90 % homologous to corresponding to amino acids 622 	                  .         .         .         .         .  
						- 709 of Q9NVJ9, which also corresponds to amino acids 1190 -	     819 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 868                                                          
						1277 of M86053_P3, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     251 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 300                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     869 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 918                                                          
						M86053_P3, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     301 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 350                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MHQDQRFRMDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGD 	     919 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 968                                                          
						LDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASG 	     351 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 400                                                          
						DATSGDAPSGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASS 	                  .         .         .         .         .  
						EITSVDLASGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPK 	     969 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 1018                                                         
						SVPVCEPVPEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINE 	     401 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 450                                                          
						NVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKME 	                  .         .         .         .         .  
						SSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEE 	    1019 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 1068                                                         
						EEQVIHEDDERPSEKNEFSRRKRSKSED                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of M86053_P3.     	     451 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1069 VVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGL 1118                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1119 TLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 1168                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1169 QKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSATVPS 1218                                                         
						                                                            	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     601 QKPHLKLARVQSQNGIVLSWGVLEVDRSCATVDSYHLYAYHEEPSATVPS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1219 QWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQST 1268                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQST 700                                                          
						                                                            	                                                             
						                                                            	    1269 DVISSTQSS                                          1277                                                         
						                                                            	         |||||||||                                           
						                                                            	     701 DVISSTQSS                                          709                                                          

						Comparison report between M86053_P3 and Q8IWJ4unique head    	Sequence name: Q8IWJ4                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						M86053_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22762 x Q8IWJ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MHQDQRFR     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of M86053_P3, a second    	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	                     Quality: 4930.00                      Escore:       0                                               
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	             Matching length:     513                Total length:     513                                               
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.81                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                        Gaps:       0                        
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	                                                            
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	Alignment:                                                   
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTS                         	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       9 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 58                                                           
						corresponding to amino acids 1 - 456 of Q8IWJ4, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 9 - 464 of M86053_P3, a bridging  	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						amino acid L corresponding to amino acid 465 of M86053_P3, a 	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	      59 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 108                                                          
						LPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQ     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 458 - 513 of Q8IWJ4, which also 	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						corresponds to amino acids 466 - 521 of M86053_P3, and a     	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     109 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 158                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						NETCSPEVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYME 	                  .         .         .         .         .  
						EEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKR 	     159 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 208                                                          
						HKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLP 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						APNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNV 	                  .         .         .         .         .  
						EFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQA 	     209 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 258                                                          
						VPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVP 	                  .         .         .         .         .  
						RAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLG 	     259 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 308                                                          
						STGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFV 	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						SGSKYYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                         	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     309 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 358                                                          
						522 - 1277 of M86053_P3, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid,   	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     359 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 408                                                          
						polypeptide encoding for a head of M86053_P3, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     409 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 458                                                          
						to the sequence MHQDQRFR of M86053_P3.3.An isolated          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of M86053_P3, comprising a   	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     459 CFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 508                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||:|||||||||||||||||||||||||||||||||||||||||||  
						NETCSPEVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYME 	     451 CFSKTSVLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						EEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKR 	                  .                                          
						HKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 	     509 ISGEKDESEVISQ                                      521                                                          
						VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLP 	         |||||||||||||                                       
						APNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNV 	     501 ISGEKDESEVISQ                                      513                                                          
						EFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQA 	                                                            
						VPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIEN 	                                                            
						QTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 	                                                            
						SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVP 	                                                            
						RAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLG 	                                                            
						STGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQ 	                                                            
						NGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFV 	                                                            
						SGSKYYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                         	                                                            
						to the sequence in M86053_P3.                                	                                                            

22760	HMR136_M86053_5_tr0_r1_1_gPRT		Comparison report between M86053_P5 and Q9NWC2unique head    	Sequence name: Q9NWC2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22760 x Q9NWC2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 1257.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     130                Total length:     130                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDRPPENEKKVEEDIITELALGEDAISSS                                	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 389 of M86053_P5, a second amino acid     	Alignment:                                                   
						MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDEL 	                  .         .         .         .         .  
						TCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESE 	     390 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 439                                                          
						VISQNETCSP                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 50                                                           
						amino acids 1 - 130 of Q9NWC2, which also corresponds to     	                  .         .         .         .         .  
						amino acids 390 - 519 of M86053_P5, and a third amino acid   	     440 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 489                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .                      
						DEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLC 	     490 EAFLVLSDEEDISGEKDESEVISQNETCSP                     519                                                          
						ALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPP 	         ||||||||||||||||||||||||||||||                      
						NPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTP 	     101 EAFLVLSDEEDISGEKDESEVISQNETCSP                     130                                                          
						PAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVP 	                                                            
						VAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVP 	                                                            
						SVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQ 	                                                            
						MKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVID 	                                                            
						LTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIH 	                                                            
						LLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQ 	                                                            
						VNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQP 	                                                            
						QRLPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSAT 	                                                            
						VPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQSTDVISSTQ 	                                                            
						SS                                                           	                                                            
						having the sequence corresponding to amino acids 520 - 1241  	                                                            
						of M86053_P5, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M86053_P5, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	                                                            
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                                                            
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                                                            
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                                                            
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	                                                            
						SDRPPENEKKVEEDIITELALGEDAISSS                                	                                                            
						to the sequence of M86053_P5.3.An isolated polypeptide       	                                                            
						encoding for a tail of M86053_P5, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLC 	                                                            
						ALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPP 	                                                            
						NPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTP 	                                                            
						PAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVP 	                                                            
						VAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVP 	                                                            
						SVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQ 	                                                            
						MKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVID 	                                                            
						LTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIH 	                                                            
						LLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQ 	                                                            
						VNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQP 	                                                            
						QRLPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSAT 	                                                            
						VPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQSTDVISSTQ 	                                                            
						SS                                                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M86053_P5.                                                	                                                            

						Comparison report between M86053_P5 and AAO91864partial WT   	Sequence name: AAO91864                                      
						sequence followed by mismatch and a featuring a skipped exon 	                                                            
						plus extra amino acids.1.An isolated chimeric polypeptide    	Sequence documentation:                                      
						encoding for M86053_P5, comprising a first amino acid        	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment of: 22760 x AAO91864   ..                          
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	Alignment segment 1/1:                                       
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                                                            
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                     Quality: 11939.00                      Escore:       0                                              
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDA              	             Matching length:    1241                Total length:    1270                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:   99.92   Matching Percent Identity:   99.84                                               
						amino acids 1 - 347 of AAO91864, which also corresponds to   	    Total Percent Similarity:   97.64      Total Percent Identity:   97.56                                               
						amino acids 1 - 347 of M86053_P5, a bridging amino acid N    	                        Gaps:       1                        
						corresponding to amino acid 348 of M86053_P5, a second amino 	                                                            
						EETLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVE 	Alignment:                                                   
						TINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLE 	                  .         .         .         .         .  
						EKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSP          	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 349 - 519 of AAO91864, which also corresponds 	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						to amino acids 349 - 519 of M86053_P5, a third amino acid    	                  .         .         .         .         .  
						sequence bridging amino acid sequence comprising of D, and a 	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						EFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPN 	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						PPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPP 	                  .         .         .         .         .  
						AVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPV 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						AVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQM 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						KIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDL 	                  .         .         .         .         .  
						TMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHL 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						LPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NPQNSVTVRVPQTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQ 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						RLPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSATV 	                  .         .         .         .         .  
						PSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQSTDVISSTQS 	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						S                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						corresponding to amino acids 550 - 1270 of AAO91864, which   	                  .         .         .         .         .  
						also corresponds to amino acids 521 - 1241 of M86053_P5,     	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						wherein said first amino acid sequence, bridging amino acid, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						of M86053_P5, comprising a polypeptide having a length "n",  	         ||||||||||||||||||||||||||||||||||||||||||||||| ||  
						wherein n is at least about 10 amino acids in length,        	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDAIEE 350                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						at least two amino acids comprise PDE having a structure as  	                  .         .         .         .         .  
						follows (numbering according to M86053_P5): a sequence       	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						starting from any of amino acid numbers 519-x to 519; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 521 + ((n-2) - x), in    	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     451 CFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 CFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ISGEKDESEVISQNETCSP.............................DE 521                                                          
						                                                            	         |||||||||||||||||||                             :|  
						                                                            	     501 ISGEKDESEVISQNETCSPAEVESNEKDNKPEEEEQVIHEDDERPSEKNE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     522 FSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQ 571                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     572 WLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLT 621                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 WLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLT 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     622 KRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 671                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     672 SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTAT 721                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTAT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     722 SVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQS 771                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 SVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQS 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     772 HPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSV 821                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 HPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     822 PSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSP 871                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 PSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSP 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     872 STNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAAD 921                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 STNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAAD 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     922 STSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 971                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 STSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     972 RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTR 1021                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTR 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1022 LPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVP 1071                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVP 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1072 QTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQR 1121                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 QTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQR 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1122 LPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYA 1171                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 LPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1172 YHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYG 1221                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 YHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYG 1250                                                         
						                                                            	                  .         .                                
						                                                            	    1222 RFGPFCDPQSTDVISSTQSS                               1241                                                         
						                                                            	         ||||||||||||||||||||                                
						                                                            	    1251 RFGPFCDPQSTDVISSTQSS                               1270                                                         

						Comparison report between M86053_P5 and Q9Y4X8unique head    	Sequence name: Q9Y4X8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22760 x Q9Y4X8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 4946.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     510                Total length:     510                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	                        Gaps:       0                        
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	                                                            
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPD                     	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 520 of M86053_P5, a second amino acid     	     520 DEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKV 569                                                          
						EFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCA 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						LQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPN 	       5 NEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKV 54                                                           
						PPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPP 	                  .         .         .         .         .  
						AVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPV 	     570 IQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIAR 619                                                          
						AVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQM 	      55 IQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIAR 104                                                          
						KIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDL 	                  .         .         .         .         .  
						TMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHL 	     620 LTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQM 669                                                          
						LPTAPTTVNVTHRPVTQVTTRLPVPRAPA                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     105 LTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQM 154                                                          
						amino acids 6 - 514 of Q9Y4X8, which also corresponds to     	                  .         .         .         .         .  
						amino acids 521 - 1029 of M86053_P5, and a third amino acid  	     670 LESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLT 719                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     155 LESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLT 204                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGP 	     720 ATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLL 769                                                          
						QLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSK 	     205 ATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLL 254                                                          
						YYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                             	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1030 - 1241 	     770 QSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVP 819                                                          
						of M86053_P5, wherein said first amino acid sequence, second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     255 QSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVP 304                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of M86053_P5, comprising a   	     820 SVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLY 869                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     305 SVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLY 354                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	     870 SPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKA 919                                                          
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	     355 SPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKA 404                                                          
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                  .         .         .         .         .  
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	     920 ADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQP 969                                                          
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	     405 ADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQP 454                                                          
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	                  .         .         .         .         .  
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPD                     	     970 VSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVT 1019                                                         
						to the sequence of M86053_P5.3.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of M86053_P5, comprising a polypeptide   	     455 VSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVT 504                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .                                          
						at least about 85%, more preferably at least about 90% and   	    1020 TRLPVPRAPA                                         1029                                                         
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGP 	         ||||||||||                                          
						QLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIV 	     505 TRLPVPRAPA                                         514                                                          
						LSWSVLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSK 	                                                            
						YYFAVRAKDIYGRFGPFCDPQSTDVISSTQSS                             	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M86053_P5.                                                	                                                            

						Comparison report between M86053_P5 and Q9NVJ9unique head    	Sequence name: Q9NVJ9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for M86053_P5, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 22760 x Q9NVJ9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 6924.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     709                Total length:     709                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:   99.86      Total Percent Identity:   99.86                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	                        Gaps:       0                        
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	                                                            
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPDEFSRRKRSKSED         	Alignment:                                                   
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						1 - 532 of M86053_P5, a second amino acid sequence being at  	     533 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 582                                                          
						MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDV 	       1 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 50                                                           
						NSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTP 	                  .         .         .         .         .  
						VTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSH 	     583 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 632                                                          
						PGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSA 	      51 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 100                                                          
						AEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQD 	                  .         .         .         .         .  
						PKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTH 	     633 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 682                                                          
						RPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 	     101 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 150                                                          
						QKPHLKLARVQSQNGIVLSW                                         	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 620	     683 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 732                                                          
						of Q9NVJ9, which also corresponds to amino acids 533 - 1152  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of M86053_P5, a bridging amino acid S corresponding to amino 	     151 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 200                                                          
						acid 1153 of M86053_P5, and a third amino acid sequence being	                  .         .         .         .         .  
						VLEVDRSCATVDSYHLYAYHEEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFA 	     733 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 782                                                          
						VRAKDIYGRFGPFCDPQSTDVISSTQSS                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 622 	     201 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 250                                                          
						- 709 of Q9NVJ9, which also corresponds to amino acids 1154 -	                  .         .         .         .         .  
						1241 of M86053_P5, wherein said first amino acid sequence,   	     783 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 832                                                          
						second amino acid sequence, bridging amino acid and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     251 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 300                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						M86053_P5, comprising a polypeptide being at least 70%,      	     833 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 882                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     301 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 350                                                          
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	                  .         .         .         .         .  
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	     883 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 932                                                          
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	     351 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 400                                                          
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                  .         .         .         .         .  
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	     933 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 982                                                          
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	     401 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 450                                                          
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPDEFSRRKRSKSED         	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M86053_P5.     	     983 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 1032                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1033 VVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGL 1082                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VVYTTLPAPPAQAPLRGTVMQAPAVRQVNPQNSVTVRVPQTTTYVVNNGL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1083 TLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 1132                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TLGSTGPQLTVHHRPPQVHTEPPRPVHPAPLPEAPQPQRLPPEAASTSLP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1133 QKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYHEEPSATVPS 1182                                                         
						                                                            	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     601 QKPHLKLARVQSQNGIVLSWGVLEVDRSCATVDSYHLYAYHEEPSATVPS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1183 QWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQST 1232                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQST 700                                                          
						                                                            	                                                             
						                                                            	    1233 DVISSTQSS                                          1241                                                         
						                                                            	         |||||||||                                           
						                                                            	     701 DVISSTQSS                                          709                                                          

						Comparison report between M86053_P5 and Q8IWJ4partial WT     	Sequence name: Q8IWJ4                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P5, comprising a first amino acid sequence being at   	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment of: 22760 x Q8IWJ4   ..                            
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	Alignment segment 1/1:                                       
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                                                            
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                     Quality: 4930.00                      Escore:       0                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	             Matching length:     513                Total length:     513                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTS                         	    Total Percent Similarity:  100.00      Total Percent Identity:   99.81                                               
						least 90 % homologous to corresponding to amino acids 1 - 456	                        Gaps:       0                        
						of Q8IWJ4, which also corresponds to amino acids 1 - 456 of  	                                                            
						M86053_P5, a bridging amino acid L corresponding to amino    	Alignment:                                                   
						acid 457 of M86053_P5, a second amino acid sequence being at 	                  .         .         .         .         .  
						least 90 % homologous to                                     	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						LPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQ     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 458 - 513 of Q8IWJ4, which also 	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						corresponds to amino acids 458 - 513 of M86053_P5, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						NETCSPDEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWL 	                  .         .         .         .         .  
						LEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKK 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						RHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLP 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						VILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPT 	                  .         .         .         .         .  
						KPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPST 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						NRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGP 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						SQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQ 	                  .         .         .         .         .  
						APAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPL 	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						PEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQSTD 	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						VISSTQSS                                                     	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						514 - 1241 of M86053_P5, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid, second amino acid sequence and	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						M86053_P5, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						NETCSPDEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWL 	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						LEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSS 	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						TNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLP 	                  .         .         .         .         .  
						VILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPT 	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						KPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSD 	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						SSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGP 	                  .         .         .         .         .  
						SQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQ 	     451 CFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						APAVRQVNPQNSVTVRVPQTTTYVVNNGLTLGSTGPQLTVHHRPPQVHTEPPRPVHPAPL 	         ||||||:|||||||||||||||||||||||||||||||||||||||||||  
						PEAPQPQRLPPEAASTSLPQKPHLKLARVQSQNGIVLSWSVLEVDRSCATVDSYHLYAYH 	     451 CFSKTSVLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						EEPSATVPSQWKKIGEVKALPLPMACTLTQFVSGSKYYFAVRAKDIYGRFGPFCDPQSTD 	                  .                                          
						VISSTQSS                                                     	     501 ISGEKDESEVISQ                                      513                                                          
						least about 95% homologous to the sequence in M86053_P5.     	         |||||||||||||                                       
						                                                            	     501 ISGEKDESEVISQ                                      513                                                          

22758	HMR136_M86053_6_tr0_r1_1_gPRT		Comparison report between M86053_P6 and Q9NWC2unique head    	Sequence name: Q9NWC2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22758 x Q9NWC2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 1257.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     130                Total length:     130                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDRPPENEKKVEEDIITELALGEDAISSS                                	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 389 of M86053_P6, a second amino acid     	Alignment:                                                   
						MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDEL 	                  .         .         .         .         .  
						TCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESE 	     390 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 439                                                          
						VISQNETCSP                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MEIDQGEKNEDETSADLVETINENVIEDNKSENILENTDSMETDEIIPIL 50                                                           
						amino acids 1 - 130 of Q9NWC2, which also corresponds to     	                  .         .         .         .         .  
						amino acids 390 - 519 of M86053_P6, and a third amino acid   	     440 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 489                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 EKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPK 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .                      
						EVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAE 	     490 EAFLVLSDEEDISGEKDESEVISQNETCSP                     519                                                          
						FQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLT 	         ||||||||||||||||||||||||||||||                      
						ELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 	     101 EAFLVLSDEEDISGEKDESEVISQNETCSP                     130                                                          
						SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTAT 	                                                            
						VVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQ 	                                                            
						SPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHS 	                                                            
						IVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTI 	                                                            
						DASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 	                                                            
						RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANH 	                                                            
						QVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML                    	                                                            
						having the sequence corresponding to amino acids 520 - 1100  	                                                            
						of M86053_P6, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of M86053_P6, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	                                                            
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                                                            
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                                                            
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                                                            
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	                                                            
						SDRPPENEKKVEEDIITELALGEDAISSS                                	                                                            
						to the sequence of M86053_P6.3.An isolated polypeptide       	                                                            
						encoding for a tail of M86053_P6, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						EVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAE 	                                                            
						FQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLT 	                                                            
						ELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLE 	                                                            
						SKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTAT 	                                                            
						VVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQ 	                                                            
						SPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHS 	                                                            
						IVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTI 	                                                            
						DASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVS 	                                                            
						RPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANH 	                                                            
						QVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in M86053_P6.                                                	                                                            

						Comparison report between M86053_P6 and Q9Y4X8unique head    	Sequence name: Q9Y4X8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22758 x Q9Y4X8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 4997.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     514                Total length:     514                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	                        Gaps:       0                        
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	                                                            
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEEEEQVIHED 	Alignment:                                                   
						DER                                                          	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     544 PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQK 593                                                          
						to amino acids 1 - 543 of M86053_P6, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLE 	       1 PSEKNEFSRRKRSKSEDMDNVQSKRRRYMEEEYEAEFQVKITAKGDINQK 50                                                           
						EKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRH 	                  .         .         .         .         .  
						EHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTN 	     594 LQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQA 643                                                          
						LVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHVPVAVSSQPQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 	      51 LQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKRHKTVLTELQA 100                                                          
						NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNR 	                  .         .         .         .         .  
						GPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSS 	     644 KIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 693                                                          
						GVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPA                           	     101 KIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 514 of Q9Y4X8, which also corresponds to     	     694 VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTS 743                                                          
						amino acids 544 - 1057 of M86053_P6, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTS 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     744 GSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQ 793                                                          
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML corresponding to 	     201 GSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQ 250                                                          
						amino acids 1058 - 1100 of M86053_P6, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     794 PQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 843                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     251 PQLLQSHPGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKP 300                                                          
						M86053_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     844 NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGP 893                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	     301 NNVPSVPSPSIQRNPTASAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGP 350                                                          
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                  .         .         .         .         .  
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	     894 SGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASV 943                                                          
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	     351 SGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIENQTNKTIDASV 400                                                          
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	                  .         .         .         .         .  
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	     944 SKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 993                                                          
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEEEEQVIHED 	     401 SKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 450                                                          
						DER                                                          	                  .         .         .         .         .  
						least about 95% homologous to the sequence of M86053_P6.3.An 	     994 SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPV 1043                                                         
						isolated polypeptide encoding for a tail of M86053_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     451 SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPV 500                                                          
						least about 80%, preferably at least about 85%, more         	                  .                                          
						preferably at least about 90% and most preferably at least   	    1044 TQVTTRLPVPRAPA                                     1057                                                         
						about 95% homologous to the sequence                         	         ||||||||||||||                                      
						NHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML in M86053_P6.    	     501 TQVTTRLPVPRAPA                                     514                                                          

						Comparison report between M86053_P6 and Q9NVJ9unique head    	Sequence name: Q9NVJ9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22758 x Q9NVJ9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment segment 1/1:                                       
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                     Quality: 5131.00                      Escore:       0                                               
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	             Matching length:     528                Total length:     528                                               
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	                        Gaps:       0                        
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	                                                            
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEEEEQVIHED 	Alignment:                                                   
						DERPSEKNEFSRRKRSKSED                                         	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     561 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 610                                                          
						to amino acids 1 - 560 of M86053_P6, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAE 	       1 MDNVQSKRRRYMEEEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQ 50                                                           
						LKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDV 	                  .         .         .         .         .  
						NSNNNMSYRNAGTVRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTP 	     611 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 660                                                          
						VTSGSLTATSVLPAPNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGTLVTNQPSGNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 	      51 CAVFDKTLAELKTRVEKIECNKRHKTVLTELQAKIARLTKRFEAAKEDLK 100                                                          
						SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSA 	                  .         .         .         .         .  
						AEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQD 	     661 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 710                                                          
						PKKLNHTPVSTMSSSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPVTQVTTRLPVPRAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQV             	     101 KRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGTVRQMLESKRNVSESAPP 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 528 of Q9NVJ9, which also corresponds to     	     711 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 760                                                          
						amino acids 561 - 1088 of M86053_P6, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 SFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLPAPNTATV 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     761 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 810                                                          
						having the sequence LQFECLKQPHML corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1089 - 1100 of M86053_P6, wherein said first amino acid      	     201 VATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPS 250                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     811 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 860                                                          
						isolated polypeptide encoding for a head of M86053_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     251 GNVEFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTA 300                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     861 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 910                                                          
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	     301 SAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKI 350                                                          
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	                  .         .         .         .         .  
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	     911 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 960                                                          
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	     351 PISAFSTSSAAEQNSNTTPRIENQTNKTIDASVSKKAADSTSQCGKATGS 400                                                          
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	                  .         .         .         .         .  
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTSLLPIDETNPDLEEKMESSFGSPSK 	     961 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 1010                                                         
						QESSESLPKEAFLVLSDEEDISGEKDESEVISQNETCSPEVESNEKDNRPEEEEQVIHED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DERPSEKNEFSRRKRSKSED                                         	     401 DSSGVIDLTMDDEESGASQDPKKLNHTPVSTMSSSQPVSRPLQPIQPAPP 450                                                          
						about 95% homologous to the sequence of M86053_P6.3.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of M86053_P6,       	    1011 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 1060                                                         
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     451 LQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVPRAPANHQ 500                                                          
						preferably at least about 90% and most preferably at least   	                  .         .                                
						about 95% homologous to the sequence LQFECLKQPHML in         	    1061 VVYTTLPAPPAQAPLRGTVMQAPAVRQV                       1088                                                         
						M86053_P6.                                                   	         ||||||||||||||||||||||||||||                        
						                                                            	     501 VVYTTLPAPPAQAPLRGTVMQAPAVRQV                       528                                                          

						Comparison report between M86053_P6 and Q8IWJ4partial WT     	Sequence name: Q8IWJ4                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86053_P6, comprising a first amino acid sequence being at   	                                                            
						MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHENGDLDPTSPLE 	Alignment of: 22758 x Q8IWJ4   ..                            
						NMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVKNKQDDDLNCEPLSPHNITPE 	                                                            
						PVSKLPAEPVSGDPAPGDLDAGDPASGVLASGDSTSGDPTSSEPSSSDAASGDATSGDAP 	Alignment segment 1/1:                                       
						SGDVSPGDATSGDATADDLSSGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLA 	                                                            
						SGAPASTDPASDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 	                     Quality: 4930.00                      Escore:       0                                               
						PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEETLETDDTTIC 	             Matching length:     513                Total length:     513                                               
						SDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNEDETSADLVETINENVIEDNKS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						ENILENTDSMETDEIIPILEKLAPSEDELTCFSKTS                         	    Total Percent Similarity:  100.00      Total Percent Identity:   99.81                                               
						least 90 % homologous to corresponding to amino acids 1 - 456	                        Gaps:       0                        
						of Q8IWJ4, which also corresponds to amino acids 1 - 456 of  	                                                            
						M86053_P6, a bridging amino acid L corresponding to amino    	Alignment:                                                   
						acid 457 of M86053_P6, a second amino acid sequence being at 	                  .         .         .         .         .  
						least 90 % homologous to                                     	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						LPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEEDISGEKDESEVISQ     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 458 - 513 of Q8IWJ4, which also 	       1 MDSLEEPQKKVFKARKTMRVSDRQQLEAVYKVKEELLKTDVKLLNGNHEN 50                                                           
						corresponds to amino acids 458 - 513 of M86053_P6, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      51 GDLDPTSPLENMDYIKDKEEVNGIEEICFDPEGSKAEWKETPCILSVNVK 100                                                          
						NETCSPEVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYME 	                  .         .         .         .         .  
						EEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKR 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						HKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLP 	     101 NKQDDDLNCEPLSPHNITPEPVSKLPAEPVSGDPAPGDLDAGDPASGVLA 150                                                          
						APNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNV 	                  .         .         .         .         .  
						EFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQA 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						VPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 	     151 SGDSTSGDPTSSEPSSSDAASGDATSGDAPSGDVSPGDATSGDATADDLS 200                                                          
						SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVP 	                  .         .         .         .         .  
						RAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML              	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						514 - 1100 of M86053_P6, wherein said first amino acid       	     201 SGDPTSSDPIPGEPVPVEPISGDCAADDIASSEITSVDLASGAPASTDPA 250                                                          
						sequence, bridging amino acid, second amino acid sequence and	                  .         .         .         .         .  
						third amino acid sequence are contiguous and in a sequential 	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86053_P6, comprising a polypeptide being at least 70%,      	     251 SDDLASGDLSSSELASDDLATGELASDELTSESTFDRTFEPKSVPVCEPV 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						NETCSPEVESNEKDNRPEEEEQVIHEDDERPSEKNEFSRRKRSKSEDMDNVQSKRRRYME 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEYEAEFQVKITAKGDINQKLQKVIQWLLEEKLCALQCAVFDKTLAELKTRVEKIECNKR 	     301 PEIDNIEPSSNKDDDFLEKNGADEKLEQIQSKDSLDEKNKADNNIDANEE 350                                                          
						HKTVLTELQAKIARLTKRFEAAKEDLKKRHEHPPNPPVSPGKTVNDVNSNNNMSYRNAGT 	                  .         .         .         .         .  
						VRQMLESKRNVSESAPPSFQTPVNTVSSTNLVTPPAVVSSQPKLQTPVTSGSLTATSVLP 	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						APNTATVVATTQVPSGNPQPTISLQPLPVILHVPVAVSSQPQLLQSHPGTLVTNQPSGNV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EFISVQSPPTVSGLTKNPVSLPSLPNPTKPNNVPSVPSPSIQRNPTASAAPLGTTLAVQA 	     351 TLETDDTTICSDRPPENEKKVEEDIITELALGEDAISSSMEIDQGEKNED 400                                                          
						VPTAHSIVQATRTSLPTVGPSGLYSPSTNRGPIQMKIPISAFSTSSAAEQNSNTTPRIEN 	                  .         .         .         .         .  
						QTNKTIDASVSKKAADSTSQCGKATGSDSSGVIDLTMDDEESGASQDPKKLNHTPVSTMS 	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						SSQPVSRPLQPIQPAPPLQPSGVPTSGPSQTTIHLLPTAPTTVNVTHRPVTQVTTRLPVP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RAPANHQVVYTTLPAPPAQAPLRGTVMQAPAVRQVLQFECLKQPHML              	     401 ETSADLVETINENVIEDNKSENILENTDSMETDEIIPILEKLAPSEDELT 450                                                          
						least about 95% homologous to the sequence in M86053_P6.     	                  .         .         .         .         .  
						                                                            	     451 CFSKTSLLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						                                                            	         ||||||:|||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 CFSKTSVLPIDETNPDLEEKMESSFGSPSKQESSESLPKEAFLVLSDEED 500                                                          
						                                                            	                  .                                          
						                                                            	     501 ISGEKDESEVISQ                                      513                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     501 ISGEKDESEVISQ                                      513                                                          

23653	HMR136_M86068_13_tr0_r1_1_gPRT		Comparison report between M86068_P13 and TR2B_HUMANpartial   	Sequence name: TR2B_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for M86068_P13, comprising a first amino	                                                            
						MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRG 	Alignment of: 23653 x TR2B_HUMAN   ..                        
						FAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPHTPTPGIYMGRPTYGSSRRRD 	                                                            
						YYDRGYDRGYDDRDYYSRSYRGGGGGGGGWRAAQDRDQIYRRRSPSPYYSRGGYRSRSRS 	Alignment segment 1/1:                                       
						RSYSPRRY                                                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 1878.00                      Escore:       0                                               
						to amino acids 101 - 288 of TR2B_HUMAN, which also           	             Matching length:     188                Total length:     188                                               
						corresponds to amino acids 1 - 188 of M86068_P13.            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     251 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             288                                                          

23651	HMR136_M86068_15_tr0_r1_1_gPRT		Comparison report between M86068_P15 and TR2B_HUMANpartial   	Sequence name: TR2B_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86068_P15, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSDSGEQNYGERESRSASRSGSAHGSGKSARHTPARSRSKEDSRRSRSKSRSRSES     	Alignment of: 23651 x TR2B_HUMAN   ..                        
						corresponding to amino acids 1 - 56 of TR2B_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 56 of M86068_P15, and a second	Alignment segment 1/1:                                       
						RRSRSRSYSRDYRRRHSHSHSPMSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVF 	                                                            
						SKYGPIADVSIVYDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKR 	                     Quality: 2548.00                      Escore:       0                                               
						PHTPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGWRAAQDRDQ 	             Matching length:     266                Total length:     288                                               
						IYRRRSPSPYYSRGGYRSRSRSRSYSPRRY                               	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   92.36      Total Percent Identity:   92.36                                               
						corresponding to amino acids 79 - 288 of TR2B_HUMAN, which   	                        Gaps:       1                        
						also corresponds to amino acids 57 - 266 of M86068_P15,      	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	       1 MSDSGEQNYGERESRSASRSGSAHGSGKSARHTPARSRSKEDSRRSRSKS 50                                                           
						M86068_P15, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	       1 MSDSGEQNYGERESRSASRSGSAHGSGKSARHTPARSRSKEDSRRSRSKS 50                                                           
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 RSRSES......................RRSRSRSYSRDYRRRHSHSHSP 78                                                           
						preferably at least about 40 amino acids in length and most  	         ||||||                      ||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	      51 RSRSESRSRSRRSSRRHYTRSRSRSRSHRRSRSRSYSRDYRRRHSHSHSP 100                                                          
						at least two amino acids comprise SR, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	      79 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 128                                                          
						56-x to 57; and ending at any of amino acid numbers 57+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     101 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     129 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 178                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     179 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 228                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     229 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     251 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             288                                                          

23649	HMR136_M86068_9_tr0_r1_1_gPRT		Comparison report between M86068_P9 and TR2B_HUMANpartial WT 	Sequence name: TR2B_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M86068_P9, comprising a first amino acid        	                                                            
						MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRG 	Alignment of: 23649 x TR2B_HUMAN   ..                        
						FAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPHTPTPGIYMGRPTYGSSRRRD 	                                                            
						YYDRGYDRGYDDRDYYSRSYRGGGGGGGGWRAAQDRDQIYRRRSPSPYYSRGGYRSRSRS 	Alignment segment 1/1:                                       
						RSYSPRRY                                                     	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1878.00                      Escore:       0                                               
						amino acids 101 - 288 of TR2B_HUMAN, which also corresponds  	             Matching length:     188                Total length:     188                                               
						to amino acids 1 - 188 of M86068_P9.                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGW 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     251 RAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY             288                                                          

2385	HMR136_M86079_3_tr0_r1_1_gPRT		Comparison report between M86079_P3 and SHK2_HUMANpartial WT 	Sequence name: SHK2_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M86079_P3, comprising a first amino acid        	                                                            
						MSTISGTRSTTVTFTVRPGTSQPITLQSRPPDYESRTSGTRRAPSPVVSPTEMNKETLPA 	Alignment of: 2385 x SHK2_HUMAN   ..                         
						PLSAATASPSPALSDVFSLPSQPPSGDLFGLNPAGRSRSPSPSILQQPISNKPFTTKPVH 	                                                            
						LWTKPDVADWLESLNLGEHKEAFMDNEIDGSHLPNLQKEDLIDLGVTRVGHRMNIERALK 	Alignment segment 1/1:                                       
						QLLDR                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1809.00                      Escore:       0                                               
						amino acids 1069 - 1253 of SHK2_HUMAN, which also corresponds	             Matching length:     185                Total length:     185                                               
						to amino acids 1 - 185 of M86079_P3.                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSTISGTRSTTVTFTVRPGTSQPITLQSRPPDYESRTSGTRRAPSPVVSP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1069 MSTISGTRSTTVTFTVRPGTSQPITLQSRPPDYESRTSGTRRAPSPVVSP 1118                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TEMNKETLPAPLSAATASPSPALSDVFSLPSQPPSGDLFGLNPAGRSRSP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1119 TEMNKETLPAPLSAATASPSPALSDVFSLPSQPPSGDLFGLNPAGRSRSP 1168                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPSILQQPISNKPFTTKPVHLWTKPDVADWLESLNLGEHKEAFMDNEIDG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1169 SPSILQQPISNKPFTTKPVHLWTKPDVADWLESLNLGEHKEAFMDNEIDG 1218                                                         
						                                                            	                  .         .         .                      
						                                                            	     151 SHLPNLQKEDLIDLGVTRVGHRMNIERALKQLLDR                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1219 SHLPNLQKEDLIDLGVTRVGHRMNIERALKQLLDR                1253                                                         

24363	HMR136_M86085_3_tr0_r1_1_gPRT		Comparison report between M86085_P3 and O00533partial WT     	Sequence name: O00533                                        
						sequence featuring skipped exon plus extra amino acids and a 	                                                            
						mismatch.1.An isolated chimeric polypeptide encoding for     	Sequence documentation:                                      
						M86085_P3, comprising a first amino acid sequence being at   	                                                            
						MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAK 	Alignment of: 24363 x O00533   ..                            
						GNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMS 	                                                            
						EEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERV 	Alignment segment 1/1:                                       
						YMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNS               	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 226	                     Quality: 11201.00                      Escore:       0                                              
						of O00533, which also corresponds to amino acids 1 - 226 of  	             Matching length:    1155                Total length:    1224                                               
						M86085_P3, a second amino acid sequence bridging amino acid  	 Matching Percent Similarity:   99.91   Matching Percent Identity:   99.74                                               
						sequence comprising of S, a third amino acid sequence being  	    Total Percent Similarity:   94.28      Total Percent Identity:   94.12                                               
						at least 90 % homologous to                                  	                        Gaps:       2                        
						NSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRE  	                                                            
						corresponding to amino acids 244 - 302 of O00533, which also 	Alignment:                                                   
						corresponds to amino acids 228 - 286 of M86085_P3, a bridging	                  .         .         .         .         .  
						amino acid T corresponding to amino acid 287 of M86085_P3, a 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						KENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVH 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						GTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLE 	                  .         .         .         .         .  
						GRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIP 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						KLHMLELHCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLEDQG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEAGADHNSNISEYIV 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						EFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQFRVIAVNEVGRSQPSQPSDHHETP 	                  .         .         .         .         .  
						PAAPDRNPQNIRVQASQPKEMIIKWEPLKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTN 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						HTLRVMTPAVYAPYDVKVQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTWSTVPKDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDAFSE 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						FHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATLSWGLPKKLNGNLT 	                  .         .         .         .         .  
						GYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLNATTKYKFYLRACTSQGCGKPITE 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						ESSTLGEG                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						corresponding to amino acids 304 - 1031 of O00533, which also	                  .         .         .         .         .  
						corresponds to amino acids 288 - 1015 of M86085_P3, a fifth  	     201 DYCCFAAFPRLRTIVQKMPMKLTVNS................SNSIKQRK 234                                                          
						amino acid sequence bridging amino acid sequence comprising  	         ||||||||||||||||||||||||||                :|||||||  
						of K, and a sixth amino acid sequence being at least 90 %    	     201 DYCCFAAFPRLRTIVQKMPMKLTVNSLKHANDSSSSTEIGSKANSIKQRK 250                                                          
						YAGLYDDISTQGWFIGLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVK 	                  .         .         .         .         .  
						DETFGEYSDSDEKPLKGSLRSLNRDMQPTESADSLVEYGEGDHGLFSEDGSFIGAYAGSK 	     235 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 284                                                          
						EKGSVESNGSSTATFPLRA                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 1086 - 1224 of    	     251 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 300                                                          
						O00533, which also corresponds to amino acids 1017 - 1155 of 	                  .         .         .         .         .  
						M86085_P3, wherein said first amino acid sequence, second    	     285 RETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 334                                                          
						amino acid sequence, third amino acid sequence, bridging     	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid, fourth amino acid sequence, fifth amino acid     	     301 REAKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 350                                                          
						sequence and sixth amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	     335 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 384                                                          
						edge portion of M86085_P3, comprising a polypeptide having a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     351 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 400                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     385 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 434                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 450                                                          
						at least two amino acids comprise SSN having a structure as  	                  .         .         .         .         .  
						follows (numbering according to M86085_P3): a sequence       	     435 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 484                                                          
						starting from any of amino acid numbers 226-x to 226; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 228 + ((n-2) - x), in    	     451 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 500                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for an edge portion of M86085_P3, comprising a      	     485 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 534                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     501 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 550                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     535 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 584                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise GKY having 	     551 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 600                                                          
						a structure as follows (numbering according to M86085_P3): a 	                  .         .         .         .         .  
						sequence starting from any of amino acid numbers 1015-x to   	     585 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 634                                                          
						1015; and ending at any of amino acid numbers 1017 + ((n-2) -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						x), in which x varies from 0 to n-2.                         	     601 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     635 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 684                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     685 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 734                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     735 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 784                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     785 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVKVTWSTVP 834                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVKVTWSTVP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     835 KDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDA 884                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 KDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     885 FSEFHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATL 934                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 FSEFHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATL 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     935 SWGLPKKLNGNLTGYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLN 984                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SWGLPKKLNGNLTGYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLN 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     985 ATTKYKFYLRACTSQGCGKPITEESSTLGEG................... 1015                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1001 ATTKYKFYLRACTSQGCGKPITEESSTLGEGSKGIGKISGVNLTQKTHPV 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 ..................................KYAGLYDDISTQGWFI 1031                                                         
						                                                            	                                           :|||||||||||||||  
						                                                            	    1051 EVFEPGAEHIVRLMTKNWGDNDSIFQDVIETRGREYAGLYDDISTQGWFI 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1032 GLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVKDETFG 1081                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 GLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVKDETFG 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1082 EYSDSDEKPLKGSLRSLNRDMQPTESADSLVEYGEGDHGLFSEDGSFIGA 1131                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 EYSDSDEKPLKGSLRSLNRDMQPTESADSLVEYGEGDHGLFSEDGSFIGA 1200                                                         
						                                                            	                  .         .                                
						                                                            	    1132 YAGSKEKGSVESNGSSTATFPLRA                           1155                                                         
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	    1201 YAGSKEKGSVESNGSSTATFPLRA                           1224                                                         

24361	HMR136_M86085_4_tr0_r1_1_gPRT		Comparison report between M86085_P4 and O00533partial WT     	Sequence name: O00533                                        
						sequence featuring skipped exon plus extra amino acids, a    	                                                            
						mismatch and a followed by a short unique tail.1.An isolated 	Sequence documentation:                                      
						chimeric polypeptide encoding for M86085_P4, comprising a    	                                                            
						MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAK 	Alignment of: 24361 x O00533   ..                            
						GNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMS 	                                                            
						EEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERV 	Alignment segment 1/1:                                       
						YMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNS               	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 8050.00                      Escore:       0                                               
						corresponding to amino acids 1 - 226 of O00533, which also   	             Matching length:     822                Total length:     838                                               
						corresponds to amino acids 1 - 226 of M86085_P4, a second    	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.76                                               
						amino acid sequence bridging amino acid sequence comprising  	    Total Percent Similarity:   97.97      Total Percent Identity:   97.85                                               
						of S, a third amino acid sequence being at least 90 %        	                        Gaps:       1                        
						homologous to                                                	                                                            
						NSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRE  	Alignment:                                                   
						corresponding to amino acids 244 - 302 of O00533, which also 	                  .         .         .         .         .  
						corresponds to amino acids 228 - 286 of M86085_P4, a bridging	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						amino acid T corresponding to amino acid 287 of M86085_P4, a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSN 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						GILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVH 	                  .         .         .         .         .  
						GTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLE 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						GRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLHMLELHCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLEDQG 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						IYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEAGADHNSNISEYIV 	                  .         .         .         .         .  
						EFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQFRVIAVNEVGRSQPSQPSDHHETP 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						PAAPDRNPQNIRVQASQPKEMIIKWEPLKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HTLRVMTPAVYAPYDVKVQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVIN      	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 304 - 838 of O00533, which also 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						corresponds to amino acids 288 - 822 of M86085_P4, and a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     201 DYCCFAAFPRLRTIVQKMPMKLTVNS................SNSIKQRK 234                                                          
						polypeptide having the sequence KHM corresponding to amino   	         ||||||||||||||||||||||||||                :|||||||  
						acids 823 - 825 of M86085_P4, wherein said first amino acid  	     201 DYCCFAAFPRLRTIVQKMPMKLTVNSLKHANDSSSSTEIGSKANSIKQRK 250                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .         .         .  
						sequence, bridging amino acid, fourth amino acid sequence and	     235 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 284                                                          
						fifth amino acid sequence are contiguous and in a sequential 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for an edge portion 	     251 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 300                                                          
						of M86085_P4, comprising a polypeptide having a length "n",  	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     285 RETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 334                                                          
						optionally at least about 20 amino acids in length,          	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     301 REAKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 350                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     335 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 384                                                          
						at least two amino acids comprise SSN having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows (numbering according to M86085_P4): a sequence       	     351 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 400                                                          
						starting from any of amino acid numbers 226-x to 226; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 228 + ((n-2) - x), in    	     385 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 434                                                          
						which x varies from 0 to n-2.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     435 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 484                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     485 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 534                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     585 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 634                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     635 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 684                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     685 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 734                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     735 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 784                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 800                                                          
						                                                            	                  .         .         .                      
						                                                            	     785 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVIN             822                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     801 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVIN             838                                                          

24359	HMR136_M86085_6_tr0_r1_1_gPRT		Comparison report between M86085_P6 and O00533partial WT     	Sequence name: O00533                                        
						sequence featuring skipped exon plus extra amino acids, a    	                                                            
						mismatch and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M86085_P6, comprising a    	                                                            
						MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAK 	Alignment of: 24359 x O00533   ..                            
						GNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMS 	                                                            
						EEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERV 	Alignment segment 1/1:                                       
						YMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNS               	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 10513.00                      Escore:       0                                              
						corresponding to amino acids 1 - 226 of O00533, which also   	             Matching length:    1083                Total length:    1152                                               
						corresponds to amino acids 1 - 226 of M86085_P6, a second    	 Matching Percent Similarity:   99.91   Matching Percent Identity:   99.72                                               
						amino acid sequence bridging amino acid sequence comprising  	    Total Percent Similarity:   93.92      Total Percent Identity:   93.75                                               
						of S, a third amino acid sequence being at least 90 %        	                        Gaps:       2                        
						homologous to                                                	                                                            
						NSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRE  	Alignment:                                                   
						corresponding to amino acids 244 - 302 of O00533, which also 	                  .         .         .         .         .  
						corresponds to amino acids 228 - 286 of M86085_P6, a bridging	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						amino acid T corresponding to amino acid 287 of M86085_P6, a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSN 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						GILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVH 	                  .         .         .         .         .  
						GTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLE 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						GRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLHMLELHCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLEDQG 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						IYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEAGADHNSNISEYIV 	                  .         .         .         .         .  
						EFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQFRVIAVNEVGRSQPSQPSDHHETP 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						PAAPDRNPQNIRVQASQPKEMIIKWEPLKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HTLRVMTPAVYAPYDVKVQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVK 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						VTWSTVPKDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDAFSE 	                  .         .         .         .         .  
						FHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATLSWGLPKKLNGNLT 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						GYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLNATTKYKFYLRACTSQGCGKPITE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESSTLGEG                                                     	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 304 - 1031 of O00533, which also	     201 DYCCFAAFPRLRTIVQKMPMKLTVNS................SNSIKQRK 234                                                          
						corresponds to amino acids 288 - 1015 of M86085_P6, a fifth  	         ||||||||||||||||||||||||||                :|||||||  
						amino acid sequence bridging amino acid sequence comprising  	     201 DYCCFAAFPRLRTIVQKMPMKLTVNSLKHANDSSSSTEIGSKANSIKQRK 250                                                          
						of K, a sixth amino acid sequence being at least 90 %        	                  .         .         .         .         .  
						YAGLYDDISTQGWFIGLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVK 	     235 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 284                                                          
						DETFGEY                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 1086 - 1152 of    	     251 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 300                                                          
						O00533, which also corresponds to amino acids 1017 - 1083 of 	                  .         .         .         .         .  
						M86085_P6, and a seventh amino acid sequence being at least  	     285 RETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 334                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     301 REAKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 350                                                          
						homologous to a polypeptide having the sequence RIKNNKEKERKRE	                  .         .         .         .         .  
						corresponding to amino acids 1084 - 1096 of M86085_P6,       	     335 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 384                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, bridging amino acid,    	     351 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 400                                                          
						fourth amino acid sequence, fifth amino acid sequence, sixth 	                  .         .         .         .         .  
						amino acid sequence and seventh amino acid sequence are      	     385 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 434                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of M86085_P6,       	     401 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 450                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     435 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 484                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     451 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 500                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     485 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 534                                                          
						comprise SSN having a structure as follows (numbering        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						according to M86085_P6): a sequence starting from any of     	     501 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 550                                                          
						amino acid numbers 226-x to 226; and ending at any of amino  	                  .         .         .         .         .  
						acid numbers 228 + ((n-2) - x), in which x varies from 0 to  	     535 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 584                                                          
						n-2.3.An isolated polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86085_P6, comprising a polypeptide having a length "n",     	     551 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 600                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     585 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 634                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     601 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 650                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise GKY having a structure as  	     635 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 684                                                          
						follows (numbering according to M86085_P6): a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 1015-x to 1015; and  	     651 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 700                                                          
						ending at any of amino acid numbers 1017 + ((n-2) - x), in   	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     685 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 734                                                          
						encoding for a tail of M86085_P6, comprising a polypeptide   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     701 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEP 750                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     735 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 784                                                          
						RIKNNKEKERKRE in M86085_P6.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVK 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     785 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVKVTWSTVP 834                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 VQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVKVTWSTVP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     835 KDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDA 884                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 KDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     885 FSEFHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATL 934                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 FSEFHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATL 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     935 SWGLPKKLNGNLTGYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLN 984                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 SWGLPKKLNGNLTGYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLN 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     985 ATTKYKFYLRACTSQGCGKPITEESSTLGEG................... 1015                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1001 ATTKYKFYLRACTSQGCGKPITEESSTLGEGSKGIGKISGVNLTQKTHPV 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1016 ..................................KYAGLYDDISTQGWFI 1031                                                         
						                                                            	                                           :|||||||||||||||  
						                                                            	    1051 EVFEPGAEHIVRLMTKNWGDNDSIFQDVIETRGREYAGLYDDISTQGWFI 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1032 GLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVKDETFG 1081                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 GLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVKDETFG 1150                                                         
						                                                            	                                                             
						                                                            	    1082 EY                                                 1083                                                         
						                                                            	         ||                                                  
						                                                            	    1151 EY                                                 1152                                                         

24357	HMR136_M86085_7_tr0_r1_1_gPRT		Comparison report between M86085_P7 and O00533partial WT     	Sequence name: O00533                                        
						sequence featuring skipped exon plus extra amino acids and a 	                                                            
						mismatch.1.An isolated chimeric polypeptide encoding for     	Sequence documentation:                                      
						M86085_P7, comprising a first amino acid sequence being at   	                                                            
						MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAK 	Alignment of: 24357 x O00533   ..                            
						GNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMS 	                                                            
						EEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERV 	Alignment segment 1/1:                                       
						YMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNS               	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 226	                     Quality: 7163.00                      Escore:       0                                               
						of O00533, which also corresponds to amino acids 1 - 226 of  	             Matching length:     733                Total length:     749                                               
						M86085_P7, a second amino acid sequence bridging amino acid  	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.73                                               
						sequence comprising of S, a third amino acid sequence being  	    Total Percent Similarity:   97.73      Total Percent Identity:   97.60                                               
						at least 90 % homologous to                                  	                        Gaps:       1                        
						NSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRE  	                                                            
						corresponding to amino acids 244 - 302 of O00533, which also 	Alignment:                                                   
						corresponds to amino acids 228 - 286 of M86085_P7, a bridging	                  .         .         .         .         .  
						amino acid T corresponding to amino acid 287 of M86085_P7,   	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						and a fourth amino acid sequence being at least 90 %         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSN 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						GILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVH 	                  .         .         .         .         .  
						GTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLE 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						GRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLHMLELHCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLEDQG 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						IYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEAGADHNSNISEYIV 	                  .         .         .         .         .  
						EFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQFRVIAVNEVGRSQPSQPSDHHETP 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						PAAPDRNPQNIRVQASQPKEMIIKWE                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 304 - 749 of      	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						O00533, which also corresponds to amino acids 288 - 733 of   	                  .         .         .         .         .  
						M86085_P7, wherein said first amino acid sequence, second    	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						amino acid sequence, third amino acid sequence, bridging     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid and fourth amino acid sequence are contiguous and 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						an edge portion of M86085_P7, comprising a polypeptide having	     201 DYCCFAAFPRLRTIVQKMPMKLTVNS................SNSIKQRK 234                                                          
						a length "n", wherein n is at least about 10 amino acids in  	         ||||||||||||||||||||||||||                :|||||||  
						length, optionally at least about 20 amino acids in length,  	     201 DYCCFAAFPRLRTIVQKMPMKLTVNSLKHANDSSSSTEIGSKANSIKQRK 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     235 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 284                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise SSN having a structure as  	     251 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 300                                                          
						follows (numbering according to M86085_P7): a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 226-x to 226; and    	     285 RETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 334                                                          
						ending at any of amino acid numbers 228 + ((n-2) - x), in    	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.                                	     301 REAKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     335 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 384                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     385 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 434                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     435 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 484                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     485 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 534                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLEL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 HCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     585 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 634                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     635 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 684                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQF 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     685 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWE  733                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     701 RVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWE  749                                                          

24355	HMR136_M86085_8_tr0_r1_1_gPRT		Comparison report between M86085_P8 and O00533partial WT     	Sequence name: O00533                                        
						sequence featuring skipped exon plus extra amino acids, a    	                                                            
						mismatch and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for M86085_P8, comprising a    	                                                            
						MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAK 	Alignment of: 24355 x O00533   ..                            
						GNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMS 	                                                            
						EEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERV 	Alignment segment 1/1:                                       
						YMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNS               	                                                            
						first amino acid sequence being at least 90 % homologous to  	                     Quality: 4972.00                      Escore:       0                                               
						corresponding to amino acids 1 - 226 of O00533, which also   	             Matching length:     512                Total length:     528                                               
						corresponds to amino acids 1 - 226 of M86085_P8, a second    	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.61                                               
						amino acid sequence bridging amino acid sequence comprising  	    Total Percent Similarity:   96.78      Total Percent Identity:   96.59                                               
						of S, a third amino acid sequence being at least 90 %        	                        Gaps:       1                        
						homologous to                                                	                                                            
						NSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRE  	Alignment:                                                   
						corresponding to amino acids 244 - 302 of O00533, which also 	                  .         .         .         .         .  
						corresponds to amino acids 228 - 286 of M86085_P8, a bridging	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						amino acid T corresponding to amino acid 287 of M86085_P8, a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSN 	       1 MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFD 50                                                           
						GILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVH 	                  .         .         .         .         .  
						GTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLE 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						GRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIR                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	      51 EYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHI 100                                                          
						corresponding to amino acids 304 - 528 of O00533, which also 	                  .         .         .         .         .  
						corresponds to amino acids 288 - 512 of M86085_P8, and a     	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     101 SHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIV 150                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence SIFISLLLCMNCHMGSVCLHLPKWNNTI 	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						corresponding to amino acids 513 - 540 of M86085_P8, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 LPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRN 200                                                          
						third amino acid sequence, bridging amino acid, fourth amino 	                  .         .         .         .         .  
						acid sequence and fifth amino acid sequence are contiguous   	     201 DYCCFAAFPRLRTIVQKMPMKLTVNS................SNSIKQRK 234                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||                :|||||||  
						for an edge portion of M86085_P8, comprising a polypeptide   	     201 DYCCFAAFPRLRTIVQKMPMKLTVNSLKHANDSSSSTEIGSKANSIKQRK 250                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     235 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 284                                                          
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     251 PKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKG 300                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise SSN having a       	     285 RETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 334                                                          
						structure as follows (numbering according to M86085_P8): a   	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						sequence starting from any of amino acid numbers 226-x to    	     301 REAKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWT 350                                                          
						226; and ending at any of amino acid numbers 228 + ((n-2) -  	                  .         .         .         .         .  
						x), in which x varies from 0 to n-2.3.An isolated polypeptide	     335 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 384                                                          
						encoding for a tail of M86085_P8, comprising a polypeptide   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     351 KKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPR 400                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     385 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 434                                                          
						SIFISLLLCMNCHMGSVCLHLPKWNNTI in M86085_P8.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     435 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 484                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRT 500                                                          
						                                                            	                  .         .                                
						                                                            	     485 TEEDAGSYSCWVENAIGKTAVTANLDIR                       512                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     501 TEEDAGSYSCWVENAIGKTAVTANLDIR                       528                                                          

24603	HMR136_M86099_4_tr0_r1_1_gPRT		Comparison report between M86099_P4 and Q96EU5partial WT     	Sequence name: Q96EU5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86099_P4, comprising a first amino 	Sequence documentation:                                      
						MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRKRMEKEVSDFI 	                                                            
						QDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDDCRYVMIFKKEFAPSDEELDS 	Alignment of: 24603 x Q96EU5   ..                            
						YRRGEEWDPQKAEEKRKLK                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 139 of Q96EU5, which also corresponds to  	                                                            
						amino acids 1 - 139 of M86099_P4, and a second amino acid    	                     Quality: 1369.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     139                Total length:     139                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VSYALQPLGSRSPPPGRGGGLGWGPEHQCPHFHP       	                        Gaps:       0                        
						corresponding to amino acids 140 - 173 of M86099_P4, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M86099_P4, comprising a   	       1 MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRK 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRK 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSYALQPLGSRSPPPGRGGGLGWGPEHQCPHFHP in        	      51 RMEKEVSDFIQDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDD 100                                                          
						M86099_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RMEKEVSDFIQDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDD 100                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 CRYVMIFKKEFAPSDEELDSYRRGEEWDPQKAEEKRKLK            139                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     101 CRYVMIFKKEFAPSDEELDSYRRGEEWDPQKAEEKRKLK            139                                                          

						Comparison report between M86099_P4 and O75391partial WT     	Sequence name: O75391                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86099_P4, comprising a first amino 	Sequence documentation:                                      
						MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRKRMEKEVSDFI 	                                                            
						QDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDDCRYVMIFKKEFAPSDEELDS 	Alignment of: 24603 x O75391   ..                            
						YRRGEEWDPQKAEEKRKLK                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 139 of O75391, which also corresponds to  	                                                            
						amino acids 1 - 139 of M86099_P4, and a second amino acid    	                     Quality: 1369.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     139                Total length:     139                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VSYALQPLGSRSPPPGRGGGLGWGPEHQCPHFHP       	                        Gaps:       0                        
						corresponding to amino acids 140 - 173 of M86099_P4, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of M86099_P4, comprising a   	       1 MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRK 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MADLLGSILSSMEKPPSLGDQETRRKAREQAARLKKLQEQEKQQKVEFRK 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSYALQPLGSRSPPPGRGGGLGWGPEHQCPHFHP in        	      51 RMEKEVSDFIQDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDD 100                                                          
						M86099_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RMEKEVSDFIQDSGQIKKKFQPMNKIERSILHDVVEVAGLTSFSFGEDDD 100                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 CRYVMIFKKEFAPSDEELDSYRRGEEWDPQKAEEKRKLK            139                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     101 CRYVMIFKKEFAPSDEELDSYRRGEEWDPQKAEEKRKLK            139                                                          

25020	HMR136_M86114_12_tr0_r1_1_gPRT		Comparison report between M86114_P12 and SNAG_HUMANunique    	Sequence name: SNAG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86114_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25020 x SNAG_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						FLAPEEEAGSPSLHVRDLTVE corresponding to amino acids 1 - 21 of 	                                                            
						M86114_P12, a second amino acid sequence being at least 90 % 	                     Quality:  406.00                      Escore:       0                                               
						homologous to MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKA      	             Matching length:      43                Total length:      43                                               
						corresponding to amino acids 1 - 41 of SNAG_HUMAN, which also	 Matching Percent Similarity:   97.67   Matching Percent Identity:   95.35                                               
						corresponds to amino acids 22 - 62 of M86114_P12, and a third	    Total Percent Similarity:   97.67      Total Percent Identity:   95.35                                               
						amino acid sequence being at least 70%, optionally at least  	                        Gaps:       0                        
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment:                                                   
						having the sequence GIFDYSPVA corresponding to amino acids 63	                  .         .         .         .            
						- 71 of M86114_P12, wherein said first amino acid sequence,  	      22 MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKAGI        64                                                           
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||| :         
						contiguous and in a sequential order.2.An isolated           	       1 MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKAAV        43                                                           
						polypeptide encoding for a head of M86114_P12, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence FLAPEEEAGSPSLHVRDLTVE of M86114_P12.3.An     	                                                            
						isolated polypeptide encoding for a tail of M86114_P12,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence GIFDYSPVA in M86114_P12.	                                                            

25016	HMR136_M86114_2_tr0_r1_1_gPRT		Comparison report between M86114_P2 and SNAG_HUMANunique     	Sequence name: SNAG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86114_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25016 x SNAG_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						FLAPEEEAGSPSLHVRDLTVE corresponding to amino acids 1 - 21 of 	                                                            
						M86114_P2, a second amino acid sequence being at least 90 %  	                     Quality: 1204.00                      Escore:       0                                               
						MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKAAVAFKNAKQFEQAKDACLR 	             Matching length:     124                Total length:     124                                               
						EAVAHENNRALFHAAKAYEQAGMMLKEMQKLPEAVQLIEKASMMYLENGTPDTAAMALER 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.19                                               
						AGK                                                          	    Total Percent Similarity:  100.00      Total Percent Identity:   99.19                                               
						homologous to corresponding to amino acids 1 - 123 of        	                        Gaps:       0                        
						SNAG_HUMAN, which also corresponds to amino acids 22 - 144 of	                                                            
						M86114_P2, and a third amino acid sequence being at least    	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	      22 MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKAAVAFKNAKQ 71                                                           
						homologous to a polypeptide having the sequence MKNAYDRQLNY  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 145 - 155 of M86114_P2, wherein 	       1 MAAQKINEGLEHLAKAEKYLKTGFLKWKPDYDSAASEYGKAAVAFKNAKQ 50                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      72 FEQAKDACLREAVAHENNRALFHAAKAYEQAGMMLKEMQKLPEAVQLIEK 121                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of M86114_P2, comprising a polypeptide being at least   	      51 FEQAKDACLREAVAHENNRALFHAAKAYEQAGMMLKEMQKLPEAVQLIEK 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .                                
						85%, more preferably at least about 90% and most preferably  	     122 ASMMYLENGTPDTAAMALERAGKM                           145                                                          
						at least about 95% homologous to the sequence                	         |||||||||||||||||||||||:                            
						FLAPEEEAGSPSLHVRDLTVE of M86114_P2.3.An isolated polypeptide 	     101 ASMMYLENGTPDTAAMALERAGKL                           124                                                          
						encoding for a tail of M86114_P2, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						MKNAYDRQLNY in M86114_P2.                                    	                                                            

25018	HMR136_M86114_5_tr0_r1_1_gPRT		Comparison report between M86114_P5 and SNAG_HUMANpartial WT 	Sequence name: SNAG_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for M86114_P5, comprising a first amino acid        	                                                            
						MLKEMQKLPEAVQLIEKASMMYLENGTPDTAAMALERAGKLIENVDPEKAVQLYQQTANV 	Alignment of: 25018 x SNAG_HUMAN   ..                        
						FENEERLRQAVELLGKASRLLVRGRRFDEAALSIQKEKNIYKEIENYPTCYKKTIAQVLV 	                                                            
						HLHRNDYVAAERCVRESYSIPGFNGSEDCAALEQLLEGYDQQDQDQVSDVCNSPLFKYMD 	Alignment segment 1/1:                                       
						NDYAKLGLSLVVPGGGIKKKSPATPQAKPDGVTATAADEEEDEYSGGLC            	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2227.00                      Escore:       0                                               
						amino acids 84 - 312 of SNAG_HUMAN, which also corresponds to	             Matching length:     229                Total length:     229                                               
						amino acids 1 - 229 of M86114_P5.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLKEMQKLPEAVQLIEKASMMYLENGTPDTAAMALERAGKLIENVDPEKA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      84 MLKEMQKLPEAVQLIEKASMMYLENGTPDTAAMALERAGKLIENVDPEKA 133                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VQLYQQTANVFENEERLRQAVELLGKASRLLVRGRRFDEAALSIQKEKNI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     134 VQLYQQTANVFENEERLRQAVELLGKASRLLVRGRRFDEAALSIQKEKNI 183                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YKEIENYPTCYKKTIAQVLVHLHRNDYVAAERCVRESYSIPGFNGSEDCA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 YKEIENYPTCYKKTIAQVLVHLHRNDYVAAERCVRESYSIPGFNGSEDCA 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ALEQLLEGYDQQDQDQVSDVCNSPLFKYMDNDYAKLGLSLVVPGGGIKKK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 ALEQLLEGYDQQDQDQVSDVCNSPLFKYMDNDYAKLGLSLVVPGGGIKKK 283                                                          
						                                                            	                  .         .                                
						                                                            	     201 SPATPQAKPDGVTATAADEEEDEYSGGLC                      229                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     284 SPATPQAKPDGVTATAADEEEDEYSGGLC                      312                                                          

25124	HMR136_M86118_2_tr0_r1_1_gPRT		Comparison report between M86118_P2 and Q96DH8unique head    	Sequence name: Q96DH8                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for M86118_P2,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 25124 x Q96DH8   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	Alignment segment 1/1:                                       
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                     Quality: 4285.00                      Escore:       0                                               
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	             Matching length:     452                Total length:     484                                               
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN           	    Total Percent Similarity:   93.39      Total Percent Identity:   93.39                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 350 of M86118_P2, a second amino acid     	                                                            
						sequence being at least 90 % homologous to                   	Alignment:                                                   
						MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQ corresponding to amino   	                  .         .         .         .         .  
						acids 1 - 35 of Q96DH8, which also corresponds to amino acids	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQ............... 385                                                          
						351 - 385 of M86118_P2, and a third amino acid sequence being	         |||||||||||||||||||||||||||||||||||                 
						SAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQE 	       1 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 50                                                           
						EELRGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQE 	                  .         .         .         .         .  
						EALKQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILE 	     386 .................SAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 418                                                          
						KKGSAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDS 	                          |||||||||||||||||||||||||||||||||  
						SSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWM 	      51 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 100                                                          
						LEEKVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPG 	                  .         .         .         .         .  
						DENLREMNKKLQNMLEEQLTKNMHLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS    	     419 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 468                                                          
						at least 90 % homologous to corresponding to amino acids 68 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						484 of Q96DH8, which also corresponds to amino acids 386 -   	     101 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 150                                                          
						802 of M86118_P2, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     469 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 518                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of M86118_P2, comprising a   	     151 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     519 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 568                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	     201 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 250                                                          
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                  .         .         .         .         .  
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	     569 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 618                                                          
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	     251 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 300                                                          
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN           	                  .         .         .         .         .  
						to the sequence of M86118_P2.3.An isolated chimeric          	     619 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 668                                                          
						polypeptide encoding for an edge portion of M86118_P2,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     301 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 350                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     669 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 718                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     351 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 400                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QS, having a structure as follows: a sequence       	     719 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 768                                                          
						starting from any of amino acid numbers 385-x to 386; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 386+ ((n-2) - x), in     	     401 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 450                                                          
						which x varies from 0 to n-2.                                	                  .         .         .                      
						                                                            	     769 HLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS                 802                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     451 HLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS                 484                                                          

						Comparison report between M86118_P2 and Q9NQ43unique head    	Sequence name: Q9NQ43                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for M86118_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 25124 x Q9NQ43   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	Alignment segment 1/1:                                       
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                     Quality: 1597.00                      Escore:       0                                               
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	             Matching length:     164                Total length:     164                                               
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AELQQQQAEYEDLMGQKDDLNSQLQSAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHE 	                        Gaps:       0                        
						KEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQTVEELQAQVHSMD 	                                                            
						GAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAELKGKEEELQDVRDQLEQAQEER 	Alignment:                                                   
						DCHLKTISSLKQEVKDTVDGQRILEKKGSAALKDLKRQLHLERKRADKLQERLQDILTNS 	                  .         .         .         .         .  
						KSRSGLEELVLSEMNSPSRTQTGDSSSISSFSYREILR                       	     639 EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEE 688                                                          
						having the sequence corresponding to amino acids 1 - 638 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						M86118_P2, and a second amino acid sequence being at least 90	       2 EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEE 51                                                           
						EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEEKVKHLEVSSA 	                  .         .         .         .         .  
						SMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQN 	     689 KVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVL 738                                                          
						MLEEQLTKNMHLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 2 - 165 of      	      52 KVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVL 101                                                          
						Q9NQ43, which also corresponds to amino acids 639 - 802 of   	                  .         .         .         .         .  
						M86118_P2, wherein said first amino acid sequence and second 	     739 RDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHKDMEVLSQEIVRLSKEC 788                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     102 RDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHKDMEVLSQEIVRLSKEC 151                                                          
						M86118_P2, comprising a polypeptide being at least 70%,      	                  .                                          
						optionally at least about 80%, preferably at least about 85%,	     789 VGPPDPDLEPGETS                                     802                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||                                      
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	     152 VGPPDPDLEPGETS                                     165                                                          
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                                                            
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	                                                            
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	                                                            
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	                                                            
						AELQQQQAEYEDLMGQKDDLNSQLQSAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHE 	                                                            
						KEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQTVEELQAQVHSMD 	                                                            
						GAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAELKGKEEELQDVRDQLEQAQEER 	                                                            
						DCHLKTISSLKQEVKDTVDGQRILEKKGSAALKDLKRQLHLERKRADKLQERLQDILTNS 	                                                            
						KSRSGLEELVLSEMNSPSRTQTGDSSSISSFSYREILR                       	                                                            
						least about 95% homologous to the sequence of M86118_P2.     	                                                            

						Comparison report between M86118_P2 and Q9ULQ3partial WT     	Sequence name: Q9ULQ3                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for M86118_P2, comprising a first amino 	Sequence documentation:                                      
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	                                                            
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	Alignment of: 25124 x Q9ULQ3   ..                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                                                            
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	Alignment segment 1/1:                                       
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	                                                            
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	                     Quality: 7649.00                      Escore:       0                                               
						AELQQQQAEYEDLMGQKDDLNSQLQ                                    	             Matching length:     802                Total length:     834                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 385 of Q9ULQ3, which also corresponds to  	    Total Percent Similarity:   96.16      Total Percent Identity:   96.16                                               
						amino acids 1 - 385 of M86118_P2, and a second amino acid    	                        Gaps:       1                        
						SAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQE 	                                                            
						EELRGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQE 	Alignment:                                                   
						EALKQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILE 	                  .         .         .         .         .  
						KKGSAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDS 	       1 EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQK 50                                                           
						SSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LEEKVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPG 	       1 EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQK 50                                                           
						DENLREMNKKLQNMLEEQLTKNMHLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS    	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      51 ALSKSKKAQEVEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQM 100                                                          
						amino acids 418 - 834 of Q9ULQ3, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 386 - 802 of M86118_P2, wherein said first amino 	      51 ALSKSKKAQEVEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQM 100                                                          
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	     101 EQLEQENQQLKEGAAGAGVAQAGPLVDGELLRLQAENTALQKNVAALQER 150                                                          
						encoding for an edge portion of M86118_P2, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     101 EQLEQENQQLKEGAAGAGVAQAGPLVDGELLRLQAENTALQKNVAALQER 150                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     151 YGKEAGKFSAVSEGQGDPPGGPAPTVLAPMPLAEVELKWEMEKEEKRLLW 200                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     151 YGKEAGKFSAVSEGQGDPPGGPAPTVLAPMPLAEVELKWEMEKEEKRLLW 200                                                          
						length, wherein at least two amino acids comprise QS, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     201 EQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQTEKETLFNDSR 250                                                          
						acid numbers 385-x to 386; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 386+ ((n-2) - x), in which x varies from 0 to n-2.   	     201 EQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQTEKETLFNDSR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQ............... 385                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 .................SAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 418                                                          
						                                                            	                          |||||||||||||||||||||||||||||||||  
						                                                            	     401 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     419 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 468                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     469 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 518                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 618                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     619 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 668                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     669 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 718                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     719 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 768                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 800                                                          
						                                                            	                  .         .         .                      
						                                                            	     769 HLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS                 802                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     801 HLHKDMEVLSQEIVRLSKECVGPPDPDLEPGETS                 834                                                          

25126	HMR136_M86118_5_tr0_r1_1_gPRT		Comparison report between M86118_P5 and Q96DH8unique head    	Sequence name: Q96DH8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86118_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25126 x Q96DH8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	Alignment segment 1/1:                                       
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                     Quality: 4395.00                      Escore:       0                                               
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	             Matching length:     454                Total length:     454                                               
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 350 of M86118_P5, a second amino acid     	                                                            
						MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQEIGQEKEQLTQ 	Alignment:                                                   
						ELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELH 	                  .         .         .         .         .  
						EDKKRQEEELRGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQ 	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 400                                                          
						QQQQEQEEALKQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGQRILEKKGSAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 	       1 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 50                                                           
						RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAE 	                  .         .         .         .         .  
						TQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVL 	     401 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 450                                                          
						RDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHK                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 100                                                          
						amino acids 1 - 454 of Q96DH8, which also corresponds to     	                  .         .         .         .         .  
						amino acids 351 - 804 of M86118_P5, and a third amino acid   	     451 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 500                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ASVACQPTHLFTQPPAYPAT corresponding to    	     501 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 550                                                          
						amino acids 805 - 824 of M86118_P5, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	     151 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 200                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of M86118_P5,       	     551 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 600                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     201 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 250                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	     601 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 650                                                          
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	     251 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 300                                                          
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	                  .         .         .         .         .  
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	     651 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 700                                                          
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of M86118_P5.3.An       	     301 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 350                                                          
						isolated polypeptide encoding for a tail of M86118_P5,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     701 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 750                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     351 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 400                                                          
						about 95% homologous to the sequence ASVACQPTHLFTQPPAYPAT in 	                  .         .         .         .         .  
						M86118_P5.                                                   	     751 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 450                                                          
						                                                            	                                                             
						                                                            	     801 HLHK                                               804                                                          
						                                                            	         ||||                                                
						                                                            	     451 HLHK                                               454                                                          

						Comparison report between M86118_P5 and Q9NQ43unique head    	Sequence name: Q9NQ43                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86118_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25126 x Q9NQ43   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	Alignment segment 1/1:                                       
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                     Quality: 1302.00                      Escore:       0                                               
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	             Matching length:     134                Total length:     134                                               
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQEIGQEKEQLTQELQEARKSAE 	                        Gaps:       0                        
						KRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQEEEL 	                                                            
						RGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEAL 	Alignment:                                                   
						KQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 	                  .         .         .         .         .  
						SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDSSSI 	     671 EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEE 720                                                          
						SSFSYREILR                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	       2 EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEE 51                                                           
						to amino acids 1 - 670 of M86118_P5, a second amino acid     	                  .         .         .         .         .  
						EKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEEKVKHLEVSSA 	     721 KVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVL 770                                                          
						SMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLEEQLTKNMHLHK                                               	      52 KVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVL 101                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .                      
						amino acids 2 - 135 of Q9NQ43, which also corresponds to     	     771 RDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHK                 804                                                          
						amino acids 671 - 804 of M86118_P5, and a third amino acid   	         ||||||||||||||||||||||||||||||||||                  
						sequence being at least 70%, optionally at least 80%,        	     102 RDLVKPGDENLREMNKKLQNMLEEQLTKNMHLHK                 135                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence ASVACQPTHLFTQPPAYPAT corresponding to    	                                                            
						amino acids 805 - 824 of M86118_P5, wherein said first amino 	                                                            
						acid sequence, second amino acid sequence and third amino    	                                                            
						acid sequence are contiguous and in a sequential order.2.An  	                                                            
						isolated polypeptide encoding for a head of M86118_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	                                                            
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	                                                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                                                            
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	                                                            
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	                                                            
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	                                                            
						AELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQEIGQEKEQLTQELQEARKSAE 	                                                            
						KRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQEEEL 	                                                            
						RGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEAL 	                                                            
						KQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 	                                                            
						SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDSSSI 	                                                            
						SSFSYREILR                                                   	                                                            
						about 95% homologous to the sequence of M86118_P5.3.An       	                                                            
						isolated polypeptide encoding for a tail of M86118_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence ASVACQPTHLFTQPPAYPAT in 	                                                            
						M86118_P5.                                                   	                                                            

						Comparison report between M86118_P5 and Q9ULQ3partial WT     	Sequence name: Q9ULQ3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for M86118_P5, comprising a first amino 	Sequence documentation:                                      
						EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQKALSKSKKAQE 	                                                            
						VEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQMEQLEQENQQLKEGAAGAGVA 	Alignment of: 25126 x Q9ULQ3   ..                            
						QAGPLVDGELLRLQAENTALQKNVAALQERYGKEAGKFSAVSEGQGDPPGGPAPTVLAPM 	                                                            
						PLAEVELKWEMEKEEKRLLWEQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQT 	Alignment segment 1/1:                                       
						EKETLFNDSRNKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 	                                                            
						AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELNMLREQTTGLA 	                     Quality: 7759.00                      Escore:       0                                               
						AELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQEIGQEKEQLTQELQEARKSAE 	             Matching length:     804                Total length:     804                                               
						KRKAMLDELAMETLQEKSQHKEELGAVRLRHEKEVLGVRARYERELRELHEDKKRQEEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RGQIREEKARTRELETLQQTVEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEAL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQCREQHAAELKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 	                        Gaps:       0                        
						SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPSRTQTGDSSSI 	                                                            
						SSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEEVAELFQRLAETQQEKWMLEE 	Alignment:                                                   
						KVKHLEVSSASMAEDLCRKSAIIETYVMDSRIDVSVAAGHTDRSGLGSVLRDLVKPGDEN 	                  .         .         .         .         .  
						LREMNKKLQNMLEEQLTKNMHLHK                                     	       1 EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQK 50                                                           
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 804 of Q9ULQ3, which also corresponds to  	       1 EEFQRMQAQLLELRTNNYQLSDELRKNGVELTSLRQKVAYLDKEFSKAQK 50                                                           
						amino acids 1 - 804 of M86118_P5, and a second amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      51 ALSKSKKAQEVEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQM 100                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 ALSKSKKAQEVEVLLSENEMLQAKLHSQEEDFRLQNSTLMAEFSKLCSQM 100                                                          
						having the sequence ASVACQPTHLFTQPPAYPAT corresponding to    	                  .         .         .         .         .  
						amino acids 805 - 824 of M86118_P5, wherein said first amino 	     101 EQLEQENQQLKEGAAGAGVAQAGPLVDGELLRLQAENTALQKNVAALQER 150                                                          
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     101 EQLEQENQQLKEGAAGAGVAQAGPLVDGELLRLQAENTALQKNVAALQER 150                                                          
						for a tail of M86118_P5, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     151 YGKEAGKFSAVSEGQGDPPGGPAPTVLAPMPLAEVELKWEMEKEEKRLLW 200                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     151 YGKEAGKFSAVSEGQGDPPGGPAPTVLAPMPLAEVELKWEMEKEEKRLLW 200                                                          
						ASVACQPTHLFTQPPAYPAT in M86118_P5.                           	                  .         .         .         .         .  
						                                                            	     201 EQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQTEKETLFNDSR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EQLQGLESSKQAETSRLQEELAKLSEKLKKKQESFCRLQTEKETLFNDSR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NKIEELQQRKEADHKAQLARTQKLQQELEAANQSLAELRDQRQGERLEHA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AALRALQDQVSIQSADAQEQVEGLLAENNALRTSLAALEQIQTAKTQELN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 MLREQTTGLAAELQQQQAEYEDLMGQKDDLNSQLQESLRANSRLLEQLQE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 IGQEKEQLTQELQEARKSAEKRKAMLDELAMETLQEKSQHKEELGAVRLR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 HEKEVLGVRARYERELRELHEDKKRQEEELRGQIREEKARTRELETLQQT 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VEELQAQVHSMDGAKGWFERRLKEAEESLQQQQQEQEEALKQCREQHAAE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LKGKEEELQDVRDQLEQAQEERDCHLKTISSLKQEVKDTVDGQRILEKKG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SAALKDLKRQLHLERKRADKLQERLQDILTNSKSRSGLEELVLSEMNSPS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 RTQTGDSSSISSFSYREILREKESSAVPARSLSSSPQAQPPRPAELSDEE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VAELFQRLAETQQEKWMLEEKVKHLEVSSASMAEDLCRKSAIIETYVMDS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 RIDVSVAAGHTDRSGLGSVLRDLVKPGDENLREMNKKLQNMLEEQLTKNM 800                                                          
						                                                            	                                                             
						                                                            	     801 HLHK                                               804                                                          
						                                                            	         ||||                                                
						                                                            	     801 HLHK                                               804                                                          

12444	HMR136_M86167_20_tr0_r1_1_gPRT		Comparison report between M86167_P20 and Q9BWD6partial WT    	Sequence name: Q9BWD6                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						M86167_P20, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to MQIFVKTLTGKTITLE corresponding to   	Alignment of: 12444 x Q9BWD6   ..                            
						amino acids 1 - 16 of Q9BWD6, which also corresponds to amino	                                                            
						acids 1 - 16 of M86167_P20, a second amino acid sequence     	Alignment segment 1/1:                                       
						being at least 90 % homologous to                            	                                                            
						RLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRG corresponding to amino    	                     Quality:  369.00                      Escore:       0                                               
						acids 42 - 75 of Q9BWD6, which also corresponds to amino     	             Matching length:      50                Total length:      75                                               
						acids 17 - 50 of M86167_P20, and a third amino acid sequence 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						being at least 70%, optionally at least 80%, preferably at   	    Total Percent Similarity:   66.67      Total Percent Identity:   66.67                                               
						least 85%, more preferably at least 90% and most preferably  	                        Gaps:       1                        
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						WLLILQSWHSQCPVMALLCTIAICPNLSLEITSFSNS corresponding to amino 	Alignment:                                                   
						acids 51 - 87 of M86167_P20, wherein said first amino acid   	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	       1 MQIFVKTLTGKTITLE.........................RLIFAGKQL 25                                                           
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||                         |||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	       1 MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQL 50                                                           
						M86167_P20, comprising a polypeptide having a length "n",    	                  .         .                                
						wherein n is at least about 10 amino acids in length,        	      26 EDGRTLSDYNIQKESTLHLVLRLRG                          50                                                           
						optionally at least about 20 amino acids in length,          	         |||||||||||||||||||||||||                           
						preferably at least about 30 amino acids in length, more     	      51 EDGRTLSDYNIQKESTLHLVLRLRG                          75                                                           
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise ER, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						16-x to 17; and ending at any of amino acid numbers 17+      	                                                            
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                                                            
						polypeptide encoding for a tail of M86167_P20, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence WLLILQSWHSQCPVMALLCTIAICPNLSLEITSFSNS in     	                                                            
						M86167_P20.                                                  	                                                            

3434	HMR136_MIHS75KDA_13_tr0_r1_1_gPRT		Comparison report between MIHS75KDA_P13 and                  	Sequence name: NUAM_HUMAN                                    
						NUAM_HUMANpartial WT sequence followed by mismatch and a     	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for MIHS75KDA_P13, comprising a first amino acid    	                                                            
						sequence being at least 90 % homologous to MLRIPVR           	Alignment of: 3434 x NUAM_HUMAN   ..                         
						corresponding to amino acids 1 - 7 of NUAM_HUMAN, which also 	                                                            
						corresponds to amino acids 1 - 7 of MIHS75KDA_P13, a bridging	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 8 of MIHS75KDA_P13, 	                                                            
						a second amino acid sequence being at least 90 % homologous  	                     Quality: 3228.00                      Escore:       0                                               
						ALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQIPRFCYHER 	             Matching length:     331                Total length:     331                                               
						LSVAGNCRMCLVEIEKAPKVVAACAMPVMKGWNILTNSEKSKKAREGVMEFLLANHPLDC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.09                                               
						PICDQGGECDLQDQSMMFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASE 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.09                                               
						IAGVDDLGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKT 	                        Gaps:       0                        
						ESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQRLTEPMVR 	                                                            
						NEKGLLTYTSWEDALSRVAGM                                        	Alignment:                                                   
						to corresponding to amino acids 9 - 329 of NUAM_HUMAN, which 	                  .         .         .         .         .  
						also corresponds to amino acids 9 - 329 of MIHS75KDA_P13, and	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						a third amino acid sequence being at least 70%, optionally at	         |||||||:||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 MLRIPVRRALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VKFEINSVK corresponding to   	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						amino acids 330 - 338 of MIHS75KDA_P13, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						tail of MIHS75KDA_P13, comprising a polypeptide being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						VKFEINSVK in MIHS75KDA_P13.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTES 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTES 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMVK                    331                                                          
						                                                            	         |||||||||||||||||||||||||||||::                     
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQ                    331                                                          

3430	HMR136_MIHS75KDA_16_tr0_r1_1_gPRT		Comparison report between MIHS75KDA_P16 and Q8N1C4partial WT 	Sequence name: Q8N1C4                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for MIHS75KDA_P16, comprising a first   	Sequence documentation:                                      
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	                                                            
						PRFCYHERLSVAGNCRMCLVEIEKAPKV                                 	Alignment of: 3430 x Q8N1C4   ..                             
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 88 of Q8N1C4, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 88 of MIHS75KDA_P16, and a    	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  854.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      88                Total length:      88                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence LDT corresponding to amino   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 89 - 91 of MIHS75KDA_P16, wherein said first amino acid	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.                                          	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						                                                            	                  .         .         .                      
						                                                            	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKV             88                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKV             88                                                           

						Comparison report between MIHS75KDA_P16 and Q8TCC9partial WT 	Sequence name: Q8TCC9                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for MIHS75KDA_P16, comprising a first   	Sequence documentation:                                      
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	                                                            
						PRFCYHERLSVAGNCRMCLVEIEKAPKV                                 	Alignment of: 3430 x Q8TCC9   ..                             
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 88 of Q8TCC9, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 88 of MIHS75KDA_P16, and a    	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  854.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      88                Total length:      88                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence LDT corresponding to amino   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 89 - 91 of MIHS75KDA_P16, wherein said first amino acid	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.                                          	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						                                                            	                  .         .         .                      
						                                                            	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKV             88                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKV             88                                                           

3428	HMR136_MIHS75KDA_7_tr0_r1_1_gPRT		Comparison report between MIHS75KDA_P7 and Q8N1C4partial WT  	Sequence name: Q8N1C4                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for MIHS75KDA_P7, comprising a first    	Sequence documentation:                                      
						MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGRGNDM 	                                                            
						QVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTA                         	Alignment of: 3428 x Q8N1C4   ..                             
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 145 - 240 of Q8N1C4, which also 	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 96 of MIHS75KDA_P7, a bridging	                                                            
						amino acid R corresponding to amino acid 97 of MIHS75KDA_P7, 	                     Quality: 5596.00                      Escore:       0                                               
						and a second amino acid sequence being at least 90 %         	             Matching length:     583                Total length:     583                                               
						PWETRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						LTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNRV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						DSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRKS 	                        Gaps:       0                        
						WLHNDLKVALIGSPVDLTYTYDHLGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSAL 	                                                            
						QRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNP 	Alignment:                                                   
						PKVLFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTEG 	                  .         .         .         .         .  
						RAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEG 	       1 MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDD 50                                                           
						ANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMTDSISRASQTMAKCVKAVTEGAQAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEPSIC                                                       	     145 MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDD 194                                                          
						homologous to corresponding to amino acids 242 - 727 of      	                  .         .         .         .         .  
						Q8N1C4, which also corresponds to amino acids 98 - 583 of    	      51 LGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWE 100                                                          
						MIHS75KDA_P7, wherein said first amino acid sequence,        	         ||||||||||||||||||||||||||||||||||||||||||||||:|||  
						bridging amino acid and second amino acid sequence are       	     195 LGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTAQPWE 244                                                          
						contiguous and in a sequential order.                        	                  .         .         .         .         .  
						                                                            	     101 TRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 TRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAY 294                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGLKRQRLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     295 DGLKRQRLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGG 344                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 LVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGV 394                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     395 EEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 444                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 LGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVS 494                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     495 SIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKV 544                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     545 LFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSA 594                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     595 TYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRN 644                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RLEEVSPNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDF 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     645 RLEEVSPNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDF 694                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 YMTDSISRASQTMAKCVKAVTEGAQAVEEPSIC                  583                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     695 YMTDSISRASQTMAKCVKAVTEGAQAVEEPSIC                  727                                                          

						Comparison report between MIHS75KDA_P7 and Q8TCC9partial WT  	Sequence name: Q8TCC9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for MIHS75KDA_P7, comprising a first amino acid     	                                                            
						MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGRGNDM 	Alignment of: 3428 x Q8TCC9   ..                             
						QVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTESIDVMDAVGSNIVVS 	                                                            
						TRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQRLTEPMVRNEKGLLTYTSWEDALS 	Alignment segment 1/1:                                       
						RVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSN 	                                                            
						YLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 	                     Quality: 5606.00                      Escore:       0                                               
						LGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVSSIAQKIRMTS 	             Matching length:     583                Total length:     583                                               
						GVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKVLFLLGADGGCITRQDLPKDC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTEGRAQQTKVAVTPPGLAREDWKIIR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEGANYFQQANELSKLVNQQLLADPL 	                        Gaps:       0                        
						VPPQLTIKDFYMTDSISRASQTMAKCVKAVTEGAQAVEEPSIC                  	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 145 - 727 of Q8TCC9, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1 - 583 of MIHS75KDA_P7.                         	       1 MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDD 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     145 MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDD 194                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     195 LGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWE 244                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 TRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAY 294                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGLKRQRLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     295 DGLKRQRLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGG 344                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 LVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGV 394                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     395 EEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 444                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 LGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVS 494                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     495 SIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKV 544                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     545 LFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSA 594                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     595 TYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRN 644                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RLEEVSPNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDF 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     645 RLEEVSPNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDF 694                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 YMTDSISRASQTMAKCVKAVTEGAQAVEEPSIC                  583                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     695 YMTDSISRASQTMAKCVKAVTEGAQAVEEPSIC                  727                                                          

						Comparison report between MIHS75KDA_P7 and Q9P1A0unique head 	Sequence name: Q9P1A0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for MIHS75KDA_P7, comprising a first    	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 3428 x Q9P1A0   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGRGNDM 	Alignment segment 1/1:                                       
						QVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTESIDVMDAVGSNIVVS 	                                                            
						TRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQRLTEPMVRNEKGLLTYTSWEDALS 	                     Quality: 2445.00                      Escore:       0                                               
						RVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSN 	             Matching length:     255                Total length:     255                                               
						YLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LGDSPKILQDIASGSHPFSQVLKEAKKP                                 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 328 of  	                        Gaps:       0                        
						MIHS75KDA_P7, and a second amino acid sequence being at least	                                                            
						MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKP 	Alignment:                                                   
						GVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEK 	                  .         .         .         .         .  
						SATYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVSPN 	     329 MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQ 378                                                          
						LVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMTDSISRASQTMAKCVK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVTEGAQAVEEPSIC                                              	       1 MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQ 50                                                           
						90 % homologous to corresponding to amino acids 1 - 255 of   	                  .         .         .         .         .  
						Q9P1A0, which also corresponds to amino acids 329 - 583 of   	     379 VAALDLGYKPGVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHH 428                                                          
						MIHS75KDA_P7, wherein said first amino acid sequence and     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 VAALDLGYKPGVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHH 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						MIHS75KDA_P7, comprising a polypeptide being at least 70%,   	     429 GDVGAPIADVILPGAAYTEKSATYVNTEGRAQQTKVAVTPPGLAREDWKI 478                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 GDVGAPIADVILPGAAYTEKSATYVNTEGRAQQTKVAVTPPGLAREDWKI 150                                                          
						MFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGRGNDM 	                  .         .         .         .         .  
						QVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTESIDVMDAVGSNIVVS 	     479 IRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEGANYFQQANELS 528                                                          
						TRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQRLTEPMVRNEKGLLTYTSWEDALS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSN 	     151 IRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEGANYFQQANELS 200                                                          
						YLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDH 	                  .         .         .         .         .  
						LGDSPKILQDIASGSHPFSQVLKEAKKP                                 	     529 KLVNQQLLADPLVPPQLTIKDFYMTDSISRASQTMAKCVKAVTEGAQAVE 578                                                          
						least about 95% homologous to the sequence of MIHS75KDA_P7.  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KLVNQQLLADPLVPPQLTIKDFYMTDSISRASQTMAKCVKAVTEGAQAVE 250                                                          
						                                                            	                                                             
						                                                            	     579 EPSIC                                              583                                                          
						                                                            	         |||||                                               
						                                                            	     251 EPSIC                                              255                                                          

3432	HMR136_MIHS75KDA_9_tr0_r1_1_gPRT		Comparison report between MIHS75KDA_P9 and Q8N1C4partial WT  	Sequence name: Q8N1C4                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						MIHS75KDA_P9, comprising a first amino acid sequence being at	                                                            
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	Alignment of: 3432 x Q8N1C4   ..                             
						PRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGWNILTNSEKSKKAREGVMEFL 	                                                            
						LANHPLDCPICDQGGECDLQDQSMMFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCT 	Alignment segment 1/1:                                       
						RCIRFASEIAGVDDLGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTA 	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 240	                     Quality: 6732.00                      Escore:       0                                               
						of Q8N1C4, which also corresponds to amino acids 1 - 240 of  	             Matching length:     697                Total length:     697                                               
						MIHS75KDA_P9, a bridging amino acid R corresponding to amino 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						acid 241 of MIHS75KDA_P9, a second amino acid sequence being 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						PWETRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQR 	                        Gaps:       0                        
						LTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNRV 	                                                            
						DSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRKS 	Alignment:                                                   
						WLHNDLKVALIGSPVDLTYTYDHLGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSAL 	                  .         .         .         .         .  
						QRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNP 	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						PKVLFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEG 	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						ANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT                         	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 242 	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						- 697 of Q8N1C4, which also corresponds to amino acids 242 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						697 of MIHS75KDA_P9, and a third amino acid sequence being at	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						homologous to a polypeptide having the sequence VLLM         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 698 - 701 of MIHS75KDA_P9,      	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						wherein said first amino acid sequence, bridging amino acid, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of MIHS75KDA_P9, comprising a	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTES 250                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||:|||||||||  
						to the sequence VLLM in MIHS75KDA_P9.                        	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTAQPWETRKTES 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDHLGDSPK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDHLGDSPK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVSSIAQKI 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVSSIAQKI 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKVLFLLGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKVLFLLGA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVS 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	     651 PNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT    697                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     651 PNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT    697                                                          

						Comparison report between MIHS75KDA_P9 and Q8TCC9partial WT  	Sequence name: Q8TCC9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for MIHS75KDA_P9, comprising a first    	Sequence documentation:                                      
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	                                                            
						PRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGWNILTNSEKSKKAREGVMEFL 	Alignment of: 3432 x Q8TCC9   ..                             
						LANHPLDCPICDQGGECDLQDQSMMFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCT 	                                                            
						RCIRFASEIAGVDDLGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTA 	Alignment segment 1/1:                                       
						RPWETRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 	                                                            
						RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNR 	                     Quality: 6742.00                      Escore:       0                                               
						VDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRK 	             Matching length:     697                Total length:     697                                               
						SWLHNDLKVALIGSPVDLTYTYDHLGDSPKILQDIASGSHPFSQVLKEAKKPMVVLGSSA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PPKVLFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTE 	                        Gaps:       0                        
						GRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIE 	                                                            
						GANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT                        	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 697 of Q8TCC9, which also   	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						corresponds to amino acids 1 - 697 of MIHS75KDA_P9, and a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 70%, optionally at 	       1 MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVL 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						polypeptide having the sequence VLLM corresponding to amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 698 - 701 of MIHS75KDA_P9, wherein said first amino    	      51 QACEKVGMQIPRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGW 100                                                          
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						for a tail of MIHS75KDA_P9, comprising a polypeptide being at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     101 NILTNSEKSKKAREGVMEFLLANHPLDCPICDQGGECDLQDQSMMFGNDR 150                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence VLLM	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						in MIHS75KDA_P9.                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SRFLEGKRAVEDKNIGPLVKTIMTRCIQCTRCIRFASEIAGVDDLGTTGR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTES 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTARPWETRKTES 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LVALKDLLNRVDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDHLGDSPK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LLVGTNPRFEAPLFNARIRKSWLHNDLKVALIGSPVDLTYTYDHLGDSPK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVSSIAQKI 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ILQDIASGSHPFSQVLKEAKKPMVVLGSSALQRNDGAAILAAVSSIAQKI 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKVLFLLGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RMTSGVTGDWKVMNILHRIASQVAALDLGYKPGVEAIRKNPPKVLFLLGA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEKSATYVNTE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVS 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	     651 PNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT    697                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     651 PNLVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT    697                                                          

						Comparison report between MIHS75KDA_P9 and Q9P1A0unique head 	Sequence name: Q9P1A0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						MIHS75KDA_P9, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 3432 x Q9P1A0   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	Alignment segment 1/1:                                       
						PRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGWNILTNSEKSKKAREGVMEFL 	                                                            
						LANHPLDCPICDQGGECDLQDQSMMFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCT 	                     Quality: 2158.00                      Escore:       0                                               
						RCIRFASEIAGVDDLGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTA 	             Matching length:     225                Total length:     225                                               
						RPWETRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRK 	                        Gaps:       0                        
						SWLHNDLKVALIGSPVDLTYTYDHLGDSPKILQDIASGSHPFSQVLKEAKKP         	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 472 of MIHS75KDA_P9, a second amino acid  	                  .         .         .         .         .  
						MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQVAALDLGYKP 	     473 MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQ 522                                                          
						GVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHHGDVGAPIADVILPGAAYTEK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SATYVNTEGRAQQTKVAVTPPGLAREDWKIIRALSEIAGMTLPYDTLDQVRNRLEEVSPN 	       1 MVVLGSSALQRNDGAAILAAVSSIAQKIRMTSGVTGDWKVMNILHRIASQ 50                                                           
						LVRYDDIEGANYFQQANELSKLVNQQLLADPLVPPQLTIKDFYMT                	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     523 VAALDLGYKPGVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHH 572                                                          
						amino acids 1 - 225 of Q9P1A0, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 473 - 697 of MIHS75KDA_P9, and a third amino acid	      51 VAALDLGYKPGVEAIRKNPPKVLFLLGADGGCITRQDLPKDCFIIYQGHH 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     573 GDVGAPIADVILPGAAYTEKSATYVNTEGRAQQTKVAVTPPGLAREDWKI 622                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VLLM corresponding to amino acids 698 -  	     101 GDVGAPIADVILPGAAYTEKSATYVNTEGRAQQTKVAVTPPGLAREDWKI 150                                                          
						701 of MIHS75KDA_P9, wherein said first amino acid sequence, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     623 IRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEGANYFQQANELS 672                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of MIHS75KDA_P9, comprising a	     151 IRALSEIAGMTLPYDTLDQVRNRLEEVSPNLVRYDDIEGANYFQQANELS 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .                                
						80%, preferably at least about 85%, more preferably at least 	     673 KLVNQQLLADPLVPPQLTIKDFYMT                          697                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||||||||||||||                           
						MLRIPVRKALVGLSKSPKGCVRTTATAASNLIEVFVDGQSVMVEPGTTVLQACEKVGMQI 	     201 KLVNQQLLADPLVPPQLTIKDFYMT                          225                                                          
						PRFCYHERLSVAGNCRMCLVEIEKAPKVVAACAMPVMKGWNILTNSEKSKKAREGVMEFL 	                                                            
						LANHPLDCPICDQGGECDLQDQSMMFGNDRSRFLEGKRAVEDKNIGPLVKTIMTRCIQCT 	                                                            
						RCIRFASEIAGVDDLGTTGRGNDMQVGTYIEKMFMSELSGNIIDICPVGALTSKPYAFTA 	                                                            
						RPWETRKTESIDVMDAVGSNIVVSTRTGEVMRILPRMHEDINEEWISDKTRFAYDGLKRQ 	                                                            
						RLTEPMVRNEKGLLTYTSWEDALSRVAGMLQSFQGKDVAAIAGGLVDAEALVALKDLLNR 	                                                            
						VDSDTLCTEEVFPTAGAGTDLRSNYLLNTTIAGVEEADVVLLVGTNPRFEAPLFNARIRK 	                                                            
						SWLHNDLKVALIGSPVDLTYTYDHLGDSPKILQDIASGSHPFSQVLKEAKKP         	                                                            
						to the sequence of MIHS75KDA_P9.3.An isolated polypeptide    	                                                            
						encoding for a tail of MIHS75KDA_P9, comprising a polypeptide	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						VLLM in MIHS75KDA_P9.                                        	                                                            

28050	HMR136_N20493_8_tr0_r1_1_gPRT		Comparison report between N20493_P8 and Q8NFR4unique head    	Sequence name: Q8NFR4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N20493_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28050 x Q8NFR4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence CLVIGMWKRYQAHRSLCMCSCTCVFQ corresponding 	Alignment segment 1/1:                                       
						to amino acids 1 - 26 of N20493_P8, and a second amino acid  	                                                            
						ANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQDVRQKFEDEKK 	                     Quality: 1514.00                      Escore:       0                                               
						QLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQEQITYIRQEYETKLKGLMPAS 	             Matching length:     158                Total length:     158                                               
						LRQELEDTISSLKSQVNFLQKRASILQEELTTYQGRR                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.37                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.37                                               
						amino acids 434 - 590 of Q8NFR4, which also corresponds to   	                        Gaps:       0                        
						amino acids 27 - 183 of N20493_P8, wherein said first amino  	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of N20493_P8, comprising a polypeptide being at   	      26 QANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQ 75                                                           
						least 70%, optionally at least about 80%, preferably at least	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     433 KANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQ 482                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						CLVIGMWKRYQAHRSLCMCSCTCVFQ of N20493_P8.                     	      76 DVRQKFEDEKKQLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQ 125                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     483 DVRQKFEDEKKQLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQ 532                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     126 EQITYIRQEYETKLKGLMPASLRQELEDTISSLKSQVNFLQKRASILQEE 175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     533 EQITYIRQEYETKLKGLMPASLRQELEDTISSLKSQVNFLQKRASILQEE 582                                                          
						                                                            	                                                             
						                                                            	     176 LTTYQGRR                                           183                                                          
						                                                            	         ||||||||                                            
						                                                            	     583 LTTYQGRR                                           590                                                          

						Comparison report between N20493_P8 and Q8NCR4unique head    	Sequence name: Q8NCR4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N20493_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28050 x Q8NCR4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence CLVIGMWKRYQAHRSLCMCSCTCVFQ corresponding 	Alignment segment 1/1:                                       
						to amino acids 1 - 26 of N20493_P8, and a second amino acid  	                                                            
						ANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQDVRQKFEDEKK 	                     Quality: 1514.00                      Escore:       0                                               
						QLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQEQITYIRQEYETKLKGLMPAS 	             Matching length:     158                Total length:     158                                               
						LRQELEDTISSLKSQVNFLQKRASILQEELTTYQGRR                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.37                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.37                                               
						amino acids 55 - 211 of Q8NCR4, which also corresponds to    	                        Gaps:       0                        
						amino acids 27 - 183 of N20493_P8, wherein said first amino  	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of N20493_P8, comprising a polypeptide being at   	      26 QANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQ 75                                                           
						least 70%, optionally at least about 80%, preferably at least	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      54 KANSKLKQIEKEYTQKLAKSSQIIAELQTTISSLKEENSQQQLAAERRLQ 103                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						CLVIGMWKRYQAHRSLCMCSCTCVFQ of N20493_P8.                     	      76 DVRQKFEDEKKQLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQ 125                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     104 DVRQKFEDEKKQLIRDNDQAIKVLQDELENRSNQVRCAEKKLQHKELESQ 153                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     126 EQITYIRQEYETKLKGLMPASLRQELEDTISSLKSQVNFLQKRASILQEE 175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 EQITYIRQEYETKLKGLMPASLRQELEDTISSLKSQVNFLQKRASILQEE 203                                                          
						                                                            	                                                             
						                                                            	     176 LTTYQGRR                                           183                                                          
						                                                            	         ||||||||                                            
						                                                            	     204 LTTYQGRR                                           211                                                          

7962	HMR136_N21322_6_tr0_r1_1_gPRT		Comparison report between N21322_P6 and Q96NT8unique head    	Sequence name: Q96NT8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for N21322_P6, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 7962 x Q96NT8   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	Alignment segment 1/1:                                       
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	                                                            
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	                     Quality: 3108.00                      Escore:       0                                               
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	             Matching length:     312                Total length:     312                                               
						EVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEA 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						AGEIVRLTTPGFSHSCS                                            	                        Gaps:       0                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 377 of N21322_P6, a second amino acid sequence being at  	Alignment:                                                   
						MSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIF 	                  .         .         .         .         .  
						HFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLG 	     378 MSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASC 427                                                          
						YAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGFLSLMGLIHKPQVFKVAIA                                        	       1 MSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASC 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 201	                  .         .         .         .         .  
						of Q96NT8, which also corresponds to amino acids 378 - 578 of	     428 PPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQL 477                                                          
						N21322_P6, a bridging amino acid G corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 579 of N21322_P6, and a third amino acid sequence being 	      51 PPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQL 100                                                          
						APVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHF 	                  .         .         .         .         .  
						FHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL           	     478 VNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVE 527                                                          
						at least 90 % homologous to corresponding to amino acids 203 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 312 of Q96NT8, which also corresponds to amino acids 580 - 	     101 VNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVE 150                                                          
						689 of N21322_P6, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence, bridging amino acid and third    	     528 IEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAI 577                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 IEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAI 200                                                          
						N21322_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     578 AGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLL 627                                                          
						more preferably at least about 90% and most preferably at    	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	     201 ACAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLL 250                                                          
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	                  .         .         .         .         .  
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	     628 ILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHY 677                                                          
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 	     251 ILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHY 300                                                          
						GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEA 	                  .                                          
						AGEIVRLTTPGFSHSCS                                            	     678 EVTLLHFLQEYL                                       689                                                          
						least about 95% homologous to the sequence of N21322_P6.     	         ||||||||||||                                        
						                                                            	     301 EVTLLHFLQEYL                                       312                                                          

						Comparison report between N21322_P6 and AAO73880partial WT   	Sequence name: AAO73880                                      
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for N21322_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MKPLEIKTQCSGPRMDPKICPADPAFFSF corresponding to amino acids   	Alignment of: 7962 x AAO73880   ..                           
						281 - 309 of AAO73880, which also corresponds to amino acids 	                                                            
						1 - 29 of N21322_P6, a bridging amino acid I corresponding to	Alignment segment 1/1:                                       
						amino acid 30 of N21322_P6, and a second amino acid sequence 	                                                            
						NNSDLWVANIETGEERRLTFCHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASW 	                     Quality: 6885.00                      Escore:       0                                               
						EGSEGLKTLRILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQT 	             Matching length:     689                Total length:     689                                               
						DSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQWLQLVLLPPA 	 Matching Percent Similarity:   99.85   Matching Percent Identity:   99.85                                               
						LFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVHDIFYPFPQSEGEDELCFLRA 	    Total Percent Similarity:   99.85      Total Percent Identity:   99.85                                               
						NECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIKEEIALTSGEWEVLARHGSKI 	                        Gaps:       0                        
						WVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYS 	                                                            
						SVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 	Alignment:                                                   
						IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQ 	                  .         .         .         .         .  
						RGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKP 	       1 MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTF 50                                                           
						QVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILH 	         ||||||||||||||||||||||||||||| ||||||||||||||||||||  
						GFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL  	     281 MKPLEIKTQCSGPRMDPKICPADPAFFSFNNNSDLWVANIETGEERRLTF 330                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 311 - 969 of AAO73880, which also corresponds to amino 	      51 CHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLR 100                                                          
						acids 31 - 689 of N21322_P6, wherein said first amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid and second amino acid sequence 	     331 CHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLR 380                                                          
						are contiguous and in a sequential order.                    	                  .         .         .         .         .  
						                                                            	     101 ILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 ILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQT 430                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 DSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQ 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 WLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVH 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     531 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     581 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 630                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     631 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 680                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     681 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 730                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     731 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 780                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     781 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 830                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     831 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 880                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     881 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 930                                                          
						                                                            	                  .         .         .                      
						                                                            	     651 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            689                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     931 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            969                                                          

						Comparison report between N21322_P6 and Q8N2J7unique head    	Sequence name: Q8N2J7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N21322_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7962 x Q8N2J7   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	Alignment segment 1/1:                                       
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	                                                            
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	                     Quality: 1661.00                      Escore:       0                                               
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	             Matching length:     167                Total length:     167                                               
						EVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWAS 	                        Gaps:       0                        
						MMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNN 	                                                            
						SFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQ                   	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 522 of  	                  .         .         .         .         .  
						N21322_P6, and a second amino acid sequence being at least 90	     523 MGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQV 572                                                          
						MGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHT 	       1 MGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQV 50                                                           
						NFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL              	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 167 of      	     573 FKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNE 622                                                          
						Q8N2J7, which also corresponds to amino acids 523 - 689 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N21322_P6, wherein said first amino acid sequence and second 	      51 FKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNE 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     623 PNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPE 672                                                          
						N21322_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 PNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPE 150                                                          
						more preferably at least about 90% and most preferably at    	                  .                                          
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	     673 SGEHYEVTLLHFLQEYL                                  689                                                          
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	         |||||||||||||||||                                   
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	     151 SGEHYEVTLLHFLQEYL                                  167                                                          
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	                                                            
						EVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 	                                                            
						GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEA 	                                                            
						AGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWAS 	                                                            
						MMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNN 	                                                            
						SFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQ                   	                                                            
						least about 95% homologous to the sequence of N21322_P6.     	                                                            

						Comparison report between N21322_P6 and Q9BVR3unique head    	Sequence name: Q9BVR3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N21322_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7962 x Q9BVR3   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	Alignment segment 1/1:                                       
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	                                                            
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	                     Quality: 4404.00                      Escore:       0                                               
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	             Matching length:     439                Total length:     439                                               
						EVTNVWINVH                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 250 of  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						N21322_P6, and a second amino acid sequence being at least 90	                        Gaps:       0                        
						DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIK 	                                                            
						EEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTP 	Alignment:                                                   
						GFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPD 	                  .         .         .         .         .  
						YVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRL 	     251 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 300                                                          
						NTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAG 	       1 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 50                                                           
						SVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRC 	                  .         .         .         .         .  
						PESGEHYEVTLLHFLQEYL                                          	     301 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 350                                                          
						% homologous to corresponding to amino acids 1 - 439 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9BVR3, which also corresponds to amino acids 251 - 689 of   	      51 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 100                                                          
						N21322_P6, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     351 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 400                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N21322_P6, comprising a polypeptide being at least 70%,      	     101 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     401 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 450                                                          
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	     151 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 200                                                          
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	                  .         .         .         .         .  
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	     451 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 500                                                          
						EVTNVWINVH                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of N21322_P6.     	     201 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     651 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            689                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     401 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            439                                                          

						Comparison report between N21322_P6 and Q8WXD8partial WT     	Sequence name: Q8WXD8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N21322_P6, comprising a first amino acid        	                                                            
						MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLD 	Alignment of: 7962 x Q8WXD8   ..                             
						DPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPA 	                                                            
						LEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIAR 	Alignment segment 1/1:                                       
						AGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYE 	                                                            
						EVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 	                     Quality: 6900.00                      Escore:       0                                               
						GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEA 	             Matching length:     689                Total length:     689                                               
						AGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWAS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAE 	                        Gaps:       0                        
						KYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 	                                                            
						ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQI 	Alignment:                                                   
						YPNERHSIRCPESGEHYEVTLLHFLQEYL                                	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	       1 MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTF 50                                                           
						amino acids 175 - 863 of Q8WXD8, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 689 of N21322_P6.                            	     175 MKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTF 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 CHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLR 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 ILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQT 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 DSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQ 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 WLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVH 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 DIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSP 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 GEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLE 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 HHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHV 574                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     575 YKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGM 624                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     625 IYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAV 674                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     675 VVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRV 724                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     725 AIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVP 774                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     775 ENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLI 824                                                          
						                                                            	                  .         .         .                      
						                                                            	     651 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            689                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     825 RAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL            863                                                          

8653	HMR136_N22179_0_tr0_r1_1_gPRT		Comparison report between N22179_P0 and YD09_HUMANunique     	Sequence name: YD09_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for N22179_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8653 x YD09_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence IIQLLEVMDHLHRGELVAAILRN corresponding to 	Alignment segment 1/1:                                       
						amino acids 1 - 23 of N22179_P0, and a second amino acid     	                                                            
						RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFDQLRLEGLLC 	                     Quality: 6167.00                      Escore:       0                                               
						DVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLMCIKLHGVSKVGLRKIIDFI 	             Matching length:     623                Total length:     623                                               
						YTAKLSLNMDNLQDTLEAASFLQILPVLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KYVNSFVLKNFPALLSTGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DFAAKLMKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 	                        Gaps:       0                        
						TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHGIAVIGNFLY 	                                                            
						VVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTFFHLSALKGYLYAVGGRNAA 	Alignment:                                                   
						GELPTVECYNPRTNEWTYVAKMSEPHYGHAGTVYGGVMYISGGITHDTFQKELMCFDPDT 	                  .         .         .         .         .  
						DKWIQKAPMTTVRGLHCMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAA 	      24 RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGF 73                                                           
						MLRGQSDVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLTVFPPEETTPSPSRESPLSAP                                      	      17 RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGF 66                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 17 - 639 of YD09_HUMAN, which also corresponds to	      74 DQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDL 123                                                          
						amino acids 24 - 646 of N22179_P0, wherein said first amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	      67 DQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDL 116                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of N22179_P0, comprising a polypeptide being at   	     124 MCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDF 173                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     117 MCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDF 166                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						IIQLLEVMDHLHRGELVAAILRN of N22179_P0.                        	     174 CKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEF 223                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     167 CKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEF 216                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     224 LKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNI 273                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 LKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNI 266                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     274 RFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 323                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 RFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     324 TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQH 373                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQH 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     374 GIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRT 423                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 GIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRT 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     424 FFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHA 473                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 FFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHA 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     474 GTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCT 523                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 GTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCT 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     524 VGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGV 573                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 VGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGV 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     574 AVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 623                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 AVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 616                                                          
						                                                            	                  .         .                                
						                                                            	     624 TLTVFPPEETTPSPSRESPLSAP                            646                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     617 TLTVFPPEETTPSPSRESPLSAP                            639                                                          

8649	HMR136_N22179_3_tr0_r1_1_gPRT		Comparison report between N22179_P3 and YD09_HUMANunique     	Sequence name: YD09_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for N22179_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8649 x YD09_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLRFISHLYCCSSKEDCSEDDKCILS corresponding 	Alignment segment 1/1:                                       
						to amino acids 1 - 26 of N22179_P3, and a second amino acid  	                                                            
						RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFDQLRLEGLLC 	                     Quality: 6167.00                      Escore:       0                                               
						DVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLMCIKLHGVSKVGLRKIIDFI 	             Matching length:     623                Total length:     623                                               
						YTAKLSLNMDNLQDTLEAASFLQILPVLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KYVNSFVLKNFPALLSTGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DFAAKLMKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 	                        Gaps:       0                        
						TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHGIAVIGNFLY 	                                                            
						VVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTFFHLSALKGYLYAVGGRNAA 	Alignment:                                                   
						GELPTVECYNPRTNEWTYVAKMSEPHYGHAGTVYGGVMYISGGITHDTFQKELMCFDPDT 	                  .         .         .         .         .  
						DKWIQKAPMTTVRGLHCMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAA 	      27 RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGF 76                                                           
						MLRGQSDVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLTVFPPEETTPSPSRESPLSAP                                      	      17 RSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGF 66                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 17 - 639 of YD09_HUMAN, which also corresponds to	      77 DQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDL 126                                                          
						amino acids 27 - 649 of N22179_P3, wherein said first amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	      67 DQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDL 116                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of N22179_P3, comprising a polypeptide being at   	     127 MCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDF 176                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     117 MCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDF 166                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MLRFISHLYCCSSKEDCSEDDKCILS of N22179_P3.                     	     177 CKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEF 226                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     167 CKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEF 216                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     227 LKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNI 276                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 LKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNI 266                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     277 RFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 326                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 RFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDR 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQH 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 TAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQH 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 GIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRT 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 GIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRT 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 FFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHA 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 FFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHA 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 GTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCT 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 GTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCT 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 VGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGV 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 VGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGV 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 AVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 AVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRAC 616                                                          
						                                                            	                  .         .                                
						                                                            	     627 TLTVFPPEETTPSPSRESPLSAP                            649                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     617 TLTVFPPEETTPSPSRESPLSAP                            639                                                          

8647	HMR136_N22179_6_tr0_r1_1_gPRT		Comparison report between N22179_P6 and YD09_HUMANunique     	Sequence name: YD09_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for N22179_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8647 x YD09_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MMRVQTLREKWAYWRRRQLSLKQADFKDIFKKSTSG     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 36 of N22179_P6, and a      	                                                            
						SLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFDQLRLEGLLCD 	                     Quality: 6163.00                      Escore:       0                                               
						VTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLMCIKLHGVSKVGLRKIIDFIY 	             Matching length:     627                Total length:     627                                               
						TAKLSLNMDNLQDTLEAASFLQILPVLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVDK 	 Matching Percent Similarity:   99.52   Matching Percent Identity:   99.52                                               
						YVNSFVLKNFPALLSTGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMD 	    Total Percent Similarity:   99.52      Total Percent Identity:   99.52                                               
						FAAKLMKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDRT 	                        Gaps:       0                        
						AIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHGIAVIGNFLYV 	                                                            
						VGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTFFHLSALKGYLYAVGGRNAAG 	Alignment:                                                   
						ELPTVECYNPRTNEWTYVAKMSEPHYGHAGTVYGGVMYISGGITHDTFQKELMCFDPDTD 	                  .         .         .         .         .  
						KWIQKAPMTTVRGLHCMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAM 	      32 KSTSGSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVV 81                                                           
						LRGQSDVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRACT 	         | |  |||||||||||||||||||||||||||||||||||||||||||||  
						LTVFPPEETTPSPSRESPLSAP                                       	      13 KKTFRSLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVV 62                                                           
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 18 - 639 of YD09_HUMAN, which   	      82 LQGFDQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMK 131                                                          
						also corresponds to amino acids 37 - 658 of N22179_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	      63 LQGFDQLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMK 112                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of N22179_P6,       	     132 EQDLMCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILP 181                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     113 EQDLMCIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILP 162                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     182 VLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLS 231                                                          
						MMRVQTLREKWAYWRRRQLSLKQADFKDIFKKSTSG of N22179_P6.           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     163 VLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLS 212                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     232 TGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKL 281                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     213 TGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKL 262                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     282 MKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVM 331                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     263 MKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVM 312                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     332 QSDRTAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAP 381                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     313 QSDRTAIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAP 362                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     382 RYQHGIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLN 431                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     363 RYQHGIAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLN 412                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     432 EKRTFFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPH 481                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     413 EKRTFFHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPH 462                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     482 YGHAGTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLH 531                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     463 YGHAGTVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLH 512                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     532 CMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQS 581                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     513 CMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQS 562                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     582 DVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGG 631                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 DVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGG 612                                                          
						                                                            	                  .         .                                
						                                                            	     632 IRACTLTVFPPEETTPSPSRESPLSAP                        658                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     613 IRACTLTVFPPEETTPSPSRESPLSAP                        639                                                          

8651	HMR136_N22179_7_tr0_r1_1_gPRT		Comparison report between N22179_P7 and YD09_HUMANunique     	Sequence name: YD09_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for N22179_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8651 x YD09_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MDGKYFEERLFLDFLFKL corresponding to amino	Alignment segment 1/1:                                       
						acids 1 - 18 of N22179_P7, and a second amino acid sequence  	                                                            
						SLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFDQLRLEGLLCD 	                     Quality: 6157.00                      Escore:       0                                               
						VTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLMCIKLHGVSKVGLRKIIDFIY 	             Matching length:     622                Total length:     622                                               
						TAKLSLNMDNLQDTLEAASFLQILPVLDFCKVFLISGVTLDNCVEVGRIANTYNLTEVDK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YVNSFVLKNFPALLSTGEFLKLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FAAKLMKNIRFPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDRT 	                        Gaps:       0                        
						AIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHGIAVIGNFLYV 	                                                            
						VGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTFFHLSALKGYLYAVGGRNAAG 	Alignment:                                                   
						ELPTVECYNPRTNEWTYVAKMSEPHYGHAGTVYGGVMYISGGITHDTFQKELMCFDPDTD 	                  .         .         .         .         .  
						KWIQKAPMTTVRGLHCMCTVGERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAM 	      19 SLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFD 68                                                           
						LRGQSDVGVAVFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRACT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTVFPPEETTPSPSRESPLSAP                                       	      18 SLVEEEDQHMKLSLGGSEMGLSSHLQSSKAGPTRIFTSNTHSSVVLQGFD 67                                                           
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 18 - 639 of YD09_HUMAN, which also corresponds to amino	      69 QLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLM 118                                                          
						acids 19 - 640 of N22179_P7, wherein said first amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      68 QLRLEGLLCDVTLMPGDTDDAFPVHRVMMASASDYFKAMFTGGMKEQDLM 117                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of N22179_P7, comprising a polypeptide being at least   	     119 CIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDFC 168                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     118 CIKLHGVSKVGLRKIIDFIYTAKLSLNMDNLQDTLEAASFLQILPVLDFC 167                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MDGKYFEERLFLDFLFKL of N22179_P7.                             	     169 KVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEFL 218                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     168 KVFLISGVTLDNCVEVGRIANTYNLTEVDKYVNSFVLKNFPALLSTGEFL 217                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     219 KLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNIR 268                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     218 KLPFERLAFVLSSNSLKHCTELELFKATCRWLRLEEPRMDFAAKLMKNIR 267                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     269 FPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDRT 318                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     268 FPLMTPQELINYVQTVDFMRTDNTCVNLLLEASNYQMMPYMQPVMQSDRT 317                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     319 AIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHG 368                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     318 AIRSDTTHLVTLGGVLRQQLVVSKELRMYDEKAHEWKSLAPMDAPRYQHG 367                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     369 IAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTF 418                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     368 IAVIGNFLYVVGGQSNYDTKGKTAVDTVFRFDPRYNKWMQVASLNEKRTF 417                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     419 FHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHAG 468                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     418 FHLSALKGYLYAVGGRNAAGELPTVECYNPRTNEWTYVAKMSEPHYGHAG 467                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     469 TVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCTV 518                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     468 TVYGGVMYISGGITHDTFQKELMCFDPDTDKWIQKAPMTTVRGLHCMCTV 517                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 GERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGVA 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     518 GERLYVIGGNHFRGTSDYDDVLSCEYYSPILDQWTPIAAMLRGQSDVGVA 567                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 VFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRACT 618                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     568 VFENKIYVVGGYSWNNRCMVEIVQKYDPDKDEWHKVFDLPESLGGIRACT 617                                                          
						                                                            	                  .         .                                
						                                                            	     619 LTVFPPEETTPSPSRESPLSAP                             640                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     618 LTVFPPEETTPSPSRESPLSAP                             639                                                          

9600	HMR136_N22283_9_tr0_r1_1_gPRT		Comparison report between N22283_P9 and EYA1_HUMANunique     	Sequence name: EYA1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N22283_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9600 x EYA1_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MNLVHLSNGRLLVFRS corresponding to amino acids 1 - 16 of      	                                                            
						N22283_P9, a second amino acid sequence being at least 90 %  	                     Quality: 3788.00                      Escore:       0                                               
						MEMQDLTSPHSRLSGSSESPSGPKLGNSHINSNSMTPNGTEVKTEPMSSSETASTTADGS 	             Matching length:     381                Total length:     381                                               
						LNNFSGSAIGSSSFSPRPTHQFSPPQIYPSNRPYPHILPTPSSQTMAAYGQTQFTTGMQQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.74                                               
						ATAYATYPQPGQPYGISSYGALWAGIKTEGGLSQSQSPGQTGFLSYGTSFSTPQPGQAPY 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.74                                               
						SYQMQGSSFTTSSGIYTGNNSLTNSSGFNSSQQDYPSYPSFGQGQYAQYYNSSPYPAHYM 	                        Gaps:       0                        
						TSSNTSPTTPSTNATYQLQEPPSGITSQAVTDPTAEYSTIHSPSTPIKDSDSDRLRRGSD 	                                                            
						GKSRGRGRRNNNPSPPPDSDLERVFIWDLDETIIVFHSLLTGSYANRYGRDPPTSVSLGL 	Alignment:                                                   
						RMEEMIFNLADTHLFFNDLE                                         	                  .         .         .         .         .  
						homologous to corresponding to amino acids 1 - 380 of        	      17 MEMQDLTSPHSRLSGSSESPSGPKLGNSHINSNSMTPNGTEVKTEPMSSS 66                                                           
						EYA1_HUMAN, which also corresponds to amino acids 17 - 396 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N22283_P9, and a third amino acid sequence being at least    	       1 MEMQDLTSPHSRLSGSSESPSGPKLGNSHINSNSMTPNGTEVKTEPMSSS 50                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	      67 ETASTTADGSLNNFSGSAIGSSSFSPRPTHQFSPPQIYPSNRPYPHILPT 116                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNAPYLIDEPKSFEKCQCVTELKCGLFNICPVF corresponding to amino     	      51 ETASTTADGSLNNFSGSAIGSSSFSPRPTHQFSPPQIYPSNRPYPHILPT 100                                                          
						acids 397 - 429 of N22283_P9, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	     117 PSSQTMAAYGQTQFTTGMQQATAYATYPQPGQPYGISSYGALWAGIKTEG 166                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of N22283_P9,       	     101 PSSQTMAAYGQTQFTTGMQQATAYATYPQPGQPYGISSYGALWAGIKTEG 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     167 GLSQSQSPGQTGFLSYGTSFSTPQPGQAPYSYQMQGSSFTTSSGIYTGNN 216                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence MNLVHLSNGRLLVFRS of     	     151 GLSQSQSPGQTGFLSYGTSFSTPQPGQAPYSYQMQGSSFTTSSGIYTGNN 200                                                          
						N22283_P9.3.An isolated polypeptide encoding for a tail of   	                  .         .         .         .         .  
						N22283_P9, comprising a polypeptide being at least 70%,      	     217 SLTNSSGFNSSQQDYPSYPSFGQGQYAQYYNSSPYPAHYMTSSNTSPTTP 266                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     201 SLTNSSGFNSSQQDYPSYPSFGQGQYAQYYNSSPYPAHYMTSSNTSPTTP 250                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						QNAPYLIDEPKSFEKCQCVTELKCGLFNICPVF in N22283_P9.              	     267 STNATYQLQEPPSGITSQAVTDPTAEYSTIHSPSTPIKDSDSDRLRRGSD 316                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 STNATYQLQEPPSGITSQAVTDPTAEYSTIHSPSTPIKDSDSDRLRRGSD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     317 GKSRGRGRRNNNPSPPPDSDLERVFIWDLDETIIVFHSLLTGSYANRYGR 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GKSRGRGRRNNNPSPPPDSDLERVFIWDLDETIIVFHSLLTGSYANRYGR 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     367 DPPTSVSLGLRMEEMIFNLADTHLFFNDLEQ                    397                                                          
						                                                            	         ||||||||||||||||||||||||||||||:                     
						                                                            	     351 DPPTSVSLGLRMEEMIFNLADTHLFFNDLEE                    381                                                          

10188	HMR136_N22500_2_tr0_r1_1_gPRT		Comparison report between N22500_P2 and Q8IVF9partial WT     	Sequence name: Q8IVF9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N22500_P2, comprising a first amino 	Sequence documentation:                                      
						MRSRSDHLDLFSSLIFTTANTEPRANLHMNLYETSPLTQTTEKQGAQQSLEAAAQKTGEP 	                                                            
						QSCINKALICSNRKEFYTRKLHIDMTPFLKESGNALDYQEEAGRPLRETHHNDQDPEPRS 	Alignment of: 10188 x Q8IVF9   ..                            
						MTLDSPRASRTEHIQTPEADIVQKVGRDYDVHHLHRGLLGYGPESPERLSAVYTSLLPRE 	                                                            
						REGKAEPRLFSQETSANISHERDLINEAKRKEKPKKDKTKGPKSEREGKVYGQAEAAIGK 	Alignment segment 1/1:                                       
						SKDSKAKKKLEKKTRPQRKRTQKERNLEIAAELSGPDVSYEETEDTSNRGSFASDSFVED 	                                                            
						PWLSPKYDAQESQVSLDGRSSPSQIATVTGNMESKEERRCEDPSKALLTKREQEKASWDR 	                     Quality: 5351.00                      Escore:       0                                               
						LRAERAEMRWLEVEKKRREQEEQRQLQQEQLERAKKMEEELELEQQRRTEEIRLRKQRLQ 	             Matching length:     544                Total length:     544                                               
						EEQQRQEEEERKQQLRLKAAQERARQQQEEFRRKLRELQRKKQQEEAERAEAEKQRQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EMQLEEEQKHLMEMAEEERLEYQRRKQEAEEKARLEAEERRQKEEEAARLALEEATKQAQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EQAR                                                         	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 3 - 546 of Q8IVF9, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 544 of N22500_P2, and a second amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MRSRSDHLDLFSSLIFTTANTEPRANLHMNLYETSPLTQTTEKQGAQQSL 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       3 MRSRSDHLDLFSSLIFTTANTEPRANLHMNLYETSPLTQTTEKQGAQQSL 52                                                           
						having the sequence                                          	                  .         .         .         .         .  
						QKAALEKHFHFYQELHKEASGLQWTQNISRPWVYSYFQFLQIPRP corresponding  	      51 EAAAQKTGEPQSCINKALICSNRKEFYTRKLHIDMTPFLKESGNALDYQE 100                                                          
						to amino acids 545 - 589 of N22500_P2, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	      53 EAAAQKTGEPQSCINKALICSNRKEFYTRKLHIDMTPFLKESGNALDYQE 102                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of N22500_P2, comprising a   	     101 EAGRPLRETHHNDQDPEPRSMTLDSPRASRTEHIQTPEADIVQKVGRDYD 150                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     103 EAGRPLRETHHNDQDPEPRSMTLDSPRASRTEHIQTPEADIVQKVGRDYD 152                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence QKAALEKHFHFYQELHKEASGLQWTQNISRPWVYSYFQFLQIPRP	     151 VHHLHRGLLGYGPESPERLSAVYTSLLPREREGKAEPRLFSQETSANISH 200                                                          
						in N22500_P2.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 VHHLHRGLLGYGPESPERLSAVYTSLLPREREGKAEPRLFSQETSANISH 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ERDLINEAKRKEKPKKDKTKGPKSEREGKVYGQAEAAIGKSKDSKAKKKL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 ERDLINEAKRKEKPKKDKTKGPKSEREGKVYGQAEAAIGKSKDSKAKKKL 252                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EKKTRPQRKRTQKERNLEIAAELSGPDVSYEETEDTSNRGSFASDSFVED 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     253 EKKTRPQRKRTQKERNLEIAAELSGPDVSYEETEDTSNRGSFASDSFVED 302                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PWLSPKYDAQESQVSLDGRSSPSQIATVTGNMESKEERRCEDPSKALLTK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 PWLSPKYDAQESQVSLDGRSSPSQIATVTGNMESKEERRCEDPSKALLTK 352                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 REQEKASWDRLRAERAEMRWLEVEKKRREQEEQRQLQQEQLERAKKMEEE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     353 REQEKASWDRLRAERAEMRWLEVEKKRREQEEQRQLQQEQLERAKKMEEE 402                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LELEQQRRTEEIRLRKQRLQEEQQRQEEEERKQQLRLKAAQERARQQQEE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     403 LELEQQRRTEEIRLRKQRLQEEQQRQEEEERKQQLRLKAAQERARQQQEE 452                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FRRKLRELQRKKQQEEAERAEAEKQRQEELEMQLEEEQKHLMEMAEEERL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     453 FRRKLRELQRKKQQEEAERAEAEKQRQEELEMQLEEEQKHLMEMAEEERL 502                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 EYQRRKQEAEEKARLEAEERRQKEEEAARLALEEATKQAQEQAR       544                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     503 EYQRRKQEAEEKARLEAEERRQKEEEAARLALEEATKQAQEQAR       546                                                          

11079	HMR136_N22913_5_tr0_r1_1_gPRT		Comparison report between N22913_P5 and Q9NXU5partial WT     	Sequence name: Q9NXU5                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for N22913_P5, comprising a first amino 	Sequence documentation:                                      
						MSDLRITEAFLYMDYLCFRALCCKGPPPARPEYDLVCIGLTGSGKTSLLSKLCSESPDNV 	                                                            
						VSTT                                                         	Alignment of: 11079 x Q9NXU5   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 64 of Q9NXU5, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 64 of N22913_P5, and a second amino acid     	                                                            
						GADNIRKYWSRYYQGSQGVIFVLDSASSEDDLEAARNELHSALQHPQLCTLPFLILANHQ 	                     Quality: 1716.00                      Escore:       0                                               
						DKPAARSVQEIKKYFELEPLARGKRWILQPCSLDDMDALKDSFSQLINLLEEKDHEAVRM 	             Matching length:     184                Total length:     204                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 85 - 204 of Q9NXU5, which also corresponds to    	    Total Percent Similarity:   90.20      Total Percent Identity:   90.20                                               
						amino acids 65 - 184 of N22913_P5, wherein said first amino  	                        Gaps:       1                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated chimeric polypeptide 	Alignment:                                                   
						encoding for an edge portion of N22913_P5, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	       1 MSDLRITEAFLYMDYLCFRALCCKGPPPARPEYDLVCIGLTGSGKTSLLS 50                                                           
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	       1 MSDLRITEAFLYMDYLCFRALCCKGPPPARPEYDLVCIGLTGSGKTSLLS 50                                                           
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      51 KLCSESPDNVVSTT....................GADNIRKYWSRYYQGS 80                                                           
						length, wherein at least two amino acids comprise TG, having 	         ||||||||||||||                    ||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	      51 KLCSESPDNVVSTTGFSIKAVPFQNAILNVKELGGADNIRKYWSRYYQGS 100                                                          
						acid numbers 64-x to 65; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 65+ ((n-2) - x), in which x varies from 0 to n-2.    	      81 QGVIFVLDSASSEDDLEAARNELHSALQHPQLCTLPFLILANHQDKPAAR 130                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QGVIFVLDSASSEDDLEAARNELHSALQHPQLCTLPFLILANHQDKPAAR 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     131 SVQEIKKYFELEPLARGKRWILQPCSLDDMDALKDSFSQLINLLEEKDHE 180                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SVQEIKKYFELEPLARGKRWILQPCSLDDMDALKDSFSQLINLLEEKDHE 200                                                          
						                                                            	                                                             
						                                                            	     181 AVRM                                               184                                                          
						                                                            	         ||||                                                
						                                                            	     201 AVRM                                               204                                                          

5650	HMR136_N23036_15_tr0_r1_1_gPRT		Comparison report between N23036_P15 and Q9H9A5partial WT    	Sequence name: Q9H9A5                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for N23036_P15, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT corresponding to     	Alignment of: 5650 x Q9H9A5   ..                             
						amino acids 1 - 39 of Q9H9A5, which also corresponds to amino	                                                            
						acids 1 - 39 of N23036_P15, and a second amino acid sequence 	Alignment segment 1/1:                                       
						VHSAVEEMDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCF 	                                                            
						LLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEA 	                     Quality: 6656.00                      Escore:       0                                               
						AKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLL 	             Matching length:     690                Total length:     744                                               
						NSSNIAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						STDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 	    Total Percent Similarity:   92.74      Total Percent Identity:   92.74                                               
						RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAI 	                        Gaps:       1                        
						PVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDK 	                                                            
						FIPAPPSSPLRKQELENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLG 	Alignment:                                                   
						HLYAAEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQC 	                  .         .         .         .         .  
						YPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQN 	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT........... 39                                                           
						GNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK          	         |||||||||||||||||||||||||||||||||||||||             
						being at least 90 % homologous to corresponding to amino     	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						acids 94 - 744 of Q9H9A5, which also corresponds to amino    	                  .         .         .         .         .  
						acids 40 - 690 of N23036_P15, wherein said first amino acid  	      40 ...........................................VHSAVEE 46                                                           
						sequence and second amino acid sequence are contiguous and in	                                                    |||||||  
						a sequential order.2.An isolated chimeric polypeptide        	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						encoding for an edge portion of N23036_P15, comprising a     	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	      47 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 96                                                           
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      97 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 146                                                          
						length, wherein at least two amino acids comprise TV, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						acid numbers 39-x to 40; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 40+ ((n-2) - x), in which x varies from 0 to n-2.    	     147 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 196                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     197 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 246                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     247 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 296                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 396                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     447 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 496                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     497 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 546                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     547 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 596                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     647 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       690                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     701 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       744                                                          

						Comparison report between N23036_P15 and Q9HAH3unique head   	Sequence name: Q9HAH3                                        
						followed by partial WT sequence a mismatch, followed by a    	                                                            
						unique insertion with extra amino acids and a followed by a  	Sequence documentation:                                      
						unique insertion.1.An isolated chimeric polypeptide encoding 	                                                            
						for N23036_P15, comprising a first amino acid sequence being 	Alignment of: 5650 x Q9HAH3   ..                             
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						least 95% homologous to a polypeptide having the sequence    	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEE corresponding 	                     Quality: 5620.00                      Escore:       0                                               
						to amino acids 1 - 46 of N23036_P15, a second amino acid     	             Matching length:     595                Total length:     644                                               
						MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.66                                               
						LTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQ 	    Total Percent Similarity:   92.39      Total Percent Identity:   92.08                                               
						YKVRAYIQMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKA            	                        Gaps:       2                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 169 of Q9HAH3, which also corresponds to     	Alignment:                                                   
						amino acids 47 - 215 of N23036_P15, a bridging amino acid V  	                  .         .         .         .         .  
						corresponding to amino acid 216 of N23036_P15, a third amino 	      47 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 96                                                           
						KLLNSSNIAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPR 	       1 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 50                                                           
						LWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 	                  .         .         .         .         .  
						SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSESSETC       	      97 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 146                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 171 - 404 of Q9HAH3, which also corresponds to	      51 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 100                                                          
						amino acids 217 - 450 of N23036_P15, a fourth amino acid     	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     147 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 196                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     101 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 150                                                          
						having the sequence SSKSHDGDKFIPAPPSSPLRKQELENLK             	                  .         .         .         .         .  
						corresponding to amino acids 451 - 478 of N23036_P15, a fifth	     197 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 246                                                          
						amino acid sequence being at least 90 % homologous to        	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						CSILACSAYVALALGDNLMALNH corresponding to amino acids 406 -   	     151 PSLFLKSNFEYLRGNYRKAMKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 200                                                          
						428 of Q9HAH3, which also corresponds to amino acids 479 -   	                  .         .         .         .         .  
						501 of N23036_P15, a sixth amino acid sequence being at least	     247 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 296                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     201 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 250                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						ADKLLQQPKLSGSLKFLGHLYA corresponding to amino acids 502 - 523	     297 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 346                                                          
						of N23036_P15, and a seventh amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSS 	     251 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 300                                                          
						VNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQ 	                  .         .         .         .         .  
						LALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK              	     347 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 396                                                          
						least 90 % homologous to corresponding to amino acids 429 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						595 of Q9HAH3, which also corresponds to amino acids 524 -   	     301 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 350                                                          
						690 of N23036_P15, wherein said first amino acid sequence,   	                  .         .         .         .         .  
						second amino acid sequence, bridging amino acid, third amino 	     397 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 446                                                          
						acid sequence, fourth amino acid sequence, fifth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, sixth amino acid sequence and seventh amino acid   	     351 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 400                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of N23036_P15,      	     447 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 496                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||                           :||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     401 SETC...........................RCSILACSAYVALALGDNL 423                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     497 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 546                                                          
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEE of            	         |||||                      |||||||||||||||||||||||  
						N23036_P15.3.An isolated polypeptide encoding for an edge    	     424 MALNH......................AEALISLDRISDAITHLNPENVT 451                                                          
						portion of N23036_P15, comprising an amino acid sequence     	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     547 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 596                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     452 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 501                                                          
						encoding for SSKSHDGDKFIPAPPSSPLRKQELENLK, corresponding to  	                  .         .         .         .         .  
						N23036_P15.4.A bridge portion of N23036_P15, comprising a    	     597 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 646                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     502 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 551                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .            
						length, more preferably at least about 40 amino acids in     	     647 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       690                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||        
						length, wherein at least two amino acids comprise C, having a	     552 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       595                                                          
						structure as follows (numbering according to N23036_P15): a  	                                                            
						sequence starting from any of amino acid numbers 404-x to    	                                                            
						404; and ending at any of amino acid numbers 451 + ((n-2) -  	                                                            
						x), in which x varies from 0 to n-2.5.An isolated polypeptide	                                                            
						encoding for an edge portion of N23036_P15, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						ADKLLQQPKLSGSLKFLGHLYA, corresponding to N23036_P15.         	                                                            

						Comparison report between N23036_P15 and Q9H5J7unique head   	Sequence name: Q9H5J7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N23036_P15, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 5650 x Q9H5J7   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEEMDGLDDVENSMLYY 	Alignment segment 1/1:                                       
						NQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAV 	                                                            
						LEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKA 	                     Quality: 4422.00                      Escore:       0                                               
						CKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRC  	             Matching length:     451                Total length:     451                                               
						having the sequence corresponding to amino acids 1 - 239 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						N23036_P15, and a second amino acid sequence being at least  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNK 	                        Gaps:       0                        
						RYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKG 	                                                            
						LPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLP 	Alignment:                                                   
						EEQQDPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKC 	                  .         .         .         .         .  
						SILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 	     240 MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSG 289                                                          
						LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSAY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVK 	       1 MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSG 50                                                           
						THSEVRKKPVFQPVHPIQPIQMPAFTTVQRK                              	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 451 of   	     290 RPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 339                                                          
						Q9H5J7, which also corresponds to amino acids 240 - 690 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N23036_P15, wherein said first amino acid sequence and second	      51 RPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     340 RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNT 389                                                          
						N23036_P15, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNT 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEEMDGLDDVENSMLYY 	     390 VYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGG 439                                                          
						NQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKA 	     151 VYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGG 200                                                          
						CKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRC  	                  .         .         .         .         .  
						least about 95% homologous to the sequence of N23036_P15.    	     440 NTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVA 489                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     490 LALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 539                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     540 LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSART 589                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSART 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     590 VMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQN 639                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     640 GNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQR 689                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQR 450                                                          
						                                                            	                                                             
						                                                            	     690 K                                                  690                                                          
						                                                            	         |                                                   
						                                                            	     451 K                                                  451                                                          

						Comparison report between N23036_P15 and Q9BU30partial WT    	Sequence name: Q9BU30                                        
						sequence featuring skipped exon, followed by a unique        	                                                            
						insertion with extra amino acids and a mismatch.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for N23036_P15, comprising a   	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment of: 5650 x Q9BU30   ..                             
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT corresponding to     	                                                            
						amino acids 1 - 39 of Q9BU30, which also corresponds to amino	Alignment segment 1/1:                                       
						acids 1 - 39 of N23036_P15, a second amino acid sequence     	                                                            
						VHSAVEEMDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCF 	                     Quality: 6266.00                      Escore:       0                                               
						LLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEA 	             Matching length:     663                Total length:     744                                               
						AKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLL 	 Matching Percent Similarity:   99.85   Matching Percent Identity:   99.70                                               
						NSSNIAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAG 	    Total Percent Similarity:   88.98      Total Percent Identity:   88.84                                               
						STDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 	                        Gaps:       2                        
						RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAI 	                                                            
						PVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSESSETC          	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 94 - 504 of Q9BU30, which also corresponds to amino    	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT........... 39                                                           
						acids 40 - 450 of N23036_P15, a third amino acid sequence    	         |||||||||||||||||||||||||||||||||||||||             
						being at least 70%, optionally at least 80%, preferably at   	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	      40 ...........................................VHSAVEE 46                                                           
						SSKSHDGDKFIPAPPSSPLRKQELENLK corresponding to amino acids 451	                                                    |||||||  
						- 478 of N23036_P15, a fourth amino acid sequence being at   	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						CSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAIT 	                  .         .         .         .         .  
						HLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSA 	      47 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 96                                                           
						YCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KTHSEVRKKPVFQPVHPIQPIQM                                      	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						least 90 % homologous to corresponding to amino acids 506 -  	                  .         .         .         .         .  
						708 of Q9BU30, which also corresponds to amino acids 479 -   	      97 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 146                                                          
						681 of N23036_P15, a bridging amino acid P corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid 682 of N23036_P15, and a fifth amino acid sequence	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						being at least 90 % homologous to AFTTVQRK corresponding to  	                  .         .         .         .         .  
						amino acids 710 - 717 of Q9BU30, which also corresponds to   	     147 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 196                                                          
						amino acids 683 - 690 of N23036_P15, wherein said first amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, third amino acid  	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 250                                                          
						sequence, fourth amino acid sequence, bridging amino acid and	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     197 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 246                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of N23036_P15, comprising a polypeptide having a     	     251 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 300                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     247 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 296                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     301 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 350                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TV, having a structure as  	     297 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 346                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						39-x to 40; and ending at any of amino acid numbers 40+      	     351 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of N23036_P15,      	     347 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 396                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     401 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 450                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     397 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 446                                                          
						SSKSHDGDKFIPAPPSSPLRKQELENLK, corresponding to N23036_P15.4.A	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridge portion of N23036_P15, comprising a polypeptide having	     451 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 500                                                          
						a length "n", wherein n is at least about 10 amino acids in  	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     447 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 496                                                          
						preferably at least about 30 amino acids in length, more     	         ||||                           :||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     501 SETC...........................RCSILACSAYVALALGDNL 523                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise C, having a structure as   	     497 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 546                                                          
						follows (numbering according to N23036_P15): a sequence      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 504-x to 504; and    	     524 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 573                                                          
						ending at any of amino acid numbers 451 + ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     547 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 596                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     574 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 623                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     624 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 673                                                          
						                                                            	                  .         .         .         .            
						                                                            	     647 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       690                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||| ||||||||        
						                                                            	     674 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMSAFTTVQRK       717                                                          

						Comparison report between N23036_P15 and Q9H8X1partial WT    	Sequence name: Q9H8X1                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for N23036_P15, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT corresponding to     	Alignment of: 5650 x Q9H8X1   ..                             
						amino acids 1 - 39 of Q9H8X1, which also corresponds to amino	                                                            
						acids 1 - 39 of N23036_P15, a second amino acid sequence     	Alignment segment 1/1:                                       
						VHSAVEEMDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCF 	                                                            
						LLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEA 	                     Quality: 6647.00                      Escore:       0                                               
						AKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLL 	             Matching length:     690                Total length:     744                                               
						NSSNIAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAG 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						STDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 	    Total Percent Similarity:   92.61      Total Percent Identity:   92.61                                               
						RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAI 	                        Gaps:       1                        
						PVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDK 	                                                            
						FIPAPPSSPLRKQELENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLG 	Alignment:                                                   
						HLYAAEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENE             	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFT........... 39                                                           
						acids 94 - 621 of Q9H8X1, which also corresponds to amino    	         |||||||||||||||||||||||||||||||||||||||             
						acids 40 - 567 of N23036_P15, a bridging amino acid A        	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						corresponding to amino acid 568 of N23036_P15, and a third   	                  .         .         .         .         .  
						MESSGKRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEA 	      40 ...........................................VHSAVEE 46                                                           
						ILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQ 	                                                    |||||||  
						RK                                                           	      51 ARLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 623 - 744 of Q9H8X1, which also 	      47 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 96                                                           
						corresponds to amino acids 569 - 690 of N23036_P15, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						bridging amino acid and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	      97 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 146                                                          
						polypeptide encoding for an edge portion of N23036_P15,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     147 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 196                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGNSA 250                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise TV, having a structure as follows: a sequence       	     197 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 246                                                          
						starting from any of amino acid numbers 39-x to 40; and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 40+ ((n-2) - x), in which	     251 PSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWNNLG 300                                                          
						x varies from 0 to n-2.                                      	                  .         .         .         .         .  
						                                                            	     247 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 296                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 TNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 396                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSES 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     447 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 496                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVALALGDNL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     497 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 546                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 MALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     547 DVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLG 596                                                          
						                                                            	         ||||||||||||||||||||| ||||||||||||||||||||||||||||  
						                                                            	     601 DVSLGISSNEQDQGSDKGENETMESSGKRAPQCYPSSVNSARTVMLFNLG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLAL 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     647 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       690                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     701 QIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK       744                                                          

						Comparison report between N23036_P15 and Q9UFJ2unique head   	Sequence name: Q9UFJ2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N23036_P15, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 5650 x Q9UFJ2   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEEMDGLDDVENSMLYY 	Alignment segment 1/1:                                       
						NQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAV 	                                                            
						LEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKA 	                     Quality: 2562.00                      Escore:       0                                               
						CKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCM 	             Matching length:     263                Total length:     263                                               
						FWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPE 	                        Gaps:       0                        
						EQQDPKQ                                                      	                                                            
						having the sequence corresponding to amino acids 1 - 427 of  	Alignment:                                                   
						N23036_P15, and a second amino acid sequence being at least  	                  .         .         .         .         .  
						ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAY 	     428 ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENL 477                                                          
						VALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVTD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDK 	       4 ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENL 53                                                           
						ARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKK 	                  .         .         .         .         .  
						PVFQPVHPIQPIQMPAFTTVQRK                                      	     478 KCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEAL 527                                                          
						90 % homologous to corresponding to amino acids 4 - 266 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9UFJ2, which also corresponds to amino acids 428 - 690 of   	      54 KCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEAL 103                                                          
						N23036_P15, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     528 ISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAP 577                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N23036_P15, comprising a polypeptide being at least 70%,     	     104 ISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAP 153                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     578 QCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPE 627                                                          
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTVHSAVEEMDGLDDVENSMLYY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAV 	     154 QCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPE 203                                                          
						LEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKA 	                  .         .         .         .         .  
						CKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCM 	     628 AILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQ 677                                                          
						FWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGL 	     204 AILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQ 253                                                          
						PSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPE 	                  .                                          
						EQQDPKQ                                                      	     678 PIQMPAFTTVQRK                                      690                                                          
						least about 95% homologous to the sequence of N23036_P15.    	         |||||||||||||                                       
						                                                            	     254 PIQMPAFTTVQRK                                      266                                                          

5648	HMR136_N23036_17_tr0_r1_1_gPRT		Comparison report between N23036_P17 and Q9H9A5partial WT    	Sequence name: Q9H9A5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N23036_P17, comprising a first amino acid       	                                                            
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	Alignment of: 5648 x Q9H9A5   ..                             
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWN 	                                                            
						NLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKRYEL 	Alignment segment 1/1:                                       
						LYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSK 	                                                            
						KGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 	                     Quality: 5568.00                      Escore:       0                                               
						DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILA 	             Matching length:     567                Total length:     567                                               
						CSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSAYCLRS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSE 	                        Gaps:       0                        
						VRKKPVFQPVHPIQPIQMPAFTTVQRK                                  	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 178 - 744 of Q9H9A5, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1 - 567 of N23036_P17.                           	       1 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 427                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     428 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 477                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     478 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 527                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     528 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 577                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     578 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 627                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     628 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 677                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     678 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 727                                                          
						                                                            	                  .                                          
						                                                            	     551 HPIQPIQMPAFTTVQRK                                  567                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     728 HPIQPIQMPAFTTVQRK                                  744                                                          

						Comparison report between N23036_P17 and Q9HAH3partial WT    	Sequence name: Q9HAH3                                        
						sequence followed by mismatch, followed by a unique insertion	                                                            
						with extra amino acids and a followed by a unique            	Sequence documentation:                                      
						insertion.1.An isolated chimeric polypeptide encoding for    	                                                            
						N23036_P17, comprising a first amino acid sequence being at  	Alignment of: 5648 x Q9HAH3   ..                             
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	                                                            
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKA                             	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 78 -   	                                                            
						169 of Q9HAH3, which also corresponds to amino acids 1 - 92  	                     Quality: 4875.00                      Escore:       0                                               
						of N23036_P17, a bridging amino acid V corresponding to amino	             Matching length:     518                Total length:     567                                               
						acid 93 of N23036_P17, a second amino acid sequence being at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.61                                               
						KLLNSSNIAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQL 	    Total Percent Similarity:   91.36      Total Percent Identity:   91.01                                               
						SAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPR 	                        Gaps:       2                        
						LWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQS 	                                                            
						SAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGGNTESSESSETC       	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 171 -  	                  .         .         .         .         .  
						404 of Q9HAH3, which also corresponds to amino acids 94 - 327	       1 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 50                                                           
						of N23036_P17, a third amino acid sequence being at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	      78 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 127                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      51 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 100                                                          
						SSKSHDGDKFIPAPPSSPLRKQELENLK corresponding to amino acids 328	         ||||||||||||||||||||||||||||||||||||||||||:|||||||  
						- 355 of N23036_P17, a fourth amino acid sequence being at   	     128 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAMKLLNSSN 177                                                          
						least 90 % homologous to CSILACSAYVALALGDNLMALNH             	                  .         .         .         .         .  
						corresponding to amino acids 406 - 428 of Q9HAH3, which also 	     101 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 150                                                          
						corresponds to amino acids 356 - 378 of N23036_P17, a fifth  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	     178 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 227                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     151 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 200                                                          
						having the sequence ADKLLQQPKLSGSLKFLGHLYA corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 400 of N23036_P17, and a sixth amino acid  	     228 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 277                                                          
						AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSS 	                  .         .         .         .         .  
						VNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQ 	     201 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 250                                                          
						LALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQRK              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     278 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 327                                                          
						amino acids 429 - 595 of Q9HAH3, which also corresponds to   	                  .         .         .         .         .  
						amino acids 401 - 567 of N23036_P17, wherein said first amino	     251 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 300                                                          
						acid sequence, bridging amino acid, second amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     328 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 377                                                          
						sequence, fifth amino acid sequence and sixth amino acid     	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     301 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 350                                                          
						isolated polypeptide encoding for an edge portion of         	         |||||||||||||||||||||||||||                         
						N23036_P17, comprising an amino acid sequence being at least 	     378 DPKQENGAKNSNQLGGNTESSESSETC....................... 404                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     351 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 400                                                          
						at least about 95% homologous to the sequence encoding for   	             :|||||||||||||||||||||||                        
						SSKSHDGDKFIPAPPSSPLRKQELENLK, corresponding to N23036_P17.3.A	     405 ....RCSILACSAYVALALGDNLMALNH...................... 428                                                          
						bridge portion of N23036_P17, comprising a polypeptide having	                  .         .         .         .         .  
						a length "n", wherein n is at least about 10 amino acids in  	     401 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 450                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     429 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 478                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     451 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 500                                                          
						at least two amino acids comprise C, having a structure as   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows (numbering according to N23036_P17): a sequence      	     479 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 528                                                          
						starting from any of amino acid numbers 404-x to 404; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 328 + ((n-2) - x), in    	     501 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 550                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of N23036_P17, comprising an    	     529 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 578                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .                                          
						about 80%, preferably at least about 85%, more preferably at 	     551 HPIQPIQMPAFTTVQRK                                  567                                                          
						least about 90% and most preferably at least about 95%       	         |||||||||||||||||                                   
						homologous to the sequence encoding for                      	     579 HPIQPIQMPAFTTVQRK                                  595                                                          
						ADKLLQQPKLSGSLKFLGHLYA, corresponding to N23036_P17.         	                                                            

						Comparison report between N23036_P17 and Q9H5J7unique head   	Sequence name: Q9H5J7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N23036_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 5648 x Q9H5J7   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	Alignment segment 1/1:                                       
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRC     	                                                            
						having the sequence corresponding to amino acids 1 - 116 of  	                     Quality: 4422.00                      Escore:       0                                               
						N23036_P17, and a second amino acid sequence being at least  	             Matching length:     451                Total length:     451                                               
						MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LPSKKGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLP 	                        Gaps:       0                        
						EEQQDPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKC 	                                                            
						SILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 	Alignment:                                                   
						LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSAY 	                  .         .         .         .         .  
						CLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVK 	     117 MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSG 166                                                          
						THSEVRKKPVFQPVHPIQPIQMPAFTTVQRK                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 451 of   	       1 MFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSG 50                                                           
						Q9H5J7, which also corresponds to amino acids 117 - 567 of   	                  .         .         .         .         .  
						N23036_P17, wherein said first amino acid sequence and second	     167 RPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 216                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 RPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWL 100                                                          
						N23036_P17, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     217 RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNT 266                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	     101 RLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQGYHRKIVLASQSIQNT 150                                                          
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRC     	                  .         .         .         .         .  
						least about 95% homologous to the sequence of N23036_P17.    	     267 VYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGG 316                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQDPKQENGAKNSNQLGG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     317 NTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVA 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAYVA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     367 LALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 416                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     417 LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSART 466                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSART 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     467 VMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQN 516                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     517 GNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQR 566                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQR 450                                                          
						                                                            	                                                             
						                                                            	     567 K                                                  567                                                          
						                                                            	         |                                                   
						                                                            	     451 K                                                  451                                                          

						Comparison report between N23036_P17 and Q9BU30partial WT    	Sequence name: Q9BU30                                        
						sequence followed by unique insertion with extra amino acids 	                                                            
						and a mismatch.1.An isolated chimeric polypeptide encoding   	Sequence documentation:                                      
						for N23036_P17, comprising a first amino acid sequence being 	                                                            
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	Alignment of: 5648 x Q9BU30   ..                             
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWN 	                                                            
						NLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKRYEL 	Alignment segment 1/1:                                       
						LYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSK 	                                                            
						KGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 	                     Quality: 5178.00                      Escore:       0                                               
						DPKQENGAKNSNQLGGNTESSESSETC                                  	             Matching length:     540                Total length:     567                                               
						at least 90 % homologous to corresponding to amino acids 178 	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.63                                               
						- 504 of Q9BU30, which also corresponds to amino acids 1 -   	    Total Percent Similarity:   95.06      Total Percent Identity:   94.89                                               
						327 of N23036_P17, a second amino acid sequence being at     	                        Gaps:       1                        
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment:                                                   
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						SSKSHDGDKFIPAPPSSPLRKQELENLK corresponding to amino acids 328	       1 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 50                                                           
						- 355 of N23036_P17, a third amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAIT 	     178 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 227                                                          
						HLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSA 	                  .         .         .         .         .  
						YCLRSEYDKARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAV 	      51 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 100                                                          
						KTHSEVRKKPVFQPVHPIQPIQM                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 506 -  	     228 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 277                                                          
						708 of Q9BU30, which also corresponds to amino acids 356 -   	                  .         .         .         .         .  
						558 of N23036_P17, a bridging amino acid P corresponding to  	     101 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 150                                                          
						amino acid 559 of N23036_P17, and a fourth amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to AFTTVQRK          	     278 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 327                                                          
						corresponding to amino acids 710 - 717 of Q9BU30, which also 	                  .         .         .         .         .  
						corresponds to amino acids 560 - 567 of N23036_P17, wherein  	     151 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 200                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence, bridging amino acid and fourth    	     328 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 377                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     201 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 250                                                          
						of N23036_P17, comprising an amino acid sequence being at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     378 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 427                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     251 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 300                                                          
						encoding for SSKSHDGDKFIPAPPSSPLRKQELENLK, corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N23036_P17.3.A bridge portion of N23036_P17, comprising a    	     428 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 477                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     301 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 350                                                          
						acids in length, preferably at least about 30 amino acids in 	         |||||||||||||||||||||||||||                         
						length, more preferably at least about 40 amino acids in     	     478 DPKQENGAKNSNQLGGNTESSESSETC....................... 504                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise C, having a	     351 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 400                                                          
						structure as follows (numbering according to N23036_P17): a  	             :|||||||||||||||||||||||||||||||||||||||||||||  
						sequence starting from any of amino acid numbers 504-x to    	     505 ....RCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 550                                                          
						504; and ending at any of amino acid numbers 328 + ((n-2) -  	                  .         .         .         .         .  
						x), in which x varies from 0 to n-2.                         	     401 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 700                                                          
						                                                            	                  .                                          
						                                                            	     551 HPIQPIQMPAFTTVQRK                                  567                                                          
						                                                            	         |||||||| ||||||||                                   
						                                                            	     701 HPIQPIQMSAFTTVQRK                                  717                                                          

						Comparison report between N23036_P17 and Q9H8X1partial WT    	Sequence name: Q9H8X1                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for N23036_P17, comprising a first amino	Sequence documentation:                                      
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	                                                            
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWN 	Alignment of: 5648 x Q9H8X1   ..                             
						NLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKRYEL 	                                                            
						LYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSK 	Alignment segment 1/1:                                       
						KGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 	                                                            
						DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILA 	                     Quality: 5559.00                      Escore:       0                                               
						CSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPE 	             Matching length:     567                Total length:     567                                               
						NVTDVSLGISSNEQDQGSDKGENE                                     	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.82                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:   99.82      Total Percent Identity:   99.82                                               
						to amino acids 178 - 621 of Q9H8X1, which also corresponds to	                        Gaps:       0                        
						amino acids 1 - 444 of N23036_P17, a bridging amino acid A   	                                                            
						corresponding to amino acid 445 of N23036_P17, and a second  	Alignment:                                                   
						MESSGKRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPEA 	                  .         .         .         .         .  
						ILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQPIQMPAFTTVQ 	       1 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 50                                                           
						RK                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     178 MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYI 227                                                          
						corresponding to amino acids 623 - 744 of Q9H8X1, which also 	                  .         .         .         .         .  
						corresponds to amino acids 446 - 567 of N23036_P17, wherein  	      51 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 100                                                          
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     228 QMKSLKACKREIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSN 277                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	     101 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 IAEHPGFMKTGECLRCMFWNNLGCIHFAMSKHNLGIFYFKKALQENDNVC 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AQLSAGSTDPGKKFSGRPMCTLLTNKRYELLYNCGIQLLHIGRPLAAFEC 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 LIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSKKGIVQSIVGQ 427                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     428 GYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 477                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     478 DPKQENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQE 527                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     528 LENLKCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYA 577                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSG 450                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||| |||||  
						                                                            	     578 AEALISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENETMESSG 627                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     628 KRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKE 677                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     678 VPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPV 727                                                          
						                                                            	                  .                                          
						                                                            	     551 HPIQPIQMPAFTTVQRK                                  567                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     728 HPIQPIQMPAFTTVQRK                                  744                                                          

						Comparison report between N23036_P17 and Q9UFJ2unique head   	Sequence name: Q9UFJ2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N23036_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 5648 x Q9UFJ2   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	Alignment segment 1/1:                                       
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWN 	                                                            
						NLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKRYEL 	                     Quality: 2562.00                      Escore:       0                                               
						LYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSK 	             Matching length:     263                Total length:     263                                               
						KGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DPKQ                                                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 304 of  	                        Gaps:       0                        
						N23036_P17, and a second amino acid sequence being at least  	                                                            
						ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENLKCSILACSAY 	Alignment:                                                   
						VALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEALISLDRISDAITHLNPENVTD 	                  .         .         .         .         .  
						VSLGISSNEQDQGSDKGENEAMESSGKRAPQCYPSSVNSARTVMLFNLGSAYCLRSEYDK 	     305 ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENL 354                                                          
						ARKCLHQAASMIHPKEVPPEAILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVFQPVHPIQPIQMPAFTTVQRK                                      	       4 ENGAKNSNQLGGNTESSESSETCSSKSHDGDKFIPAPPSSPLRKQELENL 53                                                           
						90 % homologous to corresponding to amino acids 4 - 266 of   	                  .         .         .         .         .  
						Q9UFJ2, which also corresponds to amino acids 305 - 567 of   	     355 KCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEAL 404                                                          
						N23036_P17, wherein said first amino acid sequence and second	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      54 KCSILACSAYVALALGDNLMALNHADKLLQQPKLSGSLKFLGHLYAAEAL 103                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						N23036_P17, comprising a polypeptide being at least 70%,     	     405 ISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAP 454                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     104 ISLDRISDAITHLNPENVTDVSLGISSNEQDQGSDKGENEAMESSGKRAP 153                                                          
						MISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKR 	                  .         .         .         .         .  
						EIKSVMNTAGNSAPSLFLKSNFEYLRGNYRKAVKLLNSSNIAEHPGFMKTGECLRCMFWN 	     455 QCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPE 504                                                          
						NLGCIHFAMSKHNLGIFYFKKALQENDNVCAQLSAGSTDPGKKFSGRPMCTLLTNKRYEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LYNCGIQLLHIGRPLAAFECLIEAVQVYHANPRLWLRLAECCIAANKGTSEQETKGLPSK 	     154 QCYPSSVNSARTVMLFNLGSAYCLRSEYDKARKCLHQAASMIHPKEVPPE 203                                                          
						KGIVQSIVGQGYHRKIVLASQSIQNTVYNDGQSSAIPVASMEFAAICLRNALLLLPEEQQ 	                  .         .         .         .         .  
						DPKQ                                                         	     505 AILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQ 554                                                          
						least about 95% homologous to the sequence of N23036_P17.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 AILLAVYLELQNGNTQLALQIIKRNQLLPAVKTHSEVRKKPVFQPVHPIQ 253                                                          
						                                                            	                  .                                          
						                                                            	     555 PIQMPAFTTVQRK                                      567                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     254 PIQMPAFTTVQRK                                      266                                                          

5652	HMR136_N23036_19_tr0_r1_1_gPRT		Comparison report between N23036_P19 and Q9H9A5partial WT    	Sequence name: Q9H9A5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N23036_P19, comprising a first amino	Sequence documentation:                                      
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLACLQDINKDD 	                                                            
						YKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEEMDGLDDVENSMLYYNQAVIL 	Alignment of: 5652 x Q9H9A5   ..                             
						YHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAVLEKMIS 	                                                            
						QGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIK 	Alignment segment 1/1:                                       
						SVMNTAGN                                                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2419.00                      Escore:       0                                               
						to amino acids 1 - 248 of Q9H9A5, which also corresponds to  	             Matching length:     248                Total length:     248                                               
						amino acids 1 - 248 of N23036_P19, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VSFFWTFVFQFVSFLFRLWVLS corresponding to  	Alignment:                                                   
						amino acids 249 - 270 of N23036_P19, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a tail of N23036_P19, comprising a polypeptide being at  	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSFFWTFVFQFVSFLFRLWVLS in N23036_P19.                        	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          

						Comparison report between N23036_P19 and Q9HAH3unique head   	Sequence name: Q9HAH3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N23036_P19, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 5652 x Q9HAH3   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLACLQDINKDD 	Alignment segment 1/1:                                       
						YKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE                     	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1444.00                      Escore:       0                                               
						to amino acids 1 - 100 of N23036_P19, a second amino acid    	             Matching length:     148                Total length:     148                                               
						MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						YKVRAYIQMKSLKACKREIKSVMNTAGN                                 	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 148 of Q9HAH3, which also corresponds to     	Alignment:                                                   
						amino acids 101 - 248 of N23036_P19, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 50                                                           
						having the sequence VSFFWTFVFQFVSFLFRLWVLS corresponding to  	                  .         .         .         .         .  
						amino acids 249 - 270 of N23036_P19, wherein said first amino	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	      51 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 100                                                          
						isolated polypeptide encoding for a head of N23036_P19,      	                  .         .         .         .            
						comprising a polypeptide being at least 70%, optionally at   	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						preferably at least about 90% and most preferably at least   	     101 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   148                                                          
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLACLQDINKDD 	                                                            
						YKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE                     	                                                            
						about 95% homologous to the sequence of N23036_P19.3.An      	                                                            
						isolated polypeptide encoding for a tail of N23036_P19,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VSFFWTFVFQFVSFLFRLWVLS  	                                                            
						in N23036_P19.                                               	                                                            

						Comparison report between N23036_P19 and Q9H9W0partial WT    	Sequence name: Q9H9W0                                        
						sequence followed by mismatch, with a short unique insertion 	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for N23036_P19, comprising a first amino	                                                            
						acid sequence being at least 90 % homologous to MAAD         	Alignment of: 5652 x Q9H9W0   ..                             
						corresponding to amino acids 1 - 4 of Q9H9W0, which also     	                                                            
						corresponds to amino acids 1 - 4 of N23036_P19, a bridging   	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 5 of N23036_P19, a  	                                                            
						PADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLACLQDINKDDYKIIL 	                     Quality: 2302.00                      Escore:       0                                               
						NTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEEMDGLDDVENSMLYYNQAVILYHLRQ 	             Matching length:     247                Total length:     248                                               
						YTEAISVGEKLYQFIEPF                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.60                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   99.60      Total Percent Identity:   99.19                                               
						corresponding to amino acids 6 - 143 of Q9H9W0, which also   	                        Gaps:       1                        
						corresponds to amino acids 6 - 143 of N23036_P19, a third    	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						having the sequence E corresponding to amino acids 144 - 144 	         ||||:|||||||||||||||||||||||||||||||||||||||||||||  
						of N23036_P19, a fourth amino acid sequence being at least 90	       1 MAADRPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						EKFAQAVCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDGSNHK 	                  .         .         .         .         .  
						AESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN                 	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						% homologous to corresponding to amino acids 144 - 247 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H9W0, which also corresponds to amino acids 145 - 248 of   	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						N23036_P19, and a fifth amino acid sequence being at least   	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						homologous to a polypeptide having the sequence              	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPF.EKFAQA 149                                                          
						VSFFWTFVFQFVSFLFRLWVLS corresponding to amino acids 249 - 270	                  .         .         .         .         .  
						of N23036_P19, wherein said first amino acid sequence,       	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						bridging amino acid, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, fourth amino acid sequence and fifth amino    	     150 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 199                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .            
						isolated polypeptide encoding for an edge portion of         	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          
						N23036_P19, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						70%, optionally at least about 80%, preferably at least about	     200 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   247                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for E,	                                                            
						corresponding to N23036_P19.3.An isolated polypeptide        	                                                            
						encoding for a tail of N23036_P19, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						VSFFWTFVFQFVSFLFRLWVLS in N23036_P19.                        	                                                            

						Comparison report between N23036_P19 and Q9BU30partial WT    	Sequence name: Q9BU30                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N23036_P19, comprising a first amino	Sequence documentation:                                      
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLACLQDINKDD 	                                                            
						YKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEEMDGLDDVENSMLYYNQAVIL 	Alignment of: 5652 x Q9BU30   ..                             
						YHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLLAVLEKMIS 	                                                            
						QGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIK 	Alignment segment 1/1:                                       
						SVMNTAGN                                                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2419.00                      Escore:       0                                               
						to amino acids 1 - 248 of Q9BU30, which also corresponds to  	             Matching length:     248                Total length:     248                                               
						amino acids 1 - 248 of N23036_P19, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VSFFWTFVFQFVSFLFRLWVLS corresponding to  	Alignment:                                                   
						amino acids 249 - 270 of N23036_P19, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a tail of N23036_P19, comprising a polypeptide being at  	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSFFWTFVFQFVSFLFRLWVLS in N23036_P19.                        	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          

						Comparison report between N23036_P19 and Q9H8X1partial WT    	Sequence name: Q9H8X1                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N23036_P19, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 5652 x Q9H8X1   ..                             
						MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHLA          	                                                            
						corresponding to amino acids 1 - 51 of Q9H8X1, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 51 of N23036_P19, a bridging  	                                                            
						amino acid C corresponding to amino acid 52 of N23036_P19, a 	                     Quality: 2397.00                      Escore:       0                                               
						LQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEEMDGLDDVENSML 	             Matching length:     248                Total length:     248                                               
						YYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQAVCFLLVDLYILTYQAEKALHLL 	 Matching Percent Similarity:   99.60   Matching Percent Identity:   99.60                                               
						AVLEKMISQGNNNKNGKNETGNNNNKDGSNHKAESGALIEAAKSKIHQYKVRAYIQMKSL 	    Total Percent Similarity:   99.60      Total Percent Identity:   99.60                                               
						KACKREIKSVMNTAGN                                             	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 53 - 248 of Q9H8X1, which also  	Alignment:                                                   
						corresponds to amino acids 53 - 248 of N23036_P19, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MAADKPADQGAEKHEGTGQSSGITDQEKELSTNAFQAFTSGNYDACLQHL 50                                                           
						polypeptide having the sequence VSFFWTFVFQFVSFLFRLWVLS       	                  .         .         .         .         .  
						corresponding to amino acids 249 - 270 of N23036_P19, wherein	      51 ACLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						said first amino acid sequence, bridging amino acid, second  	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      51 ARLQDINKDDYKIILNTAVAEFFKSNQTTTDNLRQTLNQLKNQVHSAVEE 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of N23036_P19, comprising a  	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 MDGLDDVENSMLYYNQAVILYHLRQYTEAISVGEKLYQFIEPFEEKFAQA 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSFFWTFVFQFVSFLFRLWVLS in N23036_P19.        	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VCFLLVDLYILTYQAEKALHLLAVLEKMISQGNNNKNGKNETGNNNNKDG 200                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     201 SNHKAESGALIEAAKSKIHQYKVRAYIQMKSLKACKREIKSVMNTAGN   248                                                          

6126	HMR136_N23383_8_tr0_r1_1_gPRT		Comparison report between N23383_P8 and MO2L_HUMANunique     	Sequence name: MO2L_HUMAN                                    
						head followed by partial WT sequence a mismatch and a        	                                                            
						featuring a skipped exon.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for N23383_P8, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6126 x MO2L_HUMAN   ..                         
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MKK corresponding to amino acids 1 - 3 of	                                                            
						N23383_P8, a second amino acid sequence being at least 90 %  	                     Quality: 2935.00                      Escore:       0                                               
						MPLFSKSHKNPAEIVKILKDNLAILEKQDKKTDKASEEVSKSLQAMKEILCGTNEKEPPT 	             Matching length:     314                Total length:     334                                               
						EAVAQLAQELYSSGLLVTLIADLQLIDFEGKKDVTQIFNNILRRQIGTRSPTVEYISAHP 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						HILFMLLKGYEAPQIALRCGIMLRECIRHEPL                             	    Total Percent Similarity:   93.71      Total Percent Identity:   93.71                                               
						homologous to corresponding to amino acids 1 - 152 of        	                        Gaps:       1                        
						MO2L_HUMAN, which also corresponds to amino acids 4 - 155 of 	                                                            
						N23383_P8, a bridging amino acid A corresponding to amino    	Alignment:                                                   
						acid 156 of N23383_P8, a third amino acid sequence being at  	                  .         .         .         .         .  
						least 90 % homologous to KIILFSNQFRDFFKYVELSTFDIASDAFATFK    	       4 MPLFSKSHKNPAEIVKILKDNLAILEKQDKKTDKASEEVSKSLQAMKEIL 53                                                           
						corresponding to amino acids 154 - 185 of MO2L_HUMAN, which  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 157 - 188 of N23383_P8, and a	       1 MPLFSKSHKNPAEIVKILKDNLAILEKQDKKTDKASEEVSKSLQAMKEIL 50                                                           
						IFEDYEKLLQSENYVTKRQSLKLLGELILDRHNFAIMTKYISKPENLKLMMNLLRDKSPN 	                  .         .         .         .         .  
						IQFEAFHVFKVFVASPHKTQPIVEILLKNQPKLIEFLSSFQKERTDDEQFADEKNYLIKQ 	      54 CGTNEKEPPTEAVAQLAQELYSSGLLVTLIADLQLIDFEGKKDVTQIFNN 103                                                          
						IRDLKKTAP                                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	      51 CGTNEKEPPTEAVAQLAQELYSSGLLVTLIADLQLIDFEGKKDVTQIFNN 100                                                          
						corresponding to amino acids 206 - 334 of MO2L_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 189 - 317 of N23383_P8,      	     104 ILRRQIGTRSPTVEYISAHPHILFMLLKGYEAPQIALRCGIMLRECIRHE 153                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid, third amino acid sequence and 	     101 ILRRQIGTRSPTVEYISAHPHILFMLLKGYEAPQIALRCGIMLRECIRHE 150                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     154 PLAKIILFSNQFRDFFKYVELSTFDIASDAFATFK............... 188                                                          
						N23383_P8, comprising a polypeptide being at least 70%,      	         || ||||||||||||||||||||||||||||||||                 
						optionally at least about 80%, preferably at least about 85%,	     151 PLVKIILFSNQFRDFFKYVELSTFDIASDAFATFKDLLTRHKVLVADFLE 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MKK of            	     189 .....IFEDYEKLLQSENYVTKRQSLKLLGELILDRHNFAIMTKYISKPE 233                                                          
						N23383_P8.3.An isolated chimeric polypeptide encoding for an 	              |||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of N23383_P8, comprising a polypeptide having a 	     201 QNYDTIFEDYEKLLQSENYVTKRQSLKLLGELILDRHNFAIMTKYISKPE 250                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     234 NLKLMMNLLRDKSPNIQFEAFHVFKVFVASPHKTQPIVEILLKNQPKLIE 283                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 NLKLMMNLLRDKSPNIQFEAFHVFKVFVASPHKTQPIVEILLKNQPKLIE 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .                      
						at least two amino acids comprise KI, having a structure as  	     284 FLSSFQKERTDDEQFADEKNYLIKQIRDLKKTAP                 317                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||                  
						188-x to 189; and ending at any of amino acid numbers 189+   	     301 FLSSFQKERTDDEQFADEKNYLIKQIRDLKKTAP                 334                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

13510	HMR136_N23924_8_tr0_r1_1_gPRT		Comparison report between N23924_P8 and Q9H0U2partial WT     	Sequence name: Q9H0U2                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N23924_P8, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to                                     	Alignment of: 13510 x Q9H0U2   ..                            
						MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEVNVDMLEQM   	                                                            
						corresponding to amino acids 184 - 241 of Q9H0U2, which also 	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 58 of N23924_P8, a bridging   	                                                            
						amino acid D corresponding to amino acid 59 of N23924_P8, a  	                     Quality:  850.00                      Escore:       0                                               
						second amino acid sequence being at least 90 % homologous to 	             Matching length:      88                Total length:      88                                               
						LMDISDQEALDVFLNSGGEENTVLSPALG corresponding to amino acids   	 Matching Percent Similarity:   98.86   Matching Percent Identity:   98.86                                               
						243 - 271 of Q9H0U2, which also corresponds to amino acids 60	    Total Percent Similarity:   98.86      Total Percent Identity:   98.86                                               
						- 88 of N23924_P8, and a third amino acid sequence being at  	                        Gaps:       0                        
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment:                                                   
						PESSTCQNEITLQVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTA 	                  .         .         .         .         .  
						LATSHTDREATPDGGEDSDS                                         	       1 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 50                                                           
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 89 - 168 of N23924_P8, wherein said first     	     184 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 233                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .                      
						sequence and third amino acid sequence are contiguous and in 	      51 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALG             88                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         |||||||| |||||||||||||||||||||||||||||              
						tail of N23924_P8, comprising a polypeptide being at least   	     234 NVDMLEQMVLMDISDQEALDVFLNSGGEENTVLSPALG             271                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						PESSTCQNEITLQVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTA 	                                                            
						LATSHTDREATPDGGEDSDS                                         	                                                            
						at least about 95% homologous to the sequence in N23924_P8.  	                                                            

						Comparison report between N23924_P8 and Q96NV2partial WT     	Sequence name: Q96NV2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N23924_P8, comprising a first amino acid        	                                                            
						MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEVNVDMLEQMDL 	Alignment of: 13510 x Q96NV2   ..                            
						MDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITLQVPNPSELRAKPPSSSSTCT 	                                                            
						DSATRDISEGGESPVVQSDEEEVQVDTALATSHTDREATPDGGEDSDS             	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 103 - 270 of Q96NV2, which also corresponds to   	                     Quality: 1642.00                      Escore:       0                                               
						amino acids 1 - 168 of N23924_P8.                            	             Matching length:     168                Total length:     168                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 252                                                          
						                                                            	                  .                                          
						                                                            	     151 TSHTDREATPDGGEDSDS                                 168                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     253 TSHTDREATPDGGEDSDS                                 270                                                          

						Comparison report between N23924_P8 and Q9H3J5partial WT     	Sequence name: Q9H3J5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N23924_P8, comprising a first amino acid        	                                                            
						MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEVNVDMLEQMDL 	Alignment of: 13510 x Q9H3J5   ..                            
						MDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITLQVPNPSELRAKPPSSSSTCT 	                                                            
						DSATRDISEGGESPVVQSDEEEVQVDTALATSHTDREATPDGGEDSDS             	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 71 - 238 of Q9H3J5, which also corresponds to    	                     Quality: 1642.00                      Escore:       0                                               
						amino acids 1 - 168 of N23924_P8.                            	             Matching length:     168                Total length:     168                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      71 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 120                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 220                                                          
						                                                            	                  .                                          
						                                                            	     151 TSHTDREATPDGGEDSDS                                 168                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     221 TSHTDREATPDGGEDSDS                                 238                                                          

						Comparison report between N23924_P8 and Q96EV8partial WT     	Sequence name: Q96EV8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N23924_P8, comprising a first amino acid        	                                                            
						MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEVNVDMLEQMDL 	Alignment of: 13510 x Q96EV8   ..                            
						MDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITLQVPNPSELRAKPPSSSSTCT 	                                                            
						DSATRDISEGGESPVVQSDEEEVQVDTALATSHTDREATPDGGEDSDS             	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 184 - 351 of Q96EV8, which also corresponds to   	                     Quality: 1642.00                      Escore:       0                                               
						amino acids 1 - 168 of N23924_P8.                            	             Matching length:     168                Total length:     168                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 MEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEV 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 NVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITL 283                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 QVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALA 333                                                          
						                                                            	                  .                                          
						                                                            	     151 TSHTDREATPDGGEDSDS                                 168                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     334 TSHTDREATPDGGEDSDS                                 351                                                          

13649	HMR136_N24002_12_tr0_r1_1_gPRT		Comparison report between N24002_P12 and Q8N4A2partial WT    	Sequence name: Q8N4A2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24002_P12, comprising a first amino	Sequence documentation:                                      
						MQQKKEEEEVLKEVTAHFQITLTETQAQLEQHEIHNAKLQQENMEMGEKLKKLTDQYALR 	                                                            
						EE                                                           	Alignment of: 13649 x Q8N4A2   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 32 - 93 of Q8N4A2, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 62 of N24002_P12, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  613.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      62                Total length:      62                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QINKAFKHKELRQQLVDARLQQTAQLIKEADERHQREREFLLKEATESRHKYEEMKQEEA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QLKEQLFLYMDKFEEFQTTMAKTNELFTAFKQETEKLTKKIKKLEKEMVIWYTKWENNNT 	                        Gaps:       0                        
						TLLQMAEEKTIRDKNYKVFQIKLERLEKLYKALQIERNELSEKLGILKGQVSVKVADVDL 	                                                            
						AVPVTHSCADLDSSNMLNTSSKRAPGVHLEADPKGMNEVKCYSKALSTGSPLGID      	Alignment:                                                   
						having the sequence corresponding to amino acids 63 - 297 of 	                  .         .         .         .         .  
						N24002_P12, wherein said first amino acid sequence and second	       1 MQQKKEEEEVLKEVTAHFQITLTETQAQLEQHEIHNAKLQQENMEMGEKL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	      32 MQQKKEEEEVLKEVTAHFQITLTETQAQLEQHEIHNAKLQQENMEMGEKL 81                                                           
						N24002_P12, comprising a polypeptide being at least 70%,     	                  .                                          
						optionally at least about 80%, preferably at least about 85%,	      51 KKLTDQYALREE                                       62                                                           
						more preferably at least about 90% and most preferably at    	         ||||||||||||                                        
						QINKAFKHKELRQQLVDARLQQTAQLIKEADERHQREREFLLKEATESRHKYEEMKQEEA 	      82 KKLTDQYALREE                                       93                                                           
						QLKEQLFLYMDKFEEFQTTMAKTNELFTAFKQETEKLTKKIKKLEKEMVIWYTKWENNNT 	                                                            
						TLLQMAEEKTIRDKNYKVFQIKLERLEKLYKALQIERNELSEKLGILKGQVSVKVADVDL 	                                                            
						AVPVTHSCADLDSSNMLNTSSKRAPGVHLEADPKGMNEVKCYSKALSTGSPLGID      	                                                            
						least about 95% homologous to the sequence in N24002_P12.    	                                                            

						Comparison report between N24002_P12 and Q9BZA4unique head   	Sequence name: Q9BZA4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N24002_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13649 x Q9BZA4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MQQKKEEEEVLKEVTAHFQITLTETQAQLEQHEIHNAKLQQENMEMGEKLKKLTDQYALR 	Alignment segment 1/1:                                       
						EEQINKAFKHKELRQQLVDARLQQTAQLIKEADERHQREREFLLKEATESRHKYEE     	                                                            
						having the sequence corresponding to amino acids 1 - 116 of  	                     Quality: 1767.00                      Escore:       0                                               
						N24002_P12, and a second amino acid sequence being at least  	             Matching length:     181                Total length:     181                                               
						MKQEEAQLKEQLFLYMDKFEEFQTTMAKTNELFTAFKQETEKLTKKIKKLEKEMVIWYTK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WENNNTTLLQMAEEKTIRDKNYKVFQIKLERLEKLYKALQIERNELSEKLGILKGQVSVK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VADVDLAVPVTHSCADLDSSNMLNTSSKRAPGVHLEADPKGMNEVKCYSKALSTGSPLGI 	                        Gaps:       0                        
						D                                                            	                                                            
						90 % homologous to corresponding to amino acids 1 - 181 of   	Alignment:                                                   
						Q9BZA4, which also corresponds to amino acids 117 - 297 of   	                  .         .         .         .         .  
						N24002_P12, wherein said first amino acid sequence and second	     117 MKQEEAQLKEQLFLYMDKFEEFQTTMAKTNELFTAFKQETEKLTKKIKKL 166                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       1 MKQEEAQLKEQLFLYMDKFEEFQTTMAKTNELFTAFKQETEKLTKKIKKL 50                                                           
						N24002_P12, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     167 EKEMVIWYTKWENNNTTLLQMAEEKTIRDKNYKVFQIKLERLEKLYKALQ 216                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQQKKEEEEVLKEVTAHFQITLTETQAQLEQHEIHNAKLQQENMEMGEKLKKLTDQYALR 	      51 EKEMVIWYTKWENNNTTLLQMAEEKTIRDKNYKVFQIKLERLEKLYKALQ 100                                                          
						EEQINKAFKHKELRQQLVDARLQQTAQLIKEADERHQREREFLLKEATESRHKYEE     	                  .         .         .         .         .  
						least about 95% homologous to the sequence of N24002_P12.    	     217 IERNELSEKLGILKGQVSVKVADVDLAVPVTHSCADLDSSNMLNTSSKRA 266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IERNELSEKLGILKGQVSVKVADVDLAVPVTHSCADLDSSNMLNTSSKRA 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     267 PGVHLEADPKGMNEVKCYSKALSTGSPLGID                    297                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     151 PGVHLEADPKGMNEVKCYSKALSTGSPLGID                    181                                                          

13643	HMR136_N24002_7_tr0_r1_1_gPRT		Comparison report between N24002_P7 and Q9BZA5partial WT     	Sequence name: Q9BZA5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24002_P7, comprising a first amino 	Sequence documentation:                                      
						MEEAGLCGLREKADMLCNSESHDILQHQDSNCSATSNKHLLEDEEGRDFITKNRSWVSPV 	                                                            
						HCTQESRRELPEQEVAPPSGQQALQ                                    	Alignment of: 13643 x Q9BZA5   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 39 - 123 of Q9BZA5, which also corresponds to 	Alignment segment 1/1:                                       
						amino acids 1 - 85 of N24002_P7, and a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  867.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      96                Total length:      96                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:   93.75   Matching Percent Identity:   91.67                                               
						CNRNKEKVLGKEVLLLMQALNTLSTPEEKLAALCKKYADLLEESRNVQRQMKILQNKQAQ 	    Total Percent Similarity:   93.75      Total Percent Identity:   91.67                                               
						IVKEKVHLQSEYSKTILARSKLESLCRELQQN                             	                        Gaps:       0                        
						having the sequence corresponding to amino acids 86 - 177 of 	                                                            
						N24002_P7, wherein said first amino acid sequence and second 	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MEEAGLCGLREKADMLCNSESHDILQHQDSNCSATSNKHLLEDEEGRDFI 50                                                           
						N24002_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      39 MEEAGLCGLREKADMLCNSESHDILQHQDSNCSATSNKHLLEDEEGRDFI 88                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						CNRNKEKVLGKEVLLLMQALNTLSTPEEKLAALCKKYADLLEESRNVQRQMKILQNKQAQ 	      51 TKNRSWVSPVHCTQESRRELPEQEVAPPSGQQALQCNRNKEKVLGK     96                                                           
						IVKEKVHLQSEYSKTILARSKLESLCRELQQN                             	         |||||||||||||||||||||||||||||||||||  : : | | |      
						least about 95% homologous to the sequence in N24002_P7.     	      89 TKNRSWVSPVHCTQESRRELPEQEVAPPSGQQALQLQQEQRKSLRK     134                                                          

14674	HMR136_N24782_3_tr0_r1_1_gPRT		Comparison report between N24782_P3 and Q9BYE7partial WT     	Sequence name: Q9BYE7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P3, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14674 x Q9BYE7   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNIRLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSK 	Alignment segment 1/1:                                       
						KVLESVFRIPPELDMSLLLEFIGANEGTGHFK                             	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2682.00                      Escore:       0                                               
						to amino acids 1 - 272 of Q9BYE7, which also corresponds to  	             Matching length:     272                Total length:     272                                               
						amino acids 1 - 272 of N24782_P3, and a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS        	Alignment:                                                   
						corresponding to amino acids 273 - 305 of N24782_P3, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of N24782_P3, comprising a   	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence LSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS in         	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						N24782_P3.                                                   	                  .         .         .         .         .  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIP 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 PELDMSLLLEFIGANEGTGHFK                             272                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     251 PELDMSLLLEFIGANEGTGHFK                             272                                                          

						Comparison report between N24782_P3 and Q96ID9partial WT     	Sequence name: Q96ID9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P3, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14674 x Q96ID9   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNI                                                      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 187 of Q96ID9, which also corresponds to  	                     Quality: 1851.00                      Escore:       0                                               
						amino acids 1 - 187 of N24782_P3, and a second amino acid    	             Matching length:     187                Total length:     187                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						RLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVF 	                                                            
						RIPPELDMSLLLEFIGANEGTGHFKLSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS   	Alignment:                                                   
						having the sequence corresponding to amino acids 188 - 305 of	                  .         .         .         .         .  
						N24782_P3, wherein said first amino acid sequence and second 	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						N24782_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVF 	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						RIPPELDMSLLLEFIGANEGTGHFKLSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS   	                  .         .         .         .         .  
						least about 95% homologous to the sequence in N24782_P3.     	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNI              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNI              187                                                          

						Comparison report between N24782_P3 and Q96SJ1partial WT     	Sequence name: Q96SJ1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P3, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14674 x Q96SJ1   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNIRLDRQLQDIVYKLVINLEE                                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 206 of Q96SJ1, which also corresponds to  	                     Quality: 2030.00                      Escore:       0                                               
						amino acids 1 - 206 of N24782_P3, and a second amino acid    	             Matching length:     206                Total length:     206                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						REKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIPPELDMSLLLEFIGANE 	                                                            
						GTGHFKLSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS                      	Alignment:                                                   
						having the sequence corresponding to amino acids 207 - 305 of	                  .         .         .         .         .  
						N24782_P3, wherein said first amino acid sequence and second 	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						N24782_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIPPELDMSLLLEFIGANE 	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						GTGHFKLSVFVAIGKEVCSSFRRSNYWTCRKIPQKKNGS                      	                  .         .         .         .         .  
						least about 95% homologous to the sequence in N24782_P3.     	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	                                                             
						                                                            	     201 VINLEE                                             206                                                          
						                                                            	         ||||||                                              
						                                                            	     201 VINLEE                                             206                                                          

14672	HMR136_N24782_5_tr0_r1_1_gPRT		Comparison report between N24782_P5 and Q9BYE7partial WT     	Sequence name: Q9BYE7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P5, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14672 x Q9BYE7   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNIRLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSK 	Alignment segment 1/1:                                       
						KVLESVFRIPPELDMSLLLEFIGANEGTGHFK                             	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2682.00                      Escore:       0                                               
						to amino acids 1 - 272 of Q9BYE7, which also corresponds to  	             Matching length:     272                Total length:     272                                               
						amino acids 1 - 272 of N24782_P5, and a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VFYFFFHSFHKRTL corresponding to amino    	Alignment:                                                   
						acids 273 - 286 of N24782_P5, wherein said first amino acid  	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of N24782_P5, comprising a polypeptide being at least   	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						at least about 95% homologous to the sequence VFYFFFHSFHKRTL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in N24782_P5.                                                	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIP 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 PELDMSLLLEFIGANEGTGHFK                             272                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     251 PELDMSLLLEFIGANEGTGHFK                             272                                                          

						Comparison report between N24782_P5 and Q96ID9partial WT     	Sequence name: Q96ID9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P5, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14672 x Q96ID9   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNI                                                      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 187 of Q96ID9, which also corresponds to  	                     Quality: 1851.00                      Escore:       0                                               
						amino acids 1 - 187 of N24782_P5, and a second amino acid    	             Matching length:     187                Total length:     187                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						RLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVF 	                                                            
						RIPPELDMSLLLEFIGANEGTGHFKVFYFFFHSFHKRTL                      	Alignment:                                                   
						having the sequence corresponding to amino acids 188 - 286 of	                  .         .         .         .         .  
						N24782_P5, wherein said first amino acid sequence and second 	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						N24782_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLDRQLQDIVYKLVINLEEREKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVF 	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						RIPPELDMSLLLEFIGANEGTGHFKVFYFFFHSFHKRTL                      	                  .         .         .         .         .  
						least about 95% homologous to the sequence in N24782_P5.     	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNI              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNI              187                                                          

						Comparison report between N24782_P5 and Q96SJ1partial WT     	Sequence name: Q96SJ1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N24782_P5, comprising a first amino 	Sequence documentation:                                      
						MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPLSETGAPGCSG 	                                                            
						SRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEEEDMSHFSLRLEGGRQDSEDE 	Alignment of: 14672 x Q96SJ1   ..                            
						EERLINLSELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQ 	                                                            
						TQPLYNIRLDRQLQDIVYKLVINLEE                                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 206 of Q96SJ1, which also corresponds to  	                     Quality: 2030.00                      Escore:       0                                               
						amino acids 1 - 206 of N24782_P5, and a second amino acid    	             Matching length:     206                Total length:     206                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						REKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIPPELDMSLLLEFIGANE 	                                                            
						GTGHFKVFYFFFHSFHKRTL                                         	Alignment:                                                   
						having the sequence corresponding to amino acids 207 - 286 of	                  .         .         .         .         .  
						N24782_P5, wherein said first amino acid sequence and second 	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MEGVAVVTAGSVGAAKTEGAAALPPPPPPPVSPPALTPAPAAGEEGPAPL 50                                                           
						N24782_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REKKQMHDFYKERGLEVPKPAVPQPVPSSKGRSKKVLESVFRIPPELDMSLLLEFIGANE 	      51 SETGAPGCSGSRPPELEPERSLGRFRGRFEDEDEELEEEEELEEEEEEEE 100                                                          
						GTGHFKVFYFFFHSFHKRTL                                         	                  .         .         .         .         .  
						least about 95% homologous to the sequence in N24782_P5.     	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EDMSHFSLRLEGGRQDSEDEEERLINLSELTPYILCSICKGYLIDATTIT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLYNIRLDRQLQDIVYKL 200                                                          
						                                                            	                                                             
						                                                            	     201 VINLEE                                             206                                                          
						                                                            	         ||||||                                              
						                                                            	     201 VINLEE                                             206                                                          

15191	HMR136_N25083_5_tr0_r1_1_gPRT		Comparison report between N25083_P5 and Q8IV02unique head    	Sequence name: Q8IV02                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N25083_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15191 x Q8IV02   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MKITNGRHGDSAGAEGT corresponding to amino acids 1 - 17 of     	                                                            
						N25083_P5, a second amino acid sequence being at least 90 %  	                     Quality: 1195.00                      Escore:       0                                               
						MENFTALFGAQADPPPPPTALGFGPGKPPPPPPPPAGGGPGTAPPPTAATAPPGADKSGA 	             Matching length:     119                Total length:     119                                               
						GCGPFYLMRELPGSTELTGSTNLITHYNLEQAYNKFCGKKVKEKLSNFLPDLPGMIDLP  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 1 - 119 of Q8IV02,	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						which also corresponds to amino acids 18 - 136 of N25083_P5, 	                        Gaps:       0                        
						and a third amino acid sequence being at least 70%,          	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      18 MENFTALFGAQADPPPPPTALGFGPGKPPPPPPPPAGGGPGTAPPPTAAT 67                                                           
						APRPAAAAAYANRTTGLFARMAFPAVLNLLIKAAFQALGHCLGSILQLGQRPAPVGLS   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 137 - 194 of N25083_P5, wherein 	       1 MENFTALFGAQADPPPPPTALGFGPGKPPPPPPPPAGGGPGTAPPPTAAT 50                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      68 APPGADKSGAGCGPFYLMRELPGSTELTGSTNLITHYNLEQAYNKFCGKK 117                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of N25083_P5, comprising a polypeptide being at least   	      51 APPGADKSGAGCGPFYLMRELPGSTELTGSTNLITHYNLEQAYNKFCGKK 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .                                          
						85%, more preferably at least about 90% and most preferably  	     118 VKEKLSNFLPDLPGMIDLP                                136                                                          
						at least about 95% homologous to the sequence                	         |||||||||||||||||||                                 
						MKITNGRHGDSAGAEGT of N25083_P5.3.An isolated polypeptide     	     101 VKEKLSNFLPDLPGMIDLP                                119                                                          
						encoding for a tail of N25083_P5, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						APRPAAAAAYANRTTGLFARMAFPAVLNLLIKAAFQALGHCLGSILQLGQRPAPVGLS in	                                                            
						N25083_P5.                                                   	                                                            

15558	HMR136_N25320_7_tr0_r1_1_gPRT		Comparison report between N25320_P7 and CLN6_HUMANpartial WT 	Sequence name: CLN6_HUMAN                                    
						sequence featuring skipped exon plus extra amino acids.1.An  	                                                            
						isolated chimeric polypeptide encoding for N25320_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MEATRRRQHLGATGGPGAQLGASFLQARHGSVSADEAARTAPFHLDLWFYFTLQNWVLDF 	Alignment of: 15558 x CLN6_HUMAN   ..                        
						GRPIAMLVFPLEWFPLNKPSVGDYFHMAYNVITPFLLLKLIERSPRTLPRSITYVSIIIF 	                                                            
						IMGASIHLVGDSVNHRLLFSGYQHHLSVRENPIIKNLKPETLIDSFELLYYYDEYLGHCM 	Alignment segment 1/1:                                       
						homologous to corresponding to amino acids 1 - 180 of        	                                                            
						CLN6_HUMAN, which also corresponds to amino acids 1 - 180 of 	                     Quality: 2220.00                      Escore:       0                                               
						N25320_P7, a second amino acid sequence bridging amino acid  	             Matching length:     235                Total length:     311                                               
						sequence comprising of C, and a third amino acid sequence    	 Matching Percent Similarity:   99.57   Matching Percent Identity:   99.57                                               
						being at least 90 % homologous to                            	    Total Percent Similarity:   75.24      Total Percent Identity:   75.24                                               
						NGLFLFSSFALTLLLVALWVAWLWNDPVLRKKYPGVIYVPEPWAFYTLHVSSRH       	                        Gaps:       1                        
						corresponding to amino acids 258 - 311 of CLN6_HUMAN, which  	                                                            
						also corresponds to amino acids 182 - 235 of N25320_P7,      	Alignment:                                                   
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	       1 MEATRRRQHLGATGGPGAQLGASFLQARHGSVSADEAARTAPFHLDLWFY 50                                                           
						a sequential order.2.An isolated polypeptide encoding for an 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of N25320_P7, comprising a polypeptide having a 	       1 MEATRRRQHLGATGGPGAQLGASFLQARHGSVSADEAARTAPFHLDLWFY 50                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      51 FTLQNWVLDFGRPIAMLVFPLEWFPLNKPSVGDYFHMAYNVITPFLLLKL 100                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      51 FTLQNWVLDFGRPIAMLVFPLEWFPLNKPSVGDYFHMAYNVITPFLLLKL 100                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise MCN having a structure as  	     101 IERSPRTLPRSITYVSIIIFIMGASIHLVGDSVNHRLLFSGYQHHLSVRE 150                                                          
						follows (numbering according to N25320_P7): a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 180-x to 180; and    	     101 IERSPRTLPRSITYVSIIIFIMGASIHLVGDSVNHRLLFSGYQHHLSVRE 150                                                          
						ending at any of amino acid numbers 182 + ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     151 NPIIKNLKPETLIDSFELLYYYDEYLGHCM.................... 180                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     151 NPIIKNLKPETLIDSFELLYYYDEYLGHCMWYIPFFLILFMYFSGCFTAS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     180 .................................................. 180                                                          
						                                                            	                                                            
						                                                            	     201 KAESLIPGPALLLVAPSGLYYWYLVTEGQIFILFIFTFFAMLALVLHQKR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     181 ......CNGLFLFSSFALTLLLVALWVAWLWNDPVLRKKYPGVIYVPEPW 224                                                          
						                                                            	                |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KRLFLDSNGLFLFSSFALTLLLVALWVAWLWNDPVLRKKYPGVIYVPEPW 300                                                          
						                                                            	                  .                                          
						                                                            	     225 AFYTLHVSSRH                                        235                                                          
						                                                            	         |||||||||||                                         
						                                                            	     301 AFYTLHVSSRH                                        311                                                          

15997	HMR136_N25855_5_tr0_r1_1_gPRT		Comparison report between N25855_P5 and Q8N1H1unique head    	Sequence name: Q8N1H1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N25855_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15997 x Q8N1H1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DSTYELVFFS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of N25855_P5, and a second amino acid sequence being at 	                                                            
						ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVADSESSTVRTVS 	                     Quality: 3363.00                      Escore:       0                                               
						LKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGVTWDKKRNLLYVADSYNHKIK 	             Matching length:     346                Total length:     346                                               
						VVDPKTKNCTTLAGTGDTNNVTSSSFTESTFNEPGGLCIGENGELLYVADTNNHQIKVMD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LETKMVSVLPIFRSENAVVDGPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DLPSGSKLTEGVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 	                        Gaps:       0                        
						SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF               	                                                            
						least 90 % homologous to corresponding to amino acids 95 -   	Alignment:                                                   
						440 of Q8N1H1, which also corresponds to amino acids 11 - 356	                  .         .         .         .         .  
						of N25855_P5, wherein said first amino acid sequence and     	      11 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 60                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      95 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 144                                                          
						N25855_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      61 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 110                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence DSTYELVFFS of     	     145 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 194                                                          
						N25855_P5.                                                   	                  .         .         .         .         .  
						                                                            	     111 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     195 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 244                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 294                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     295 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 344                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     261 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 310                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 394                                                          
						                                                            	                  .         .         .         .            
						                                                            	     311 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     395 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     440                                                          

						Comparison report between N25855_P5 and Q8N5A6unique head    	Sequence name: Q8N5A6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N25855_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15997 x Q8N5A6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DSTYELVFFS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of N25855_P5, and a second amino acid sequence being at 	                                                            
						ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVADSESSTVRTVS 	                     Quality: 3363.00                      Escore:       0                                               
						LKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGVTWDKKRNLLYVADSYNHKIK 	             Matching length:     346                Total length:     346                                               
						VVDPKTKNCTTLAGTGDTNNVTSSSFTESTFNEPGGLCIGENGELLYVADTNNHQIKVMD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LETKMVSVLPIFRSENAVVDGPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DLPSGSKLTEGVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 	                        Gaps:       0                        
						SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF               	                                                            
						least 90 % homologous to corresponding to amino acids 22 -   	Alignment:                                                   
						367 of Q8N5A6, which also corresponds to amino acids 11 - 356	                  .         .         .         .         .  
						of N25855_P5, wherein said first amino acid sequence and     	      11 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 60                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      22 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 71                                                           
						N25855_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      61 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 110                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence DSTYELVFFS of     	      72 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 121                                                          
						N25855_P5.                                                   	                  .         .         .         .         .  
						                                                            	     111 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     122 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 171                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     261 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 310                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 321                                                          
						                                                            	                  .         .         .         .            
						                                                            	     311 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     322 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     367                                                          

						Comparison report between N25855_P5 and Q8NBF2unique head    	Sequence name: Q8NBF2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N25855_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15997 x Q8NBF2   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DSTYELVFFS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of N25855_P5, and a second amino acid sequence being at 	                                                            
						ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVADSESSTVRTVS 	                     Quality: 3363.00                      Escore:       0                                               
						LKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGVTWDKKRNLLYVADSYNHKIK 	             Matching length:     346                Total length:     346                                               
						VVDPKTKNCTTLAGTGDTNNVTSSSFTESTFNEPGGLCIGENGELLYVADTNNHQIKVMD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LETKMVSVLPIFRSENAVVDGPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DLPSGSKLTEGVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 	                        Gaps:       0                        
						SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF               	                                                            
						least 90 % homologous to corresponding to amino acids 381 -  	Alignment:                                                   
						726 of Q8NBF2, which also corresponds to amino acids 11 - 356	                  .         .         .         .         .  
						of N25855_P5, wherein said first amino acid sequence and     	      11 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 60                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     381 ELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVAD 430                                                          
						N25855_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      61 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 110                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence DSTYELVFFS of     	     431 SESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGV 480                                                          
						N25855_P5.                                                   	                  .         .         .         .         .  
						                                                            	     111 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 TWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTEST 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     531 FNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIFRSENAVVD 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     581 GPFLVEKQKTLPKLPKSAPSIRLSPVTACAGQTLQFKLRLDLPSGSKLTE 630                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     261 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 310                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     631 GVSSCWFLTAEGNEWLLQGQIAAGDIENISSQPTISLQIPDDCLSLEAIV 680                                                          
						                                                            	                  .         .         .         .            
						                                                            	     311 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     681 SVSVFLYYCSADSSACMMKAILFSQPLQITDTQQGCIAPVELRYVF     726                                                          

49	HMR136_N26299_3_tr0_r1_1_gPRT		Comparison report between N26299_P3 and Q9H659unique head    	Sequence name: Q9H659                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N26299_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 49 x Q9H659   ..                               
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 2991.00                      Escore:       0                                               
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	             Matching length:     308                Total length:     308                                               
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYN 	                        Gaps:       0                        
						IDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRLG 	                                                            
						SLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVR                    	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 521 of  	                  .         .         .         .         .  
						N26299_P3, and a second amino acid sequence being at least 90	     522 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 571                                                          
						MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFT 	       1 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 50                                                           
						VNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAK 	                  .         .         .         .         .  
						GKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKI 	     572 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 621                                                          
						PKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPRCLKKL                                                     	      51 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 100                                                          
						% homologous to corresponding to amino acids 1 - 308 of      	                  .         .         .         .         .  
						Q9H659, which also corresponds to amino acids 522 - 829 of   	     622 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 671                                                          
						N26299_P3, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     101 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 150                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						N26299_P3, comprising a polypeptide being at least 70%,      	     672 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 721                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     151 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 200                                                          
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                  .         .         .         .         .  
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	     722 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 771                                                          
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	     201 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 250                                                          
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 	                  .         .         .         .         .  
						NFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMK 	     772 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 821                                                          
						GLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRLG 	     251 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 300                                                          
						SLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVR                    	                                                             
						least about 95% homologous to the sequence of N26299_P3.     	     822 SPRCLKKL                                           829                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 SPRCLKKL                                           308                                                          

						Comparison report between N26299_P3 and Q8ND20unique head    	Sequence name: Q8ND20                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 49 x Q8ND20   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 5105.00                      Escore:       0                                               
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	             Matching length:     529                Total length:     530                                               
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYREL  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						to amino acids 1 - 299 of N26299_P3, a second amino acid     	                        Gaps:       1                        
						GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYM 	                                                            
						KGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 	Alignment:                                                   
						NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRL 	                  .         .         .         .         .  
						GSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAV 	     300 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 349                                                          
						KWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YHGANNPKGLLEVREALEKVHKVEDLLPIMK                              	       1 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 331 of Q8ND20, which also corresponds to     	     350 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 399                                                          
						amino acids 300 - 630 of N26299_P3, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     400 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 449                                                          
						having the sequence Q corresponding to amino acids 631 - 631 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of N26299_P3, and a fourth amino acid sequence being at least	     101 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 150                                                          
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	                  .         .         .         .         .  
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	     450 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 499                                                          
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMIEVLNTDSSPRCLKKL                                           	     151 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 200                                                          
						90 % homologous to corresponding to amino acids 332 - 529 of 	                  .         .         .         .         .  
						Q8ND20, which also corresponds to amino acids 632 - 829 of   	     500 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 549                                                          
						N26299_P3, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, third amino acid sequence and fourth    	     201 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 250                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     550 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 599                                                          
						N26299_P3, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	     600 YHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVPSL 649                                                          
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	     301 YHGANNPKGLLEVREALEKVHKVEDLLPIMK.FNTKTKDGFTVNTKVPSL 349                                                          
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	                  .         .         .         .         .  
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYREL  	     650 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 699                                                          
						least about 95% homologous to the sequence of N26299_P3.3.An 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     350 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 399                                                          
						N26299_P3, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     700 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 749                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for Q,	     400 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 449                                                          
						corresponding to N26299_P3.                                  	                  .         .         .         .         .  
						                                                            	     750 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 799                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 499                                                          
						                                                            	                  .         .         .                      
						                                                            	     800 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     829                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     500 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     529                                                          

						Comparison report between N26299_P3 and Q8NBI0partial WT     	Sequence name: Q8NBI0                                        
						sequence followed by mismatch, followed by a unique insertion	                                                            
						and a with a short unique insertion.1.An isolated chimeric   	Sequence documentation:                                      
						polypeptide encoding for N26299_P3, comprising a first amino 	                                                            
						acid sequence being at least 90 % homologous to              	Alignment of: 49 x Q8NBI0   ..                               
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSA corresponding to amino 	                                                            
						acids 1 - 37 of Q8NBI0, which also corresponds to amino acids	Alignment segment 1/1:                                       
						1 - 37 of N26299_P3, a bridging amino acid G corresponding to	                                                            
						amino acid 38 of N26299_P3, a second amino acid sequence     	                     Quality: 7695.00                      Escore:       0                                               
						LRPGALATEHYSPLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFH 	             Matching length:     806                Total length:     829                                               
						DSDCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGL 	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.88                                               
						YDEAIRHFSTMLQ                                                	    Total Percent Similarity:   97.10      Total Percent Identity:   97.10                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       2                        
						acids 39 - 171 of Q8NBI0, which also corresponds to amino    	                                                            
						acids 39 - 171 of N26299_P3, a third amino acid sequence     	Alignment:                                                   
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						EEPDLVSAIYGRGIAYGKKGLH corresponding to amino acids 172 - 193	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSARLRPGALATEHYS 50                                                           
						of N26299_P3, a fourth amino acid sequence being at least 90 	                  .         .         .         .         .  
						ILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHEDFQQSLELNKNQPI 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						AMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEG 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						IKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHW 	                  .         .         .         .         .  
						AKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPN 	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						KRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVR 	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						EALEKVHKVEDLLPIMK                                            	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 172 - 608 of    	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLHILSPLGR 200                                                          
						Q8NBI0, which also corresponds to amino acids 194 - 630 of   	         |||||||||||||||||||||                      |||||||  
						N26299_P3, a fifth amino acid sequence being at least 70%,   	     151 YVLIGSGLYDEAIRHFSTMLQ......................ILSPLGR 178                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     201 INEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHEDFQQSLELNKN 250                                                          
						homologous to a polypeptide having the sequence Q            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 631 - 631 of N26299_P3, and a   	     179 INEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHEDFQQSLELNKN 228                                                          
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	                  .         .         .         .         .  
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	     251 QPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 300                                                          
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMIEVLNTDSSPRCLKKL                                           	     229 QPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 278                                                          
						sixth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 609 - 806 of Q8NBI0, which also 	     301 NFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLE 350                                                          
						corresponds to amino acids 632 - 829 of N26299_P3, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid, second  	     279 NFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLE 328                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence, fifth amino acid sequence and sixth amino acid	     351 PYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKY 400                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     329 PYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKY 378                                                          
						N26299_P3, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     401 LREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGL 450                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     379 LREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGL 428                                                          
						EEPDLVSAIYGRGIAYGKKGLH, corresponding to N26299_P3.3.An      	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     451 QPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAM 500                                                          
						N26299_P3, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     429 QPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAM 478                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for Q,	     501 GLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQP 550                                                          
						corresponding to N26299_P3.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 GLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQP 528                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 VLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILVY 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     529 VLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILVY 578                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 HGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVPSLK 650                                                          
						                                                            	         |||||||||||||||||||||||||||||| |||||||||||||||||||  
						                                                            	     579 HGANNPKGLLEVREALEKVHKVEDLLPIMK.FNTKTKDGFTVNTKVPSLK 627                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTA 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     628 DQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTA 677                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 KGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGAL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     678 KGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGAL 727                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 MASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     728 MASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTL 777                                                          
						                                                            	                  .         .                                
						                                                            	     801 PSVSETFPTLRSMIEVLNTDSSPRCLKKL                      829                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     778 PSVSETFPTLRSMIEVLNTDSSPRCLKKL                      806                                                          

						Comparison report between N26299_P3 and Q8NBP0partial WT     	Sequence name: Q8NBP0                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for N26299_P3, comprising a    	Sequence documentation:                                      
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                                                            
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	Alignment of: 49 x Q8NBP0   ..                               
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                                                            
						YGRGIAYGKKGLH                                                	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 193 of Q8NBP0, which also   	                     Quality: 8020.00                      Escore:       0                                               
						corresponds to amino acids 1 - 193 of N26299_P3, a second    	             Matching length:     829                Total length:     860                                               
						ILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHEDFQQSLELNKNQPI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.88                                               
						AMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKAL 	    Total Percent Similarity:   96.40      Total Percent Identity:   96.28                                               
						LLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEG 	                        Gaps:       1                        
						IKAQTKVMLNDPLPGQKASPEYLKVKYLREYSR                            	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 225 - 437 of Q8NBP0, which also 	                  .         .         .         .         .  
						corresponds to amino acids 194 - 406 of N26299_P3, a bridging	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						amino acid Y corresponding to amino acid 407 of N26299_P3,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and a third amino acid sequence being at least 90 %          	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						LHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKP 	                  .         .         .         .         .  
						EVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTR 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						LMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVP 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						SLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLIL 	                  .         .         .         .         .  
						SSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLV 	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						DFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KL                                                           	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						homologous to corresponding to amino acids 439 - 860 of      	                  .         .         .         .         .  
						Q8NBP0, which also corresponds to amino acids 408 - 829 of   	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLH....... 193                                                          
						N26299_P3, wherein said first amino acid sequence, second    	         |||||||||||||||||||||||||||||||||||||||||||         
						amino acid sequence, bridging amino acid and third amino acid	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLHDIKNAEL 200                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     194 ........................ILSPLGRINEAVNDLTKAIQLQPSAR 219                                                          
						N26299_P3, comprising a polypeptide having a length "n",     	                                 ||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     201 ALFELSRVITLEPDRPEVFEQRAEILSPLGRINEAVNDLTKAIQLQPSAR 250                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     220 LYRHRGTLYFISEDYATAHEDFQQSLELNKNQPIAMLYKGLTFFHRGLLK 269                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     251 LYRHRGTLYFISEDYATAHEDFQQSLELNKNQPIAMLYKGLTFFHRGLLK 300                                                          
						at least two amino acids comprise HI, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     270 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 319                                                          
						193-x to 194; and ending at any of amino acid numbers 194+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     301 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     320 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 369                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     370 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 419                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:||||||||||||  
						                                                            	     401 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRHLHAHLDTPLTEY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     420 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 469                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     470 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 519                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     520 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 569                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     570 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 619                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     620 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 669                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     670 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 719                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     720 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 769                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     770 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 819                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 850                                                          
						                                                            	                  .                                          
						                                                            	     820 DSSPRCLKKL                                         829                                                          
						                                                            	         ||||||||||                                          
						                                                            	     851 DSSPRCLKKL                                         860                                                          

						Comparison report between N26299_P3 and Q8IVP8unique head    	Sequence name: Q8IVP8                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 49 x Q8IVP8   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 4845.00                      Escore:       0                                               
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	             Matching length:     502                Total length:     503                                               
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NFEAATESFQKALLLNQNHVQTLQLR                                   	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 326 of N26299_P3, a second amino acid     	                                                            
						GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPL 	Alignment:                                                   
						PGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEE 	                  .         .         .         .         .  
						QPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALE 	     327 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 376                                                          
						VMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NNHINLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 	       1 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 50                                                           
						PIMK                                                         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     377 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 426                                                          
						amino acids 1 - 304 of Q8IVP8, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 327 - 630 of N26299_P3, a third amino acid       	      51 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     427 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 476                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence Q corresponding to amino acids 631 - 631 	     101 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 150                                                          
						of N26299_P3, and a fourth amino acid sequence being at least	                  .         .         .         .         .  
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	     477 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 526                                                          
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	     151 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 200                                                          
						SMIEVLNTDSSPRCLKKL                                           	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 305 - 502 of 	     527 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 576                                                          
						Q8IVP8, which also corresponds to amino acids 632 - 829 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N26299_P3, wherein said first amino acid sequence, second    	     201 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 250                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     577 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 626                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N26299_P3, comprising a polypeptide being at least 70%,      	     251 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     627 PIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 676                                                          
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	     301 PIMK.FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 349                                                          
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                  .         .         .         .         .  
						YGRGIAYGKKGLHILSPLGRINEAVNDLTKAIQLQPSARLYRHRGTLYFISEDYATAHED 	     677 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 726                                                          
						FQQSLELNKNQPIAMLYKGLTFFHRGLLKEAIESFKEALKQKVDFIDAYKSLGQAYRELG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NFEAATESFQKALLLNQNHVQTLQLR                                   	     350 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 399                                                          
						least about 95% homologous to the sequence of N26299_P3.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     727 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 776                                                          
						N26299_P3, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     400 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 449                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for Q,	     777 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 826                                                          
						corresponding to N26299_P3.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 499                                                          
						                                                            	                                                             
						                                                            	     827 KKL                                                829                                                          
						                                                            	         |||                                                 
						                                                            	     500 KKL                                                502                                                          

47	HMR136_N26299_5_tr0_r1_1_gPRT		Comparison report between N26299_P5 and Q9H659unique head    	Sequence name: Q9H659                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N26299_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 47 x Q9H659   ..                               
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 2991.00                      Escore:       0                                               
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLN 	             Matching length:     308                Total length:     308                                               
						QNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRI 	                        Gaps:       0                        
						HRAMGLAALEVMQAVQRTWTNSKVR                                    	                                                            
						having the sequence corresponding to amino acids 1 - 445 of  	Alignment:                                                   
						N26299_P5, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMR 	     446 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 495                                                          
						YLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAK 	       1 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 50                                                           
						GKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKI 	                  .         .         .         .         .  
						PKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 	     496 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 545                                                          
						SPRCLKKL                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 308 of      	      51 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 100                                                          
						Q9H659, which also corresponds to amino acids 446 - 753 of   	                  .         .         .         .         .  
						N26299_P5, wherein said first amino acid sequence and second 	     546 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 595                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     101 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 150                                                          
						N26299_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     596 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 645                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	     151 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 200                                                          
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                  .         .         .         .         .  
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	     646 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 695                                                          
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 	     201 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 250                                                          
						QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKN 	                  .         .         .         .         .  
						LPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRI 	     696 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 745                                                          
						HRAMGLAALEVMQAVQRTWTNSKVR                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of N26299_P5.     	     251 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 300                                                          
						                                                            	                                                             
						                                                            	     746 SPRCLKKL                                           753                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 SPRCLKKL                                           308                                                          

						Comparison report between N26299_P5 and Q8ND20unique head    	Sequence name: Q8ND20                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 47 x Q8ND20   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 5105.00                      Escore:       0                                               
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYREL                  	             Matching length:     529                Total length:     530                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 223 of N26299_P5, a second amino acid     	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYM 	                        Gaps:       1                        
						KGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 	                                                            
						NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRL 	Alignment:                                                   
						GSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAV 	                  .         .         .         .         .  
						KWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 	     224 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 273                                                          
						YHGANNPKGLLEVREALEKVHKVEDLLPIMK                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 50                                                           
						amino acids 1 - 331 of Q8ND20, which also corresponds to     	                  .         .         .         .         .  
						amino acids 224 - 554 of N26299_P5, a third amino acid       	     274 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 323                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence Q corresponding to amino acids 555 - 555 	     324 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 373                                                          
						of N26299_P5, and a fourth amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	     101 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 150                                                          
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	                  .         .         .         .         .  
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	     374 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 423                                                          
						SMIEVLNTDSSPRCLKKL                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 332 - 529 of 	     151 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 200                                                          
						Q8ND20, which also corresponds to amino acids 556 - 753 of   	                  .         .         .         .         .  
						N26299_P5, wherein said first amino acid sequence, second    	     424 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 473                                                          
						amino acid sequence, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						N26299_P5, comprising a polypeptide being at least 70%,      	     474 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 523                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 300                                                          
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                  .         .         .         .         .  
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	     524 YHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVPSL 573                                                          
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYREL                  	     301 YHGANNPKGLLEVREALEKVHKVEDLLPIMK.FNTKTKDGFTVNTKVPSL 349                                                          
						least about 95% homologous to the sequence of N26299_P5.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     574 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 623                                                          
						N26299_P5, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     350 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 399                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for Q,	     624 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 673                                                          
						corresponding to N26299_P5.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     400 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 449                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     674 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 723                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 499                                                          
						                                                            	                  .         .         .                      
						                                                            	     724 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     753                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     500 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     529                                                          

						Comparison report between N26299_P5 and Q8NBP0partial WT     	Sequence name: Q8NBP0                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for N26299_P5, comprising a    	Sequence documentation:                                      
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                                                            
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	Alignment of: 47 x Q8NBP0   ..                               
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                                                            
						YGRGIAYGKKGLH                                                	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 193 of Q8NBP0, which also   	                     Quality: 7282.00                      Escore:       0                                               
						corresponds to amino acids 1 - 193 of N26299_P5, a second    	             Matching length:     753                Total length:     860                                               
						EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLRGMM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						LYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQ 	    Total Percent Similarity:   87.56      Total Percent Identity:   87.44                                               
						KASPEYLKVKYLREYSR                                            	                        Gaps:       1                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 301 - 437 of Q8NBP0, which also 	Alignment:                                                   
						corresponds to amino acids 194 - 330 of N26299_P5, a bridging	                  .         .         .         .         .  
						amino acid Y corresponding to amino acid 331 of N26299_P5,   	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						and a third amino acid sequence being at least 90 %          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKP 	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						EVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTR 	                  .         .         .         .         .  
						LMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFE 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						KILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLIL 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						SSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLV 	                  .         .         .         .         .  
						DFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCLK 	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						KL                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 439 - 860 of      	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						Q8NBP0, which also corresponds to amino acids 332 - 753 of   	                  .         .         .         .         .  
						N26299_P5, wherein said first amino acid sequence, second    	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLH....... 193                                                          
						amino acid sequence, bridging amino acid and third amino acid	         |||||||||||||||||||||||||||||||||||||||||||         
						sequence are contiguous and in a sequential order.2.An       	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLHDIKNAEL 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						N26299_P5, comprising a polypeptide having a length "n",     	     193 .................................................. 193                                                          
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	     201 ALFELSRVITLEPDRPEVFEQRAEILSPLGRINEAVNDLTKAIQLQPSAR 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     193 .................................................. 193                                                          
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise HE, having a structure as  	     251 LYRHRGTLYFISEDYATAHEDFQQSLELNKNQPIAMLYKGLTFFHRGLLK 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						193-x to 194; and ending at any of amino acid numbers 194+   	     194 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 243                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 343                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:||||||||||||  
						                                                            	     401 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRHLHAHLDTPLTEY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     344 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 393                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     394 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 443                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     494 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 543                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     544 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 593                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     594 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 643                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     644 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 693                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     694 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 743                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 850                                                          
						                                                            	                  .                                          
						                                                            	     744 DSSPRCLKKL                                         753                                                          
						                                                            	         ||||||||||                                          
						                                                            	     851 DSSPRCLKKL                                         860                                                          

						Comparison report between N26299_P5 and Q8IVP8unique head    	Sequence name: Q8IVP8                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 47 x Q8IVP8   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	                     Quality: 4845.00                      Escore:       0                                               
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLN 	             Matching length:     502                Total length:     503                                               
						QNHVQTLQLR                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						to amino acids 1 - 250 of N26299_P5, a second amino acid     	                        Gaps:       1                        
						GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPL 	                                                            
						PGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEE 	Alignment:                                                   
						QPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALE 	                  .         .         .         .         .  
						VMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGF 	     251 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 300                                                          
						NNHINLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIMK                                                         	       1 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 304 of Q8IVP8, which also corresponds to     	     301 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 350                                                          
						amino acids 251 - 554 of N26299_P5, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     351 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 400                                                          
						having the sequence Q corresponding to amino acids 555 - 555 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of N26299_P5, and a fourth amino acid sequence being at least	     101 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 150                                                          
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	                  .         .         .         .         .  
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	     401 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 450                                                          
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMIEVLNTDSSPRCLKKL                                           	     151 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 200                                                          
						90 % homologous to corresponding to amino acids 305 - 502 of 	                  .         .         .         .         .  
						Q8IVP8, which also corresponds to amino acids 556 - 753 of   	     451 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 500                                                          
						N26299_P5, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, third amino acid sequence and fourth    	     201 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 250                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     501 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 550                                                          
						N26299_P5, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	     551 PIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 600                                                          
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEEPDLVSAI 	     301 PIMK.FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 349                                                          
						YGRGIAYGKKGLHEAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLN 	                  .         .         .         .         .  
						QNHVQTLQLR                                                   	     601 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 650                                                          
						least about 95% homologous to the sequence of N26299_P5.3.An 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     350 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 399                                                          
						N26299_P5, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     651 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 700                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for Q,	     400 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 449                                                          
						corresponding to N26299_P5.                                  	                  .         .         .         .         .  
						                                                            	     701 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 499                                                          
						                                                            	                                                             
						                                                            	     751 KKL                                                753                                                          
						                                                            	         |||                                                 
						                                                            	     500 KKL                                                502                                                          

51	HMR136_N26299_6_tr0_r1_1_gPRT		Comparison report between N26299_P6 and Q9H659unique head    	Sequence name: Q9H659                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N26299_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 51 x Q9H659   ..                               
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	                     Quality: 2991.00                      Escore:       0                                               
						LKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQE 	             Matching length:     308                Total length:     308                                               
						ALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNS 	                        Gaps:       0                        
						KVR                                                          	                                                            
						having the sequence corresponding to amino acids 1 - 423 of  	Alignment:                                                   
						N26299_P6, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMR 	     424 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 473                                                          
						YLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAK 	       1 MNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHIN 50                                                           
						GKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKI 	                  .         .         .         .         .  
						PKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 	     474 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 523                                                          
						SPRCLKKL                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 308 of      	      51 LIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHK 100                                                          
						Q9H659, which also corresponds to amino acids 424 - 731 of   	                  .         .         .         .         .  
						N26299_P6, wherein said first amino acid sequence and second 	     524 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 573                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     101 VEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNI 150                                                          
						N26299_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     574 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 623                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	     151 LFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLI 200                                                          
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                  .         .         .         .         .  
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	     624 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 673                                                          
						LKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKV 	     201 LSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEA 250                                                          
						KYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVL 	                  .         .         .         .         .  
						HQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNS 	     674 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 723                                                          
						KVR                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of N26299_P6.     	     251 MTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDS 300                                                          
						                                                            	                                                             
						                                                            	     724 SPRCLKKL                                           731                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 SPRCLKKL                                           308                                                          

						Comparison report between N26299_P6 and Q8ND20unique head    	Sequence name: Q8ND20                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 51 x Q8ND20   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	                     Quality: 5105.00                      Escore:       0                                               
						LKQKVDFIDAYKSLGQAYREL                                        	             Matching length:     529                Total length:     530                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 201 of N26299_P6, a second amino acid     	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYM 	                        Gaps:       1                        
						KGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 	                                                            
						NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVADRL 	Alignment:                                                   
						GSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAV 	                  .         .         .         .         .  
						KWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 	     202 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 251                                                          
						YHGANNPKGLLEVREALEKVHKVEDLLPIMK                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 GNFEAATESFQKALLLNQNHVQTLQLRGMMLYHHGSLQEALKNFKRCLQL 50                                                           
						amino acids 1 - 331 of Q8ND20, which also corresponds to     	                  .         .         .         .         .  
						amino acids 202 - 532 of N26299_P6, a third amino acid       	     252 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 301                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 EPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQKASPEYLKVK 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence Q corresponding to amino acids 533 - 533 	     302 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 351                                                          
						of N26299_P6, and a fourth amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	     101 YLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 150                                                          
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	                  .         .         .         .         .  
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	     352 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 401                                                          
						SMIEVLNTDSSPRCLKKL                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 332 - 529 of 	     151 LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRA 200                                                          
						Q8ND20, which also corresponds to amino acids 534 - 731 of   	                  .         .         .         .         .  
						N26299_P6, wherein said first amino acid sequence, second    	     402 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 451                                                          
						amino acid sequence, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 MGLAALEVMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQ 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						N26299_P6, comprising a polypeptide being at least 70%,      	     452 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 501                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 PVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFEKILHFIKDRILV 300                                                          
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                  .         .         .         .         .  
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	     502 YHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVPSL 551                                                          
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						LKQKVDFIDAYKSLGQAYREL                                        	     301 YHGANNPKGLLEVREALEKVHKVEDLLPIMK.FNTKTKDGFTVNTKVPSL 349                                                          
						least about 95% homologous to the sequence of N26299_P6.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     552 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 601                                                          
						N26299_P6, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     350 KDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLT 399                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for Q,	     602 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 651                                                          
						corresponding to N26299_P6.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     400 AKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGA 449                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     652 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 701                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LMASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKT 499                                                          
						                                                            	                  .         .         .                      
						                                                            	     702 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     731                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     500 LPSVSETFPTLRSMIEVLNTDSSPRCLKKL                     529                                                          

						Comparison report between N26299_P6 and Q8NBI0partial WT     	Sequence name: Q8NBI0                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						with a short unique insertion.1.An isolated chimeric         	Sequence documentation:                                      
						polypeptide encoding for N26299_P6, comprising a first amino 	                                                            
						acid sequence being at least 90 % homologous to              	Alignment of: 51 x Q8NBI0   ..                               
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSA corresponding to amino 	                                                            
						acids 1 - 37 of Q8NBI0, which also corresponds to amino acids	Alignment segment 1/1:                                       
						1 - 37 of N26299_P6, a bridging amino acid G corresponding to	                                                            
						amino acid 38 of N26299_P6, a second amino acid sequence     	                     Quality: 6957.00                      Escore:       0                                               
						LRPGALATEHYSPLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFH 	             Matching length:     730                Total length:     807                                               
						DSDCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGL 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						YDEAIRHFSTMLQ                                                	    Total Percent Similarity:   90.33      Total Percent Identity:   90.33                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       2                        
						acids 39 - 171 of Q8NBI0, which also corresponds to amino    	                                                            
						acids 39 - 171 of N26299_P6, a third amino acid sequence     	Alignment:                                                   
						EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLRGMM 	                  .         .         .         .         .  
						LYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQ 	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						KASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPG 	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						LQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQ 	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSARLRPGALATEHYS 50                                                           
						AVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 	                  .         .         .         .         .  
						INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIM 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						K                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						acids 248 - 608 of Q8NBI0, which also corresponds to amino   	                  .         .         .         .         .  
						acids 172 - 532 of N26299_P6, a fourth amino acid sequence   	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						Q corresponding to amino acids 533 - 533 of N26299_P6, and a 	     151 YVLIGSGLYDEAIRHFSTMLQ............................. 171                                                          
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	         |||||||||||||||||||||                               
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	     151 YVLIGSGLYDEAIRHFSTMLQILSPLGRINEAVNDLTKAIQLQPSARLYR 200                                                          
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	                  .         .         .         .         .  
						SMIEVLNTDSSPRCLKKL                                           	     172 ...............................................EAI 174                                                          
						fifth amino acid sequence being at least 90 % homologous to  	                                                        |||  
						corresponding to amino acids 609 - 806 of Q8NBI0, which also 	     201 HRGTLYFISEDYATAHEDFQQSLELNKNQPIAMLYKGLTFFHRGLLKEAI 250                                                          
						corresponds to amino acids 534 - 731 of N26299_P6, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid, second  	     175 ESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQT 224                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fifth amino acid sequence are contiguous   	     251 ESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQT 300                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	                  .         .         .         .         .  
						encoding for an edge portion of N26299_P6, comprising a      	     225 LQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYE 274                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     301 LQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYE 350                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     275 GIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNID 324                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise QE, having 	     351 GIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNID 400                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 171-x to 172; and ending at any of amino acid   	     325 VDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQEL 374                                                          
						numbers 172+ ((n-2) - x), in which x varies from 0 to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						n-2.3.An isolated polypeptide encoding for an edge portion of	     401 VDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQEL 450                                                          
						N26299_P6, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     375 ICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRM 424                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for Q,	     451 ICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRM 500                                                          
						corresponding to N26299_P6.                                  	                  .         .         .         .         .  
						                                                            	     425 NGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINL 474                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     475 IRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKV 524                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 IRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     525 EDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNIL 574                                                          
						                                                            	         |||||||| |||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EDLLPIMK.FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNIL 649                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     575 FSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLIL 624                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     650 FSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLIL 699                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     625 SLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAM 674                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     700 SLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAM 749                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     675 TAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSS 724                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     750 TAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSS 799                                                          
						                                                            	                                                             
						                                                            	     725 PRCLKKL                                            731                                                          
						                                                            	         |||||||                                             
						                                                            	     800 PRCLKKL                                            806                                                          

						Comparison report between N26299_P6 and Q8NBP0partial WT     	Sequence name: Q8NBP0                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for N26299_P6, comprising a    	Sequence documentation:                                      
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                                                            
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	Alignment of: 51 x Q8NBP0   ..                               
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQ          	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 171 of Q8NBP0, which also   	                                                            
						corresponds to amino acids 1 - 171 of N26299_P6, a second    	                     Quality: 7072.00                      Escore:       0                                               
						EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLRGMM 	             Matching length:     731                Total length:     860                                               
						LYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPLPGQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						KASPEYLKVKYLREYSR                                            	    Total Percent Similarity:   85.00      Total Percent Identity:   84.88                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       1                        
						corresponding to amino acids 301 - 437 of Q8NBP0, which also 	                                                            
						corresponds to amino acids 172 - 308 of N26299_P6, a bridging	Alignment:                                                   
						amino acid Y corresponding to amino acid 309 of N26299_P6,   	                  .         .         .         .         .  
						and a third amino acid sequence being at least 90 %          	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						LHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKTR 	       1 MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYS 50                                                           
						LMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQVINMRYLEYFE 	                  .         .         .         .         .  
						KILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLLPIMKQFNTKTKDGFTVNTKVP 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						SLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLIL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLV 	      51 PLSLLKQELQHRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDS 100                                                          
						DFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCLK 	                  .         .         .         .         .  
						KL                                                           	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						homologous to corresponding to amino acids 439 - 860 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8NBP0, which also corresponds to amino acids 310 - 731 of   	     101 DCEPKGSSPCDSLLSLNTEKILSQAKSIAEQKRFPFATDNDSTNEELAIA 150                                                          
						N26299_P6, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and third amino acid	     151 YVLIGSGLYDEAIRHFSTMLQ............................. 171                                                          
						sequence are contiguous and in a sequential order.2.An       	         |||||||||||||||||||||                               
						isolated chimeric polypeptide encoding for an edge portion of	     151 YVLIGSGLYDEAIRHFSTMLQEEPDLVSAIYGRGIAYGKKGLHDIKNAEL 200                                                          
						N26299_P6, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     171 .................................................. 171                                                          
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	     201 ALFELSRVITLEPDRPEVFEQRAEILSPLGRINEAVNDLTKAIQLQPSAR 250                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     171 .................................................. 171                                                          
						at least two amino acids comprise QE, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	     251 LYRHRGTLYFISEDYATAHEDFQQSLELNKNQPIAMLYKGLTFFHRGLLK 300                                                          
						171-x to 172; and ending at any of amino acid numbers 172+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     172 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 221                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EAIESFKEALKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     222 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 271                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VQTLQLRGMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQ 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     272 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEY 321                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:||||||||||||  
						                                                            	     401 FYEGIKAQTKVMLNDPLPGQKASPEYLKVKYLREYSRHLHAHLDTPLTEY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     322 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 371                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NIDVDLPGSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 QELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     422 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 471                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNH 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     472 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 521                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 INLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     522 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 571                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 HKVEDLLPIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     572 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 621                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NILFSVETQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCN 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     622 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 671                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LILSLVYYFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDF 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     672 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 721                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 EAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNT 850                                                          
						                                                            	                  .                                          
						                                                            	     722 DSSPRCLKKL                                         731                                                          
						                                                            	         ||||||||||                                          
						                                                            	     851 DSSPRCLKKL                                         860                                                          

						Comparison report between N26299_P6 and Q8IVP8unique head    	Sequence name: Q8IVP8                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						N26299_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 51 x Q8IVP8   ..                               
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	Alignment segment 1/1:                                       
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	                                                            
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	                     Quality: 4845.00                      Escore:       0                                               
						LKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLR             	             Matching length:     502                Total length:     503                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 228 of N26299_P6, a second amino acid     	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKAQTKVMLNDPL 	                        Gaps:       1                        
						PGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLPGSFKDHWAKNLPFLIEDYEE 	                                                            
						QPGLQPHIKDVLHQNFESYKPEVQELICVADRLGSLMQYETPGFLPNKRIHRAMGLAALE 	Alignment:                                                   
						VMQAVQRTWTNSKVRMNGKTRLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGF 	                  .         .         .         .         .  
						NNHINLIRGQVINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 	     229 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 278                                                          
						PIMK                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 GMMLYHHGSLQEALKNFKRCLQLEPYNEVCQYMKGLSHVAMGQFYEGIKA 50                                                           
						amino acids 1 - 304 of Q8IVP8, which also corresponds to     	                  .         .         .         .         .  
						amino acids 229 - 532 of N26299_P6, a third amino acid       	     279 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 328                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 QTKVMLNDPLPGQKASPEYLKVKYLREYSRYLHAHLDTPLTEYNIDVDLP 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence Q corresponding to amino acids 533 - 533 	     329 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 378                                                          
						of N26299_P6, and a fourth amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVETQTTEERTQLYHAEI 	     101 GSFKDHWAKNLPFLIEDYEEQPGLQPHIKDVLHQNFESYKPEVQELICVA 150                                                          
						DALYKDLTAKGKVLILSSEFGEADAVCNLILSLVYYFYNLMPLSRGSSVIAYSVIVGALM 	                  .         .         .         .         .  
						ASGKEVAGKIPKGKLVDFEAMTAPGSEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLR 	     379 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 428                                                          
						SMIEVLNTDSSPRCLKKL                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 305 - 502 of 	     151 DRLGSLMQYETPGFLPNKRIHRAMGLAALEVMQAVQRTWTNSKVRMNGKT 200                                                          
						Q8IVP8, which also corresponds to amino acids 534 - 731 of   	                  .         .         .         .         .  
						N26299_P6, wherein said first amino acid sequence, second    	     429 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 478                                                          
						amino acid sequence, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 RLMQWRDMFDIAVKWRRIADPDQPVLWLDQMPARSLSRGFNNHINLIRGQ 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						N26299_P6, comprising a polypeptide being at least 70%,      	     479 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 528                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 VINMRYLEYFEKILHFIKDRILVYHGANNPKGLLEVREALEKVHKVEDLL 300                                                          
						MAPAGCCCCCCFWGGAVAAAGAARRVLLLLLLGVLSAGLRPGALATEHYSPLSLLKQELQ 	                  .         .         .         .         .  
						HRQQQEAPAGGGGCSPQSGDWGDQYSAECGESSFLNFHDSDCEPKGSSPCDSLLSLNTEK 	     529 PIMKQFNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 578                                                          
						ILSQAKSIAEQKRFPFATDNDSTNEELAIAYVLIGSGLYDEAIRHFSTMLQEAIESFKEA 	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						LKQKVDFIDAYKSLGQAYRELGNFEAATESFQKALLLNQNHVQTLQLR             	     301 PIMK.FNTKTKDGFTVNTKVPSLKDQGKEYDGFTITITGDKVGNILFSVE 349                                                          
						least about 95% homologous to the sequence of N26299_P6.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     579 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 628                                                          
						N26299_P6, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     350 TQTTEERTQLYHAEIDALYKDLTAKGKVLILSSEFGEADAVCNLILSLVY 399                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for Q,	     629 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 678                                                          
						corresponding to N26299_P6.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     400 YFYNLMPLSRGSSVIAYSVIVGALMASGKEVAGKIPKGKLVDFEAMTAPG 449                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     679 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 728                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 SEAFSKVAKSWMNLKSISPSYKTLPSVSETFPTLRSMIEVLNTDSSPRCL 499                                                          
						                                                            	                                                             
						                                                            	     729 KKL                                                731                                                          
						                                                            	         |||                                                 
						                                                            	     500 KKL                                                502                                                          

9215	HMR136_N27125_6_tr0_r1_1_gPRT		Comparison report between N27125_P6 and PTC1_HUMANunique     	Sequence name: PTC1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for N27125_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 9215 x PTC1_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence RRRVWSCFWTAFNSEGKKHLSQ corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 22 of N27125_P6, and a second amino acid     	                                                            
						VGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLDSALQASRVHVY 	                     Quality: 12964.00                      Escore:       0                                              
						MYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIITPLDCFWEGAKLQSGTAYLLGK 	             Matching length:    1317                Total length:    1317                                               
						PPLRWTNFDPLEFLEELKKINYQVDSWEEMLNKAEVGHGYMDRPCLNPADPDCPATAPNK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.92                                               
						NSTKPLDMALVLNGGCHGLSRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQ 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.92                                               
						MYEHFKGYEYVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDIL 	                        Gaps:       0                        
						KSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALSVAAGLGLCSLI 	                                                            
						GISFNAATTQVLPFLALGVGVDDVFLLAHAFSETGQNKRIPFEDRTGECLKRTGASVALT 	Alignment:                                                   
						SISNVTAFFMAALIPIPALRAFSLQAAVVVVFNFAMVLLIFPAILSMDLYRREDRRLDIF 	                  .         .         .         .         .  
						CCFTSPCVSRVIQVEPQAYTDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPH 	      22 QVGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLD 71                                                           
						THVYYTTAEPRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKWT 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						LSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDIVPRETREYDFI 	     131 EVGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLD 180                                                          
						AAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVKYVMLEENKQLPKMWLHYFRDW 	                  .         .         .         .         .  
						LQGLQDAFDSDWETGKIMPNNYKNGSDDGVLAYKLLVQTGSRDKPIDISQLTKQRLVDAD 	      72 SALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIIT 121                                                          
						GIINPSAFYIYLTAWVSNDPVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQFPFYLNGLRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLLF 	     181 SALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIIT 230                                                          
						ISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIASVG 	                  .         .         .         .         .  
						IGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGAVSTLLGVLMLAGSEFDFIVRY 	     122 PLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEE 171                                                          
						FFAVLAILTILGVLNGLVLLPVLLSFFGPYPEVSPANGLNRLPTPSPEPPPSVVRFAMPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GHTHSGSDSSDSEYSSQTTVSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVH 	     231 PLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEE 280                                                          
						PESRHHPPSNPRQQPHLDSGSLPPGRQGQQPRRDPPREGLWPPLYRPRRDAFEISTEGHS 	                  .         .         .         .         .  
						GPSNRARWGPRGARSHNPRNPASTAMGSSVPGYCQPITTVTASASVTVAVHPPPVPGPGR 	     172 MLNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGL 221                                                          
						NPRGGLCPGYPETDHGLFEDPHVPFHVRCERRDSKVEVIELQDVECEERPRGSSSN     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     281 MLNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGL 330                                                          
						amino acids 132 - 1447 of PTC1_HUMAN, which also corresponds 	                  .         .         .         .         .  
						to amino acids 23 - 1338 of N27125_P6, wherein said first    	     222 SRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYE 271                                                          
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     331 SRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYE 380                                                          
						polypeptide encoding for a head of N27125_P6, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     272 YVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDI 321                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     381 YVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDI 430                                                          
						to the sequence RRRVWSCFWTAFNSEGKKHLSQ of N27125_P6.         	                  .         .         .         .         .  
						                                                            	     322 LKSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALS 371                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 LKSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALS 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 VAAGLGLCSLIGISFNAATTQVLPFLALGVGVDDVFLLAHAFSETGQNKR 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 VAAGLGLCSLIGISFNAATTQVLPFLALGVGVDDVFLLAHAFSETGQNKR 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     422 IPFEDRTGECLKRTGASVALTSISNVTAFFMAALIPIPALRAFSLQAAVV 471                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     531 IPFEDRTGECLKRTGASVALTSISNVTAFFMAALIPIPALRAFSLQAAVV 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     472 VVFNFAMVLLIFPAILSMDLYRREDRRLDIFCCFTSPCVSRVIQVEPQAY 521                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     581 VVFNFAMVLLIFPAILSMDLYRREDRRLDIFCCFTSPCVSRVIQVEPQAY 630                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     522 TDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPHTHVYYTTAE 571                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     631 TDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPHTHVYYTTAE 680                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     572 PRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKW 621                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     681 PRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKW 730                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     622 TLSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDI 671                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     731 TLSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDI 780                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     672 VPRETREYDFIAAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVK 721                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     781 VPRETREYDFIAAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVK 830                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     722 YVMLEENKQLPKMWLHYFRDWLQGLQDAFDSDWETGKIMPNNYKNGSDDG 771                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     831 YVMLEENKQLPKMWLHYFRDWLQGLQDAFDSDWETGKIMPNNYKNGSDDG 880                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     772 VLAYKLLVQTGSRDKPIDISQLTKQRLVDADGIINPSAFYIYLTAWVSND 821                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     881 VLAYKLLVQTGSRDKPIDISQLTKQRLVDADGIINPSAFYIYLTAWVSND 930                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     822 PVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEYAQFPFYLNG 871                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     931 PVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEYAQFPFYLNG 980                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     872 LRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLL 921                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     981 LRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLL 1030                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     922 FISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSA 971                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1031 FISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSA 1080                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     972 VPVVILIASVGIGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGA 1021                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1081 VPVVILIASVGIGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGA 1130                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1022 VSTLLGVLMLAGSEFDFIVRYFFAVLAILTILGVLNGLVLLPVLLSFFGP 1071                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1131 VSTLLGVLMLAGSEFDFIVRYFFAVLAILTILGVLNGLVLLPVLLSFFGP 1180                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1072 YPEVSPANGLNRLPTPSPEPPPSVVRFAMPPGHTHSGSDSSDSEYSSQTT 1121                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1181 YPEVSPANGLNRLPTPSPEPPPSVVRFAMPPGHTHSGSDSSDSEYSSQTT 1230                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1122 VSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVHPESRHHPPS 1171                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1231 VSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVHPESRHHPPS 1280                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1172 NPRQQPHLDSGSLPPGRQGQQPRRDPPREGLWPPLYRPRRDAFEISTEGH 1221                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1281 NPRQQPHLDSGSLPPGRQGQQPRRDPPREGLWPPLYRPRRDAFEISTEGH 1330                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1222 SGPSNRARWGPRGARSHNPRNPASTAMGSSVPGYCQPITTVTASASVTVA 1271                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1331 SGPSNRARWGPRGARSHNPRNPASTAMGSSVPGYCQPITTVTASASVTVA 1380                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1272 VHPPPVPGPGRNPRGGLCPGYPETDHGLFEDPHVPFHVRCERRDSKVEVI 1321                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1381 VHPPPVPGPGRNPRGGLCPGYPETDHGLFEDPHVPFHVRCERRDSKVEVI 1430                                                         
						                                                            	                  .                                          
						                                                            	    1322 ELQDVECEERPRGSSSN                                  1338                                                         
						                                                            	         |||||||||||||||||                                   
						                                                            	    1431 ELQDVECEERPRGSSSN                                  1447                                                         

12248	HMR136_N27163_1_tr0_r1_1_gPRT		Comparison report between N27163_P1 and Q8N819unique head    	Sequence name: Q8N819                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N27163_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12248 x Q8N819   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR corresponding to amino     	                                                            
						acids 1 - 33 of N27163_P1, a second amino acid sequence being	                     Quality: 2258.00                      Escore:       0                                               
						MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGPEPSEPEGVRE 	             Matching length:     235                Total length:     235                                               
						ALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLAHCGDSRAVLSRAGAVAFSTE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DHRPLRPRERERIHAAGGTIRRRRVEGSLAVSRALGDFTYKEAPGRPPELQLVSAEPEVA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALARQAEDEFMLLASDGVWDTVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK      	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 1 - 	                                                            
						235 of Q8N819, which also corresponds to amino acids 34 - 268	Alignment:                                                   
						of N27163_P1, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      34 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 83                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	       1 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 50                                                           
						EDIPDLPPGGGLDCKATVIAEVYSQICQVSEECGEKGQDGAGKSNPTHLGSALDMEA    	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	      84 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 133                                                          
						to amino acids 269 - 385 of N27163_P1, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	      51 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     134 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 183                                                          
						N27163_P1, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     184 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 233                                                          
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR of N27163_P1.3.An isolated 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of N27163_P1, comprising a   	     151 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .                      
						80%, preferably at least about 85%, more preferably at least 	     234 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                268                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||||||||||||||||||||||||                 
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	     201 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                235                                                          
						EDIPDLPPGGGLDCKATVIAEVYSQICQVSEECGEKGQDGAGKSNPTHLGSALDMEA    	                                                            
						to the sequence in N27163_P1.                                	                                                            

12250	HMR136_N27163_3_tr0_r1_1_gPRT		Comparison report between N27163_P3 and Q8N819unique head    	Sequence name: Q8N819                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N27163_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12250 x Q8N819   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR corresponding to amino     	                                                            
						acids 1 - 33 of N27163_P3, a second amino acid sequence being	                     Quality: 2258.00                      Escore:       0                                               
						MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGPEPSEPEGVRE 	             Matching length:     235                Total length:     235                                               
						ALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLAHCGDSRAVLSRAGAVAFSTE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DHRPLRPRERERIHAAGGTIRRRRVEGSLAVSRALGDFTYKEAPGRPPELQLVSAEPEVA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALARQAEDEFMLLASDGVWDTVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK      	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 1 - 	                                                            
						235 of Q8N819, which also corresponds to amino acids 34 - 268	Alignment:                                                   
						of N27163_P3, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      34 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 83                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	       1 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 50                                                           
						EDIPDLPPGGGLDCKSARSQKSAERRGRMGLGSPTPRIWAQPWTWRPDSCCPLGILCFSG 	                  .         .         .         .         .  
						ASTELKKKTDPFPNYMYQRKEGRPM                                    	      84 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 133                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 269 - 413 of N27163_P3, wherein said first    	      51 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 100                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     134 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 183                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N27163_P3, comprising a polypeptide being at least 70%,      	     101 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     184 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 233                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR of N27163_P3.3.An isolated 	     151 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 200                                                          
						polypeptide encoding for a tail of N27163_P3, comprising a   	                  .         .         .                      
						polypeptide being at least 70%, optionally at least about    	     234 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                268                                                          
						80%, preferably at least about 85%, more preferably at least 	         |||||||||||||||||||||||||||||||||||                 
						about 90% and most preferably at least about 95% homologous  	     201 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                235                                                          
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	                                                            
						EDIPDLPPGGGLDCKSARSQKSAERRGRMGLGSPTPRIWAQPWTWRPDSCCPLGILCFSG 	                                                            
						ASTELKKKTDPFPNYMYQRKEGRPM                                    	                                                            
						to the sequence in N27163_P3.                                	                                                            

12252	HMR136_N27163_4_tr0_r1_1_gPRT		Comparison report between N27163_P4 and Q8N819unique head    	Sequence name: Q8N819                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N27163_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12252 x Q8N819   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR corresponding to amino     	                                                            
						acids 1 - 33 of N27163_P4, a second amino acid sequence being	                     Quality: 2258.00                      Escore:       0                                               
						MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGPEPSEPEGVRE 	             Matching length:     235                Total length:     235                                               
						ALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLAHCGDSRAVLSRAGAVAFSTE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DHRPLRPRERERIHAAGGTIRRRRVEGSLAVSRALGDFTYKEAPGRPPELQLVSAEPEVA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALARQAEDEFMLLASDGVWDTVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK      	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 1 - 	                                                            
						235 of Q8N819, which also corresponds to amino acids 34 - 268	Alignment:                                                   
						of N27163_P4, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      34 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 83                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	       1 MEDAHCTWLSLPGLPPGWALFAVLDGHGGARAARFGARHLPGHVLQELGP 50                                                           
						EDIPDLPPGGGLDCKRGRMGLGSPTPRIWAQPWTWRPDSCCPLGILCFSGASTELKKKTD 	                  .         .         .         .         .  
						PFPNYMYQRKEGRPM                                              	      84 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 133                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 269 - 403 of N27163_P4, wherein said first    	      51 EPSEPEGVREALRRAFLSADERLRSLWPRVETGGCTAVVLLVSPRFLYLA 100                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     134 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 183                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N27163_P4, comprising a polypeptide being at least 70%,      	     101 HCGDSRAVLSRAGAVAFSTEDHRPLRPRERERIHAAGGTIRRRRVEGSLA 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     184 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 233                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTAPRRAQRPHGGAEASGGLRFGASAAQGWRAR of N27163_P4.3.An isolated 	     151 VSRALGDFTYKEAPGRPPELQLVSAEPEVAALARQAEDEFMLLASDGVWD 200                                                          
						polypeptide encoding for a tail of N27163_P4, comprising a   	                  .         .         .                      
						polypeptide being at least 70%, optionally at least about    	     234 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                268                                                          
						80%, preferably at least about 85%, more preferably at least 	         |||||||||||||||||||||||||||||||||||                 
						about 90% and most preferably at least about 95% homologous  	     201 TVSGAALAGLVASRLRLGLAPELLCAQLLDTCLCK                235                                                          
						GSLDNMTCILVCFPGAPRPSEEAIRRELALDAALGCRIAELCASAQKPPSLNTVFRTLAS 	                                                            
						EDIPDLPPGGGLDCKRGRMGLGSPTPRIWAQPWTWRPDSCCPLGILCFSGASTELKKKTD 	                                                            
						PFPNYMYQRKEGRPM                                              	                                                            
						to the sequence in N27163_P4.                                	                                                            

15319	HMR136_N27282_6_tr0_r1_1_gPRT		Comparison report between N27282_P6 and Q96A35partial WT     	Sequence name: Q96A35                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N27282_P6, comprising a first amino acid        	                                                            
						MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSGRIIPKPEFPR 	Alignment of: 15319 x Q96A35   ..                            
						ADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEAMGIKETRKYKKVYWY      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 102 - 216 of Q96A35, which also corresponds to   	                                                            
						amino acids 1 - 115 of N27282_P6.                            	                     Quality: 1149.00                      Escore:       0                                               
						                                                            	             Matching length:     115                Total length:     115                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSG 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 RIIPKPEFPRADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 RIIPKPEFPRADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEA 201                                                          
						                                                            	                  .                                          
						                                                            	     101 MGIKETRKYKKVYWY                                    115                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     202 MGIKETRKYKKVYWY                                    216                                                          

15321	HMR136_N27282_7_tr0_r1_1_gPRT		Comparison report between N27282_P7 and Q96A35partial WT     	Sequence name: Q96A35                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N27282_P7, comprising a first amino acid        	                                                            
						MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSGRIIPKPEFPR 	Alignment of: 15321 x Q96A35   ..                            
						ADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEAMGIKETRKYKKVYWY      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 102 - 216 of Q96A35, which also corresponds to   	                                                            
						amino acids 1 - 115 of N27282_P7.                            	                     Quality: 1149.00                      Escore:       0                                               
						                                                            	             Matching length:     115                Total length:     115                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 MDYRGTMIPSEAPLLHRQVKLVDPMDRKPTEIEWRFTEAGERVRVSTRSG 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 RIIPKPEFPRADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 RIIPKPEFPRADGIVPETWIDGPKDTSVEDALERTYVPCLKTLQEEVMEA 201                                                          
						                                                            	                  .                                          
						                                                            	     101 MGIKETRKYKKVYWY                                    115                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     202 MGIKETRKYKKVYWY                                    216                                                          

16881	HMR136_N27455_12_tr0_r1_1_gPRT		Comparison report between N27455_P12 and CT26_HUMANpartial   	Sequence name: CT26_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for N27455_P12, comprising a first amino	                                                            
						MSYALNHTNRKLTLEPKITVNAKIIVVGASSVGISFLETLVFCSHMKFNNLTLISTHGLP 	Alignment of: 16881 x CT26_HUMAN   ..                        
						GKKLLDTEQRKFLASDHCFNDKDYALMSLCSWVNVVVGRMTGIDRAAKHVVLSTDEIVPY 	                                                            
						DHLILCTGQQYQVPCPTEADISQHLTNREVPNSSQRRYTGKVPCNHFTLNEEEDCFKALI 	Alignment segment 1/1:                                       
						WIRNNSITTEGNIIVYGNTIDTYTTVETLLNLGVSGSRIHLVQPPPASTITCINNYSVES 	                                                            
						AVADALGAAGVTMYRDAILAQWNDGLHPDPIYSASFTTPTKPFRLQCSMFFSFCEKNVDY 	                     Quality: 5864.00                      Escore:       0                                               
						ETFKALNDACLVYDSRLVIDTNFHTNDIAIRAAGSLTKFSNRYYSNEWTHSNFSSKEIGF 	             Matching length:     593                Total length:     593                                               
						QLAAAMLHLFDPTLEPVTEPPANLDRLIPMYKGAKIQGGILPGSYHYLHIAKPAIPTPLE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VQMAQPNYGLELVTGSAKNGTYFRIHINKYKMVETITCLSREPFPASNYIRLFGQHEQLL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NNLCARYDENLITDLYSYFTEPWCLALFHDRFIDLRKELRQILASKEEEDLPSIEQLAHQ 	                        Gaps:       0                        
						IEDEEINPTEKPRQYLKRVFEESIYKTLVERSTLDYLHYNRYHLPMYAWPGIV        	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 645 - 1237 of CT26_HUMAN, which also          	                  .         .         .         .         .  
						corresponds to amino acids 1 - 593 of N27455_P12.            	       1 MSYALNHTNRKLTLEPKITVNAKIIVVGASSVGISFLETLVFCSHMKFNN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     645 MSYALNHTNRKLTLEPKITVNAKIIVVGASSVGISFLETLVFCSHMKFNN 694                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LTLISTHGLPGKKLLDTEQRKFLASDHCFNDKDYALMSLCSWVNVVVGRM 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     695 LTLISTHGLPGKKLLDTEQRKFLASDHCFNDKDYALMSLCSWVNVVVGRM 744                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TGIDRAAKHVVLSTDEIVPYDHLILCTGQQYQVPCPTEADISQHLTNREV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     745 TGIDRAAKHVVLSTDEIVPYDHLILCTGQQYQVPCPTEADISQHLTNREV 794                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PNSSQRRYTGKVPCNHFTLNEEEDCFKALIWIRNNSITTEGNIIVYGNTI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     795 PNSSQRRYTGKVPCNHFTLNEEEDCFKALIWIRNNSITTEGNIIVYGNTI 844                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DTYTTVETLLNLGVSGSRIHLVQPPPASTITCINNYSVESAVADALGAAG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     845 DTYTTVETLLNLGVSGSRIHLVQPPPASTITCINNYSVESAVADALGAAG 894                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VTMYRDAILAQWNDGLHPDPIYSASFTTPTKPFRLQCSMFFSFCEKNVDY 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     895 VTMYRDAILAQWNDGLHPDPIYSASFTTPTKPFRLQCSMFFSFCEKNVDY 944                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ETFKALNDACLVYDSRLVIDTNFHTNDIAIRAAGSLTKFSNRYYSNEWTH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     945 ETFKALNDACLVYDSRLVIDTNFHTNDIAIRAAGSLTKFSNRYYSNEWTH 994                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SNFSSKEIGFQLAAAMLHLFDPTLEPVTEPPANLDRLIPMYKGAKIQGGI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     995 SNFSSKEIGFQLAAAMLHLFDPTLEPVTEPPANLDRLIPMYKGAKIQGGI 1044                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPGSYHYLHIAKPAIPTPLEVQMAQPNYGLELVTGSAKNGTYFRIHINKY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1045 LPGSYHYLHIAKPAIPTPLEVQMAQPNYGLELVTGSAKNGTYFRIHINKY 1094                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KMVETITCLSREPFPASNYIRLFGQHEQLLNNLCARYDENLITDLYSYFT 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1095 KMVETITCLSREPFPASNYIRLFGQHEQLLNNLCARYDENLITDLYSYFT 1144                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 EPWCLALFHDRFIDLRKELRQILASKEEEDLPSIEQLAHQIEDEEINPTE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1145 EPWCLALFHDRFIDLRKELRQILASKEEEDLPSIEQLAHQIEDEEINPTE 1194                                                         
						                                                            	                  .         .         .         .            
						                                                            	     551 KPRQYLKRVFEESIYKTLVERSTLDYLHYNRYHLPMYAWPGIV        593                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	    1195 KPRQYLKRVFEESIYKTLVERSTLDYLHYNRYHLPMYAWPGIV        1237                                                         

18278	HMR136_N28519_0_tr0_r1_1_gPRT		Comparison report between N28519_P0 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N28519_P0, comprising a first amino 	Sequence documentation:                                      
						MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTDSQRRRILTGL 	                                                            
						LERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLDPRSLCRCAQVCWHWKN 	Alignment of: 18278 x FX16_HUMAN   ..                        
						LAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHITKPKTPPKDGFVIADV 	                                                            
						QLVTSNSPEEKQSPLSAFRSSSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPM 	Alignment segment 1/1:                                       
						ETVQQGRRKRNQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2876.00                      Escore:       0                                               
						to amino acids 2 - 283 of FX16_HUMAN, which also corresponds 	             Matching length:     282                Total length:     282                                               
						to amino acids 1 - 282 of N28519_P0, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment:                                                   
						LSASSPLKVPAHLAWPPPESVGLPDTATTAEILMQHPHRHPGPQA corresponding  	                  .         .         .         .         .  
						to amino acids 283 - 327 of N28519_P0, wherein said first    	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						polypeptide encoding for a tail of N28519_P0, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						to the sequence LSASSPLKVPAHLAWPPPESVGLPDTATTAEILMQHPHRHPGPQA	                  .         .         .         .         .  
						in N28519_P0.                                                	     101 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 251                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   282                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     252 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   283                                                          

18276	HMR136_N28519_1_tr0_r1_1_gPRT		Comparison report between N28519_P1 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N28519_P1, comprising a first amino acid        	                                                            
						MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTDSQRRRILTGL 	Alignment of: 18276 x FX16_HUMAN   ..                        
						LERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLDPRSLCRCAQVCWHWKN 	                                                            
						LAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHITKPKTPPKDGFVIADV 	Alignment segment 1/1:                                       
						QLVTSNSPEEKQSPLSAFRSSSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPM 	                                                            
						ETVQQGRRKRNQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMSRRNPFPLCP          	                     Quality: 2976.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     291                Total length:     291                                               
						amino acids 2 - 292 of FX16_HUMAN, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 291 of N28519_P1.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 251                                                          
						                                                            	                  .         .         .         .            
						                                                            	     251 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMSRRNPFPLCP          291                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     252 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMSRRNPFPLCP          292                                                          

18274	HMR136_N28519_2_tr0_r1_1_gPRT		Comparison report between N28519_P2 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N28519_P2, comprising a first amino 	Sequence documentation:                                      
						MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTDSQRRRILTGL 	                                                            
						LERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLDPRSLCRCAQVCWHWKN 	Alignment of: 18274 x FX16_HUMAN   ..                        
						LAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHITKPKTPPKDGFVIADV 	                                                            
						QLVTSNSPEEKQSPLSAFRSSSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPM 	Alignment segment 1/1:                                       
						ETVQQGRRKRNQMTPDFSRQSHDKKNKLQDRTRLRKAQSM                     	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2864.00                      Escore:       0                                               
						to amino acids 2 - 281 of FX16_HUMAN, which also corresponds 	             Matching length:     282                Total length:     282                                               
						to amino acids 1 - 280 of N28519_P2, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.65                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VSIVYERFITITLMKISRSLILFAKLNSFI           	Alignment:                                                   
						corresponding to amino acids 281 - 310 of N28519_P2, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of N28519_P2, comprising a   	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSIVYERFITITLMKISRSLILFAKLNSFI in N28519_P2. 	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 251                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMVS                   282                                                          
						                                                            	         ||||||||||||||||||||||||||||||:|                    
						                                                            	     252 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   283                                                          

18281	HMR136_N28519_4_tr0_r1_1_gPRT		Comparison report between N28519_P4 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for N28519_P4, comprising a first amino 	Sequence documentation:                                      
						MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTDSQRRRILTGL 	                                                            
						LERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLDPRSLCRCAQVCWHWKN 	Alignment of: 18281 x FX16_HUMAN   ..                        
						LAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHITKPKTPPKDGFVIADV 	                                                            
						QLVTSNSPEEKQSPLSAFRSSSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPM 	Alignment segment 1/1:                                       
						ETVQQG                                                       	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2510.00                      Escore:       0                                               
						to amino acids 2 - 247 of FX16_HUMAN, which also corresponds 	             Matching length:     246                Total length:     246                                               
						to amino acids 1 - 246 of N28519_P4, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence CP corresponding to amino acids 247 - 248	Alignment:                                                   
						of N28519_P4, wherein said first amino acid sequence and     	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 201                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQG     246                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     202 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQG     247                                                          

18283	HMR136_N28519_5_tr0_r1_1_gPRT		Comparison report between N28519_P5 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						N28519_P5, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDR    	Alignment of: 18283 x FX16_HUMAN   ..                        
						corresponding to amino acids 2 - 33 of FX16_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 32 of N28519_P5, a second     	Alignment segment 1/1:                                       
						FDKWTDSQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLD 	                                                            
						PRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHI 	                     Quality: 2657.00                      Escore:       0                                               
						TKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRSSSSLRKKNNSGEKALPPWRSSDKH 	             Matching length:     270                Total length:     282                                               
						PTDIIRFNYLDNRDPMETVQQGRRKRNQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   95.74      Total Percent Identity:   95.74                                               
						corresponding to amino acids 46 - 283 of FX16_HUMAN, which   	                        Gaps:       1                        
						also corresponds to amino acids 33 - 270 of N28519_P5, and a 	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDR............FDKWTD 38                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||            ||||||  
						LSASSPLKVPAHLAWPPPESVGLPDTATTAEILMQHPHRHPGPQA corresponding  	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						to amino acids 271 - 315 of N28519_P5, wherein said first    	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	      39 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 88                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated chimeric polypeptide encoding for an edge	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						portion of N28519_P5, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	      89 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 138                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     139 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 188                                                          
						at least two amino acids comprise RF, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     152 WKKHYIQMVKELHITKPKTPPKDGFVIADVQLVTSNSPEEKQSPLSAFRS 201                                                          
						32-x to 33; and ending at any of amino acid numbers 33+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     189 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 238                                                          
						polypeptide encoding for a tail of N28519_P5, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     202 SSSLRKKNNSGEKALPPWRSSDKHPTDIIRFNYLDNRDPMETVQQGRRKR 251                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .                      
						about 90% and most preferably at least about 95% homologous  	     239 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   270                                                          
						to the sequence LSASSPLKVPAHLAWPPPESVGLPDTATTAEILMQHPHRHPGPQA	         ||||||||||||||||||||||||||||||||                    
						in N28519_P5.                                                	     252 NQMTPDFSRQSHDKKNKLQDRTRLRKAQSMMS                   283                                                          

18272	HMR136_N28519_8_tr0_r1_1_gPRT		Comparison report between N28519_P8 and FX16_HUMANpartial WT 	Sequence name: FX16_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N28519_P8, comprising a first amino 	Sequence documentation:                                      
						MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTDSQRRRILTGL 	                                                            
						LERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIFSFLDPRSLCRCAQVCWHWKN 	Alignment of: 18272 x FX16_HUMAN   ..                        
						LAELDQLWMLKCLRFNWYINFSPTPFEQGIWKKHYIQMVKELHITKPK             	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 2 - 169 of FX16_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 168 of N28519_P8, and a second amino acid 	                     Quality: 1736.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     168                Total length:     168                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VNFRQKATSLQTLALCKF corresponding to amino	                        Gaps:       0                        
						acids 169 - 186 of N28519_P8, wherein said first amino acid  	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of N28519_P8, comprising a polypeptide being at least   	       1 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       2 MAFAPPKNTDGPKMQTKMSTWTPLNHQLLNDRVFEERRALLGKWFDKWTD 51                                                           
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						VNFRQKATSLQTLALCKF in N28519_P8.                             	      51 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 SQRRRILTGLLERCSLSQQKFCCRKLQEKIPAEALDFTTKLPRVLSLYIF 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 SFLDPRSLCRCAQVCWHWKNLAELDQLWMLKCLRFNWYINFSPTPFEQGI 151                                                          
						                                                            	                  .                                          
						                                                            	     151 WKKHYIQMVKELHITKPK                                 168                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     152 WKKHYIQMVKELHITKPK                                 169                                                          

19657	HMR136_N29114_2_tr0_r1_1_gPRT		Comparison report between N29114_P2 and Q96JN0partial WT     	Sequence name: Q96JN0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N29114_P2, comprising a first amino acid        	                                                            
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	Alignment of: 19657 x Q96JN0   ..                            
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYR 	                                                            
						PDGLRSGDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGL 	Alignment segment 1/1:                                       
						QNHGQHLILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQD 	                                                            
						GKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 	                     Quality: 4237.00                      Escore:       0                                               
						RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYNSEILEEAISV 	             Matching length:     433                Total length:     433                                               
						VMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKKMKLMRSEGPDVSVKIELDPQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEAAQSANESKNE                                                	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 140 - 572 of Q96JN0, which also corresponds to   	                                                            
						amino acids 1 - 433 of N29114_P2.                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     140 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 189                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     190 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 239                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     240 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 289                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     290 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 339                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     340 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 389                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     390 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 439                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     440 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 489                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     490 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 539                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  433                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     540 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  572                                                          

						Comparison report between N29114_P2 and CAD91159partial WT   	Sequence name: CAD91159                                      
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for N29114_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MQRMI        	                                                            
						corresponding to amino acids 1 - 5 of CAD91159, which also   	Alignment of: 19657 x CAD91159   ..                          
						corresponds to amino acids 1 - 5 of N29114_P2, a bridging    	                                                            
						amino acid Q corresponding to amino acid 6 of N29114_P2, and 	Alignment segment 1/1:                                       
						a second amino acid sequence being at least 90 % homologous  	                                                            
						QFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMADQDSPLD 	                     Quality: 4222.00                      Escore:       0                                               
						LTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYRPDGLRS 	             Matching length:     433                Total length:     433                                               
						GDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQH 	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.77                                               
						LILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVS 	    Total Percent Similarity:   99.77      Total Percent Identity:   99.77                                               
						HSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQSRKSMLD 	                        Gaps:       0                        
						AGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYNSEILEEAISVVMSGKM 	                                                            
						SVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKKMKLMRSEGPDVSVKIELDPQGEAAQS 	Alignment:                                                   
						ANESKNE                                                      	                  .         .         .         .         .  
						to corresponding to amino acids 7 - 433 of CAD91159, which   	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						also corresponds to amino acids 7 - 433 of N29114_P2, wherein	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid and      	       1 MQRMIPQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  433                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     401 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  433                                                          

						Comparison report between N29114_P2 and CAD91160unique head  	Sequence name: CAD91160                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for N29114_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19657 x CAD91160   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	Alignment segment 1/1:                                       
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYR 	                                                            
						PDGLRSGDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGL 	                     Quality: 1957.00                      Escore:       0                                               
						QNHGQHLILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKM        	             Matching length:     200                Total length:     200                                               
						having the sequence corresponding to amino acids 1 - 233 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						N29114_P2, and a second amino acid sequence being at least 90	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALQAKQDGKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLR 	                        Gaps:       0                        
						AILPKQSRKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYNSEI 	                                                            
						LEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKKMKLMRSEGPDVSV 	Alignment:                                                   
						KIELDPQGEAAQSANESKNE                                         	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 200 of      	     234 ALQAKQDGKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQ 283                                                          
						CAD91160, which also corresponds to amino acids 234 - 433 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N29114_P2, wherein said first amino acid sequence and second 	       1 ALQAKQDGKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQ 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     284 TESALSKKLRAILPKQSRKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGD 333                                                          
						N29114_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 TESALSKKLRAILPKQSRKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGD 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	     334 PGSKQPRKKRGRYRQYNSEILEEAISVVMSGKMSVSKAQSIYGIPHSTLE 383                                                          
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PDGLRSGDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGL 	     101 PGSKQPRKKRGRYRQYNSEILEEAISVVMSGKMSVSKAQSIYGIPHSTLE 150                                                          
						QNHGQHLILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKM        	                  .         .         .         .         .  
						least about 95% homologous to the sequence of N29114_P2.     	     384 YKVKERLGTLKNPPKKKMKLMRSEGPDVSVKIELDPQGEAAQSANESKNE 433                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YKVKERLGTLKNPPKKKMKLMRSEGPDVSVKIELDPQGEAAQSANESKNE 200                                                          

						Comparison report between N29114_P2 and AAH53359partial WT   	Sequence name: AAH53359                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N29114_P2, comprising a first amino 	Sequence documentation:                                      
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	                                                            
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYR 	Alignment of: 19657 x AAH53359   ..                          
						PDGLRSGDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGL 	                                                            
						QNHGQHLILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQD 	Alignment segment 1/1:                                       
						GKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 	                                                            
						RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYNSEILEEAISV 	                     Quality: 3959.00                      Escore:       0                                               
						VMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKKMKLM                 	             Matching length:     404                Total length:     404                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 404 of AAH53359, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 404 of N29114_P2, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence RSEGPDVSVKIELDPQGEAAQSANESKNE            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						corresponding to amino acids 405 - 433 of N29114_P2, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of N29114_P2, comprising a   	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence RSEGPDVSVKIELDPQGEAAQSANESKNE in N29114_P2.  	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	                                                             
						                                                            	     401 MKLM                                               404                                                          
						                                                            	         ||||                                                
						                                                            	     401 MKLM                                               404                                                          

						Comparison report between N29114_P2 and Q8N3L6partial WT     	Sequence name: Q8N3L6                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for N29114_P2, comprising a first amino 	Sequence documentation:                                      
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	                                                            
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNGRPGRPSQYR 	Alignment of: 19657 x Q8N3L6   ..                            
						PDGLRSGDGVPPRSLQDGTREGFGHSTSLKVPLARSLQISEELLSRNQLSTAASLGPSGL 	                                                            
						QNHGQHLILSREASWAKPHYEFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQD 	Alignment segment 1/1:                                       
						GKKDVSHSSPVDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 	                                                            
						RKSMLDAGPDSWGSDAEQST                                         	                     Quality: 4225.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     433                Total length:     433                                               
						to amino acids 1 - 320 of Q8N3L6, which also corresponds to  	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.77                                               
						amino acids 1 - 320 of N29114_P2, a bridging amino acid S    	    Total Percent Similarity:   99.77      Total Percent Identity:   99.77                                               
						corresponding to amino acid 321 of N29114_P2, and a second   	                        Gaps:       0                        
						GQPYPTSDQEGDPGSKQPRKKRGRYRQYNSEILEEAISVVMSGKMSVSKAQSIYGIPHST 	                                                            
						LEYKVKERLGTLKNPPKKKMKLMRSEGPDVSVKIELDPQGEAAQSANESKNE         	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 322 - 433 of Q8N3L6, which also 	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						corresponds to amino acids 322 - 433 of N29114_P2, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid and      	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SPGCSSTQGNGRPGRPSQYRPDGLRSGDGVPPRSLQDGTREGFGHSTSLK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VPLARSLQISEELLSRNQLSTAASLGPSGLQNHGQHLILSREASWAKPHY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EFNLSRMKFRGNGALSNISDLPFLAENSAFPKMALQAKQDGKKDVSHSSP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VDLKIPQVRGMDLSWESRTGDQYSYSSLVMGSQTESALSKKLRAILPKQS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTSGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						                                                            	     301 RKSMLDAGPDSWGSDAEQSTPGQPYPTSDQEGDPGSKQPRKKRGRYRQYN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SEILEEAISVVMSGKMSVSKAQSIYGIPHSTLEYKVKERLGTLKNPPKKK 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  433                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     401 MKLMRSEGPDVSVKIELDPQGEAAQSANESKNE                  433                                                          

19655	HMR136_N29114_6_tr0_r1_1_gPRT		Comparison report between N29114_P6 and Q96JN0partial WT     	Sequence name: Q96JN0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N29114_P6, comprising a first amino acid        	                                                            
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	Alignment of: 19655 x Q96JN0   ..                            
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNG          	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 140 - 250 of Q96JN0, which also corresponds to   	                                                            
						amino acids 1 - 111 of N29114_P6.                            	                     Quality: 1086.00                      Escore:       0                                               
						                                                            	             Matching length:     111                Total length:     111                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     140 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 189                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     190 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 239                                                          
						                                                            	                  .                                          
						                                                            	     101 SPGCSSTQGNG                                        111                                                          
						                                                            	         |||||||||||                                         
						                                                            	     240 SPGCSSTQGNG                                        250                                                          

						Comparison report between N29114_P6 and CAD91159partial WT   	Sequence name: CAD91159                                      
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for N29114_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MQRMI        	                                                            
						corresponding to amino acids 1 - 5 of CAD91159, which also   	Alignment of: 19655 x CAD91159   ..                          
						corresponds to amino acids 1 - 5 of N29114_P6, a bridging    	                                                            
						amino acid Q corresponding to amino acid 6 of N29114_P6, and 	Alignment segment 1/1:                                       
						a second amino acid sequence being at least 90 % homologous  	                                                            
						QFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMADQDSPLD 	                     Quality: 1071.00                      Escore:       0                                               
						LTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNG                	             Matching length:     111                Total length:     111                                               
						to corresponding to amino acids 7 - 111 of CAD91159, which   	 Matching Percent Similarity:   99.10   Matching Percent Identity:   99.10                                               
						also corresponds to amino acids 7 - 111 of N29114_P6, wherein	    Total Percent Similarity:   99.10      Total Percent Identity:   99.10                                               
						said first amino acid sequence, bridging amino acid and      	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MQRMIPQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	                  .                                          
						                                                            	     101 SPGCSSTQGNG                                        111                                                          
						                                                            	         |||||||||||                                         
						                                                            	     101 SPGCSSTQGNG                                        111                                                          

						Comparison report between N29114_P6 and AAH53359partial WT   	Sequence name: AAH53359                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N29114_P6, comprising a first amino acid        	                                                            
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	Alignment of: 19655 x AAH53359   ..                          
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNG          	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 111 of AAH53359, which also corresponds to   	                                                            
						amino acids 1 - 111 of N29114_P6.                            	                     Quality: 1086.00                      Escore:       0                                               
						                                                            	             Matching length:     111                Total length:     111                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	                  .                                          
						                                                            	     101 SPGCSSTQGNG                                        111                                                          
						                                                            	         |||||||||||                                         
						                                                            	     101 SPGCSSTQGNG                                        111                                                          

						Comparison report between N29114_P6 and Q8N3L6partial WT     	Sequence name: Q8N3L6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for N29114_P6, comprising a first amino acid        	                                                            
						MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQNPVLSKLLMAD 	Alignment of: 19655 x Q8N3L6   ..                            
						QDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSHSPGCSSTQGNG          	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 111 of Q8N3L6, which also corresponds to     	                                                            
						amino acids 1 - 111 of N29114_P6.                            	                     Quality: 1086.00                      Escore:       0                                               
						                                                            	             Matching length:     111                Total length:     111                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MQRMIQQFAAEYTSKNSSTQDPSQPNSTKNQSLPKASPVTTSPTAATTQN 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PVLSKLLMADQDSPLDLTVRKSQSEPSEQDGVLDLSTKKSPCAGSTSLSH 100                                                          
						                                                            	                  .                                          
						                                                            	     101 SPGCSSTQGNG                                        111                                                          
						                                                            	         |||||||||||                                         
						                                                            	     101 SPGCSSTQGNG                                        111                                                          

19940	HMR136_N29439_4_tr0_r1_1_gPRT		Comparison report between N29439_P4 and SGCD_HUMAN_V1partial 	Sequence name: SGCD_HUMAN_V1                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for N29439_P4, comprising a first amino 	                                                            
						MPQEQYTHHRSTMPGSVGPQVYKVGIYGWRKRCLYFFVLLLMILILVNLAMTIWILKVMN 	Alignment of: 19940 x SGCD_HUMAN_V1   ..                     
						FTIDGMGNLRITEKGLKLEGDSEFLQPLYAKEIQSRPGNALYFKSARNVTVNILNDQTKV 	                                                            
						LTQLITGPKAVEAYGKKFEVKTVSGKLLFSADNNEVVVGAERLRVLGAEGTVFPKSIETP 	Alignment segment 1/1:                                       
						NVRADPFKELRLESPTRSLVMEAPKGVEINAEAGNMEATCRTELRLESKDGEIKLDAAKI 	                                                            
						RLPRLPHGSYTPTGTRQKVFEICVCANGRLFLSQAGAGSTCQINTSVCL            	                     Quality: 2794.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     289                Total length:     289                                               
						to amino acids 2 - 290 of SGCD_HUMAN_V1, which also          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 289 of N29439_P4.             	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPQEQYTHHRSTMPGSVGPQVYKVGIYGWRKRCLYFFVLLLMILILVNLA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       2 MPQEQYTHHRSTMPGSVGPQVYKVGIYGWRKRCLYFFVLLLMILILVNLA 51                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 MTIWILKVMNFTIDGMGNLRITEKGLKLEGDSEFLQPLYAKEIQSRPGNA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      52 MTIWILKVMNFTIDGMGNLRITEKGLKLEGDSEFLQPLYAKEIQSRPGNA 101                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LYFKSARNVTVNILNDQTKVLTQLITGPKAVEAYGKKFEVKTVSGKLLFS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 LYFKSARNVTVNILNDQTKVLTQLITGPKAVEAYGKKFEVKTVSGKLLFS 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ADNNEVVVGAERLRVLGAEGTVFPKSIETPNVRADPFKELRLESPTRSLV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 ADNNEVVVGAERLRVLGAEGTVFPKSIETPNVRADPFKELRLESPTRSLV 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 MEAPKGVEINAEAGNMEATCRTELRLESKDGEIKLDAAKIRLPRLPHGSY 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 MEAPKGVEINAEAGNMEATCRTELRLESKDGEIKLDAAKIRLPRLPHGSY 251                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 TPTGTRQKVFEICVCANGRLFLSQAGAGSTCQINTSVCL            289                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     252 TPTGTRQKVFEICVCANGRLFLSQAGAGSTCQINTSVCL            290                                                          

20495	HMR136_N29660_6_tr0_r1_1_gPRT		Comparison report between N29660_P6 and SFX2_HUMANpartial WT 	Sequence name: SFX2_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N29660_P6, comprising a first amino 	Sequence documentation:                                      
						MEADLSGFNIDAPRWDQRTFLGRVKHFLNITDPRTVFVSERELDWAKVMVEKSRMGVVPP 	                                                            
						GTQVEQLLYAKKLYDSAFHPDTGEKMNVIGRMSFQLPGGMIITGFMLQFYRTMPAVIFWQ 	Alignment of: 20495 x SFX2_HUMAN   ..                        
						WVNQSFNALVNYTNRNAASPTSVRQMALSYFTATTTAVATAVGMNMLTK            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 169 of SFX2_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 169 of N29660_P6, and a second amino acid 	                     Quality: 1675.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     171                Total length:     171                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:   99.42   Matching Percent Identity:   99.42                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   99.42      Total Percent Identity:   99.42                                               
						having the sequence GAHKGNLREGQE corresponding to amino acids	                        Gaps:       0                        
						170 - 181 of N29660_P6, wherein said first amino acid        	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of N29660_P6, comprising a polypeptide being at least   	       1 MEADLSGFNIDAPRWDQRTFLGRVKHFLNITDPRTVFVSERELDWAKVMV 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MEADLSGFNIDAPRWDQRTFLGRVKHFLNITDPRTVFVSERELDWAKVMV 50                                                           
						at least about 95% homologous to the sequence GAHKGNLREGQE in	                  .         .         .         .         .  
						N29660_P6.                                                   	      51 EKSRMGVVPPGTQVEQLLYAKKLYDSAFHPDTGEKMNVIGRMSFQLPGGM 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EKSRMGVVPPGTQVEQLLYAKKLYDSAFHPDTGEKMNVIGRMSFQLPGGM 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IITGFMLQFYRTMPAVIFWQWVNQSFNALVNYTNRNAASPTSVRQMALSY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IITGFMLQFYRTMPAVIFWQWVNQSFNALVNYTNRNAASPTSVRQMALSY 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 FTATTTAVATAVGMNMLTKGA                              171                                                          
						                                                            	         ||||||||||||||||||| |                               
						                                                            	     151 FTATTTAVATAVGMNMLTKKA                              171                                                          

20741	HMR136_N29765_10_tr0_r1_1_gPRT		Comparison report between N29765_P10 and R51D_HUMANpartial   	Sequence name: R51D_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for N29765_P10, comprising a first amino	Sequence documentation:                                      
						MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQ 	                                                            
						FSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCM 	Alignment of: 20741 x R51D_HUMAN   ..                        
						AANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLD 	                                                            
						VLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARD 	Alignment segment 1/1:                                       
						LGMAVVVTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 	                                                            
						Q                                                            	                     Quality: 2817.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     301                Total length:     301                                               
						to amino acids 1 - 301 of R51D_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 301 of N29765_P10, and a second amino acid	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						ILSCGQPAATGSAWMDSLRRSHHPREPGCRPIPTLGTAPSLPQQAWNQAASPVGLTLQTR 	                  .         .         .         .         .  
						PGSRPAWTVRKIFA                                               	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						having the sequence corresponding to amino acids 302 - 375 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N29765_P10, wherein said first amino acid sequence and second	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						N29765_P10, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						ILSCGQPAATGSAWMDSLRRSHHPREPGCRPIPTLGTAPSLPQQAWNQAASPVGLTLQTR 	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						PGSRPAWTVRKIFA                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in N29765_P10.    	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 300                                                          
						                                                            	                                                             
						                                                            	     301 Q                                                  301                                                          
						                                                            	         |                                                   
						                                                            	     301 Q                                                  301                                                          

20751	HMR136_N29765_19_tr0_r1_1_gPRT		Comparison report between N29765_P19 and R51D_HUMANpartial   	Sequence name: R51D_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for N29765_P19, comprising a first amino	Sequence documentation:                                      
						MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQ 	                                                            
						FSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCM 	Alignment of: 20751 x R51D_HUMAN   ..                        
						AANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLD 	                                                            
						VLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREG                  	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 223 of R51D_HUMAN, which also corresponds 	                     Quality: 2080.00                      Escore:       0                                               
						to amino acids 1 - 223 of N29765_P19, and a second amino acid	             Matching length:     223                Total length:     223                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						DQPHNSRQGQREAQTCPRTLLELCAQHSDSPGHHRGSRSIRRPAHGVSGQIFPTANRFPG 	                                                            
						DGRHWDLGDLRAECHITG                                           	Alignment:                                                   
						having the sequence corresponding to amino acids 224 - 301 of	                  .         .         .         .         .  
						N29765_P19, wherein said first amino acid sequence and second	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						N29765_P19, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DQPHNSRQGQREAQTCPRTLLELCAQHSDSPGHHRGSRSIRRPAHGVSGQIFPTANRFPG 	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						DGRHWDLGDLRAECHITG                                           	                  .         .         .         .         .  
						least about 95% homologous to the sequence in N29765_P19.    	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREG                            223                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREG                            223                                                          

20747	HMR136_N29765_20_tr0_r1_1_gPRT		Comparison report between N29765_P20 and R51D_HUMANpartial   	Sequence name: R51D_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for N29765_P20, comprising a first amino	Sequence documentation:                                      
						MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQ 	                                                            
						FSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCM 	Alignment of: 20747 x R51D_HUMAN   ..                        
						AANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLD 	                                                            
						VLQELRGTVAQQ                                                 	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 192 of R51D_HUMAN, which also corresponds 	                     Quality: 2495.00                      Escore:       0                                               
						to amino acids 1 - 192 of N29765_P20, and a second amino acid	             Matching length:     274                Total length:     328                                               
						VTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSRQPTGFQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EMVDIGTWGTSEQSATLQGDQT                                       	    Total Percent Similarity:   83.54      Total Percent Identity:   83.54                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 247 - 328 of R51D_HUMAN, which also corresponds  	                                                            
						to amino acids 193 - 274 of N29765_P20, wherein said first   	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						polypeptide encoding for an edge portion of N29765_P20,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QV, having a structure as follows: a sequence       	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						starting from any of amino acid numbers 192-x to 193; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 193+ ((n-2) - x), in     	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQ........ 192                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     193 ..............................................VTNH 196                                                          
						                                                            	                                                       ||||  
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     197 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 246                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 300                                                          
						                                                            	                  .         .                                
						                                                            	     247 QPTGFQEMVDIGTWGTSEQSATLQGDQT                       274                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     301 QPTGFQEMVDIGTWGTSEQSATLQGDQT                       328                                                          

20739	HMR136_N29765_9_tr0_r1_1_gPRT		Comparison report between N29765_P9 and R51D_HUMANpartial WT 	Sequence name: R51D_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N29765_P9, comprising a first amino 	Sequence documentation:                                      
						MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQ 	                                                            
						FSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCM 	Alignment of: 20739 x R51D_HUMAN   ..                        
						AANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLD 	                                                            
						VLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARD 	Alignment segment 1/1:                                       
						LGMAVVVTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 	                                                            
						Q                                                            	                     Quality: 2817.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     301                Total length:     301                                               
						to amino acids 1 - 301 of R51D_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 301 of N29765_P9, and a second amino acid 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						ILSCGQPAATGSAWMDSLRRSHHPREPGCRPIPTLGTAPSLPQQAWNQAASPVGLTLQTR 	                  .         .         .         .         .  
						PGSRPAWTVRKIFA                                               	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						having the sequence corresponding to amino acids 302 - 375 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						N29765_P9, wherein said first amino acid sequence and second 	       1 MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKAL 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						N29765_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 VALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTG 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						ILSCGQPAATGSAWMDSLRRSHHPREPGCRPIPTLGTAPSLPQQAWNQAASPVGLTLQTR 	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						PGSRPAWTVRKIFA                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in N29765_P9.     	     101 EVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 QAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSR 300                                                          
						                                                            	                                                             
						                                                            	     301 Q                                                  301                                                          
						                                                            	         |                                                   
						                                                            	     301 Q                                                  301                                                          

20879	HMR136_N30034_3_tr0_r1_1_gPRT		Comparison report between N30034_P3 and Q8NBP8unique head    	Sequence name: Q8NBP8                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids and a mismatch.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for N30034_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 20879 x Q8NBP8   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATIFFNSGLSLKT 	                                                            
						EELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPINEWLLKGLQTVGC        	                     Quality: 1626.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 113 of  	             Matching length:     185                Total length:     227                                               
						N30034_P3, a second amino acid sequence being at least 90 %  	 Matching Percent Similarity:   99.46   Matching Percent Identity:   98.92                                               
						MPPPVSSAVILTKAVGGNEAAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQL 	    Total Percent Similarity:   81.06      Total Percent Identity:   80.62                                               
						FMTVVVPLIIGQIVRRYIKDWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKFS 	                        Gaps:       1                        
						LVLILFI                                                      	                                                            
						homologous to corresponding to amino acids 1 - 127 of Q8NBP8,	Alignment:                                                   
						which also corresponds to amino acids 114 - 240 of N30034_P3,	                  .         .         .         .         .  
						a third amino acid sequence bridging amino acid sequence     	     114 MPPPVSSAVILTKAVGGNEAAAIFNSAFGSFLGIVITPLLLLLFLGSSSS 163                                                          
						comprising of R, a fourth amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to IPMLKIVFAGHE corresponding to amino acids 	       1 MPPPVSSAVILTKAVGGNEAAAIFNSAFGSFLGIVITPLLLLLFLGSSSS 50                                                           
						171 - 182 of Q8NBP8, which also corresponds to amino acids   	                  .         .         .         .         .  
						242 - 253 of N30034_P3, a bridging amino acid H corresponding	     164 VPFTSIFSQLFMTVVVPLIIGQIVRRYIKDWLERKKPPFGAISSSVLLMI 213                                                          
						to amino acid 254 of N30034_P3, and a fifth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to                   	      51 VPFTSIFSQLFMTVVVPLIIGQIVRRYIKDWLERKKPPFGAISSSVLLMI 100                                                          
						LSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV corresponding to	                  .         .         .         .         .  
						amino acids 184 - 227 of Q8NBP8, which also corresponds to   	     214 IYTTFCDTFSNPNIDLDKFSLVLILFI....................... 240                                                          
						amino acids 255 - 298 of N30034_P3, wherein said first amino 	         |||||||||||||||||||||||||||                         
						acid sequence, second amino acid sequence, third amino acid  	     101 IYTTFCDTFSNPNIDLDKFSLVLILFIIFSIQLSFMLLTFIFSTRNNSGF 150                                                          
						sequence, fourth amino acid sequence, bridging amino acid and	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     241 ...................RIPMLKIVFAGHEHLSLISVPLLIYHPAQIL 271                                                          
						order.2.An isolated polypeptide encoding for a head of       	                             ||||||||||||:|||||||||||||||||  
						N30034_P3, comprising a polypeptide being at least 70%,      	     151 TPADTVAIIFCSTHKSLTLGIPMLKIVFAGHEYLSLISVPLLIYHPAQIL 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .                                
						more preferably at least about 90% and most preferably at    	     272 LGSVLVPTIKSWMVSRQKGVKLTRPTV                        298                                                          
						MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATIFFNSGLSLKT 	         |||||||||||||||||||||||||||                         
						EELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPINEWLLKGLQTVGC        	     201 LGSVLVPTIKSWMVSRQKGVKLTRPTV                        227                                                          
						least about 95% homologous to the sequence of N30034_P3.3.An 	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						N30034_P3, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise IRI having a structure as  	                                                            
						follows (numbering according to N30034_P3): a sequence       	                                                            
						starting from any of amino acid numbers 240-x to 240; and    	                                                            
						ending at any of amino acid numbers 242 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between N30034_P3 and Q9H0M9partial WT     	Sequence name: Q9H0M9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N30034_P3, comprising a first amino 	Sequence documentation:                                      
						MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATIFFNSGLSLKT 	                                                            
						EELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPINEWLLKGLQTVGCMPPPVSS 	Alignment of: 20879 x Q9H0M9   ..                            
						AVILTKAVGGNEAAAIFNSAFGSFL                                    	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 145 of Q9H0M9, which also corresponds to  	                                                            
						amino acids 1 - 145 of N30034_P3, and a second amino acid    	                     Quality: 1378.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     145                Total length:     145                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPLIIGQIVRRYIKDWLERKKPPFGAI 	                        Gaps:       0                        
						SSSVLLMIIYTTFCDTFSNPNIDLDKFSLVLILFIRIPMLKIVFAGHEHLSLISVPLLIY 	                                                            
						HPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV                            	Alignment:                                                   
						having the sequence corresponding to amino acids 146 - 298 of	                  .         .         .         .         .  
						N30034_P3, wherein said first amino acid sequence and second 	       1 MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATI 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATI 50                                                           
						N30034_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 FFNSGLSLKTEELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPI 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPLIIGQIVRRYIKDWLERKKPPFGAI 	      51 FFNSGLSLKTEELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPI 100                                                          
						SSSVLLMIIYTTFCDTFSNPNIDLDKFSLVLILFIRIPMLKIVFAGHEHLSLISVPLLIY 	                  .         .         .         .            
						HPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV                            	     101 NEWLLKGLQTVGCMPPPVSSAVILTKAVGGNEAAAIFNSAFGSFL      145                                                          
						least about 95% homologous to the sequence in N30034_P3.     	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     101 NEWLLKGLQTVGCMPPPVSSAVILTKAVGGNEAAAIFNSAFGSFL      145                                                          

						Comparison report between N30034_P3 and Q8IZ62partial WT     	Sequence name: Q8IZ62                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for N30034_P3, comprising a first amino 	Sequence documentation:                                      
						MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATIFFNSGLSLKT 	                                                            
						E                                                            	Alignment of: 20879 x Q8IZ62   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 61 of Q8IZ62, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 61 of N30034_P3, and a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  587.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      64                Total length:      64                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:   98.44   Matching Percent Identity:   98.44                                               
						ELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPINEWLLKGLQTVGCMPPPVSSA 	    Total Percent Similarity:   98.44      Total Percent Identity:   98.44                                               
						VILTKAVGGNEAAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPL 	                        Gaps:       0                        
						IIGQIVRRYIKDWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKFSLVLILFIR 	                                                            
						IPMLKIVFAGHEHLSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV    	Alignment:                                                   
						having the sequence corresponding to amino acids 62 - 298 of 	                  .         .         .         .         .  
						N30034_P3, wherein said first amino acid sequence and second 	       1 MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATI 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MRLLERMRKDWFMVGIVLAIAGAKLEPSIGVNGGPLKPEITVSYIAVATI 50                                                           
						N30034_P3, comprising a polypeptide being at least 70%,      	                  .                                          
						optionally at least about 80%, preferably at least about 85%,	      51 FFNSGLSLKTEELT                                     64                                                           
						more preferably at least about 90% and most preferably at    	         ||||||||||| ||                                      
						ELTSALVHLKLHLFIQIFTLAFFPATIWLFLQLLSITPINEWLLKGLQTVGCMPPPVSSA 	      51 FFNSGLSLKTELLT                                     64                                                           
						VILTKAVGGNEAAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPL 	                                                            
						IIGQIVRRYIKDWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKFSLVLILFIR 	                                                            
						IPMLKIVFAGHEHLSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV    	                                                            
						least about 95% homologous to the sequence in N30034_P3.     	                                                            

20881	HMR136_N30034_6_tr0_r1_1_gPRT		Comparison report between N30034_P6 and Q8NBP8unique head    	Sequence name: Q8NBP8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for N30034_P6, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 20881 x Q8NBP8   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MAFSSAFINHTHQRMAFKR          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 19 of N30034_P6, a second   	                                                            
						AAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPLIIGQIVRRYIK 	                     Quality: 1962.00                      Escore:       0                                               
						DWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKFSLVLILFIIFSIQLSFMLLT 	             Matching length:     208                Total length:     208                                               
						FIFSTRNNSGFTPADTVAIIFCSTHKSLTLGIPMLKIVFAGHE                  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						corresponding to amino acids 20 - 182 of Q8NBP8, which also  	                        Gaps:       0                        
						corresponds to amino acids 20 - 182 of N30034_P6, a bridging 	                                                            
						amino acid H corresponding to amino acid 183 of N30034_P6,   	Alignment:                                                   
						and a third amino acid sequence being at least 90 %          	                  .         .         .         .         .  
						homologous to LSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKGVKLTRPTV   	      20 AAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPLI 69                                                           
						corresponding to amino acids 184 - 227 of Q8NBP8, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 184 - 227 of N30034_P6, wherein   	      20 AAAIFNSAFGSFLGIVITPLLLLLFLGSSSSVPFTSIFSQLFMTVVVPLI 69                                                           
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid and third amino acid sequence are        	      70 IGQIVRRYIKDWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKF 119                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of N30034_P6, comprising a   	      70 IGQIVRRYIKDWLERKKPPFGAISSSVLLMIIYTTFCDTFSNPNIDLDKF 119                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     120 SLVLILFIIFSIQLSFMLLTFIFSTRNNSGFTPADTVAIIFCSTHKSLTL 169                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MAFSSAFINHTHQRMAFKR of N30034_P6.            	     120 SLVLILFIIFSIQLSFMLLTFIFSTRNNSGFTPADTVAIIFCSTHKSLTL 169                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     170 GIPMLKIVFAGHEHLSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKG 219                                                          
						                                                            	         |||||||||||||:||||||||||||||||||||||||||||||||||||  
						                                                            	     170 GIPMLKIVFAGHEYLSLISVPLLIYHPAQILLGSVLVPTIKSWMVSRQKG 219                                                          
						                                                            	                                                             
						                                                            	     220 VKLTRPTV                                           227                                                          
						                                                            	         ||||||||                                            
						                                                            	     220 VKLTRPTV                                           227                                                          

